<!DOCTYPE html>
<html>
<head><meta charset="utf-8" />

<title>trials</title>

<script src="https://cdnjs.cloudflare.com/ajax/libs/require.js/2.1.10/require.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/2.0.3/jquery.min.js"></script>



<style type="text/css">
    /*!
*
* Twitter Bootstrap
*
*/
/*!
 * Bootstrap v3.3.7 (http://getbootstrap.com)
 * Copyright 2011-2016 Twitter, Inc.
 * Licensed under MIT (https://github.com/twbs/bootstrap/blob/master/LICENSE)
 */
/*! normalize.css v3.0.3 | MIT License | github.com/necolas/normalize.css */
html {
  font-family: sans-serif;
  -ms-text-size-adjust: 100%;
  -webkit-text-size-adjust: 100%;
}
body {
  margin: 0;
}
article,
aside,
details,
figcaption,
figure,
footer,
header,
hgroup,
main,
menu,
nav,
section,
summary {
  display: block;
}
audio,
canvas,
progress,
video {
  display: inline-block;
  vertical-align: baseline;
}
audio:not([controls]) {
  display: none;
  height: 0;
}
[hidden],
template {
  display: none;
}
a {
  background-color: transparent;
}
a:active,
a:hover {
  outline: 0;
}
abbr[title] {
  border-bottom: 1px dotted;
}
b,
strong {
  font-weight: bold;
}
dfn {
  font-style: italic;
}
h1 {
  font-size: 2em;
  margin: 0.67em 0;
}
mark {
  background: #ff0;
  color: #000;
}
small {
  font-size: 80%;
}
sub,
sup {
  font-size: 75%;
  line-height: 0;
  position: relative;
  vertical-align: baseline;
}
sup {
  top: -0.5em;
}
sub {
  bottom: -0.25em;
}
img {
  border: 0;
}
svg:not(:root) {
  overflow: hidden;
}
figure {
  margin: 1em 40px;
}
hr {
  box-sizing: content-box;
  height: 0;
}
pre {
  overflow: auto;
}
code,
kbd,
pre,
samp {
  font-family: monospace, monospace;
  font-size: 1em;
}
button,
input,
optgroup,
select,
textarea {
  color: inherit;
  font: inherit;
  margin: 0;
}
button {
  overflow: visible;
}
button,
select {
  text-transform: none;
}
button,
html input[type="button"],
input[type="reset"],
input[type="submit"] {
  -webkit-appearance: button;
  cursor: pointer;
}
button[disabled],
html input[disabled] {
  cursor: default;
}
button::-moz-focus-inner,
input::-moz-focus-inner {
  border: 0;
  padding: 0;
}
input {
  line-height: normal;
}
input[type="checkbox"],
input[type="radio"] {
  box-sizing: border-box;
  padding: 0;
}
input[type="number"]::-webkit-inner-spin-button,
input[type="number"]::-webkit-outer-spin-button {
  height: auto;
}
input[type="search"] {
  -webkit-appearance: textfield;
  box-sizing: content-box;
}
input[type="search"]::-webkit-search-cancel-button,
input[type="search"]::-webkit-search-decoration {
  -webkit-appearance: none;
}
fieldset {
  border: 1px solid #c0c0c0;
  margin: 0 2px;
  padding: 0.35em 0.625em 0.75em;
}
legend {
  border: 0;
  padding: 0;
}
textarea {
  overflow: auto;
}
optgroup {
  font-weight: bold;
}
table {
  border-collapse: collapse;
  border-spacing: 0;
}
td,
th {
  padding: 0;
}
/*! Source: https://github.com/h5bp/html5-boilerplate/blob/master/src/css/main.css */
@media print {
  *,
  *:before,
  *:after {
    background: transparent !important;
    box-shadow: none !important;
    text-shadow: none !important;
  }
  a,
  a:visited {
    text-decoration: underline;
  }
  a[href]:after {
    content: " (" attr(href) ")";
  }
  abbr[title]:after {
    content: " (" attr(title) ")";
  }
  a[href^="#"]:after,
  a[href^="javascript:"]:after {
    content: "";
  }
  pre,
  blockquote {
    border: 1px solid #999;
    page-break-inside: avoid;
  }
  thead {
    display: table-header-group;
  }
  tr,
  img {
    page-break-inside: avoid;
  }
  img {
    max-width: 100% !important;
  }
  p,
  h2,
  h3 {
    orphans: 3;
    widows: 3;
  }
  h2,
  h3 {
    page-break-after: avoid;
  }
  .navbar {
    display: none;
  }
  .btn > .caret,
  .dropup > .btn > .caret {
    border-top-color: #000 !important;
  }
  .label {
    border: 1px solid #000;
  }
  .table {
    border-collapse: collapse !important;
  }
  .table td,
  .table th {
    background-color: #fff !important;
  }
  .table-bordered th,
  .table-bordered td {
    border: 1px solid #ddd !important;
  }
}
@font-face {
  font-family: 'Glyphicons Halflings';
  src: url('../components/bootstrap/fonts/glyphicons-halflings-regular.eot');
  src: url('../components/bootstrap/fonts/glyphicons-halflings-regular.eot?#iefix') format('embedded-opentype'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.woff2') format('woff2'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.woff') format('woff'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.ttf') format('truetype'), url('../components/bootstrap/fonts/glyphicons-halflings-regular.svg#glyphicons_halflingsregular') format('svg');
}
.glyphicon {
  position: relative;
  top: 1px;
  display: inline-block;
  font-family: 'Glyphicons Halflings';
  font-style: normal;
  font-weight: normal;
  line-height: 1;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}
.glyphicon-asterisk:before {
  content: "\002a";
}
.glyphicon-plus:before {
  content: "\002b";
}
.glyphicon-euro:before,
.glyphicon-eur:before {
  content: "\20ac";
}
.glyphicon-minus:before {
  content: "\2212";
}
.glyphicon-cloud:before {
  content: "\2601";
}
.glyphicon-envelope:before {
  content: "\2709";
}
.glyphicon-pencil:before {
  content: "\270f";
}
.glyphicon-glass:before {
  content: "\e001";
}
.glyphicon-music:before {
  content: "\e002";
}
.glyphicon-search:before {
  content: "\e003";
}
.glyphicon-heart:before {
  content: "\e005";
}
.glyphicon-star:before {
  content: "\e006";
}
.glyphicon-star-empty:before {
  content: "\e007";
}
.glyphicon-user:before {
  content: "\e008";
}
.glyphicon-film:before {
  content: "\e009";
}
.glyphicon-th-large:before {
  content: "\e010";
}
.glyphicon-th:before {
  content: "\e011";
}
.glyphicon-th-list:before {
  content: "\e012";
}
.glyphicon-ok:before {
  content: "\e013";
}
.glyphicon-remove:before {
  content: "\e014";
}
.glyphicon-zoom-in:before {
  content: "\e015";
}
.glyphicon-zoom-out:before {
  content: "\e016";
}
.glyphicon-off:before {
  content: "\e017";
}
.glyphicon-signal:before {
  content: "\e018";
}
.glyphicon-cog:before {
  content: "\e019";
}
.glyphicon-trash:before {
  content: "\e020";
}
.glyphicon-home:before {
  content: "\e021";
}
.glyphicon-file:before {
  content: "\e022";
}
.glyphicon-time:before {
  content: "\e023";
}
.glyphicon-road:before {
  content: "\e024";
}
.glyphicon-download-alt:before {
  content: "\e025";
}
.glyphicon-download:before {
  content: "\e026";
}
.glyphicon-upload:before {
  content: "\e027";
}
.glyphicon-inbox:before {
  content: "\e028";
}
.glyphicon-play-circle:before {
  content: "\e029";
}
.glyphicon-repeat:before {
  content: "\e030";
}
.glyphicon-refresh:before {
  content: "\e031";
}
.glyphicon-list-alt:before {
  content: "\e032";
}
.glyphicon-lock:before {
  content: "\e033";
}
.glyphicon-flag:before {
  content: "\e034";
}
.glyphicon-headphones:before {
  content: "\e035";
}
.glyphicon-volume-off:before {
  content: "\e036";
}
.glyphicon-volume-down:before {
  content: "\e037";
}
.glyphicon-volume-up:before {
  content: "\e038";
}
.glyphicon-qrcode:before {
  content: "\e039";
}
.glyphicon-barcode:before {
  content: "\e040";
}
.glyphicon-tag:before {
  content: "\e041";
}
.glyphicon-tags:before {
  content: "\e042";
}
.glyphicon-book:before {
  content: "\e043";
}
.glyphicon-bookmark:before {
  content: "\e044";
}
.glyphicon-print:before {
  content: "\e045";
}
.glyphicon-camera:before {
  content: "\e046";
}
.glyphicon-font:before {
  content: "\e047";
}
.glyphicon-bold:before {
  content: "\e048";
}
.glyphicon-italic:before {
  content: "\e049";
}
.glyphicon-text-height:before {
  content: "\e050";
}
.glyphicon-text-width:before {
  content: "\e051";
}
.glyphicon-align-left:before {
  content: "\e052";
}
.glyphicon-align-center:before {
  content: "\e053";
}
.glyphicon-align-right:before {
  content: "\e054";
}
.glyphicon-align-justify:before {
  content: "\e055";
}
.glyphicon-list:before {
  content: "\e056";
}
.glyphicon-indent-left:before {
  content: "\e057";
}
.glyphicon-indent-right:before {
  content: "\e058";
}
.glyphicon-facetime-video:before {
  content: "\e059";
}
.glyphicon-picture:before {
  content: "\e060";
}
.glyphicon-map-marker:before {
  content: "\e062";
}
.glyphicon-adjust:before {
  content: "\e063";
}
.glyphicon-tint:before {
  content: "\e064";
}
.glyphicon-edit:before {
  content: "\e065";
}
.glyphicon-share:before {
  content: "\e066";
}
.glyphicon-check:before {
  content: "\e067";
}
.glyphicon-move:before {
  content: "\e068";
}
.glyphicon-step-backward:before {
  content: "\e069";
}
.glyphicon-fast-backward:before {
  content: "\e070";
}
.glyphicon-backward:before {
  content: "\e071";
}
.glyphicon-play:before {
  content: "\e072";
}
.glyphicon-pause:before {
  content: "\e073";
}
.glyphicon-stop:before {
  content: "\e074";
}
.glyphicon-forward:before {
  content: "\e075";
}
.glyphicon-fast-forward:before {
  content: "\e076";
}
.glyphicon-step-forward:before {
  content: "\e077";
}
.glyphicon-eject:before {
  content: "\e078";
}
.glyphicon-chevron-left:before {
  content: "\e079";
}
.glyphicon-chevron-right:before {
  content: "\e080";
}
.glyphicon-plus-sign:before {
  content: "\e081";
}
.glyphicon-minus-sign:before {
  content: "\e082";
}
.glyphicon-remove-sign:before {
  content: "\e083";
}
.glyphicon-ok-sign:before {
  content: "\e084";
}
.glyphicon-question-sign:before {
  content: "\e085";
}
.glyphicon-info-sign:before {
  content: "\e086";
}
.glyphicon-screenshot:before {
  content: "\e087";
}
.glyphicon-remove-circle:before {
  content: "\e088";
}
.glyphicon-ok-circle:before {
  content: "\e089";
}
.glyphicon-ban-circle:before {
  content: "\e090";
}
.glyphicon-arrow-left:before {
  content: "\e091";
}
.glyphicon-arrow-right:before {
  content: "\e092";
}
.glyphicon-arrow-up:before {
  content: "\e093";
}
.glyphicon-arrow-down:before {
  content: "\e094";
}
.glyphicon-share-alt:before {
  content: "\e095";
}
.glyphicon-resize-full:before {
  content: "\e096";
}
.glyphicon-resize-small:before {
  content: "\e097";
}
.glyphicon-exclamation-sign:before {
  content: "\e101";
}
.glyphicon-gift:before {
  content: "\e102";
}
.glyphicon-leaf:before {
  content: "\e103";
}
.glyphicon-fire:before {
  content: "\e104";
}
.glyphicon-eye-open:before {
  content: "\e105";
}
.glyphicon-eye-close:before {
  content: "\e106";
}
.glyphicon-warning-sign:before {
  content: "\e107";
}
.glyphicon-plane:before {
  content: "\e108";
}
.glyphicon-calendar:before {
  content: "\e109";
}
.glyphicon-random:before {
  content: "\e110";
}
.glyphicon-comment:before {
  content: "\e111";
}
.glyphicon-magnet:before {
  content: "\e112";
}
.glyphicon-chevron-up:before {
  content: "\e113";
}
.glyphicon-chevron-down:before {
  content: "\e114";
}
.glyphicon-retweet:before {
  content: "\e115";
}
.glyphicon-shopping-cart:before {
  content: "\e116";
}
.glyphicon-folder-close:before {
  content: "\e117";
}
.glyphicon-folder-open:before {
  content: "\e118";
}
.glyphicon-resize-vertical:before {
  content: "\e119";
}
.glyphicon-resize-horizontal:before {
  content: "\e120";
}
.glyphicon-hdd:before {
  content: "\e121";
}
.glyphicon-bullhorn:before {
  content: "\e122";
}
.glyphicon-bell:before {
  content: "\e123";
}
.glyphicon-certificate:before {
  content: "\e124";
}
.glyphicon-thumbs-up:before {
  content: "\e125";
}
.glyphicon-thumbs-down:before {
  content: "\e126";
}
.glyphicon-hand-right:before {
  content: "\e127";
}
.glyphicon-hand-left:before {
  content: "\e128";
}
.glyphicon-hand-up:before {
  content: "\e129";
}
.glyphicon-hand-down:before {
  content: "\e130";
}
.glyphicon-circle-arrow-right:before {
  content: "\e131";
}
.glyphicon-circle-arrow-left:before {
  content: "\e132";
}
.glyphicon-circle-arrow-up:before {
  content: "\e133";
}
.glyphicon-circle-arrow-down:before {
  content: "\e134";
}
.glyphicon-globe:before {
  content: "\e135";
}
.glyphicon-wrench:before {
  content: "\e136";
}
.glyphicon-tasks:before {
  content: "\e137";
}
.glyphicon-filter:before {
  content: "\e138";
}
.glyphicon-briefcase:before {
  content: "\e139";
}
.glyphicon-fullscreen:before {
  content: "\e140";
}
.glyphicon-dashboard:before {
  content: "\e141";
}
.glyphicon-paperclip:before {
  content: "\e142";
}
.glyphicon-heart-empty:before {
  content: "\e143";
}
.glyphicon-link:before {
  content: "\e144";
}
.glyphicon-phone:before {
  content: "\e145";
}
.glyphicon-pushpin:before {
  content: "\e146";
}
.glyphicon-usd:before {
  content: "\e148";
}
.glyphicon-gbp:before {
  content: "\e149";
}
.glyphicon-sort:before {
  content: "\e150";
}
.glyphicon-sort-by-alphabet:before {
  content: "\e151";
}
.glyphicon-sort-by-alphabet-alt:before {
  content: "\e152";
}
.glyphicon-sort-by-order:before {
  content: "\e153";
}
.glyphicon-sort-by-order-alt:before {
  content: "\e154";
}
.glyphicon-sort-by-attributes:before {
  content: "\e155";
}
.glyphicon-sort-by-attributes-alt:before {
  content: "\e156";
}
.glyphicon-unchecked:before {
  content: "\e157";
}
.glyphicon-expand:before {
  content: "\e158";
}
.glyphicon-collapse-down:before {
  content: "\e159";
}
.glyphicon-collapse-up:before {
  content: "\e160";
}
.glyphicon-log-in:before {
  content: "\e161";
}
.glyphicon-flash:before {
  content: "\e162";
}
.glyphicon-log-out:before {
  content: "\e163";
}
.glyphicon-new-window:before {
  content: "\e164";
}
.glyphicon-record:before {
  content: "\e165";
}
.glyphicon-save:before {
  content: "\e166";
}
.glyphicon-open:before {
  content: "\e167";
}
.glyphicon-saved:before {
  content: "\e168";
}
.glyphicon-import:before {
  content: "\e169";
}
.glyphicon-export:before {
  content: "\e170";
}
.glyphicon-send:before {
  content: "\e171";
}
.glyphicon-floppy-disk:before {
  content: "\e172";
}
.glyphicon-floppy-saved:before {
  content: "\e173";
}
.glyphicon-floppy-remove:before {
  content: "\e174";
}
.glyphicon-floppy-save:before {
  content: "\e175";
}
.glyphicon-floppy-open:before {
  content: "\e176";
}
.glyphicon-credit-card:before {
  content: "\e177";
}
.glyphicon-transfer:before {
  content: "\e178";
}
.glyphicon-cutlery:before {
  content: "\e179";
}
.glyphicon-header:before {
  content: "\e180";
}
.glyphicon-compressed:before {
  content: "\e181";
}
.glyphicon-earphone:before {
  content: "\e182";
}
.glyphicon-phone-alt:before {
  content: "\e183";
}
.glyphicon-tower:before {
  content: "\e184";
}
.glyphicon-stats:before {
  content: "\e185";
}
.glyphicon-sd-video:before {
  content: "\e186";
}
.glyphicon-hd-video:before {
  content: "\e187";
}
.glyphicon-subtitles:before {
  content: "\e188";
}
.glyphicon-sound-stereo:before {
  content: "\e189";
}
.glyphicon-sound-dolby:before {
  content: "\e190";
}
.glyphicon-sound-5-1:before {
  content: "\e191";
}
.glyphicon-sound-6-1:before {
  content: "\e192";
}
.glyphicon-sound-7-1:before {
  content: "\e193";
}
.glyphicon-copyright-mark:before {
  content: "\e194";
}
.glyphicon-registration-mark:before {
  content: "\e195";
}
.glyphicon-cloud-download:before {
  content: "\e197";
}
.glyphicon-cloud-upload:before {
  content: "\e198";
}
.glyphicon-tree-conifer:before {
  content: "\e199";
}
.glyphicon-tree-deciduous:before {
  content: "\e200";
}
.glyphicon-cd:before {
  content: "\e201";
}
.glyphicon-save-file:before {
  content: "\e202";
}
.glyphicon-open-file:before {
  content: "\e203";
}
.glyphicon-level-up:before {
  content: "\e204";
}
.glyphicon-copy:before {
  content: "\e205";
}
.glyphicon-paste:before {
  content: "\e206";
}
.glyphicon-alert:before {
  content: "\e209";
}
.glyphicon-equalizer:before {
  content: "\e210";
}
.glyphicon-king:before {
  content: "\e211";
}
.glyphicon-queen:before {
  content: "\e212";
}
.glyphicon-pawn:before {
  content: "\e213";
}
.glyphicon-bishop:before {
  content: "\e214";
}
.glyphicon-knight:before {
  content: "\e215";
}
.glyphicon-baby-formula:before {
  content: "\e216";
}
.glyphicon-tent:before {
  content: "\26fa";
}
.glyphicon-blackboard:before {
  content: "\e218";
}
.glyphicon-bed:before {
  content: "\e219";
}
.glyphicon-apple:before {
  content: "\f8ff";
}
.glyphicon-erase:before {
  content: "\e221";
}
.glyphicon-hourglass:before {
  content: "\231b";
}
.glyphicon-lamp:before {
  content: "\e223";
}
.glyphicon-duplicate:before {
  content: "\e224";
}
.glyphicon-piggy-bank:before {
  content: "\e225";
}
.glyphicon-scissors:before {
  content: "\e226";
}
.glyphicon-bitcoin:before {
  content: "\e227";
}
.glyphicon-btc:before {
  content: "\e227";
}
.glyphicon-xbt:before {
  content: "\e227";
}
.glyphicon-yen:before {
  content: "\00a5";
}
.glyphicon-jpy:before {
  content: "\00a5";
}
.glyphicon-ruble:before {
  content: "\20bd";
}
.glyphicon-rub:before {
  content: "\20bd";
}
.glyphicon-scale:before {
  content: "\e230";
}
.glyphicon-ice-lolly:before {
  content: "\e231";
}
.glyphicon-ice-lolly-tasted:before {
  content: "\e232";
}
.glyphicon-education:before {
  content: "\e233";
}
.glyphicon-option-horizontal:before {
  content: "\e234";
}
.glyphicon-option-vertical:before {
  content: "\e235";
}
.glyphicon-menu-hamburger:before {
  content: "\e236";
}
.glyphicon-modal-window:before {
  content: "\e237";
}
.glyphicon-oil:before {
  content: "\e238";
}
.glyphicon-grain:before {
  content: "\e239";
}
.glyphicon-sunglasses:before {
  content: "\e240";
}
.glyphicon-text-size:before {
  content: "\e241";
}
.glyphicon-text-color:before {
  content: "\e242";
}
.glyphicon-text-background:before {
  content: "\e243";
}
.glyphicon-object-align-top:before {
  content: "\e244";
}
.glyphicon-object-align-bottom:before {
  content: "\e245";
}
.glyphicon-object-align-horizontal:before {
  content: "\e246";
}
.glyphicon-object-align-left:before {
  content: "\e247";
}
.glyphicon-object-align-vertical:before {
  content: "\e248";
}
.glyphicon-object-align-right:before {
  content: "\e249";
}
.glyphicon-triangle-right:before {
  content: "\e250";
}
.glyphicon-triangle-left:before {
  content: "\e251";
}
.glyphicon-triangle-bottom:before {
  content: "\e252";
}
.glyphicon-triangle-top:before {
  content: "\e253";
}
.glyphicon-console:before {
  content: "\e254";
}
.glyphicon-superscript:before {
  content: "\e255";
}
.glyphicon-subscript:before {
  content: "\e256";
}
.glyphicon-menu-left:before {
  content: "\e257";
}
.glyphicon-menu-right:before {
  content: "\e258";
}
.glyphicon-menu-down:before {
  content: "\e259";
}
.glyphicon-menu-up:before {
  content: "\e260";
}
* {
  -webkit-box-sizing: border-box;
  -moz-box-sizing: border-box;
  box-sizing: border-box;
}
*:before,
*:after {
  -webkit-box-sizing: border-box;
  -moz-box-sizing: border-box;
  box-sizing: border-box;
}
html {
  font-size: 10px;
  -webkit-tap-highlight-color: rgba(0, 0, 0, 0);
}
body {
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
  font-size: 13px;
  line-height: 1.42857143;
  color: #000;
  background-color: #fff;
}
input,
button,
select,
textarea {
  font-family: inherit;
  font-size: inherit;
  line-height: inherit;
}
a {
  color: #337ab7;
  text-decoration: none;
}
a:hover,
a:focus {
  color: #23527c;
  text-decoration: underline;
}
a:focus {
  outline: 5px auto -webkit-focus-ring-color;
  outline-offset: -2px;
}
figure {
  margin: 0;
}
img {
  vertical-align: middle;
}
.img-responsive,
.thumbnail > img,
.thumbnail a > img,
.carousel-inner > .item > img,
.carousel-inner > .item > a > img {
  display: block;
  max-width: 100%;
  height: auto;
}
.img-rounded {
  border-radius: 3px;
}
.img-thumbnail {
  padding: 4px;
  line-height: 1.42857143;
  background-color: #fff;
  border: 1px solid #ddd;
  border-radius: 2px;
  -webkit-transition: all 0.2s ease-in-out;
  -o-transition: all 0.2s ease-in-out;
  transition: all 0.2s ease-in-out;
  display: inline-block;
  max-width: 100%;
  height: auto;
}
.img-circle {
  border-radius: 50%;
}
hr {
  margin-top: 18px;
  margin-bottom: 18px;
  border: 0;
  border-top: 1px solid #eeeeee;
}
.sr-only {
  position: absolute;
  width: 1px;
  height: 1px;
  margin: -1px;
  padding: 0;
  overflow: hidden;
  clip: rect(0, 0, 0, 0);
  border: 0;
}
.sr-only-focusable:active,
.sr-only-focusable:focus {
  position: static;
  width: auto;
  height: auto;
  margin: 0;
  overflow: visible;
  clip: auto;
}
[role="button"] {
  cursor: pointer;
}
h1,
h2,
h3,
h4,
h5,
h6,
.h1,
.h2,
.h3,
.h4,
.h5,
.h6 {
  font-family: inherit;
  font-weight: 500;
  line-height: 1.1;
  color: inherit;
}
h1 small,
h2 small,
h3 small,
h4 small,
h5 small,
h6 small,
.h1 small,
.h2 small,
.h3 small,
.h4 small,
.h5 small,
.h6 small,
h1 .small,
h2 .small,
h3 .small,
h4 .small,
h5 .small,
h6 .small,
.h1 .small,
.h2 .small,
.h3 .small,
.h4 .small,
.h5 .small,
.h6 .small {
  font-weight: normal;
  line-height: 1;
  color: #777777;
}
h1,
.h1,
h2,
.h2,
h3,
.h3 {
  margin-top: 18px;
  margin-bottom: 9px;
}
h1 small,
.h1 small,
h2 small,
.h2 small,
h3 small,
.h3 small,
h1 .small,
.h1 .small,
h2 .small,
.h2 .small,
h3 .small,
.h3 .small {
  font-size: 65%;
}
h4,
.h4,
h5,
.h5,
h6,
.h6 {
  margin-top: 9px;
  margin-bottom: 9px;
}
h4 small,
.h4 small,
h5 small,
.h5 small,
h6 small,
.h6 small,
h4 .small,
.h4 .small,
h5 .small,
.h5 .small,
h6 .small,
.h6 .small {
  font-size: 75%;
}
h1,
.h1 {
  font-size: 33px;
}
h2,
.h2 {
  font-size: 27px;
}
h3,
.h3 {
  font-size: 23px;
}
h4,
.h4 {
  font-size: 17px;
}
h5,
.h5 {
  font-size: 13px;
}
h6,
.h6 {
  font-size: 12px;
}
p {
  margin: 0 0 9px;
}
.lead {
  margin-bottom: 18px;
  font-size: 14px;
  font-weight: 300;
  line-height: 1.4;
}
@media (min-width: 768px) {
  .lead {
    font-size: 19.5px;
  }
}
small,
.small {
  font-size: 92%;
}
mark,
.mark {
  background-color: #fcf8e3;
  padding: .2em;
}
.text-left {
  text-align: left;
}
.text-right {
  text-align: right;
}
.text-center {
  text-align: center;
}
.text-justify {
  text-align: justify;
}
.text-nowrap {
  white-space: nowrap;
}
.text-lowercase {
  text-transform: lowercase;
}
.text-uppercase {
  text-transform: uppercase;
}
.text-capitalize {
  text-transform: capitalize;
}
.text-muted {
  color: #777777;
}
.text-primary {
  color: #337ab7;
}
a.text-primary:hover,
a.text-primary:focus {
  color: #286090;
}
.text-success {
  color: #3c763d;
}
a.text-success:hover,
a.text-success:focus {
  color: #2b542c;
}
.text-info {
  color: #31708f;
}
a.text-info:hover,
a.text-info:focus {
  color: #245269;
}
.text-warning {
  color: #8a6d3b;
}
a.text-warning:hover,
a.text-warning:focus {
  color: #66512c;
}
.text-danger {
  color: #a94442;
}
a.text-danger:hover,
a.text-danger:focus {
  color: #843534;
}
.bg-primary {
  color: #fff;
  background-color: #337ab7;
}
a.bg-primary:hover,
a.bg-primary:focus {
  background-color: #286090;
}
.bg-success {
  background-color: #dff0d8;
}
a.bg-success:hover,
a.bg-success:focus {
  background-color: #c1e2b3;
}
.bg-info {
  background-color: #d9edf7;
}
a.bg-info:hover,
a.bg-info:focus {
  background-color: #afd9ee;
}
.bg-warning {
  background-color: #fcf8e3;
}
a.bg-warning:hover,
a.bg-warning:focus {
  background-color: #f7ecb5;
}
.bg-danger {
  background-color: #f2dede;
}
a.bg-danger:hover,
a.bg-danger:focus {
  background-color: #e4b9b9;
}
.page-header {
  padding-bottom: 8px;
  margin: 36px 0 18px;
  border-bottom: 1px solid #eeeeee;
}
ul,
ol {
  margin-top: 0;
  margin-bottom: 9px;
}
ul ul,
ol ul,
ul ol,
ol ol {
  margin-bottom: 0;
}
.list-unstyled {
  padding-left: 0;
  list-style: none;
}
.list-inline {
  padding-left: 0;
  list-style: none;
  margin-left: -5px;
}
.list-inline > li {
  display: inline-block;
  padding-left: 5px;
  padding-right: 5px;
}
dl {
  margin-top: 0;
  margin-bottom: 18px;
}
dt,
dd {
  line-height: 1.42857143;
}
dt {
  font-weight: bold;
}
dd {
  margin-left: 0;
}
@media (min-width: 541px) {
  .dl-horizontal dt {
    float: left;
    width: 160px;
    clear: left;
    text-align: right;
    overflow: hidden;
    text-overflow: ellipsis;
    white-space: nowrap;
  }
  .dl-horizontal dd {
    margin-left: 180px;
  }
}
abbr[title],
abbr[data-original-title] {
  cursor: help;
  border-bottom: 1px dotted #777777;
}
.initialism {
  font-size: 90%;
  text-transform: uppercase;
}
blockquote {
  padding: 9px 18px;
  margin: 0 0 18px;
  font-size: inherit;
  border-left: 5px solid #eeeeee;
}
blockquote p:last-child,
blockquote ul:last-child,
blockquote ol:last-child {
  margin-bottom: 0;
}
blockquote footer,
blockquote small,
blockquote .small {
  display: block;
  font-size: 80%;
  line-height: 1.42857143;
  color: #777777;
}
blockquote footer:before,
blockquote small:before,
blockquote .small:before {
  content: '\2014 \00A0';
}
.blockquote-reverse,
blockquote.pull-right {
  padding-right: 15px;
  padding-left: 0;
  border-right: 5px solid #eeeeee;
  border-left: 0;
  text-align: right;
}
.blockquote-reverse footer:before,
blockquote.pull-right footer:before,
.blockquote-reverse small:before,
blockquote.pull-right small:before,
.blockquote-reverse .small:before,
blockquote.pull-right .small:before {
  content: '';
}
.blockquote-reverse footer:after,
blockquote.pull-right footer:after,
.blockquote-reverse small:after,
blockquote.pull-right small:after,
.blockquote-reverse .small:after,
blockquote.pull-right .small:after {
  content: '\00A0 \2014';
}
address {
  margin-bottom: 18px;
  font-style: normal;
  line-height: 1.42857143;
}
code,
kbd,
pre,
samp {
  font-family: monospace;
}
code {
  padding: 2px 4px;
  font-size: 90%;
  color: #c7254e;
  background-color: #f9f2f4;
  border-radius: 2px;
}
kbd {
  padding: 2px 4px;
  font-size: 90%;
  color: #888;
  background-color: transparent;
  border-radius: 1px;
  box-shadow: inset 0 -1px 0 rgba(0, 0, 0, 0.25);
}
kbd kbd {
  padding: 0;
  font-size: 100%;
  font-weight: bold;
  box-shadow: none;
}
pre {
  display: block;
  padding: 8.5px;
  margin: 0 0 9px;
  font-size: 12px;
  line-height: 1.42857143;
  word-break: break-all;
  word-wrap: break-word;
  color: #333333;
  background-color: #f5f5f5;
  border: 1px solid #ccc;
  border-radius: 2px;
}
pre code {
  padding: 0;
  font-size: inherit;
  color: inherit;
  white-space: pre-wrap;
  background-color: transparent;
  border-radius: 0;
}
.pre-scrollable {
  max-height: 340px;
  overflow-y: scroll;
}
.container {
  margin-right: auto;
  margin-left: auto;
  padding-left: 0px;
  padding-right: 0px;
}
@media (min-width: 768px) {
  .container {
    width: 768px;
  }
}
@media (min-width: 992px) {
  .container {
    width: 940px;
  }
}
@media (min-width: 1200px) {
  .container {
    width: 1140px;
  }
}
.container-fluid {
  margin-right: auto;
  margin-left: auto;
  padding-left: 0px;
  padding-right: 0px;
}
.row {
  margin-left: 0px;
  margin-right: 0px;
}
.col-xs-1, .col-sm-1, .col-md-1, .col-lg-1, .col-xs-2, .col-sm-2, .col-md-2, .col-lg-2, .col-xs-3, .col-sm-3, .col-md-3, .col-lg-3, .col-xs-4, .col-sm-4, .col-md-4, .col-lg-4, .col-xs-5, .col-sm-5, .col-md-5, .col-lg-5, .col-xs-6, .col-sm-6, .col-md-6, .col-lg-6, .col-xs-7, .col-sm-7, .col-md-7, .col-lg-7, .col-xs-8, .col-sm-8, .col-md-8, .col-lg-8, .col-xs-9, .col-sm-9, .col-md-9, .col-lg-9, .col-xs-10, .col-sm-10, .col-md-10, .col-lg-10, .col-xs-11, .col-sm-11, .col-md-11, .col-lg-11, .col-xs-12, .col-sm-12, .col-md-12, .col-lg-12 {
  position: relative;
  min-height: 1px;
  padding-left: 0px;
  padding-right: 0px;
}
.col-xs-1, .col-xs-2, .col-xs-3, .col-xs-4, .col-xs-5, .col-xs-6, .col-xs-7, .col-xs-8, .col-xs-9, .col-xs-10, .col-xs-11, .col-xs-12 {
  float: left;
}
.col-xs-12 {
  width: 100%;
}
.col-xs-11 {
  width: 91.66666667%;
}
.col-xs-10 {
  width: 83.33333333%;
}
.col-xs-9 {
  width: 75%;
}
.col-xs-8 {
  width: 66.66666667%;
}
.col-xs-7 {
  width: 58.33333333%;
}
.col-xs-6 {
  width: 50%;
}
.col-xs-5 {
  width: 41.66666667%;
}
.col-xs-4 {
  width: 33.33333333%;
}
.col-xs-3 {
  width: 25%;
}
.col-xs-2 {
  width: 16.66666667%;
}
.col-xs-1 {
  width: 8.33333333%;
}
.col-xs-pull-12 {
  right: 100%;
}
.col-xs-pull-11 {
  right: 91.66666667%;
}
.col-xs-pull-10 {
  right: 83.33333333%;
}
.col-xs-pull-9 {
  right: 75%;
}
.col-xs-pull-8 {
  right: 66.66666667%;
}
.col-xs-pull-7 {
  right: 58.33333333%;
}
.col-xs-pull-6 {
  right: 50%;
}
.col-xs-pull-5 {
  right: 41.66666667%;
}
.col-xs-pull-4 {
  right: 33.33333333%;
}
.col-xs-pull-3 {
  right: 25%;
}
.col-xs-pull-2 {
  right: 16.66666667%;
}
.col-xs-pull-1 {
  right: 8.33333333%;
}
.col-xs-pull-0 {
  right: auto;
}
.col-xs-push-12 {
  left: 100%;
}
.col-xs-push-11 {
  left: 91.66666667%;
}
.col-xs-push-10 {
  left: 83.33333333%;
}
.col-xs-push-9 {
  left: 75%;
}
.col-xs-push-8 {
  left: 66.66666667%;
}
.col-xs-push-7 {
  left: 58.33333333%;
}
.col-xs-push-6 {
  left: 50%;
}
.col-xs-push-5 {
  left: 41.66666667%;
}
.col-xs-push-4 {
  left: 33.33333333%;
}
.col-xs-push-3 {
  left: 25%;
}
.col-xs-push-2 {
  left: 16.66666667%;
}
.col-xs-push-1 {
  left: 8.33333333%;
}
.col-xs-push-0 {
  left: auto;
}
.col-xs-offset-12 {
  margin-left: 100%;
}
.col-xs-offset-11 {
  margin-left: 91.66666667%;
}
.col-xs-offset-10 {
  margin-left: 83.33333333%;
}
.col-xs-offset-9 {
  margin-left: 75%;
}
.col-xs-offset-8 {
  margin-left: 66.66666667%;
}
.col-xs-offset-7 {
  margin-left: 58.33333333%;
}
.col-xs-offset-6 {
  margin-left: 50%;
}
.col-xs-offset-5 {
  margin-left: 41.66666667%;
}
.col-xs-offset-4 {
  margin-left: 33.33333333%;
}
.col-xs-offset-3 {
  margin-left: 25%;
}
.col-xs-offset-2 {
  margin-left: 16.66666667%;
}
.col-xs-offset-1 {
  margin-left: 8.33333333%;
}
.col-xs-offset-0 {
  margin-left: 0%;
}
@media (min-width: 768px) {
  .col-sm-1, .col-sm-2, .col-sm-3, .col-sm-4, .col-sm-5, .col-sm-6, .col-sm-7, .col-sm-8, .col-sm-9, .col-sm-10, .col-sm-11, .col-sm-12 {
    float: left;
  }
  .col-sm-12 {
    width: 100%;
  }
  .col-sm-11 {
    width: 91.66666667%;
  }
  .col-sm-10 {
    width: 83.33333333%;
  }
  .col-sm-9 {
    width: 75%;
  }
  .col-sm-8 {
    width: 66.66666667%;
  }
  .col-sm-7 {
    width: 58.33333333%;
  }
  .col-sm-6 {
    width: 50%;
  }
  .col-sm-5 {
    width: 41.66666667%;
  }
  .col-sm-4 {
    width: 33.33333333%;
  }
  .col-sm-3 {
    width: 25%;
  }
  .col-sm-2 {
    width: 16.66666667%;
  }
  .col-sm-1 {
    width: 8.33333333%;
  }
  .col-sm-pull-12 {
    right: 100%;
  }
  .col-sm-pull-11 {
    right: 91.66666667%;
  }
  .col-sm-pull-10 {
    right: 83.33333333%;
  }
  .col-sm-pull-9 {
    right: 75%;
  }
  .col-sm-pull-8 {
    right: 66.66666667%;
  }
  .col-sm-pull-7 {
    right: 58.33333333%;
  }
  .col-sm-pull-6 {
    right: 50%;
  }
  .col-sm-pull-5 {
    right: 41.66666667%;
  }
  .col-sm-pull-4 {
    right: 33.33333333%;
  }
  .col-sm-pull-3 {
    right: 25%;
  }
  .col-sm-pull-2 {
    right: 16.66666667%;
  }
  .col-sm-pull-1 {
    right: 8.33333333%;
  }
  .col-sm-pull-0 {
    right: auto;
  }
  .col-sm-push-12 {
    left: 100%;
  }
  .col-sm-push-11 {
    left: 91.66666667%;
  }
  .col-sm-push-10 {
    left: 83.33333333%;
  }
  .col-sm-push-9 {
    left: 75%;
  }
  .col-sm-push-8 {
    left: 66.66666667%;
  }
  .col-sm-push-7 {
    left: 58.33333333%;
  }
  .col-sm-push-6 {
    left: 50%;
  }
  .col-sm-push-5 {
    left: 41.66666667%;
  }
  .col-sm-push-4 {
    left: 33.33333333%;
  }
  .col-sm-push-3 {
    left: 25%;
  }
  .col-sm-push-2 {
    left: 16.66666667%;
  }
  .col-sm-push-1 {
    left: 8.33333333%;
  }
  .col-sm-push-0 {
    left: auto;
  }
  .col-sm-offset-12 {
    margin-left: 100%;
  }
  .col-sm-offset-11 {
    margin-left: 91.66666667%;
  }
  .col-sm-offset-10 {
    margin-left: 83.33333333%;
  }
  .col-sm-offset-9 {
    margin-left: 75%;
  }
  .col-sm-offset-8 {
    margin-left: 66.66666667%;
  }
  .col-sm-offset-7 {
    margin-left: 58.33333333%;
  }
  .col-sm-offset-6 {
    margin-left: 50%;
  }
  .col-sm-offset-5 {
    margin-left: 41.66666667%;
  }
  .col-sm-offset-4 {
    margin-left: 33.33333333%;
  }
  .col-sm-offset-3 {
    margin-left: 25%;
  }
  .col-sm-offset-2 {
    margin-left: 16.66666667%;
  }
  .col-sm-offset-1 {
    margin-left: 8.33333333%;
  }
  .col-sm-offset-0 {
    margin-left: 0%;
  }
}
@media (min-width: 992px) {
  .col-md-1, .col-md-2, .col-md-3, .col-md-4, .col-md-5, .col-md-6, .col-md-7, .col-md-8, .col-md-9, .col-md-10, .col-md-11, .col-md-12 {
    float: left;
  }
  .col-md-12 {
    width: 100%;
  }
  .col-md-11 {
    width: 91.66666667%;
  }
  .col-md-10 {
    width: 83.33333333%;
  }
  .col-md-9 {
    width: 75%;
  }
  .col-md-8 {
    width: 66.66666667%;
  }
  .col-md-7 {
    width: 58.33333333%;
  }
  .col-md-6 {
    width: 50%;
  }
  .col-md-5 {
    width: 41.66666667%;
  }
  .col-md-4 {
    width: 33.33333333%;
  }
  .col-md-3 {
    width: 25%;
  }
  .col-md-2 {
    width: 16.66666667%;
  }
  .col-md-1 {
    width: 8.33333333%;
  }
  .col-md-pull-12 {
    right: 100%;
  }
  .col-md-pull-11 {
    right: 91.66666667%;
  }
  .col-md-pull-10 {
    right: 83.33333333%;
  }
  .col-md-pull-9 {
    right: 75%;
  }
  .col-md-pull-8 {
    right: 66.66666667%;
  }
  .col-md-pull-7 {
    right: 58.33333333%;
  }
  .col-md-pull-6 {
    right: 50%;
  }
  .col-md-pull-5 {
    right: 41.66666667%;
  }
  .col-md-pull-4 {
    right: 33.33333333%;
  }
  .col-md-pull-3 {
    right: 25%;
  }
  .col-md-pull-2 {
    right: 16.66666667%;
  }
  .col-md-pull-1 {
    right: 8.33333333%;
  }
  .col-md-pull-0 {
    right: auto;
  }
  .col-md-push-12 {
    left: 100%;
  }
  .col-md-push-11 {
    left: 91.66666667%;
  }
  .col-md-push-10 {
    left: 83.33333333%;
  }
  .col-md-push-9 {
    left: 75%;
  }
  .col-md-push-8 {
    left: 66.66666667%;
  }
  .col-md-push-7 {
    left: 58.33333333%;
  }
  .col-md-push-6 {
    left: 50%;
  }
  .col-md-push-5 {
    left: 41.66666667%;
  }
  .col-md-push-4 {
    left: 33.33333333%;
  }
  .col-md-push-3 {
    left: 25%;
  }
  .col-md-push-2 {
    left: 16.66666667%;
  }
  .col-md-push-1 {
    left: 8.33333333%;
  }
  .col-md-push-0 {
    left: auto;
  }
  .col-md-offset-12 {
    margin-left: 100%;
  }
  .col-md-offset-11 {
    margin-left: 91.66666667%;
  }
  .col-md-offset-10 {
    margin-left: 83.33333333%;
  }
  .col-md-offset-9 {
    margin-left: 75%;
  }
  .col-md-offset-8 {
    margin-left: 66.66666667%;
  }
  .col-md-offset-7 {
    margin-left: 58.33333333%;
  }
  .col-md-offset-6 {
    margin-left: 50%;
  }
  .col-md-offset-5 {
    margin-left: 41.66666667%;
  }
  .col-md-offset-4 {
    margin-left: 33.33333333%;
  }
  .col-md-offset-3 {
    margin-left: 25%;
  }
  .col-md-offset-2 {
    margin-left: 16.66666667%;
  }
  .col-md-offset-1 {
    margin-left: 8.33333333%;
  }
  .col-md-offset-0 {
    margin-left: 0%;
  }
}
@media (min-width: 1200px) {
  .col-lg-1, .col-lg-2, .col-lg-3, .col-lg-4, .col-lg-5, .col-lg-6, .col-lg-7, .col-lg-8, .col-lg-9, .col-lg-10, .col-lg-11, .col-lg-12 {
    float: left;
  }
  .col-lg-12 {
    width: 100%;
  }
  .col-lg-11 {
    width: 91.66666667%;
  }
  .col-lg-10 {
    width: 83.33333333%;
  }
  .col-lg-9 {
    width: 75%;
  }
  .col-lg-8 {
    width: 66.66666667%;
  }
  .col-lg-7 {
    width: 58.33333333%;
  }
  .col-lg-6 {
    width: 50%;
  }
  .col-lg-5 {
    width: 41.66666667%;
  }
  .col-lg-4 {
    width: 33.33333333%;
  }
  .col-lg-3 {
    width: 25%;
  }
  .col-lg-2 {
    width: 16.66666667%;
  }
  .col-lg-1 {
    width: 8.33333333%;
  }
  .col-lg-pull-12 {
    right: 100%;
  }
  .col-lg-pull-11 {
    right: 91.66666667%;
  }
  .col-lg-pull-10 {
    right: 83.33333333%;
  }
  .col-lg-pull-9 {
    right: 75%;
  }
  .col-lg-pull-8 {
    right: 66.66666667%;
  }
  .col-lg-pull-7 {
    right: 58.33333333%;
  }
  .col-lg-pull-6 {
    right: 50%;
  }
  .col-lg-pull-5 {
    right: 41.66666667%;
  }
  .col-lg-pull-4 {
    right: 33.33333333%;
  }
  .col-lg-pull-3 {
    right: 25%;
  }
  .col-lg-pull-2 {
    right: 16.66666667%;
  }
  .col-lg-pull-1 {
    right: 8.33333333%;
  }
  .col-lg-pull-0 {
    right: auto;
  }
  .col-lg-push-12 {
    left: 100%;
  }
  .col-lg-push-11 {
    left: 91.66666667%;
  }
  .col-lg-push-10 {
    left: 83.33333333%;
  }
  .col-lg-push-9 {
    left: 75%;
  }
  .col-lg-push-8 {
    left: 66.66666667%;
  }
  .col-lg-push-7 {
    left: 58.33333333%;
  }
  .col-lg-push-6 {
    left: 50%;
  }
  .col-lg-push-5 {
    left: 41.66666667%;
  }
  .col-lg-push-4 {
    left: 33.33333333%;
  }
  .col-lg-push-3 {
    left: 25%;
  }
  .col-lg-push-2 {
    left: 16.66666667%;
  }
  .col-lg-push-1 {
    left: 8.33333333%;
  }
  .col-lg-push-0 {
    left: auto;
  }
  .col-lg-offset-12 {
    margin-left: 100%;
  }
  .col-lg-offset-11 {
    margin-left: 91.66666667%;
  }
  .col-lg-offset-10 {
    margin-left: 83.33333333%;
  }
  .col-lg-offset-9 {
    margin-left: 75%;
  }
  .col-lg-offset-8 {
    margin-left: 66.66666667%;
  }
  .col-lg-offset-7 {
    margin-left: 58.33333333%;
  }
  .col-lg-offset-6 {
    margin-left: 50%;
  }
  .col-lg-offset-5 {
    margin-left: 41.66666667%;
  }
  .col-lg-offset-4 {
    margin-left: 33.33333333%;
  }
  .col-lg-offset-3 {
    margin-left: 25%;
  }
  .col-lg-offset-2 {
    margin-left: 16.66666667%;
  }
  .col-lg-offset-1 {
    margin-left: 8.33333333%;
  }
  .col-lg-offset-0 {
    margin-left: 0%;
  }
}
table {
  background-color: transparent;
}
caption {
  padding-top: 8px;
  padding-bottom: 8px;
  color: #777777;
  text-align: left;
}
th {
  text-align: left;
}
.table {
  width: 100%;
  max-width: 100%;
  margin-bottom: 18px;
}
.table > thead > tr > th,
.table > tbody > tr > th,
.table > tfoot > tr > th,
.table > thead > tr > td,
.table > tbody > tr > td,
.table > tfoot > tr > td {
  padding: 8px;
  line-height: 1.42857143;
  vertical-align: top;
  border-top: 1px solid #ddd;
}
.table > thead > tr > th {
  vertical-align: bottom;
  border-bottom: 2px solid #ddd;
}
.table > caption + thead > tr:first-child > th,
.table > colgroup + thead > tr:first-child > th,
.table > thead:first-child > tr:first-child > th,
.table > caption + thead > tr:first-child > td,
.table > colgroup + thead > tr:first-child > td,
.table > thead:first-child > tr:first-child > td {
  border-top: 0;
}
.table > tbody + tbody {
  border-top: 2px solid #ddd;
}
.table .table {
  background-color: #fff;
}
.table-condensed > thead > tr > th,
.table-condensed > tbody > tr > th,
.table-condensed > tfoot > tr > th,
.table-condensed > thead > tr > td,
.table-condensed > tbody > tr > td,
.table-condensed > tfoot > tr > td {
  padding: 5px;
}
.table-bordered {
  border: 1px solid #ddd;
}
.table-bordered > thead > tr > th,
.table-bordered > tbody > tr > th,
.table-bordered > tfoot > tr > th,
.table-bordered > thead > tr > td,
.table-bordered > tbody > tr > td,
.table-bordered > tfoot > tr > td {
  border: 1px solid #ddd;
}
.table-bordered > thead > tr > th,
.table-bordered > thead > tr > td {
  border-bottom-width: 2px;
}
.table-striped > tbody > tr:nth-of-type(odd) {
  background-color: #f9f9f9;
}
.table-hover > tbody > tr:hover {
  background-color: #f5f5f5;
}
table col[class*="col-"] {
  position: static;
  float: none;
  display: table-column;
}
table td[class*="col-"],
table th[class*="col-"] {
  position: static;
  float: none;
  display: table-cell;
}
.table > thead > tr > td.active,
.table > tbody > tr > td.active,
.table > tfoot > tr > td.active,
.table > thead > tr > th.active,
.table > tbody > tr > th.active,
.table > tfoot > tr > th.active,
.table > thead > tr.active > td,
.table > tbody > tr.active > td,
.table > tfoot > tr.active > td,
.table > thead > tr.active > th,
.table > tbody > tr.active > th,
.table > tfoot > tr.active > th {
  background-color: #f5f5f5;
}
.table-hover > tbody > tr > td.active:hover,
.table-hover > tbody > tr > th.active:hover,
.table-hover > tbody > tr.active:hover > td,
.table-hover > tbody > tr:hover > .active,
.table-hover > tbody > tr.active:hover > th {
  background-color: #e8e8e8;
}
.table > thead > tr > td.success,
.table > tbody > tr > td.success,
.table > tfoot > tr > td.success,
.table > thead > tr > th.success,
.table > tbody > tr > th.success,
.table > tfoot > tr > th.success,
.table > thead > tr.success > td,
.table > tbody > tr.success > td,
.table > tfoot > tr.success > td,
.table > thead > tr.success > th,
.table > tbody > tr.success > th,
.table > tfoot > tr.success > th {
  background-color: #dff0d8;
}
.table-hover > tbody > tr > td.success:hover,
.table-hover > tbody > tr > th.success:hover,
.table-hover > tbody > tr.success:hover > td,
.table-hover > tbody > tr:hover > .success,
.table-hover > tbody > tr.success:hover > th {
  background-color: #d0e9c6;
}
.table > thead > tr > td.info,
.table > tbody > tr > td.info,
.table > tfoot > tr > td.info,
.table > thead > tr > th.info,
.table > tbody > tr > th.info,
.table > tfoot > tr > th.info,
.table > thead > tr.info > td,
.table > tbody > tr.info > td,
.table > tfoot > tr.info > td,
.table > thead > tr.info > th,
.table > tbody > tr.info > th,
.table > tfoot > tr.info > th {
  background-color: #d9edf7;
}
.table-hover > tbody > tr > td.info:hover,
.table-hover > tbody > tr > th.info:hover,
.table-hover > tbody > tr.info:hover > td,
.table-hover > tbody > tr:hover > .info,
.table-hover > tbody > tr.info:hover > th {
  background-color: #c4e3f3;
}
.table > thead > tr > td.warning,
.table > tbody > tr > td.warning,
.table > tfoot > tr > td.warning,
.table > thead > tr > th.warning,
.table > tbody > tr > th.warning,
.table > tfoot > tr > th.warning,
.table > thead > tr.warning > td,
.table > tbody > tr.warning > td,
.table > tfoot > tr.warning > td,
.table > thead > tr.warning > th,
.table > tbody > tr.warning > th,
.table > tfoot > tr.warning > th {
  background-color: #fcf8e3;
}
.table-hover > tbody > tr > td.warning:hover,
.table-hover > tbody > tr > th.warning:hover,
.table-hover > tbody > tr.warning:hover > td,
.table-hover > tbody > tr:hover > .warning,
.table-hover > tbody > tr.warning:hover > th {
  background-color: #faf2cc;
}
.table > thead > tr > td.danger,
.table > tbody > tr > td.danger,
.table > tfoot > tr > td.danger,
.table > thead > tr > th.danger,
.table > tbody > tr > th.danger,
.table > tfoot > tr > th.danger,
.table > thead > tr.danger > td,
.table > tbody > tr.danger > td,
.table > tfoot > tr.danger > td,
.table > thead > tr.danger > th,
.table > tbody > tr.danger > th,
.table > tfoot > tr.danger > th {
  background-color: #f2dede;
}
.table-hover > tbody > tr > td.danger:hover,
.table-hover > tbody > tr > th.danger:hover,
.table-hover > tbody > tr.danger:hover > td,
.table-hover > tbody > tr:hover > .danger,
.table-hover > tbody > tr.danger:hover > th {
  background-color: #ebcccc;
}
.table-responsive {
  overflow-x: auto;
  min-height: 0.01%;
}
@media screen and (max-width: 767px) {
  .table-responsive {
    width: 100%;
    margin-bottom: 13.5px;
    overflow-y: hidden;
    -ms-overflow-style: -ms-autohiding-scrollbar;
    border: 1px solid #ddd;
  }
  .table-responsive > .table {
    margin-bottom: 0;
  }
  .table-responsive > .table > thead > tr > th,
  .table-responsive > .table > tbody > tr > th,
  .table-responsive > .table > tfoot > tr > th,
  .table-responsive > .table > thead > tr > td,
  .table-responsive > .table > tbody > tr > td,
  .table-responsive > .table > tfoot > tr > td {
    white-space: nowrap;
  }
  .table-responsive > .table-bordered {
    border: 0;
  }
  .table-responsive > .table-bordered > thead > tr > th:first-child,
  .table-responsive > .table-bordered > tbody > tr > th:first-child,
  .table-responsive > .table-bordered > tfoot > tr > th:first-child,
  .table-responsive > .table-bordered > thead > tr > td:first-child,
  .table-responsive > .table-bordered > tbody > tr > td:first-child,
  .table-responsive > .table-bordered > tfoot > tr > td:first-child {
    border-left: 0;
  }
  .table-responsive > .table-bordered > thead > tr > th:last-child,
  .table-responsive > .table-bordered > tbody > tr > th:last-child,
  .table-responsive > .table-bordered > tfoot > tr > th:last-child,
  .table-responsive > .table-bordered > thead > tr > td:last-child,
  .table-responsive > .table-bordered > tbody > tr > td:last-child,
  .table-responsive > .table-bordered > tfoot > tr > td:last-child {
    border-right: 0;
  }
  .table-responsive > .table-bordered > tbody > tr:last-child > th,
  .table-responsive > .table-bordered > tfoot > tr:last-child > th,
  .table-responsive > .table-bordered > tbody > tr:last-child > td,
  .table-responsive > .table-bordered > tfoot > tr:last-child > td {
    border-bottom: 0;
  }
}
fieldset {
  padding: 0;
  margin: 0;
  border: 0;
  min-width: 0;
}
legend {
  display: block;
  width: 100%;
  padding: 0;
  margin-bottom: 18px;
  font-size: 19.5px;
  line-height: inherit;
  color: #333333;
  border: 0;
  border-bottom: 1px solid #e5e5e5;
}
label {
  display: inline-block;
  max-width: 100%;
  margin-bottom: 5px;
  font-weight: bold;
}
input[type="search"] {
  -webkit-box-sizing: border-box;
  -moz-box-sizing: border-box;
  box-sizing: border-box;
}
input[type="radio"],
input[type="checkbox"] {
  margin: 4px 0 0;
  margin-top: 1px \9;
  line-height: normal;
}
input[type="file"] {
  display: block;
}
input[type="range"] {
  display: block;
  width: 100%;
}
select[multiple],
select[size] {
  height: auto;
}
input[type="file"]:focus,
input[type="radio"]:focus,
input[type="checkbox"]:focus {
  outline: 5px auto -webkit-focus-ring-color;
  outline-offset: -2px;
}
output {
  display: block;
  padding-top: 7px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
}
.form-control {
  display: block;
  width: 100%;
  height: 32px;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
  background-color: #fff;
  background-image: none;
  border: 1px solid #ccc;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  -webkit-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  -o-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
}
.form-control:focus {
  border-color: #66afe9;
  outline: 0;
  -webkit-box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
  box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
}
.form-control::-moz-placeholder {
  color: #999;
  opacity: 1;
}
.form-control:-ms-input-placeholder {
  color: #999;
}
.form-control::-webkit-input-placeholder {
  color: #999;
}
.form-control::-ms-expand {
  border: 0;
  background-color: transparent;
}
.form-control[disabled],
.form-control[readonly],
fieldset[disabled] .form-control {
  background-color: #eeeeee;
  opacity: 1;
}
.form-control[disabled],
fieldset[disabled] .form-control {
  cursor: not-allowed;
}
textarea.form-control {
  height: auto;
}
input[type="search"] {
  -webkit-appearance: none;
}
@media screen and (-webkit-min-device-pixel-ratio: 0) {
  input[type="date"].form-control,
  input[type="time"].form-control,
  input[type="datetime-local"].form-control,
  input[type="month"].form-control {
    line-height: 32px;
  }
  input[type="date"].input-sm,
  input[type="time"].input-sm,
  input[type="datetime-local"].input-sm,
  input[type="month"].input-sm,
  .input-group-sm input[type="date"],
  .input-group-sm input[type="time"],
  .input-group-sm input[type="datetime-local"],
  .input-group-sm input[type="month"] {
    line-height: 30px;
  }
  input[type="date"].input-lg,
  input[type="time"].input-lg,
  input[type="datetime-local"].input-lg,
  input[type="month"].input-lg,
  .input-group-lg input[type="date"],
  .input-group-lg input[type="time"],
  .input-group-lg input[type="datetime-local"],
  .input-group-lg input[type="month"] {
    line-height: 45px;
  }
}
.form-group {
  margin-bottom: 15px;
}
.radio,
.checkbox {
  position: relative;
  display: block;
  margin-top: 10px;
  margin-bottom: 10px;
}
.radio label,
.checkbox label {
  min-height: 18px;
  padding-left: 20px;
  margin-bottom: 0;
  font-weight: normal;
  cursor: pointer;
}
.radio input[type="radio"],
.radio-inline input[type="radio"],
.checkbox input[type="checkbox"],
.checkbox-inline input[type="checkbox"] {
  position: absolute;
  margin-left: -20px;
  margin-top: 4px \9;
}
.radio + .radio,
.checkbox + .checkbox {
  margin-top: -5px;
}
.radio-inline,
.checkbox-inline {
  position: relative;
  display: inline-block;
  padding-left: 20px;
  margin-bottom: 0;
  vertical-align: middle;
  font-weight: normal;
  cursor: pointer;
}
.radio-inline + .radio-inline,
.checkbox-inline + .checkbox-inline {
  margin-top: 0;
  margin-left: 10px;
}
input[type="radio"][disabled],
input[type="checkbox"][disabled],
input[type="radio"].disabled,
input[type="checkbox"].disabled,
fieldset[disabled] input[type="radio"],
fieldset[disabled] input[type="checkbox"] {
  cursor: not-allowed;
}
.radio-inline.disabled,
.checkbox-inline.disabled,
fieldset[disabled] .radio-inline,
fieldset[disabled] .checkbox-inline {
  cursor: not-allowed;
}
.radio.disabled label,
.checkbox.disabled label,
fieldset[disabled] .radio label,
fieldset[disabled] .checkbox label {
  cursor: not-allowed;
}
.form-control-static {
  padding-top: 7px;
  padding-bottom: 7px;
  margin-bottom: 0;
  min-height: 31px;
}
.form-control-static.input-lg,
.form-control-static.input-sm {
  padding-left: 0;
  padding-right: 0;
}
.input-sm {
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
select.input-sm {
  height: 30px;
  line-height: 30px;
}
textarea.input-sm,
select[multiple].input-sm {
  height: auto;
}
.form-group-sm .form-control {
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
.form-group-sm select.form-control {
  height: 30px;
  line-height: 30px;
}
.form-group-sm textarea.form-control,
.form-group-sm select[multiple].form-control {
  height: auto;
}
.form-group-sm .form-control-static {
  height: 30px;
  min-height: 30px;
  padding: 6px 10px;
  font-size: 12px;
  line-height: 1.5;
}
.input-lg {
  height: 45px;
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
select.input-lg {
  height: 45px;
  line-height: 45px;
}
textarea.input-lg,
select[multiple].input-lg {
  height: auto;
}
.form-group-lg .form-control {
  height: 45px;
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
.form-group-lg select.form-control {
  height: 45px;
  line-height: 45px;
}
.form-group-lg textarea.form-control,
.form-group-lg select[multiple].form-control {
  height: auto;
}
.form-group-lg .form-control-static {
  height: 45px;
  min-height: 35px;
  padding: 11px 16px;
  font-size: 17px;
  line-height: 1.3333333;
}
.has-feedback {
  position: relative;
}
.has-feedback .form-control {
  padding-right: 40px;
}
.form-control-feedback {
  position: absolute;
  top: 0;
  right: 0;
  z-index: 2;
  display: block;
  width: 32px;
  height: 32px;
  line-height: 32px;
  text-align: center;
  pointer-events: none;
}
.input-lg + .form-control-feedback,
.input-group-lg + .form-control-feedback,
.form-group-lg .form-control + .form-control-feedback {
  width: 45px;
  height: 45px;
  line-height: 45px;
}
.input-sm + .form-control-feedback,
.input-group-sm + .form-control-feedback,
.form-group-sm .form-control + .form-control-feedback {
  width: 30px;
  height: 30px;
  line-height: 30px;
}
.has-success .help-block,
.has-success .control-label,
.has-success .radio,
.has-success .checkbox,
.has-success .radio-inline,
.has-success .checkbox-inline,
.has-success.radio label,
.has-success.checkbox label,
.has-success.radio-inline label,
.has-success.checkbox-inline label {
  color: #3c763d;
}
.has-success .form-control {
  border-color: #3c763d;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
}
.has-success .form-control:focus {
  border-color: #2b542c;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #67b168;
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #67b168;
}
.has-success .input-group-addon {
  color: #3c763d;
  border-color: #3c763d;
  background-color: #dff0d8;
}
.has-success .form-control-feedback {
  color: #3c763d;
}
.has-warning .help-block,
.has-warning .control-label,
.has-warning .radio,
.has-warning .checkbox,
.has-warning .radio-inline,
.has-warning .checkbox-inline,
.has-warning.radio label,
.has-warning.checkbox label,
.has-warning.radio-inline label,
.has-warning.checkbox-inline label {
  color: #8a6d3b;
}
.has-warning .form-control {
  border-color: #8a6d3b;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
}
.has-warning .form-control:focus {
  border-color: #66512c;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #c0a16b;
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #c0a16b;
}
.has-warning .input-group-addon {
  color: #8a6d3b;
  border-color: #8a6d3b;
  background-color: #fcf8e3;
}
.has-warning .form-control-feedback {
  color: #8a6d3b;
}
.has-error .help-block,
.has-error .control-label,
.has-error .radio,
.has-error .checkbox,
.has-error .radio-inline,
.has-error .checkbox-inline,
.has-error.radio label,
.has-error.checkbox label,
.has-error.radio-inline label,
.has-error.checkbox-inline label {
  color: #a94442;
}
.has-error .form-control {
  border-color: #a94442;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
}
.has-error .form-control:focus {
  border-color: #843534;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #ce8483;
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075), 0 0 6px #ce8483;
}
.has-error .input-group-addon {
  color: #a94442;
  border-color: #a94442;
  background-color: #f2dede;
}
.has-error .form-control-feedback {
  color: #a94442;
}
.has-feedback label ~ .form-control-feedback {
  top: 23px;
}
.has-feedback label.sr-only ~ .form-control-feedback {
  top: 0;
}
.help-block {
  display: block;
  margin-top: 5px;
  margin-bottom: 10px;
  color: #404040;
}
@media (min-width: 768px) {
  .form-inline .form-group {
    display: inline-block;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .form-inline .form-control {
    display: inline-block;
    width: auto;
    vertical-align: middle;
  }
  .form-inline .form-control-static {
    display: inline-block;
  }
  .form-inline .input-group {
    display: inline-table;
    vertical-align: middle;
  }
  .form-inline .input-group .input-group-addon,
  .form-inline .input-group .input-group-btn,
  .form-inline .input-group .form-control {
    width: auto;
  }
  .form-inline .input-group > .form-control {
    width: 100%;
  }
  .form-inline .control-label {
    margin-bottom: 0;
    vertical-align: middle;
  }
  .form-inline .radio,
  .form-inline .checkbox {
    display: inline-block;
    margin-top: 0;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .form-inline .radio label,
  .form-inline .checkbox label {
    padding-left: 0;
  }
  .form-inline .radio input[type="radio"],
  .form-inline .checkbox input[type="checkbox"] {
    position: relative;
    margin-left: 0;
  }
  .form-inline .has-feedback .form-control-feedback {
    top: 0;
  }
}
.form-horizontal .radio,
.form-horizontal .checkbox,
.form-horizontal .radio-inline,
.form-horizontal .checkbox-inline {
  margin-top: 0;
  margin-bottom: 0;
  padding-top: 7px;
}
.form-horizontal .radio,
.form-horizontal .checkbox {
  min-height: 25px;
}
.form-horizontal .form-group {
  margin-left: 0px;
  margin-right: 0px;
}
@media (min-width: 768px) {
  .form-horizontal .control-label {
    text-align: right;
    margin-bottom: 0;
    padding-top: 7px;
  }
}
.form-horizontal .has-feedback .form-control-feedback {
  right: 0px;
}
@media (min-width: 768px) {
  .form-horizontal .form-group-lg .control-label {
    padding-top: 11px;
    font-size: 17px;
  }
}
@media (min-width: 768px) {
  .form-horizontal .form-group-sm .control-label {
    padding-top: 6px;
    font-size: 12px;
  }
}
.btn {
  display: inline-block;
  margin-bottom: 0;
  font-weight: normal;
  text-align: center;
  vertical-align: middle;
  touch-action: manipulation;
  cursor: pointer;
  background-image: none;
  border: 1px solid transparent;
  white-space: nowrap;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  border-radius: 2px;
  -webkit-user-select: none;
  -moz-user-select: none;
  -ms-user-select: none;
  user-select: none;
}
.btn:focus,
.btn:active:focus,
.btn.active:focus,
.btn.focus,
.btn:active.focus,
.btn.active.focus {
  outline: 5px auto -webkit-focus-ring-color;
  outline-offset: -2px;
}
.btn:hover,
.btn:focus,
.btn.focus {
  color: #333;
  text-decoration: none;
}
.btn:active,
.btn.active {
  outline: 0;
  background-image: none;
  -webkit-box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
  box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
}
.btn.disabled,
.btn[disabled],
fieldset[disabled] .btn {
  cursor: not-allowed;
  opacity: 0.65;
  filter: alpha(opacity=65);
  -webkit-box-shadow: none;
  box-shadow: none;
}
a.btn.disabled,
fieldset[disabled] a.btn {
  pointer-events: none;
}
.btn-default {
  color: #333;
  background-color: #fff;
  border-color: #ccc;
}
.btn-default:focus,
.btn-default.focus {
  color: #333;
  background-color: #e6e6e6;
  border-color: #8c8c8c;
}
.btn-default:hover {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.btn-default:active,
.btn-default.active,
.open > .dropdown-toggle.btn-default {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.btn-default:active:hover,
.btn-default.active:hover,
.open > .dropdown-toggle.btn-default:hover,
.btn-default:active:focus,
.btn-default.active:focus,
.open > .dropdown-toggle.btn-default:focus,
.btn-default:active.focus,
.btn-default.active.focus,
.open > .dropdown-toggle.btn-default.focus {
  color: #333;
  background-color: #d4d4d4;
  border-color: #8c8c8c;
}
.btn-default:active,
.btn-default.active,
.open > .dropdown-toggle.btn-default {
  background-image: none;
}
.btn-default.disabled:hover,
.btn-default[disabled]:hover,
fieldset[disabled] .btn-default:hover,
.btn-default.disabled:focus,
.btn-default[disabled]:focus,
fieldset[disabled] .btn-default:focus,
.btn-default.disabled.focus,
.btn-default[disabled].focus,
fieldset[disabled] .btn-default.focus {
  background-color: #fff;
  border-color: #ccc;
}
.btn-default .badge {
  color: #fff;
  background-color: #333;
}
.btn-primary {
  color: #fff;
  background-color: #337ab7;
  border-color: #2e6da4;
}
.btn-primary:focus,
.btn-primary.focus {
  color: #fff;
  background-color: #286090;
  border-color: #122b40;
}
.btn-primary:hover {
  color: #fff;
  background-color: #286090;
  border-color: #204d74;
}
.btn-primary:active,
.btn-primary.active,
.open > .dropdown-toggle.btn-primary {
  color: #fff;
  background-color: #286090;
  border-color: #204d74;
}
.btn-primary:active:hover,
.btn-primary.active:hover,
.open > .dropdown-toggle.btn-primary:hover,
.btn-primary:active:focus,
.btn-primary.active:focus,
.open > .dropdown-toggle.btn-primary:focus,
.btn-primary:active.focus,
.btn-primary.active.focus,
.open > .dropdown-toggle.btn-primary.focus {
  color: #fff;
  background-color: #204d74;
  border-color: #122b40;
}
.btn-primary:active,
.btn-primary.active,
.open > .dropdown-toggle.btn-primary {
  background-image: none;
}
.btn-primary.disabled:hover,
.btn-primary[disabled]:hover,
fieldset[disabled] .btn-primary:hover,
.btn-primary.disabled:focus,
.btn-primary[disabled]:focus,
fieldset[disabled] .btn-primary:focus,
.btn-primary.disabled.focus,
.btn-primary[disabled].focus,
fieldset[disabled] .btn-primary.focus {
  background-color: #337ab7;
  border-color: #2e6da4;
}
.btn-primary .badge {
  color: #337ab7;
  background-color: #fff;
}
.btn-success {
  color: #fff;
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.btn-success:focus,
.btn-success.focus {
  color: #fff;
  background-color: #449d44;
  border-color: #255625;
}
.btn-success:hover {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.btn-success:active,
.btn-success.active,
.open > .dropdown-toggle.btn-success {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.btn-success:active:hover,
.btn-success.active:hover,
.open > .dropdown-toggle.btn-success:hover,
.btn-success:active:focus,
.btn-success.active:focus,
.open > .dropdown-toggle.btn-success:focus,
.btn-success:active.focus,
.btn-success.active.focus,
.open > .dropdown-toggle.btn-success.focus {
  color: #fff;
  background-color: #398439;
  border-color: #255625;
}
.btn-success:active,
.btn-success.active,
.open > .dropdown-toggle.btn-success {
  background-image: none;
}
.btn-success.disabled:hover,
.btn-success[disabled]:hover,
fieldset[disabled] .btn-success:hover,
.btn-success.disabled:focus,
.btn-success[disabled]:focus,
fieldset[disabled] .btn-success:focus,
.btn-success.disabled.focus,
.btn-success[disabled].focus,
fieldset[disabled] .btn-success.focus {
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.btn-success .badge {
  color: #5cb85c;
  background-color: #fff;
}
.btn-info {
  color: #fff;
  background-color: #5bc0de;
  border-color: #46b8da;
}
.btn-info:focus,
.btn-info.focus {
  color: #fff;
  background-color: #31b0d5;
  border-color: #1b6d85;
}
.btn-info:hover {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.btn-info:active,
.btn-info.active,
.open > .dropdown-toggle.btn-info {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.btn-info:active:hover,
.btn-info.active:hover,
.open > .dropdown-toggle.btn-info:hover,
.btn-info:active:focus,
.btn-info.active:focus,
.open > .dropdown-toggle.btn-info:focus,
.btn-info:active.focus,
.btn-info.active.focus,
.open > .dropdown-toggle.btn-info.focus {
  color: #fff;
  background-color: #269abc;
  border-color: #1b6d85;
}
.btn-info:active,
.btn-info.active,
.open > .dropdown-toggle.btn-info {
  background-image: none;
}
.btn-info.disabled:hover,
.btn-info[disabled]:hover,
fieldset[disabled] .btn-info:hover,
.btn-info.disabled:focus,
.btn-info[disabled]:focus,
fieldset[disabled] .btn-info:focus,
.btn-info.disabled.focus,
.btn-info[disabled].focus,
fieldset[disabled] .btn-info.focus {
  background-color: #5bc0de;
  border-color: #46b8da;
}
.btn-info .badge {
  color: #5bc0de;
  background-color: #fff;
}
.btn-warning {
  color: #fff;
  background-color: #f0ad4e;
  border-color: #eea236;
}
.btn-warning:focus,
.btn-warning.focus {
  color: #fff;
  background-color: #ec971f;
  border-color: #985f0d;
}
.btn-warning:hover {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.btn-warning:active,
.btn-warning.active,
.open > .dropdown-toggle.btn-warning {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.btn-warning:active:hover,
.btn-warning.active:hover,
.open > .dropdown-toggle.btn-warning:hover,
.btn-warning:active:focus,
.btn-warning.active:focus,
.open > .dropdown-toggle.btn-warning:focus,
.btn-warning:active.focus,
.btn-warning.active.focus,
.open > .dropdown-toggle.btn-warning.focus {
  color: #fff;
  background-color: #d58512;
  border-color: #985f0d;
}
.btn-warning:active,
.btn-warning.active,
.open > .dropdown-toggle.btn-warning {
  background-image: none;
}
.btn-warning.disabled:hover,
.btn-warning[disabled]:hover,
fieldset[disabled] .btn-warning:hover,
.btn-warning.disabled:focus,
.btn-warning[disabled]:focus,
fieldset[disabled] .btn-warning:focus,
.btn-warning.disabled.focus,
.btn-warning[disabled].focus,
fieldset[disabled] .btn-warning.focus {
  background-color: #f0ad4e;
  border-color: #eea236;
}
.btn-warning .badge {
  color: #f0ad4e;
  background-color: #fff;
}
.btn-danger {
  color: #fff;
  background-color: #d9534f;
  border-color: #d43f3a;
}
.btn-danger:focus,
.btn-danger.focus {
  color: #fff;
  background-color: #c9302c;
  border-color: #761c19;
}
.btn-danger:hover {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.btn-danger:active,
.btn-danger.active,
.open > .dropdown-toggle.btn-danger {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.btn-danger:active:hover,
.btn-danger.active:hover,
.open > .dropdown-toggle.btn-danger:hover,
.btn-danger:active:focus,
.btn-danger.active:focus,
.open > .dropdown-toggle.btn-danger:focus,
.btn-danger:active.focus,
.btn-danger.active.focus,
.open > .dropdown-toggle.btn-danger.focus {
  color: #fff;
  background-color: #ac2925;
  border-color: #761c19;
}
.btn-danger:active,
.btn-danger.active,
.open > .dropdown-toggle.btn-danger {
  background-image: none;
}
.btn-danger.disabled:hover,
.btn-danger[disabled]:hover,
fieldset[disabled] .btn-danger:hover,
.btn-danger.disabled:focus,
.btn-danger[disabled]:focus,
fieldset[disabled] .btn-danger:focus,
.btn-danger.disabled.focus,
.btn-danger[disabled].focus,
fieldset[disabled] .btn-danger.focus {
  background-color: #d9534f;
  border-color: #d43f3a;
}
.btn-danger .badge {
  color: #d9534f;
  background-color: #fff;
}
.btn-link {
  color: #337ab7;
  font-weight: normal;
  border-radius: 0;
}
.btn-link,
.btn-link:active,
.btn-link.active,
.btn-link[disabled],
fieldset[disabled] .btn-link {
  background-color: transparent;
  -webkit-box-shadow: none;
  box-shadow: none;
}
.btn-link,
.btn-link:hover,
.btn-link:focus,
.btn-link:active {
  border-color: transparent;
}
.btn-link:hover,
.btn-link:focus {
  color: #23527c;
  text-decoration: underline;
  background-color: transparent;
}
.btn-link[disabled]:hover,
fieldset[disabled] .btn-link:hover,
.btn-link[disabled]:focus,
fieldset[disabled] .btn-link:focus {
  color: #777777;
  text-decoration: none;
}
.btn-lg,
.btn-group-lg > .btn {
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
.btn-sm,
.btn-group-sm > .btn {
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
.btn-xs,
.btn-group-xs > .btn {
  padding: 1px 5px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
.btn-block {
  display: block;
  width: 100%;
}
.btn-block + .btn-block {
  margin-top: 5px;
}
input[type="submit"].btn-block,
input[type="reset"].btn-block,
input[type="button"].btn-block {
  width: 100%;
}
.fade {
  opacity: 0;
  -webkit-transition: opacity 0.15s linear;
  -o-transition: opacity 0.15s linear;
  transition: opacity 0.15s linear;
}
.fade.in {
  opacity: 1;
}
.collapse {
  display: none;
}
.collapse.in {
  display: block;
}
tr.collapse.in {
  display: table-row;
}
tbody.collapse.in {
  display: table-row-group;
}
.collapsing {
  position: relative;
  height: 0;
  overflow: hidden;
  -webkit-transition-property: height, visibility;
  transition-property: height, visibility;
  -webkit-transition-duration: 0.35s;
  transition-duration: 0.35s;
  -webkit-transition-timing-function: ease;
  transition-timing-function: ease;
}
.caret {
  display: inline-block;
  width: 0;
  height: 0;
  margin-left: 2px;
  vertical-align: middle;
  border-top: 4px dashed;
  border-top: 4px solid \9;
  border-right: 4px solid transparent;
  border-left: 4px solid transparent;
}
.dropup,
.dropdown {
  position: relative;
}
.dropdown-toggle:focus {
  outline: 0;
}
.dropdown-menu {
  position: absolute;
  top: 100%;
  left: 0;
  z-index: 1000;
  display: none;
  float: left;
  min-width: 160px;
  padding: 5px 0;
  margin: 2px 0 0;
  list-style: none;
  font-size: 13px;
  text-align: left;
  background-color: #fff;
  border: 1px solid #ccc;
  border: 1px solid rgba(0, 0, 0, 0.15);
  border-radius: 2px;
  -webkit-box-shadow: 0 6px 12px rgba(0, 0, 0, 0.175);
  box-shadow: 0 6px 12px rgba(0, 0, 0, 0.175);
  background-clip: padding-box;
}
.dropdown-menu.pull-right {
  right: 0;
  left: auto;
}
.dropdown-menu .divider {
  height: 1px;
  margin: 8px 0;
  overflow: hidden;
  background-color: #e5e5e5;
}
.dropdown-menu > li > a {
  display: block;
  padding: 3px 20px;
  clear: both;
  font-weight: normal;
  line-height: 1.42857143;
  color: #333333;
  white-space: nowrap;
}
.dropdown-menu > li > a:hover,
.dropdown-menu > li > a:focus {
  text-decoration: none;
  color: #262626;
  background-color: #f5f5f5;
}
.dropdown-menu > .active > a,
.dropdown-menu > .active > a:hover,
.dropdown-menu > .active > a:focus {
  color: #fff;
  text-decoration: none;
  outline: 0;
  background-color: #337ab7;
}
.dropdown-menu > .disabled > a,
.dropdown-menu > .disabled > a:hover,
.dropdown-menu > .disabled > a:focus {
  color: #777777;
}
.dropdown-menu > .disabled > a:hover,
.dropdown-menu > .disabled > a:focus {
  text-decoration: none;
  background-color: transparent;
  background-image: none;
  filter: progid:DXImageTransform.Microsoft.gradient(enabled = false);
  cursor: not-allowed;
}
.open > .dropdown-menu {
  display: block;
}
.open > a {
  outline: 0;
}
.dropdown-menu-right {
  left: auto;
  right: 0;
}
.dropdown-menu-left {
  left: 0;
  right: auto;
}
.dropdown-header {
  display: block;
  padding: 3px 20px;
  font-size: 12px;
  line-height: 1.42857143;
  color: #777777;
  white-space: nowrap;
}
.dropdown-backdrop {
  position: fixed;
  left: 0;
  right: 0;
  bottom: 0;
  top: 0;
  z-index: 990;
}
.pull-right > .dropdown-menu {
  right: 0;
  left: auto;
}
.dropup .caret,
.navbar-fixed-bottom .dropdown .caret {
  border-top: 0;
  border-bottom: 4px dashed;
  border-bottom: 4px solid \9;
  content: "";
}
.dropup .dropdown-menu,
.navbar-fixed-bottom .dropdown .dropdown-menu {
  top: auto;
  bottom: 100%;
  margin-bottom: 2px;
}
@media (min-width: 541px) {
  .navbar-right .dropdown-menu {
    left: auto;
    right: 0;
  }
  .navbar-right .dropdown-menu-left {
    left: 0;
    right: auto;
  }
}
.btn-group,
.btn-group-vertical {
  position: relative;
  display: inline-block;
  vertical-align: middle;
}
.btn-group > .btn,
.btn-group-vertical > .btn {
  position: relative;
  float: left;
}
.btn-group > .btn:hover,
.btn-group-vertical > .btn:hover,
.btn-group > .btn:focus,
.btn-group-vertical > .btn:focus,
.btn-group > .btn:active,
.btn-group-vertical > .btn:active,
.btn-group > .btn.active,
.btn-group-vertical > .btn.active {
  z-index: 2;
}
.btn-group .btn + .btn,
.btn-group .btn + .btn-group,
.btn-group .btn-group + .btn,
.btn-group .btn-group + .btn-group {
  margin-left: -1px;
}
.btn-toolbar {
  margin-left: -5px;
}
.btn-toolbar .btn,
.btn-toolbar .btn-group,
.btn-toolbar .input-group {
  float: left;
}
.btn-toolbar > .btn,
.btn-toolbar > .btn-group,
.btn-toolbar > .input-group {
  margin-left: 5px;
}
.btn-group > .btn:not(:first-child):not(:last-child):not(.dropdown-toggle) {
  border-radius: 0;
}
.btn-group > .btn:first-child {
  margin-left: 0;
}
.btn-group > .btn:first-child:not(:last-child):not(.dropdown-toggle) {
  border-bottom-right-radius: 0;
  border-top-right-radius: 0;
}
.btn-group > .btn:last-child:not(:first-child),
.btn-group > .dropdown-toggle:not(:first-child) {
  border-bottom-left-radius: 0;
  border-top-left-radius: 0;
}
.btn-group > .btn-group {
  float: left;
}
.btn-group > .btn-group:not(:first-child):not(:last-child) > .btn {
  border-radius: 0;
}
.btn-group > .btn-group:first-child:not(:last-child) > .btn:last-child,
.btn-group > .btn-group:first-child:not(:last-child) > .dropdown-toggle {
  border-bottom-right-radius: 0;
  border-top-right-radius: 0;
}
.btn-group > .btn-group:last-child:not(:first-child) > .btn:first-child {
  border-bottom-left-radius: 0;
  border-top-left-radius: 0;
}
.btn-group .dropdown-toggle:active,
.btn-group.open .dropdown-toggle {
  outline: 0;
}
.btn-group > .btn + .dropdown-toggle {
  padding-left: 8px;
  padding-right: 8px;
}
.btn-group > .btn-lg + .dropdown-toggle {
  padding-left: 12px;
  padding-right: 12px;
}
.btn-group.open .dropdown-toggle {
  -webkit-box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
  box-shadow: inset 0 3px 5px rgba(0, 0, 0, 0.125);
}
.btn-group.open .dropdown-toggle.btn-link {
  -webkit-box-shadow: none;
  box-shadow: none;
}
.btn .caret {
  margin-left: 0;
}
.btn-lg .caret {
  border-width: 5px 5px 0;
  border-bottom-width: 0;
}
.dropup .btn-lg .caret {
  border-width: 0 5px 5px;
}
.btn-group-vertical > .btn,
.btn-group-vertical > .btn-group,
.btn-group-vertical > .btn-group > .btn {
  display: block;
  float: none;
  width: 100%;
  max-width: 100%;
}
.btn-group-vertical > .btn-group > .btn {
  float: none;
}
.btn-group-vertical > .btn + .btn,
.btn-group-vertical > .btn + .btn-group,
.btn-group-vertical > .btn-group + .btn,
.btn-group-vertical > .btn-group + .btn-group {
  margin-top: -1px;
  margin-left: 0;
}
.btn-group-vertical > .btn:not(:first-child):not(:last-child) {
  border-radius: 0;
}
.btn-group-vertical > .btn:first-child:not(:last-child) {
  border-top-right-radius: 2px;
  border-top-left-radius: 2px;
  border-bottom-right-radius: 0;
  border-bottom-left-radius: 0;
}
.btn-group-vertical > .btn:last-child:not(:first-child) {
  border-top-right-radius: 0;
  border-top-left-radius: 0;
  border-bottom-right-radius: 2px;
  border-bottom-left-radius: 2px;
}
.btn-group-vertical > .btn-group:not(:first-child):not(:last-child) > .btn {
  border-radius: 0;
}
.btn-group-vertical > .btn-group:first-child:not(:last-child) > .btn:last-child,
.btn-group-vertical > .btn-group:first-child:not(:last-child) > .dropdown-toggle {
  border-bottom-right-radius: 0;
  border-bottom-left-radius: 0;
}
.btn-group-vertical > .btn-group:last-child:not(:first-child) > .btn:first-child {
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.btn-group-justified {
  display: table;
  width: 100%;
  table-layout: fixed;
  border-collapse: separate;
}
.btn-group-justified > .btn,
.btn-group-justified > .btn-group {
  float: none;
  display: table-cell;
  width: 1%;
}
.btn-group-justified > .btn-group .btn {
  width: 100%;
}
.btn-group-justified > .btn-group .dropdown-menu {
  left: auto;
}
[data-toggle="buttons"] > .btn input[type="radio"],
[data-toggle="buttons"] > .btn-group > .btn input[type="radio"],
[data-toggle="buttons"] > .btn input[type="checkbox"],
[data-toggle="buttons"] > .btn-group > .btn input[type="checkbox"] {
  position: absolute;
  clip: rect(0, 0, 0, 0);
  pointer-events: none;
}
.input-group {
  position: relative;
  display: table;
  border-collapse: separate;
}
.input-group[class*="col-"] {
  float: none;
  padding-left: 0;
  padding-right: 0;
}
.input-group .form-control {
  position: relative;
  z-index: 2;
  float: left;
  width: 100%;
  margin-bottom: 0;
}
.input-group .form-control:focus {
  z-index: 3;
}
.input-group-lg > .form-control,
.input-group-lg > .input-group-addon,
.input-group-lg > .input-group-btn > .btn {
  height: 45px;
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
  border-radius: 3px;
}
select.input-group-lg > .form-control,
select.input-group-lg > .input-group-addon,
select.input-group-lg > .input-group-btn > .btn {
  height: 45px;
  line-height: 45px;
}
textarea.input-group-lg > .form-control,
textarea.input-group-lg > .input-group-addon,
textarea.input-group-lg > .input-group-btn > .btn,
select[multiple].input-group-lg > .form-control,
select[multiple].input-group-lg > .input-group-addon,
select[multiple].input-group-lg > .input-group-btn > .btn {
  height: auto;
}
.input-group-sm > .form-control,
.input-group-sm > .input-group-addon,
.input-group-sm > .input-group-btn > .btn {
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
}
select.input-group-sm > .form-control,
select.input-group-sm > .input-group-addon,
select.input-group-sm > .input-group-btn > .btn {
  height: 30px;
  line-height: 30px;
}
textarea.input-group-sm > .form-control,
textarea.input-group-sm > .input-group-addon,
textarea.input-group-sm > .input-group-btn > .btn,
select[multiple].input-group-sm > .form-control,
select[multiple].input-group-sm > .input-group-addon,
select[multiple].input-group-sm > .input-group-btn > .btn {
  height: auto;
}
.input-group-addon,
.input-group-btn,
.input-group .form-control {
  display: table-cell;
}
.input-group-addon:not(:first-child):not(:last-child),
.input-group-btn:not(:first-child):not(:last-child),
.input-group .form-control:not(:first-child):not(:last-child) {
  border-radius: 0;
}
.input-group-addon,
.input-group-btn {
  width: 1%;
  white-space: nowrap;
  vertical-align: middle;
}
.input-group-addon {
  padding: 6px 12px;
  font-size: 13px;
  font-weight: normal;
  line-height: 1;
  color: #555555;
  text-align: center;
  background-color: #eeeeee;
  border: 1px solid #ccc;
  border-radius: 2px;
}
.input-group-addon.input-sm {
  padding: 5px 10px;
  font-size: 12px;
  border-radius: 1px;
}
.input-group-addon.input-lg {
  padding: 10px 16px;
  font-size: 17px;
  border-radius: 3px;
}
.input-group-addon input[type="radio"],
.input-group-addon input[type="checkbox"] {
  margin-top: 0;
}
.input-group .form-control:first-child,
.input-group-addon:first-child,
.input-group-btn:first-child > .btn,
.input-group-btn:first-child > .btn-group > .btn,
.input-group-btn:first-child > .dropdown-toggle,
.input-group-btn:last-child > .btn:not(:last-child):not(.dropdown-toggle),
.input-group-btn:last-child > .btn-group:not(:last-child) > .btn {
  border-bottom-right-radius: 0;
  border-top-right-radius: 0;
}
.input-group-addon:first-child {
  border-right: 0;
}
.input-group .form-control:last-child,
.input-group-addon:last-child,
.input-group-btn:last-child > .btn,
.input-group-btn:last-child > .btn-group > .btn,
.input-group-btn:last-child > .dropdown-toggle,
.input-group-btn:first-child > .btn:not(:first-child),
.input-group-btn:first-child > .btn-group:not(:first-child) > .btn {
  border-bottom-left-radius: 0;
  border-top-left-radius: 0;
}
.input-group-addon:last-child {
  border-left: 0;
}
.input-group-btn {
  position: relative;
  font-size: 0;
  white-space: nowrap;
}
.input-group-btn > .btn {
  position: relative;
}
.input-group-btn > .btn + .btn {
  margin-left: -1px;
}
.input-group-btn > .btn:hover,
.input-group-btn > .btn:focus,
.input-group-btn > .btn:active {
  z-index: 2;
}
.input-group-btn:first-child > .btn,
.input-group-btn:first-child > .btn-group {
  margin-right: -1px;
}
.input-group-btn:last-child > .btn,
.input-group-btn:last-child > .btn-group {
  z-index: 2;
  margin-left: -1px;
}
.nav {
  margin-bottom: 0;
  padding-left: 0;
  list-style: none;
}
.nav > li {
  position: relative;
  display: block;
}
.nav > li > a {
  position: relative;
  display: block;
  padding: 10px 15px;
}
.nav > li > a:hover,
.nav > li > a:focus {
  text-decoration: none;
  background-color: #eeeeee;
}
.nav > li.disabled > a {
  color: #777777;
}
.nav > li.disabled > a:hover,
.nav > li.disabled > a:focus {
  color: #777777;
  text-decoration: none;
  background-color: transparent;
  cursor: not-allowed;
}
.nav .open > a,
.nav .open > a:hover,
.nav .open > a:focus {
  background-color: #eeeeee;
  border-color: #337ab7;
}
.nav .nav-divider {
  height: 1px;
  margin: 8px 0;
  overflow: hidden;
  background-color: #e5e5e5;
}
.nav > li > a > img {
  max-width: none;
}
.nav-tabs {
  border-bottom: 1px solid #ddd;
}
.nav-tabs > li {
  float: left;
  margin-bottom: -1px;
}
.nav-tabs > li > a {
  margin-right: 2px;
  line-height: 1.42857143;
  border: 1px solid transparent;
  border-radius: 2px 2px 0 0;
}
.nav-tabs > li > a:hover {
  border-color: #eeeeee #eeeeee #ddd;
}
.nav-tabs > li.active > a,
.nav-tabs > li.active > a:hover,
.nav-tabs > li.active > a:focus {
  color: #555555;
  background-color: #fff;
  border: 1px solid #ddd;
  border-bottom-color: transparent;
  cursor: default;
}
.nav-tabs.nav-justified {
  width: 100%;
  border-bottom: 0;
}
.nav-tabs.nav-justified > li {
  float: none;
}
.nav-tabs.nav-justified > li > a {
  text-align: center;
  margin-bottom: 5px;
}
.nav-tabs.nav-justified > .dropdown .dropdown-menu {
  top: auto;
  left: auto;
}
@media (min-width: 768px) {
  .nav-tabs.nav-justified > li {
    display: table-cell;
    width: 1%;
  }
  .nav-tabs.nav-justified > li > a {
    margin-bottom: 0;
  }
}
.nav-tabs.nav-justified > li > a {
  margin-right: 0;
  border-radius: 2px;
}
.nav-tabs.nav-justified > .active > a,
.nav-tabs.nav-justified > .active > a:hover,
.nav-tabs.nav-justified > .active > a:focus {
  border: 1px solid #ddd;
}
@media (min-width: 768px) {
  .nav-tabs.nav-justified > li > a {
    border-bottom: 1px solid #ddd;
    border-radius: 2px 2px 0 0;
  }
  .nav-tabs.nav-justified > .active > a,
  .nav-tabs.nav-justified > .active > a:hover,
  .nav-tabs.nav-justified > .active > a:focus {
    border-bottom-color: #fff;
  }
}
.nav-pills > li {
  float: left;
}
.nav-pills > li > a {
  border-radius: 2px;
}
.nav-pills > li + li {
  margin-left: 2px;
}
.nav-pills > li.active > a,
.nav-pills > li.active > a:hover,
.nav-pills > li.active > a:focus {
  color: #fff;
  background-color: #337ab7;
}
.nav-stacked > li {
  float: none;
}
.nav-stacked > li + li {
  margin-top: 2px;
  margin-left: 0;
}
.nav-justified {
  width: 100%;
}
.nav-justified > li {
  float: none;
}
.nav-justified > li > a {
  text-align: center;
  margin-bottom: 5px;
}
.nav-justified > .dropdown .dropdown-menu {
  top: auto;
  left: auto;
}
@media (min-width: 768px) {
  .nav-justified > li {
    display: table-cell;
    width: 1%;
  }
  .nav-justified > li > a {
    margin-bottom: 0;
  }
}
.nav-tabs-justified {
  border-bottom: 0;
}
.nav-tabs-justified > li > a {
  margin-right: 0;
  border-radius: 2px;
}
.nav-tabs-justified > .active > a,
.nav-tabs-justified > .active > a:hover,
.nav-tabs-justified > .active > a:focus {
  border: 1px solid #ddd;
}
@media (min-width: 768px) {
  .nav-tabs-justified > li > a {
    border-bottom: 1px solid #ddd;
    border-radius: 2px 2px 0 0;
  }
  .nav-tabs-justified > .active > a,
  .nav-tabs-justified > .active > a:hover,
  .nav-tabs-justified > .active > a:focus {
    border-bottom-color: #fff;
  }
}
.tab-content > .tab-pane {
  display: none;
}
.tab-content > .active {
  display: block;
}
.nav-tabs .dropdown-menu {
  margin-top: -1px;
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.navbar {
  position: relative;
  min-height: 30px;
  margin-bottom: 18px;
  border: 1px solid transparent;
}
@media (min-width: 541px) {
  .navbar {
    border-radius: 2px;
  }
}
@media (min-width: 541px) {
  .navbar-header {
    float: left;
  }
}
.navbar-collapse {
  overflow-x: visible;
  padding-right: 0px;
  padding-left: 0px;
  border-top: 1px solid transparent;
  box-shadow: inset 0 1px 0 rgba(255, 255, 255, 0.1);
  -webkit-overflow-scrolling: touch;
}
.navbar-collapse.in {
  overflow-y: auto;
}
@media (min-width: 541px) {
  .navbar-collapse {
    width: auto;
    border-top: 0;
    box-shadow: none;
  }
  .navbar-collapse.collapse {
    display: block !important;
    height: auto !important;
    padding-bottom: 0;
    overflow: visible !important;
  }
  .navbar-collapse.in {
    overflow-y: visible;
  }
  .navbar-fixed-top .navbar-collapse,
  .navbar-static-top .navbar-collapse,
  .navbar-fixed-bottom .navbar-collapse {
    padding-left: 0;
    padding-right: 0;
  }
}
.navbar-fixed-top .navbar-collapse,
.navbar-fixed-bottom .navbar-collapse {
  max-height: 340px;
}
@media (max-device-width: 540px) and (orientation: landscape) {
  .navbar-fixed-top .navbar-collapse,
  .navbar-fixed-bottom .navbar-collapse {
    max-height: 200px;
  }
}
.container > .navbar-header,
.container-fluid > .navbar-header,
.container > .navbar-collapse,
.container-fluid > .navbar-collapse {
  margin-right: 0px;
  margin-left: 0px;
}
@media (min-width: 541px) {
  .container > .navbar-header,
  .container-fluid > .navbar-header,
  .container > .navbar-collapse,
  .container-fluid > .navbar-collapse {
    margin-right: 0;
    margin-left: 0;
  }
}
.navbar-static-top {
  z-index: 1000;
  border-width: 0 0 1px;
}
@media (min-width: 541px) {
  .navbar-static-top {
    border-radius: 0;
  }
}
.navbar-fixed-top,
.navbar-fixed-bottom {
  position: fixed;
  right: 0;
  left: 0;
  z-index: 1030;
}
@media (min-width: 541px) {
  .navbar-fixed-top,
  .navbar-fixed-bottom {
    border-radius: 0;
  }
}
.navbar-fixed-top {
  top: 0;
  border-width: 0 0 1px;
}
.navbar-fixed-bottom {
  bottom: 0;
  margin-bottom: 0;
  border-width: 1px 0 0;
}
.navbar-brand {
  float: left;
  padding: 6px 0px;
  font-size: 17px;
  line-height: 18px;
  height: 30px;
}
.navbar-brand:hover,
.navbar-brand:focus {
  text-decoration: none;
}
.navbar-brand > img {
  display: block;
}
@media (min-width: 541px) {
  .navbar > .container .navbar-brand,
  .navbar > .container-fluid .navbar-brand {
    margin-left: 0px;
  }
}
.navbar-toggle {
  position: relative;
  float: right;
  margin-right: 0px;
  padding: 9px 10px;
  margin-top: -2px;
  margin-bottom: -2px;
  background-color: transparent;
  background-image: none;
  border: 1px solid transparent;
  border-radius: 2px;
}
.navbar-toggle:focus {
  outline: 0;
}
.navbar-toggle .icon-bar {
  display: block;
  width: 22px;
  height: 2px;
  border-radius: 1px;
}
.navbar-toggle .icon-bar + .icon-bar {
  margin-top: 4px;
}
@media (min-width: 541px) {
  .navbar-toggle {
    display: none;
  }
}
.navbar-nav {
  margin: 3px 0px;
}
.navbar-nav > li > a {
  padding-top: 10px;
  padding-bottom: 10px;
  line-height: 18px;
}
@media (max-width: 540px) {
  .navbar-nav .open .dropdown-menu {
    position: static;
    float: none;
    width: auto;
    margin-top: 0;
    background-color: transparent;
    border: 0;
    box-shadow: none;
  }
  .navbar-nav .open .dropdown-menu > li > a,
  .navbar-nav .open .dropdown-menu .dropdown-header {
    padding: 5px 15px 5px 25px;
  }
  .navbar-nav .open .dropdown-menu > li > a {
    line-height: 18px;
  }
  .navbar-nav .open .dropdown-menu > li > a:hover,
  .navbar-nav .open .dropdown-menu > li > a:focus {
    background-image: none;
  }
}
@media (min-width: 541px) {
  .navbar-nav {
    float: left;
    margin: 0;
  }
  .navbar-nav > li {
    float: left;
  }
  .navbar-nav > li > a {
    padding-top: 6px;
    padding-bottom: 6px;
  }
}
.navbar-form {
  margin-left: 0px;
  margin-right: 0px;
  padding: 10px 0px;
  border-top: 1px solid transparent;
  border-bottom: 1px solid transparent;
  -webkit-box-shadow: inset 0 1px 0 rgba(255, 255, 255, 0.1), 0 1px 0 rgba(255, 255, 255, 0.1);
  box-shadow: inset 0 1px 0 rgba(255, 255, 255, 0.1), 0 1px 0 rgba(255, 255, 255, 0.1);
  margin-top: -1px;
  margin-bottom: -1px;
}
@media (min-width: 768px) {
  .navbar-form .form-group {
    display: inline-block;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .navbar-form .form-control {
    display: inline-block;
    width: auto;
    vertical-align: middle;
  }
  .navbar-form .form-control-static {
    display: inline-block;
  }
  .navbar-form .input-group {
    display: inline-table;
    vertical-align: middle;
  }
  .navbar-form .input-group .input-group-addon,
  .navbar-form .input-group .input-group-btn,
  .navbar-form .input-group .form-control {
    width: auto;
  }
  .navbar-form .input-group > .form-control {
    width: 100%;
  }
  .navbar-form .control-label {
    margin-bottom: 0;
    vertical-align: middle;
  }
  .navbar-form .radio,
  .navbar-form .checkbox {
    display: inline-block;
    margin-top: 0;
    margin-bottom: 0;
    vertical-align: middle;
  }
  .navbar-form .radio label,
  .navbar-form .checkbox label {
    padding-left: 0;
  }
  .navbar-form .radio input[type="radio"],
  .navbar-form .checkbox input[type="checkbox"] {
    position: relative;
    margin-left: 0;
  }
  .navbar-form .has-feedback .form-control-feedback {
    top: 0;
  }
}
@media (max-width: 540px) {
  .navbar-form .form-group {
    margin-bottom: 5px;
  }
  .navbar-form .form-group:last-child {
    margin-bottom: 0;
  }
}
@media (min-width: 541px) {
  .navbar-form {
    width: auto;
    border: 0;
    margin-left: 0;
    margin-right: 0;
    padding-top: 0;
    padding-bottom: 0;
    -webkit-box-shadow: none;
    box-shadow: none;
  }
}
.navbar-nav > li > .dropdown-menu {
  margin-top: 0;
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.navbar-fixed-bottom .navbar-nav > li > .dropdown-menu {
  margin-bottom: 0;
  border-top-right-radius: 2px;
  border-top-left-radius: 2px;
  border-bottom-right-radius: 0;
  border-bottom-left-radius: 0;
}
.navbar-btn {
  margin-top: -1px;
  margin-bottom: -1px;
}
.navbar-btn.btn-sm {
  margin-top: 0px;
  margin-bottom: 0px;
}
.navbar-btn.btn-xs {
  margin-top: 4px;
  margin-bottom: 4px;
}
.navbar-text {
  margin-top: 6px;
  margin-bottom: 6px;
}
@media (min-width: 541px) {
  .navbar-text {
    float: left;
    margin-left: 0px;
    margin-right: 0px;
  }
}
@media (min-width: 541px) {
  .navbar-left {
    float: left !important;
    float: left;
  }
  .navbar-right {
    float: right !important;
    float: right;
    margin-right: 0px;
  }
  .navbar-right ~ .navbar-right {
    margin-right: 0;
  }
}
.navbar-default {
  background-color: #f8f8f8;
  border-color: #e7e7e7;
}
.navbar-default .navbar-brand {
  color: #777;
}
.navbar-default .navbar-brand:hover,
.navbar-default .navbar-brand:focus {
  color: #5e5e5e;
  background-color: transparent;
}
.navbar-default .navbar-text {
  color: #777;
}
.navbar-default .navbar-nav > li > a {
  color: #777;
}
.navbar-default .navbar-nav > li > a:hover,
.navbar-default .navbar-nav > li > a:focus {
  color: #333;
  background-color: transparent;
}
.navbar-default .navbar-nav > .active > a,
.navbar-default .navbar-nav > .active > a:hover,
.navbar-default .navbar-nav > .active > a:focus {
  color: #555;
  background-color: #e7e7e7;
}
.navbar-default .navbar-nav > .disabled > a,
.navbar-default .navbar-nav > .disabled > a:hover,
.navbar-default .navbar-nav > .disabled > a:focus {
  color: #ccc;
  background-color: transparent;
}
.navbar-default .navbar-toggle {
  border-color: #ddd;
}
.navbar-default .navbar-toggle:hover,
.navbar-default .navbar-toggle:focus {
  background-color: #ddd;
}
.navbar-default .navbar-toggle .icon-bar {
  background-color: #888;
}
.navbar-default .navbar-collapse,
.navbar-default .navbar-form {
  border-color: #e7e7e7;
}
.navbar-default .navbar-nav > .open > a,
.navbar-default .navbar-nav > .open > a:hover,
.navbar-default .navbar-nav > .open > a:focus {
  background-color: #e7e7e7;
  color: #555;
}
@media (max-width: 540px) {
  .navbar-default .navbar-nav .open .dropdown-menu > li > a {
    color: #777;
  }
  .navbar-default .navbar-nav .open .dropdown-menu > li > a:hover,
  .navbar-default .navbar-nav .open .dropdown-menu > li > a:focus {
    color: #333;
    background-color: transparent;
  }
  .navbar-default .navbar-nav .open .dropdown-menu > .active > a,
  .navbar-default .navbar-nav .open .dropdown-menu > .active > a:hover,
  .navbar-default .navbar-nav .open .dropdown-menu > .active > a:focus {
    color: #555;
    background-color: #e7e7e7;
  }
  .navbar-default .navbar-nav .open .dropdown-menu > .disabled > a,
  .navbar-default .navbar-nav .open .dropdown-menu > .disabled > a:hover,
  .navbar-default .navbar-nav .open .dropdown-menu > .disabled > a:focus {
    color: #ccc;
    background-color: transparent;
  }
}
.navbar-default .navbar-link {
  color: #777;
}
.navbar-default .navbar-link:hover {
  color: #333;
}
.navbar-default .btn-link {
  color: #777;
}
.navbar-default .btn-link:hover,
.navbar-default .btn-link:focus {
  color: #333;
}
.navbar-default .btn-link[disabled]:hover,
fieldset[disabled] .navbar-default .btn-link:hover,
.navbar-default .btn-link[disabled]:focus,
fieldset[disabled] .navbar-default .btn-link:focus {
  color: #ccc;
}
.navbar-inverse {
  background-color: #222;
  border-color: #080808;
}
.navbar-inverse .navbar-brand {
  color: #9d9d9d;
}
.navbar-inverse .navbar-brand:hover,
.navbar-inverse .navbar-brand:focus {
  color: #fff;
  background-color: transparent;
}
.navbar-inverse .navbar-text {
  color: #9d9d9d;
}
.navbar-inverse .navbar-nav > li > a {
  color: #9d9d9d;
}
.navbar-inverse .navbar-nav > li > a:hover,
.navbar-inverse .navbar-nav > li > a:focus {
  color: #fff;
  background-color: transparent;
}
.navbar-inverse .navbar-nav > .active > a,
.navbar-inverse .navbar-nav > .active > a:hover,
.navbar-inverse .navbar-nav > .active > a:focus {
  color: #fff;
  background-color: #080808;
}
.navbar-inverse .navbar-nav > .disabled > a,
.navbar-inverse .navbar-nav > .disabled > a:hover,
.navbar-inverse .navbar-nav > .disabled > a:focus {
  color: #444;
  background-color: transparent;
}
.navbar-inverse .navbar-toggle {
  border-color: #333;
}
.navbar-inverse .navbar-toggle:hover,
.navbar-inverse .navbar-toggle:focus {
  background-color: #333;
}
.navbar-inverse .navbar-toggle .icon-bar {
  background-color: #fff;
}
.navbar-inverse .navbar-collapse,
.navbar-inverse .navbar-form {
  border-color: #101010;
}
.navbar-inverse .navbar-nav > .open > a,
.navbar-inverse .navbar-nav > .open > a:hover,
.navbar-inverse .navbar-nav > .open > a:focus {
  background-color: #080808;
  color: #fff;
}
@media (max-width: 540px) {
  .navbar-inverse .navbar-nav .open .dropdown-menu > .dropdown-header {
    border-color: #080808;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu .divider {
    background-color: #080808;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > li > a {
    color: #9d9d9d;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > li > a:hover,
  .navbar-inverse .navbar-nav .open .dropdown-menu > li > a:focus {
    color: #fff;
    background-color: transparent;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > .active > a,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .active > a:hover,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .active > a:focus {
    color: #fff;
    background-color: #080808;
  }
  .navbar-inverse .navbar-nav .open .dropdown-menu > .disabled > a,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .disabled > a:hover,
  .navbar-inverse .navbar-nav .open .dropdown-menu > .disabled > a:focus {
    color: #444;
    background-color: transparent;
  }
}
.navbar-inverse .navbar-link {
  color: #9d9d9d;
}
.navbar-inverse .navbar-link:hover {
  color: #fff;
}
.navbar-inverse .btn-link {
  color: #9d9d9d;
}
.navbar-inverse .btn-link:hover,
.navbar-inverse .btn-link:focus {
  color: #fff;
}
.navbar-inverse .btn-link[disabled]:hover,
fieldset[disabled] .navbar-inverse .btn-link:hover,
.navbar-inverse .btn-link[disabled]:focus,
fieldset[disabled] .navbar-inverse .btn-link:focus {
  color: #444;
}
.breadcrumb {
  padding: 8px 15px;
  margin-bottom: 18px;
  list-style: none;
  background-color: #f5f5f5;
  border-radius: 2px;
}
.breadcrumb > li {
  display: inline-block;
}
.breadcrumb > li + li:before {
  content: "/\00a0";
  padding: 0 5px;
  color: #5e5e5e;
}
.breadcrumb > .active {
  color: #777777;
}
.pagination {
  display: inline-block;
  padding-left: 0;
  margin: 18px 0;
  border-radius: 2px;
}
.pagination > li {
  display: inline;
}
.pagination > li > a,
.pagination > li > span {
  position: relative;
  float: left;
  padding: 6px 12px;
  line-height: 1.42857143;
  text-decoration: none;
  color: #337ab7;
  background-color: #fff;
  border: 1px solid #ddd;
  margin-left: -1px;
}
.pagination > li:first-child > a,
.pagination > li:first-child > span {
  margin-left: 0;
  border-bottom-left-radius: 2px;
  border-top-left-radius: 2px;
}
.pagination > li:last-child > a,
.pagination > li:last-child > span {
  border-bottom-right-radius: 2px;
  border-top-right-radius: 2px;
}
.pagination > li > a:hover,
.pagination > li > span:hover,
.pagination > li > a:focus,
.pagination > li > span:focus {
  z-index: 2;
  color: #23527c;
  background-color: #eeeeee;
  border-color: #ddd;
}
.pagination > .active > a,
.pagination > .active > span,
.pagination > .active > a:hover,
.pagination > .active > span:hover,
.pagination > .active > a:focus,
.pagination > .active > span:focus {
  z-index: 3;
  color: #fff;
  background-color: #337ab7;
  border-color: #337ab7;
  cursor: default;
}
.pagination > .disabled > span,
.pagination > .disabled > span:hover,
.pagination > .disabled > span:focus,
.pagination > .disabled > a,
.pagination > .disabled > a:hover,
.pagination > .disabled > a:focus {
  color: #777777;
  background-color: #fff;
  border-color: #ddd;
  cursor: not-allowed;
}
.pagination-lg > li > a,
.pagination-lg > li > span {
  padding: 10px 16px;
  font-size: 17px;
  line-height: 1.3333333;
}
.pagination-lg > li:first-child > a,
.pagination-lg > li:first-child > span {
  border-bottom-left-radius: 3px;
  border-top-left-radius: 3px;
}
.pagination-lg > li:last-child > a,
.pagination-lg > li:last-child > span {
  border-bottom-right-radius: 3px;
  border-top-right-radius: 3px;
}
.pagination-sm > li > a,
.pagination-sm > li > span {
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
}
.pagination-sm > li:first-child > a,
.pagination-sm > li:first-child > span {
  border-bottom-left-radius: 1px;
  border-top-left-radius: 1px;
}
.pagination-sm > li:last-child > a,
.pagination-sm > li:last-child > span {
  border-bottom-right-radius: 1px;
  border-top-right-radius: 1px;
}
.pager {
  padding-left: 0;
  margin: 18px 0;
  list-style: none;
  text-align: center;
}
.pager li {
  display: inline;
}
.pager li > a,
.pager li > span {
  display: inline-block;
  padding: 5px 14px;
  background-color: #fff;
  border: 1px solid #ddd;
  border-radius: 15px;
}
.pager li > a:hover,
.pager li > a:focus {
  text-decoration: none;
  background-color: #eeeeee;
}
.pager .next > a,
.pager .next > span {
  float: right;
}
.pager .previous > a,
.pager .previous > span {
  float: left;
}
.pager .disabled > a,
.pager .disabled > a:hover,
.pager .disabled > a:focus,
.pager .disabled > span {
  color: #777777;
  background-color: #fff;
  cursor: not-allowed;
}
.label {
  display: inline;
  padding: .2em .6em .3em;
  font-size: 75%;
  font-weight: bold;
  line-height: 1;
  color: #fff;
  text-align: center;
  white-space: nowrap;
  vertical-align: baseline;
  border-radius: .25em;
}
a.label:hover,
a.label:focus {
  color: #fff;
  text-decoration: none;
  cursor: pointer;
}
.label:empty {
  display: none;
}
.btn .label {
  position: relative;
  top: -1px;
}
.label-default {
  background-color: #777777;
}
.label-default[href]:hover,
.label-default[href]:focus {
  background-color: #5e5e5e;
}
.label-primary {
  background-color: #337ab7;
}
.label-primary[href]:hover,
.label-primary[href]:focus {
  background-color: #286090;
}
.label-success {
  background-color: #5cb85c;
}
.label-success[href]:hover,
.label-success[href]:focus {
  background-color: #449d44;
}
.label-info {
  background-color: #5bc0de;
}
.label-info[href]:hover,
.label-info[href]:focus {
  background-color: #31b0d5;
}
.label-warning {
  background-color: #f0ad4e;
}
.label-warning[href]:hover,
.label-warning[href]:focus {
  background-color: #ec971f;
}
.label-danger {
  background-color: #d9534f;
}
.label-danger[href]:hover,
.label-danger[href]:focus {
  background-color: #c9302c;
}
.badge {
  display: inline-block;
  min-width: 10px;
  padding: 3px 7px;
  font-size: 12px;
  font-weight: bold;
  color: #fff;
  line-height: 1;
  vertical-align: middle;
  white-space: nowrap;
  text-align: center;
  background-color: #777777;
  border-radius: 10px;
}
.badge:empty {
  display: none;
}
.btn .badge {
  position: relative;
  top: -1px;
}
.btn-xs .badge,
.btn-group-xs > .btn .badge {
  top: 0;
  padding: 1px 5px;
}
a.badge:hover,
a.badge:focus {
  color: #fff;
  text-decoration: none;
  cursor: pointer;
}
.list-group-item.active > .badge,
.nav-pills > .active > a > .badge {
  color: #337ab7;
  background-color: #fff;
}
.list-group-item > .badge {
  float: right;
}
.list-group-item > .badge + .badge {
  margin-right: 5px;
}
.nav-pills > li > a > .badge {
  margin-left: 3px;
}
.jumbotron {
  padding-top: 30px;
  padding-bottom: 30px;
  margin-bottom: 30px;
  color: inherit;
  background-color: #eeeeee;
}
.jumbotron h1,
.jumbotron .h1 {
  color: inherit;
}
.jumbotron p {
  margin-bottom: 15px;
  font-size: 20px;
  font-weight: 200;
}
.jumbotron > hr {
  border-top-color: #d5d5d5;
}
.container .jumbotron,
.container-fluid .jumbotron {
  border-radius: 3px;
  padding-left: 0px;
  padding-right: 0px;
}
.jumbotron .container {
  max-width: 100%;
}
@media screen and (min-width: 768px) {
  .jumbotron {
    padding-top: 48px;
    padding-bottom: 48px;
  }
  .container .jumbotron,
  .container-fluid .jumbotron {
    padding-left: 60px;
    padding-right: 60px;
  }
  .jumbotron h1,
  .jumbotron .h1 {
    font-size: 59px;
  }
}
.thumbnail {
  display: block;
  padding: 4px;
  margin-bottom: 18px;
  line-height: 1.42857143;
  background-color: #fff;
  border: 1px solid #ddd;
  border-radius: 2px;
  -webkit-transition: border 0.2s ease-in-out;
  -o-transition: border 0.2s ease-in-out;
  transition: border 0.2s ease-in-out;
}
.thumbnail > img,
.thumbnail a > img {
  margin-left: auto;
  margin-right: auto;
}
a.thumbnail:hover,
a.thumbnail:focus,
a.thumbnail.active {
  border-color: #337ab7;
}
.thumbnail .caption {
  padding: 9px;
  color: #000;
}
.alert {
  padding: 15px;
  margin-bottom: 18px;
  border: 1px solid transparent;
  border-radius: 2px;
}
.alert h4 {
  margin-top: 0;
  color: inherit;
}
.alert .alert-link {
  font-weight: bold;
}
.alert > p,
.alert > ul {
  margin-bottom: 0;
}
.alert > p + p {
  margin-top: 5px;
}
.alert-dismissable,
.alert-dismissible {
  padding-right: 35px;
}
.alert-dismissable .close,
.alert-dismissible .close {
  position: relative;
  top: -2px;
  right: -21px;
  color: inherit;
}
.alert-success {
  background-color: #dff0d8;
  border-color: #d6e9c6;
  color: #3c763d;
}
.alert-success hr {
  border-top-color: #c9e2b3;
}
.alert-success .alert-link {
  color: #2b542c;
}
.alert-info {
  background-color: #d9edf7;
  border-color: #bce8f1;
  color: #31708f;
}
.alert-info hr {
  border-top-color: #a6e1ec;
}
.alert-info .alert-link {
  color: #245269;
}
.alert-warning {
  background-color: #fcf8e3;
  border-color: #faebcc;
  color: #8a6d3b;
}
.alert-warning hr {
  border-top-color: #f7e1b5;
}
.alert-warning .alert-link {
  color: #66512c;
}
.alert-danger {
  background-color: #f2dede;
  border-color: #ebccd1;
  color: #a94442;
}
.alert-danger hr {
  border-top-color: #e4b9c0;
}
.alert-danger .alert-link {
  color: #843534;
}
@-webkit-keyframes progress-bar-stripes {
  from {
    background-position: 40px 0;
  }
  to {
    background-position: 0 0;
  }
}
@keyframes progress-bar-stripes {
  from {
    background-position: 40px 0;
  }
  to {
    background-position: 0 0;
  }
}
.progress {
  overflow: hidden;
  height: 18px;
  margin-bottom: 18px;
  background-color: #f5f5f5;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 2px rgba(0, 0, 0, 0.1);
  box-shadow: inset 0 1px 2px rgba(0, 0, 0, 0.1);
}
.progress-bar {
  float: left;
  width: 0%;
  height: 100%;
  font-size: 12px;
  line-height: 18px;
  color: #fff;
  text-align: center;
  background-color: #337ab7;
  -webkit-box-shadow: inset 0 -1px 0 rgba(0, 0, 0, 0.15);
  box-shadow: inset 0 -1px 0 rgba(0, 0, 0, 0.15);
  -webkit-transition: width 0.6s ease;
  -o-transition: width 0.6s ease;
  transition: width 0.6s ease;
}
.progress-striped .progress-bar,
.progress-bar-striped {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-size: 40px 40px;
}
.progress.active .progress-bar,
.progress-bar.active {
  -webkit-animation: progress-bar-stripes 2s linear infinite;
  -o-animation: progress-bar-stripes 2s linear infinite;
  animation: progress-bar-stripes 2s linear infinite;
}
.progress-bar-success {
  background-color: #5cb85c;
}
.progress-striped .progress-bar-success {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.progress-bar-info {
  background-color: #5bc0de;
}
.progress-striped .progress-bar-info {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.progress-bar-warning {
  background-color: #f0ad4e;
}
.progress-striped .progress-bar-warning {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.progress-bar-danger {
  background-color: #d9534f;
}
.progress-striped .progress-bar-danger {
  background-image: -webkit-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: -o-linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
  background-image: linear-gradient(45deg, rgba(255, 255, 255, 0.15) 25%, transparent 25%, transparent 50%, rgba(255, 255, 255, 0.15) 50%, rgba(255, 255, 255, 0.15) 75%, transparent 75%, transparent);
}
.media {
  margin-top: 15px;
}
.media:first-child {
  margin-top: 0;
}
.media,
.media-body {
  zoom: 1;
  overflow: hidden;
}
.media-body {
  width: 10000px;
}
.media-object {
  display: block;
}
.media-object.img-thumbnail {
  max-width: none;
}
.media-right,
.media > .pull-right {
  padding-left: 10px;
}
.media-left,
.media > .pull-left {
  padding-right: 10px;
}
.media-left,
.media-right,
.media-body {
  display: table-cell;
  vertical-align: top;
}
.media-middle {
  vertical-align: middle;
}
.media-bottom {
  vertical-align: bottom;
}
.media-heading {
  margin-top: 0;
  margin-bottom: 5px;
}
.media-list {
  padding-left: 0;
  list-style: none;
}
.list-group {
  margin-bottom: 20px;
  padding-left: 0;
}
.list-group-item {
  position: relative;
  display: block;
  padding: 10px 15px;
  margin-bottom: -1px;
  background-color: #fff;
  border: 1px solid #ddd;
}
.list-group-item:first-child {
  border-top-right-radius: 2px;
  border-top-left-radius: 2px;
}
.list-group-item:last-child {
  margin-bottom: 0;
  border-bottom-right-radius: 2px;
  border-bottom-left-radius: 2px;
}
a.list-group-item,
button.list-group-item {
  color: #555;
}
a.list-group-item .list-group-item-heading,
button.list-group-item .list-group-item-heading {
  color: #333;
}
a.list-group-item:hover,
button.list-group-item:hover,
a.list-group-item:focus,
button.list-group-item:focus {
  text-decoration: none;
  color: #555;
  background-color: #f5f5f5;
}
button.list-group-item {
  width: 100%;
  text-align: left;
}
.list-group-item.disabled,
.list-group-item.disabled:hover,
.list-group-item.disabled:focus {
  background-color: #eeeeee;
  color: #777777;
  cursor: not-allowed;
}
.list-group-item.disabled .list-group-item-heading,
.list-group-item.disabled:hover .list-group-item-heading,
.list-group-item.disabled:focus .list-group-item-heading {
  color: inherit;
}
.list-group-item.disabled .list-group-item-text,
.list-group-item.disabled:hover .list-group-item-text,
.list-group-item.disabled:focus .list-group-item-text {
  color: #777777;
}
.list-group-item.active,
.list-group-item.active:hover,
.list-group-item.active:focus {
  z-index: 2;
  color: #fff;
  background-color: #337ab7;
  border-color: #337ab7;
}
.list-group-item.active .list-group-item-heading,
.list-group-item.active:hover .list-group-item-heading,
.list-group-item.active:focus .list-group-item-heading,
.list-group-item.active .list-group-item-heading > small,
.list-group-item.active:hover .list-group-item-heading > small,
.list-group-item.active:focus .list-group-item-heading > small,
.list-group-item.active .list-group-item-heading > .small,
.list-group-item.active:hover .list-group-item-heading > .small,
.list-group-item.active:focus .list-group-item-heading > .small {
  color: inherit;
}
.list-group-item.active .list-group-item-text,
.list-group-item.active:hover .list-group-item-text,
.list-group-item.active:focus .list-group-item-text {
  color: #c7ddef;
}
.list-group-item-success {
  color: #3c763d;
  background-color: #dff0d8;
}
a.list-group-item-success,
button.list-group-item-success {
  color: #3c763d;
}
a.list-group-item-success .list-group-item-heading,
button.list-group-item-success .list-group-item-heading {
  color: inherit;
}
a.list-group-item-success:hover,
button.list-group-item-success:hover,
a.list-group-item-success:focus,
button.list-group-item-success:focus {
  color: #3c763d;
  background-color: #d0e9c6;
}
a.list-group-item-success.active,
button.list-group-item-success.active,
a.list-group-item-success.active:hover,
button.list-group-item-success.active:hover,
a.list-group-item-success.active:focus,
button.list-group-item-success.active:focus {
  color: #fff;
  background-color: #3c763d;
  border-color: #3c763d;
}
.list-group-item-info {
  color: #31708f;
  background-color: #d9edf7;
}
a.list-group-item-info,
button.list-group-item-info {
  color: #31708f;
}
a.list-group-item-info .list-group-item-heading,
button.list-group-item-info .list-group-item-heading {
  color: inherit;
}
a.list-group-item-info:hover,
button.list-group-item-info:hover,
a.list-group-item-info:focus,
button.list-group-item-info:focus {
  color: #31708f;
  background-color: #c4e3f3;
}
a.list-group-item-info.active,
button.list-group-item-info.active,
a.list-group-item-info.active:hover,
button.list-group-item-info.active:hover,
a.list-group-item-info.active:focus,
button.list-group-item-info.active:focus {
  color: #fff;
  background-color: #31708f;
  border-color: #31708f;
}
.list-group-item-warning {
  color: #8a6d3b;
  background-color: #fcf8e3;
}
a.list-group-item-warning,
button.list-group-item-warning {
  color: #8a6d3b;
}
a.list-group-item-warning .list-group-item-heading,
button.list-group-item-warning .list-group-item-heading {
  color: inherit;
}
a.list-group-item-warning:hover,
button.list-group-item-warning:hover,
a.list-group-item-warning:focus,
button.list-group-item-warning:focus {
  color: #8a6d3b;
  background-color: #faf2cc;
}
a.list-group-item-warning.active,
button.list-group-item-warning.active,
a.list-group-item-warning.active:hover,
button.list-group-item-warning.active:hover,
a.list-group-item-warning.active:focus,
button.list-group-item-warning.active:focus {
  color: #fff;
  background-color: #8a6d3b;
  border-color: #8a6d3b;
}
.list-group-item-danger {
  color: #a94442;
  background-color: #f2dede;
}
a.list-group-item-danger,
button.list-group-item-danger {
  color: #a94442;
}
a.list-group-item-danger .list-group-item-heading,
button.list-group-item-danger .list-group-item-heading {
  color: inherit;
}
a.list-group-item-danger:hover,
button.list-group-item-danger:hover,
a.list-group-item-danger:focus,
button.list-group-item-danger:focus {
  color: #a94442;
  background-color: #ebcccc;
}
a.list-group-item-danger.active,
button.list-group-item-danger.active,
a.list-group-item-danger.active:hover,
button.list-group-item-danger.active:hover,
a.list-group-item-danger.active:focus,
button.list-group-item-danger.active:focus {
  color: #fff;
  background-color: #a94442;
  border-color: #a94442;
}
.list-group-item-heading {
  margin-top: 0;
  margin-bottom: 5px;
}
.list-group-item-text {
  margin-bottom: 0;
  line-height: 1.3;
}
.panel {
  margin-bottom: 18px;
  background-color: #fff;
  border: 1px solid transparent;
  border-radius: 2px;
  -webkit-box-shadow: 0 1px 1px rgba(0, 0, 0, 0.05);
  box-shadow: 0 1px 1px rgba(0, 0, 0, 0.05);
}
.panel-body {
  padding: 15px;
}
.panel-heading {
  padding: 10px 15px;
  border-bottom: 1px solid transparent;
  border-top-right-radius: 1px;
  border-top-left-radius: 1px;
}
.panel-heading > .dropdown .dropdown-toggle {
  color: inherit;
}
.panel-title {
  margin-top: 0;
  margin-bottom: 0;
  font-size: 15px;
  color: inherit;
}
.panel-title > a,
.panel-title > small,
.panel-title > .small,
.panel-title > small > a,
.panel-title > .small > a {
  color: inherit;
}
.panel-footer {
  padding: 10px 15px;
  background-color: #f5f5f5;
  border-top: 1px solid #ddd;
  border-bottom-right-radius: 1px;
  border-bottom-left-radius: 1px;
}
.panel > .list-group,
.panel > .panel-collapse > .list-group {
  margin-bottom: 0;
}
.panel > .list-group .list-group-item,
.panel > .panel-collapse > .list-group .list-group-item {
  border-width: 1px 0;
  border-radius: 0;
}
.panel > .list-group:first-child .list-group-item:first-child,
.panel > .panel-collapse > .list-group:first-child .list-group-item:first-child {
  border-top: 0;
  border-top-right-radius: 1px;
  border-top-left-radius: 1px;
}
.panel > .list-group:last-child .list-group-item:last-child,
.panel > .panel-collapse > .list-group:last-child .list-group-item:last-child {
  border-bottom: 0;
  border-bottom-right-radius: 1px;
  border-bottom-left-radius: 1px;
}
.panel > .panel-heading + .panel-collapse > .list-group .list-group-item:first-child {
  border-top-right-radius: 0;
  border-top-left-radius: 0;
}
.panel-heading + .list-group .list-group-item:first-child {
  border-top-width: 0;
}
.list-group + .panel-footer {
  border-top-width: 0;
}
.panel > .table,
.panel > .table-responsive > .table,
.panel > .panel-collapse > .table {
  margin-bottom: 0;
}
.panel > .table caption,
.panel > .table-responsive > .table caption,
.panel > .panel-collapse > .table caption {
  padding-left: 15px;
  padding-right: 15px;
}
.panel > .table:first-child,
.panel > .table-responsive:first-child > .table:first-child {
  border-top-right-radius: 1px;
  border-top-left-radius: 1px;
}
.panel > .table:first-child > thead:first-child > tr:first-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child,
.panel > .table:first-child > tbody:first-child > tr:first-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child {
  border-top-left-radius: 1px;
  border-top-right-radius: 1px;
}
.panel > .table:first-child > thead:first-child > tr:first-child td:first-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child td:first-child,
.panel > .table:first-child > tbody:first-child > tr:first-child td:first-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child td:first-child,
.panel > .table:first-child > thead:first-child > tr:first-child th:first-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child th:first-child,
.panel > .table:first-child > tbody:first-child > tr:first-child th:first-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child th:first-child {
  border-top-left-radius: 1px;
}
.panel > .table:first-child > thead:first-child > tr:first-child td:last-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child td:last-child,
.panel > .table:first-child > tbody:first-child > tr:first-child td:last-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child td:last-child,
.panel > .table:first-child > thead:first-child > tr:first-child th:last-child,
.panel > .table-responsive:first-child > .table:first-child > thead:first-child > tr:first-child th:last-child,
.panel > .table:first-child > tbody:first-child > tr:first-child th:last-child,
.panel > .table-responsive:first-child > .table:first-child > tbody:first-child > tr:first-child th:last-child {
  border-top-right-radius: 1px;
}
.panel > .table:last-child,
.panel > .table-responsive:last-child > .table:last-child {
  border-bottom-right-radius: 1px;
  border-bottom-left-radius: 1px;
}
.panel > .table:last-child > tbody:last-child > tr:last-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child {
  border-bottom-left-radius: 1px;
  border-bottom-right-radius: 1px;
}
.panel > .table:last-child > tbody:last-child > tr:last-child td:first-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child td:first-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child td:first-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child td:first-child,
.panel > .table:last-child > tbody:last-child > tr:last-child th:first-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child th:first-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child th:first-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child th:first-child {
  border-bottom-left-radius: 1px;
}
.panel > .table:last-child > tbody:last-child > tr:last-child td:last-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child td:last-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child td:last-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child td:last-child,
.panel > .table:last-child > tbody:last-child > tr:last-child th:last-child,
.panel > .table-responsive:last-child > .table:last-child > tbody:last-child > tr:last-child th:last-child,
.panel > .table:last-child > tfoot:last-child > tr:last-child th:last-child,
.panel > .table-responsive:last-child > .table:last-child > tfoot:last-child > tr:last-child th:last-child {
  border-bottom-right-radius: 1px;
}
.panel > .panel-body + .table,
.panel > .panel-body + .table-responsive,
.panel > .table + .panel-body,
.panel > .table-responsive + .panel-body {
  border-top: 1px solid #ddd;
}
.panel > .table > tbody:first-child > tr:first-child th,
.panel > .table > tbody:first-child > tr:first-child td {
  border-top: 0;
}
.panel > .table-bordered,
.panel > .table-responsive > .table-bordered {
  border: 0;
}
.panel > .table-bordered > thead > tr > th:first-child,
.panel > .table-responsive > .table-bordered > thead > tr > th:first-child,
.panel > .table-bordered > tbody > tr > th:first-child,
.panel > .table-responsive > .table-bordered > tbody > tr > th:first-child,
.panel > .table-bordered > tfoot > tr > th:first-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > th:first-child,
.panel > .table-bordered > thead > tr > td:first-child,
.panel > .table-responsive > .table-bordered > thead > tr > td:first-child,
.panel > .table-bordered > tbody > tr > td:first-child,
.panel > .table-responsive > .table-bordered > tbody > tr > td:first-child,
.panel > .table-bordered > tfoot > tr > td:first-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > td:first-child {
  border-left: 0;
}
.panel > .table-bordered > thead > tr > th:last-child,
.panel > .table-responsive > .table-bordered > thead > tr > th:last-child,
.panel > .table-bordered > tbody > tr > th:last-child,
.panel > .table-responsive > .table-bordered > tbody > tr > th:last-child,
.panel > .table-bordered > tfoot > tr > th:last-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > th:last-child,
.panel > .table-bordered > thead > tr > td:last-child,
.panel > .table-responsive > .table-bordered > thead > tr > td:last-child,
.panel > .table-bordered > tbody > tr > td:last-child,
.panel > .table-responsive > .table-bordered > tbody > tr > td:last-child,
.panel > .table-bordered > tfoot > tr > td:last-child,
.panel > .table-responsive > .table-bordered > tfoot > tr > td:last-child {
  border-right: 0;
}
.panel > .table-bordered > thead > tr:first-child > td,
.panel > .table-responsive > .table-bordered > thead > tr:first-child > td,
.panel > .table-bordered > tbody > tr:first-child > td,
.panel > .table-responsive > .table-bordered > tbody > tr:first-child > td,
.panel > .table-bordered > thead > tr:first-child > th,
.panel > .table-responsive > .table-bordered > thead > tr:first-child > th,
.panel > .table-bordered > tbody > tr:first-child > th,
.panel > .table-responsive > .table-bordered > tbody > tr:first-child > th {
  border-bottom: 0;
}
.panel > .table-bordered > tbody > tr:last-child > td,
.panel > .table-responsive > .table-bordered > tbody > tr:last-child > td,
.panel > .table-bordered > tfoot > tr:last-child > td,
.panel > .table-responsive > .table-bordered > tfoot > tr:last-child > td,
.panel > .table-bordered > tbody > tr:last-child > th,
.panel > .table-responsive > .table-bordered > tbody > tr:last-child > th,
.panel > .table-bordered > tfoot > tr:last-child > th,
.panel > .table-responsive > .table-bordered > tfoot > tr:last-child > th {
  border-bottom: 0;
}
.panel > .table-responsive {
  border: 0;
  margin-bottom: 0;
}
.panel-group {
  margin-bottom: 18px;
}
.panel-group .panel {
  margin-bottom: 0;
  border-radius: 2px;
}
.panel-group .panel + .panel {
  margin-top: 5px;
}
.panel-group .panel-heading {
  border-bottom: 0;
}
.panel-group .panel-heading + .panel-collapse > .panel-body,
.panel-group .panel-heading + .panel-collapse > .list-group {
  border-top: 1px solid #ddd;
}
.panel-group .panel-footer {
  border-top: 0;
}
.panel-group .panel-footer + .panel-collapse .panel-body {
  border-bottom: 1px solid #ddd;
}
.panel-default {
  border-color: #ddd;
}
.panel-default > .panel-heading {
  color: #333333;
  background-color: #f5f5f5;
  border-color: #ddd;
}
.panel-default > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #ddd;
}
.panel-default > .panel-heading .badge {
  color: #f5f5f5;
  background-color: #333333;
}
.panel-default > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #ddd;
}
.panel-primary {
  border-color: #337ab7;
}
.panel-primary > .panel-heading {
  color: #fff;
  background-color: #337ab7;
  border-color: #337ab7;
}
.panel-primary > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #337ab7;
}
.panel-primary > .panel-heading .badge {
  color: #337ab7;
  background-color: #fff;
}
.panel-primary > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #337ab7;
}
.panel-success {
  border-color: #d6e9c6;
}
.panel-success > .panel-heading {
  color: #3c763d;
  background-color: #dff0d8;
  border-color: #d6e9c6;
}
.panel-success > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #d6e9c6;
}
.panel-success > .panel-heading .badge {
  color: #dff0d8;
  background-color: #3c763d;
}
.panel-success > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #d6e9c6;
}
.panel-info {
  border-color: #bce8f1;
}
.panel-info > .panel-heading {
  color: #31708f;
  background-color: #d9edf7;
  border-color: #bce8f1;
}
.panel-info > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #bce8f1;
}
.panel-info > .panel-heading .badge {
  color: #d9edf7;
  background-color: #31708f;
}
.panel-info > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #bce8f1;
}
.panel-warning {
  border-color: #faebcc;
}
.panel-warning > .panel-heading {
  color: #8a6d3b;
  background-color: #fcf8e3;
  border-color: #faebcc;
}
.panel-warning > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #faebcc;
}
.panel-warning > .panel-heading .badge {
  color: #fcf8e3;
  background-color: #8a6d3b;
}
.panel-warning > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #faebcc;
}
.panel-danger {
  border-color: #ebccd1;
}
.panel-danger > .panel-heading {
  color: #a94442;
  background-color: #f2dede;
  border-color: #ebccd1;
}
.panel-danger > .panel-heading + .panel-collapse > .panel-body {
  border-top-color: #ebccd1;
}
.panel-danger > .panel-heading .badge {
  color: #f2dede;
  background-color: #a94442;
}
.panel-danger > .panel-footer + .panel-collapse > .panel-body {
  border-bottom-color: #ebccd1;
}
.embed-responsive {
  position: relative;
  display: block;
  height: 0;
  padding: 0;
  overflow: hidden;
}
.embed-responsive .embed-responsive-item,
.embed-responsive iframe,
.embed-responsive embed,
.embed-responsive object,
.embed-responsive video {
  position: absolute;
  top: 0;
  left: 0;
  bottom: 0;
  height: 100%;
  width: 100%;
  border: 0;
}
.embed-responsive-16by9 {
  padding-bottom: 56.25%;
}
.embed-responsive-4by3 {
  padding-bottom: 75%;
}
.well {
  min-height: 20px;
  padding: 19px;
  margin-bottom: 20px;
  background-color: #f5f5f5;
  border: 1px solid #e3e3e3;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.05);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.05);
}
.well blockquote {
  border-color: #ddd;
  border-color: rgba(0, 0, 0, 0.15);
}
.well-lg {
  padding: 24px;
  border-radius: 3px;
}
.well-sm {
  padding: 9px;
  border-radius: 1px;
}
.close {
  float: right;
  font-size: 19.5px;
  font-weight: bold;
  line-height: 1;
  color: #000;
  text-shadow: 0 1px 0 #fff;
  opacity: 0.2;
  filter: alpha(opacity=20);
}
.close:hover,
.close:focus {
  color: #000;
  text-decoration: none;
  cursor: pointer;
  opacity: 0.5;
  filter: alpha(opacity=50);
}
button.close {
  padding: 0;
  cursor: pointer;
  background: transparent;
  border: 0;
  -webkit-appearance: none;
}
.modal-open {
  overflow: hidden;
}
.modal {
  display: none;
  overflow: hidden;
  position: fixed;
  top: 0;
  right: 0;
  bottom: 0;
  left: 0;
  z-index: 1050;
  -webkit-overflow-scrolling: touch;
  outline: 0;
}
.modal.fade .modal-dialog {
  -webkit-transform: translate(0, -25%);
  -ms-transform: translate(0, -25%);
  -o-transform: translate(0, -25%);
  transform: translate(0, -25%);
  -webkit-transition: -webkit-transform 0.3s ease-out;
  -moz-transition: -moz-transform 0.3s ease-out;
  -o-transition: -o-transform 0.3s ease-out;
  transition: transform 0.3s ease-out;
}
.modal.in .modal-dialog {
  -webkit-transform: translate(0, 0);
  -ms-transform: translate(0, 0);
  -o-transform: translate(0, 0);
  transform: translate(0, 0);
}
.modal-open .modal {
  overflow-x: hidden;
  overflow-y: auto;
}
.modal-dialog {
  position: relative;
  width: auto;
  margin: 10px;
}
.modal-content {
  position: relative;
  background-color: #fff;
  border: 1px solid #999;
  border: 1px solid rgba(0, 0, 0, 0.2);
  border-radius: 3px;
  -webkit-box-shadow: 0 3px 9px rgba(0, 0, 0, 0.5);
  box-shadow: 0 3px 9px rgba(0, 0, 0, 0.5);
  background-clip: padding-box;
  outline: 0;
}
.modal-backdrop {
  position: fixed;
  top: 0;
  right: 0;
  bottom: 0;
  left: 0;
  z-index: 1040;
  background-color: #000;
}
.modal-backdrop.fade {
  opacity: 0;
  filter: alpha(opacity=0);
}
.modal-backdrop.in {
  opacity: 0.5;
  filter: alpha(opacity=50);
}
.modal-header {
  padding: 15px;
  border-bottom: 1px solid #e5e5e5;
}
.modal-header .close {
  margin-top: -2px;
}
.modal-title {
  margin: 0;
  line-height: 1.42857143;
}
.modal-body {
  position: relative;
  padding: 15px;
}
.modal-footer {
  padding: 15px;
  text-align: right;
  border-top: 1px solid #e5e5e5;
}
.modal-footer .btn + .btn {
  margin-left: 5px;
  margin-bottom: 0;
}
.modal-footer .btn-group .btn + .btn {
  margin-left: -1px;
}
.modal-footer .btn-block + .btn-block {
  margin-left: 0;
}
.modal-scrollbar-measure {
  position: absolute;
  top: -9999px;
  width: 50px;
  height: 50px;
  overflow: scroll;
}
@media (min-width: 768px) {
  .modal-dialog {
    width: 600px;
    margin: 30px auto;
  }
  .modal-content {
    -webkit-box-shadow: 0 5px 15px rgba(0, 0, 0, 0.5);
    box-shadow: 0 5px 15px rgba(0, 0, 0, 0.5);
  }
  .modal-sm {
    width: 300px;
  }
}
@media (min-width: 992px) {
  .modal-lg {
    width: 900px;
  }
}
.tooltip {
  position: absolute;
  z-index: 1070;
  display: block;
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
  font-style: normal;
  font-weight: normal;
  letter-spacing: normal;
  line-break: auto;
  line-height: 1.42857143;
  text-align: left;
  text-align: start;
  text-decoration: none;
  text-shadow: none;
  text-transform: none;
  white-space: normal;
  word-break: normal;
  word-spacing: normal;
  word-wrap: normal;
  font-size: 12px;
  opacity: 0;
  filter: alpha(opacity=0);
}
.tooltip.in {
  opacity: 0.9;
  filter: alpha(opacity=90);
}
.tooltip.top {
  margin-top: -3px;
  padding: 5px 0;
}
.tooltip.right {
  margin-left: 3px;
  padding: 0 5px;
}
.tooltip.bottom {
  margin-top: 3px;
  padding: 5px 0;
}
.tooltip.left {
  margin-left: -3px;
  padding: 0 5px;
}
.tooltip-inner {
  max-width: 200px;
  padding: 3px 8px;
  color: #fff;
  text-align: center;
  background-color: #000;
  border-radius: 2px;
}
.tooltip-arrow {
  position: absolute;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
}
.tooltip.top .tooltip-arrow {
  bottom: 0;
  left: 50%;
  margin-left: -5px;
  border-width: 5px 5px 0;
  border-top-color: #000;
}
.tooltip.top-left .tooltip-arrow {
  bottom: 0;
  right: 5px;
  margin-bottom: -5px;
  border-width: 5px 5px 0;
  border-top-color: #000;
}
.tooltip.top-right .tooltip-arrow {
  bottom: 0;
  left: 5px;
  margin-bottom: -5px;
  border-width: 5px 5px 0;
  border-top-color: #000;
}
.tooltip.right .tooltip-arrow {
  top: 50%;
  left: 0;
  margin-top: -5px;
  border-width: 5px 5px 5px 0;
  border-right-color: #000;
}
.tooltip.left .tooltip-arrow {
  top: 50%;
  right: 0;
  margin-top: -5px;
  border-width: 5px 0 5px 5px;
  border-left-color: #000;
}
.tooltip.bottom .tooltip-arrow {
  top: 0;
  left: 50%;
  margin-left: -5px;
  border-width: 0 5px 5px;
  border-bottom-color: #000;
}
.tooltip.bottom-left .tooltip-arrow {
  top: 0;
  right: 5px;
  margin-top: -5px;
  border-width: 0 5px 5px;
  border-bottom-color: #000;
}
.tooltip.bottom-right .tooltip-arrow {
  top: 0;
  left: 5px;
  margin-top: -5px;
  border-width: 0 5px 5px;
  border-bottom-color: #000;
}
.popover {
  position: absolute;
  top: 0;
  left: 0;
  z-index: 1060;
  display: none;
  max-width: 276px;
  padding: 1px;
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
  font-style: normal;
  font-weight: normal;
  letter-spacing: normal;
  line-break: auto;
  line-height: 1.42857143;
  text-align: left;
  text-align: start;
  text-decoration: none;
  text-shadow: none;
  text-transform: none;
  white-space: normal;
  word-break: normal;
  word-spacing: normal;
  word-wrap: normal;
  font-size: 13px;
  background-color: #fff;
  background-clip: padding-box;
  border: 1px solid #ccc;
  border: 1px solid rgba(0, 0, 0, 0.2);
  border-radius: 3px;
  -webkit-box-shadow: 0 5px 10px rgba(0, 0, 0, 0.2);
  box-shadow: 0 5px 10px rgba(0, 0, 0, 0.2);
}
.popover.top {
  margin-top: -10px;
}
.popover.right {
  margin-left: 10px;
}
.popover.bottom {
  margin-top: 10px;
}
.popover.left {
  margin-left: -10px;
}
.popover-title {
  margin: 0;
  padding: 8px 14px;
  font-size: 13px;
  background-color: #f7f7f7;
  border-bottom: 1px solid #ebebeb;
  border-radius: 2px 2px 0 0;
}
.popover-content {
  padding: 9px 14px;
}
.popover > .arrow,
.popover > .arrow:after {
  position: absolute;
  display: block;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
}
.popover > .arrow {
  border-width: 11px;
}
.popover > .arrow:after {
  border-width: 10px;
  content: "";
}
.popover.top > .arrow {
  left: 50%;
  margin-left: -11px;
  border-bottom-width: 0;
  border-top-color: #999999;
  border-top-color: rgba(0, 0, 0, 0.25);
  bottom: -11px;
}
.popover.top > .arrow:after {
  content: " ";
  bottom: 1px;
  margin-left: -10px;
  border-bottom-width: 0;
  border-top-color: #fff;
}
.popover.right > .arrow {
  top: 50%;
  left: -11px;
  margin-top: -11px;
  border-left-width: 0;
  border-right-color: #999999;
  border-right-color: rgba(0, 0, 0, 0.25);
}
.popover.right > .arrow:after {
  content: " ";
  left: 1px;
  bottom: -10px;
  border-left-width: 0;
  border-right-color: #fff;
}
.popover.bottom > .arrow {
  left: 50%;
  margin-left: -11px;
  border-top-width: 0;
  border-bottom-color: #999999;
  border-bottom-color: rgba(0, 0, 0, 0.25);
  top: -11px;
}
.popover.bottom > .arrow:after {
  content: " ";
  top: 1px;
  margin-left: -10px;
  border-top-width: 0;
  border-bottom-color: #fff;
}
.popover.left > .arrow {
  top: 50%;
  right: -11px;
  margin-top: -11px;
  border-right-width: 0;
  border-left-color: #999999;
  border-left-color: rgba(0, 0, 0, 0.25);
}
.popover.left > .arrow:after {
  content: " ";
  right: 1px;
  border-right-width: 0;
  border-left-color: #fff;
  bottom: -10px;
}
.carousel {
  position: relative;
}
.carousel-inner {
  position: relative;
  overflow: hidden;
  width: 100%;
}
.carousel-inner > .item {
  display: none;
  position: relative;
  -webkit-transition: 0.6s ease-in-out left;
  -o-transition: 0.6s ease-in-out left;
  transition: 0.6s ease-in-out left;
}
.carousel-inner > .item > img,
.carousel-inner > .item > a > img {
  line-height: 1;
}
@media all and (transform-3d), (-webkit-transform-3d) {
  .carousel-inner > .item {
    -webkit-transition: -webkit-transform 0.6s ease-in-out;
    -moz-transition: -moz-transform 0.6s ease-in-out;
    -o-transition: -o-transform 0.6s ease-in-out;
    transition: transform 0.6s ease-in-out;
    -webkit-backface-visibility: hidden;
    -moz-backface-visibility: hidden;
    backface-visibility: hidden;
    -webkit-perspective: 1000px;
    -moz-perspective: 1000px;
    perspective: 1000px;
  }
  .carousel-inner > .item.next,
  .carousel-inner > .item.active.right {
    -webkit-transform: translate3d(100%, 0, 0);
    transform: translate3d(100%, 0, 0);
    left: 0;
  }
  .carousel-inner > .item.prev,
  .carousel-inner > .item.active.left {
    -webkit-transform: translate3d(-100%, 0, 0);
    transform: translate3d(-100%, 0, 0);
    left: 0;
  }
  .carousel-inner > .item.next.left,
  .carousel-inner > .item.prev.right,
  .carousel-inner > .item.active {
    -webkit-transform: translate3d(0, 0, 0);
    transform: translate3d(0, 0, 0);
    left: 0;
  }
}
.carousel-inner > .active,
.carousel-inner > .next,
.carousel-inner > .prev {
  display: block;
}
.carousel-inner > .active {
  left: 0;
}
.carousel-inner > .next,
.carousel-inner > .prev {
  position: absolute;
  top: 0;
  width: 100%;
}
.carousel-inner > .next {
  left: 100%;
}
.carousel-inner > .prev {
  left: -100%;
}
.carousel-inner > .next.left,
.carousel-inner > .prev.right {
  left: 0;
}
.carousel-inner > .active.left {
  left: -100%;
}
.carousel-inner > .active.right {
  left: 100%;
}
.carousel-control {
  position: absolute;
  top: 0;
  left: 0;
  bottom: 0;
  width: 15%;
  opacity: 0.5;
  filter: alpha(opacity=50);
  font-size: 20px;
  color: #fff;
  text-align: center;
  text-shadow: 0 1px 2px rgba(0, 0, 0, 0.6);
  background-color: rgba(0, 0, 0, 0);
}
.carousel-control.left {
  background-image: -webkit-linear-gradient(left, rgba(0, 0, 0, 0.5) 0%, rgba(0, 0, 0, 0.0001) 100%);
  background-image: -o-linear-gradient(left, rgba(0, 0, 0, 0.5) 0%, rgba(0, 0, 0, 0.0001) 100%);
  background-image: linear-gradient(to right, rgba(0, 0, 0, 0.5) 0%, rgba(0, 0, 0, 0.0001) 100%);
  background-repeat: repeat-x;
  filter: progid:DXImageTransform.Microsoft.gradient(startColorstr='#80000000', endColorstr='#00000000', GradientType=1);
}
.carousel-control.right {
  left: auto;
  right: 0;
  background-image: -webkit-linear-gradient(left, rgba(0, 0, 0, 0.0001) 0%, rgba(0, 0, 0, 0.5) 100%);
  background-image: -o-linear-gradient(left, rgba(0, 0, 0, 0.0001) 0%, rgba(0, 0, 0, 0.5) 100%);
  background-image: linear-gradient(to right, rgba(0, 0, 0, 0.0001) 0%, rgba(0, 0, 0, 0.5) 100%);
  background-repeat: repeat-x;
  filter: progid:DXImageTransform.Microsoft.gradient(startColorstr='#00000000', endColorstr='#80000000', GradientType=1);
}
.carousel-control:hover,
.carousel-control:focus {
  outline: 0;
  color: #fff;
  text-decoration: none;
  opacity: 0.9;
  filter: alpha(opacity=90);
}
.carousel-control .icon-prev,
.carousel-control .icon-next,
.carousel-control .glyphicon-chevron-left,
.carousel-control .glyphicon-chevron-right {
  position: absolute;
  top: 50%;
  margin-top: -10px;
  z-index: 5;
  display: inline-block;
}
.carousel-control .icon-prev,
.carousel-control .glyphicon-chevron-left {
  left: 50%;
  margin-left: -10px;
}
.carousel-control .icon-next,
.carousel-control .glyphicon-chevron-right {
  right: 50%;
  margin-right: -10px;
}
.carousel-control .icon-prev,
.carousel-control .icon-next {
  width: 20px;
  height: 20px;
  line-height: 1;
  font-family: serif;
}
.carousel-control .icon-prev:before {
  content: '\2039';
}
.carousel-control .icon-next:before {
  content: '\203a';
}
.carousel-indicators {
  position: absolute;
  bottom: 10px;
  left: 50%;
  z-index: 15;
  width: 60%;
  margin-left: -30%;
  padding-left: 0;
  list-style: none;
  text-align: center;
}
.carousel-indicators li {
  display: inline-block;
  width: 10px;
  height: 10px;
  margin: 1px;
  text-indent: -999px;
  border: 1px solid #fff;
  border-radius: 10px;
  cursor: pointer;
  background-color: #000 \9;
  background-color: rgba(0, 0, 0, 0);
}
.carousel-indicators .active {
  margin: 0;
  width: 12px;
  height: 12px;
  background-color: #fff;
}
.carousel-caption {
  position: absolute;
  left: 15%;
  right: 15%;
  bottom: 20px;
  z-index: 10;
  padding-top: 20px;
  padding-bottom: 20px;
  color: #fff;
  text-align: center;
  text-shadow: 0 1px 2px rgba(0, 0, 0, 0.6);
}
.carousel-caption .btn {
  text-shadow: none;
}
@media screen and (min-width: 768px) {
  .carousel-control .glyphicon-chevron-left,
  .carousel-control .glyphicon-chevron-right,
  .carousel-control .icon-prev,
  .carousel-control .icon-next {
    width: 30px;
    height: 30px;
    margin-top: -10px;
    font-size: 30px;
  }
  .carousel-control .glyphicon-chevron-left,
  .carousel-control .icon-prev {
    margin-left: -10px;
  }
  .carousel-control .glyphicon-chevron-right,
  .carousel-control .icon-next {
    margin-right: -10px;
  }
  .carousel-caption {
    left: 20%;
    right: 20%;
    padding-bottom: 30px;
  }
  .carousel-indicators {
    bottom: 20px;
  }
}
.clearfix:before,
.clearfix:after,
.dl-horizontal dd:before,
.dl-horizontal dd:after,
.container:before,
.container:after,
.container-fluid:before,
.container-fluid:after,
.row:before,
.row:after,
.form-horizontal .form-group:before,
.form-horizontal .form-group:after,
.btn-toolbar:before,
.btn-toolbar:after,
.btn-group-vertical > .btn-group:before,
.btn-group-vertical > .btn-group:after,
.nav:before,
.nav:after,
.navbar:before,
.navbar:after,
.navbar-header:before,
.navbar-header:after,
.navbar-collapse:before,
.navbar-collapse:after,
.pager:before,
.pager:after,
.panel-body:before,
.panel-body:after,
.modal-header:before,
.modal-header:after,
.modal-footer:before,
.modal-footer:after,
.item_buttons:before,
.item_buttons:after {
  content: " ";
  display: table;
}
.clearfix:after,
.dl-horizontal dd:after,
.container:after,
.container-fluid:after,
.row:after,
.form-horizontal .form-group:after,
.btn-toolbar:after,
.btn-group-vertical > .btn-group:after,
.nav:after,
.navbar:after,
.navbar-header:after,
.navbar-collapse:after,
.pager:after,
.panel-body:after,
.modal-header:after,
.modal-footer:after,
.item_buttons:after {
  clear: both;
}
.center-block {
  display: block;
  margin-left: auto;
  margin-right: auto;
}
.pull-right {
  float: right !important;
}
.pull-left {
  float: left !important;
}
.hide {
  display: none !important;
}
.show {
  display: block !important;
}
.invisible {
  visibility: hidden;
}
.text-hide {
  font: 0/0 a;
  color: transparent;
  text-shadow: none;
  background-color: transparent;
  border: 0;
}
.hidden {
  display: none !important;
}
.affix {
  position: fixed;
}
@-ms-viewport {
  width: device-width;
}
.visible-xs,
.visible-sm,
.visible-md,
.visible-lg {
  display: none !important;
}
.visible-xs-block,
.visible-xs-inline,
.visible-xs-inline-block,
.visible-sm-block,
.visible-sm-inline,
.visible-sm-inline-block,
.visible-md-block,
.visible-md-inline,
.visible-md-inline-block,
.visible-lg-block,
.visible-lg-inline,
.visible-lg-inline-block {
  display: none !important;
}
@media (max-width: 767px) {
  .visible-xs {
    display: block !important;
  }
  table.visible-xs {
    display: table !important;
  }
  tr.visible-xs {
    display: table-row !important;
  }
  th.visible-xs,
  td.visible-xs {
    display: table-cell !important;
  }
}
@media (max-width: 767px) {
  .visible-xs-block {
    display: block !important;
  }
}
@media (max-width: 767px) {
  .visible-xs-inline {
    display: inline !important;
  }
}
@media (max-width: 767px) {
  .visible-xs-inline-block {
    display: inline-block !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm {
    display: block !important;
  }
  table.visible-sm {
    display: table !important;
  }
  tr.visible-sm {
    display: table-row !important;
  }
  th.visible-sm,
  td.visible-sm {
    display: table-cell !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm-block {
    display: block !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm-inline {
    display: inline !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .visible-sm-inline-block {
    display: inline-block !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md {
    display: block !important;
  }
  table.visible-md {
    display: table !important;
  }
  tr.visible-md {
    display: table-row !important;
  }
  th.visible-md,
  td.visible-md {
    display: table-cell !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md-block {
    display: block !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md-inline {
    display: inline !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .visible-md-inline-block {
    display: inline-block !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg {
    display: block !important;
  }
  table.visible-lg {
    display: table !important;
  }
  tr.visible-lg {
    display: table-row !important;
  }
  th.visible-lg,
  td.visible-lg {
    display: table-cell !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg-block {
    display: block !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg-inline {
    display: inline !important;
  }
}
@media (min-width: 1200px) {
  .visible-lg-inline-block {
    display: inline-block !important;
  }
}
@media (max-width: 767px) {
  .hidden-xs {
    display: none !important;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  .hidden-sm {
    display: none !important;
  }
}
@media (min-width: 992px) and (max-width: 1199px) {
  .hidden-md {
    display: none !important;
  }
}
@media (min-width: 1200px) {
  .hidden-lg {
    display: none !important;
  }
}
.visible-print {
  display: none !important;
}
@media print {
  .visible-print {
    display: block !important;
  }
  table.visible-print {
    display: table !important;
  }
  tr.visible-print {
    display: table-row !important;
  }
  th.visible-print,
  td.visible-print {
    display: table-cell !important;
  }
}
.visible-print-block {
  display: none !important;
}
@media print {
  .visible-print-block {
    display: block !important;
  }
}
.visible-print-inline {
  display: none !important;
}
@media print {
  .visible-print-inline {
    display: inline !important;
  }
}
.visible-print-inline-block {
  display: none !important;
}
@media print {
  .visible-print-inline-block {
    display: inline-block !important;
  }
}
@media print {
  .hidden-print {
    display: none !important;
  }
}
/*!
*
* Font Awesome
*
*/
/*!
 *  Font Awesome 4.7.0 by @davegandy - http://fontawesome.io - @fontawesome
 *  License - http://fontawesome.io/license (Font: SIL OFL 1.1, CSS: MIT License)
 */
/* FONT PATH
 * -------------------------- */
@font-face {
  font-family: 'FontAwesome';
  src: url('../components/font-awesome/fonts/fontawesome-webfont.eot?v=4.7.0');
  src: url('../components/font-awesome/fonts/fontawesome-webfont.eot?#iefix&v=4.7.0') format('embedded-opentype'), url('../components/font-awesome/fonts/fontawesome-webfont.woff2?v=4.7.0') format('woff2'), url('../components/font-awesome/fonts/fontawesome-webfont.woff?v=4.7.0') format('woff'), url('../components/font-awesome/fonts/fontawesome-webfont.ttf?v=4.7.0') format('truetype'), url('../components/font-awesome/fonts/fontawesome-webfont.svg?v=4.7.0#fontawesomeregular') format('svg');
  font-weight: normal;
  font-style: normal;
}
.fa {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
}
/* makes the font 33% larger relative to the icon container */
.fa-lg {
  font-size: 1.33333333em;
  line-height: 0.75em;
  vertical-align: -15%;
}
.fa-2x {
  font-size: 2em;
}
.fa-3x {
  font-size: 3em;
}
.fa-4x {
  font-size: 4em;
}
.fa-5x {
  font-size: 5em;
}
.fa-fw {
  width: 1.28571429em;
  text-align: center;
}
.fa-ul {
  padding-left: 0;
  margin-left: 2.14285714em;
  list-style-type: none;
}
.fa-ul > li {
  position: relative;
}
.fa-li {
  position: absolute;
  left: -2.14285714em;
  width: 2.14285714em;
  top: 0.14285714em;
  text-align: center;
}
.fa-li.fa-lg {
  left: -1.85714286em;
}
.fa-border {
  padding: .2em .25em .15em;
  border: solid 0.08em #eee;
  border-radius: .1em;
}
.fa-pull-left {
  float: left;
}
.fa-pull-right {
  float: right;
}
.fa.fa-pull-left {
  margin-right: .3em;
}
.fa.fa-pull-right {
  margin-left: .3em;
}
/* Deprecated as of 4.4.0 */
.pull-right {
  float: right;
}
.pull-left {
  float: left;
}
.fa.pull-left {
  margin-right: .3em;
}
.fa.pull-right {
  margin-left: .3em;
}
.fa-spin {
  -webkit-animation: fa-spin 2s infinite linear;
  animation: fa-spin 2s infinite linear;
}
.fa-pulse {
  -webkit-animation: fa-spin 1s infinite steps(8);
  animation: fa-spin 1s infinite steps(8);
}
@-webkit-keyframes fa-spin {
  0% {
    -webkit-transform: rotate(0deg);
    transform: rotate(0deg);
  }
  100% {
    -webkit-transform: rotate(359deg);
    transform: rotate(359deg);
  }
}
@keyframes fa-spin {
  0% {
    -webkit-transform: rotate(0deg);
    transform: rotate(0deg);
  }
  100% {
    -webkit-transform: rotate(359deg);
    transform: rotate(359deg);
  }
}
.fa-rotate-90 {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=1)";
  -webkit-transform: rotate(90deg);
  -ms-transform: rotate(90deg);
  transform: rotate(90deg);
}
.fa-rotate-180 {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=2)";
  -webkit-transform: rotate(180deg);
  -ms-transform: rotate(180deg);
  transform: rotate(180deg);
}
.fa-rotate-270 {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=3)";
  -webkit-transform: rotate(270deg);
  -ms-transform: rotate(270deg);
  transform: rotate(270deg);
}
.fa-flip-horizontal {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=0, mirror=1)";
  -webkit-transform: scale(-1, 1);
  -ms-transform: scale(-1, 1);
  transform: scale(-1, 1);
}
.fa-flip-vertical {
  -ms-filter: "progid:DXImageTransform.Microsoft.BasicImage(rotation=2, mirror=1)";
  -webkit-transform: scale(1, -1);
  -ms-transform: scale(1, -1);
  transform: scale(1, -1);
}
:root .fa-rotate-90,
:root .fa-rotate-180,
:root .fa-rotate-270,
:root .fa-flip-horizontal,
:root .fa-flip-vertical {
  filter: none;
}
.fa-stack {
  position: relative;
  display: inline-block;
  width: 2em;
  height: 2em;
  line-height: 2em;
  vertical-align: middle;
}
.fa-stack-1x,
.fa-stack-2x {
  position: absolute;
  left: 0;
  width: 100%;
  text-align: center;
}
.fa-stack-1x {
  line-height: inherit;
}
.fa-stack-2x {
  font-size: 2em;
}
.fa-inverse {
  color: #fff;
}
/* Font Awesome uses the Unicode Private Use Area (PUA) to ensure screen
   readers do not read off random characters that represent icons */
.fa-glass:before {
  content: "\f000";
}
.fa-music:before {
  content: "\f001";
}
.fa-search:before {
  content: "\f002";
}
.fa-envelope-o:before {
  content: "\f003";
}
.fa-heart:before {
  content: "\f004";
}
.fa-star:before {
  content: "\f005";
}
.fa-star-o:before {
  content: "\f006";
}
.fa-user:before {
  content: "\f007";
}
.fa-film:before {
  content: "\f008";
}
.fa-th-large:before {
  content: "\f009";
}
.fa-th:before {
  content: "\f00a";
}
.fa-th-list:before {
  content: "\f00b";
}
.fa-check:before {
  content: "\f00c";
}
.fa-remove:before,
.fa-close:before,
.fa-times:before {
  content: "\f00d";
}
.fa-search-plus:before {
  content: "\f00e";
}
.fa-search-minus:before {
  content: "\f010";
}
.fa-power-off:before {
  content: "\f011";
}
.fa-signal:before {
  content: "\f012";
}
.fa-gear:before,
.fa-cog:before {
  content: "\f013";
}
.fa-trash-o:before {
  content: "\f014";
}
.fa-home:before {
  content: "\f015";
}
.fa-file-o:before {
  content: "\f016";
}
.fa-clock-o:before {
  content: "\f017";
}
.fa-road:before {
  content: "\f018";
}
.fa-download:before {
  content: "\f019";
}
.fa-arrow-circle-o-down:before {
  content: "\f01a";
}
.fa-arrow-circle-o-up:before {
  content: "\f01b";
}
.fa-inbox:before {
  content: "\f01c";
}
.fa-play-circle-o:before {
  content: "\f01d";
}
.fa-rotate-right:before,
.fa-repeat:before {
  content: "\f01e";
}
.fa-refresh:before {
  content: "\f021";
}
.fa-list-alt:before {
  content: "\f022";
}
.fa-lock:before {
  content: "\f023";
}
.fa-flag:before {
  content: "\f024";
}
.fa-headphones:before {
  content: "\f025";
}
.fa-volume-off:before {
  content: "\f026";
}
.fa-volume-down:before {
  content: "\f027";
}
.fa-volume-up:before {
  content: "\f028";
}
.fa-qrcode:before {
  content: "\f029";
}
.fa-barcode:before {
  content: "\f02a";
}
.fa-tag:before {
  content: "\f02b";
}
.fa-tags:before {
  content: "\f02c";
}
.fa-book:before {
  content: "\f02d";
}
.fa-bookmark:before {
  content: "\f02e";
}
.fa-print:before {
  content: "\f02f";
}
.fa-camera:before {
  content: "\f030";
}
.fa-font:before {
  content: "\f031";
}
.fa-bold:before {
  content: "\f032";
}
.fa-italic:before {
  content: "\f033";
}
.fa-text-height:before {
  content: "\f034";
}
.fa-text-width:before {
  content: "\f035";
}
.fa-align-left:before {
  content: "\f036";
}
.fa-align-center:before {
  content: "\f037";
}
.fa-align-right:before {
  content: "\f038";
}
.fa-align-justify:before {
  content: "\f039";
}
.fa-list:before {
  content: "\f03a";
}
.fa-dedent:before,
.fa-outdent:before {
  content: "\f03b";
}
.fa-indent:before {
  content: "\f03c";
}
.fa-video-camera:before {
  content: "\f03d";
}
.fa-photo:before,
.fa-image:before,
.fa-picture-o:before {
  content: "\f03e";
}
.fa-pencil:before {
  content: "\f040";
}
.fa-map-marker:before {
  content: "\f041";
}
.fa-adjust:before {
  content: "\f042";
}
.fa-tint:before {
  content: "\f043";
}
.fa-edit:before,
.fa-pencil-square-o:before {
  content: "\f044";
}
.fa-share-square-o:before {
  content: "\f045";
}
.fa-check-square-o:before {
  content: "\f046";
}
.fa-arrows:before {
  content: "\f047";
}
.fa-step-backward:before {
  content: "\f048";
}
.fa-fast-backward:before {
  content: "\f049";
}
.fa-backward:before {
  content: "\f04a";
}
.fa-play:before {
  content: "\f04b";
}
.fa-pause:before {
  content: "\f04c";
}
.fa-stop:before {
  content: "\f04d";
}
.fa-forward:before {
  content: "\f04e";
}
.fa-fast-forward:before {
  content: "\f050";
}
.fa-step-forward:before {
  content: "\f051";
}
.fa-eject:before {
  content: "\f052";
}
.fa-chevron-left:before {
  content: "\f053";
}
.fa-chevron-right:before {
  content: "\f054";
}
.fa-plus-circle:before {
  content: "\f055";
}
.fa-minus-circle:before {
  content: "\f056";
}
.fa-times-circle:before {
  content: "\f057";
}
.fa-check-circle:before {
  content: "\f058";
}
.fa-question-circle:before {
  content: "\f059";
}
.fa-info-circle:before {
  content: "\f05a";
}
.fa-crosshairs:before {
  content: "\f05b";
}
.fa-times-circle-o:before {
  content: "\f05c";
}
.fa-check-circle-o:before {
  content: "\f05d";
}
.fa-ban:before {
  content: "\f05e";
}
.fa-arrow-left:before {
  content: "\f060";
}
.fa-arrow-right:before {
  content: "\f061";
}
.fa-arrow-up:before {
  content: "\f062";
}
.fa-arrow-down:before {
  content: "\f063";
}
.fa-mail-forward:before,
.fa-share:before {
  content: "\f064";
}
.fa-expand:before {
  content: "\f065";
}
.fa-compress:before {
  content: "\f066";
}
.fa-plus:before {
  content: "\f067";
}
.fa-minus:before {
  content: "\f068";
}
.fa-asterisk:before {
  content: "\f069";
}
.fa-exclamation-circle:before {
  content: "\f06a";
}
.fa-gift:before {
  content: "\f06b";
}
.fa-leaf:before {
  content: "\f06c";
}
.fa-fire:before {
  content: "\f06d";
}
.fa-eye:before {
  content: "\f06e";
}
.fa-eye-slash:before {
  content: "\f070";
}
.fa-warning:before,
.fa-exclamation-triangle:before {
  content: "\f071";
}
.fa-plane:before {
  content: "\f072";
}
.fa-calendar:before {
  content: "\f073";
}
.fa-random:before {
  content: "\f074";
}
.fa-comment:before {
  content: "\f075";
}
.fa-magnet:before {
  content: "\f076";
}
.fa-chevron-up:before {
  content: "\f077";
}
.fa-chevron-down:before {
  content: "\f078";
}
.fa-retweet:before {
  content: "\f079";
}
.fa-shopping-cart:before {
  content: "\f07a";
}
.fa-folder:before {
  content: "\f07b";
}
.fa-folder-open:before {
  content: "\f07c";
}
.fa-arrows-v:before {
  content: "\f07d";
}
.fa-arrows-h:before {
  content: "\f07e";
}
.fa-bar-chart-o:before,
.fa-bar-chart:before {
  content: "\f080";
}
.fa-twitter-square:before {
  content: "\f081";
}
.fa-facebook-square:before {
  content: "\f082";
}
.fa-camera-retro:before {
  content: "\f083";
}
.fa-key:before {
  content: "\f084";
}
.fa-gears:before,
.fa-cogs:before {
  content: "\f085";
}
.fa-comments:before {
  content: "\f086";
}
.fa-thumbs-o-up:before {
  content: "\f087";
}
.fa-thumbs-o-down:before {
  content: "\f088";
}
.fa-star-half:before {
  content: "\f089";
}
.fa-heart-o:before {
  content: "\f08a";
}
.fa-sign-out:before {
  content: "\f08b";
}
.fa-linkedin-square:before {
  content: "\f08c";
}
.fa-thumb-tack:before {
  content: "\f08d";
}
.fa-external-link:before {
  content: "\f08e";
}
.fa-sign-in:before {
  content: "\f090";
}
.fa-trophy:before {
  content: "\f091";
}
.fa-github-square:before {
  content: "\f092";
}
.fa-upload:before {
  content: "\f093";
}
.fa-lemon-o:before {
  content: "\f094";
}
.fa-phone:before {
  content: "\f095";
}
.fa-square-o:before {
  content: "\f096";
}
.fa-bookmark-o:before {
  content: "\f097";
}
.fa-phone-square:before {
  content: "\f098";
}
.fa-twitter:before {
  content: "\f099";
}
.fa-facebook-f:before,
.fa-facebook:before {
  content: "\f09a";
}
.fa-github:before {
  content: "\f09b";
}
.fa-unlock:before {
  content: "\f09c";
}
.fa-credit-card:before {
  content: "\f09d";
}
.fa-feed:before,
.fa-rss:before {
  content: "\f09e";
}
.fa-hdd-o:before {
  content: "\f0a0";
}
.fa-bullhorn:before {
  content: "\f0a1";
}
.fa-bell:before {
  content: "\f0f3";
}
.fa-certificate:before {
  content: "\f0a3";
}
.fa-hand-o-right:before {
  content: "\f0a4";
}
.fa-hand-o-left:before {
  content: "\f0a5";
}
.fa-hand-o-up:before {
  content: "\f0a6";
}
.fa-hand-o-down:before {
  content: "\f0a7";
}
.fa-arrow-circle-left:before {
  content: "\f0a8";
}
.fa-arrow-circle-right:before {
  content: "\f0a9";
}
.fa-arrow-circle-up:before {
  content: "\f0aa";
}
.fa-arrow-circle-down:before {
  content: "\f0ab";
}
.fa-globe:before {
  content: "\f0ac";
}
.fa-wrench:before {
  content: "\f0ad";
}
.fa-tasks:before {
  content: "\f0ae";
}
.fa-filter:before {
  content: "\f0b0";
}
.fa-briefcase:before {
  content: "\f0b1";
}
.fa-arrows-alt:before {
  content: "\f0b2";
}
.fa-group:before,
.fa-users:before {
  content: "\f0c0";
}
.fa-chain:before,
.fa-link:before {
  content: "\f0c1";
}
.fa-cloud:before {
  content: "\f0c2";
}
.fa-flask:before {
  content: "\f0c3";
}
.fa-cut:before,
.fa-scissors:before {
  content: "\f0c4";
}
.fa-copy:before,
.fa-files-o:before {
  content: "\f0c5";
}
.fa-paperclip:before {
  content: "\f0c6";
}
.fa-save:before,
.fa-floppy-o:before {
  content: "\f0c7";
}
.fa-square:before {
  content: "\f0c8";
}
.fa-navicon:before,
.fa-reorder:before,
.fa-bars:before {
  content: "\f0c9";
}
.fa-list-ul:before {
  content: "\f0ca";
}
.fa-list-ol:before {
  content: "\f0cb";
}
.fa-strikethrough:before {
  content: "\f0cc";
}
.fa-underline:before {
  content: "\f0cd";
}
.fa-table:before {
  content: "\f0ce";
}
.fa-magic:before {
  content: "\f0d0";
}
.fa-truck:before {
  content: "\f0d1";
}
.fa-pinterest:before {
  content: "\f0d2";
}
.fa-pinterest-square:before {
  content: "\f0d3";
}
.fa-google-plus-square:before {
  content: "\f0d4";
}
.fa-google-plus:before {
  content: "\f0d5";
}
.fa-money:before {
  content: "\f0d6";
}
.fa-caret-down:before {
  content: "\f0d7";
}
.fa-caret-up:before {
  content: "\f0d8";
}
.fa-caret-left:before {
  content: "\f0d9";
}
.fa-caret-right:before {
  content: "\f0da";
}
.fa-columns:before {
  content: "\f0db";
}
.fa-unsorted:before,
.fa-sort:before {
  content: "\f0dc";
}
.fa-sort-down:before,
.fa-sort-desc:before {
  content: "\f0dd";
}
.fa-sort-up:before,
.fa-sort-asc:before {
  content: "\f0de";
}
.fa-envelope:before {
  content: "\f0e0";
}
.fa-linkedin:before {
  content: "\f0e1";
}
.fa-rotate-left:before,
.fa-undo:before {
  content: "\f0e2";
}
.fa-legal:before,
.fa-gavel:before {
  content: "\f0e3";
}
.fa-dashboard:before,
.fa-tachometer:before {
  content: "\f0e4";
}
.fa-comment-o:before {
  content: "\f0e5";
}
.fa-comments-o:before {
  content: "\f0e6";
}
.fa-flash:before,
.fa-bolt:before {
  content: "\f0e7";
}
.fa-sitemap:before {
  content: "\f0e8";
}
.fa-umbrella:before {
  content: "\f0e9";
}
.fa-paste:before,
.fa-clipboard:before {
  content: "\f0ea";
}
.fa-lightbulb-o:before {
  content: "\f0eb";
}
.fa-exchange:before {
  content: "\f0ec";
}
.fa-cloud-download:before {
  content: "\f0ed";
}
.fa-cloud-upload:before {
  content: "\f0ee";
}
.fa-user-md:before {
  content: "\f0f0";
}
.fa-stethoscope:before {
  content: "\f0f1";
}
.fa-suitcase:before {
  content: "\f0f2";
}
.fa-bell-o:before {
  content: "\f0a2";
}
.fa-coffee:before {
  content: "\f0f4";
}
.fa-cutlery:before {
  content: "\f0f5";
}
.fa-file-text-o:before {
  content: "\f0f6";
}
.fa-building-o:before {
  content: "\f0f7";
}
.fa-hospital-o:before {
  content: "\f0f8";
}
.fa-ambulance:before {
  content: "\f0f9";
}
.fa-medkit:before {
  content: "\f0fa";
}
.fa-fighter-jet:before {
  content: "\f0fb";
}
.fa-beer:before {
  content: "\f0fc";
}
.fa-h-square:before {
  content: "\f0fd";
}
.fa-plus-square:before {
  content: "\f0fe";
}
.fa-angle-double-left:before {
  content: "\f100";
}
.fa-angle-double-right:before {
  content: "\f101";
}
.fa-angle-double-up:before {
  content: "\f102";
}
.fa-angle-double-down:before {
  content: "\f103";
}
.fa-angle-left:before {
  content: "\f104";
}
.fa-angle-right:before {
  content: "\f105";
}
.fa-angle-up:before {
  content: "\f106";
}
.fa-angle-down:before {
  content: "\f107";
}
.fa-desktop:before {
  content: "\f108";
}
.fa-laptop:before {
  content: "\f109";
}
.fa-tablet:before {
  content: "\f10a";
}
.fa-mobile-phone:before,
.fa-mobile:before {
  content: "\f10b";
}
.fa-circle-o:before {
  content: "\f10c";
}
.fa-quote-left:before {
  content: "\f10d";
}
.fa-quote-right:before {
  content: "\f10e";
}
.fa-spinner:before {
  content: "\f110";
}
.fa-circle:before {
  content: "\f111";
}
.fa-mail-reply:before,
.fa-reply:before {
  content: "\f112";
}
.fa-github-alt:before {
  content: "\f113";
}
.fa-folder-o:before {
  content: "\f114";
}
.fa-folder-open-o:before {
  content: "\f115";
}
.fa-smile-o:before {
  content: "\f118";
}
.fa-frown-o:before {
  content: "\f119";
}
.fa-meh-o:before {
  content: "\f11a";
}
.fa-gamepad:before {
  content: "\f11b";
}
.fa-keyboard-o:before {
  content: "\f11c";
}
.fa-flag-o:before {
  content: "\f11d";
}
.fa-flag-checkered:before {
  content: "\f11e";
}
.fa-terminal:before {
  content: "\f120";
}
.fa-code:before {
  content: "\f121";
}
.fa-mail-reply-all:before,
.fa-reply-all:before {
  content: "\f122";
}
.fa-star-half-empty:before,
.fa-star-half-full:before,
.fa-star-half-o:before {
  content: "\f123";
}
.fa-location-arrow:before {
  content: "\f124";
}
.fa-crop:before {
  content: "\f125";
}
.fa-code-fork:before {
  content: "\f126";
}
.fa-unlink:before,
.fa-chain-broken:before {
  content: "\f127";
}
.fa-question:before {
  content: "\f128";
}
.fa-info:before {
  content: "\f129";
}
.fa-exclamation:before {
  content: "\f12a";
}
.fa-superscript:before {
  content: "\f12b";
}
.fa-subscript:before {
  content: "\f12c";
}
.fa-eraser:before {
  content: "\f12d";
}
.fa-puzzle-piece:before {
  content: "\f12e";
}
.fa-microphone:before {
  content: "\f130";
}
.fa-microphone-slash:before {
  content: "\f131";
}
.fa-shield:before {
  content: "\f132";
}
.fa-calendar-o:before {
  content: "\f133";
}
.fa-fire-extinguisher:before {
  content: "\f134";
}
.fa-rocket:before {
  content: "\f135";
}
.fa-maxcdn:before {
  content: "\f136";
}
.fa-chevron-circle-left:before {
  content: "\f137";
}
.fa-chevron-circle-right:before {
  content: "\f138";
}
.fa-chevron-circle-up:before {
  content: "\f139";
}
.fa-chevron-circle-down:before {
  content: "\f13a";
}
.fa-html5:before {
  content: "\f13b";
}
.fa-css3:before {
  content: "\f13c";
}
.fa-anchor:before {
  content: "\f13d";
}
.fa-unlock-alt:before {
  content: "\f13e";
}
.fa-bullseye:before {
  content: "\f140";
}
.fa-ellipsis-h:before {
  content: "\f141";
}
.fa-ellipsis-v:before {
  content: "\f142";
}
.fa-rss-square:before {
  content: "\f143";
}
.fa-play-circle:before {
  content: "\f144";
}
.fa-ticket:before {
  content: "\f145";
}
.fa-minus-square:before {
  content: "\f146";
}
.fa-minus-square-o:before {
  content: "\f147";
}
.fa-level-up:before {
  content: "\f148";
}
.fa-level-down:before {
  content: "\f149";
}
.fa-check-square:before {
  content: "\f14a";
}
.fa-pencil-square:before {
  content: "\f14b";
}
.fa-external-link-square:before {
  content: "\f14c";
}
.fa-share-square:before {
  content: "\f14d";
}
.fa-compass:before {
  content: "\f14e";
}
.fa-toggle-down:before,
.fa-caret-square-o-down:before {
  content: "\f150";
}
.fa-toggle-up:before,
.fa-caret-square-o-up:before {
  content: "\f151";
}
.fa-toggle-right:before,
.fa-caret-square-o-right:before {
  content: "\f152";
}
.fa-euro:before,
.fa-eur:before {
  content: "\f153";
}
.fa-gbp:before {
  content: "\f154";
}
.fa-dollar:before,
.fa-usd:before {
  content: "\f155";
}
.fa-rupee:before,
.fa-inr:before {
  content: "\f156";
}
.fa-cny:before,
.fa-rmb:before,
.fa-yen:before,
.fa-jpy:before {
  content: "\f157";
}
.fa-ruble:before,
.fa-rouble:before,
.fa-rub:before {
  content: "\f158";
}
.fa-won:before,
.fa-krw:before {
  content: "\f159";
}
.fa-bitcoin:before,
.fa-btc:before {
  content: "\f15a";
}
.fa-file:before {
  content: "\f15b";
}
.fa-file-text:before {
  content: "\f15c";
}
.fa-sort-alpha-asc:before {
  content: "\f15d";
}
.fa-sort-alpha-desc:before {
  content: "\f15e";
}
.fa-sort-amount-asc:before {
  content: "\f160";
}
.fa-sort-amount-desc:before {
  content: "\f161";
}
.fa-sort-numeric-asc:before {
  content: "\f162";
}
.fa-sort-numeric-desc:before {
  content: "\f163";
}
.fa-thumbs-up:before {
  content: "\f164";
}
.fa-thumbs-down:before {
  content: "\f165";
}
.fa-youtube-square:before {
  content: "\f166";
}
.fa-youtube:before {
  content: "\f167";
}
.fa-xing:before {
  content: "\f168";
}
.fa-xing-square:before {
  content: "\f169";
}
.fa-youtube-play:before {
  content: "\f16a";
}
.fa-dropbox:before {
  content: "\f16b";
}
.fa-stack-overflow:before {
  content: "\f16c";
}
.fa-instagram:before {
  content: "\f16d";
}
.fa-flickr:before {
  content: "\f16e";
}
.fa-adn:before {
  content: "\f170";
}
.fa-bitbucket:before {
  content: "\f171";
}
.fa-bitbucket-square:before {
  content: "\f172";
}
.fa-tumblr:before {
  content: "\f173";
}
.fa-tumblr-square:before {
  content: "\f174";
}
.fa-long-arrow-down:before {
  content: "\f175";
}
.fa-long-arrow-up:before {
  content: "\f176";
}
.fa-long-arrow-left:before {
  content: "\f177";
}
.fa-long-arrow-right:before {
  content: "\f178";
}
.fa-apple:before {
  content: "\f179";
}
.fa-windows:before {
  content: "\f17a";
}
.fa-android:before {
  content: "\f17b";
}
.fa-linux:before {
  content: "\f17c";
}
.fa-dribbble:before {
  content: "\f17d";
}
.fa-skype:before {
  content: "\f17e";
}
.fa-foursquare:before {
  content: "\f180";
}
.fa-trello:before {
  content: "\f181";
}
.fa-female:before {
  content: "\f182";
}
.fa-male:before {
  content: "\f183";
}
.fa-gittip:before,
.fa-gratipay:before {
  content: "\f184";
}
.fa-sun-o:before {
  content: "\f185";
}
.fa-moon-o:before {
  content: "\f186";
}
.fa-archive:before {
  content: "\f187";
}
.fa-bug:before {
  content: "\f188";
}
.fa-vk:before {
  content: "\f189";
}
.fa-weibo:before {
  content: "\f18a";
}
.fa-renren:before {
  content: "\f18b";
}
.fa-pagelines:before {
  content: "\f18c";
}
.fa-stack-exchange:before {
  content: "\f18d";
}
.fa-arrow-circle-o-right:before {
  content: "\f18e";
}
.fa-arrow-circle-o-left:before {
  content: "\f190";
}
.fa-toggle-left:before,
.fa-caret-square-o-left:before {
  content: "\f191";
}
.fa-dot-circle-o:before {
  content: "\f192";
}
.fa-wheelchair:before {
  content: "\f193";
}
.fa-vimeo-square:before {
  content: "\f194";
}
.fa-turkish-lira:before,
.fa-try:before {
  content: "\f195";
}
.fa-plus-square-o:before {
  content: "\f196";
}
.fa-space-shuttle:before {
  content: "\f197";
}
.fa-slack:before {
  content: "\f198";
}
.fa-envelope-square:before {
  content: "\f199";
}
.fa-wordpress:before {
  content: "\f19a";
}
.fa-openid:before {
  content: "\f19b";
}
.fa-institution:before,
.fa-bank:before,
.fa-university:before {
  content: "\f19c";
}
.fa-mortar-board:before,
.fa-graduation-cap:before {
  content: "\f19d";
}
.fa-yahoo:before {
  content: "\f19e";
}
.fa-google:before {
  content: "\f1a0";
}
.fa-reddit:before {
  content: "\f1a1";
}
.fa-reddit-square:before {
  content: "\f1a2";
}
.fa-stumbleupon-circle:before {
  content: "\f1a3";
}
.fa-stumbleupon:before {
  content: "\f1a4";
}
.fa-delicious:before {
  content: "\f1a5";
}
.fa-digg:before {
  content: "\f1a6";
}
.fa-pied-piper-pp:before {
  content: "\f1a7";
}
.fa-pied-piper-alt:before {
  content: "\f1a8";
}
.fa-drupal:before {
  content: "\f1a9";
}
.fa-joomla:before {
  content: "\f1aa";
}
.fa-language:before {
  content: "\f1ab";
}
.fa-fax:before {
  content: "\f1ac";
}
.fa-building:before {
  content: "\f1ad";
}
.fa-child:before {
  content: "\f1ae";
}
.fa-paw:before {
  content: "\f1b0";
}
.fa-spoon:before {
  content: "\f1b1";
}
.fa-cube:before {
  content: "\f1b2";
}
.fa-cubes:before {
  content: "\f1b3";
}
.fa-behance:before {
  content: "\f1b4";
}
.fa-behance-square:before {
  content: "\f1b5";
}
.fa-steam:before {
  content: "\f1b6";
}
.fa-steam-square:before {
  content: "\f1b7";
}
.fa-recycle:before {
  content: "\f1b8";
}
.fa-automobile:before,
.fa-car:before {
  content: "\f1b9";
}
.fa-cab:before,
.fa-taxi:before {
  content: "\f1ba";
}
.fa-tree:before {
  content: "\f1bb";
}
.fa-spotify:before {
  content: "\f1bc";
}
.fa-deviantart:before {
  content: "\f1bd";
}
.fa-soundcloud:before {
  content: "\f1be";
}
.fa-database:before {
  content: "\f1c0";
}
.fa-file-pdf-o:before {
  content: "\f1c1";
}
.fa-file-word-o:before {
  content: "\f1c2";
}
.fa-file-excel-o:before {
  content: "\f1c3";
}
.fa-file-powerpoint-o:before {
  content: "\f1c4";
}
.fa-file-photo-o:before,
.fa-file-picture-o:before,
.fa-file-image-o:before {
  content: "\f1c5";
}
.fa-file-zip-o:before,
.fa-file-archive-o:before {
  content: "\f1c6";
}
.fa-file-sound-o:before,
.fa-file-audio-o:before {
  content: "\f1c7";
}
.fa-file-movie-o:before,
.fa-file-video-o:before {
  content: "\f1c8";
}
.fa-file-code-o:before {
  content: "\f1c9";
}
.fa-vine:before {
  content: "\f1ca";
}
.fa-codepen:before {
  content: "\f1cb";
}
.fa-jsfiddle:before {
  content: "\f1cc";
}
.fa-life-bouy:before,
.fa-life-buoy:before,
.fa-life-saver:before,
.fa-support:before,
.fa-life-ring:before {
  content: "\f1cd";
}
.fa-circle-o-notch:before {
  content: "\f1ce";
}
.fa-ra:before,
.fa-resistance:before,
.fa-rebel:before {
  content: "\f1d0";
}
.fa-ge:before,
.fa-empire:before {
  content: "\f1d1";
}
.fa-git-square:before {
  content: "\f1d2";
}
.fa-git:before {
  content: "\f1d3";
}
.fa-y-combinator-square:before,
.fa-yc-square:before,
.fa-hacker-news:before {
  content: "\f1d4";
}
.fa-tencent-weibo:before {
  content: "\f1d5";
}
.fa-qq:before {
  content: "\f1d6";
}
.fa-wechat:before,
.fa-weixin:before {
  content: "\f1d7";
}
.fa-send:before,
.fa-paper-plane:before {
  content: "\f1d8";
}
.fa-send-o:before,
.fa-paper-plane-o:before {
  content: "\f1d9";
}
.fa-history:before {
  content: "\f1da";
}
.fa-circle-thin:before {
  content: "\f1db";
}
.fa-header:before {
  content: "\f1dc";
}
.fa-paragraph:before {
  content: "\f1dd";
}
.fa-sliders:before {
  content: "\f1de";
}
.fa-share-alt:before {
  content: "\f1e0";
}
.fa-share-alt-square:before {
  content: "\f1e1";
}
.fa-bomb:before {
  content: "\f1e2";
}
.fa-soccer-ball-o:before,
.fa-futbol-o:before {
  content: "\f1e3";
}
.fa-tty:before {
  content: "\f1e4";
}
.fa-binoculars:before {
  content: "\f1e5";
}
.fa-plug:before {
  content: "\f1e6";
}
.fa-slideshare:before {
  content: "\f1e7";
}
.fa-twitch:before {
  content: "\f1e8";
}
.fa-yelp:before {
  content: "\f1e9";
}
.fa-newspaper-o:before {
  content: "\f1ea";
}
.fa-wifi:before {
  content: "\f1eb";
}
.fa-calculator:before {
  content: "\f1ec";
}
.fa-paypal:before {
  content: "\f1ed";
}
.fa-google-wallet:before {
  content: "\f1ee";
}
.fa-cc-visa:before {
  content: "\f1f0";
}
.fa-cc-mastercard:before {
  content: "\f1f1";
}
.fa-cc-discover:before {
  content: "\f1f2";
}
.fa-cc-amex:before {
  content: "\f1f3";
}
.fa-cc-paypal:before {
  content: "\f1f4";
}
.fa-cc-stripe:before {
  content: "\f1f5";
}
.fa-bell-slash:before {
  content: "\f1f6";
}
.fa-bell-slash-o:before {
  content: "\f1f7";
}
.fa-trash:before {
  content: "\f1f8";
}
.fa-copyright:before {
  content: "\f1f9";
}
.fa-at:before {
  content: "\f1fa";
}
.fa-eyedropper:before {
  content: "\f1fb";
}
.fa-paint-brush:before {
  content: "\f1fc";
}
.fa-birthday-cake:before {
  content: "\f1fd";
}
.fa-area-chart:before {
  content: "\f1fe";
}
.fa-pie-chart:before {
  content: "\f200";
}
.fa-line-chart:before {
  content: "\f201";
}
.fa-lastfm:before {
  content: "\f202";
}
.fa-lastfm-square:before {
  content: "\f203";
}
.fa-toggle-off:before {
  content: "\f204";
}
.fa-toggle-on:before {
  content: "\f205";
}
.fa-bicycle:before {
  content: "\f206";
}
.fa-bus:before {
  content: "\f207";
}
.fa-ioxhost:before {
  content: "\f208";
}
.fa-angellist:before {
  content: "\f209";
}
.fa-cc:before {
  content: "\f20a";
}
.fa-shekel:before,
.fa-sheqel:before,
.fa-ils:before {
  content: "\f20b";
}
.fa-meanpath:before {
  content: "\f20c";
}
.fa-buysellads:before {
  content: "\f20d";
}
.fa-connectdevelop:before {
  content: "\f20e";
}
.fa-dashcube:before {
  content: "\f210";
}
.fa-forumbee:before {
  content: "\f211";
}
.fa-leanpub:before {
  content: "\f212";
}
.fa-sellsy:before {
  content: "\f213";
}
.fa-shirtsinbulk:before {
  content: "\f214";
}
.fa-simplybuilt:before {
  content: "\f215";
}
.fa-skyatlas:before {
  content: "\f216";
}
.fa-cart-plus:before {
  content: "\f217";
}
.fa-cart-arrow-down:before {
  content: "\f218";
}
.fa-diamond:before {
  content: "\f219";
}
.fa-ship:before {
  content: "\f21a";
}
.fa-user-secret:before {
  content: "\f21b";
}
.fa-motorcycle:before {
  content: "\f21c";
}
.fa-street-view:before {
  content: "\f21d";
}
.fa-heartbeat:before {
  content: "\f21e";
}
.fa-venus:before {
  content: "\f221";
}
.fa-mars:before {
  content: "\f222";
}
.fa-mercury:before {
  content: "\f223";
}
.fa-intersex:before,
.fa-transgender:before {
  content: "\f224";
}
.fa-transgender-alt:before {
  content: "\f225";
}
.fa-venus-double:before {
  content: "\f226";
}
.fa-mars-double:before {
  content: "\f227";
}
.fa-venus-mars:before {
  content: "\f228";
}
.fa-mars-stroke:before {
  content: "\f229";
}
.fa-mars-stroke-v:before {
  content: "\f22a";
}
.fa-mars-stroke-h:before {
  content: "\f22b";
}
.fa-neuter:before {
  content: "\f22c";
}
.fa-genderless:before {
  content: "\f22d";
}
.fa-facebook-official:before {
  content: "\f230";
}
.fa-pinterest-p:before {
  content: "\f231";
}
.fa-whatsapp:before {
  content: "\f232";
}
.fa-server:before {
  content: "\f233";
}
.fa-user-plus:before {
  content: "\f234";
}
.fa-user-times:before {
  content: "\f235";
}
.fa-hotel:before,
.fa-bed:before {
  content: "\f236";
}
.fa-viacoin:before {
  content: "\f237";
}
.fa-train:before {
  content: "\f238";
}
.fa-subway:before {
  content: "\f239";
}
.fa-medium:before {
  content: "\f23a";
}
.fa-yc:before,
.fa-y-combinator:before {
  content: "\f23b";
}
.fa-optin-monster:before {
  content: "\f23c";
}
.fa-opencart:before {
  content: "\f23d";
}
.fa-expeditedssl:before {
  content: "\f23e";
}
.fa-battery-4:before,
.fa-battery:before,
.fa-battery-full:before {
  content: "\f240";
}
.fa-battery-3:before,
.fa-battery-three-quarters:before {
  content: "\f241";
}
.fa-battery-2:before,
.fa-battery-half:before {
  content: "\f242";
}
.fa-battery-1:before,
.fa-battery-quarter:before {
  content: "\f243";
}
.fa-battery-0:before,
.fa-battery-empty:before {
  content: "\f244";
}
.fa-mouse-pointer:before {
  content: "\f245";
}
.fa-i-cursor:before {
  content: "\f246";
}
.fa-object-group:before {
  content: "\f247";
}
.fa-object-ungroup:before {
  content: "\f248";
}
.fa-sticky-note:before {
  content: "\f249";
}
.fa-sticky-note-o:before {
  content: "\f24a";
}
.fa-cc-jcb:before {
  content: "\f24b";
}
.fa-cc-diners-club:before {
  content: "\f24c";
}
.fa-clone:before {
  content: "\f24d";
}
.fa-balance-scale:before {
  content: "\f24e";
}
.fa-hourglass-o:before {
  content: "\f250";
}
.fa-hourglass-1:before,
.fa-hourglass-start:before {
  content: "\f251";
}
.fa-hourglass-2:before,
.fa-hourglass-half:before {
  content: "\f252";
}
.fa-hourglass-3:before,
.fa-hourglass-end:before {
  content: "\f253";
}
.fa-hourglass:before {
  content: "\f254";
}
.fa-hand-grab-o:before,
.fa-hand-rock-o:before {
  content: "\f255";
}
.fa-hand-stop-o:before,
.fa-hand-paper-o:before {
  content: "\f256";
}
.fa-hand-scissors-o:before {
  content: "\f257";
}
.fa-hand-lizard-o:before {
  content: "\f258";
}
.fa-hand-spock-o:before {
  content: "\f259";
}
.fa-hand-pointer-o:before {
  content: "\f25a";
}
.fa-hand-peace-o:before {
  content: "\f25b";
}
.fa-trademark:before {
  content: "\f25c";
}
.fa-registered:before {
  content: "\f25d";
}
.fa-creative-commons:before {
  content: "\f25e";
}
.fa-gg:before {
  content: "\f260";
}
.fa-gg-circle:before {
  content: "\f261";
}
.fa-tripadvisor:before {
  content: "\f262";
}
.fa-odnoklassniki:before {
  content: "\f263";
}
.fa-odnoklassniki-square:before {
  content: "\f264";
}
.fa-get-pocket:before {
  content: "\f265";
}
.fa-wikipedia-w:before {
  content: "\f266";
}
.fa-safari:before {
  content: "\f267";
}
.fa-chrome:before {
  content: "\f268";
}
.fa-firefox:before {
  content: "\f269";
}
.fa-opera:before {
  content: "\f26a";
}
.fa-internet-explorer:before {
  content: "\f26b";
}
.fa-tv:before,
.fa-television:before {
  content: "\f26c";
}
.fa-contao:before {
  content: "\f26d";
}
.fa-500px:before {
  content: "\f26e";
}
.fa-amazon:before {
  content: "\f270";
}
.fa-calendar-plus-o:before {
  content: "\f271";
}
.fa-calendar-minus-o:before {
  content: "\f272";
}
.fa-calendar-times-o:before {
  content: "\f273";
}
.fa-calendar-check-o:before {
  content: "\f274";
}
.fa-industry:before {
  content: "\f275";
}
.fa-map-pin:before {
  content: "\f276";
}
.fa-map-signs:before {
  content: "\f277";
}
.fa-map-o:before {
  content: "\f278";
}
.fa-map:before {
  content: "\f279";
}
.fa-commenting:before {
  content: "\f27a";
}
.fa-commenting-o:before {
  content: "\f27b";
}
.fa-houzz:before {
  content: "\f27c";
}
.fa-vimeo:before {
  content: "\f27d";
}
.fa-black-tie:before {
  content: "\f27e";
}
.fa-fonticons:before {
  content: "\f280";
}
.fa-reddit-alien:before {
  content: "\f281";
}
.fa-edge:before {
  content: "\f282";
}
.fa-credit-card-alt:before {
  content: "\f283";
}
.fa-codiepie:before {
  content: "\f284";
}
.fa-modx:before {
  content: "\f285";
}
.fa-fort-awesome:before {
  content: "\f286";
}
.fa-usb:before {
  content: "\f287";
}
.fa-product-hunt:before {
  content: "\f288";
}
.fa-mixcloud:before {
  content: "\f289";
}
.fa-scribd:before {
  content: "\f28a";
}
.fa-pause-circle:before {
  content: "\f28b";
}
.fa-pause-circle-o:before {
  content: "\f28c";
}
.fa-stop-circle:before {
  content: "\f28d";
}
.fa-stop-circle-o:before {
  content: "\f28e";
}
.fa-shopping-bag:before {
  content: "\f290";
}
.fa-shopping-basket:before {
  content: "\f291";
}
.fa-hashtag:before {
  content: "\f292";
}
.fa-bluetooth:before {
  content: "\f293";
}
.fa-bluetooth-b:before {
  content: "\f294";
}
.fa-percent:before {
  content: "\f295";
}
.fa-gitlab:before {
  content: "\f296";
}
.fa-wpbeginner:before {
  content: "\f297";
}
.fa-wpforms:before {
  content: "\f298";
}
.fa-envira:before {
  content: "\f299";
}
.fa-universal-access:before {
  content: "\f29a";
}
.fa-wheelchair-alt:before {
  content: "\f29b";
}
.fa-question-circle-o:before {
  content: "\f29c";
}
.fa-blind:before {
  content: "\f29d";
}
.fa-audio-description:before {
  content: "\f29e";
}
.fa-volume-control-phone:before {
  content: "\f2a0";
}
.fa-braille:before {
  content: "\f2a1";
}
.fa-assistive-listening-systems:before {
  content: "\f2a2";
}
.fa-asl-interpreting:before,
.fa-american-sign-language-interpreting:before {
  content: "\f2a3";
}
.fa-deafness:before,
.fa-hard-of-hearing:before,
.fa-deaf:before {
  content: "\f2a4";
}
.fa-glide:before {
  content: "\f2a5";
}
.fa-glide-g:before {
  content: "\f2a6";
}
.fa-signing:before,
.fa-sign-language:before {
  content: "\f2a7";
}
.fa-low-vision:before {
  content: "\f2a8";
}
.fa-viadeo:before {
  content: "\f2a9";
}
.fa-viadeo-square:before {
  content: "\f2aa";
}
.fa-snapchat:before {
  content: "\f2ab";
}
.fa-snapchat-ghost:before {
  content: "\f2ac";
}
.fa-snapchat-square:before {
  content: "\f2ad";
}
.fa-pied-piper:before {
  content: "\f2ae";
}
.fa-first-order:before {
  content: "\f2b0";
}
.fa-yoast:before {
  content: "\f2b1";
}
.fa-themeisle:before {
  content: "\f2b2";
}
.fa-google-plus-circle:before,
.fa-google-plus-official:before {
  content: "\f2b3";
}
.fa-fa:before,
.fa-font-awesome:before {
  content: "\f2b4";
}
.fa-handshake-o:before {
  content: "\f2b5";
}
.fa-envelope-open:before {
  content: "\f2b6";
}
.fa-envelope-open-o:before {
  content: "\f2b7";
}
.fa-linode:before {
  content: "\f2b8";
}
.fa-address-book:before {
  content: "\f2b9";
}
.fa-address-book-o:before {
  content: "\f2ba";
}
.fa-vcard:before,
.fa-address-card:before {
  content: "\f2bb";
}
.fa-vcard-o:before,
.fa-address-card-o:before {
  content: "\f2bc";
}
.fa-user-circle:before {
  content: "\f2bd";
}
.fa-user-circle-o:before {
  content: "\f2be";
}
.fa-user-o:before {
  content: "\f2c0";
}
.fa-id-badge:before {
  content: "\f2c1";
}
.fa-drivers-license:before,
.fa-id-card:before {
  content: "\f2c2";
}
.fa-drivers-license-o:before,
.fa-id-card-o:before {
  content: "\f2c3";
}
.fa-quora:before {
  content: "\f2c4";
}
.fa-free-code-camp:before {
  content: "\f2c5";
}
.fa-telegram:before {
  content: "\f2c6";
}
.fa-thermometer-4:before,
.fa-thermometer:before,
.fa-thermometer-full:before {
  content: "\f2c7";
}
.fa-thermometer-3:before,
.fa-thermometer-three-quarters:before {
  content: "\f2c8";
}
.fa-thermometer-2:before,
.fa-thermometer-half:before {
  content: "\f2c9";
}
.fa-thermometer-1:before,
.fa-thermometer-quarter:before {
  content: "\f2ca";
}
.fa-thermometer-0:before,
.fa-thermometer-empty:before {
  content: "\f2cb";
}
.fa-shower:before {
  content: "\f2cc";
}
.fa-bathtub:before,
.fa-s15:before,
.fa-bath:before {
  content: "\f2cd";
}
.fa-podcast:before {
  content: "\f2ce";
}
.fa-window-maximize:before {
  content: "\f2d0";
}
.fa-window-minimize:before {
  content: "\f2d1";
}
.fa-window-restore:before {
  content: "\f2d2";
}
.fa-times-rectangle:before,
.fa-window-close:before {
  content: "\f2d3";
}
.fa-times-rectangle-o:before,
.fa-window-close-o:before {
  content: "\f2d4";
}
.fa-bandcamp:before {
  content: "\f2d5";
}
.fa-grav:before {
  content: "\f2d6";
}
.fa-etsy:before {
  content: "\f2d7";
}
.fa-imdb:before {
  content: "\f2d8";
}
.fa-ravelry:before {
  content: "\f2d9";
}
.fa-eercast:before {
  content: "\f2da";
}
.fa-microchip:before {
  content: "\f2db";
}
.fa-snowflake-o:before {
  content: "\f2dc";
}
.fa-superpowers:before {
  content: "\f2dd";
}
.fa-wpexplorer:before {
  content: "\f2de";
}
.fa-meetup:before {
  content: "\f2e0";
}
.sr-only {
  position: absolute;
  width: 1px;
  height: 1px;
  padding: 0;
  margin: -1px;
  overflow: hidden;
  clip: rect(0, 0, 0, 0);
  border: 0;
}
.sr-only-focusable:active,
.sr-only-focusable:focus {
  position: static;
  width: auto;
  height: auto;
  margin: 0;
  overflow: visible;
  clip: auto;
}
.sr-only-focusable:active,
.sr-only-focusable:focus {
  position: static;
  width: auto;
  height: auto;
  margin: 0;
  overflow: visible;
  clip: auto;
}
/*!
*
* IPython base
*
*/
.modal.fade .modal-dialog {
  -webkit-transform: translate(0, 0);
  -ms-transform: translate(0, 0);
  -o-transform: translate(0, 0);
  transform: translate(0, 0);
}
code {
  color: #000;
}
pre {
  font-size: inherit;
  line-height: inherit;
}
label {
  font-weight: normal;
}
/* Make the page background atleast 100% the height of the view port */
/* Make the page itself atleast 70% the height of the view port */
.border-box-sizing {
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
.corner-all {
  border-radius: 2px;
}
.no-padding {
  padding: 0px;
}
/* Flexible box model classes */
/* Taken from Alex Russell http://infrequently.org/2009/08/css-3-progress/ */
/* This file is a compatability layer.  It allows the usage of flexible box 
model layouts accross multiple browsers, including older browsers.  The newest,
universal implementation of the flexible box model is used when available (see
`Modern browsers` comments below).  Browsers that are known to implement this 
new spec completely include:

    Firefox 28.0+
    Chrome 29.0+
    Internet Explorer 11+ 
    Opera 17.0+

Browsers not listed, including Safari, are supported via the styling under the
`Old browsers` comments below.
*/
.hbox {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
.hbox > * {
  /* Old browsers */
  -webkit-box-flex: 0;
  -moz-box-flex: 0;
  box-flex: 0;
  /* Modern browsers */
  flex: none;
}
.vbox {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
}
.vbox > * {
  /* Old browsers */
  -webkit-box-flex: 0;
  -moz-box-flex: 0;
  box-flex: 0;
  /* Modern browsers */
  flex: none;
}
.hbox.reverse,
.vbox.reverse,
.reverse {
  /* Old browsers */
  -webkit-box-direction: reverse;
  -moz-box-direction: reverse;
  box-direction: reverse;
  /* Modern browsers */
  flex-direction: row-reverse;
}
.hbox.box-flex0,
.vbox.box-flex0,
.box-flex0 {
  /* Old browsers */
  -webkit-box-flex: 0;
  -moz-box-flex: 0;
  box-flex: 0;
  /* Modern browsers */
  flex: none;
  width: auto;
}
.hbox.box-flex1,
.vbox.box-flex1,
.box-flex1 {
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
.hbox.box-flex,
.vbox.box-flex,
.box-flex {
  /* Old browsers */
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
.hbox.box-flex2,
.vbox.box-flex2,
.box-flex2 {
  /* Old browsers */
  -webkit-box-flex: 2;
  -moz-box-flex: 2;
  box-flex: 2;
  /* Modern browsers */
  flex: 2;
}
.box-group1 {
  /*  Deprecated */
  -webkit-box-flex-group: 1;
  -moz-box-flex-group: 1;
  box-flex-group: 1;
}
.box-group2 {
  /* Deprecated */
  -webkit-box-flex-group: 2;
  -moz-box-flex-group: 2;
  box-flex-group: 2;
}
.hbox.start,
.vbox.start,
.start {
  /* Old browsers */
  -webkit-box-pack: start;
  -moz-box-pack: start;
  box-pack: start;
  /* Modern browsers */
  justify-content: flex-start;
}
.hbox.end,
.vbox.end,
.end {
  /* Old browsers */
  -webkit-box-pack: end;
  -moz-box-pack: end;
  box-pack: end;
  /* Modern browsers */
  justify-content: flex-end;
}
.hbox.center,
.vbox.center,
.center {
  /* Old browsers */
  -webkit-box-pack: center;
  -moz-box-pack: center;
  box-pack: center;
  /* Modern browsers */
  justify-content: center;
}
.hbox.baseline,
.vbox.baseline,
.baseline {
  /* Old browsers */
  -webkit-box-pack: baseline;
  -moz-box-pack: baseline;
  box-pack: baseline;
  /* Modern browsers */
  justify-content: baseline;
}
.hbox.stretch,
.vbox.stretch,
.stretch {
  /* Old browsers */
  -webkit-box-pack: stretch;
  -moz-box-pack: stretch;
  box-pack: stretch;
  /* Modern browsers */
  justify-content: stretch;
}
.hbox.align-start,
.vbox.align-start,
.align-start {
  /* Old browsers */
  -webkit-box-align: start;
  -moz-box-align: start;
  box-align: start;
  /* Modern browsers */
  align-items: flex-start;
}
.hbox.align-end,
.vbox.align-end,
.align-end {
  /* Old browsers */
  -webkit-box-align: end;
  -moz-box-align: end;
  box-align: end;
  /* Modern browsers */
  align-items: flex-end;
}
.hbox.align-center,
.vbox.align-center,
.align-center {
  /* Old browsers */
  -webkit-box-align: center;
  -moz-box-align: center;
  box-align: center;
  /* Modern browsers */
  align-items: center;
}
.hbox.align-baseline,
.vbox.align-baseline,
.align-baseline {
  /* Old browsers */
  -webkit-box-align: baseline;
  -moz-box-align: baseline;
  box-align: baseline;
  /* Modern browsers */
  align-items: baseline;
}
.hbox.align-stretch,
.vbox.align-stretch,
.align-stretch {
  /* Old browsers */
  -webkit-box-align: stretch;
  -moz-box-align: stretch;
  box-align: stretch;
  /* Modern browsers */
  align-items: stretch;
}
div.error {
  margin: 2em;
  text-align: center;
}
div.error > h1 {
  font-size: 500%;
  line-height: normal;
}
div.error > p {
  font-size: 200%;
  line-height: normal;
}
div.traceback-wrapper {
  text-align: left;
  max-width: 800px;
  margin: auto;
}
div.traceback-wrapper pre.traceback {
  max-height: 600px;
  overflow: auto;
}
/**
 * Primary styles
 *
 * Author: Jupyter Development Team
 */
body {
  background-color: #fff;
  /* This makes sure that the body covers the entire window and needs to
       be in a different element than the display: box in wrapper below */
  position: absolute;
  left: 0px;
  right: 0px;
  top: 0px;
  bottom: 0px;
  overflow: visible;
}
body > #header {
  /* Initially hidden to prevent FLOUC */
  display: none;
  background-color: #fff;
  /* Display over codemirror */
  position: relative;
  z-index: 100;
}
body > #header #header-container {
  display: flex;
  flex-direction: row;
  justify-content: space-between;
  padding: 5px;
  padding-bottom: 5px;
  padding-top: 5px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
body > #header .header-bar {
  width: 100%;
  height: 1px;
  background: #e7e7e7;
  margin-bottom: -1px;
}
@media print {
  body > #header {
    display: none !important;
  }
}
#header-spacer {
  width: 100%;
  visibility: hidden;
}
@media print {
  #header-spacer {
    display: none;
  }
}
#ipython_notebook {
  padding-left: 0px;
  padding-top: 1px;
  padding-bottom: 1px;
}
[dir="rtl"] #ipython_notebook {
  margin-right: 10px;
  margin-left: 0;
}
[dir="rtl"] #ipython_notebook.pull-left {
  float: right !important;
  float: right;
}
.flex-spacer {
  flex: 1;
}
#noscript {
  width: auto;
  padding-top: 16px;
  padding-bottom: 16px;
  text-align: center;
  font-size: 22px;
  color: red;
  font-weight: bold;
}
#ipython_notebook img {
  height: 28px;
}
#site {
  width: 100%;
  display: none;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  overflow: auto;
}
@media print {
  #site {
    height: auto !important;
  }
}
/* Smaller buttons */
.ui-button .ui-button-text {
  padding: 0.2em 0.8em;
  font-size: 77%;
}
input.ui-button {
  padding: 0.3em 0.9em;
}
span#kernel_logo_widget {
  margin: 0 10px;
}
span#login_widget {
  float: right;
}
[dir="rtl"] span#login_widget {
  float: left;
}
span#login_widget > .button,
#logout {
  color: #333;
  background-color: #fff;
  border-color: #ccc;
}
span#login_widget > .button:focus,
#logout:focus,
span#login_widget > .button.focus,
#logout.focus {
  color: #333;
  background-color: #e6e6e6;
  border-color: #8c8c8c;
}
span#login_widget > .button:hover,
#logout:hover {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
span#login_widget > .button:active,
#logout:active,
span#login_widget > .button.active,
#logout.active,
.open > .dropdown-togglespan#login_widget > .button,
.open > .dropdown-toggle#logout {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
span#login_widget > .button:active:hover,
#logout:active:hover,
span#login_widget > .button.active:hover,
#logout.active:hover,
.open > .dropdown-togglespan#login_widget > .button:hover,
.open > .dropdown-toggle#logout:hover,
span#login_widget > .button:active:focus,
#logout:active:focus,
span#login_widget > .button.active:focus,
#logout.active:focus,
.open > .dropdown-togglespan#login_widget > .button:focus,
.open > .dropdown-toggle#logout:focus,
span#login_widget > .button:active.focus,
#logout:active.focus,
span#login_widget > .button.active.focus,
#logout.active.focus,
.open > .dropdown-togglespan#login_widget > .button.focus,
.open > .dropdown-toggle#logout.focus {
  color: #333;
  background-color: #d4d4d4;
  border-color: #8c8c8c;
}
span#login_widget > .button:active,
#logout:active,
span#login_widget > .button.active,
#logout.active,
.open > .dropdown-togglespan#login_widget > .button,
.open > .dropdown-toggle#logout {
  background-image: none;
}
span#login_widget > .button.disabled:hover,
#logout.disabled:hover,
span#login_widget > .button[disabled]:hover,
#logout[disabled]:hover,
fieldset[disabled] span#login_widget > .button:hover,
fieldset[disabled] #logout:hover,
span#login_widget > .button.disabled:focus,
#logout.disabled:focus,
span#login_widget > .button[disabled]:focus,
#logout[disabled]:focus,
fieldset[disabled] span#login_widget > .button:focus,
fieldset[disabled] #logout:focus,
span#login_widget > .button.disabled.focus,
#logout.disabled.focus,
span#login_widget > .button[disabled].focus,
#logout[disabled].focus,
fieldset[disabled] span#login_widget > .button.focus,
fieldset[disabled] #logout.focus {
  background-color: #fff;
  border-color: #ccc;
}
span#login_widget > .button .badge,
#logout .badge {
  color: #fff;
  background-color: #333;
}
.nav-header {
  text-transform: none;
}
#header > span {
  margin-top: 10px;
}
.modal_stretch .modal-dialog {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  min-height: 80vh;
}
.modal_stretch .modal-dialog .modal-body {
  max-height: calc(100vh - 200px);
  overflow: auto;
  flex: 1;
}
.modal-header {
  cursor: move;
}
@media (min-width: 768px) {
  .modal .modal-dialog {
    width: 700px;
  }
}
@media (min-width: 768px) {
  select.form-control {
    margin-left: 12px;
    margin-right: 12px;
  }
}
/*!
*
* IPython auth
*
*/
.center-nav {
  display: inline-block;
  margin-bottom: -4px;
}
[dir="rtl"] .center-nav form.pull-left {
  float: right !important;
  float: right;
}
[dir="rtl"] .center-nav .navbar-text {
  float: right;
}
[dir="rtl"] .navbar-inner {
  text-align: right;
}
[dir="rtl"] div.text-left {
  text-align: right;
}
/*!
*
* IPython tree view
*
*/
/* We need an invisible input field on top of the sentense*/
/* "Drag file onto the list ..." */
.alternate_upload {
  background-color: none;
  display: inline;
}
.alternate_upload.form {
  padding: 0;
  margin: 0;
}
.alternate_upload input.fileinput {
  position: absolute;
  display: block;
  width: 100%;
  height: 100%;
  overflow: hidden;
  cursor: pointer;
  opacity: 0;
  z-index: 2;
}
.alternate_upload .btn-xs > input.fileinput {
  margin: -1px -5px;
}
.alternate_upload .btn-upload {
  position: relative;
  height: 22px;
}
::-webkit-file-upload-button {
  cursor: pointer;
}
/**
 * Primary styles
 *
 * Author: Jupyter Development Team
 */
ul#tabs {
  margin-bottom: 4px;
}
ul#tabs a {
  padding-top: 6px;
  padding-bottom: 4px;
}
[dir="rtl"] ul#tabs.nav-tabs > li {
  float: right;
}
[dir="rtl"] ul#tabs.nav.nav-tabs {
  padding-right: 0;
}
ul.breadcrumb a:focus,
ul.breadcrumb a:hover {
  text-decoration: none;
}
ul.breadcrumb i.icon-home {
  font-size: 16px;
  margin-right: 4px;
}
ul.breadcrumb span {
  color: #5e5e5e;
}
.list_toolbar {
  padding: 4px 0 4px 0;
  vertical-align: middle;
}
.list_toolbar .tree-buttons {
  padding-top: 1px;
}
[dir="rtl"] .list_toolbar .tree-buttons .pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .list_toolbar .col-sm-4,
[dir="rtl"] .list_toolbar .col-sm-8 {
  float: right;
}
.dynamic-buttons {
  padding-top: 3px;
  display: inline-block;
}
.list_toolbar [class*="span"] {
  min-height: 24px;
}
.list_header {
  font-weight: bold;
  background-color: #EEE;
}
.list_placeholder {
  font-weight: bold;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 7px;
  padding-right: 7px;
}
.list_container {
  margin-top: 4px;
  margin-bottom: 20px;
  border: 1px solid #ddd;
  border-radius: 2px;
}
.list_container > div {
  border-bottom: 1px solid #ddd;
}
.list_container > div:hover .list-item {
  background-color: red;
}
.list_container > div:last-child {
  border: none;
}
.list_item:hover .list_item {
  background-color: #ddd;
}
.list_item a {
  text-decoration: none;
}
.list_item:hover {
  background-color: #fafafa;
}
.list_header > div,
.list_item > div {
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 7px;
  padding-right: 7px;
  line-height: 22px;
}
.list_header > div input,
.list_item > div input {
  margin-right: 7px;
  margin-left: 14px;
  vertical-align: text-bottom;
  line-height: 22px;
  position: relative;
  top: -1px;
}
.list_header > div .item_link,
.list_item > div .item_link {
  margin-left: -1px;
  vertical-align: baseline;
  line-height: 22px;
}
[dir="rtl"] .list_item > div input {
  margin-right: 0;
}
.new-file input[type=checkbox] {
  visibility: hidden;
}
.item_name {
  line-height: 22px;
  height: 24px;
}
.item_icon {
  font-size: 14px;
  color: #5e5e5e;
  margin-right: 7px;
  margin-left: 7px;
  line-height: 22px;
  vertical-align: baseline;
}
.item_modified {
  margin-right: 7px;
  margin-left: 7px;
}
[dir="rtl"] .item_modified.pull-right {
  float: left !important;
  float: left;
}
.item_buttons {
  line-height: 1em;
  margin-left: -5px;
}
.item_buttons .btn,
.item_buttons .btn-group,
.item_buttons .input-group {
  float: left;
}
.item_buttons > .btn,
.item_buttons > .btn-group,
.item_buttons > .input-group {
  margin-left: 5px;
}
.item_buttons .btn {
  min-width: 13ex;
}
.item_buttons .running-indicator {
  padding-top: 4px;
  color: #5cb85c;
}
.item_buttons .kernel-name {
  padding-top: 4px;
  color: #5bc0de;
  margin-right: 7px;
  float: left;
}
[dir="rtl"] .item_buttons.pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .item_buttons .kernel-name {
  margin-left: 7px;
  float: right;
}
.toolbar_info {
  height: 24px;
  line-height: 24px;
}
.list_item input:not([type=checkbox]) {
  padding-top: 3px;
  padding-bottom: 3px;
  height: 22px;
  line-height: 14px;
  margin: 0px;
}
.highlight_text {
  color: blue;
}
#project_name {
  display: inline-block;
  padding-left: 7px;
  margin-left: -2px;
}
#project_name > .breadcrumb {
  padding: 0px;
  margin-bottom: 0px;
  background-color: transparent;
  font-weight: bold;
}
.sort_button {
  display: inline-block;
  padding-left: 7px;
}
[dir="rtl"] .sort_button.pull-right {
  float: left !important;
  float: left;
}
#tree-selector {
  padding-right: 0px;
}
#button-select-all {
  min-width: 50px;
}
[dir="rtl"] #button-select-all.btn {
  float: right ;
}
#select-all {
  margin-left: 7px;
  margin-right: 2px;
  margin-top: 2px;
  height: 16px;
}
[dir="rtl"] #select-all.pull-left {
  float: right !important;
  float: right;
}
.menu_icon {
  margin-right: 2px;
}
.tab-content .row {
  margin-left: 0px;
  margin-right: 0px;
}
.folder_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f114";
}
.folder_icon:before.fa-pull-left {
  margin-right: .3em;
}
.folder_icon:before.fa-pull-right {
  margin-left: .3em;
}
.folder_icon:before.pull-left {
  margin-right: .3em;
}
.folder_icon:before.pull-right {
  margin-left: .3em;
}
.notebook_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f02d";
  position: relative;
  top: -1px;
}
.notebook_icon:before.fa-pull-left {
  margin-right: .3em;
}
.notebook_icon:before.fa-pull-right {
  margin-left: .3em;
}
.notebook_icon:before.pull-left {
  margin-right: .3em;
}
.notebook_icon:before.pull-right {
  margin-left: .3em;
}
.running_notebook_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f02d";
  position: relative;
  top: -1px;
  color: #5cb85c;
}
.running_notebook_icon:before.fa-pull-left {
  margin-right: .3em;
}
.running_notebook_icon:before.fa-pull-right {
  margin-left: .3em;
}
.running_notebook_icon:before.pull-left {
  margin-right: .3em;
}
.running_notebook_icon:before.pull-right {
  margin-left: .3em;
}
.file_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f016";
  position: relative;
  top: -2px;
}
.file_icon:before.fa-pull-left {
  margin-right: .3em;
}
.file_icon:before.fa-pull-right {
  margin-left: .3em;
}
.file_icon:before.pull-left {
  margin-right: .3em;
}
.file_icon:before.pull-right {
  margin-left: .3em;
}
#notebook_toolbar .pull-right {
  padding-top: 0px;
  margin-right: -1px;
}
ul#new-menu {
  left: auto;
  right: 0;
}
#new-menu .dropdown-header {
  font-size: 10px;
  border-bottom: 1px solid #e5e5e5;
  padding: 0 0 3px;
  margin: -3px 20px 0;
}
.kernel-menu-icon {
  padding-right: 12px;
  width: 24px;
  content: "\f096";
}
.kernel-menu-icon:before {
  content: "\f096";
}
.kernel-menu-icon-current:before {
  content: "\f00c";
}
#tab_content {
  padding-top: 20px;
}
#running .panel-group .panel {
  margin-top: 3px;
  margin-bottom: 1em;
}
#running .panel-group .panel .panel-heading {
  background-color: #EEE;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 7px;
  padding-right: 7px;
  line-height: 22px;
}
#running .panel-group .panel .panel-heading a:focus,
#running .panel-group .panel .panel-heading a:hover {
  text-decoration: none;
}
#running .panel-group .panel .panel-body {
  padding: 0px;
}
#running .panel-group .panel .panel-body .list_container {
  margin-top: 0px;
  margin-bottom: 0px;
  border: 0px;
  border-radius: 0px;
}
#running .panel-group .panel .panel-body .list_container .list_item {
  border-bottom: 1px solid #ddd;
}
#running .panel-group .panel .panel-body .list_container .list_item:last-child {
  border-bottom: 0px;
}
.delete-button {
  display: none;
}
.duplicate-button {
  display: none;
}
.rename-button {
  display: none;
}
.move-button {
  display: none;
}
.download-button {
  display: none;
}
.shutdown-button {
  display: none;
}
.dynamic-instructions {
  display: inline-block;
  padding-top: 4px;
}
/*!
*
* IPython text editor webapp
*
*/
.selected-keymap i.fa {
  padding: 0px 5px;
}
.selected-keymap i.fa:before {
  content: "\f00c";
}
#mode-menu {
  overflow: auto;
  max-height: 20em;
}
.edit_app #header {
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
}
.edit_app #menubar .navbar {
  /* Use a negative 1 bottom margin, so the border overlaps the border of the
    header */
  margin-bottom: -1px;
}
.dirty-indicator {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  width: 20px;
}
.dirty-indicator.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator.pull-left {
  margin-right: .3em;
}
.dirty-indicator.pull-right {
  margin-left: .3em;
}
.dirty-indicator-dirty {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  width: 20px;
}
.dirty-indicator-dirty.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator-dirty.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator-dirty.pull-left {
  margin-right: .3em;
}
.dirty-indicator-dirty.pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  width: 20px;
}
.dirty-indicator-clean.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean.pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean.pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f00c";
}
.dirty-indicator-clean:before.fa-pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean:before.fa-pull-right {
  margin-left: .3em;
}
.dirty-indicator-clean:before.pull-left {
  margin-right: .3em;
}
.dirty-indicator-clean:before.pull-right {
  margin-left: .3em;
}
#filename {
  font-size: 16pt;
  display: table;
  padding: 0px 5px;
}
#current-mode {
  padding-left: 5px;
  padding-right: 5px;
}
#texteditor-backdrop {
  padding-top: 20px;
  padding-bottom: 20px;
}
@media not print {
  #texteditor-backdrop {
    background-color: #EEE;
  }
}
@media print {
  #texteditor-backdrop #texteditor-container .CodeMirror-gutter,
  #texteditor-backdrop #texteditor-container .CodeMirror-gutters {
    background-color: #fff;
  }
}
@media not print {
  #texteditor-backdrop #texteditor-container .CodeMirror-gutter,
  #texteditor-backdrop #texteditor-container .CodeMirror-gutters {
    background-color: #fff;
  }
}
@media not print {
  #texteditor-backdrop #texteditor-container {
    padding: 0px;
    background-color: #fff;
    -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
    box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  }
}
.CodeMirror-dialog {
  background-color: #fff;
}
/*!
*
* IPython notebook
*
*/
/* CSS font colors for translated ANSI escape sequences */
/* The color values are a mix of
   http://www.xcolors.net/dl/baskerville-ivorylight and
   http://www.xcolors.net/dl/euphrasia */
.ansi-black-fg {
  color: #3E424D;
}
.ansi-black-bg {
  background-color: #3E424D;
}
.ansi-black-intense-fg {
  color: #282C36;
}
.ansi-black-intense-bg {
  background-color: #282C36;
}
.ansi-red-fg {
  color: #E75C58;
}
.ansi-red-bg {
  background-color: #E75C58;
}
.ansi-red-intense-fg {
  color: #B22B31;
}
.ansi-red-intense-bg {
  background-color: #B22B31;
}
.ansi-green-fg {
  color: #00A250;
}
.ansi-green-bg {
  background-color: #00A250;
}
.ansi-green-intense-fg {
  color: #007427;
}
.ansi-green-intense-bg {
  background-color: #007427;
}
.ansi-yellow-fg {
  color: #DDB62B;
}
.ansi-yellow-bg {
  background-color: #DDB62B;
}
.ansi-yellow-intense-fg {
  color: #B27D12;
}
.ansi-yellow-intense-bg {
  background-color: #B27D12;
}
.ansi-blue-fg {
  color: #208FFB;
}
.ansi-blue-bg {
  background-color: #208FFB;
}
.ansi-blue-intense-fg {
  color: #0065CA;
}
.ansi-blue-intense-bg {
  background-color: #0065CA;
}
.ansi-magenta-fg {
  color: #D160C4;
}
.ansi-magenta-bg {
  background-color: #D160C4;
}
.ansi-magenta-intense-fg {
  color: #A03196;
}
.ansi-magenta-intense-bg {
  background-color: #A03196;
}
.ansi-cyan-fg {
  color: #60C6C8;
}
.ansi-cyan-bg {
  background-color: #60C6C8;
}
.ansi-cyan-intense-fg {
  color: #258F8F;
}
.ansi-cyan-intense-bg {
  background-color: #258F8F;
}
.ansi-white-fg {
  color: #C5C1B4;
}
.ansi-white-bg {
  background-color: #C5C1B4;
}
.ansi-white-intense-fg {
  color: #A1A6B2;
}
.ansi-white-intense-bg {
  background-color: #A1A6B2;
}
.ansi-default-inverse-fg {
  color: #FFFFFF;
}
.ansi-default-inverse-bg {
  background-color: #000000;
}
.ansi-bold {
  font-weight: bold;
}
.ansi-underline {
  text-decoration: underline;
}
/* The following styles are deprecated an will be removed in a future version */
.ansibold {
  font-weight: bold;
}
.ansi-inverse {
  outline: 0.5px dotted;
}
/* use dark versions for foreground, to improve visibility */
.ansiblack {
  color: black;
}
.ansired {
  color: darkred;
}
.ansigreen {
  color: darkgreen;
}
.ansiyellow {
  color: #c4a000;
}
.ansiblue {
  color: darkblue;
}
.ansipurple {
  color: darkviolet;
}
.ansicyan {
  color: steelblue;
}
.ansigray {
  color: gray;
}
/* and light for background, for the same reason */
.ansibgblack {
  background-color: black;
}
.ansibgred {
  background-color: red;
}
.ansibggreen {
  background-color: green;
}
.ansibgyellow {
  background-color: yellow;
}
.ansibgblue {
  background-color: blue;
}
.ansibgpurple {
  background-color: magenta;
}
.ansibgcyan {
  background-color: cyan;
}
.ansibggray {
  background-color: gray;
}
div.cell {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  border-radius: 2px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  border-width: 1px;
  border-style: solid;
  border-color: transparent;
  width: 100%;
  padding: 5px;
  /* This acts as a spacer between cells, that is outside the border */
  margin: 0px;
  outline: none;
  position: relative;
  overflow: visible;
}
div.cell:before {
  position: absolute;
  display: block;
  top: -1px;
  left: -1px;
  width: 5px;
  height: calc(100% +  2px);
  content: '';
  background: transparent;
}
div.cell.jupyter-soft-selected {
  border-left-color: #E3F2FD;
  border-left-width: 1px;
  padding-left: 5px;
  border-right-color: #E3F2FD;
  border-right-width: 1px;
  background: #E3F2FD;
}
@media print {
  div.cell.jupyter-soft-selected {
    border-color: transparent;
  }
}
div.cell.selected,
div.cell.selected.jupyter-soft-selected {
  border-color: #ababab;
}
div.cell.selected:before,
div.cell.selected.jupyter-soft-selected:before {
  position: absolute;
  display: block;
  top: -1px;
  left: -1px;
  width: 5px;
  height: calc(100% +  2px);
  content: '';
  background: #42A5F5;
}
@media print {
  div.cell.selected,
  div.cell.selected.jupyter-soft-selected {
    border-color: transparent;
  }
}
.edit_mode div.cell.selected {
  border-color: #66BB6A;
}
.edit_mode div.cell.selected:before {
  position: absolute;
  display: block;
  top: -1px;
  left: -1px;
  width: 5px;
  height: calc(100% +  2px);
  content: '';
  background: #66BB6A;
}
@media print {
  .edit_mode div.cell.selected {
    border-color: transparent;
  }
}
.prompt {
  /* This needs to be wide enough for 3 digit prompt numbers: In[100]: */
  min-width: 14ex;
  /* This padding is tuned to match the padding on the CodeMirror editor. */
  padding: 0.4em;
  margin: 0px;
  font-family: monospace;
  text-align: right;
  /* This has to match that of the the CodeMirror class line-height below */
  line-height: 1.21429em;
  /* Don't highlight prompt number selection */
  -webkit-touch-callout: none;
  -webkit-user-select: none;
  -khtml-user-select: none;
  -moz-user-select: none;
  -ms-user-select: none;
  user-select: none;
  /* Use default cursor */
  cursor: default;
}
@media (max-width: 540px) {
  .prompt {
    text-align: left;
  }
}
div.inner_cell {
  min-width: 0;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
/* input_area and input_prompt must match in top border and margin for alignment */
div.input_area {
  border: 1px solid #cfcfcf;
  border-radius: 2px;
  background: #f7f7f7;
  line-height: 1.21429em;
}
/* This is needed so that empty prompt areas can collapse to zero height when there
   is no content in the output_subarea and the prompt. The main purpose of this is
   to make sure that empty JavaScript output_subareas have no height. */
div.prompt:empty {
  padding-top: 0;
  padding-bottom: 0;
}
div.unrecognized_cell {
  padding: 5px 5px 5px 0px;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
div.unrecognized_cell .inner_cell {
  border-radius: 2px;
  padding: 5px;
  font-weight: bold;
  color: red;
  border: 1px solid #cfcfcf;
  background: #eaeaea;
}
div.unrecognized_cell .inner_cell a {
  color: inherit;
  text-decoration: none;
}
div.unrecognized_cell .inner_cell a:hover {
  color: inherit;
  text-decoration: none;
}
@media (max-width: 540px) {
  div.unrecognized_cell > div.prompt {
    display: none;
  }
}
div.code_cell {
  /* avoid page breaking on code cells when printing */
}
@media print {
  div.code_cell {
    page-break-inside: avoid;
  }
}
/* any special styling for code cells that are currently running goes here */
div.input {
  page-break-inside: avoid;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
@media (max-width: 540px) {
  div.input {
    /* Old browsers */
    display: -webkit-box;
    -webkit-box-orient: vertical;
    -webkit-box-align: stretch;
    display: -moz-box;
    -moz-box-orient: vertical;
    -moz-box-align: stretch;
    display: box;
    box-orient: vertical;
    box-align: stretch;
    /* Modern browsers */
    display: flex;
    flex-direction: column;
    align-items: stretch;
  }
}
/* input_area and input_prompt must match in top border and margin for alignment */
div.input_prompt {
  color: #303F9F;
  border-top: 1px solid transparent;
}
div.input_area > div.highlight {
  margin: 0.4em;
  border: none;
  padding: 0px;
  background-color: transparent;
}
div.input_area > div.highlight > pre {
  margin: 0px;
  border: none;
  padding: 0px;
  background-color: transparent;
}
/* The following gets added to the <head> if it is detected that the user has a
 * monospace font with inconsistent normal/bold/italic height.  See
 * notebookmain.js.  Such fonts will have keywords vertically offset with
 * respect to the rest of the text.  The user should select a better font.
 * See: https://github.com/ipython/ipython/issues/1503
 *
 * .CodeMirror span {
 *      vertical-align: bottom;
 * }
 */
.CodeMirror {
  line-height: 1.21429em;
  /* Changed from 1em to our global default */
  font-size: 14px;
  height: auto;
  /* Changed to auto to autogrow */
  background: none;
  /* Changed from white to allow our bg to show through */
}
.CodeMirror-scroll {
  /*  The CodeMirror docs are a bit fuzzy on if overflow-y should be hidden or visible.*/
  /*  We have found that if it is visible, vertical scrollbars appear with font size changes.*/
  overflow-y: hidden;
  overflow-x: auto;
}
.CodeMirror-lines {
  /* In CM2, this used to be 0.4em, but in CM3 it went to 4px. We need the em value because */
  /* we have set a different line-height and want this to scale with that. */
  /* Note that this should set vertical padding only, since CodeMirror assumes
       that horizontal padding will be set on CodeMirror pre */
  padding: 0.4em 0;
}
.CodeMirror-linenumber {
  padding: 0 8px 0 4px;
}
.CodeMirror-gutters {
  border-bottom-left-radius: 2px;
  border-top-left-radius: 2px;
}
.CodeMirror pre {
  /* In CM3 this went to 4px from 0 in CM2. This sets horizontal padding only,
    use .CodeMirror-lines for vertical */
  padding: 0 0.4em;
  border: 0;
  border-radius: 0;
}
.CodeMirror-cursor {
  border-left: 1.4px solid black;
}
@media screen and (min-width: 2138px) and (max-width: 4319px) {
  .CodeMirror-cursor {
    border-left: 2px solid black;
  }
}
@media screen and (min-width: 4320px) {
  .CodeMirror-cursor {
    border-left: 4px solid black;
  }
}
/*

Original style from softwaremaniacs.org (c) Ivan Sagalaev <Maniac@SoftwareManiacs.Org>
Adapted from GitHub theme

*/
.highlight-base {
  color: #000;
}
.highlight-variable {
  color: #000;
}
.highlight-variable-2 {
  color: #1a1a1a;
}
.highlight-variable-3 {
  color: #333333;
}
.highlight-string {
  color: #BA2121;
}
.highlight-comment {
  color: #408080;
  font-style: italic;
}
.highlight-number {
  color: #080;
}
.highlight-atom {
  color: #88F;
}
.highlight-keyword {
  color: #008000;
  font-weight: bold;
}
.highlight-builtin {
  color: #008000;
}
.highlight-error {
  color: #f00;
}
.highlight-operator {
  color: #AA22FF;
  font-weight: bold;
}
.highlight-meta {
  color: #AA22FF;
}
/* previously not defined, copying from default codemirror */
.highlight-def {
  color: #00f;
}
.highlight-string-2 {
  color: #f50;
}
.highlight-qualifier {
  color: #555;
}
.highlight-bracket {
  color: #997;
}
.highlight-tag {
  color: #170;
}
.highlight-attribute {
  color: #00c;
}
.highlight-header {
  color: blue;
}
.highlight-quote {
  color: #090;
}
.highlight-link {
  color: #00c;
}
/* apply the same style to codemirror */
.cm-s-ipython span.cm-keyword {
  color: #008000;
  font-weight: bold;
}
.cm-s-ipython span.cm-atom {
  color: #88F;
}
.cm-s-ipython span.cm-number {
  color: #080;
}
.cm-s-ipython span.cm-def {
  color: #00f;
}
.cm-s-ipython span.cm-variable {
  color: #000;
}
.cm-s-ipython span.cm-operator {
  color: #AA22FF;
  font-weight: bold;
}
.cm-s-ipython span.cm-variable-2 {
  color: #1a1a1a;
}
.cm-s-ipython span.cm-variable-3 {
  color: #333333;
}
.cm-s-ipython span.cm-comment {
  color: #408080;
  font-style: italic;
}
.cm-s-ipython span.cm-string {
  color: #BA2121;
}
.cm-s-ipython span.cm-string-2 {
  color: #f50;
}
.cm-s-ipython span.cm-meta {
  color: #AA22FF;
}
.cm-s-ipython span.cm-qualifier {
  color: #555;
}
.cm-s-ipython span.cm-builtin {
  color: #008000;
}
.cm-s-ipython span.cm-bracket {
  color: #997;
}
.cm-s-ipython span.cm-tag {
  color: #170;
}
.cm-s-ipython span.cm-attribute {
  color: #00c;
}
.cm-s-ipython span.cm-header {
  color: blue;
}
.cm-s-ipython span.cm-quote {
  color: #090;
}
.cm-s-ipython span.cm-link {
  color: #00c;
}
.cm-s-ipython span.cm-error {
  color: #f00;
}
.cm-s-ipython span.cm-tab {
  background: url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAADAAAAAMCAYAAAAkuj5RAAAAAXNSR0IArs4c6QAAAGFJREFUSMft1LsRQFAQheHPowAKoACx3IgEKtaEHujDjORSgWTH/ZOdnZOcM/sgk/kFFWY0qV8foQwS4MKBCS3qR6ixBJvElOobYAtivseIE120FaowJPN75GMu8j/LfMwNjh4HUpwg4LUAAAAASUVORK5CYII=);
  background-position: right;
  background-repeat: no-repeat;
}
div.output_wrapper {
  /* this position must be relative to enable descendents to be absolute within it */
  position: relative;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
  z-index: 1;
}
/* class for the output area when it should be height-limited */
div.output_scroll {
  /* ideally, this would be max-height, but FF barfs all over that */
  height: 24em;
  /* FF needs this *and the wrapper* to specify full width, or it will shrinkwrap */
  width: 100%;
  overflow: auto;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 2px 8px rgba(0, 0, 0, 0.8);
  box-shadow: inset 0 2px 8px rgba(0, 0, 0, 0.8);
  display: block;
}
/* output div while it is collapsed */
div.output_collapsed {
  margin: 0px;
  padding: 0px;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
}
div.out_prompt_overlay {
  height: 100%;
  padding: 0px 0.4em;
  position: absolute;
  border-radius: 2px;
}
div.out_prompt_overlay:hover {
  /* use inner shadow to get border that is computed the same on WebKit/FF */
  -webkit-box-shadow: inset 0 0 1px #000;
  box-shadow: inset 0 0 1px #000;
  background: rgba(240, 240, 240, 0.5);
}
div.output_prompt {
  color: #D84315;
}
/* This class is the outer container of all output sections. */
div.output_area {
  padding: 0px;
  page-break-inside: avoid;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
div.output_area .MathJax_Display {
  text-align: left !important;
}
div.output_area .rendered_html table {
  margin-left: 0;
  margin-right: 0;
}
div.output_area .rendered_html img {
  margin-left: 0;
  margin-right: 0;
}
div.output_area img,
div.output_area svg {
  max-width: 100%;
  height: auto;
}
div.output_area img.unconfined,
div.output_area svg.unconfined {
  max-width: none;
}
div.output_area .mglyph > img {
  max-width: none;
}
/* This is needed to protect the pre formating from global settings such
   as that of bootstrap */
.output {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: vertical;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: vertical;
  -moz-box-align: stretch;
  display: box;
  box-orient: vertical;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: column;
  align-items: stretch;
}
@media (max-width: 540px) {
  div.output_area {
    /* Old browsers */
    display: -webkit-box;
    -webkit-box-orient: vertical;
    -webkit-box-align: stretch;
    display: -moz-box;
    -moz-box-orient: vertical;
    -moz-box-align: stretch;
    display: box;
    box-orient: vertical;
    box-align: stretch;
    /* Modern browsers */
    display: flex;
    flex-direction: column;
    align-items: stretch;
  }
}
div.output_area pre {
  margin: 0;
  padding: 1px 0 1px 0;
  border: 0;
  vertical-align: baseline;
  color: black;
  background-color: transparent;
  border-radius: 0;
}
/* This class is for the output subarea inside the output_area and after
   the prompt div. */
div.output_subarea {
  overflow-x: auto;
  padding: 0.4em;
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
  max-width: calc(100% - 14ex);
}
div.output_scroll div.output_subarea {
  overflow-x: visible;
}
/* The rest of the output_* classes are for special styling of the different
   output types */
/* all text output has this class: */
div.output_text {
  text-align: left;
  color: #000;
  /* This has to match that of the the CodeMirror class line-height below */
  line-height: 1.21429em;
}
/* stdout/stderr are 'text' as well as 'stream', but execute_result/error are *not* streams */
div.output_stderr {
  background: #fdd;
  /* very light red background for stderr */
}
div.output_latex {
  text-align: left;
}
/* Empty output_javascript divs should have no height */
div.output_javascript:empty {
  padding: 0;
}
.js-error {
  color: darkred;
}
/* raw_input styles */
div.raw_input_container {
  line-height: 1.21429em;
  padding-top: 5px;
}
pre.raw_input_prompt {
  /* nothing needed here. */
}
input.raw_input {
  font-family: monospace;
  font-size: inherit;
  color: inherit;
  width: auto;
  /* make sure input baseline aligns with prompt */
  vertical-align: baseline;
  /* padding + margin = 0.5em between prompt and cursor */
  padding: 0em 0.25em;
  margin: 0em 0.25em;
}
input.raw_input:focus {
  box-shadow: none;
}
p.p-space {
  margin-bottom: 10px;
}
div.output_unrecognized {
  padding: 5px;
  font-weight: bold;
  color: red;
}
div.output_unrecognized a {
  color: inherit;
  text-decoration: none;
}
div.output_unrecognized a:hover {
  color: inherit;
  text-decoration: none;
}
.rendered_html {
  color: #000;
  /* any extras will just be numbers: */
}
.rendered_html em {
  font-style: italic;
}
.rendered_html strong {
  font-weight: bold;
}
.rendered_html u {
  text-decoration: underline;
}
.rendered_html :link {
  text-decoration: underline;
}
.rendered_html :visited {
  text-decoration: underline;
}
.rendered_html h1 {
  font-size: 185.7%;
  margin: 1.08em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h2 {
  font-size: 157.1%;
  margin: 1.27em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h3 {
  font-size: 128.6%;
  margin: 1.55em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h4 {
  font-size: 100%;
  margin: 2em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
}
.rendered_html h5 {
  font-size: 100%;
  margin: 2em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
  font-style: italic;
}
.rendered_html h6 {
  font-size: 100%;
  margin: 2em 0 0 0;
  font-weight: bold;
  line-height: 1.0;
  font-style: italic;
}
.rendered_html h1:first-child {
  margin-top: 0.538em;
}
.rendered_html h2:first-child {
  margin-top: 0.636em;
}
.rendered_html h3:first-child {
  margin-top: 0.777em;
}
.rendered_html h4:first-child {
  margin-top: 1em;
}
.rendered_html h5:first-child {
  margin-top: 1em;
}
.rendered_html h6:first-child {
  margin-top: 1em;
}
.rendered_html ul:not(.list-inline),
.rendered_html ol:not(.list-inline) {
  padding-left: 2em;
}
.rendered_html ul {
  list-style: disc;
}
.rendered_html ul ul {
  list-style: square;
  margin-top: 0;
}
.rendered_html ul ul ul {
  list-style: circle;
}
.rendered_html ol {
  list-style: decimal;
}
.rendered_html ol ol {
  list-style: upper-alpha;
  margin-top: 0;
}
.rendered_html ol ol ol {
  list-style: lower-alpha;
}
.rendered_html ol ol ol ol {
  list-style: lower-roman;
}
.rendered_html ol ol ol ol ol {
  list-style: decimal;
}
.rendered_html * + ul {
  margin-top: 1em;
}
.rendered_html * + ol {
  margin-top: 1em;
}
.rendered_html hr {
  color: black;
  background-color: black;
}
.rendered_html pre {
  margin: 1em 2em;
  padding: 0px;
  background-color: #fff;
}
.rendered_html code {
  background-color: #eff0f1;
}
.rendered_html p code {
  padding: 1px 5px;
}
.rendered_html pre code {
  background-color: #fff;
}
.rendered_html pre,
.rendered_html code {
  border: 0;
  color: #000;
  font-size: 100%;
}
.rendered_html blockquote {
  margin: 1em 2em;
}
.rendered_html table {
  margin-left: auto;
  margin-right: auto;
  border: none;
  border-collapse: collapse;
  border-spacing: 0;
  color: black;
  font-size: 12px;
  table-layout: fixed;
}
.rendered_html thead {
  border-bottom: 1px solid black;
  vertical-align: bottom;
}
.rendered_html tr,
.rendered_html th,
.rendered_html td {
  text-align: right;
  vertical-align: middle;
  padding: 0.5em 0.5em;
  line-height: normal;
  white-space: normal;
  max-width: none;
  border: none;
}
.rendered_html th {
  font-weight: bold;
}
.rendered_html tbody tr:nth-child(odd) {
  background: #f5f5f5;
}
.rendered_html tbody tr:hover {
  background: rgba(66, 165, 245, 0.2);
}
.rendered_html * + table {
  margin-top: 1em;
}
.rendered_html p {
  text-align: left;
}
.rendered_html * + p {
  margin-top: 1em;
}
.rendered_html img {
  display: block;
  margin-left: auto;
  margin-right: auto;
}
.rendered_html * + img {
  margin-top: 1em;
}
.rendered_html img,
.rendered_html svg {
  max-width: 100%;
  height: auto;
}
.rendered_html img.unconfined,
.rendered_html svg.unconfined {
  max-width: none;
}
.rendered_html .alert {
  margin-bottom: initial;
}
.rendered_html * + .alert {
  margin-top: 1em;
}
[dir="rtl"] .rendered_html p {
  text-align: right;
}
div.text_cell {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
}
@media (max-width: 540px) {
  div.text_cell > div.prompt {
    display: none;
  }
}
div.text_cell_render {
  /*font-family: "Helvetica Neue", Arial, Helvetica, Geneva, sans-serif;*/
  outline: none;
  resize: none;
  width: inherit;
  border-style: none;
  padding: 0.5em 0.5em 0.5em 0.4em;
  color: #000;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
a.anchor-link:link {
  text-decoration: none;
  padding: 0px 20px;
  visibility: hidden;
}
h1:hover .anchor-link,
h2:hover .anchor-link,
h3:hover .anchor-link,
h4:hover .anchor-link,
h5:hover .anchor-link,
h6:hover .anchor-link {
  visibility: visible;
}
.text_cell.rendered .input_area {
  display: none;
}
.text_cell.rendered .rendered_html {
  overflow-x: auto;
  overflow-y: hidden;
}
.text_cell.rendered .rendered_html tr,
.text_cell.rendered .rendered_html th,
.text_cell.rendered .rendered_html td {
  max-width: none;
}
.text_cell.unrendered .text_cell_render {
  display: none;
}
.text_cell .dropzone .input_area {
  border: 2px dashed #bababa;
  margin: -1px;
}
.cm-header-1,
.cm-header-2,
.cm-header-3,
.cm-header-4,
.cm-header-5,
.cm-header-6 {
  font-weight: bold;
  font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
}
.cm-header-1 {
  font-size: 185.7%;
}
.cm-header-2 {
  font-size: 157.1%;
}
.cm-header-3 {
  font-size: 128.6%;
}
.cm-header-4 {
  font-size: 110%;
}
.cm-header-5 {
  font-size: 100%;
  font-style: italic;
}
.cm-header-6 {
  font-size: 100%;
  font-style: italic;
}
/*!
*
* IPython notebook webapp
*
*/
@media (max-width: 767px) {
  .notebook_app {
    padding-left: 0px;
    padding-right: 0px;
  }
}
#ipython-main-app {
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  height: 100%;
}
div#notebook_panel {
  margin: 0px;
  padding: 0px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  height: 100%;
}
div#notebook {
  font-size: 14px;
  line-height: 20px;
  overflow-y: hidden;
  overflow-x: auto;
  width: 100%;
  /* This spaces the page away from the edge of the notebook area */
  padding-top: 20px;
  margin: 0px;
  outline: none;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  min-height: 100%;
}
@media not print {
  #notebook-container {
    padding: 15px;
    background-color: #fff;
    min-height: 0;
    -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
    box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  }
}
@media print {
  #notebook-container {
    width: 100%;
  }
}
div.ui-widget-content {
  border: 1px solid #ababab;
  outline: none;
}
pre.dialog {
  background-color: #f7f7f7;
  border: 1px solid #ddd;
  border-radius: 2px;
  padding: 0.4em;
  padding-left: 2em;
}
p.dialog {
  padding: 0.2em;
}
/* Word-wrap output correctly.  This is the CSS3 spelling, though Firefox seems
   to not honor it correctly.  Webkit browsers (Chrome, rekonq, Safari) do.
 */
pre,
code,
kbd,
samp {
  white-space: pre-wrap;
}
#fonttest {
  font-family: monospace;
}
p {
  margin-bottom: 0;
}
.end_space {
  min-height: 100px;
  transition: height .2s ease;
}
.notebook_app > #header {
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
}
@media not print {
  .notebook_app {
    background-color: #EEE;
  }
}
kbd {
  border-style: solid;
  border-width: 1px;
  box-shadow: none;
  margin: 2px;
  padding-left: 2px;
  padding-right: 2px;
  padding-top: 1px;
  padding-bottom: 1px;
}
.jupyter-keybindings {
  padding: 1px;
  line-height: 24px;
  border-bottom: 1px solid gray;
}
.jupyter-keybindings input {
  margin: 0;
  padding: 0;
  border: none;
}
.jupyter-keybindings i {
  padding: 6px;
}
.well code {
  background-color: #ffffff;
  border-color: #ababab;
  border-width: 1px;
  border-style: solid;
  padding: 2px;
  padding-top: 1px;
  padding-bottom: 1px;
}
/* CSS for the cell toolbar */
.celltoolbar {
  border: thin solid #CFCFCF;
  border-bottom: none;
  background: #EEE;
  border-radius: 2px 2px 0px 0px;
  width: 100%;
  height: 29px;
  padding-right: 4px;
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
  /* Old browsers */
  -webkit-box-pack: end;
  -moz-box-pack: end;
  box-pack: end;
  /* Modern browsers */
  justify-content: flex-end;
  display: -webkit-flex;
}
@media print {
  .celltoolbar {
    display: none;
  }
}
.ctb_hideshow {
  display: none;
  vertical-align: bottom;
}
/* ctb_show is added to the ctb_hideshow div to show the cell toolbar.
   Cell toolbars are only shown when the ctb_global_show class is also set.
*/
.ctb_global_show .ctb_show.ctb_hideshow {
  display: block;
}
.ctb_global_show .ctb_show + .input_area,
.ctb_global_show .ctb_show + div.text_cell_input,
.ctb_global_show .ctb_show ~ div.text_cell_render {
  border-top-right-radius: 0px;
  border-top-left-radius: 0px;
}
.ctb_global_show .ctb_show ~ div.text_cell_render {
  border: 1px solid #cfcfcf;
}
.celltoolbar {
  font-size: 87%;
  padding-top: 3px;
}
.celltoolbar select {
  display: block;
  width: 100%;
  height: 32px;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
  background-color: #fff;
  background-image: none;
  border: 1px solid #ccc;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  -webkit-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  -o-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
  width: inherit;
  font-size: inherit;
  height: 22px;
  padding: 0px;
  display: inline-block;
}
.celltoolbar select:focus {
  border-color: #66afe9;
  outline: 0;
  -webkit-box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
  box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
}
.celltoolbar select::-moz-placeholder {
  color: #999;
  opacity: 1;
}
.celltoolbar select:-ms-input-placeholder {
  color: #999;
}
.celltoolbar select::-webkit-input-placeholder {
  color: #999;
}
.celltoolbar select::-ms-expand {
  border: 0;
  background-color: transparent;
}
.celltoolbar select[disabled],
.celltoolbar select[readonly],
fieldset[disabled] .celltoolbar select {
  background-color: #eeeeee;
  opacity: 1;
}
.celltoolbar select[disabled],
fieldset[disabled] .celltoolbar select {
  cursor: not-allowed;
}
textarea.celltoolbar select {
  height: auto;
}
select.celltoolbar select {
  height: 30px;
  line-height: 30px;
}
textarea.celltoolbar select,
select[multiple].celltoolbar select {
  height: auto;
}
.celltoolbar label {
  margin-left: 5px;
  margin-right: 5px;
}
.tags_button_container {
  width: 100%;
  display: flex;
}
.tag-container {
  display: flex;
  flex-direction: row;
  flex-grow: 1;
  overflow: hidden;
  position: relative;
}
.tag-container > * {
  margin: 0 4px;
}
.remove-tag-btn {
  margin-left: 4px;
}
.tags-input {
  display: flex;
}
.cell-tag:last-child:after {
  content: "";
  position: absolute;
  right: 0;
  width: 40px;
  height: 100%;
  /* Fade to background color of cell toolbar */
  background: linear-gradient(to right, rgba(0, 0, 0, 0), #EEE);
}
.tags-input > * {
  margin-left: 4px;
}
.cell-tag,
.tags-input input,
.tags-input button {
  display: block;
  width: 100%;
  height: 32px;
  padding: 6px 12px;
  font-size: 13px;
  line-height: 1.42857143;
  color: #555555;
  background-color: #fff;
  background-image: none;
  border: 1px solid #ccc;
  border-radius: 2px;
  -webkit-box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  box-shadow: inset 0 1px 1px rgba(0, 0, 0, 0.075);
  -webkit-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  -o-transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  transition: border-color ease-in-out .15s, box-shadow ease-in-out .15s;
  height: 30px;
  padding: 5px 10px;
  font-size: 12px;
  line-height: 1.5;
  border-radius: 1px;
  box-shadow: none;
  width: inherit;
  font-size: inherit;
  height: 22px;
  line-height: 22px;
  padding: 0px 4px;
  display: inline-block;
}
.cell-tag:focus,
.tags-input input:focus,
.tags-input button:focus {
  border-color: #66afe9;
  outline: 0;
  -webkit-box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
  box-shadow: inset 0 1px 1px rgba(0,0,0,.075), 0 0 8px rgba(102, 175, 233, 0.6);
}
.cell-tag::-moz-placeholder,
.tags-input input::-moz-placeholder,
.tags-input button::-moz-placeholder {
  color: #999;
  opacity: 1;
}
.cell-tag:-ms-input-placeholder,
.tags-input input:-ms-input-placeholder,
.tags-input button:-ms-input-placeholder {
  color: #999;
}
.cell-tag::-webkit-input-placeholder,
.tags-input input::-webkit-input-placeholder,
.tags-input button::-webkit-input-placeholder {
  color: #999;
}
.cell-tag::-ms-expand,
.tags-input input::-ms-expand,
.tags-input button::-ms-expand {
  border: 0;
  background-color: transparent;
}
.cell-tag[disabled],
.tags-input input[disabled],
.tags-input button[disabled],
.cell-tag[readonly],
.tags-input input[readonly],
.tags-input button[readonly],
fieldset[disabled] .cell-tag,
fieldset[disabled] .tags-input input,
fieldset[disabled] .tags-input button {
  background-color: #eeeeee;
  opacity: 1;
}
.cell-tag[disabled],
.tags-input input[disabled],
.tags-input button[disabled],
fieldset[disabled] .cell-tag,
fieldset[disabled] .tags-input input,
fieldset[disabled] .tags-input button {
  cursor: not-allowed;
}
textarea.cell-tag,
textarea.tags-input input,
textarea.tags-input button {
  height: auto;
}
select.cell-tag,
select.tags-input input,
select.tags-input button {
  height: 30px;
  line-height: 30px;
}
textarea.cell-tag,
textarea.tags-input input,
textarea.tags-input button,
select[multiple].cell-tag,
select[multiple].tags-input input,
select[multiple].tags-input button {
  height: auto;
}
.cell-tag,
.tags-input button {
  padding: 0px 4px;
}
.cell-tag {
  background-color: #fff;
  white-space: nowrap;
}
.tags-input input[type=text]:focus {
  outline: none;
  box-shadow: none;
  border-color: #ccc;
}
.completions {
  position: absolute;
  z-index: 110;
  overflow: hidden;
  border: 1px solid #ababab;
  border-radius: 2px;
  -webkit-box-shadow: 0px 6px 10px -1px #adadad;
  box-shadow: 0px 6px 10px -1px #adadad;
  line-height: 1;
}
.completions select {
  background: white;
  outline: none;
  border: none;
  padding: 0px;
  margin: 0px;
  overflow: auto;
  font-family: monospace;
  font-size: 110%;
  color: #000;
  width: auto;
}
.completions select option.context {
  color: #286090;
}
#kernel_logo_widget .current_kernel_logo {
  display: none;
  margin-top: -1px;
  margin-bottom: -1px;
  width: 32px;
  height: 32px;
}
[dir="rtl"] #kernel_logo_widget {
  float: left !important;
  float: left;
}
.modal .modal-body .move-path {
  display: flex;
  flex-direction: row;
  justify-content: space;
  align-items: center;
}
.modal .modal-body .move-path .server-root {
  padding-right: 20px;
}
.modal .modal-body .move-path .path-input {
  flex: 1;
}
#menubar {
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
  margin-top: 1px;
}
#menubar .navbar {
  border-top: 1px;
  border-radius: 0px 0px 2px 2px;
  margin-bottom: 0px;
}
#menubar .navbar-toggle {
  float: left;
  padding-top: 7px;
  padding-bottom: 7px;
  border: none;
}
#menubar .navbar-collapse {
  clear: left;
}
[dir="rtl"] #menubar .navbar-toggle {
  float: right;
}
[dir="rtl"] #menubar .navbar-collapse {
  clear: right;
}
[dir="rtl"] #menubar .navbar-nav {
  float: right;
}
[dir="rtl"] #menubar .nav {
  padding-right: 0px;
}
[dir="rtl"] #menubar .navbar-nav > li {
  float: right;
}
[dir="rtl"] #menubar .navbar-right {
  float: left !important;
}
[dir="rtl"] ul.dropdown-menu {
  text-align: right;
  left: auto;
}
[dir="rtl"] ul#new-menu.dropdown-menu {
  right: auto;
  left: 0;
}
.nav-wrapper {
  border-bottom: 1px solid #e7e7e7;
}
i.menu-icon {
  padding-top: 4px;
}
[dir="rtl"] i.menu-icon.pull-right {
  float: left !important;
  float: left;
}
ul#help_menu li a {
  overflow: hidden;
  padding-right: 2.2em;
}
ul#help_menu li a i {
  margin-right: -1.2em;
}
[dir="rtl"] ul#help_menu li a {
  padding-left: 2.2em;
}
[dir="rtl"] ul#help_menu li a i {
  margin-right: 0;
  margin-left: -1.2em;
}
[dir="rtl"] ul#help_menu li a i.pull-right {
  float: left !important;
  float: left;
}
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu > .dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
}
[dir="rtl"] .dropdown-submenu > .dropdown-menu {
  right: 100%;
  margin-right: -1px;
}
.dropdown-submenu:hover > .dropdown-menu {
  display: block;
}
.dropdown-submenu > a:after {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  display: block;
  content: "\f0da";
  float: right;
  color: #333333;
  margin-top: 2px;
  margin-right: -10px;
}
.dropdown-submenu > a:after.fa-pull-left {
  margin-right: .3em;
}
.dropdown-submenu > a:after.fa-pull-right {
  margin-left: .3em;
}
.dropdown-submenu > a:after.pull-left {
  margin-right: .3em;
}
.dropdown-submenu > a:after.pull-right {
  margin-left: .3em;
}
[dir="rtl"] .dropdown-submenu > a:after {
  float: left;
  content: "\f0d9";
  margin-right: 0;
  margin-left: -10px;
}
.dropdown-submenu:hover > a:after {
  color: #262626;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left > .dropdown-menu {
  left: -100%;
  margin-left: 10px;
}
#notification_area {
  float: right !important;
  float: right;
  z-index: 10;
}
[dir="rtl"] #notification_area {
  float: left !important;
  float: left;
}
.indicator_area {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
}
[dir="rtl"] .indicator_area {
  float: left !important;
  float: left;
}
#kernel_indicator {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
  border-left: 1px solid;
}
#kernel_indicator .kernel_indicator_name {
  padding-left: 5px;
  padding-right: 5px;
}
[dir="rtl"] #kernel_indicator {
  float: left !important;
  float: left;
  border-left: 0;
  border-right: 1px solid;
}
#modal_indicator {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
}
[dir="rtl"] #modal_indicator {
  float: left !important;
  float: left;
}
#readonly-indicator {
  float: right !important;
  float: right;
  color: #777;
  margin-left: 5px;
  margin-right: 5px;
  width: 11px;
  z-index: 10;
  text-align: center;
  width: auto;
  margin-top: 2px;
  margin-bottom: 0px;
  margin-left: 0px;
  margin-right: 0px;
  display: none;
}
.modal_indicator:before {
  width: 1.28571429em;
  text-align: center;
}
.edit_mode .modal_indicator:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f040";
}
.edit_mode .modal_indicator:before.fa-pull-left {
  margin-right: .3em;
}
.edit_mode .modal_indicator:before.fa-pull-right {
  margin-left: .3em;
}
.edit_mode .modal_indicator:before.pull-left {
  margin-right: .3em;
}
.edit_mode .modal_indicator:before.pull-right {
  margin-left: .3em;
}
.command_mode .modal_indicator:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: ' ';
}
.command_mode .modal_indicator:before.fa-pull-left {
  margin-right: .3em;
}
.command_mode .modal_indicator:before.fa-pull-right {
  margin-left: .3em;
}
.command_mode .modal_indicator:before.pull-left {
  margin-right: .3em;
}
.command_mode .modal_indicator:before.pull-right {
  margin-left: .3em;
}
.kernel_idle_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f10c";
}
.kernel_idle_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_idle_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_idle_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_idle_icon:before.pull-right {
  margin-left: .3em;
}
.kernel_busy_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f111";
}
.kernel_busy_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_busy_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_busy_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_busy_icon:before.pull-right {
  margin-left: .3em;
}
.kernel_dead_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f1e2";
}
.kernel_dead_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_dead_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_dead_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_dead_icon:before.pull-right {
  margin-left: .3em;
}
.kernel_disconnected_icon:before {
  display: inline-block;
  font: normal normal normal 14px/1 FontAwesome;
  font-size: inherit;
  text-rendering: auto;
  -webkit-font-smoothing: antialiased;
  -moz-osx-font-smoothing: grayscale;
  content: "\f127";
}
.kernel_disconnected_icon:before.fa-pull-left {
  margin-right: .3em;
}
.kernel_disconnected_icon:before.fa-pull-right {
  margin-left: .3em;
}
.kernel_disconnected_icon:before.pull-left {
  margin-right: .3em;
}
.kernel_disconnected_icon:before.pull-right {
  margin-left: .3em;
}
.notification_widget {
  color: #777;
  z-index: 10;
  background: rgba(240, 240, 240, 0.5);
  margin-right: 4px;
  color: #333;
  background-color: #fff;
  border-color: #ccc;
}
.notification_widget:focus,
.notification_widget.focus {
  color: #333;
  background-color: #e6e6e6;
  border-color: #8c8c8c;
}
.notification_widget:hover {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.notification_widget:active,
.notification_widget.active,
.open > .dropdown-toggle.notification_widget {
  color: #333;
  background-color: #e6e6e6;
  border-color: #adadad;
}
.notification_widget:active:hover,
.notification_widget.active:hover,
.open > .dropdown-toggle.notification_widget:hover,
.notification_widget:active:focus,
.notification_widget.active:focus,
.open > .dropdown-toggle.notification_widget:focus,
.notification_widget:active.focus,
.notification_widget.active.focus,
.open > .dropdown-toggle.notification_widget.focus {
  color: #333;
  background-color: #d4d4d4;
  border-color: #8c8c8c;
}
.notification_widget:active,
.notification_widget.active,
.open > .dropdown-toggle.notification_widget {
  background-image: none;
}
.notification_widget.disabled:hover,
.notification_widget[disabled]:hover,
fieldset[disabled] .notification_widget:hover,
.notification_widget.disabled:focus,
.notification_widget[disabled]:focus,
fieldset[disabled] .notification_widget:focus,
.notification_widget.disabled.focus,
.notification_widget[disabled].focus,
fieldset[disabled] .notification_widget.focus {
  background-color: #fff;
  border-color: #ccc;
}
.notification_widget .badge {
  color: #fff;
  background-color: #333;
}
.notification_widget.warning {
  color: #fff;
  background-color: #f0ad4e;
  border-color: #eea236;
}
.notification_widget.warning:focus,
.notification_widget.warning.focus {
  color: #fff;
  background-color: #ec971f;
  border-color: #985f0d;
}
.notification_widget.warning:hover {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.notification_widget.warning:active,
.notification_widget.warning.active,
.open > .dropdown-toggle.notification_widget.warning {
  color: #fff;
  background-color: #ec971f;
  border-color: #d58512;
}
.notification_widget.warning:active:hover,
.notification_widget.warning.active:hover,
.open > .dropdown-toggle.notification_widget.warning:hover,
.notification_widget.warning:active:focus,
.notification_widget.warning.active:focus,
.open > .dropdown-toggle.notification_widget.warning:focus,
.notification_widget.warning:active.focus,
.notification_widget.warning.active.focus,
.open > .dropdown-toggle.notification_widget.warning.focus {
  color: #fff;
  background-color: #d58512;
  border-color: #985f0d;
}
.notification_widget.warning:active,
.notification_widget.warning.active,
.open > .dropdown-toggle.notification_widget.warning {
  background-image: none;
}
.notification_widget.warning.disabled:hover,
.notification_widget.warning[disabled]:hover,
fieldset[disabled] .notification_widget.warning:hover,
.notification_widget.warning.disabled:focus,
.notification_widget.warning[disabled]:focus,
fieldset[disabled] .notification_widget.warning:focus,
.notification_widget.warning.disabled.focus,
.notification_widget.warning[disabled].focus,
fieldset[disabled] .notification_widget.warning.focus {
  background-color: #f0ad4e;
  border-color: #eea236;
}
.notification_widget.warning .badge {
  color: #f0ad4e;
  background-color: #fff;
}
.notification_widget.success {
  color: #fff;
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.notification_widget.success:focus,
.notification_widget.success.focus {
  color: #fff;
  background-color: #449d44;
  border-color: #255625;
}
.notification_widget.success:hover {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.notification_widget.success:active,
.notification_widget.success.active,
.open > .dropdown-toggle.notification_widget.success {
  color: #fff;
  background-color: #449d44;
  border-color: #398439;
}
.notification_widget.success:active:hover,
.notification_widget.success.active:hover,
.open > .dropdown-toggle.notification_widget.success:hover,
.notification_widget.success:active:focus,
.notification_widget.success.active:focus,
.open > .dropdown-toggle.notification_widget.success:focus,
.notification_widget.success:active.focus,
.notification_widget.success.active.focus,
.open > .dropdown-toggle.notification_widget.success.focus {
  color: #fff;
  background-color: #398439;
  border-color: #255625;
}
.notification_widget.success:active,
.notification_widget.success.active,
.open > .dropdown-toggle.notification_widget.success {
  background-image: none;
}
.notification_widget.success.disabled:hover,
.notification_widget.success[disabled]:hover,
fieldset[disabled] .notification_widget.success:hover,
.notification_widget.success.disabled:focus,
.notification_widget.success[disabled]:focus,
fieldset[disabled] .notification_widget.success:focus,
.notification_widget.success.disabled.focus,
.notification_widget.success[disabled].focus,
fieldset[disabled] .notification_widget.success.focus {
  background-color: #5cb85c;
  border-color: #4cae4c;
}
.notification_widget.success .badge {
  color: #5cb85c;
  background-color: #fff;
}
.notification_widget.info {
  color: #fff;
  background-color: #5bc0de;
  border-color: #46b8da;
}
.notification_widget.info:focus,
.notification_widget.info.focus {
  color: #fff;
  background-color: #31b0d5;
  border-color: #1b6d85;
}
.notification_widget.info:hover {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.notification_widget.info:active,
.notification_widget.info.active,
.open > .dropdown-toggle.notification_widget.info {
  color: #fff;
  background-color: #31b0d5;
  border-color: #269abc;
}
.notification_widget.info:active:hover,
.notification_widget.info.active:hover,
.open > .dropdown-toggle.notification_widget.info:hover,
.notification_widget.info:active:focus,
.notification_widget.info.active:focus,
.open > .dropdown-toggle.notification_widget.info:focus,
.notification_widget.info:active.focus,
.notification_widget.info.active.focus,
.open > .dropdown-toggle.notification_widget.info.focus {
  color: #fff;
  background-color: #269abc;
  border-color: #1b6d85;
}
.notification_widget.info:active,
.notification_widget.info.active,
.open > .dropdown-toggle.notification_widget.info {
  background-image: none;
}
.notification_widget.info.disabled:hover,
.notification_widget.info[disabled]:hover,
fieldset[disabled] .notification_widget.info:hover,
.notification_widget.info.disabled:focus,
.notification_widget.info[disabled]:focus,
fieldset[disabled] .notification_widget.info:focus,
.notification_widget.info.disabled.focus,
.notification_widget.info[disabled].focus,
fieldset[disabled] .notification_widget.info.focus {
  background-color: #5bc0de;
  border-color: #46b8da;
}
.notification_widget.info .badge {
  color: #5bc0de;
  background-color: #fff;
}
.notification_widget.danger {
  color: #fff;
  background-color: #d9534f;
  border-color: #d43f3a;
}
.notification_widget.danger:focus,
.notification_widget.danger.focus {
  color: #fff;
  background-color: #c9302c;
  border-color: #761c19;
}
.notification_widget.danger:hover {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.notification_widget.danger:active,
.notification_widget.danger.active,
.open > .dropdown-toggle.notification_widget.danger {
  color: #fff;
  background-color: #c9302c;
  border-color: #ac2925;
}
.notification_widget.danger:active:hover,
.notification_widget.danger.active:hover,
.open > .dropdown-toggle.notification_widget.danger:hover,
.notification_widget.danger:active:focus,
.notification_widget.danger.active:focus,
.open > .dropdown-toggle.notification_widget.danger:focus,
.notification_widget.danger:active.focus,
.notification_widget.danger.active.focus,
.open > .dropdown-toggle.notification_widget.danger.focus {
  color: #fff;
  background-color: #ac2925;
  border-color: #761c19;
}
.notification_widget.danger:active,
.notification_widget.danger.active,
.open > .dropdown-toggle.notification_widget.danger {
  background-image: none;
}
.notification_widget.danger.disabled:hover,
.notification_widget.danger[disabled]:hover,
fieldset[disabled] .notification_widget.danger:hover,
.notification_widget.danger.disabled:focus,
.notification_widget.danger[disabled]:focus,
fieldset[disabled] .notification_widget.danger:focus,
.notification_widget.danger.disabled.focus,
.notification_widget.danger[disabled].focus,
fieldset[disabled] .notification_widget.danger.focus {
  background-color: #d9534f;
  border-color: #d43f3a;
}
.notification_widget.danger .badge {
  color: #d9534f;
  background-color: #fff;
}
div#pager {
  background-color: #fff;
  font-size: 14px;
  line-height: 20px;
  overflow: hidden;
  display: none;
  position: fixed;
  bottom: 0px;
  width: 100%;
  max-height: 50%;
  padding-top: 8px;
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  /* Display over codemirror */
  z-index: 100;
  /* Hack which prevents jquery ui resizable from changing top. */
  top: auto !important;
}
div#pager pre {
  line-height: 1.21429em;
  color: #000;
  background-color: #f7f7f7;
  padding: 0.4em;
}
div#pager #pager-button-area {
  position: absolute;
  top: 8px;
  right: 20px;
}
div#pager #pager-contents {
  position: relative;
  overflow: auto;
  width: 100%;
  height: 100%;
}
div#pager #pager-contents #pager-container {
  position: relative;
  padding: 15px 0px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
div#pager .ui-resizable-handle {
  top: 0px;
  height: 8px;
  background: #f7f7f7;
  border-top: 1px solid #cfcfcf;
  border-bottom: 1px solid #cfcfcf;
  /* This injects handle bars (a short, wide = symbol) for 
        the resize handle. */
}
div#pager .ui-resizable-handle::after {
  content: '';
  top: 2px;
  left: 50%;
  height: 3px;
  width: 30px;
  margin-left: -15px;
  position: absolute;
  border-top: 1px solid #cfcfcf;
}
.quickhelp {
  /* Old browsers */
  display: -webkit-box;
  -webkit-box-orient: horizontal;
  -webkit-box-align: stretch;
  display: -moz-box;
  -moz-box-orient: horizontal;
  -moz-box-align: stretch;
  display: box;
  box-orient: horizontal;
  box-align: stretch;
  /* Modern browsers */
  display: flex;
  flex-direction: row;
  align-items: stretch;
  line-height: 1.8em;
}
.shortcut_key {
  display: inline-block;
  width: 21ex;
  text-align: right;
  font-family: monospace;
}
.shortcut_descr {
  display: inline-block;
  /* Old browsers */
  -webkit-box-flex: 1;
  -moz-box-flex: 1;
  box-flex: 1;
  /* Modern browsers */
  flex: 1;
}
span.save_widget {
  height: 30px;
  margin-top: 4px;
  display: flex;
  justify-content: flex-start;
  align-items: baseline;
  width: 50%;
  flex: 1;
}
span.save_widget span.filename {
  height: 100%;
  line-height: 1em;
  margin-left: 16px;
  border: none;
  font-size: 146.5%;
  text-overflow: ellipsis;
  overflow: hidden;
  white-space: nowrap;
  border-radius: 2px;
}
span.save_widget span.filename:hover {
  background-color: #e6e6e6;
}
[dir="rtl"] span.save_widget.pull-left {
  float: right !important;
  float: right;
}
[dir="rtl"] span.save_widget span.filename {
  margin-left: 0;
  margin-right: 16px;
}
span.checkpoint_status,
span.autosave_status {
  font-size: small;
  white-space: nowrap;
  padding: 0 5px;
}
@media (max-width: 767px) {
  span.save_widget {
    font-size: small;
    padding: 0 0 0 5px;
  }
  span.checkpoint_status,
  span.autosave_status {
    display: none;
  }
}
@media (min-width: 768px) and (max-width: 991px) {
  span.checkpoint_status {
    display: none;
  }
  span.autosave_status {
    font-size: x-small;
  }
}
.toolbar {
  padding: 0px;
  margin-left: -5px;
  margin-top: 2px;
  margin-bottom: 5px;
  box-sizing: border-box;
  -moz-box-sizing: border-box;
  -webkit-box-sizing: border-box;
}
.toolbar select,
.toolbar label {
  width: auto;
  vertical-align: middle;
  margin-right: 2px;
  margin-bottom: 0px;
  display: inline;
  font-size: 92%;
  margin-left: 0.3em;
  margin-right: 0.3em;
  padding: 0px;
  padding-top: 3px;
}
.toolbar .btn {
  padding: 2px 8px;
}
.toolbar .btn-group {
  margin-top: 0px;
  margin-left: 5px;
}
.toolbar-btn-label {
  margin-left: 6px;
}
#maintoolbar {
  margin-bottom: -3px;
  margin-top: -8px;
  border: 0px;
  min-height: 27px;
  margin-left: 0px;
  padding-top: 11px;
  padding-bottom: 3px;
}
#maintoolbar .navbar-text {
  float: none;
  vertical-align: middle;
  text-align: right;
  margin-left: 5px;
  margin-right: 0px;
  margin-top: 0px;
}
.select-xs {
  height: 24px;
}
[dir="rtl"] .btn-group > .btn,
.btn-group-vertical > .btn {
  float: right;
}
.pulse,
.dropdown-menu > li > a.pulse,
li.pulse > a.dropdown-toggle,
li.pulse.open > a.dropdown-toggle {
  background-color: #F37626;
  color: white;
}
/**
 * Primary styles
 *
 * Author: Jupyter Development Team
 */
/** WARNING IF YOU ARE EDITTING THIS FILE, if this is a .css file, It has a lot
 * of chance of beeing generated from the ../less/[samename].less file, you can
 * try to get back the less file by reverting somme commit in history
 **/
/*
 * We'll try to get something pretty, so we
 * have some strange css to have the scroll bar on
 * the left with fix button on the top right of the tooltip
 */
@-moz-keyframes fadeOut {
  from {
    opacity: 1;
  }
  to {
    opacity: 0;
  }
}
@-webkit-keyframes fadeOut {
  from {
    opacity: 1;
  }
  to {
    opacity: 0;
  }
}
@-moz-keyframes fadeIn {
  from {
    opacity: 0;
  }
  to {
    opacity: 1;
  }
}
@-webkit-keyframes fadeIn {
  from {
    opacity: 0;
  }
  to {
    opacity: 1;
  }
}
/*properties of tooltip after "expand"*/
.bigtooltip {
  overflow: auto;
  height: 200px;
  -webkit-transition-property: height;
  -webkit-transition-duration: 500ms;
  -moz-transition-property: height;
  -moz-transition-duration: 500ms;
  transition-property: height;
  transition-duration: 500ms;
}
/*properties of tooltip before "expand"*/
.smalltooltip {
  -webkit-transition-property: height;
  -webkit-transition-duration: 500ms;
  -moz-transition-property: height;
  -moz-transition-duration: 500ms;
  transition-property: height;
  transition-duration: 500ms;
  text-overflow: ellipsis;
  overflow: hidden;
  height: 80px;
}
.tooltipbuttons {
  position: absolute;
  padding-right: 15px;
  top: 0px;
  right: 0px;
}
.tooltiptext {
  /*avoid the button to overlap on some docstring*/
  padding-right: 30px;
}
.ipython_tooltip {
  max-width: 700px;
  /*fade-in animation when inserted*/
  -webkit-animation: fadeOut 400ms;
  -moz-animation: fadeOut 400ms;
  animation: fadeOut 400ms;
  -webkit-animation: fadeIn 400ms;
  -moz-animation: fadeIn 400ms;
  animation: fadeIn 400ms;
  vertical-align: middle;
  background-color: #f7f7f7;
  overflow: visible;
  border: #ababab 1px solid;
  outline: none;
  padding: 3px;
  margin: 0px;
  padding-left: 7px;
  font-family: monospace;
  min-height: 50px;
  -moz-box-shadow: 0px 6px 10px -1px #adadad;
  -webkit-box-shadow: 0px 6px 10px -1px #adadad;
  box-shadow: 0px 6px 10px -1px #adadad;
  border-radius: 2px;
  position: absolute;
  z-index: 1000;
}
.ipython_tooltip a {
  float: right;
}
.ipython_tooltip .tooltiptext pre {
  border: 0;
  border-radius: 0;
  font-size: 100%;
  background-color: #f7f7f7;
}
.pretooltiparrow {
  left: 0px;
  margin: 0px;
  top: -16px;
  width: 40px;
  height: 16px;
  overflow: hidden;
  position: absolute;
}
.pretooltiparrow:before {
  background-color: #f7f7f7;
  border: 1px #ababab solid;
  z-index: 11;
  content: "";
  position: absolute;
  left: 15px;
  top: 10px;
  width: 25px;
  height: 25px;
  -webkit-transform: rotate(45deg);
  -moz-transform: rotate(45deg);
  -ms-transform: rotate(45deg);
  -o-transform: rotate(45deg);
}
ul.typeahead-list i {
  margin-left: -10px;
  width: 18px;
}
[dir="rtl"] ul.typeahead-list i {
  margin-left: 0;
  margin-right: -10px;
}
ul.typeahead-list {
  max-height: 80vh;
  overflow: auto;
}
ul.typeahead-list > li > a {
  /** Firefox bug **/
  /* see https://github.com/jupyter/notebook/issues/559 */
  white-space: normal;
}
ul.typeahead-list  > li > a.pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .typeahead-list {
  text-align: right;
}
.cmd-palette .modal-body {
  padding: 7px;
}
.cmd-palette form {
  background: white;
}
.cmd-palette input {
  outline: none;
}
.no-shortcut {
  min-width: 20px;
  color: transparent;
}
[dir="rtl"] .no-shortcut.pull-right {
  float: left !important;
  float: left;
}
[dir="rtl"] .command-shortcut.pull-right {
  float: left !important;
  float: left;
}
.command-shortcut:before {
  content: "(command mode)";
  padding-right: 3px;
  color: #777777;
}
.edit-shortcut:before {
  content: "(edit)";
  padding-right: 3px;
  color: #777777;
}
[dir="rtl"] .edit-shortcut.pull-right {
  float: left !important;
  float: left;
}
#find-and-replace #replace-preview .match,
#find-and-replace #replace-preview .insert {
  background-color: #BBDEFB;
  border-color: #90CAF9;
  border-style: solid;
  border-width: 1px;
  border-radius: 0px;
}
[dir="ltr"] #find-and-replace .input-group-btn + .form-control {
  border-left: none;
}
[dir="rtl"] #find-and-replace .input-group-btn + .form-control {
  border-right: none;
}
#find-and-replace #replace-preview .replace .match {
  background-color: #FFCDD2;
  border-color: #EF9A9A;
  border-radius: 0px;
}
#find-and-replace #replace-preview .replace .insert {
  background-color: #C8E6C9;
  border-color: #A5D6A7;
  border-radius: 0px;
}
#find-and-replace #replace-preview {
  max-height: 60vh;
  overflow: auto;
}
#find-and-replace #replace-preview pre {
  padding: 5px 10px;
}
.terminal-app {
  background: #EEE;
}
.terminal-app #header {
  background: #fff;
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.2);
}
.terminal-app .terminal {
  width: 100%;
  float: left;
  font-family: monospace;
  color: white;
  background: black;
  padding: 0.4em;
  border-radius: 2px;
  -webkit-box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.4);
  box-shadow: 0px 0px 12px 1px rgba(87, 87, 87, 0.4);
}
.terminal-app .terminal,
.terminal-app .terminal dummy-screen {
  line-height: 1em;
  font-size: 14px;
}
.terminal-app .terminal .xterm-rows {
  padding: 10px;
}
.terminal-app .terminal-cursor {
  color: black;
  background: white;
}
.terminal-app #terminado-container {
  margin-top: 20px;
}
/*# sourceMappingURL=style.min.css.map */
    </style>
<style type="text/css">
    .highlight .hll { background-color: #ffffcc }
.highlight  { background: #f8f8f8; }
.highlight .c { color: #408080; font-style: italic } /* Comment */
.highlight .err { border: 1px solid #FF0000 } /* Error */
.highlight .k { color: #008000; font-weight: bold } /* Keyword */
.highlight .o { color: #666666 } /* Operator */
.highlight .ch { color: #408080; font-style: italic } /* Comment.Hashbang */
.highlight .cm { color: #408080; font-style: italic } /* Comment.Multiline */
.highlight .cp { color: #BC7A00 } /* Comment.Preproc */
.highlight .cpf { color: #408080; font-style: italic } /* Comment.PreprocFile */
.highlight .c1 { color: #408080; font-style: italic } /* Comment.Single */
.highlight .cs { color: #408080; font-style: italic } /* Comment.Special */
.highlight .gd { color: #A00000 } /* Generic.Deleted */
.highlight .ge { font-style: italic } /* Generic.Emph */
.highlight .gr { color: #FF0000 } /* Generic.Error */
.highlight .gh { color: #000080; font-weight: bold } /* Generic.Heading */
.highlight .gi { color: #00A000 } /* Generic.Inserted */
.highlight .go { color: #888888 } /* Generic.Output */
.highlight .gp { color: #000080; font-weight: bold } /* Generic.Prompt */
.highlight .gs { font-weight: bold } /* Generic.Strong */
.highlight .gu { color: #800080; font-weight: bold } /* Generic.Subheading */
.highlight .gt { color: #0044DD } /* Generic.Traceback */
.highlight .kc { color: #008000; font-weight: bold } /* Keyword.Constant */
.highlight .kd { color: #008000; font-weight: bold } /* Keyword.Declaration */
.highlight .kn { color: #008000; font-weight: bold } /* Keyword.Namespace */
.highlight .kp { color: #008000 } /* Keyword.Pseudo */
.highlight .kr { color: #008000; font-weight: bold } /* Keyword.Reserved */
.highlight .kt { color: #B00040 } /* Keyword.Type */
.highlight .m { color: #666666 } /* Literal.Number */
.highlight .s { color: #BA2121 } /* Literal.String */
.highlight .na { color: #7D9029 } /* Name.Attribute */
.highlight .nb { color: #008000 } /* Name.Builtin */
.highlight .nc { color: #0000FF; font-weight: bold } /* Name.Class */
.highlight .no { color: #880000 } /* Name.Constant */
.highlight .nd { color: #AA22FF } /* Name.Decorator */
.highlight .ni { color: #999999; font-weight: bold } /* Name.Entity */
.highlight .ne { color: #D2413A; font-weight: bold } /* Name.Exception */
.highlight .nf { color: #0000FF } /* Name.Function */
.highlight .nl { color: #A0A000 } /* Name.Label */
.highlight .nn { color: #0000FF; font-weight: bold } /* Name.Namespace */
.highlight .nt { color: #008000; font-weight: bold } /* Name.Tag */
.highlight .nv { color: #19177C } /* Name.Variable */
.highlight .ow { color: #AA22FF; font-weight: bold } /* Operator.Word */
.highlight .w { color: #bbbbbb } /* Text.Whitespace */
.highlight .mb { color: #666666 } /* Literal.Number.Bin */
.highlight .mf { color: #666666 } /* Literal.Number.Float */
.highlight .mh { color: #666666 } /* Literal.Number.Hex */
.highlight .mi { color: #666666 } /* Literal.Number.Integer */
.highlight .mo { color: #666666 } /* Literal.Number.Oct */
.highlight .sa { color: #BA2121 } /* Literal.String.Affix */
.highlight .sb { color: #BA2121 } /* Literal.String.Backtick */
.highlight .sc { color: #BA2121 } /* Literal.String.Char */
.highlight .dl { color: #BA2121 } /* Literal.String.Delimiter */
.highlight .sd { color: #BA2121; font-style: italic } /* Literal.String.Doc */
.highlight .s2 { color: #BA2121 } /* Literal.String.Double */
.highlight .se { color: #BB6622; font-weight: bold } /* Literal.String.Escape */
.highlight .sh { color: #BA2121 } /* Literal.String.Heredoc */
.highlight .si { color: #BB6688; font-weight: bold } /* Literal.String.Interpol */
.highlight .sx { color: #008000 } /* Literal.String.Other */
.highlight .sr { color: #BB6688 } /* Literal.String.Regex */
.highlight .s1 { color: #BA2121 } /* Literal.String.Single */
.highlight .ss { color: #19177C } /* Literal.String.Symbol */
.highlight .bp { color: #008000 } /* Name.Builtin.Pseudo */
.highlight .fm { color: #0000FF } /* Name.Function.Magic */
.highlight .vc { color: #19177C } /* Name.Variable.Class */
.highlight .vg { color: #19177C } /* Name.Variable.Global */
.highlight .vi { color: #19177C } /* Name.Variable.Instance */
.highlight .vm { color: #19177C } /* Name.Variable.Magic */
.highlight .il { color: #666666 } /* Literal.Number.Integer.Long */
    </style>


<style type="text/css">
/* Overrides of notebook CSS for static HTML export */
body {
  overflow: visible;
  padding: 8px;
}

div#notebook {
  overflow: visible;
  border-top: none;
}@media print {
  div.cell {
    display: block;
    page-break-inside: avoid;
  } 
  div.output_wrapper { 
    display: block;
    page-break-inside: avoid; 
  }
  div.output { 
    display: block;
    page-break-inside: avoid; 
  }
}
</style>

<!-- Custom stylesheet, it must be in the same directory as the html file -->
<link rel="stylesheet" href="custom.css">

<!-- Loading mathjax macro -->
<!-- Load mathjax -->
    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/latest.js?config=TeX-AMS_HTML"></script>
    <!-- MathJax configuration -->
    <script type="text/x-mathjax-config">
    MathJax.Hub.Config({
        tex2jax: {
            inlineMath: [ ['$','$'], ["\\(","\\)"] ],
            displayMath: [ ['$$','$$'], ["\\[","\\]"] ],
            processEscapes: true,
            processEnvironments: true
        },
        // Center justify equations in code and markdown cells. Elsewhere
        // we use CSS to left justify single line equations in code cells.
        displayAlign: 'center',
        "HTML-CSS": {
            styles: {'.MathJax_Display': {"margin": 0}},
            linebreaks: { automatic: true }
        }
    });
    </script>
    <!-- End of mathjax configuration --></head>
<body>
  <div tabindex="-1" id="notebook" class="border-box-sizing">
    <div class="container" id="notebook-container">

<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[34]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="kn">import</span> <span class="nn">pandas</span> <span class="k">as</span> <span class="nn">pd</span>
<span class="kn">import</span> <span class="nn">regex</span>
<span class="kn">import</span> <span class="nn">numpy</span> <span class="k">as</span> <span class="nn">np</span>
<span class="kn">import</span> <span class="nn">warnings</span>
<span class="kn">import</span> <span class="nn">random</span>
<span class="kn">import</span> <span class="nn">json</span>
<span class="n">warnings</span><span class="o">.</span><span class="n">filterwarnings</span><span class="p">(</span><span class="s2">&quot;ignore&quot;</span><span class="p">,</span> <span class="n">category</span><span class="o">=</span><span class="ne">Warning</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[36]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">df2</span> <span class="o">=</span> <span class="n">pd</span><span class="o">.</span><span class="n">read_csv</span><span class="p">(</span><span class="sa">r</span><span class="s2">&quot;data/trialsdata/drugs.csv&quot;</span><span class="p">)</span>
<span class="n">df2</span><span class="o">.</span><span class="n">sample</span><span class="p">(</span><span class="n">n</span><span class="o">=</span><span class="mi">5</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[36]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">
<div>
<style scoped>
    .dataframe tbody tr th:only-of-type {
        vertical-align: middle;
    }

    .dataframe tbody tr th {
        vertical-align: top;
    }

    .dataframe thead th {
        text-align: right;
    }
</style>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>itemLabel</th>
      <th>altLabel_list</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>1942</th>
      <td>trimebutine</td>
      <td>2-Dimethylamino-2-phenylbutyl 3,4,5-trimethoxy...</td>
    </tr>
    <tr>
      <th>78</th>
      <td>ethoxzolamide</td>
      <td>6-Ethoxy-1,3-benzothiazole-2-sulfonamide|6-eth...</td>
    </tr>
    <tr>
      <th>276</th>
      <td>ketoprofen</td>
      <td>Actron|2-(3-Benzoylphenyl)propionic acid|3-Ben...</td>
    </tr>
    <tr>
      <th>2277</th>
      <td>Alirocumab</td>
      <td>REGN727|SAR-236553|SAR236553</td>
    </tr>
    <tr>
      <th>454</th>
      <td>difenoxin</td>
      <td>1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipe...</td>
    </tr>
  </tbody>
</table>
</div>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[37]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">df2</span><span class="p">[</span><span class="s1">&#39;alternatives&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df2</span><span class="p">[</span><span class="s1">&#39;itemLabel&#39;</span><span class="p">]</span> <span class="o">+</span> <span class="s2">&quot;|&quot;</span> <span class="o">+</span> <span class="n">df2</span><span class="p">[</span><span class="s1">&#39;altLabel_list&#39;</span><span class="p">]</span> 
<span class="n">df2</span><span class="p">[</span><span class="s1">&#39;alternatives&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df2</span><span class="p">[</span><span class="s1">&#39;alternatives&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">lower</span><span class="p">()</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">split</span><span class="p">(</span><span class="s1">&#39;|&#39;</span><span class="p">)</span>
<span class="n">df2</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[37]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">
<div>
<style scoped>
    .dataframe tbody tr th:only-of-type {
        vertical-align: middle;
    }

    .dataframe tbody tr th {
        vertical-align: top;
    }

    .dataframe thead th {
        text-align: right;
    }
</style>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>itemLabel</th>
      <th>altLabel_list</th>
      <th>alternatives</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>0</th>
      <td>propylthiouracil</td>
      <td>2-Mercapto-6-propyl-4-pyrimidone|2-Mercapto-6-...</td>
      <td>[propylthiouracil, 2-mercapto-6-propyl-4-pyrim...</td>
    </tr>
    <tr>
      <th>1</th>
      <td>gemfibrozil</td>
      <td>2,2-Dimethyl-5-(2,5-dimethylphenoxy)valeriansa...</td>
      <td>[gemfibrozil, 2,2-dimethyl-5-(2,5-dimethylphen...</td>
    </tr>
    <tr>
      <th>2</th>
      <td>isoflurophate</td>
      <td>DFP|Diisopropoxyphosphoryl Fluoride|Diisopropy...</td>
      <td>[isoflurophate, dfp, diisopropoxyphosphoryl fl...</td>
    </tr>
    <tr>
      <th>3</th>
      <td>6-thioguanine</td>
      <td>TG|2-Amino 6MP|2-Amino-1,7-dihydro-6H-purine-6...</td>
      <td>[6-thioguanine, tg, 2-amino 6mp, 2-amino-1,7-d...</td>
    </tr>
    <tr>
      <th>4</th>
      <td>melatonin</td>
      <td>{N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} Acetam...</td>
      <td>[melatonin, {n-[2-(5-methoxy-1h-indol-3-yl)eth...</td>
    </tr>
    <tr>
      <th>...</th>
      <td>...</td>
      <td>...</td>
      <td>...</td>
    </tr>
    <tr>
      <th>2381</th>
      <td>Somatrem</td>
      <td>Protropin|Somatrem (genetical recombination)</td>
      <td>[somatrem, protropin, somatrem (genetical reco...</td>
    </tr>
    <tr>
      <th>2382</th>
      <td>spiraprilat</td>
      <td>SCH-33861</td>
      <td>[spiraprilat, sch-33861]</td>
    </tr>
    <tr>
      <th>2383</th>
      <td>stepronin</td>
      <td>Stepronin|Stepronine|Stepronino|Steproninum|Ti...</td>
      <td>[stepronin, stepronin, stepronine, stepronino,...</td>
    </tr>
    <tr>
      <th>2384</th>
      <td>sulfacytine</td>
      <td>1-ethyl N4-sulfanilylcytosin|1-ethyl-N-sulfani...</td>
      <td>[sulfacytine, 1-ethyl n4-sulfanilylcytosin, 1-...</td>
    </tr>
    <tr>
      <th>2385</th>
      <td>suvorexant</td>
      <td>Belsomra|Belsomra®|DORA-analogue|MK 4305|MK-43...</td>
      <td>[suvorexant, belsomra, belsomra®, dora-analogu...</td>
    </tr>
  </tbody>
</table>
<p>2386 rows × 3 columns</p>
</div>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[55]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">df3</span> <span class="o">=</span> <span class="n">pd</span><span class="o">.</span><span class="n">read_json</span><span class="p">(</span><span class="sa">r</span><span class="s2">&quot;data/trialsdata/clinical_trials_2015.jsonl&quot;</span><span class="p">,</span> <span class="n">lines</span> <span class="o">=</span> <span class="kc">True</span><span class="p">)</span>
<span class="n">df3_drugs</span> <span class="o">=</span> <span class="n">df3</span><span class="p">[</span><span class="n">df3</span><span class="p">[</span><span class="s1">&#39;intervention_type&#39;</span><span class="p">]</span><span class="o">==</span> <span class="s2">&quot;Drug&quot;</span><span class="p">]</span>
<span class="sd">&quot;&quot;&quot;I filtered by intervention type drug here I was not </span>
<span class="sd">expecting to find matches in the other categories. </span>
<span class="sd">This can easily be changed with the following olumn if required.&quot;&quot;&quot;</span>
<span class="c1">#df3_drugs = df3</span>
<span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;intervention_name&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;intervention_name&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">lower</span><span class="p">()</span>
<span class="n">df3_drugs</span><span class="o">.</span><span class="n">sample</span><span class="p">(</span><span class="n">n</span><span class="o">=</span><span class="mi">10</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[55]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">
<div>
<style scoped>
    .dataframe tbody tr th:only-of-type {
        vertical-align: middle;
    }

    .dataframe tbody tr th {
        vertical-align: top;
    }

    .dataframe thead th {
        text-align: right;
    }
</style>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>nct_id</th>
      <th>intervention_name</th>
      <th>intervention_type</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>13115</th>
      <td>NCT02507440</td>
      <td>propofol</td>
      <td>Drug</td>
    </tr>
    <tr>
      <th>13207</th>
      <td>NCT02509299</td>
      <td>standard medical treatment</td>
      <td>Drug</td>
    </tr>
    <tr>
      <th>4843</th>
      <td>NCT02366585</td>
      <td>ciclosporin</td>
      <td>Drug</td>
    </tr>
    <tr>
      <th>17362</th>
      <td>NCT02581761</td>
      <td>cytotec</td>
      <td>Drug</td>
    </tr>
    <tr>
      <th>24566</th>
      <td>NCT02946606</td>
      <td>gx-h9</td>
      <td>Drug</td>
    </tr>
    <tr>
      <th>23515</th>
      <td>NCT02831894</td>
      <td>10% hypnotic medication taper</td>
      <td>Drug</td>
    </tr>
    <tr>
      <th>6230</th>
      <td>NCT02393157</td>
      <td>etoposide</td>
      <td>Drug</td>
    </tr>
    <tr>
      <th>523</th>
      <td>NCT02037126</td>
      <td>diphenhydramine</td>
      <td>Drug</td>
    </tr>
    <tr>
      <th>11640</th>
      <td>NCT02483247</td>
      <td>doxorubicin</td>
      <td>Drug</td>
    </tr>
    <tr>
      <th>22300</th>
      <td>NCT02738177</td>
      <td>misoprostol</td>
      <td>Drug</td>
    </tr>
  </tbody>
</table>
</div>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[65]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">words_to_remove</span> <span class="o">=</span> <span class="p">[</span><span class="s2">&quot;and&quot;</span><span class="p">,</span> <span class="s2">&quot;intravenous&quot;</span><span class="p">,</span> <span class="s2">&quot;+&quot;</span><span class="p">,</span> <span class="s2">&quot;- &quot;</span><span class="p">,</span> <span class="s2">&quot;/&quot;</span><span class="p">,</span> <span class="sa">r</span><span class="s2">&quot;\(.*\)&quot;</span><span class="p">,</span> <span class="s2">&quot;®&quot;</span><span class="p">,</span> <span class="s2">&quot; or&quot;</span><span class="p">]</span>
<span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;matches&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;intervention_name&#39;</span><span class="p">]</span>

<span class="k">for</span> <span class="n">item</span> <span class="ow">in</span> <span class="n">words_to_remove</span><span class="p">:</span>
    <span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;matches&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;matches&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">replace</span><span class="p">(</span><span class="n">item</span><span class="p">,</span><span class="s2">&quot;,&quot;</span><span class="p">)</span>

<span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;matches&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;matches&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">lower</span><span class="p">()</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">split</span><span class="p">(</span><span class="s1">&#39;,&#39;</span><span class="p">)</span>
<span class="c1">#df3_drugs[&#39;matches&#39;]  = df3_drugs[&#39;matches&#39;].str.replace(r&quot;\(.*\)&quot;,&quot;&quot;)</span>
<span class="n">df3_drugs</span><span class="o">.</span><span class="n">sample</span><span class="p">(</span><span class="n">n</span><span class="o">=</span><span class="mi">5</span><span class="p">)</span><span class="c1">#.intervention_type.sample(n=1).reset_index()</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[65]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">
<div>
<style scoped>
    .dataframe tbody tr th:only-of-type {
        vertical-align: middle;
    }

    .dataframe tbody tr th {
        vertical-align: top;
    }

    .dataframe thead th {
        text-align: right;
    }
</style>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>nct_id</th>
      <th>intervention_name</th>
      <th>intervention_type</th>
      <th>matches</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>17506</th>
      <td>NCT02584582</td>
      <td>liraglutide</td>
      <td>Drug</td>
      <td>[liraglutide]</td>
    </tr>
    <tr>
      <th>16907</th>
      <td>NCT02573831</td>
      <td>oxycodone</td>
      <td>Drug</td>
      <td>[oxycodone]</td>
    </tr>
    <tr>
      <th>19055</th>
      <td>NCT02613806</td>
      <td>normal saline</td>
      <td>Drug</td>
      <td>[normal saline]</td>
    </tr>
    <tr>
      <th>10173</th>
      <td>NCT02459392</td>
      <td>depomedrol</td>
      <td>Drug</td>
      <td>[depomedrol]</td>
    </tr>
    <tr>
      <th>13467</th>
      <td>NCT02513355</td>
      <td>taxol</td>
      <td>Drug</td>
      <td>[taxol]</td>
    </tr>
  </tbody>
</table>
</div>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[68]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">df3_drugs</span><span class="o">.</span><span class="n">sample</span><span class="p">(</span><span class="n">n</span><span class="o">=</span><span class="mi">15</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[68]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">
<div>
<style scoped>
    .dataframe tbody tr th:only-of-type {
        vertical-align: middle;
    }

    .dataframe tbody tr th {
        vertical-align: top;
    }

    .dataframe thead th {
        text-align: right;
    }
</style>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>nct_id</th>
      <th>intervention_name</th>
      <th>intervention_type</th>
      <th>matches</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>13292</th>
      <td>NCT02510612</td>
      <td>placebo</td>
      <td>Drug</td>
      <td>[placebo]</td>
    </tr>
    <tr>
      <th>18272</th>
      <td>NCT02598635</td>
      <td>cholecalciferol</td>
      <td>Drug</td>
      <td>[cholecalciferol]</td>
    </tr>
    <tr>
      <th>24016</th>
      <td>NCT02882984</td>
      <td>gefitinib 250mg po qd or tarceva 150mg po qd o...</td>
      <td>Drug</td>
      <td>[gefitinib 250mg po qd,  tarceva 150mg po qd, ...</td>
    </tr>
    <tr>
      <th>6259</th>
      <td>NCT02393573</td>
      <td>metformin</td>
      <td>Drug</td>
      <td>[metformin]</td>
    </tr>
    <tr>
      <th>23161</th>
      <td>NCT02802111</td>
      <td>albuterol</td>
      <td>Drug</td>
      <td>[albuterol]</td>
    </tr>
    <tr>
      <th>19625</th>
      <td>NCT02626572</td>
      <td>s47445 5mg</td>
      <td>Drug</td>
      <td>[s47445 5mg]</td>
    </tr>
    <tr>
      <th>3006</th>
      <td>NCT02326727</td>
      <td>fentanyl</td>
      <td>Drug</td>
      <td>[fentanyl]</td>
    </tr>
    <tr>
      <th>11893</th>
      <td>NCT02487082</td>
      <td>melatonin and donepezil</td>
      <td>Drug</td>
      <td>[melatonin ,  donepezil]</td>
    </tr>
    <tr>
      <th>4378</th>
      <td>NCT02357303</td>
      <td>acetylcysteine</td>
      <td>Drug</td>
      <td>[acetylcysteine]</td>
    </tr>
    <tr>
      <th>22880</th>
      <td>NCT02778789</td>
      <td>tocilizumab</td>
      <td>Drug</td>
      <td>[tocilizumab]</td>
    </tr>
    <tr>
      <th>18794</th>
      <td>NCT02608931</td>
      <td>dronabinol</td>
      <td>Drug</td>
      <td>[dronabinol]</td>
    </tr>
    <tr>
      <th>3618</th>
      <td>NCT02341911</td>
      <td>gemcitabine,cisplatin</td>
      <td>Drug</td>
      <td>[gemcitabine, cisplatin]</td>
    </tr>
    <tr>
      <th>15324</th>
      <td>NCT02544633</td>
      <td>mgcd265</td>
      <td>Drug</td>
      <td>[mgcd265]</td>
    </tr>
    <tr>
      <th>14953</th>
      <td>NCT02538367</td>
      <td>yh12852 dr2 8mg</td>
      <td>Drug</td>
      <td>[yh12852 dr2 8mg]</td>
    </tr>
    <tr>
      <th>9508</th>
      <td>NCT02449070</td>
      <td>nicorandil</td>
      <td>Drug</td>
      <td>[nicor, il]</td>
    </tr>
  </tbody>
</table>
</div>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[78]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">drugs_list</span> <span class="o">=</span> <span class="nb">list</span><span class="p">(</span><span class="n">df2</span><span class="p">[</span><span class="s1">&#39;alternatives&#39;</span><span class="p">])</span>
<span class="c1">#print(drugs_list)</span>

<span class="k">def</span> <span class="nf">match_drugs</span><span class="p">(</span><span class="n">matches</span><span class="p">):</span>
    <span class="sd">&quot;&quot;&quot;iterates over the full list of drugs available in drugs.csv, and</span>
<span class="sd">    cleaned using regex and string replace methods. Will return the first</span>
<span class="sd">    value of the list, as this is the value from &#39;itemLabel&#39; in drugs.csv &quot;&quot;&quot;</span>
    
    <span class="c1">#print(drugs_list)</span>
    <span class="n">match</span> <span class="o">=</span> <span class="s2">&quot;&quot;</span>
    <span class="k">for</span> <span class="n">item</span> <span class="ow">in</span> <span class="n">matches</span><span class="p">:</span>
        <span class="n">item</span> <span class="o">=</span> <span class="n">item</span><span class="o">.</span><span class="n">strip</span><span class="p">()</span>
        <span class="k">for</span> <span class="n">sublist</span> <span class="ow">in</span> <span class="n">drugs_list</span><span class="p">:</span>
            <span class="k">if</span> <span class="n">item</span> <span class="ow">not</span> <span class="ow">in</span> <span class="n">sublist</span><span class="p">:</span>
                <span class="k">continue</span>
            <span class="k">else</span><span class="p">:</span>
                <span class="n">match</span> <span class="o">+=</span> <span class="n">sublist</span><span class="p">[</span><span class="mi">0</span><span class="p">]</span>
                <span class="k">continue</span>
    <span class="k">return</span> <span class="n">match</span>
            
             
<span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;drugs&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;matches&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">apply</span><span class="p">(</span><span class="n">match_drugs</span><span class="p">)</span>
<span class="n">df3_drugs</span>
<span class="c1">#can see on index 25644 that hyaluronan was matched to hyaluronic acid</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[78]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">
<div>
<style scoped>
    .dataframe tbody tr th:only-of-type {
        vertical-align: middle;
    }

    .dataframe tbody tr th {
        vertical-align: top;
    }

    .dataframe thead th {
        text-align: right;
    }
</style>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>nct_id</th>
      <th>intervention_name</th>
      <th>intervention_type</th>
      <th>matches</th>
      <th>drugs</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>0</th>
      <td>NCT00293735</td>
      <td>labetalol (seizure prevention)</td>
      <td>Drug</td>
      <td>[labetalol , ]</td>
      <td>labetalololmesartan</td>
    </tr>
    <tr>
      <th>1</th>
      <td>NCT00293735</td>
      <td>mgso4 (seizure prevention)</td>
      <td>Drug</td>
      <td>[mgso4 , ]</td>
      <td>magnesium sulfateolmesartan</td>
    </tr>
    <tr>
      <th>9</th>
      <td>NCT00749853</td>
      <td>follicle stimulating hormone</td>
      <td>Drug</td>
      <td>[follicle stimulating hormone]</td>
      <td>urofollitropin</td>
    </tr>
    <tr>
      <th>25</th>
      <td>NCT01112878</td>
      <td>clonidine</td>
      <td>Drug</td>
      <td>[clonidine]</td>
      <td>clonidine</td>
    </tr>
    <tr>
      <th>26</th>
      <td>NCT01112878</td>
      <td>gabapentin</td>
      <td>Drug</td>
      <td>[gabapentin]</td>
      <td>gabapentin</td>
    </tr>
    <tr>
      <th>...</th>
      <td>...</td>
      <td>...</td>
      <td>...</td>
      <td>...</td>
      <td>...</td>
    </tr>
    <tr>
      <th>25631</th>
      <td>NCT03692299</td>
      <td>metronidazole</td>
      <td>Drug</td>
      <td>[metronidazole]</td>
      <td>metronidazole</td>
    </tr>
    <tr>
      <th>25638</th>
      <td>NCT03705962</td>
      <td>tobramycin</td>
      <td>Drug</td>
      <td>[tobramycin]</td>
      <td>tobramycin</td>
    </tr>
    <tr>
      <th>25644</th>
      <td>NCT03800810</td>
      <td>hyaluronic acid</td>
      <td>Drug</td>
      <td>[hyaluronic acid]</td>
      <td>hyaluronan</td>
    </tr>
    <tr>
      <th>25649</th>
      <td>NCT03825939</td>
      <td>intravenous placebo</td>
      <td>Drug</td>
      <td>[,  placebo]</td>
      <td>olmesartan</td>
    </tr>
    <tr>
      <th>25650</th>
      <td>NCT03825939</td>
      <td>intravenous tranexamic acid</td>
      <td>Drug</td>
      <td>[,  tranexamic acid]</td>
      <td>olmesartantranexamic acid</td>
    </tr>
  </tbody>
</table>
<p>4360 rows × 5 columns</p>
</div>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[82]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">df3_drugs</span> <span class="o">=</span> <span class="n">df3_drugs</span><span class="p">[</span><span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;drugs&#39;</span><span class="p">]</span> <span class="o">!=</span> <span class="s2">&quot;&quot;</span><span class="p">]</span>
<span class="n">df3_drugs</span><span class="p">[</span><span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;nct_id&#39;</span><span class="p">]</span> <span class="o">==</span> <span class="s1">&#39;NCT01969578&#39;</span><span class="p">]</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[82]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">
<div>
<style scoped>
    .dataframe tbody tr th:only-of-type {
        vertical-align: middle;
    }

    .dataframe tbody tr th {
        vertical-align: top;
    }

    .dataframe thead th {
        text-align: right;
    }
</style>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>nct_id</th>
      <th>intervention_name</th>
      <th>intervention_type</th>
      <th>matches</th>
      <th>drugs</th>
    </tr>
  </thead>
  <tbody>
  </tbody>
</table>
</div>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[76]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">df_output</span> <span class="o">=</span> <span class="n">df3_drugs</span><span class="p">[[</span><span class="s1">&#39;nct_id&#39;</span><span class="p">,</span> <span class="s1">&#39;drugs&#39;</span><span class="p">]]</span>
<span class="n">df_output</span>
<span class="c1">#df_output = df_output.to_json()</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[76]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">
<div>
<style scoped>
    .dataframe tbody tr th:only-of-type {
        vertical-align: middle;
    }

    .dataframe tbody tr th {
        vertical-align: top;
    }

    .dataframe thead th {
        text-align: right;
    }
</style>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>nct_id</th>
      <th>drugs</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>0</th>
      <td>NCT00293735</td>
      <td>labetalololmesartan</td>
    </tr>
    <tr>
      <th>1</th>
      <td>NCT00293735</td>
      <td>magnesium sulfateolmesartan</td>
    </tr>
    <tr>
      <th>9</th>
      <td>NCT00749853</td>
      <td>urofollitropin</td>
    </tr>
    <tr>
      <th>25</th>
      <td>NCT01112878</td>
      <td>clonidine</td>
    </tr>
    <tr>
      <th>26</th>
      <td>NCT01112878</td>
      <td>gabapentin</td>
    </tr>
    <tr>
      <th>...</th>
      <td>...</td>
      <td>...</td>
    </tr>
    <tr>
      <th>25631</th>
      <td>NCT03692299</td>
      <td>metronidazole</td>
    </tr>
    <tr>
      <th>25638</th>
      <td>NCT03705962</td>
      <td>tobramycin</td>
    </tr>
    <tr>
      <th>25644</th>
      <td>NCT03800810</td>
      <td>hyaluronan</td>
    </tr>
    <tr>
      <th>25649</th>
      <td>NCT03825939</td>
      <td>olmesartan</td>
    </tr>
    <tr>
      <th>25650</th>
      <td>NCT03825939</td>
      <td>olmesartantranexamic acid</td>
    </tr>
  </tbody>
</table>
<p>4360 rows × 2 columns</p>
</div>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[44]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">json_output</span> <span class="o">=</span> <span class="n">df_output</span><span class="o">.</span><span class="n">to_json</span><span class="p">(</span><span class="n">orient</span><span class="o">=</span><span class="s2">&quot;records&quot;</span><span class="p">)</span>

<span class="n">parsed</span> <span class="o">=</span> <span class="n">json</span><span class="o">.</span><span class="n">loads</span><span class="p">(</span><span class="n">json_output</span><span class="p">)</span>
<span class="n">json</span><span class="o">.</span><span class="n">dumps</span><span class="p">(</span><span class="n">parsed</span><span class="p">,</span> <span class="n">indent</span><span class="o">=</span><span class="mi">4</span><span class="p">)</span> 
<span class="c1">#with open(&quot;task1b.json&quot;, &quot;w&quot;) as outfile: </span>
<span class="c1">#    json.dump(json_output, outfile)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[44]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>&#39;[\n    {\n        &#34;nct_id&#34;: &#34;NCT01112878&#34;,\n        &#34;drugs&#34;: &#34;clonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01112878&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01132482&#34;,\n        &#34;drugs&#34;: &#34;sildenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01171482&#34;,\n        &#34;drugs&#34;: &#34;mitomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01232647&#34;,\n        &#34;drugs&#34;: &#34;(e)-phytonadione&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01255046&#34;,\n        &#34;drugs&#34;: &#34;donepezilolmesartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01360034&#34;,\n        &#34;drugs&#34;: &#34;indomethacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01360034&#34;,\n        &#34;drugs&#34;: &#34;nifedipine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01408849&#34;,\n        &#34;drugs&#34;: &#34;omeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01485393&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01485393&#34;,\n        &#34;drugs&#34;: &#34;zolpidem&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01528865&#34;,\n        &#34;drugs&#34;: &#34;lamivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01530984&#34;,\n        &#34;drugs&#34;: &#34;ipilimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01561222&#34;,\n        &#34;drugs&#34;: &#34;calcitriol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01589497&#34;,\n        &#34;drugs&#34;: &#34;ethambutol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01589497&#34;,\n        &#34;drugs&#34;: &#34;isoniazid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01589497&#34;,\n        &#34;drugs&#34;: &#34;moxifloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01589497&#34;,\n        &#34;drugs&#34;: &#34;pyrazinamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01589497&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01613677&#34;,\n        &#34;drugs&#34;: &#34;buparlisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01614197&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01614197&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01614197&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01614197&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01614197&#34;,\n        &#34;drugs&#34;: &#34;temsirolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01663558&#34;,\n        &#34;drugs&#34;: &#34;imiquimod&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01718444&#34;,\n        &#34;drugs&#34;: &#34;progesterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01733043&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01769911&#34;,\n        &#34;drugs&#34;: &#34;carmustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01769911&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01769911&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01769911&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01824264&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01836614&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01854762&#34;,\n        &#34;drugs&#34;: &#34;raltegravir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01883297&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01885364&#34;,\n        &#34;drugs&#34;: &#34;esmolol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01885364&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01885364&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01890200&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01922141&#34;,\n        &#34;drugs&#34;: &#34;aliskiren&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01922141&#34;,\n        &#34;drugs&#34;: &#34;ramipril&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01931098&#34;,\n        &#34;drugs&#34;: &#34;pazopanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01931098&#34;,\n        &#34;drugs&#34;: &#34;topotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01933269&#34;,\n        &#34;drugs&#34;: &#34;fluciclovine-f18&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01940536&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01942122&#34;,\n        &#34;drugs&#34;: &#34;mefenamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01953406&#34;,\n        &#34;drugs&#34;: &#34;mitomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01954290&#34;,\n        &#34;drugs&#34;: &#34;conivaptan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01954290&#34;,\n        &#34;drugs&#34;: &#34;mannitol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01960075&#34;,\n        &#34;drugs&#34;: &#34;fosphenytoin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01960075&#34;,\n        &#34;drugs&#34;: &#34;(s)-etiracetam&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01967251&#34;,\n        &#34;drugs&#34;: &#34;udenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01969149&#34;,\n        &#34;drugs&#34;: &#34;exenatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01971489&#34;,\n        &#34;drugs&#34;: &#34;buparlisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01971489&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01977339&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01979393&#34;,\n        &#34;drugs&#34;: &#34;cabozantinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01983475&#34;,\n        &#34;drugs&#34;: &#34;denosumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01984606&#34;,\n        &#34;drugs&#34;: &#34;empagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01984606&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT01996358&#34;,\n        &#34;drugs&#34;: &#34;succinylcholine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02009605&#34;,\n        &#34;drugs&#34;: &#34;icotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02014103&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02018861&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02018861&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02018861&#34;,\n        &#34;drugs&#34;: &#34;ifosfamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02018861&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02030054&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02034890&#34;,\n        &#34;drugs&#34;: &#34;hyaluronan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02036086&#34;,\n        &#34;drugs&#34;: &#34;cobimetinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02036086&#34;,\n        &#34;drugs&#34;: &#34;vemurafenib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02037126&#34;,\n        &#34;drugs&#34;: &#34;diphenhydramine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02047539&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02049762&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02056171&#34;,\n        &#34;drugs&#34;: &#34;quetiapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02056405&#34;,\n        &#34;drugs&#34;: &#34;mosapride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02058940&#34;,\n        &#34;drugs&#34;: &#34;exenatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02059499&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02059499&#34;,\n        &#34;drugs&#34;: &#34;imiquimod&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02066571&#34;,\n        &#34;drugs&#34;: &#34;droxidopa&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02067013&#34;,\n        &#34;drugs&#34;: &#34;ranibizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02071940&#34;,\n        &#34;drugs&#34;: &#34;pexidartinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02073747&#34;,\n        &#34;drugs&#34;: &#34;salbutamol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02073838&#34;,\n        &#34;drugs&#34;: &#34;decitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02073838&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02073838&#34;,\n        &#34;drugs&#34;: &#34;vismodegib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02074904&#34;,\n        &#34;drugs&#34;: &#34;topiramate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02077998&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02080637&#34;,\n        &#34;drugs&#34;: &#34;ambrisentan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02082405&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02082405&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02086500&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02086825&#34;,\n        &#34;drugs&#34;: &#34;\\u03b2-lactulose&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02086825&#34;,\n        &#34;drugs&#34;: &#34;rifaximin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02090348&#34;,\n        &#34;drugs&#34;: &#34;dimethyl fumarate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02091401&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02095184&#34;,\n        &#34;drugs&#34;: &#34;anastrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02095184&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02098629&#34;,\n        &#34;drugs&#34;: &#34;esmolol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02098629&#34;,\n        &#34;drugs&#34;: &#34;milrinone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02099747&#34;,\n        &#34;drugs&#34;: &#34;cyclosporine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02099747&#34;,\n        &#34;drugs&#34;: &#34;eltrombopag&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02101047&#34;,\n        &#34;drugs&#34;: &#34;phenylephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02106364&#34;,\n        &#34;drugs&#34;: &#34;insulin glargine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02106572&#34;,\n        &#34;drugs&#34;: &#34;mitomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02108860&#34;,\n        &#34;drugs&#34;: &#34;abatacept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02109627&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02109653&#34;,\n        &#34;drugs&#34;: &#34;encorafenib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02113891&#34;,\n        &#34;drugs&#34;: &#34;eculizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02116335&#34;,\n        &#34;drugs&#34;: &#34;bosentan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02117765&#34;,\n        &#34;drugs&#34;: &#34;ustekinumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02117817&#34;,\n        &#34;drugs&#34;: &#34;buparlisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02121405&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02121405&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02122081&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02122081&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02122081&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02124811&#34;,\n        &#34;drugs&#34;: &#34;minocycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02128360&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02129322&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02130323&#34;,\n        &#34;drugs&#34;: &#34;imiquimod&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02132598&#34;,\n        &#34;drugs&#34;: &#34;cabozantinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02137265&#34;,\n        &#34;drugs&#34;: &#34;clomiphene&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02138058&#34;,\n        &#34;drugs&#34;: &#34;topiramate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02141178&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02147834&#34;,\n        &#34;drugs&#34;: &#34;ranolazine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02153177&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02154061&#34;,\n        &#34;drugs&#34;: &#34;metronidazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02154061&#34;,\n        &#34;drugs&#34;: &#34;vancomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02155920&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02158052&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02158806&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02159027&#34;,\n        &#34;drugs&#34;: &#34;maraviroc&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02159495&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02159495&#34;,\n        &#34;drugs&#34;: &#34;fludarabine phosphate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02162420&#34;,\n        &#34;drugs&#34;: &#34;alemtuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02162420&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02162433&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02164500&#34;,\n        &#34;drugs&#34;: &#34;ruxolitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02164578&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02164578&#34;,\n        &#34;drugs&#34;: &#34;rivaroxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02165644&#34;,\n        &#34;drugs&#34;: &#34;acetazolamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02165644&#34;,\n        &#34;drugs&#34;: &#34;nimodipine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02166658&#34;,\n        &#34;drugs&#34;: &#34;cabazitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02171416&#34;,\n        &#34;drugs&#34;: &#34;rilonacept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02174094&#34;,\n        &#34;drugs&#34;: &#34;clobazam&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02176031&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02176031&#34;,\n        &#34;drugs&#34;: &#34;natalizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02177838&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02179177&#34;,\n        &#34;drugs&#34;: &#34;apixaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02180204&#34;,\n        &#34;drugs&#34;: &#34;alteplase&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02180204&#34;,\n        &#34;drugs&#34;: &#34;tenecteplase&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02186015&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferolvitamin d3&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02186158&#34;,\n        &#34;drugs&#34;: &#34;vitamin c&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02186405&#34;,\n        &#34;drugs&#34;: &#34;levothyroxine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02186574&#34;,\n        &#34;drugs&#34;: &#34;tenofovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02187211&#34;,\n        &#34;drugs&#34;: &#34;minocycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02187809&#34;,\n        &#34;drugs&#34;: &#34;clobazam&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02188121&#34;,\n        &#34;drugs&#34;: &#34;losartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02188121&#34;,\n        &#34;drugs&#34;: &#34;simvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02193347&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02194842&#34;,\n        &#34;drugs&#34;: &#34;enzalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02194933&#34;,\n        &#34;drugs&#34;: &#34;brexpiprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02197221&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02197286&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferolvitamin d3&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02201563&#34;,\n        &#34;drugs&#34;: &#34;minocycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02203643&#34;,\n        &#34;drugs&#34;: &#34;carfilzomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02203643&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02203643&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02203643&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02205047&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02205047&#34;,\n        &#34;drugs&#34;: &#34;pertuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02205047&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02206984&#34;,\n        &#34;drugs&#34;: &#34;anastrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02206984&#34;,\n        &#34;drugs&#34;: &#34;fulvestrant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02206984&#34;,\n        &#34;drugs&#34;: &#34;tamoxifen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02211014&#34;,\n        &#34;drugs&#34;: &#34;acalabrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02213289&#34;,\n        &#34;drugs&#34;: &#34;nivolumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02213289&#34;,\n        &#34;drugs&#34;: &#34;ramucirumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02213289&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02214004&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02214004&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02215174&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02216149&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02216149&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02216383&#34;,\n        &#34;drugs&#34;: &#34;carbetocin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02217501&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02220972&#34;,\n        &#34;drugs&#34;: &#34;perampanel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02222623&#34;,\n        &#34;drugs&#34;: &#34;nph insulin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02224768&#34;,\n        &#34;drugs&#34;: &#34;ipilimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02228681&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02228681&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02228681&#34;,\n        &#34;drugs&#34;: &#34;medroxyprogesterone acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02228681&#34;,\n        &#34;drugs&#34;: &#34;tamoxifen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02229240&#34;,\n        &#34;drugs&#34;: &#34;albiglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02229266&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02230176&#34;,\n        &#34;drugs&#34;: &#34;sunitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02230306&#34;,\n        &#34;drugs&#34;: &#34;cobimetinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02230306&#34;,\n        &#34;drugs&#34;: &#34;vemurafenib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02230332&#34;,\n        &#34;drugs&#34;: &#34;alendronic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02231008&#34;,\n        &#34;drugs&#34;: &#34;tasimelteon&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02232386&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02232386&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02232516&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02232516&#34;,\n        &#34;drugs&#34;: &#34;romidepsin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02234050&#34;,\n        &#34;drugs&#34;: &#34;trabectedin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02235298&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02235324&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02236078&#34;,\n        &#34;drugs&#34;: &#34;capreomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02236078&#34;,\n        &#34;drugs&#34;: &#34;moxifloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02236078&#34;,\n        &#34;drugs&#34;: &#34;rifabutin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02236078&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02237157&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02238808&#34;,\n        &#34;drugs&#34;: &#34;17\\u03b2-estradiol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02239458&#34;,\n        &#34;drugs&#34;: &#34;saxagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02240537&#34;,\n        &#34;drugs&#34;: &#34;sargramostim&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02240602&#34;,\n        &#34;drugs&#34;: &#34;oxycodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02240602&#34;,\n        &#34;drugs&#34;: &#34;oxycodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02240602&#34;,\n        &#34;drugs&#34;: &#34;oxycodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02241096&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02242097&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02248870&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02250807&#34;,\n        &#34;drugs&#34;: &#34;simeprevir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02250807&#34;,\n        &#34;drugs&#34;: &#34;sofosbuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02252328&#34;,\n        &#34;drugs&#34;: &#34;simvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02252406&#34;,\n        &#34;drugs&#34;: &#34;ranolazine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02252536&#34;,\n        &#34;drugs&#34;: &#34;gabapentin enacarbil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02254551&#34;,\n        &#34;drugs&#34;: &#34;sonidegib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02255175&#34;,\n        &#34;drugs&#34;: &#34;17\\u03b2-estradiol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02255175&#34;,\n        &#34;drugs&#34;: &#34;progesterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02255682&#34;,\n        &#34;drugs&#34;: &#34;simvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02256280&#34;,\n        &#34;drugs&#34;: &#34;neostigmine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02256345&#34;,\n        &#34;drugs&#34;: &#34;potassium chloride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02258009&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02258009&#34;,\n        &#34;drugs&#34;: &#34;ranibizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02258074&#34;,\n        &#34;drugs&#34;: &#34;lanthanum carbonate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02258074&#34;,\n        &#34;drugs&#34;: &#34;niacinamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02260154&#34;,\n        &#34;drugs&#34;: &#34;mebeverine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02260440&#34;,\n        &#34;drugs&#34;: &#34;azacitidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02260440&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02260648&#34;,\n        &#34;drugs&#34;: &#34;ezetimibe&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02262416&#34;,\n        &#34;drugs&#34;: &#34;leuprolide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02262936&#34;,\n        &#34;drugs&#34;: &#34;desmopressin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02262936&#34;,\n        &#34;drugs&#34;: &#34;fesoterodine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02263547&#34;,\n        &#34;drugs&#34;: &#34;colestipol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02263547&#34;,\n        &#34;drugs&#34;: &#34;teriflunomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02263898&#34;,\n        &#34;drugs&#34;: &#34;binimetinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02264210&#34;,\n        &#34;drugs&#34;: &#34;icotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02265367&#34;,\n        &#34;drugs&#34;: &#34;levomilnacipran&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02267707&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02268448&#34;,\n        &#34;drugs&#34;: &#34;clonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02268448&#34;,\n        &#34;drugs&#34;: &#34;naltrexone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02268864&#34;,\n        &#34;drugs&#34;: &#34;daclatasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02268864&#34;,\n        &#34;drugs&#34;: &#34;simeprevir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02269072&#34;,\n        &#34;drugs&#34;: &#34;anastrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02269072&#34;,\n        &#34;drugs&#34;: &#34;leuprolide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02269072&#34;,\n        &#34;drugs&#34;: &#34;nesiritide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02269072&#34;,\n        &#34;drugs&#34;: &#34;testosterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02269319&#34;,\n        &#34;drugs&#34;: &#34;linezolid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02269358&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02269644&#34;,\n        &#34;drugs&#34;: &#34;azithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02269644&#34;,\n        &#34;drugs&#34;: &#34;linezolid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02269969&#34;,\n        &#34;drugs&#34;: &#34;tobramycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02270242&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02272725&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02272946&#34;,\n        &#34;drugs&#34;: &#34;canakinumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02273700&#34;,\n        &#34;drugs&#34;: &#34;rivaroxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02274792&#34;,\n        &#34;drugs&#34;: &#34;etanercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02275169&#34;,\n        &#34;drugs&#34;: &#34;urofollitropin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02277132&#34;,\n        &#34;drugs&#34;: &#34;sildenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02277184&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02277197&#34;,\n        &#34;drugs&#34;: &#34;cetuximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02277457&#34;,\n        &#34;drugs&#34;: &#34;crizotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02277457&#34;,\n        &#34;drugs&#34;: &#34;erlotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02278081&#34;,\n        &#34;drugs&#34;: &#34;lansoprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02278315&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02279407&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02279576&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02279576&#34;,\n        &#34;drugs&#34;: &#34;pazopanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02280239&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02280486&#34;,\n        &#34;drugs&#34;: &#34;glimepiride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02280486&#34;,\n        &#34;drugs&#34;: &#34;saxagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02281058&#34;,\n        &#34;drugs&#34;: &#34;abatacept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02281266&#34;,\n        &#34;drugs&#34;: &#34;thymalfasin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02281799&#34;,\n        &#34;drugs&#34;: &#34;azathioprine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02282176&#34;,\n        &#34;drugs&#34;: &#34;azithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02282891&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02283177&#34;,\n        &#34;drugs&#34;: &#34;crenolanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02283177&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02283177&#34;,\n        &#34;drugs&#34;: &#34;idarubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02283281&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02283281&#34;,\n        &#34;drugs&#34;: &#34;tetrahydrocannabinol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02283294&#34;,\n        &#34;drugs&#34;: &#34;apixaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02283294&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02285140&#34;,\n        &#34;drugs&#34;: &#34;cefazolin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02285140&#34;,\n        &#34;drugs&#34;: &#34;vancomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02286206&#34;,\n        &#34;drugs&#34;: &#34;clozapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02286830&#34;,\n        &#34;drugs&#34;: &#34;zoledronic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02286921&#34;,\n        &#34;drugs&#34;: &#34;enzalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02286921&#34;,\n        &#34;drugs&#34;: &#34;testosterone cypionate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02286921&#34;,\n        &#34;drugs&#34;: &#34;testosterone enanthate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02287181&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02287181&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02287311&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02288156&#34;,\n        &#34;drugs&#34;: &#34;capsaicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02288897&#34;,\n        &#34;drugs&#34;: &#34;dacarbazine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02289144&#34;,\n        &#34;drugs&#34;: &#34;ceritinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02289547&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02289807&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02289963&#34;,\n        &#34;drugs&#34;: &#34;alirocumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02290327&#34;,\n        &#34;drugs&#34;: &#34;pantoprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02291055&#34;,\n        &#34;drugs&#34;: &#34;durvalumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02291419&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02292225&#34;,\n        &#34;drugs&#34;: &#34;obinutuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02292667&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02293109&#34;,\n        &#34;drugs&#34;: &#34;carfilzomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02293109&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02293109&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02293109&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02293109&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02293109&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02295475&#34;,\n        &#34;drugs&#34;: &#34;apixaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02295475&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02295722&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02295722&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02295826&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02296112&#34;,\n        &#34;drugs&#34;: &#34;trametinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02296281&#34;,\n        &#34;drugs&#34;: &#34;pirfenidone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02296398&#34;,\n        &#34;drugs&#34;: &#34;romidepsin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02296671&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02296671&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02296671&#34;,\n        &#34;drugs&#34;: &#34;pemetrexed&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02296801&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02296801&#34;,\n        &#34;drugs&#34;: &#34;palbociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02296931&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02297763&#34;,\n        &#34;drugs&#34;: &#34;quetiapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02297945&#34;,\n        &#34;drugs&#34;: &#34;metyrapone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02298257&#34;,\n        &#34;drugs&#34;: &#34;brentuximab vedotin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02298257&#34;,\n        &#34;drugs&#34;: &#34;dacarbazine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02298257&#34;,\n        &#34;drugs&#34;: &#34;vinblastine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02298283&#34;,\n        &#34;drugs&#34;: &#34;doxorubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02298283&#34;,\n        &#34;drugs&#34;: &#34;brentuximab vedotin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02298283&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02298283&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02298283&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02298283&#34;,\n        &#34;drugs&#34;: &#34;procarbazine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02298348&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02298348&#34;,\n        &#34;drugs&#34;: &#34;topotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02299726&#34;,\n        &#34;drugs&#34;: &#34;spironolactone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02299817&#34;,\n        &#34;drugs&#34;: &#34;denosumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02301000&#34;,\n        &#34;drugs&#34;: &#34;metronidazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02301156&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02301780&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02301806&#34;,\n        &#34;drugs&#34;: &#34;glimepiride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02301806&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02301949&#34;,\n        &#34;drugs&#34;: &#34;thalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02303730&#34;,\n        &#34;drugs&#34;: &#34;exenatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02303730&#34;,\n        &#34;drugs&#34;: &#34;insulin glargine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02303795&#34;,\n        &#34;drugs&#34;: &#34;rivaroxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02303795&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02304081&#34;,\n        &#34;drugs&#34;: &#34;saxagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02304094&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02304263&#34;,\n        &#34;drugs&#34;: &#34;iohexol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02304705&#34;,\n        &#34;drugs&#34;: &#34;sildenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02304757&#34;,\n        &#34;drugs&#34;: &#34;alendronate sodium trihydratealendronic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02305186&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02306473&#34;,\n        &#34;drugs&#34;: &#34;mannitol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02306850&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02307006&#34;,\n        &#34;drugs&#34;: &#34;ceftaroline fosamil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02307149&#34;,\n        &#34;drugs&#34;: &#34;ipilimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02308007&#34;,\n        &#34;drugs&#34;: &#34;metronidazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02308007&#34;,\n        &#34;drugs&#34;: &#34;terconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02308072&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02308072&#34;,\n        &#34;drugs&#34;: &#34;olaparib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02309359&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02309580&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02310243&#34;,\n        &#34;drugs&#34;: &#34;palbociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02310867&#34;,\n        &#34;drugs&#34;: &#34;belatacept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02311569&#34;,\n        &#34;drugs&#34;: &#34;mirabegron&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02312063&#34;,\n        &#34;drugs&#34;: &#34;glimepiride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02312063&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02312375&#34;,\n        &#34;drugs&#34;: &#34;fimasartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02312804&#34;,\n        &#34;drugs&#34;: &#34;infigratinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02312804&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02312804&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02312908&#34;,\n        &#34;drugs&#34;: &#34;clonazepam&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02313389&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02313675&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02313792&#34;,\n        &#34;drugs&#34;: &#34;palifermin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02314403&#34;,\n        &#34;drugs&#34;: &#34;belatacept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02314403&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02315495&#34;,\n        &#34;drugs&#34;: &#34;acarbose&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02315495&#34;,\n        &#34;drugs&#34;: &#34;saxagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02315534&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02315768&#34;,\n        &#34;drugs&#34;: &#34;obinutuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02315768&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02316249&#34;,\n        &#34;drugs&#34;: &#34;17\\u03b2-estradiol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02317159&#34;,\n        &#34;drugs&#34;: &#34;imatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02317926&#34;,\n        &#34;drugs&#34;: &#34;levothyroxine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02318225&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02318446&#34;,\n        &#34;drugs&#34;: &#34;folic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02319031&#34;,\n        &#34;drugs&#34;: &#34;daclatasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02319031&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02319031&#34;,\n        &#34;drugs&#34;: &#34;sofosbuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02319343&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02320734&#34;,\n        &#34;drugs&#34;: &#34;rocuronium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02321280&#34;,\n        &#34;drugs&#34;: &#34;denosumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02321852&#34;,\n        &#34;drugs&#34;: &#34;triflusal&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02322502&#34;,\n        &#34;drugs&#34;: &#34;desflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02322502&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02322502&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02322580&#34;,\n        &#34;drugs&#34;: &#34;etanercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02322892&#34;,\n        &#34;drugs&#34;: &#34;thiamine ion&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02323217&#34;,\n        &#34;drugs&#34;: &#34;isocarboxazid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02323230&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02323269&#34;,\n        &#34;drugs&#34;: &#34;dimethyl fumarate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02323399&#34;,\n        &#34;drugs&#34;: &#34;phenylephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02324010&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02324166&#34;,\n        &#34;drugs&#34;: &#34;cefazolin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02324166&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02324543&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02324543&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02324543&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02324543&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02324738&#34;,\n        &#34;drugs&#34;: &#34;mefloquinemefloquine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02325401&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02325882&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02325960&#34;,\n        &#34;drugs&#34;: &#34;exenatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02325960&#34;,\n        &#34;drugs&#34;: &#34;insulin glargine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02325986&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02325986&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326103&#34;,\n        &#34;drugs&#34;: &#34;ciprofloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326220&#34;,\n        &#34;drugs&#34;: &#34;alirocumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326285&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326285&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326285&#34;,\n        &#34;drugs&#34;: &#34;gefitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326311&#34;,\n        &#34;drugs&#34;: &#34;dasatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326311&#34;,\n        &#34;drugs&#34;: &#34;imatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326311&#34;,\n        &#34;drugs&#34;: &#34;nilotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326727&#34;,\n        &#34;drugs&#34;: &#34;isoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326727&#34;,\n        &#34;drugs&#34;: &#34;nitrous oxide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326727&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02326727&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02327039&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02327143&#34;,\n        &#34;drugs&#34;: &#34;abemaciclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02327676&#34;,\n        &#34;drugs&#34;: &#34;emtricitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02327702&#34;,\n        &#34;drugs&#34;: &#34;emtricitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02327715&#34;,\n        &#34;drugs&#34;: &#34;emtricitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02328118&#34;,\n        &#34;drugs&#34;: &#34;ranibizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02328495&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02328755&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02329379&#34;,\n        &#34;drugs&#34;: &#34;levothyroxine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02329964&#34;,\n        &#34;drugs&#34;: &#34;neostigmine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02330406&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02330419&#34;,\n        &#34;drugs&#34;: &#34;naltrexone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02330705&#34;,\n        &#34;drugs&#34;: &#34;chorionic gonadotropin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02330757&#34;,\n        &#34;drugs&#34;: &#34;estradiol valerate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02330991&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02331095&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02331368&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02331368&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02331498&#34;,\n        &#34;drugs&#34;: &#34;pazopanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02331862&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02332031&#34;,\n        &#34;drugs&#34;: &#34;levothyroxine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02332291&#34;,\n        &#34;drugs&#34;: &#34;escitalopram&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02332447&#34;,\n        &#34;drugs&#34;: &#34;naloxone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02332590&#34;,\n        &#34;drugs&#34;: &#34;adalimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02332603&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02332616&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02332629&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02332902&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02333565&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02333565&#34;,\n        &#34;drugs&#34;: &#34;octreotideoctreotide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02333643&#34;,\n        &#34;drugs&#34;: &#34;digoxin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02333643&#34;,\n        &#34;drugs&#34;: &#34;furosemide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02333799&#34;,\n        &#34;drugs&#34;: &#34;bedaquiline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02333799&#34;,\n        &#34;drugs&#34;: &#34;linezolid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02334046&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02334046&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02334124&#34;,\n        &#34;drugs&#34;: &#34;ceftriaxone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02334124&#34;,\n        &#34;drugs&#34;: &#34;flucloxacillin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02335190&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02335281&#34;,\n        &#34;drugs&#34;: &#34;mesalamine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02335346&#34;,\n        &#34;drugs&#34;: &#34;duloxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02336165&#34;,\n        &#34;drugs&#34;: &#34;durvalumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02336815&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02337491&#34;,\n        &#34;drugs&#34;: &#34;bevacizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02337491&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02337881&#34;,\n        &#34;drugs&#34;: &#34;sildenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02337985&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02337985&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02337985&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02338037&#34;,\n        &#34;drugs&#34;: &#34;eribulin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02338323&#34;,\n        &#34;drugs&#34;: &#34;febuxostat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02338414&#34;,\n        &#34;drugs&#34;: &#34;romiplostim&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02338518&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02338518&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02338570&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02338635&#34;,\n        &#34;drugs&#34;: &#34;ursodiol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02338960&#34;,\n        &#34;drugs&#34;: &#34;bremelanotide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02339662&#34;,\n        &#34;drugs&#34;: &#34;amitriptyline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02339662&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02339753&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02340117&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02340611&#34;,\n        &#34;drugs&#34;: &#34;cediranib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02340611&#34;,\n        &#34;drugs&#34;: &#34;olaparib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02340949&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02340949&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02340962&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02341482&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02341794&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02341833&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02341911&#34;,\n        &#34;drugs&#34;: &#34;gemcitabinecarboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02341911&#34;,\n        &#34;drugs&#34;: &#34;gemcitabinecisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342002&#34;,\n        &#34;drugs&#34;: &#34;mifepristone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342002&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342379&#34;,\n        &#34;drugs&#34;: &#34;bevacizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342418&#34;,\n        &#34;drugs&#34;: &#34;tedizolid phosphate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342639&#34;,\n        &#34;drugs&#34;: &#34;rifaximin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342717&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342782&#34;,\n        &#34;drugs&#34;: &#34;carmustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342782&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342782&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342782&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342886&#34;,\n        &#34;drugs&#34;: &#34;moxifloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02342886&#34;,\n        &#34;drugs&#34;: &#34;pyrazinamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02343263&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02343276&#34;,\n        &#34;drugs&#34;: &#34;nitroglycerin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02343289&#34;,\n        &#34;drugs&#34;: &#34;clarithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02343289&#34;,\n        &#34;drugs&#34;: &#34;esketamine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02343393&#34;,\n        &#34;drugs&#34;: &#34;hydralazine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02343575&#34;,\n        &#34;drugs&#34;: &#34;haloperidol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02343679&#34;,\n        &#34;drugs&#34;: &#34;ceritinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02343952&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344017&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344225&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344264&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344290&#34;,\n        &#34;drugs&#34;: &#34;pitavastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344316&#34;,\n        &#34;drugs&#34;: &#34;melatonin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344472&#34;,\n        &#34;drugs&#34;: &#34;anastrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344472&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344472&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344472&#34;,\n        &#34;drugs&#34;: &#34;exemestane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344472&#34;,\n        &#34;drugs&#34;: &#34;fulvestrant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344472&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344472&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344472&#34;,\n        &#34;drugs&#34;: &#34;pertuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344472&#34;,\n        &#34;drugs&#34;: &#34;tamoxifen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344472&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344589&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344628&#34;,\n        &#34;drugs&#34;: &#34;azithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02344641&#34;,\n        &#34;drugs&#34;: &#34;exenatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02345239&#34;,\n        &#34;drugs&#34;: &#34;pantoprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02345304&#34;,\n        &#34;drugs&#34;: &#34;digoxin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02345304&#34;,\n        &#34;drugs&#34;: &#34;omeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02345304&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02345460&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02345460&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02345616&#34;,\n        &#34;drugs&#34;: &#34;nitric oxide (radical)&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02345681&#34;,\n        &#34;drugs&#34;: &#34;furosemide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02346110&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02346253&#34;,\n        &#34;drugs&#34;: &#34;bicalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02346253&#34;,\n        &#34;drugs&#34;: &#34;degarelix&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02346253&#34;,\n        &#34;drugs&#34;: &#34;goserelin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02346539&#34;,\n        &#34;drugs&#34;: &#34;(\\u2212)-nicotine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02346682&#34;,\n        &#34;drugs&#34;: &#34;venlafaxine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02347111&#34;,\n        &#34;drugs&#34;: &#34;flecainide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02347111&#34;,\n        &#34;drugs&#34;: &#34;sotalol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02347878&#34;,\n        &#34;drugs&#34;: &#34;aprepitant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02347891&#34;,\n        &#34;drugs&#34;: &#34;belimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02348281&#34;,\n        &#34;drugs&#34;: &#34;bicalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02348450&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02348450&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02348450&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02349243&#34;,\n        &#34;drugs&#34;: &#34;entacapone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02349828&#34;,\n        &#34;drugs&#34;: &#34;aciclovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02349906&#34;,\n        &#34;drugs&#34;: &#34;treosulfan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02349919&#34;,\n        &#34;drugs&#34;: &#34;procaterol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02350543&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02351102&#34;,\n        &#34;drugs&#34;: &#34;valacyclovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02351128&#34;,\n        &#34;drugs&#34;: &#34;lanreotide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02351232&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02351310&#34;,\n        &#34;drugs&#34;: &#34;betamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02351739&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02351869&#34;,\n        &#34;drugs&#34;: &#34;nitrous oxide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02351882&#34;,\n        &#34;drugs&#34;: &#34;nabilonenabilone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02352090&#34;,\n        &#34;drugs&#34;: &#34;dienogest&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02352558&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02352558&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02352558&#34;,\n        &#34;drugs&#34;: &#34;imatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02352987&#34;,\n        &#34;drugs&#34;: &#34;salicylic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02353078&#34;,\n        &#34;drugs&#34;: &#34;sucralfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02353169&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02353182&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02353182&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02353182&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02353182&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02353676&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02353780&#34;,\n        &#34;drugs&#34;: &#34;abatacept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02353780&#34;,\n        &#34;drugs&#34;: &#34;tocilizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02353936&#34;,\n        &#34;drugs&#34;: &#34;afatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02353988&#34;,\n        &#34;drugs&#34;: &#34;bicalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02354170&#34;,\n        &#34;drugs&#34;: &#34;mifepristone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02354222&#34;,\n        &#34;drugs&#34;: &#34;canagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02354235&#34;,\n        &#34;drugs&#34;: &#34;canagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02354560&#34;,\n        &#34;drugs&#34;: &#34;erythromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02354586&#34;,\n        &#34;drugs&#34;: &#34;niraparib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02354807&#34;,\n        &#34;drugs&#34;: &#34;mirabegron&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02355119&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02355678&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02355821&#34;,\n        &#34;drugs&#34;: &#34;bisoprolol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02355821&#34;,\n        &#34;drugs&#34;: &#34;moxonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02356705&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02357004&#34;,\n        &#34;drugs&#34;: &#34;carvedilol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02357303&#34;,\n        &#34;drugs&#34;: &#34;l-cysteineacetylcysteine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02357342&#34;,\n        &#34;drugs&#34;: &#34;sirolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02357563&#34;,\n        &#34;drugs&#34;: &#34;ulipristal acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02357654&#34;,\n        &#34;drugs&#34;: &#34;gonadorelin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02357693&#34;,\n        &#34;drugs&#34;: &#34;aprepitant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02357732&#34;,\n        &#34;drugs&#34;: &#34;dabrafenib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02357732&#34;,\n        &#34;drugs&#34;: &#34;nivolumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02357732&#34;,\n        &#34;drugs&#34;: &#34;trametinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02358057&#34;,\n        &#34;drugs&#34;: &#34;alfentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02358057&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02358356&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02358356&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02358369&#34;,\n        &#34;drugs&#34;: &#34;bimatoprost&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02358473&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02358499&#34;,\n        &#34;drugs&#34;: &#34;posaconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02358824&#34;,\n        &#34;drugs&#34;: &#34;telmisartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359058&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359058&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359058&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359058&#34;,\n        &#34;drugs&#34;: &#34;ramucirumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359110&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359162&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359162&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359162&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359162&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359162&#34;,\n        &#34;drugs&#34;: &#34;pegaspargase&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359162&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359162&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359448&#34;,\n        &#34;drugs&#34;: &#34;melatonin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359474&#34;,\n        &#34;drugs&#34;: &#34;trabectedin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02359552&#34;,\n        &#34;drugs&#34;: &#34;rasagiline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02360384&#34;,\n        &#34;drugs&#34;: &#34;linaclotide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02360618&#34;,\n        &#34;drugs&#34;: &#34;simvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02360631&#34;,\n        &#34;drugs&#34;: &#34;varenicline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02360774&#34;,\n        &#34;drugs&#34;: &#34;canagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361060&#34;,\n        &#34;drugs&#34;: &#34;neostigmine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361190&#34;,\n        &#34;drugs&#34;: &#34;testosterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361216&#34;,\n        &#34;drugs&#34;: &#34;ingenol mebutate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361476&#34;,\n        &#34;drugs&#34;: &#34;clonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361502&#34;,\n        &#34;drugs&#34;: &#34;mirabegron&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361619&#34;,\n        &#34;drugs&#34;: &#34;caffeine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361619&#34;,\n        &#34;drugs&#34;: &#34;clarithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361619&#34;,\n        &#34;drugs&#34;: &#34;diclofenac&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361619&#34;,\n        &#34;drugs&#34;: &#34;esomeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361879&#34;,\n        &#34;drugs&#34;: &#34;ulipristal acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361892&#34;,\n        &#34;drugs&#34;: &#34;ulipristal acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02361905&#34;,\n        &#34;drugs&#34;: &#34;ulipristal acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02362035&#34;,\n        &#34;drugs&#34;: &#34;acalabrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02362035&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02362165&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02362165&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02362529&#34;,\n        &#34;drugs&#34;: &#34;celecoxib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02362529&#34;,\n        &#34;drugs&#34;: &#34;minocycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02362997&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02363335&#34;,\n        &#34;drugs&#34;: &#34;roflumilast&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02363335&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02363738&#34;,\n        &#34;drugs&#34;: &#34;infliximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02363946&#34;,\n        &#34;drugs&#34;: &#34;diphenhydramine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02364882&#34;,\n        &#34;drugs&#34;: &#34;sildenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02364934&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02364934&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365441&#34;,\n        &#34;drugs&#34;: &#34;imatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365532&#34;,\n        &#34;drugs&#34;: &#34;dofetilide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365558&#34;,\n        &#34;drugs&#34;: &#34;omeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365571&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365727&#34;,\n        &#34;drugs&#34;: &#34;clonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365727&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365727&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365766&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365766&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365766&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365961&#34;,\n        &#34;drugs&#34;: &#34;clonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02365961&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02366065&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02366299&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02366299&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02366663&#34;,\n        &#34;drugs&#34;: &#34;carmustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02366663&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02366663&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02366663&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02366728&#34;,\n        &#34;drugs&#34;: &#34;basiliximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02366728&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02367118&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02367248&#34;,\n        &#34;drugs&#34;: &#34;deferoxamine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02367404&#34;,\n        &#34;drugs&#34;: &#34;duloxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02368054&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02368054&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02368795&#34;,\n        &#34;drugs&#34;: &#34;indomethacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02369159&#34;,\n        &#34;drugs&#34;: &#34;oseltamivir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02369159&#34;,\n        &#34;drugs&#34;: &#34;peramivir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02369172&#34;,\n        &#34;drugs&#34;: &#34;bupropion&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02369406&#34;,\n        &#34;drugs&#34;: &#34;lopinavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02369406&#34;,\n        &#34;drugs&#34;: &#34;lamivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02369406&#34;,\n        &#34;drugs&#34;: &#34;nevirapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02369406&#34;,\n        &#34;drugs&#34;: &#34;zidovudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02369900&#34;,\n        &#34;drugs&#34;: &#34;esmolol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02370238&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02370550&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02370615&#34;,\n        &#34;drugs&#34;: &#34;digoxin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02370615&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02370680&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02371187&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02371304&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02371408&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02371408&#34;,\n        &#34;drugs&#34;: &#34;sofosbuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02371681&#34;,\n        &#34;drugs&#34;: &#34;moxifloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02371681&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02371798&#34;,\n        &#34;drugs&#34;: &#34;gadopentetate dimeglumine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02371889&#34;,\n        &#34;drugs&#34;: &#34;topiramate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02372253&#34;,\n        &#34;drugs&#34;: &#34;verapamil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02372318&#34;,\n        &#34;drugs&#34;: &#34;nalmefene&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02372955&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02373202&#34;,\n        &#34;drugs&#34;: &#34;leflunomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02373202&#34;,\n        &#34;drugs&#34;: &#34;sulfasalazine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02373202&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02373241&#34;,\n        &#34;drugs&#34;: &#34;losartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02373514&#34;,\n        &#34;drugs&#34;: &#34;dexketoprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02373514&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02373865&#34;,\n        &#34;drugs&#34;: &#34;glimepiride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02373865&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02374008&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02374489&#34;,\n        &#34;drugs&#34;: &#34;ceritinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02374853&#34;,\n        &#34;drugs&#34;: &#34;vancomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02374957&#34;,\n        &#34;drugs&#34;: &#34;cilostazol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375100&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375100&#34;,\n        &#34;drugs&#34;: &#34;(r,r) tramadol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375191&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375191&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375204&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375204&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375204&#34;,\n        &#34;drugs&#34;: &#34;ifosfamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375204&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375295&#34;,\n        &#34;drugs&#34;: &#34;ciprofloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375581&#34;,\n        &#34;drugs&#34;: &#34;icotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375646&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375672&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375880&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02375880&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02376283&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02376283&#34;,\n        &#34;drugs&#34;: &#34;prasugrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02376296&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02376803&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02377479&#34;,\n        &#34;drugs&#34;: &#34;clomiphene&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02377479&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02378142&#34;,\n        &#34;drugs&#34;: &#34;pazopanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02378480&#34;,\n        &#34;drugs&#34;: &#34;linezolid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02378480&#34;,\n        &#34;drugs&#34;: &#34;omadacycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02378623&#34;,\n        &#34;drugs&#34;: &#34;apixaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02378714&#34;,\n        &#34;drugs&#34;: &#34;varenicline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02379390&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02379676&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02379806&#34;,\n        &#34;drugs&#34;: &#34;enoxaparin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02380313&#34;,\n        &#34;drugs&#34;: &#34;abiraterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02380313&#34;,\n        &#34;drugs&#34;: &#34;enzalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02380313&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02380625&#34;,\n        &#34;drugs&#34;: &#34;azithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02381249&#34;,\n        &#34;drugs&#34;: &#34;octreotideoctreotide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02381353&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02381717&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02382354&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02382354&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02382406&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02382510&#34;,\n        &#34;drugs&#34;: &#34;tiotropium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02382575&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02382575&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02382666&#34;,\n        &#34;drugs&#34;: &#34;rolapitant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02382848&#34;,\n        &#34;drugs&#34;: &#34;prazosin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02382939&#34;,\n        &#34;drugs&#34;: &#34;somatropin recombinant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02383030&#34;,\n        &#34;drugs&#34;: &#34;fulvestrant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02383927&#34;,\n        &#34;drugs&#34;: &#34;tipifarnib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02384122&#34;,\n        &#34;drugs&#34;: &#34;octreotideoctreotide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02384200&#34;,\n        &#34;drugs&#34;: &#34;ampicillin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02384200&#34;,\n        &#34;drugs&#34;: &#34;ceftriaxone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02384200&#34;,\n        &#34;drugs&#34;: &#34;vancomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02384343&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02384746&#34;,\n        &#34;drugs&#34;: &#34;fulvestrant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02384759&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02384850&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02384915&#34;,\n        &#34;drugs&#34;: &#34;prilocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02385032&#34;,\n        &#34;drugs&#34;: &#34;ursodiol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02385136&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02385422&#34;,\n        &#34;drugs&#34;: &#34;carvedilol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02385448&#34;,\n        &#34;drugs&#34;: &#34;dienogest&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02385851&#34;,\n        &#34;drugs&#34;: &#34;pegfilgrastim&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02386059&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02386449&#34;,\n        &#34;drugs&#34;: &#34;bisacodyl&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02386449&#34;,\n        &#34;drugs&#34;: &#34;mannitol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02386449&#34;,\n        &#34;drugs&#34;: &#34;sodium picosulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02386735&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387086&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387086&#34;,\n        &#34;drugs&#34;: &#34;gefitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387086&#34;,\n        &#34;drugs&#34;: &#34;thalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387216&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387242&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387450&#34;,\n        &#34;drugs&#34;: &#34;sildenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387619&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387710&#34;,\n        &#34;drugs&#34;: &#34;tiagabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387762&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387801&#34;,\n        &#34;drugs&#34;: &#34;ixekizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387814&#34;,\n        &#34;drugs&#34;: &#34;abemaciclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02387918&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02388035&#34;,\n        &#34;drugs&#34;: &#34;cefotaxime&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02388191&#34;,\n        &#34;drugs&#34;: &#34;naproxen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02389543&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02389543&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02389712&#34;,\n        &#34;drugs&#34;: &#34;fluoxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02389712&#34;,\n        &#34;drugs&#34;: &#34;lamotrigine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02389738&#34;,\n        &#34;drugs&#34;: &#34;regadenoson&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02389738&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02389829&#34;,\n        &#34;drugs&#34;: &#34;diphenhydramine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02389868&#34;,\n        &#34;drugs&#34;: &#34;lovastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02389920&#34;,\n        &#34;drugs&#34;: &#34;nilotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02389985&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390063&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390362&#34;,\n        &#34;drugs&#34;: &#34;mycophenolate mofetil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390362&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390427&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390427&#34;,\n        &#34;drugs&#34;: &#34;pertuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390427&#34;,\n        &#34;drugs&#34;: &#34;taselisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390427&#34;,\n        &#34;drugs&#34;: &#34;ado-trastuzumab emtansine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390427&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390544&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390739&#34;,\n        &#34;drugs&#34;: &#34;aldesleukin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390739&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390817&#34;,\n        &#34;drugs&#34;: &#34;neostigmine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390843&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390843&#34;,\n        &#34;drugs&#34;: &#34;simvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02390843&#34;,\n        &#34;drugs&#34;: &#34;topotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02391571&#34;,\n        &#34;drugs&#34;: &#34;oxycodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02391636&#34;,\n        &#34;drugs&#34;: &#34;carbetocin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02392208&#34;,\n        &#34;drugs&#34;: &#34;telavancin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02392377&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02392377&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02392377&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02392377&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02392780&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02393157&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02393157&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02393157&#34;,\n        &#34;drugs&#34;: &#34;ifosfamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02393157&#34;,\n        &#34;drugs&#34;: &#34;obinutuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02393248&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02393248&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02393248&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02393586&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02393664&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02393664&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02393742&#34;,\n        &#34;drugs&#34;: &#34;sodium nitrite&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02394002&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02394106&#34;,\n        &#34;drugs&#34;: &#34;ofatumumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02394119&#34;,\n        &#34;drugs&#34;: &#34;ofatumumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02394119&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02394652&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02394665&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02394951&#34;,\n        &#34;drugs&#34;: &#34;pregabalin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02395016&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02395627&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02395627&#34;,\n        &#34;drugs&#34;: &#34;tamoxifen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02395640&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02395640&#34;,\n        &#34;drugs&#34;: &#34;epirubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02395640&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02395848&#34;,\n        &#34;drugs&#34;: &#34;fidaxomicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02396303&#34;,\n        &#34;drugs&#34;: &#34;carbetocin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02396433&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02396433&#34;,\n        &#34;drugs&#34;: &#34;eribulin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02397330&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02397421&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02397538&#34;,\n        &#34;drugs&#34;: &#34;fimasartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02397538&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02397590&#34;,\n        &#34;drugs&#34;: &#34;fimasartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02398123&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02398201&#34;,\n        &#34;drugs&#34;: &#34;bezafibrate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02398240&#34;,\n        &#34;drugs&#34;: &#34;brentuximab vedotin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02398240&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02398240&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02398539&#34;,\n        &#34;drugs&#34;: &#34;triamcinolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02398552&#34;,\n        &#34;drugs&#34;: &#34;sunitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02398656&#34;,\n        &#34;drugs&#34;: &#34;tenecteplase&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02399085&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02399137&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02399475&#34;,\n        &#34;drugs&#34;: &#34;levothyroxine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02399475&#34;,\n        &#34;drugs&#34;: &#34;liothyronine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02399566&#34;,\n        &#34;drugs&#34;: &#34;erlotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02399709&#34;,\n        &#34;drugs&#34;: &#34;simvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02399943&#34;,\n        &#34;drugs&#34;: &#34;panitumumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02399943&#34;,\n        &#34;drugs&#34;: &#34;trametinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400021&#34;,\n        &#34;drugs&#34;: &#34;progesterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400112&#34;,\n        &#34;drugs&#34;: &#34;vancomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400281&#34;,\n        &#34;drugs&#34;: &#34;azacitidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400281&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400281&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400281&#34;,\n        &#34;drugs&#34;: &#34;idarubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400281&#34;,\n        &#34;drugs&#34;: &#34;mitoxantrone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400333&#34;,\n        &#34;drugs&#34;: &#34;ticagrelor&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400437&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400437&#34;,\n        &#34;drugs&#34;: &#34;ixazomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400437&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400463&#34;,\n        &#34;drugs&#34;: &#34;ruxolitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400645&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400749&#34;,\n        &#34;drugs&#34;: &#34;apremilast&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400775&#34;,\n        &#34;drugs&#34;: &#34;azilsartan medoxomil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400866&#34;,\n        &#34;drugs&#34;: &#34;olanzapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02400879&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401048&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401048&#34;,\n        &#34;drugs&#34;: &#34;durvalumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401269&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401295&#34;,\n        &#34;drugs&#34;: &#34;tretinoin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401295&#34;,\n        &#34;drugs&#34;: &#34;celecoxib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401295&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401425&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401425&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401542&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401815&#34;,\n        &#34;drugs&#34;: &#34;pexidartinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401815&#34;,\n        &#34;drugs&#34;: &#34;sunitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401828&#34;,\n        &#34;drugs&#34;: &#34;dolutegravir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401880&#34;,\n        &#34;drugs&#34;: &#34;empagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401880&#34;,\n        &#34;drugs&#34;: &#34;linagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02401945&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02402465&#34;,\n        &#34;drugs&#34;: &#34;fluticasone propionate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02402595&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02402725&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02403063&#34;,\n        &#34;drugs&#34;: &#34;neostigmine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02403830&#34;,\n        &#34;drugs&#34;: &#34;methylnaltrexone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02404051&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02404051&#34;,\n        &#34;drugs&#34;: &#34;exemestane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02404051&#34;,\n        &#34;drugs&#34;: &#34;fulvestrant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02404077&#34;,\n        &#34;drugs&#34;: &#34;clonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02404155&#34;,\n        &#34;drugs&#34;: &#34;clozapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02404233&#34;,\n        &#34;drugs&#34;: &#34;rilpivirine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02404558&#34;,\n        &#34;drugs&#34;: &#34;tocilizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02404675&#34;,\n        &#34;drugs&#34;: &#34;icotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02404779&#34;,\n        &#34;drugs&#34;: &#34;cisatracurium besylate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02404896&#34;,\n        &#34;drugs&#34;: &#34;metreleptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02405156&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02405156&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02405585&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02405676&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02405676&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02405676&#34;,\n        &#34;drugs&#34;: &#34;prednisonevincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02405676&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02405988&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02406170&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02406183&#34;,\n        &#34;drugs&#34;: &#34;ipilimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02406261&#34;,\n        &#34;drugs&#34;: &#34;donepezil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02406261&#34;,\n        &#34;drugs&#34;: &#34;simvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02406300&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02406521&#34;,\n        &#34;drugs&#34;: &#34;pazopanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02406560&#34;,\n        &#34;drugs&#34;: &#34;tafamidis&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02406950&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02407210&#34;,\n        &#34;drugs&#34;: &#34;azilsartan medoxomil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02407210&#34;,\n        &#34;drugs&#34;: &#34;olmesartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02407314&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02407626&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02407626&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02407808&#34;,\n        &#34;drugs&#34;: &#34;tetrahydrocannabinol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02407821&#34;,\n        &#34;drugs&#34;: &#34;escitalopram&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02407899&#34;,\n        &#34;drugs&#34;: &#34;saxagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02407899&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferolvitamin d3&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02407912&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408042&#34;,\n        &#34;drugs&#34;: &#34;brentuximab vedotin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408042&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408042&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408042&#34;,\n        &#34;drugs&#34;: &#34;ifosfamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408042&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408042&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408068&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408120&#34;,\n        &#34;drugs&#34;: &#34;insulin aspart&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408120&#34;,\n        &#34;drugs&#34;: &#34;insulin glargine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408419&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408705&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408770&#34;,\n        &#34;drugs&#34;: &#34;ulipristal acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02408978&#34;,\n        &#34;drugs&#34;: &#34;naproxen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02409004&#34;,\n        &#34;drugs&#34;: &#34;ataluren&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02409004&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02409199&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02409810&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02410135&#34;,\n        &#34;drugs&#34;: &#34;mirabegron&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02410590&#34;,\n        &#34;drugs&#34;: &#34;rocuronium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02410590&#34;,\n        &#34;drugs&#34;: &#34;succinylcholine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02410707&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02410759&#34;,\n        &#34;drugs&#34;: &#34;carbetocin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02410759&#34;,\n        &#34;drugs&#34;: &#34;ergonovine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02411773&#34;,\n        &#34;drugs&#34;: &#34;sodium bicarbonate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02412085&#34;,\n        &#34;drugs&#34;: &#34;golimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02412228&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02412228&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02412228&#34;,\n        &#34;drugs&#34;: &#34;ixazomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02412670&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02412670&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02412670&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02412670&#34;,\n        &#34;drugs&#34;: &#34;vinblastine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02412852&#34;,\n        &#34;drugs&#34;: &#34;sodium nitrite&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02412917&#34;,\n        &#34;drugs&#34;: &#34;valacyclovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02413008&#34;,\n        &#34;drugs&#34;: &#34;estriol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02413047&#34;,\n        &#34;drugs&#34;: &#34;azathioprine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02413047&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02413203&#34;,\n        &#34;drugs&#34;: &#34;celecoxib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02413320&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02413320&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02413320&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02413320&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02413593&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02413658&#34;,\n        &#34;drugs&#34;: &#34;phenytoin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02413736&#34;,\n        &#34;drugs&#34;: &#34;imatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02414204&#34;,\n        &#34;drugs&#34;: &#34;sildenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02414568&#34;,\n        &#34;drugs&#34;: &#34;bendamustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02414568&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02414568&#34;,\n        &#34;drugs&#34;: &#34;vinblastine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02414685&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02414685&#34;,\n        &#34;drugs&#34;: &#34;ifosfamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02414685&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02414724&#34;,\n        &#34;drugs&#34;: &#34;ribociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02414945&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02415062&#34;,\n        &#34;drugs&#34;: &#34;donepezil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02415608&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02415699&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02415699&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02416388&#34;,\n        &#34;drugs&#34;: &#34;idarubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02416388&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02416388&#34;,\n        &#34;drugs&#34;: &#34;vosaroxin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02416570&#34;,\n        &#34;drugs&#34;: &#34;clarithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02416583&#34;,\n        &#34;drugs&#34;: &#34;dinoprostone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02416778&#34;,\n        &#34;drugs&#34;: &#34;ferric carboxymaltose&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02416999&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02417129&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02417883&#34;,\n        &#34;drugs&#34;: &#34;furosemide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02417935&#34;,\n        &#34;drugs&#34;: &#34;duloxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02417935&#34;,\n        &#34;drugs&#34;: &#34;pregabalin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02418182&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02418624&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02418884&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02418949&#34;,\n        &#34;drugs&#34;: &#34;cyproheptadine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02419105&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02419105&#34;,\n        &#34;drugs&#34;: &#34;testosterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02419378&#34;,\n        &#34;drugs&#34;: &#34;alemtuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02419651&#34;,\n        &#34;drugs&#34;: &#34;diclofenac&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02419651&#34;,\n        &#34;drugs&#34;: &#34;(r,r) tramadol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02419729&#34;,\n        &#34;drugs&#34;: &#34;ethinylestradiol17\\u03b2-estradiol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02419937&#34;,\n        &#34;drugs&#34;: &#34;tocilizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02420210&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02420314&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02420314&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02420392&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02420782&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02420782&#34;,\n        &#34;drugs&#34;: &#34;pilocarpine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02420899&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02420938&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02421419&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02421588&#34;,\n        &#34;drugs&#34;: &#34;topotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02421640&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422108&#34;,\n        &#34;drugs&#34;: &#34;denosumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422199&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422199&#34;,\n        &#34;drugs&#34;: &#34;lapatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422446&#34;,\n        &#34;drugs&#34;: &#34;icosapent ethyl&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422485&#34;,\n        &#34;drugs&#34;: &#34;salsalate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422563&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422563&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422563&#34;,\n        &#34;drugs&#34;: &#34;ifosfamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422563&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422654&#34;,\n        &#34;drugs&#34;: &#34;eliglustat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422706&#34;,\n        &#34;drugs&#34;: &#34;clarithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422706&#34;,\n        &#34;drugs&#34;: &#34;levofloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422706&#34;,\n        &#34;drugs&#34;: &#34;metronidazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422706&#34;,\n        &#34;drugs&#34;: &#34;nitazoxanide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422706&#34;,\n        &#34;drugs&#34;: &#34;omeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422719&#34;,\n        &#34;drugs&#34;: &#34;radotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422823&#34;,\n        &#34;drugs&#34;: &#34;articaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422823&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422966&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02422966&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02423018&#34;,\n        &#34;drugs&#34;: &#34;pregabalin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02423083&#34;,\n        &#34;drugs&#34;: &#34;guanabenz&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02423239&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02423265&#34;,\n        &#34;drugs&#34;: &#34;ranolazine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02423759&#34;,\n        &#34;drugs&#34;: &#34;ciprofloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02423928&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02423928&#34;,\n        &#34;drugs&#34;: &#34;ipilimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02423980&#34;,\n        &#34;drugs&#34;: &#34;glucagon&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02424071&#34;,\n        &#34;drugs&#34;: &#34;melatonin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02424149&#34;,\n        &#34;drugs&#34;: &#34;phenazopyridine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02424201&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02424201&#34;,\n        &#34;drugs&#34;: &#34;vitamin c&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02424461&#34;,\n        &#34;drugs&#34;: &#34;ceftriaxone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02424617&#34;,\n        &#34;drugs&#34;: &#34;erlotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02424968&#34;,\n        &#34;drugs&#34;: &#34;mycophenolate mofetil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02425449&#34;,\n        &#34;drugs&#34;: &#34;succinylcholine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02425566&#34;,\n        &#34;drugs&#34;: &#34;nitroglycerin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02425709&#34;,\n        &#34;drugs&#34;: &#34;diclofenac&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02425709&#34;,\n        &#34;drugs&#34;: &#34;(r,r) tramadol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02425878&#34;,\n        &#34;drugs&#34;: &#34;ulipristal acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02426060&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02426177&#34;,\n        &#34;drugs&#34;: &#34;labetalol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02426177&#34;,\n        &#34;drugs&#34;: &#34;nifedipine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02426294&#34;,\n        &#34;drugs&#34;: &#34;glimepiride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02426294&#34;,\n        &#34;drugs&#34;: &#34;pioglitazone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02426450&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02426775&#34;,\n        &#34;drugs&#34;: &#34;carglumic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02426918&#34;,\n        &#34;drugs&#34;: &#34;linezolid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02427126&#34;,\n        &#34;drugs&#34;: &#34;apixaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02427126&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02427165&#34;,\n        &#34;drugs&#34;: &#34;salbutamol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02427334&#34;,\n        &#34;drugs&#34;: &#34;dienogest&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02427334&#34;,\n        &#34;drugs&#34;: &#34;fluoxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02427594&#34;,\n        &#34;drugs&#34;: &#34;sodium bicarbonate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02427893&#34;,\n        &#34;drugs&#34;: &#34;cobimetinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02427893&#34;,\n        &#34;drugs&#34;: &#34;vemurafenib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428231&#34;,\n        &#34;drugs&#34;: &#34;dimethyl fumarate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428257&#34;,\n        &#34;drugs&#34;: &#34;ephedrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428283&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428283&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428283&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428712&#34;,\n        &#34;drugs&#34;: &#34;plx8394&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428751&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428751&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428751&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428764&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428764&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428777&#34;,\n        &#34;drugs&#34;: &#34;diclofenac&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02428777&#34;,\n        &#34;drugs&#34;: &#34;(r,r) tramadol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429037&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429089&#34;,\n        &#34;drugs&#34;: &#34;ribociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429232&#34;,\n        &#34;drugs&#34;: &#34;linagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429232&#34;,\n        &#34;drugs&#34;: &#34;pioglitazone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429271&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429557&#34;,\n        &#34;drugs&#34;: &#34;midodrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429622&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429687&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429687&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429687&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429687&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429700&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429700&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429700&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429700&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429726&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429934&#34;,\n        &#34;drugs&#34;: &#34;abatacept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02429960&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02430532&#34;,\n        &#34;drugs&#34;: &#34;dimethyl fumarate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02430545&#34;,\n        &#34;drugs&#34;: &#34;glasdegib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02430545&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02430896&#34;,\n        &#34;drugs&#34;: &#34;atomoxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02431013&#34;,\n        &#34;drugs&#34;: &#34;cilostazol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02431013&#34;,\n        &#34;drugs&#34;: &#34;pravastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02431013&#34;,\n        &#34;drugs&#34;: &#34;simvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02431065&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02431143&#34;,\n        &#34;drugs&#34;: &#34;miltefosine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02431325&#34;,\n        &#34;drugs&#34;: &#34;teduglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02431559&#34;,\n        &#34;drugs&#34;: &#34;durvalumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02431754&#34;,\n        &#34;drugs&#34;: &#34;tadalafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02431936&#34;,\n        &#34;drugs&#34;: &#34;prazosin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432365&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432365&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432456&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432456&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432456&#34;,\n        &#34;drugs&#34;: &#34;methocarbamol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432456&#34;,\n        &#34;drugs&#34;: &#34;pantoprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432560&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432560&#34;,\n        &#34;drugs&#34;: &#34;sirolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432716&#34;,\n        &#34;drugs&#34;: &#34;insulin glulisine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432833&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432846&#34;,\n        &#34;drugs&#34;: &#34;sunitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432872&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02432976&#34;,\n        &#34;drugs&#34;: &#34;exenatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02433418&#34;,\n        &#34;drugs&#34;: &#34;diclofenac&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02433626&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02433665&#34;,\n        &#34;drugs&#34;: &#34;iopamidol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02433678&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02433704&#34;,\n        &#34;drugs&#34;: &#34;cefazolin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02433730&#34;,\n        &#34;drugs&#34;: &#34;testosterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02433847&#34;,\n        &#34;drugs&#34;: &#34;mosapride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02434354&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02434614&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02434614&#34;,\n        &#34;drugs&#34;: &#34;docetaxelcisplatinfluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02434861&#34;,\n        &#34;drugs&#34;: &#34;digoxin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02434861&#34;,\n        &#34;drugs&#34;: &#34;rolapitant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02434861&#34;,\n        &#34;drugs&#34;: &#34;sulfasalazine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02435186&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02435186&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02436265&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02436265&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02436408&#34;,\n        &#34;drugs&#34;: &#34;vismodegib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02436668&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02436668&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02436993&#34;,\n        &#34;drugs&#34;: &#34;bevacizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02436993&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02436993&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02436993&#34;,\n        &#34;drugs&#34;: &#34;pertuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02436993&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02437045&#34;,\n        &#34;drugs&#34;: &#34;meropenem&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02437136&#34;,\n        &#34;drugs&#34;: &#34;entinostat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02437136&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02437253&#34;,\n        &#34;drugs&#34;: &#34;adalimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02437370&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02437370&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02437825&#34;,\n        &#34;drugs&#34;: &#34;octreotideoctreotide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02438007&#34;,\n        &#34;drugs&#34;: &#34;enzalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02438137&#34;,\n        &#34;drugs&#34;: &#34;dimethyl fumarate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02438371&#34;,\n        &#34;drugs&#34;: &#34;indomethacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02438371&#34;,\n        &#34;drugs&#34;: &#34;nifedipine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02439034&#34;,\n        &#34;drugs&#34;: &#34;ketoprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02439034&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02439190&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02439190&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02439281&#34;,\n        &#34;drugs&#34;: &#34;clonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02439281&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02439411&#34;,\n        &#34;drugs&#34;: &#34;trametinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02439814&#34;,\n        &#34;drugs&#34;: &#34;pregnenolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02439905&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02439957&#34;,\n        &#34;drugs&#34;: &#34;valganciclovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02439970&#34;,\n        &#34;drugs&#34;: &#34;valganciclovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440009&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440204&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440204&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440399&#34;,\n        &#34;drugs&#34;: &#34;diclofenac&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440399&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440464&#34;,\n        &#34;drugs&#34;: &#34;ixazomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440464&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440581&#34;,\n        &#34;drugs&#34;: &#34;alendronic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440581&#34;,\n        &#34;drugs&#34;: &#34;cinacalcet&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440581&#34;,\n        &#34;drugs&#34;: &#34;teriparatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440789&#34;,\n        &#34;drugs&#34;: &#34;sirolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440841&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02440841&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02441270&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02441491&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02441686&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02441686&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02441894&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02441894&#34;,\n        &#34;drugs&#34;: &#34;metoclopramide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02441894&#34;,\n        &#34;drugs&#34;: &#34;prednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02441907&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02441946&#34;,\n        &#34;drugs&#34;: &#34;abemaciclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02441946&#34;,\n        &#34;drugs&#34;: &#34;anastrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02441946&#34;,\n        &#34;drugs&#34;: &#34;loperamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02442063&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02442674&#34;,\n        &#34;drugs&#34;: &#34;tolvaptan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02442817&#34;,\n        &#34;drugs&#34;: &#34;linagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02443142&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02443142&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02443194&#34;,\n        &#34;drugs&#34;: &#34;duloxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02443545&#34;,\n        &#34;drugs&#34;: &#34;deferiprone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02443844&#34;,\n        &#34;drugs&#34;: &#34;tamsulosin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02443922&#34;,\n        &#34;drugs&#34;: &#34;glimepiride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02443922&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02444013&#34;,\n        &#34;drugs&#34;: &#34;folic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02444091&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02444364&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02444637&#34;,\n        &#34;drugs&#34;: &#34;rivastigmine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02444728&#34;,\n        &#34;drugs&#34;: &#34;azathioprine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02444728&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02444728&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02444819&#34;,\n        &#34;drugs&#34;: &#34;olmutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02445508&#34;,\n        &#34;drugs&#34;: &#34;sevelamer&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02445716&#34;,\n        &#34;drugs&#34;: &#34;testosterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02445872&#34;,\n        &#34;drugs&#34;: &#34;aprepitant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02445872&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02445898&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446093&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446145&#34;,\n        &#34;drugs&#34;: &#34;eltrombopag&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446652&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446652&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446704&#34;,\n        &#34;drugs&#34;: &#34;olaparib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446704&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446782&#34;,\n        &#34;drugs&#34;: &#34;cefazolin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446834&#34;,\n        &#34;drugs&#34;: &#34;acarbose&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446860&#34;,\n        &#34;drugs&#34;: &#34;nivolumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446964&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446964&#34;,\n        &#34;drugs&#34;: &#34;fludarabine phosphate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446964&#34;,\n        &#34;drugs&#34;: &#34;mycophenolate mofetil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02446964&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447055&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447055&#34;,\n        &#34;drugs&#34;: &#34;filgrastim&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447055&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447055&#34;,\n        &#34;drugs&#34;: &#34;mycophenolate mofetil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447055&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447094&#34;,\n        &#34;drugs&#34;: &#34;alteplase&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447185&#34;,\n        &#34;drugs&#34;: &#34;ranibizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447315&#34;,\n        &#34;drugs&#34;: &#34;pilocarpine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447796&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447796&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447809&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447822&#34;,\n        &#34;drugs&#34;: &#34;anti-thymocyte globulin (rabbit)&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02447874&#34;,\n        &#34;drugs&#34;: &#34;l-arginine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02448069&#34;,\n        &#34;drugs&#34;: &#34;(21r)-argatroban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02448095&#34;,\n        &#34;drugs&#34;: &#34;ponatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02448199&#34;,\n        &#34;drugs&#34;: &#34;meloxicam&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02448303&#34;,\n        &#34;drugs&#34;: &#34;acalabrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02448303&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02448550&#34;,\n        &#34;drugs&#34;: &#34;bivalirudin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02448654&#34;,\n        &#34;drugs&#34;: &#34;tolcapone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02448771&#34;,\n        &#34;drugs&#34;: &#34;bazedoxifene&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02448771&#34;,\n        &#34;drugs&#34;: &#34;palbociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02448797&#34;,\n        &#34;drugs&#34;: &#34;icotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449161&#34;,\n        &#34;drugs&#34;: &#34;progesteronemedroxyprogesterone acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449252&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449252&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449252&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449265&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449265&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449265&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449278&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449278&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449278&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449720&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02449915&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02450084&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02450253&#34;,\n        &#34;drugs&#34;: &#34;tadalafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02450552&#34;,\n        &#34;drugs&#34;: &#34;ezogabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02450656&#34;,\n        &#34;drugs&#34;: &#34;afatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02450656&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02450656&#34;,\n        &#34;drugs&#34;: &#34;selumetinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02450773&#34;,\n        &#34;drugs&#34;: &#34;furosemide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02450786&#34;,\n        &#34;drugs&#34;: &#34;donepezil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02450968&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02450994&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02451072&#34;,\n        &#34;drugs&#34;: &#34;lysergic acid diethylamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02451150&#34;,\n        &#34;drugs&#34;: &#34;azilsartan medoxomil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02451202&#34;,\n        &#34;drugs&#34;: &#34;rocuronium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02451306&#34;,\n        &#34;drugs&#34;: &#34;quetiapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02451462&#34;,\n        &#34;drugs&#34;: &#34;zoledronic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02451527&#34;,\n        &#34;drugs&#34;: &#34;digoxin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02451540&#34;,\n        &#34;drugs&#34;: &#34;roflumilast&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02451826&#34;,\n        &#34;drugs&#34;: &#34;ulipristal acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02452255&#34;,\n        &#34;drugs&#34;: &#34;fenofibrate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02452281&#34;,\n        &#34;drugs&#34;: &#34;ipilimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02452294&#34;,\n        &#34;drugs&#34;: &#34;buparlisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02452424&#34;,\n        &#34;drugs&#34;: &#34;pexidartinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02452437&#34;,\n        &#34;drugs&#34;: &#34;oxycodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02452528&#34;,\n        &#34;drugs&#34;: &#34;diphenhydramine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02452528&#34;,\n        &#34;drugs&#34;: &#34;entecavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02452528&#34;,\n        &#34;drugs&#34;: &#34;tenofovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02452983&#34;,\n        &#34;drugs&#34;: &#34;sertraline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02453321&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02453464&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02453841&#34;,\n        &#34;drugs&#34;: &#34;oxymetazoline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454179&#34;,\n        &#34;drugs&#34;: &#34;acalabrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454179&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454205&#34;,\n        &#34;drugs&#34;: &#34;bedaquiline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454205&#34;,\n        &#34;drugs&#34;: &#34;ethionamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454205&#34;,\n        &#34;drugs&#34;: &#34;isoniazid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454205&#34;,\n        &#34;drugs&#34;: &#34;levofloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454205&#34;,\n        &#34;drugs&#34;: &#34;linezolid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454205&#34;,\n        &#34;drugs&#34;: &#34;moxifloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454205&#34;,\n        &#34;drugs&#34;: &#34;pyrazinamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454322&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454491&#34;,\n        &#34;drugs&#34;: &#34;verapamil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454504&#34;,\n        &#34;drugs&#34;: &#34;neostigmine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02454894&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02455154&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02455245&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02455245&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02455609&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02455609&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02455726&#34;,\n        &#34;drugs&#34;: &#34;oxycodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02455726&#34;,\n        &#34;drugs&#34;: &#34;pregabalin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02456207&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02456350&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02456532&#34;,\n        &#34;drugs&#34;: &#34;eszopiclone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02456701&#34;,\n        &#34;drugs&#34;: &#34;vemurafenib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02456844&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02456844&#34;,\n        &#34;drugs&#34;: &#34;montelukast&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02456896&#34;,\n        &#34;drugs&#34;: &#34;oxcarbazepine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02456948&#34;,\n        &#34;drugs&#34;: &#34;minocycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02457130&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02457156&#34;,\n        &#34;drugs&#34;: &#34;octreotideoctreotide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02457650&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02457910&#34;,\n        &#34;drugs&#34;: &#34;enzalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02457910&#34;,\n        &#34;drugs&#34;: &#34;taselisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02458196&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02458235&#34;,\n        &#34;drugs&#34;: &#34;azacitidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02458781&#34;,\n        &#34;drugs&#34;: &#34;ciprofloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02458781&#34;,\n        &#34;drugs&#34;: &#34;metronidazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02459392&#34;,\n        &#34;drugs&#34;: &#34;hyaluronan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02459509&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02460133&#34;,\n        &#34;drugs&#34;: &#34;dasabuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02460133&#34;,\n        &#34;drugs&#34;: &#34;ombitasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02460133&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02460133&#34;,\n        &#34;drugs&#34;: &#34;ritonavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02460276&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02460276&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02460276&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02460419&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02460640&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02460887&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02460887&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02461693&#34;,\n        &#34;drugs&#34;: &#34;caffeine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02461745&#34;,\n        &#34;drugs&#34;: &#34;ombitasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02461745&#34;,\n        &#34;drugs&#34;: &#34;ombitasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02461836&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02461888&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02461888&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02461888&#34;,\n        &#34;drugs&#34;: &#34;ixazomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462148&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462148&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462148&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462161&#34;,\n        &#34;drugs&#34;: &#34;insulin aspart&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462174&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462252&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462304&#34;,\n        &#34;drugs&#34;: &#34;bevacizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462304&#34;,\n        &#34;drugs&#34;: &#34;ranibizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462369&#34;,\n        &#34;drugs&#34;: &#34;glimepiride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462369&#34;,\n        &#34;drugs&#34;: &#34;saxagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462473&#34;,\n        &#34;drugs&#34;: &#34;aripiprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462473&#34;,\n        &#34;drugs&#34;: &#34;olanzapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462473&#34;,\n        &#34;drugs&#34;: &#34;paliperidone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462473&#34;,\n        &#34;drugs&#34;: &#34;quetiapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462473&#34;,\n        &#34;drugs&#34;: &#34;risperidone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462538&#34;,\n        &#34;drugs&#34;: &#34;brentuximab vedotin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462538&#34;,\n        &#34;drugs&#34;: &#34;imatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462837&#34;,\n        &#34;drugs&#34;: &#34;mirabegron&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462915&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02462941&#34;,\n        &#34;drugs&#34;: &#34;adenosine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02463110&#34;,\n        &#34;drugs&#34;: &#34;sertraline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02463409&#34;,\n        &#34;drugs&#34;: &#34;theophylline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02463552&#34;,\n        &#34;drugs&#34;: &#34;naproxen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02463747&#34;,\n        &#34;drugs&#34;: &#34;ceftazidime&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02463747&#34;,\n        &#34;drugs&#34;: &#34;meropenem&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02463747&#34;,\n        &#34;drugs&#34;: &#34;vancomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464020&#34;,\n        &#34;drugs&#34;: &#34;vancomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464033&#34;,\n        &#34;drugs&#34;: &#34;etanercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464059&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferolvitamin d3&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464176&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464176&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464176&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464228&#34;,\n        &#34;drugs&#34;: &#34;tipifarnib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464722&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464722&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464722&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464722&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02464722&#34;,\n        &#34;drugs&#34;: &#34;rocuronium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02465385&#34;,\n        &#34;drugs&#34;: &#34;linaclotide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02465593&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02465736&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02465736&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02465853&#34;,\n        &#34;drugs&#34;: &#34;hyaluronan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02465983&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02466022&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02466191&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02466191&#34;,\n        &#34;drugs&#34;: &#34;memantine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02466997&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02467361&#34;,\n        &#34;drugs&#34;: &#34;ipilimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02467361&#34;,\n        &#34;drugs&#34;: &#34;nivolumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02467361&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02467504&#34;,\n        &#34;drugs&#34;: &#34;folic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02467504&#34;,\n        &#34;drugs&#34;: &#34;loxoprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02467504&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02467517&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02467595&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02467595&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02467647&#34;,\n        &#34;drugs&#34;: &#34;thalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02468557&#34;,\n        &#34;drugs&#34;: &#34;idelalisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02469077&#34;,\n        &#34;drugs&#34;: &#34;naloxone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02469155&#34;,\n        &#34;drugs&#34;: &#34;risperidone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02469740&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02469896&#34;,\n        &#34;drugs&#34;: &#34;tocilizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02469974&#34;,\n        &#34;drugs&#34;: &#34;busulfan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02469974&#34;,\n        &#34;drugs&#34;: &#34;filgrastim&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02470442&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02470637&#34;,\n        &#34;drugs&#34;: &#34;insulin lispro&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02470650&#34;,\n        &#34;drugs&#34;: &#34;darunavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02470650&#34;,\n        &#34;drugs&#34;: &#34;lamivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02470650&#34;,\n        &#34;drugs&#34;: &#34;rilpivirine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02470650&#34;,\n        &#34;drugs&#34;: &#34;ritonavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02470676&#34;,\n        &#34;drugs&#34;: &#34;progesterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02470741&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02470832&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02471391&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02471521&#34;,\n        &#34;drugs&#34;: &#34;rocuronium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02471911&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02471911&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02471911&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02471911&#34;,\n        &#34;drugs&#34;: &#34;ifosfamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02471911&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02472717&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02472873&#34;,\n        &#34;drugs&#34;: &#34;ethanol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02472938&#34;,\n        &#34;drugs&#34;: &#34;dimethyl fumarate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02473094&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02473211&#34;,\n        &#34;drugs&#34;: &#34;daclatasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02473211&#34;,\n        &#34;drugs&#34;: &#34;sofosbuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02473250&#34;,\n        &#34;drugs&#34;: &#34;fluoxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02473627&#34;,\n        &#34;drugs&#34;: &#34;omeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02473627&#34;,\n        &#34;drugs&#34;: &#34;tolbutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02473640&#34;,\n        &#34;drugs&#34;: &#34;ceftriaxone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02473640&#34;,\n        &#34;drugs&#34;: &#34;esomeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02473809&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02474069&#34;,\n        &#34;drugs&#34;: &#34;secukinumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02474082&#34;,\n        &#34;drugs&#34;: &#34;dimethyl fumarate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02474368&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02474420&#34;,\n        &#34;drugs&#34;: &#34;deferasirox&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02474654&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02474927&#34;,\n        &#34;drugs&#34;: &#34;carfilzomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02475161&#34;,\n        &#34;drugs&#34;: &#34;rabeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02475369&#34;,\n        &#34;drugs&#34;: &#34;pancrelipase&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02475681&#34;,\n        &#34;drugs&#34;: &#34;acalabrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02475681&#34;,\n        &#34;drugs&#34;: &#34;obinutuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02475746&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02475876&#34;,\n        &#34;drugs&#34;: &#34;clindamycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02475915&#34;,\n        &#34;drugs&#34;: &#34;darunavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02475915&#34;,\n        &#34;drugs&#34;: &#34;efavirenz&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02475915&#34;,\n        &#34;drugs&#34;: &#34;emtricitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02475915&#34;,\n        &#34;drugs&#34;: &#34;maraviroc&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02475915&#34;,\n        &#34;drugs&#34;: &#34;tenofovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02476045&#34;,\n        &#34;drugs&#34;: &#34;panitumumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02476045&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatinpanitumumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02476045&#34;,\n        &#34;drugs&#34;: &#34;panitumumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02476136&#34;,\n        &#34;drugs&#34;: &#34;paroxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02476409&#34;,\n        &#34;drugs&#34;: &#34;tolvaptan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02476422&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02476448&#34;,\n        &#34;drugs&#34;: &#34;phenazopyridine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02476617&#34;,\n        &#34;drugs&#34;: &#34;dasabuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02476617&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02476825&#34;,\n        &#34;drugs&#34;: &#34;fluticasone propionate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02477423&#34;,\n        &#34;drugs&#34;: &#34;ampicillin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02477488&#34;,\n        &#34;drugs&#34;: &#34;allopurinol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02477514&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02477514&#34;,\n        &#34;drugs&#34;: &#34;tedizolid phosphate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02477644&#34;,\n        &#34;drugs&#34;: &#34;olaparib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02477696&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02477852&#34;,\n        &#34;drugs&#34;: &#34;ethambutol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02477852&#34;,\n        &#34;drugs&#34;: &#34;isoniazid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02477852&#34;,\n        &#34;drugs&#34;: &#34;pyrazinamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02477852&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02478424&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02478502&#34;,\n        &#34;drugs&#34;: &#34;cabazitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02479022&#34;,\n        &#34;drugs&#34;: &#34;insulin glargine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02479256&#34;,\n        &#34;drugs&#34;: &#34;tamoxifen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02479308&#34;,\n        &#34;drugs&#34;: &#34;moxifloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02479451&#34;,\n        &#34;drugs&#34;: &#34;theophylline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02479789&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02480114&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02480114&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02480946&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481219&#34;,\n        &#34;drugs&#34;: &#34;bisacodyl&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481219&#34;,\n        &#34;drugs&#34;: &#34;erythromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481219&#34;,\n        &#34;drugs&#34;: &#34;metoclopramide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481245&#34;,\n        &#34;drugs&#34;: &#34;bezafibrate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481310&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481310&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481310&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481310&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481310&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481479&#34;,\n        &#34;drugs&#34;: &#34;saxagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481479&#34;,\n        &#34;drugs&#34;: &#34;saxagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481791&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02481947&#34;,\n        &#34;drugs&#34;: &#34;lubiprostone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02482090&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02482155&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02482207&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02482272&#34;,\n        &#34;drugs&#34;: &#34;entecavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02482272&#34;,\n        &#34;drugs&#34;: &#34;lamivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02482740&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02482740&#34;,\n        &#34;drugs&#34;: &#34;tamoxifen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02482818&#34;,\n        &#34;drugs&#34;: &#34;pregabalin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02482935&#34;,\n        &#34;drugs&#34;: &#34;abemaciclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483104&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483104&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483104&#34;,\n        &#34;drugs&#34;: &#34;veliparib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483234&#34;,\n        &#34;drugs&#34;: &#34;secukinumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483247&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483247&#34;,\n        &#34;drugs&#34;: &#34;nivolumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483247&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483247&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483247&#34;,\n        &#34;drugs&#34;: &#34;sunitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483598&#34;,\n        &#34;drugs&#34;: &#34;buspirone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483611&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483611&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483767&#34;,\n        &#34;drugs&#34;: &#34;goserelin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02483793&#34;,\n        &#34;drugs&#34;: &#34;tamsulosin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484027&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484053&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484261&#34;,\n        &#34;drugs&#34;: &#34;pravastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484677&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484677&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484755&#34;,\n        &#34;drugs&#34;: &#34;gefitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484833&#34;,\n        &#34;drugs&#34;: &#34;cetuximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484859&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484859&#34;,\n        &#34;drugs&#34;: &#34;(r,r) tramadol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484911&#34;,\n        &#34;drugs&#34;: &#34;aprepitant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484911&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02484911&#34;,\n        &#34;drugs&#34;: &#34;olanzapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02485080&#34;,\n        &#34;drugs&#34;: &#34;simeprevir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02485080&#34;,\n        &#34;drugs&#34;: &#34;sofosbuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02485106&#34;,\n        &#34;drugs&#34;: &#34;rifaximin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02485340&#34;,\n        &#34;drugs&#34;: &#34;sumatriptan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02485418&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02485548&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02485548&#34;,\n        &#34;drugs&#34;: &#34;raltitrexed&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02485652&#34;,\n        &#34;drugs&#34;: &#34;olmutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02485821&#34;,\n        &#34;drugs&#34;: &#34;17\\u03b2-estradiol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02485821&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02486211&#34;,\n        &#34;drugs&#34;: &#34;amantadine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02486276&#34;,\n        &#34;drugs&#34;: &#34;cilostazol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02486276&#34;,\n        &#34;drugs&#34;: &#34;sumatriptan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02486328&#34;,\n        &#34;drugs&#34;: &#34;pethidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02486328&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02486328&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02486367&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02487069&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02487069&#34;,\n        &#34;drugs&#34;: &#34;mycophenolate mofetil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02487225&#34;,\n        &#34;drugs&#34;: &#34;pentoxifylline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02487316&#34;,\n        &#34;drugs&#34;: &#34;crizotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02487355&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02487355&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02487355&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02487563&#34;,\n        &#34;drugs&#34;: &#34;decitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02487706&#34;,\n        &#34;drugs&#34;: &#34;dolutegravir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02487732&#34;,\n        &#34;drugs&#34;: &#34;prasugrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488473&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488473&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488486&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488486&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488538&#34;,\n        &#34;drugs&#34;: &#34;fluoxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488603&#34;,\n        &#34;drugs&#34;: &#34;tamoxifen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488694&#34;,\n        &#34;drugs&#34;: &#34;afatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488694&#34;,\n        &#34;drugs&#34;: &#34;pemetrexed&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488889&#34;,\n        &#34;drugs&#34;: &#34;ethanol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488889&#34;,\n        &#34;drugs&#34;: &#34;varenicline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488967&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488967&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02488967&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489227&#34;,\n        &#34;drugs&#34;: &#34;adalimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489266&#34;,\n        &#34;drugs&#34;: &#34;aldesleukin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489266&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489409&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489448&#34;,\n        &#34;drugs&#34;: &#34;durvalumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489500&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489500&#34;,\n        &#34;drugs&#34;: &#34;filgrastim&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489734&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489734&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489864&#34;,\n        &#34;drugs&#34;: &#34;terlipressin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489903&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489903&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489903&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489903&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489903&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489903&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489903&#34;,\n        &#34;drugs&#34;: &#34;pemetrexed&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489929&#34;,\n        &#34;drugs&#34;: &#34;azacitidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489955&#34;,\n        &#34;drugs&#34;: &#34;amikacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02489955&#34;,\n        &#34;drugs&#34;: &#34;tobramycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02490072&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02490176&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02490345&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02490436&#34;,\n        &#34;drugs&#34;: &#34;cetuximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02490670&#34;,\n        &#34;drugs&#34;: &#34;cephalexin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02491099&#34;,\n        &#34;drugs&#34;: &#34;afatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02491320&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02491736&#34;,\n        &#34;drugs&#34;: &#34;ketoprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02491879&#34;,\n        &#34;drugs&#34;: &#34;ketoprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02491944&#34;,\n        &#34;drugs&#34;: &#34;osimertinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02492217&#34;,\n        &#34;drugs&#34;: &#34;adalimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02492230&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02492282&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02492568&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02492711&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02492711&#34;,\n        &#34;drugs&#34;: &#34;eribulin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02492711&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02492867&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02492867&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02493049&#34;,\n        &#34;drugs&#34;: &#34;domperidone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02493361&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02493452&#34;,\n        &#34;drugs&#34;: &#34;plecanatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02493465&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02493530&#34;,\n        &#34;drugs&#34;: &#34;ruxolitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02493530&#34;,\n        &#34;drugs&#34;: &#34;umbralisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02493725&#34;,\n        &#34;drugs&#34;: &#34;eculizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02494336&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02494713&#34;,\n        &#34;drugs&#34;: &#34;degarelix&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02494713&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02494713&#34;,\n        &#34;drugs&#34;: &#34;estramustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02494713&#34;,\n        &#34;drugs&#34;: &#34;ketoconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02494804&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02494921&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02494921&#34;,\n        &#34;drugs&#34;: &#34;filgrastim&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02494921&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02494921&#34;,\n        &#34;drugs&#34;: &#34;ribociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495077&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495077&#34;,\n        &#34;drugs&#34;: &#34;diphenhydramine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495077&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495077&#34;,\n        &#34;drugs&#34;: &#34;mycophenolate mofetil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495077&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495077&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495389&#34;,\n        &#34;drugs&#34;: &#34;mirabegron&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495454&#34;,\n        &#34;drugs&#34;: &#34;obinutuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495467&#34;,\n        &#34;drugs&#34;: &#34;nitroglycerin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495896&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495896&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495922&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495922&#34;,\n        &#34;drugs&#34;: &#34;elotuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02495922&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02496078&#34;,\n        &#34;drugs&#34;: &#34;daclatasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02496182&#34;,\n        &#34;drugs&#34;: &#34;pirfenidone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02496299&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02496299&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02496585&#34;,\n        &#34;drugs&#34;: &#34;nintedanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02496585&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02496988&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02497131&#34;,\n        &#34;drugs&#34;: &#34;brentuximab vedotin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02497300&#34;,\n        &#34;drugs&#34;: &#34;spironolactone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02497326&#34;,\n        &#34;drugs&#34;: &#34;(r,r) tramadol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02497365&#34;,\n        &#34;drugs&#34;: &#34;besifloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02497508&#34;,\n        &#34;drugs&#34;: &#34;nivolumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02498444&#34;,\n        &#34;drugs&#34;: &#34;treprostinil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02498483&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02498509&#34;,\n        &#34;drugs&#34;: &#34;mometasone furoate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02498756&#34;,\n        &#34;drugs&#34;: &#34;ipilimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02498860&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02498977&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02499367&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02499367&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02499367&#34;,\n        &#34;drugs&#34;: &#34;nivolumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02499562&#34;,\n        &#34;drugs&#34;: &#34;entecavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02499627&#34;,\n        &#34;drugs&#34;: &#34;bendamustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02499627&#34;,\n        &#34;drugs&#34;: &#34;brentuximab vedotin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02499666&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02499822&#34;,\n        &#34;drugs&#34;: &#34;ramipril&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02499874&#34;,\n        &#34;drugs&#34;: &#34;efavirenz&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02500095&#34;,\n        &#34;drugs&#34;: &#34;pegvisomant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02500121&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02500251&#34;,\n        &#34;drugs&#34;: &#34;belimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02500251&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02500667&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02500732&#34;,\n        &#34;drugs&#34;: &#34;atomoxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02500940&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02500940&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02501109&#34;,\n        &#34;drugs&#34;: &#34;aripiprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02501954&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02501954&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02501954&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502006&#34;,\n        &#34;drugs&#34;: &#34;celecoxib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502006&#34;,\n        &#34;drugs&#34;: &#34;naproxen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502110&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502162&#34;,\n        &#34;drugs&#34;: &#34;low-dose naltrexone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502487&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502487&#34;,\n        &#34;drugs&#34;: &#34;tetracaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502500&#34;,\n        &#34;drugs&#34;: &#34;celecoxib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502708&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502708&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502708&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502877&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02502968&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02503306&#34;,\n        &#34;drugs&#34;: &#34;avanafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02503319&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02503462&#34;,\n        &#34;drugs&#34;: &#34;cobicistat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02503462&#34;,\n        &#34;drugs&#34;: &#34;darunavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02503462&#34;,\n        &#34;drugs&#34;: &#34;ritonavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02503501&#34;,\n        &#34;drugs&#34;: &#34;insulin glulisine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02503826&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02503826&#34;,\n        &#34;drugs&#34;: &#34;sufentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02504099&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02504333&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02504996&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02505009&#34;,\n        &#34;drugs&#34;: &#34;entecavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02505009&#34;,\n        &#34;drugs&#34;: &#34;tenofovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02505399&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02505750&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02505893&#34;,\n        &#34;drugs&#34;: &#34;sirolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02505971&#34;,\n        &#34;drugs&#34;: &#34;nadolol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02505997&#34;,\n        &#34;drugs&#34;: &#34;delafloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506023&#34;,\n        &#34;drugs&#34;: &#34;desmopressin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506348&#34;,\n        &#34;drugs&#34;: &#34;diclofenac&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506348&#34;,\n        &#34;drugs&#34;: &#34;nepafenac&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506517&#34;,\n        &#34;drugs&#34;: &#34;afatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506556&#34;,\n        &#34;drugs&#34;: &#34;alpelisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506660&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506751&#34;,\n        &#34;drugs&#34;: &#34;liothyronine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506777&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506777&#34;,\n        &#34;drugs&#34;: &#34;melatonin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506790&#34;,\n        &#34;drugs&#34;: &#34;melatonin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506842&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506842&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506842&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506855&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506894&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506985&#34;,\n        &#34;drugs&#34;: &#34;rivaroxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02506985&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02507128&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02507219&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02507440&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02507440&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02507479&#34;,\n        &#34;drugs&#34;: &#34;thiotepa&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02507570&#34;,\n        &#34;drugs&#34;: &#34;enzalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02507700&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02507700&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02507843&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferolvitamin d3&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02508259&#34;,\n        &#34;drugs&#34;: &#34;suramin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02508350&#34;,\n        &#34;drugs&#34;: &#34;(2r)-daptomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02508402&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02508623&#34;,\n        &#34;drugs&#34;: &#34;rifaximin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02508636&#34;,\n        &#34;drugs&#34;: &#34;enzalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02508636&#34;,\n        &#34;drugs&#34;: &#34;leuprolide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02509052&#34;,\n        &#34;drugs&#34;: &#34;leflunomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02509351&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02509949&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02510157&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02510287&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02510586&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02510612&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02510781&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02510781&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02510781&#34;,\n        &#34;drugs&#34;: &#34;epirubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02510781&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02511405&#34;,\n        &#34;drugs&#34;: &#34;bevacizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02511431&#34;,\n        &#34;drugs&#34;: &#34;ritonavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02511613&#34;,\n        &#34;drugs&#34;: &#34;ranibizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02511847&#34;,\n        &#34;drugs&#34;: &#34;afatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02512172&#34;,\n        &#34;drugs&#34;: &#34;romidepsin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02512471&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02512523&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02512692&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02512692&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02512809&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02512809&#34;,\n        &#34;drugs&#34;: &#34;isoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02512926&#34;,\n        &#34;drugs&#34;: &#34;carfilzomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02512926&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02512926&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513004&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513147&#34;,\n        &#34;drugs&#34;: &#34;dolutegravir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513303&#34;,\n        &#34;drugs&#34;: &#34;sirolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513342&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513342&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513355&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513355&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513394&#34;,\n        &#34;drugs&#34;: &#34;palbociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513446&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513550&#34;,\n        &#34;drugs&#34;: &#34;ixekizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513771&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513849&#34;,\n        &#34;drugs&#34;: &#34;tamoxifen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513901&#34;,\n        &#34;drugs&#34;: &#34;chidamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02513927&#34;,\n        &#34;drugs&#34;: &#34;nifedipine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02514044&#34;,\n        &#34;drugs&#34;: &#34;dextroamphetamine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02514083&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02514343&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02514343&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02514421&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02514642&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02514980&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02515227&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02515526&#34;,\n        &#34;drugs&#34;: &#34;caffeine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02515604&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02515734&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02515734&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02515734&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02515864&#34;,\n        &#34;drugs&#34;: &#34;moxifloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02515890&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02515955&#34;,\n        &#34;drugs&#34;: &#34;minocycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02515968&#34;,\n        &#34;drugs&#34;: &#34;desflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02515968&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02516098&#34;,\n        &#34;drugs&#34;: &#34;butylscopolamine bromide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02516332&#34;,\n        &#34;drugs&#34;: &#34;escitalopram&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02516423&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02516423&#34;,\n        &#34;drugs&#34;: &#34;ixazomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02516423&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02516423&#34;,\n        &#34;drugs&#34;: &#34;zoledronic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02516826&#34;,\n        &#34;drugs&#34;: &#34;olmesartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02516826&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02517021&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02518789&#34;,\n        &#34;drugs&#34;: &#34;etomidate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02518802&#34;,\n        &#34;drugs&#34;: &#34;gefitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02518802&#34;,\n        &#34;drugs&#34;: &#34;pemetrexed&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02518945&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02518945&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02519400&#34;,\n        &#34;drugs&#34;: &#34;amitriptyline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02519582&#34;,\n        &#34;drugs&#34;: &#34;niclosamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02519608&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02520115&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02520518&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02520934&#34;,\n        &#34;drugs&#34;: &#34;miglustat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02521051&#34;,\n        &#34;drugs&#34;: &#34;alectinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02521051&#34;,\n        &#34;drugs&#34;: &#34;bevacizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02521207&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02521714&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02522013&#34;,\n        &#34;drugs&#34;: &#34;theophyllineaminophylline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02522130&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02522130&#34;,\n        &#34;drugs&#34;: &#34;naproxen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02522169&#34;,\n        &#34;drugs&#34;: &#34;infliximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02522325&#34;,\n        &#34;drugs&#34;: &#34;cocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02522858&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02522858&#34;,\n        &#34;drugs&#34;: &#34;ephedrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02522897&#34;,\n        &#34;drugs&#34;: &#34;ranibizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523014&#34;,\n        &#34;drugs&#34;: &#34;vismodegib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523040&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523820&#34;,\n        &#34;drugs&#34;: &#34;fluticasone propionate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523859&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523976&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523976&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523976&#34;,\n        &#34;drugs&#34;: &#34;dasatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523976&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523976&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523976&#34;,\n        &#34;drugs&#34;: &#34;mercaptopurine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523976&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523976&#34;,\n        &#34;drugs&#34;: &#34;mitoxantrone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523976&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02523976&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02524184&#34;,\n        &#34;drugs&#34;: &#34;sildenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02524249&#34;,\n        &#34;drugs&#34;: &#34;caffeine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02524444&#34;,\n        &#34;drugs&#34;: &#34;mefloquinemefloquine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02524769&#34;,\n        &#34;drugs&#34;: &#34;conjugated estrogens&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02525172&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02525172&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02525484&#34;,\n        &#34;drugs&#34;: &#34;pirfenidone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02525822&#34;,\n        &#34;drugs&#34;: &#34;olmesartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02525848&#34;,\n        &#34;drugs&#34;: &#34;aprepitant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02525848&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02525848&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02526004&#34;,\n        &#34;drugs&#34;: &#34;ceftazidime&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02526004&#34;,\n        &#34;drugs&#34;: &#34;tobramycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02526199&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02526199&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02526199&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02526784&#34;,\n        &#34;drugs&#34;: &#34;degarelix&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02526810&#34;,\n        &#34;drugs&#34;: &#34;insulin glargine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02526810&#34;,\n        &#34;drugs&#34;: &#34;insulin lispro&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02527005&#34;,\n        &#34;drugs&#34;: &#34;azithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02527083&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02527083&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02527083&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02527707&#34;,\n        &#34;drugs&#34;: &#34;ritonavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02527733&#34;,\n        &#34;drugs&#34;: &#34;ranibizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02527785&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02527824&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02527837&#34;,\n        &#34;drugs&#34;: &#34;sodium nitrite&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02527941&#34;,\n        &#34;drugs&#34;: &#34;metronidazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02528019&#34;,\n        &#34;drugs&#34;: &#34;glimepiride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02528136&#34;,\n        &#34;drugs&#34;: &#34;carbetocin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02528357&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02528513&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02528513&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02528877&#34;,\n        &#34;drugs&#34;: &#34;fludarabine phosphate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02528877&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02528877&#34;,\n        &#34;drugs&#34;: &#34;sirolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02528877&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02529579&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02529839&#34;,\n        &#34;drugs&#34;: &#34;alemtuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02529839&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02530320&#34;,\n        &#34;drugs&#34;: &#34;palbociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02530411&#34;,\n        &#34;drugs&#34;: &#34;fulvestrant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02530424&#34;,\n        &#34;drugs&#34;: &#34;fulvestrant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02530424&#34;,\n        &#34;drugs&#34;: &#34;palbociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02530424&#34;,\n        &#34;drugs&#34;: &#34;pertuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02530424&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02530632&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02530632&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02530697&#34;,\n        &#34;drugs&#34;: &#34;miltefosine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02530697&#34;,\n        &#34;drugs&#34;: &#34;pentoxifylline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531152&#34;,\n        &#34;drugs&#34;: &#34;latanoprost&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531165&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531308&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531308&#34;,\n        &#34;drugs&#34;: &#34;pegfilgrastim&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531308&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531308&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531308&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531412&#34;,\n        &#34;drugs&#34;: &#34;spironolactone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531451&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531451&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531477&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531568&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531724&#34;,\n        &#34;drugs&#34;: &#34;levosimendan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531737&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531737&#34;,\n        &#34;drugs&#34;: &#34;nintedanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531906&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531932&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531932&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02531984&#34;,\n        &#34;drugs&#34;: &#34;azithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532192&#34;,\n        &#34;drugs&#34;: &#34;belinostat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532192&#34;,\n        &#34;drugs&#34;: &#34;ciprofloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532192&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532192&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532192&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532192&#34;,\n        &#34;drugs&#34;: &#34;fluconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532192&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532270&#34;,\n        &#34;drugs&#34;: &#34;phenylephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532335&#34;,\n        &#34;drugs&#34;: &#34;obeticholic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532413&#34;,\n        &#34;drugs&#34;: &#34;entecavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532777&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532777&#34;,\n        &#34;drugs&#34;: &#34;leflunomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532777&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532777&#34;,\n        &#34;drugs&#34;: &#34;mycophenolate mofetil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532777&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02532790&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02533232&#34;,\n        &#34;drugs&#34;: &#34;minocycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02533375&#34;,\n        &#34;drugs&#34;: &#34;adalimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02533570&#34;,\n        &#34;drugs&#34;: &#34;brentuximab vedotin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02533765&#34;,\n        &#34;drugs&#34;: &#34;olaparib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02534402&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02534467&#34;,\n        &#34;drugs&#34;: &#34;montelukast&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02534623&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02534623&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02534623&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02534636&#34;,\n        &#34;drugs&#34;: &#34;famotidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02534740&#34;,\n        &#34;drugs&#34;: &#34;tafamidis&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02534883&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02534961&#34;,\n        &#34;drugs&#34;: &#34;cefazolin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535039&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535078&#34;,\n        &#34;drugs&#34;: &#34;durvalumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535078&#34;,\n        &#34;drugs&#34;: &#34;tremelimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535273&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535273&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535286&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535286&#34;,\n        &#34;drugs&#34;: &#34;umbralisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535416&#34;,\n        &#34;drugs&#34;: &#34;cetirizine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535416&#34;,\n        &#34;drugs&#34;: &#34;diphenhydramine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535611&#34;,\n        &#34;drugs&#34;: &#34;memantine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535650&#34;,\n        &#34;drugs&#34;: &#34;tipifarnib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535689&#34;,\n        &#34;drugs&#34;: &#34;tofacitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535806&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535806&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535806&#34;,\n        &#34;drugs&#34;: &#34;mitoxantrone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535806&#34;,\n        &#34;drugs&#34;: &#34;pegaspargase&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535806&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535832&#34;,\n        &#34;drugs&#34;: &#34;pioglitazone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02535988&#34;,\n        &#34;drugs&#34;: &#34;thymalfasin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02536014&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02536495&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02536690&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02536690&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02536911&#34;,\n        &#34;drugs&#34;: &#34;eliglustat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02536937&#34;,\n        &#34;drugs&#34;: &#34;eliglustat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02536976&#34;,\n        &#34;drugs&#34;: &#34;mirabegron&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537054&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537223&#34;,\n        &#34;drugs&#34;: &#34;alpelisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537223&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537249&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537288&#34;,\n        &#34;drugs&#34;: &#34;moxifloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537314&#34;,\n        &#34;drugs&#34;: &#34;benzocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537353&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537444&#34;,\n        &#34;drugs&#34;: &#34;acalabrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537561&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537561&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537561&#34;,\n        &#34;drugs&#34;: &#34;talazoparib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537613&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537613&#34;,\n        &#34;drugs&#34;: &#34;obinutuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02537860&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02538627&#34;,\n        &#34;drugs&#34;: &#34;trametinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02538718&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02538744&#34;,\n        &#34;drugs&#34;: &#34;cocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02538744&#34;,\n        &#34;drugs&#34;: &#34;doxazosin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02538744&#34;,\n        &#34;drugs&#34;: &#34;modafinil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02539199&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02539199&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02539537&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02539537&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02539537&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02539979&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02540668&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02540707&#34;,\n        &#34;drugs&#34;: &#34;mirabegron&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02540720&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02540837&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02541396&#34;,\n        &#34;drugs&#34;: &#34;oxycodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02541708&#34;,\n        &#34;drugs&#34;: &#34;ferric carboxymaltose&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542046&#34;,\n        &#34;drugs&#34;: &#34;diatrizoic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542046&#34;,\n        &#34;drugs&#34;: &#34;iohexol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542111&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542111&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542111&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542150&#34;,\n        &#34;drugs&#34;: &#34;ethanol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542254&#34;,\n        &#34;drugs&#34;: &#34;salbutamol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542514&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542592&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542657&#34;,\n        &#34;drugs&#34;: &#34;clarithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542657&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542657&#34;,\n        &#34;drugs&#34;: &#34;pomalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542969&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02542969&#34;,\n        &#34;drugs&#34;: &#34;simvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02543346&#34;,\n        &#34;drugs&#34;: &#34;cetirizine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02543658&#34;,\n        &#34;drugs&#34;: &#34;neostigmine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02543879&#34;,\n        &#34;drugs&#34;: &#34;azacitidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02543918&#34;,\n        &#34;drugs&#34;: &#34;ixekizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02544113&#34;,\n        &#34;drugs&#34;: &#34;anti-thymocyte globulin (rabbit)&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02544243&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02544243&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02544321&#34;,\n        &#34;drugs&#34;: &#34;bromocriptine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02544854&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02544893&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02544893&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02544906&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02544932&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02544984&#34;,\n        &#34;drugs&#34;: &#34;azithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02544997&#34;,\n        &#34;drugs&#34;: &#34;poziotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02545010&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02545114&#34;,\n        &#34;drugs&#34;: &#34;tolvaptan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02545738&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02545842&#34;,\n        &#34;drugs&#34;: &#34;insulin glargine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02545907&#34;,\n        &#34;drugs&#34;: &#34;carfilzomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02545907&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02545907&#34;,\n        &#34;drugs&#34;: &#34;thalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02546193&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02546401&#34;,\n        &#34;drugs&#34;: &#34;insulin aspart&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02546648&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02546843&#34;,\n        &#34;drugs&#34;: &#34;rocuronium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02547038&#34;,\n        &#34;drugs&#34;: &#34;olmesartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02547402&#34;,\n        &#34;drugs&#34;: &#34;pravastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02547558&#34;,\n        &#34;drugs&#34;: &#34;indacaterol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02547766&#34;,\n        &#34;drugs&#34;: &#34;anakinra&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02548195&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02548351&#34;,\n        &#34;drugs&#34;: &#34;obeticholic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02548364&#34;,\n        &#34;drugs&#34;: &#34;calcifediol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02548611&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02548611&#34;,\n        &#34;drugs&#34;: &#34;prasugrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02548715&#34;,\n        &#34;drugs&#34;: &#34;levothyroxine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02549118&#34;,\n        &#34;drugs&#34;: &#34;pethidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02549118&#34;,\n        &#34;drugs&#34;: &#34;tenoxicam&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02549677&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02549677&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02549677&#34;,\n        &#34;drugs&#34;: &#34;epirubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02549768&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02549898&#34;,\n        &#34;drugs&#34;: &#34;cilostazol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02549963&#34;,\n        &#34;drugs&#34;: &#34;rivaroxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02550002&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02550080&#34;,\n        &#34;drugs&#34;: &#34;dapsone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02550106&#34;,\n        &#34;drugs&#34;: &#34;omalizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02550249&#34;,\n        &#34;drugs&#34;: &#34;nivolumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02550262&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02550470&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02550795&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02550912&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferolvitamin d3&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02551367&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02551432&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02551861&#34;,\n        &#34;drugs&#34;: &#34;daclatasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02551861&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02551861&#34;,\n        &#34;drugs&#34;: &#34;sofosbuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02551991&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02552342&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02552459&#34;,\n        &#34;drugs&#34;: &#34;sufentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02552537&#34;,\n        &#34;drugs&#34;: &#34;omeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02552641&#34;,\n        &#34;drugs&#34;: &#34;amoxicillin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02552641&#34;,\n        &#34;drugs&#34;: &#34;esomeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02553473&#34;,\n        &#34;drugs&#34;: &#34;doxycycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02553551&#34;,\n        &#34;drugs&#34;: &#34;vitamin c&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02553629&#34;,\n        &#34;drugs&#34;: &#34;rocuronium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02554045&#34;,\n        &#34;drugs&#34;: &#34;tadalafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02554175&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02554253&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02554734&#34;,\n        &#34;drugs&#34;: &#34;levodopa&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02554734&#34;,\n        &#34;drugs&#34;: &#34;levodopa&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02555150&#34;,\n        &#34;drugs&#34;: &#34;lisdexamfetamine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02556060&#34;,\n        &#34;drugs&#34;: &#34;lamotrigine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02556086&#34;,\n        &#34;drugs&#34;: &#34;daclatasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02556086&#34;,\n        &#34;drugs&#34;: &#34;sofosbuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02556593&#34;,\n        &#34;drugs&#34;: &#34;erlotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02556814&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02557035&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02557087&#34;,\n        &#34;drugs&#34;: &#34;l-scopolamine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02557087&#34;,\n        &#34;drugs&#34;: &#34;pethidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02557321&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02557581&#34;,\n        &#34;drugs&#34;: &#34;terbutaline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02557867&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02557945&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02558569&#34;,\n        &#34;drugs&#34;: &#34;levobupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02559180&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02559206&#34;,\n        &#34;drugs&#34;: &#34;linaclotide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02559310&#34;,\n        &#34;drugs&#34;: &#34;linezolid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02559310&#34;,\n        &#34;drugs&#34;: &#34;moxifloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02559388&#34;,\n        &#34;drugs&#34;: &#34;montelukast&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02559492&#34;,\n        &#34;drugs&#34;: &#34;epacadostat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02559778&#34;,\n        &#34;drugs&#34;: &#34;crizotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02559778&#34;,\n        &#34;drugs&#34;: &#34;dasatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02559778&#34;,\n        &#34;drugs&#34;: &#34;lapatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560025&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560025&#34;,\n        &#34;drugs&#34;: &#34;idarubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560038&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560038&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560038&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560051&#34;,\n        &#34;drugs&#34;: &#34;degarelix&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560051&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560051&#34;,\n        &#34;drugs&#34;: &#34;estramustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560051&#34;,\n        &#34;drugs&#34;: &#34;ketoconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560207&#34;,\n        &#34;drugs&#34;: &#34;cefotaxime&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560558&#34;,\n        &#34;drugs&#34;: &#34;belatacept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560649&#34;,\n        &#34;drugs&#34;: &#34;entecavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560649&#34;,\n        &#34;drugs&#34;: &#34;lamivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560649&#34;,\n        &#34;drugs&#34;: &#34;tenofovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560688&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560805&#34;,\n        &#34;drugs&#34;: &#34;atenolol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560805&#34;,\n        &#34;drugs&#34;: &#34;losartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02560805&#34;,\n        &#34;drugs&#34;: &#34;phenylephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02561169&#34;,\n        &#34;drugs&#34;: &#34;oseltamivir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02561273&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02561273&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02561273&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02561273&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02561442&#34;,\n        &#34;drugs&#34;: &#34;ceftriaxone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02561806&#34;,\n        &#34;drugs&#34;: &#34;ixekizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02561806&#34;,\n        &#34;drugs&#34;: &#34;ustekinumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02561845&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562053&#34;,\n        &#34;drugs&#34;: &#34;fluoxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562287&#34;,\n        &#34;drugs&#34;: &#34;clozapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562287&#34;,\n        &#34;drugs&#34;: &#34;olanzapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562287&#34;,\n        &#34;drugs&#34;: &#34;quetiapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562287&#34;,\n        &#34;drugs&#34;: &#34;risperidone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562365&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562521&#34;,\n        &#34;drugs&#34;: &#34;varenicline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562716&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562716&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562898&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562898&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562898&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02562924&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02563405&#34;,\n        &#34;drugs&#34;: &#34;doxazosin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02563405&#34;,\n        &#34;drugs&#34;: &#34;nifedipine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02563561&#34;,\n        &#34;drugs&#34;: &#34;apaziquone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02563795&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02563860&#34;,\n        &#34;drugs&#34;: &#34;lovastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02563925&#34;,\n        &#34;drugs&#34;: &#34;durvalumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02563925&#34;,\n        &#34;drugs&#34;: &#34;tremelimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02564978&#34;,\n        &#34;drugs&#34;: &#34;minocycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02565888&#34;,\n        &#34;drugs&#34;: &#34;atazanavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02565888&#34;,\n        &#34;drugs&#34;: &#34;cobicistat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02565888&#34;,\n        &#34;drugs&#34;: &#34;daclatasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02565888&#34;,\n        &#34;drugs&#34;: &#34;ritonavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02565992&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02566187&#34;,\n        &#34;drugs&#34;: &#34;fimasartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02566707&#34;,\n        &#34;drugs&#34;: &#34;atazanavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02566707&#34;,\n        &#34;drugs&#34;: &#34;dolutegravir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02566707&#34;,\n        &#34;drugs&#34;: &#34;lamivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02566863&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02566902&#34;,\n        &#34;drugs&#34;: &#34;salbutamol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02567383&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02567487&#34;,\n        &#34;drugs&#34;: &#34;levobupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02567773&#34;,\n        &#34;drugs&#34;: &#34;itraconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02567799&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02567799&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02567916&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02568007&#34;,\n        &#34;drugs&#34;: &#34;cyproheptadine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02568124&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02568176&#34;,\n        &#34;drugs&#34;: &#34;bupropion&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02568176&#34;,\n        &#34;drugs&#34;: &#34;esketamine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02568397&#34;,\n        &#34;drugs&#34;: &#34;dabigatran etexilate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02568449&#34;,\n        &#34;drugs&#34;: &#34;nintedanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02569242&#34;,\n        &#34;drugs&#34;: &#34;nivolumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02569307&#34;,\n        &#34;drugs&#34;: &#34;minocycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02569489&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02569489&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02569554&#34;,\n        &#34;drugs&#34;: &#34;rabeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02569645&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02569658&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02569723&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02569814&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02570373&#34;,\n        &#34;drugs&#34;: &#34;guselkumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02570490&#34;,\n        &#34;drugs&#34;: &#34;linezolid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02570503&#34;,\n        &#34;drugs&#34;: &#34;clonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02570503&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02570503&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02570971&#34;,\n        &#34;drugs&#34;: &#34;mannitol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02571166&#34;,\n        &#34;drugs&#34;: &#34;valacyclovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02571283&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02571426&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02571426&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02571816&#34;,\n        &#34;drugs&#34;: &#34;gilteritinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02572752&#34;,\n        &#34;drugs&#34;: &#34;nintedanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02572791&#34;,\n        &#34;drugs&#34;: &#34;mupirocin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02572986&#34;,\n        &#34;drugs&#34;: &#34;permethrin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02573051&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02573220&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02573558&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02573558&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02573597&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02573597&#34;,\n        &#34;drugs&#34;: &#34;sufentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02573831&#34;,\n        &#34;drugs&#34;: &#34;oxycodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02573870&#34;,\n        &#34;drugs&#34;: &#34;salbutamol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02573935&#34;,\n        &#34;drugs&#34;: &#34;clarithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574130&#34;,\n        &#34;drugs&#34;: &#34;amikacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574403&#34;,\n        &#34;drugs&#34;: &#34;eculizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574611&#34;,\n        &#34;drugs&#34;: &#34;neostigmine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574663&#34;,\n        &#34;drugs&#34;: &#34;umbralisib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574728&#34;,\n        &#34;drugs&#34;: &#34;celecoxib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574728&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574728&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574728&#34;,\n        &#34;drugs&#34;: &#34;sirolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574845&#34;,\n        &#34;drugs&#34;: &#34;furosemide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574845&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574975&#34;,\n        &#34;drugs&#34;: &#34;adenosine monophosphate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02574975&#34;,\n        &#34;drugs&#34;: &#34;methacholine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02576041&#34;,\n        &#34;drugs&#34;: &#34;bilastine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02576080&#34;,\n        &#34;drugs&#34;: &#34;imatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02576249&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02576249&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02576275&#34;,\n        &#34;drugs&#34;: &#34;bendamustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02576275&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02576327&#34;,\n        &#34;drugs&#34;: &#34;aprepitant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02576327&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02576444&#34;,\n        &#34;drugs&#34;: &#34;olaparib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02576444&#34;,\n        &#34;drugs&#34;: &#34;azd-5363&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02576444&#34;,\n        &#34;drugs&#34;: &#34;ceralasertib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02577003&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02577029&#34;,\n        &#34;drugs&#34;: &#34;entecavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02577029&#34;,\n        &#34;drugs&#34;: &#34;tenofovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02577068&#34;,\n        &#34;drugs&#34;: &#34;propacetamol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02577159&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02577315&#34;,\n        &#34;drugs&#34;: &#34;empagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02577367&#34;,\n        &#34;drugs&#34;: &#34;levothyroxine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02577458&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02577809&#34;,\n        &#34;drugs&#34;: &#34;indomethacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02578121&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02578121&#34;,\n        &#34;drugs&#34;: &#34;ixazomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02578121&#34;,\n        &#34;drugs&#34;: &#34;pomalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02578251&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02578251&#34;,\n        &#34;drugs&#34;: &#34;pethidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02578472&#34;,\n        &#34;drugs&#34;: &#34;zolpidem&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02578537&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02578550&#34;,\n        &#34;drugs&#34;: &#34;cobicistat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02578550&#34;,\n        &#34;drugs&#34;: &#34;darunavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02578706&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02578706&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02579421&#34;,\n        &#34;drugs&#34;: &#34;progesterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02580149&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02580227&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02580695&#34;,\n        &#34;drugs&#34;: &#34;hyaluronan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02581124&#34;,\n        &#34;drugs&#34;: &#34;lapatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02581202&#34;,\n        &#34;drugs&#34;: &#34;lamivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02581566&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02581683&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02581683&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02582632&#34;,\n        &#34;drugs&#34;: &#34;dasabuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02583217&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02583217&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02583542&#34;,\n        &#34;drugs&#34;: &#34;selumetinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02583594&#34;,\n        &#34;drugs&#34;: &#34;aciclovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02583594&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02583594&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02584283&#34;,\n        &#34;drugs&#34;: &#34;glutathione&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02584439&#34;,\n        &#34;drugs&#34;: &#34;ivabradine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02584452&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02584478&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02584478&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02584582&#34;,\n        &#34;drugs&#34;: &#34;exenatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02584582&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02584738&#34;,\n        &#34;drugs&#34;: &#34;ipratropium bromide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02585141&#34;,\n        &#34;drugs&#34;: &#34;clindamycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02585479&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02585570&#34;,\n        &#34;drugs&#34;: &#34;phenylephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02585804&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02585947&#34;,\n        &#34;drugs&#34;: &#34;tenofovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02586038&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02586038&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02586038&#34;,\n        &#34;drugs&#34;: &#34;thalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02586155&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02586207&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02586402&#34;,\n        &#34;drugs&#34;: &#34;epoetin alfa&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02586441&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02586454&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02586727&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02586961&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02587000&#34;,\n        &#34;drugs&#34;: &#34;ulipristal acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02588027&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02588417&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02588417&#34;,\n        &#34;drugs&#34;: &#34;levobupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02588716&#34;,\n        &#34;drugs&#34;: &#34;terlipressin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02588781&#34;,\n        &#34;drugs&#34;: &#34;pemetrexed&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02589652&#34;,\n        &#34;drugs&#34;: &#34;entecavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02589977&#34;,\n        &#34;drugs&#34;: &#34;regadenoson&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02590003&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02590510&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02590705&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02591004&#34;,\n        &#34;drugs&#34;: &#34;nifedipine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02591199&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02591225&#34;,\n        &#34;drugs&#34;: &#34;phenprocoumon&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02591953&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02592083&#34;,\n        &#34;drugs&#34;: &#34;palbociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02592408&#34;,\n        &#34;drugs&#34;: &#34;l-aspartic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02592421&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02592863&#34;,\n        &#34;drugs&#34;: &#34;pentoxifylline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02593110&#34;,\n        &#34;drugs&#34;: &#34;telmisartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02593123&#34;,\n        &#34;drugs&#34;: &#34;mycophenolate mofetil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02593721&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02593942&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02593942&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02594098&#34;,\n        &#34;drugs&#34;: &#34;secukinumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02594163&#34;,\n        &#34;drugs&#34;: &#34;bendamustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02594163&#34;,\n        &#34;drugs&#34;: &#34;brentuximab vedotin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02594163&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02594384&#34;,\n        &#34;drugs&#34;: &#34;atezolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02594384&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02594423&#34;,\n        &#34;drugs&#34;: &#34;bevacizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02594579&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferolvitamin d3&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02594735&#34;,\n        &#34;drugs&#34;: &#34;abatacept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02594800&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595138&#34;,\n        &#34;drugs&#34;: &#34;zoledronic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595242&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595242&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595242&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595268&#34;,\n        &#34;drugs&#34;: &#34;pitavastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595320&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595463&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595541&#34;,\n        &#34;drugs&#34;: &#34;milrinone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595541&#34;,\n        &#34;drugs&#34;: &#34;sildenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595554&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595554&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595684&#34;,\n        &#34;drugs&#34;: &#34;tadalafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595723&#34;,\n        &#34;drugs&#34;: &#34;megestrol acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02595723&#34;,\n        &#34;drugs&#34;: &#34;phenytoin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02596100&#34;,\n        &#34;drugs&#34;: &#34;betrixaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02596503&#34;,\n        &#34;drugs&#34;: &#34;eribulin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02596503&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02596880&#34;,\n        &#34;drugs&#34;: &#34;daclatasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02596880&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02596880&#34;,\n        &#34;drugs&#34;: &#34;sofosbuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02597049&#34;,\n        &#34;drugs&#34;: &#34;dulaglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02597101&#34;,\n        &#34;drugs&#34;: &#34;saxagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02597140&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02597140&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02597309&#34;,\n        &#34;drugs&#34;: &#34;canagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02597543&#34;,\n        &#34;drugs&#34;: &#34;regadenoson&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02597829&#34;,\n        &#34;drugs&#34;: &#34;certolizumab pegol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02597855&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02598362&#34;,\n        &#34;drugs&#34;: &#34;ciprofloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02598466&#34;,\n        &#34;drugs&#34;: &#34;abatacept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02598505&#34;,\n        &#34;drugs&#34;: &#34;indacaterol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02598635&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferolvitamin d3&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02598687&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02598687&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02599077&#34;,\n        &#34;drugs&#34;: &#34;dienogest&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02599129&#34;,\n        &#34;drugs&#34;: &#34;secukinumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02599311&#34;,\n        &#34;drugs&#34;: &#34;tolterodine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02599324&#34;,\n        &#34;drugs&#34;: &#34;cetuximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02599324&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02599324&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02599324&#34;,\n        &#34;drugs&#34;: &#34;ibrutinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02599324&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02599701&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02600247&#34;,\n        &#34;drugs&#34;: &#34;celecoxib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02600247&#34;,\n        &#34;drugs&#34;: &#34;duloxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02601027&#34;,\n        &#34;drugs&#34;: &#34;oxycodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02601508&#34;,\n        &#34;drugs&#34;: &#34;rocuronium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02601651&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02601677&#34;,\n        &#34;drugs&#34;: &#34;fluoxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02601898&#34;,\n        &#34;drugs&#34;: &#34;progesterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02601911&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02601937&#34;,\n        &#34;drugs&#34;: &#34;tazemetostat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02601950&#34;,\n        &#34;drugs&#34;: &#34;tazemetostat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02601989&#34;,\n        &#34;drugs&#34;: &#34;tadalafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02602483&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02602509&#34;,\n        &#34;drugs&#34;: &#34;celecoxib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02602509&#34;,\n        &#34;drugs&#34;: &#34;pyrazinamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02602509&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02602938&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02603003&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02603003&#34;,\n        &#34;drugs&#34;: &#34;pemetrexed&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02603510&#34;,\n        &#34;drugs&#34;: &#34;insulin lispro&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02603679&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02603770&#34;,\n        &#34;drugs&#34;: &#34;lovastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02603822&#34;,\n        &#34;drugs&#34;: &#34;indomethacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02603861&#34;,\n        &#34;drugs&#34;: &#34;modafinil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02603900&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02603900&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02604225&#34;,\n        &#34;drugs&#34;: &#34;methoxyflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02604446&#34;,\n        &#34;drugs&#34;: &#34;oxycodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02604446&#34;,\n        &#34;drugs&#34;: &#34;tapentadol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02604459&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02604459&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02605070&#34;,\n        &#34;drugs&#34;: &#34;urofollitropin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02605213&#34;,\n        &#34;drugs&#34;: &#34;vancomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02605226&#34;,\n        &#34;drugs&#34;: &#34;bicalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02605265&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02605265&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02605265&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02605694&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02605694&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02605772&#34;,\n        &#34;drugs&#34;: &#34;acarbose&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02605772&#34;,\n        &#34;drugs&#34;: &#34;saxagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02605811&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02606409&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02606409&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02606617&#34;,\n        &#34;drugs&#34;: &#34;mosapride&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02607202&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02607202&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02607254&#34;,\n        &#34;drugs&#34;: &#34;pregabalin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02607332&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02607436&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02607436&#34;,\n        &#34;drugs&#34;: &#34;sarpogrelate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02607579&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02607618&#34;,\n        &#34;drugs&#34;: &#34;vancomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02607631&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02607943&#34;,\n        &#34;drugs&#34;: &#34;insulin glargine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02608177&#34;,\n        &#34;drugs&#34;: &#34;glipizide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02608177&#34;,\n        &#34;drugs&#34;: &#34;linagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02608216&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02608216&#34;,\n        &#34;drugs&#34;: &#34;ribociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02608385&#34;,\n        &#34;drugs&#34;: &#34;pembrolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02608437&#34;,\n        &#34;drugs&#34;: &#34;ipilimumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02608606&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02608905&#34;,\n        &#34;drugs&#34;: &#34;dapagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02608931&#34;,\n        &#34;drugs&#34;: &#34;tetrahydrocannabinol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02608996&#34;,\n        &#34;drugs&#34;: &#34;nesiritide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02609087&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02609087&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02609386&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02609386&#34;,\n        &#34;drugs&#34;: &#34;indomethacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02609386&#34;,\n        &#34;drugs&#34;: &#34;omeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02609802&#34;,\n        &#34;drugs&#34;: &#34;desflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02609802&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02609945&#34;,\n        &#34;drugs&#34;: &#34;olmesartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02609945&#34;,\n        &#34;drugs&#34;: &#34;zolmitriptan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02610010&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02610868&#34;,\n        &#34;drugs&#34;: &#34;botulinum toxin type b&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02610933&#34;,\n        &#34;drugs&#34;: &#34;rivaroxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02611700&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02611700&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02612272&#34;,\n        &#34;drugs&#34;: &#34;betamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02612480&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02612844&#34;,\n        &#34;drugs&#34;: &#34;insulin aspart&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02612922&#34;,\n        &#34;drugs&#34;: &#34;nitazoxanide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02613013&#34;,\n        &#34;drugs&#34;: &#34;pilocarpine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02613013&#34;,\n        &#34;drugs&#34;: &#34;proparacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02613416&#34;,\n        &#34;drugs&#34;: &#34;denosumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02614118&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02614404&#34;,\n        &#34;drugs&#34;: &#34;imatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02614482&#34;,\n        &#34;drugs&#34;: &#34;fesoterodine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02614560&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02614833&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02615119&#34;,\n        &#34;drugs&#34;: &#34;isoprenaline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02615223&#34;,\n        &#34;drugs&#34;: &#34;bicalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02615639&#34;,\n        &#34;drugs&#34;: &#34;entecavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02615639&#34;,\n        &#34;drugs&#34;: &#34;telbivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02616354&#34;,\n        &#34;drugs&#34;: &#34;imipen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02616497&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02616497&#34;,\n        &#34;drugs&#34;: &#34;triflusal&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02616731&#34;,\n        &#34;drugs&#34;: &#34;diosmin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02616731&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02616848&#34;,\n        &#34;drugs&#34;: &#34;eribulin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02616848&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02617121&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02617121&#34;,\n        &#34;drugs&#34;: &#34;ramosetron&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02617485&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02617485&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02617485&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02617485&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02617550&#34;,\n        &#34;drugs&#34;: &#34;nitroglycerin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02617654&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02617810&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02618096&#34;,\n        &#34;drugs&#34;: &#34;dinoprostone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02618382&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02618668&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02618876&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02619019&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02619019&#34;,\n        &#34;drugs&#34;: &#34;pethidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02619201&#34;,\n        &#34;drugs&#34;: &#34;metoclopramide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02619266&#34;,\n        &#34;drugs&#34;: &#34;megestrol acetate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02619630&#34;,\n        &#34;drugs&#34;: &#34;nelarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02619799&#34;,\n        &#34;drugs&#34;: &#34;olmesartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02620007&#34;,\n        &#34;drugs&#34;: &#34;ciprofloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02620007&#34;,\n        &#34;drugs&#34;: &#34;rifaximin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02620215&#34;,\n        &#34;drugs&#34;: &#34;dinoprostone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02620501&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02620683&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02620748&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02620813&#34;,\n        &#34;drugs&#34;: &#34;isotretinoin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02620813&#34;,\n        &#34;drugs&#34;: &#34;tretinoinalitretinoin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02620865&#34;,\n        &#34;drugs&#34;: &#34;fluorouracil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02620865&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02621255&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02621255&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02621359&#34;,\n        &#34;drugs&#34;: &#34;doxycycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02621359&#34;,\n        &#34;drugs&#34;: &#34;levofloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02621359&#34;,\n        &#34;drugs&#34;: &#34;nitazoxanide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02621359&#34;,\n        &#34;drugs&#34;: &#34;omeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02621957&#34;,\n        &#34;drugs&#34;: &#34;pravastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02622243&#34;,\n        &#34;drugs&#34;: &#34;tiotropium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02623205&#34;,\n        &#34;drugs&#34;: &#34;escitalopram&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02623231&#34;,\n        &#34;drugs&#34;: &#34;escitalopram&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02623582&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02623751&#34;,\n        &#34;drugs&#34;: &#34;exemestane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02624128&#34;,\n        &#34;drugs&#34;: &#34;cetuximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02624128&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02624453&#34;,\n        &#34;drugs&#34;: &#34;fluconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02625103&#34;,\n        &#34;drugs&#34;: &#34;clozapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02625441&#34;,\n        &#34;drugs&#34;: &#34;pertuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02625441&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02625506&#34;,\n        &#34;drugs&#34;: &#34;levobupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02625558&#34;,\n        &#34;drugs&#34;: &#34;riociguat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02625948&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02626169&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02626182&#34;,\n        &#34;drugs&#34;: &#34;sildenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02626845&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02627053&#34;,\n        &#34;drugs&#34;: &#34;rivaroxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02627248&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02627248&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02627248&#34;,\n        &#34;drugs&#34;: &#34;epirubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02627625&#34;,\n        &#34;drugs&#34;: &#34;tiotropium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02627846&#34;,\n        &#34;drugs&#34;: &#34;sodium bicarbonate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02627846&#34;,\n        &#34;drugs&#34;: &#34;sodium tetradecyl sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02627950&#34;,\n        &#34;drugs&#34;: &#34;metoclopramide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02628392&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02628626&#34;,\n        &#34;drugs&#34;: &#34;clonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02628704&#34;,\n        &#34;drugs&#34;: &#34;carfilzomib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02628704&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02629120&#34;,\n        &#34;drugs&#34;: &#34;busulfan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02629120&#34;,\n        &#34;drugs&#34;: &#34;alemtuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02629120&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02629354&#34;,\n        &#34;drugs&#34;: &#34;caffeine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02629354&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02630043&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02630043&#34;,\n        &#34;drugs&#34;: &#34;tolcapone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02630290&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02630368&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02630394&#34;,\n        &#34;drugs&#34;: &#34;azithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02630485&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02631031&#34;,\n        &#34;drugs&#34;: &#34;valsartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02631109&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02631109&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02631109&#34;,\n        &#34;drugs&#34;: &#34;pegaspargase&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02631239&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02631239&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02631239&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02631239&#34;,\n        &#34;drugs&#34;: &#34;pegaspargase&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02631408&#34;,\n        &#34;drugs&#34;: &#34;vancomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02631499&#34;,\n        &#34;drugs&#34;: &#34;epirubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02631603&#34;,\n        &#34;drugs&#34;: &#34;prednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02632019&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02632474&#34;,\n        &#34;drugs&#34;: &#34;tenofovir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02632708&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02632708&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02632708&#34;,\n        &#34;drugs&#34;: &#34;idarubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02632708&#34;,\n        &#34;drugs&#34;: &#34;mitoxantrone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02633137&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02633176&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02633176&#34;,\n        &#34;drugs&#34;: &#34;cetuximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02633176&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02633176&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02633202&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02633774&#34;,\n        &#34;drugs&#34;: &#34;apixaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02633774&#34;,\n        &#34;drugs&#34;: &#34;propafenone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02633930&#34;,\n        &#34;drugs&#34;: &#34;amoxicillin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02633930&#34;,\n        &#34;drugs&#34;: &#34;clarithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02633930&#34;,\n        &#34;drugs&#34;: &#34;lansoprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02634255&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02634320&#34;,\n        &#34;drugs&#34;: &#34;aripiprazole lauroxil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02635035&#34;,\n        &#34;drugs&#34;: &#34;lisdexamfetamine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02635724&#34;,\n        &#34;drugs&#34;: &#34;peramivir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02635802&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02635802&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02635971&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02635971&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02636361&#34;,\n        &#34;drugs&#34;: &#34;insulin lispro&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02636842&#34;,\n        &#34;drugs&#34;: &#34;aripiprazole lauroxil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02637531&#34;,\n        &#34;drugs&#34;: &#34;nivolumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02637648&#34;,\n        &#34;drugs&#34;: &#34;sodium oxybate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02637973&#34;,\n        &#34;drugs&#34;: &#34;empagliflozin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638389&#34;,\n        &#34;drugs&#34;: &#34;sirolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638415&#34;,\n        &#34;drugs&#34;: &#34;carvedilol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;axitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;crizotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;dasatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;erlotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;ifosfamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;imatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;pazopanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;ruxolitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638428&#34;,\n        &#34;drugs&#34;: &#34;vemurafenib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638584&#34;,\n        &#34;drugs&#34;: &#34;rabeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638597&#34;,\n        &#34;drugs&#34;: &#34;gemfibrozil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638805&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638857&#34;,\n        &#34;drugs&#34;: &#34;epirubicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02638909&#34;,\n        &#34;drugs&#34;: &#34;ceritinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02639143&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02639637&#34;,\n        &#34;drugs&#34;: &#34;enalaprilat&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02639637&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02640118&#34;,\n        &#34;drugs&#34;: &#34;lixisenatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02640157&#34;,\n        &#34;drugs&#34;: &#34;daclatasvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02640157&#34;,\n        &#34;drugs&#34;: &#34;sofosbuvir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02640443&#34;,\n        &#34;drugs&#34;: &#34;sulfamethoxazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02640846&#34;,\n        &#34;drugs&#34;: &#34;levosimendan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02640846&#34;,\n        &#34;drugs&#34;: &#34;milrinone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02641847&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02641847&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02641847&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02641847&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02641873&#34;,\n        &#34;drugs&#34;: &#34;bevacizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02641873&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02641899&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02641899&#34;,\n        &#34;drugs&#34;: &#34;digoxin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02641899&#34;,\n        &#34;drugs&#34;: &#34;lisinopril&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02641899&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02642250&#34;,\n        &#34;drugs&#34;: &#34;metronidazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02642419&#34;,\n        &#34;drugs&#34;: &#34;rivaroxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02642939&#34;,\n        &#34;drugs&#34;: &#34;mifepristone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02643355&#34;,\n        &#34;drugs&#34;: &#34;clonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02643355&#34;,\n        &#34;drugs&#34;: &#34;olanzapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02643407&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02643407&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02643784&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02643914&#34;,\n        &#34;drugs&#34;: &#34;(\\u2212)-nicotine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02643979&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02644304&#34;,\n        &#34;drugs&#34;: &#34;cabergoline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02644421&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02644863&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02644863&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02644980&#34;,\n        &#34;drugs&#34;: &#34;etomidate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02644980&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02645565&#34;,\n        &#34;drugs&#34;: &#34;azathioprine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02645565&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02645565&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02646020&#34;,\n        &#34;drugs&#34;: &#34;aprepitant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02646124&#34;,\n        &#34;drugs&#34;: &#34;diazepam&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02646124&#34;,\n        &#34;drugs&#34;: &#34;naproxen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02646332&#34;,\n        &#34;drugs&#34;: &#34;olmesartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02646449&#34;,\n        &#34;drugs&#34;: &#34;mirtazapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02646670&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02646670&#34;,\n        &#34;drugs&#34;: &#34;ranibizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02646683&#34;,\n        &#34;drugs&#34;: &#34;vedolizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02647086&#34;,\n        &#34;drugs&#34;: &#34;caffeine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02647086&#34;,\n        &#34;drugs&#34;: &#34;omeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02647086&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02647424&#34;,\n        &#34;drugs&#34;: &#34;clomiphene&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02647424&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02648347&#34;,\n        &#34;drugs&#34;: &#34;darbepoetin alfa&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02648711&#34;,\n        &#34;drugs&#34;: &#34;bevacizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02649101&#34;,\n        &#34;drugs&#34;: &#34;thalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02650271&#34;,\n        &#34;drugs&#34;: &#34;entecavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02650271&#34;,\n        &#34;drugs&#34;: &#34;lamivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02650544&#34;,\n        &#34;drugs&#34;: &#34;mirtazapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02651272&#34;,\n        &#34;drugs&#34;: &#34;macitentan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02651350&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02652598&#34;,\n        &#34;drugs&#34;: &#34;tolcapone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02652650&#34;,\n        &#34;drugs&#34;: &#34;ethinylestradiol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02652793&#34;,\n        &#34;drugs&#34;: &#34;lamivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02652806&#34;,\n        &#34;drugs&#34;: &#34;epoetin alfa&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02653196&#34;,\n        &#34;drugs&#34;: &#34;alemtuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02653196&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02653196&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02653196&#34;,\n        &#34;drugs&#34;: &#34;mycophenolate mofetil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02653196&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02653196&#34;,\n        &#34;drugs&#34;: &#34;thiotepa&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02654977&#34;,\n        &#34;drugs&#34;: &#34;metreleptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655146&#34;,\n        &#34;drugs&#34;: &#34;17\\u03b2-estradiol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655146&#34;,\n        &#34;drugs&#34;: &#34;progesterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655354&#34;,\n        &#34;drugs&#34;: &#34;diphenhydramine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655354&#34;,\n        &#34;drugs&#34;: &#34;duloxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655354&#34;,\n        &#34;drugs&#34;: &#34;fluoxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655354&#34;,\n        &#34;drugs&#34;: &#34;fluvoxamine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655354&#34;,\n        &#34;drugs&#34;: &#34;mirtazapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655354&#34;,\n        &#34;drugs&#34;: &#34;paroxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655354&#34;,\n        &#34;drugs&#34;: &#34;prazosin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655354&#34;,\n        &#34;drugs&#34;: &#34;trazodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655354&#34;,\n        &#34;drugs&#34;: &#34;venlafaxine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655523&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655523&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655523&#34;,\n        &#34;drugs&#34;: &#34;triamcinolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02655757&#34;,\n        &#34;drugs&#34;: &#34;sitagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02656589&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02656589&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02656810&#34;,\n        &#34;drugs&#34;: &#34;teriparatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02658760&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02658760&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02659488&#34;,\n        &#34;drugs&#34;: &#34;lisdexamfetamine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02660047&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02660281&#34;,\n        &#34;drugs&#34;: &#34;busulfan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02660281&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02660281&#34;,\n        &#34;drugs&#34;: &#34;thiotepa&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02660346&#34;,\n        &#34;drugs&#34;: &#34;ceftaroline fosamil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02660346&#34;,\n        &#34;drugs&#34;: &#34;(2r)-daptomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02660346&#34;,\n        &#34;drugs&#34;: &#34;vancomycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02662959&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02663141&#34;,\n        &#34;drugs&#34;: &#34;losartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02663570&#34;,\n        &#34;drugs&#34;: &#34;melatonin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02665637&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02665936&#34;,\n        &#34;drugs&#34;: &#34;levobupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02666014&#34;,\n        &#34;drugs&#34;: &#34;neostigmine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02666846&#34;,\n        &#34;drugs&#34;: &#34;diclofenac&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02666846&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02667730&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02667730&#34;,\n        &#34;drugs&#34;: &#34;celecoxib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02667730&#34;,\n        &#34;drugs&#34;: &#34;naproxen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02668146&#34;,\n        &#34;drugs&#34;: &#34;perampanel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02668172&#34;,\n        &#34;drugs&#34;: &#34;pegvisomant&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02669368&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02669706&#34;,\n        &#34;drugs&#34;: &#34;pentamidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02669953&#34;,\n        &#34;drugs&#34;: &#34;aflibercept&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02670109&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02670109&#34;,\n        &#34;drugs&#34;: &#34;carmustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02670109&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02670954&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02673463&#34;,\n        &#34;drugs&#34;: &#34;spironolactone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02673840&#34;,\n        &#34;drugs&#34;: &#34;ketotifen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02675153&#34;,\n        &#34;drugs&#34;: &#34;sirolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02677623&#34;,\n        &#34;drugs&#34;: &#34;mannitol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02678182&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02678182&#34;,\n        &#34;drugs&#34;: &#34;durvalumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02678182&#34;,\n        &#34;drugs&#34;: &#34;rucaparib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02678182&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02678208&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02678585&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02678585&#34;,\n        &#34;drugs&#34;: &#34;nalbuphine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02678598&#34;,\n        &#34;drugs&#34;: &#34;micafungin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02678780&#34;,\n        &#34;drugs&#34;: &#34;lenvatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02679456&#34;,\n        &#34;drugs&#34;: &#34;fluconazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02682134&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02682134&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02682719&#34;,\n        &#34;drugs&#34;: &#34;valsartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02682953&#34;,\n        &#34;drugs&#34;: &#34;filgrastim&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02683161&#34;,\n        &#34;drugs&#34;: &#34;varenicline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02684708&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02686684&#34;,\n        &#34;drugs&#34;: &#34;dimethyl fumarate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02686827&#34;,\n        &#34;drugs&#34;: &#34;paricalcitol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02687958&#34;,\n        &#34;drugs&#34;: &#34;everolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02688127&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02688738&#34;,\n        &#34;drugs&#34;: &#34;doxycycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02689180&#34;,\n        &#34;drugs&#34;: &#34;furosemide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02690389&#34;,\n        &#34;drugs&#34;: &#34;flumazenil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02690987&#34;,\n        &#34;drugs&#34;: &#34;exenatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02693821&#34;,\n        &#34;drugs&#34;: &#34;gabapentin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02695654&#34;,\n        &#34;drugs&#34;: &#34;clonidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02695654&#34;,\n        &#34;drugs&#34;: &#34;levobupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02695732&#34;,\n        &#34;drugs&#34;: &#34;carvedilol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02695797&#34;,\n        &#34;drugs&#34;: &#34;prednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02696330&#34;,\n        &#34;drugs&#34;: &#34;clopidogrel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02696330&#34;,\n        &#34;drugs&#34;: &#34;enoxaparin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02696915&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02697331&#34;,\n        &#34;drugs&#34;: &#34;progesterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02698306&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02698995&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02698995&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02698995&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02698995&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02699125&#34;,\n        &#34;drugs&#34;: &#34;guanfacine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02699138&#34;,\n        &#34;drugs&#34;: &#34;trazodone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02704507&#34;,\n        &#34;drugs&#34;: &#34;tretinoinalitretinoin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02704507&#34;,\n        &#34;drugs&#34;: &#34;triamcinolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02705612&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02707224&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02707250&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02707250&#34;,\n        &#34;drugs&#34;: &#34;pethidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02707328&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02708849&#34;,\n        &#34;drugs&#34;: &#34;lamotrigine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02709863&#34;,\n        &#34;drugs&#34;: &#34;desflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02709863&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02709863&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02710071&#34;,\n        &#34;drugs&#34;: &#34;nebivolol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02711280&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02711280&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02711891&#34;,\n        &#34;drugs&#34;: &#34;loperamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02711917&#34;,\n        &#34;drugs&#34;: &#34;etomidate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02711917&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02711917&#34;,\n        &#34;drugs&#34;: &#34;rocuronium&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02712346&#34;,\n        &#34;drugs&#34;: &#34;ambrisentan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02712658&#34;,\n        &#34;drugs&#34;: &#34;terbutaline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02713087&#34;,\n        &#34;drugs&#34;: &#34;ephedrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02713087&#34;,\n        &#34;drugs&#34;: &#34;phenylephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02715154&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02715947&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02717884&#34;,\n        &#34;drugs&#34;: &#34;cytarabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02717884&#34;,\n        &#34;drugs&#34;: &#34;tranylcypromine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02725008&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02725424&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02725424&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02725424&#34;,\n        &#34;drugs&#34;: &#34;trastuzumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02726308&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02726646&#34;,\n        &#34;drugs&#34;: &#34;doxycycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02726919&#34;,\n        &#34;drugs&#34;: &#34;clobazam&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02727101&#34;,\n        &#34;drugs&#34;: &#34;perampanel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02733393&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02733445&#34;,\n        &#34;drugs&#34;: &#34;dasatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02733445&#34;,\n        &#34;drugs&#34;: &#34;nilotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02733952&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02734732&#34;,\n        &#34;drugs&#34;: &#34;ciprofloxacin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02735694&#34;,\n        &#34;drugs&#34;: &#34;cycloserine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02738177&#34;,\n        &#34;drugs&#34;: &#34;misoprostol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02741219&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02741219&#34;,\n        &#34;drugs&#34;: &#34;sufentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02742233&#34;,\n        &#34;drugs&#34;: &#34;saxagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02743247&#34;,\n        &#34;drugs&#34;: &#34;mycophenolate mofetil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02743247&#34;,\n        &#34;drugs&#34;: &#34;tacrolimus&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02747511&#34;,\n        &#34;drugs&#34;: &#34;haloperidol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02748070&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02748785&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02749162&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02749162&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02749162&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02750332&#34;,\n        &#34;drugs&#34;: &#34;nitisinone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02750709&#34;,\n        &#34;drugs&#34;: &#34;nitisinone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02752204&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02752334&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02752503&#34;,\n        &#34;drugs&#34;: &#34;nalmefene&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02752971&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02753062&#34;,\n        &#34;drugs&#34;: &#34;bendamustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02753543&#34;,\n        &#34;drugs&#34;: &#34;chidamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02754583&#34;,\n        &#34;drugs&#34;: &#34;azithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02754583&#34;,\n        &#34;drugs&#34;: &#34;tetracycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02758132&#34;,\n        &#34;drugs&#34;: &#34;abiraterone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02758132&#34;,\n        &#34;drugs&#34;: &#34;enzalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02758132&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02759393&#34;,\n        &#34;drugs&#34;: &#34;dexlansoprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02759393&#34;,\n        &#34;drugs&#34;: &#34;lansoprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02760667&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02760667&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02761395&#34;,\n        &#34;drugs&#34;: &#34;deferasirox&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02764515&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02765373&#34;,\n        &#34;drugs&#34;: &#34;anastrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02765373&#34;,\n        &#34;drugs&#34;: &#34;exemestane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02765373&#34;,\n        &#34;drugs&#34;: &#34;letrozole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02767375&#34;,\n        &#34;drugs&#34;: &#34;oxaliplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02767401&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02767713&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02770508&#34;,\n        &#34;drugs&#34;: &#34;lamivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02771418&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02771418&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02771743&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02771743&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02771743&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02771743&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02771743&#34;,\n        &#34;drugs&#34;: &#34;ifosfamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02771743&#34;,\n        &#34;drugs&#34;: &#34;isotretinoin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02772107&#34;,\n        &#34;drugs&#34;: &#34;temozolomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02774993&#34;,\n        &#34;drugs&#34;: &#34;doxycycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02777736&#34;,\n        &#34;drugs&#34;: &#34;methotrexate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02777801&#34;,\n        &#34;drugs&#34;: &#34;entecavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02778789&#34;,\n        &#34;drugs&#34;: &#34;tocilizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02780011&#34;,\n        &#34;drugs&#34;: &#34;brentuximab vedotin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02780882&#34;,\n        &#34;drugs&#34;: &#34;pasireotide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02781519&#34;,\n        &#34;drugs&#34;: &#34;tetrahydrocannabinol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02783040&#34;,\n        &#34;drugs&#34;: &#34;digoxin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02783040&#34;,\n        &#34;drugs&#34;: &#34;omeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02783040&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02784613&#34;,\n        &#34;drugs&#34;: &#34;ospemifene&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02786446&#34;,\n        &#34;drugs&#34;: &#34;olmesartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02786446&#34;,\n        &#34;drugs&#34;: &#34;naproxen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02787239&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02788591&#34;,\n        &#34;drugs&#34;: &#34;sucralfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02792803&#34;,\n        &#34;drugs&#34;: &#34;latanoprost&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02793947&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02793947&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02793986&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02793986&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02794402&#34;,\n        &#34;drugs&#34;: &#34;exenatide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02795351&#34;,\n        &#34;drugs&#34;: &#34;sildenafil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02796469&#34;,\n        &#34;drugs&#34;: &#34;pentoxifylline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02797028&#34;,\n        &#34;drugs&#34;: &#34;allopurinol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02797717&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02797717&#34;,\n        &#34;drugs&#34;: &#34;dacarbazine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02797717&#34;,\n        &#34;drugs&#34;: &#34;etoposide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02797717&#34;,\n        &#34;drugs&#34;: &#34;prednisone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02797717&#34;,\n        &#34;drugs&#34;: &#34;vincristine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02797769&#34;,\n        &#34;drugs&#34;: &#34;tocilizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02800902&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02802111&#34;,\n        &#34;drugs&#34;: &#34;salbutamol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02802137&#34;,\n        &#34;drugs&#34;: &#34;tafluprost&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02802592&#34;,\n        &#34;drugs&#34;: &#34;epoetin alfa&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02802683&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02802683&#34;,\n        &#34;drugs&#34;: &#34;levobupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02802683&#34;,\n        &#34;drugs&#34;: &#34;phenylephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02803788&#34;,\n        &#34;drugs&#34;: &#34;ramosetron&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02804776&#34;,\n        &#34;drugs&#34;: &#34;gefitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02806648&#34;,\n        &#34;drugs&#34;: &#34;palbociclib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02806882&#34;,\n        &#34;drugs&#34;: &#34;ceftaroline fosamil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02807116&#34;,\n        &#34;drugs&#34;: &#34;rifampicin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02809677&#34;,\n        &#34;drugs&#34;: &#34;aripiprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02809677&#34;,\n        &#34;drugs&#34;: &#34;buspirone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02809677&#34;,\n        &#34;drugs&#34;: &#34;escitalopram&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02809677&#34;,\n        &#34;drugs&#34;: &#34;mirtazapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02809677&#34;,\n        &#34;drugs&#34;: &#34;quetiapine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02809677&#34;,\n        &#34;drugs&#34;: &#34;sertraline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02809729&#34;,\n        &#34;drugs&#34;: &#34;cefazolin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02810899&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02812654&#34;,\n        &#34;drugs&#34;: &#34;ifosfamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02813382&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02813382&#34;,\n        &#34;drugs&#34;: &#34;prilocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02814461&#34;,\n        &#34;drugs&#34;: &#34;axitinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02814968&#34;,\n        &#34;drugs&#34;: &#34;enzalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02815033&#34;,\n        &#34;drugs&#34;: &#34;enzalutamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02818387&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02818387&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02818751&#34;,\n        &#34;drugs&#34;: &#34;escitalopram&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02819453&#34;,\n        &#34;drugs&#34;: &#34;methylprednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02820025&#34;,\n        &#34;drugs&#34;: &#34;doxapram&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02826070&#34;,\n        &#34;drugs&#34;: &#34;adefovir dipivoxil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02826070&#34;,\n        &#34;drugs&#34;: &#34;telbivudine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02830347&#34;,\n        &#34;drugs&#34;: &#34;amoxicillin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02832973&#34;,\n        &#34;drugs&#34;: &#34;bisoprolol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02832973&#34;,\n        &#34;drugs&#34;: &#34;furosemideolmesartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02832973&#34;,\n        &#34;drugs&#34;: &#34;ramipril&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02832973&#34;,\n        &#34;drugs&#34;: &#34;spironolactone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02834286&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02834286&#34;,\n        &#34;drugs&#34;: &#34;eltrombopag&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02834286&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02839408&#34;,\n        &#34;drugs&#34;: &#34;azithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02842424&#34;,\n        &#34;drugs&#34;: &#34;ramipril&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02845388&#34;,\n        &#34;drugs&#34;: &#34;estradiol valerate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02850276&#34;,\n        &#34;drugs&#34;: &#34;pyridostigmine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02851394&#34;,\n        &#34;drugs&#34;: &#34;levobupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02851394&#34;,\n        &#34;drugs&#34;: &#34;levobupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02851394&#34;,\n        &#34;drugs&#34;: &#34;(r,r) tramadol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02851745&#34;,\n        &#34;drugs&#34;: &#34;linagliptin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02853526&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02854072&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02854072&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02860221&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02860936&#34;,\n        &#34;drugs&#34;: &#34;lenvatinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02861378&#34;,\n        &#34;drugs&#34;: &#34;phentolamine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02864095&#34;,\n        &#34;drugs&#34;: &#34;epinephrine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02866370&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02866370&#34;,\n        &#34;drugs&#34;: &#34;nintedanib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02866370&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02866370&#34;,\n        &#34;drugs&#34;: &#34;topotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02868060&#34;,\n        &#34;drugs&#34;: &#34;romiplostim&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02868892&#34;,\n        &#34;drugs&#34;: &#34;pemetrexed&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02872038&#34;,\n        &#34;drugs&#34;: &#34;cefepime&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02874937&#34;,\n        &#34;drugs&#34;: &#34;atomoxetine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02881866&#34;,\n        &#34;drugs&#34;: &#34;furosemide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02882347&#34;,\n        &#34;drugs&#34;: &#34;somatostatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02884921&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02888496&#34;,\n        &#34;drugs&#34;: &#34;tocilizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02890823&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferolvitamin d3&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02893709&#34;,\n        &#34;drugs&#34;: &#34;omeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02895061&#34;,\n        &#34;drugs&#34;: &#34;alfacalcidol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02902913&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02903901&#34;,\n        &#34;drugs&#34;: &#34;melatonin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02906566&#34;,\n        &#34;drugs&#34;: &#34;retinol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02907437&#34;,\n        &#34;drugs&#34;: &#34;minocycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02909933&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02912182&#34;,\n        &#34;drugs&#34;: &#34;betamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02912182&#34;,\n        &#34;drugs&#34;: &#34;prednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02914366&#34;,\n        &#34;drugs&#34;: &#34;ambroxol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02917122&#34;,\n        &#34;drugs&#34;: &#34;sertraline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02917889&#34;,\n        &#34;drugs&#34;: &#34;caffeine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02920905&#34;,\n        &#34;drugs&#34;: &#34;atracurium besylate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02920905&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02926222&#34;,\n        &#34;drugs&#34;: &#34;lomustine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02928315&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02928419&#34;,\n        &#34;drugs&#34;: &#34;lenalidomide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02928692&#34;,\n        &#34;drugs&#34;: &#34;minocycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02930005&#34;,\n        &#34;drugs&#34;: &#34;meclofenamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02933372&#34;,\n        &#34;drugs&#34;: &#34;varenicline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02933658&#34;,\n        &#34;drugs&#34;: &#34;rosuvastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02933658&#34;,\n        &#34;drugs&#34;: &#34;telmisartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02934529&#34;,\n        &#34;drugs&#34;: &#34;bevacizumab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02934529&#34;,\n        &#34;drugs&#34;: &#34;capecitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02934529&#34;,\n        &#34;drugs&#34;: &#34;cetuximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02934529&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02935855&#34;,\n        &#34;drugs&#34;: &#34;apixaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02935855&#34;,\n        &#34;drugs&#34;: &#34;edoxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02935855&#34;,\n        &#34;drugs&#34;: &#34;rivaroxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02935855&#34;,\n        &#34;drugs&#34;: &#34;warfarin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02936895&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferolvitamin d3&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02937896&#34;,\n        &#34;drugs&#34;: &#34;desmopressin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02939079&#34;,\n        &#34;drugs&#34;: &#34;fingolimod&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02943993&#34;,\n        &#34;drugs&#34;: &#34;edoxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02944019&#34;,\n        &#34;drugs&#34;: &#34;edoxaban&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02944799&#34;,\n        &#34;drugs&#34;: &#34;alendronic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02945527&#34;,\n        &#34;drugs&#34;: &#34;acetazolamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02945527&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02946437&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02946437&#34;,\n        &#34;drugs&#34;: &#34;sevoflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02947529&#34;,\n        &#34;drugs&#34;: &#34;tranexamic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02948075&#34;,\n        &#34;drugs&#34;: &#34;carboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02948075&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02949349&#34;,\n        &#34;drugs&#34;: &#34;azathioprine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02949349&#34;,\n        &#34;drugs&#34;: &#34;mycophenolate mofetil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02949349&#34;,\n        &#34;drugs&#34;: &#34;prednisolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02954484&#34;,\n        &#34;drugs&#34;: &#34;acetaminophen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02954484&#34;,\n        &#34;drugs&#34;: &#34;pregabalin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02954484&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02957266&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02957266&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02959749&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02959749&#34;,\n        &#34;drugs&#34;: &#34;osimertinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02961829&#34;,\n        &#34;drugs&#34;: &#34;auranofin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02961829&#34;,\n        &#34;drugs&#34;: &#34;dolutegravir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02961829&#34;,\n        &#34;drugs&#34;: &#34;maraviroc&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02961998&#34;,\n        &#34;drugs&#34;: &#34;celecoxib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02967211&#34;,\n        &#34;drugs&#34;: &#34;insulin detemir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02967211&#34;,\n        &#34;drugs&#34;: &#34;nph insulin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02967224&#34;,\n        &#34;drugs&#34;: &#34;insulin detemir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02967224&#34;,\n        &#34;drugs&#34;: &#34;nph insulin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02967302&#34;,\n        &#34;drugs&#34;: &#34;triamcinolone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02969928&#34;,\n        &#34;drugs&#34;: &#34;amoxicillin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02969928&#34;,\n        &#34;drugs&#34;: &#34;clarithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02969928&#34;,\n        &#34;drugs&#34;: &#34;metronidazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02977832&#34;,\n        &#34;drugs&#34;: &#34;alfuzosin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02980562&#34;,\n        &#34;drugs&#34;: &#34;bisacodyl&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02980991&#34;,\n        &#34;drugs&#34;: &#34;cisplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02980991&#34;,\n        &#34;drugs&#34;: &#34;pemetrexed&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02987218&#34;,\n        &#34;drugs&#34;: &#34;desflurane&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02987218&#34;,\n        &#34;drugs&#34;: &#34;propofol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02988882&#34;,\n        &#34;drugs&#34;: &#34;dexamethasone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02990364&#34;,\n        &#34;drugs&#34;: &#34;lidocaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02992548&#34;,\n        &#34;drugs&#34;: &#34;pravastatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02993198&#34;,\n        &#34;drugs&#34;: &#34;carvedilol&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02993562&#34;,\n        &#34;drugs&#34;: &#34;levothyroxine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT02996916&#34;,\n        &#34;drugs&#34;: &#34;olmesartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03002038&#34;,\n        &#34;drugs&#34;: &#34;azathioprine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03002038&#34;,\n        &#34;drugs&#34;: &#34;rituximab&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03004222&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03005808&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03006952&#34;,\n        &#34;drugs&#34;: &#34;losartan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03006952&#34;,\n        &#34;drugs&#34;: &#34;pentoxifylline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03008850&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03010683&#34;,\n        &#34;drugs&#34;: &#34;liraglutide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03016806&#34;,\n        &#34;drugs&#34;: &#34;busulfan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03016806&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03016806&#34;,\n        &#34;drugs&#34;: &#34;melphalan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03017222&#34;,\n        &#34;drugs&#34;: &#34;ramosetron&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03017404&#34;,\n        &#34;drugs&#34;: &#34;cyclophosphamide&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03017404&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03019991&#34;,\n        &#34;drugs&#34;: &#34;ritonavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03020095&#34;,\n        &#34;drugs&#34;: &#34;ribavirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03020095&#34;,\n        &#34;drugs&#34;: &#34;ritonavir&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03033368&#34;,\n        &#34;drugs&#34;: &#34;rilpivirine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03037892&#34;,\n        &#34;drugs&#34;: &#34;remifentanil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03054610&#34;,\n        &#34;drugs&#34;: &#34;ropivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03054857&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03055247&#34;,\n        &#34;drugs&#34;: &#34;ibuprofen&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03067896&#34;,\n        &#34;drugs&#34;: &#34;bupivacaine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03067896&#34;,\n        &#34;drugs&#34;: &#34;dexmedetomidine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03067896&#34;,\n        &#34;drugs&#34;: &#34;magnesium sulfate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03071042&#34;,\n        &#34;drugs&#34;: &#34;docetaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03083613&#34;,\n        &#34;drugs&#34;: &#34;paclitaxel&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03083613&#34;,\n        &#34;drugs&#34;: &#34;raltitrexed&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03092544&#34;,\n        &#34;drugs&#34;: &#34;dimethyl fumarate&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03106935&#34;,\n        &#34;drugs&#34;: &#34;levothyroxine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03115177&#34;,\n        &#34;drugs&#34;: &#34;cefazolin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03115177&#34;,\n        &#34;drugs&#34;: &#34;doxycycline&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03142620&#34;,\n        &#34;drugs&#34;: &#34;clarithromycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03142620&#34;,\n        &#34;drugs&#34;: &#34;esomeprazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03142620&#34;,\n        &#34;drugs&#34;: &#34;cholecalciferolvitamin d3&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03151161&#34;,\n        &#34;drugs&#34;: &#34;icotinib&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03151161&#34;,\n        &#34;drugs&#34;: &#34;icotinibpemetrexedcarboplatin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03174288&#34;,\n        &#34;drugs&#34;: &#34;spironolactone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03182413&#34;,\n        &#34;drugs&#34;: &#34;modafinil&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03195023&#34;,\n        &#34;drugs&#34;: &#34;lisinopril&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03327831&#34;,\n        &#34;drugs&#34;: &#34;aminolevulinic acid&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03343418&#34;,\n        &#34;drugs&#34;: &#34;desmopressin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03400592&#34;,\n        &#34;drugs&#34;: &#34;irinotecan&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03404752&#34;,\n        &#34;drugs&#34;: &#34;pegfilgrastim&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03487406&#34;,\n        &#34;drugs&#34;: &#34;aspirin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03561935&#34;,\n        &#34;drugs&#34;: &#34;propafenone&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03610100&#34;,\n        &#34;drugs&#34;: &#34;gemcitabine&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03692299&#34;,\n        &#34;drugs&#34;: &#34;metronidazole&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03705962&#34;,\n        &#34;drugs&#34;: &#34;tobramycin&#34;\n    },\n    {\n        &#34;nct_id&#34;: &#34;NCT03800810&#34;,\n        &#34;drugs&#34;: &#34;hyaluronan&#34;\n    }\n]&#39;</pre>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[27]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">output_dict_nct</span> <span class="o">=</span> <span class="nb">dict</span><span class="p">(</span><span class="nb">zip</span><span class="p">(</span><span class="n">df_output</span><span class="o">.</span><span class="n">nct_id</span><span class="p">,</span> <span class="n">df_output</span><span class="o">.</span><span class="n">drugs</span><span class="p">))</span>
<span class="k">with</span> <span class="nb">open</span><span class="p">(</span><span class="s2">&quot;task1.json&quot;</span><span class="p">,</span> <span class="s2">&quot;w&quot;</span><span class="p">)</span> <span class="k">as</span> <span class="n">outfile</span><span class="p">:</span> 
    <span class="n">json</span><span class="o">.</span><span class="n">dump</span><span class="p">(</span><span class="n">output_dict_nct</span><span class="p">,</span> <span class="n">outfile</span><span class="p">)</span>
<span class="n">output_dict_nct</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[27]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>{&#39;NCT01112878&#39;: &#39;gabapentin&#39;,
 &#39;NCT01132482&#39;: &#39;sildenafil&#39;,
 &#39;NCT01171482&#39;: &#39;mitomycin&#39;,
 &#39;NCT01232647&#39;: &#39;(e)-phytonadione&#39;,
 &#39;NCT01255046&#39;: &#39;donepezilolmesartan&#39;,
 &#39;NCT01360034&#39;: &#39;nifedipine&#39;,
 &#39;NCT01408849&#39;: &#39;omeprazole&#39;,
 &#39;NCT01485393&#39;: &#39;zolpidem&#39;,
 &#39;NCT01528865&#39;: &#39;lamivudine&#39;,
 &#39;NCT01530984&#39;: &#39;ipilimumab&#39;,
 &#39;NCT01561222&#39;: &#39;calcitriol&#39;,
 &#39;NCT01589497&#39;: &#39;rifampicin&#39;,
 &#39;NCT01613677&#39;: &#39;buparlisib&#39;,
 &#39;NCT01614197&#39;: &#39;temsirolimus&#39;,
 &#39;NCT01663558&#39;: &#39;imiquimod&#39;,
 &#39;NCT01718444&#39;: &#39;progesterone&#39;,
 &#39;NCT01733043&#39;: &#39;dexmedetomidine&#39;,
 &#39;NCT01769911&#39;: &#39;melphalan&#39;,
 &#39;NCT01824264&#39;: &#39;sitagliptin&#39;,
 &#39;NCT01836614&#39;: &#39;lidocaine&#39;,
 &#39;NCT01854762&#39;: &#39;raltegravir&#39;,
 &#39;NCT01883297&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT01885364&#39;: &#39;remifentanil&#39;,
 &#39;NCT01890200&#39;: &#39;ribavirin&#39;,
 &#39;NCT01922141&#39;: &#39;ramipril&#39;,
 &#39;NCT01931098&#39;: &#39;topotecan&#39;,
 &#39;NCT01933269&#39;: &#39;fluciclovine-f18&#39;,
 &#39;NCT01940536&#39;: &#39;tranexamic acid&#39;,
 &#39;NCT01942122&#39;: &#39;mefenamic acid&#39;,
 &#39;NCT01953406&#39;: &#39;mitomycin&#39;,
 &#39;NCT01954290&#39;: &#39;mannitol&#39;,
 &#39;NCT01960075&#39;: &#39;(s)-etiracetam&#39;,
 &#39;NCT01967251&#39;: &#39;udenafil&#39;,
 &#39;NCT01969149&#39;: &#39;exenatide&#39;,
 &#39;NCT01971489&#39;: &#39;cisplatin&#39;,
 &#39;NCT01977339&#39;: &#39;bupivacaine&#39;,
 &#39;NCT01979393&#39;: &#39;cabozantinib&#39;,
 &#39;NCT01983475&#39;: &#39;denosumab&#39;,
 &#39;NCT01984606&#39;: &#39;sitagliptin&#39;,
 &#39;NCT01996358&#39;: &#39;succinylcholine&#39;,
 &#39;NCT02009605&#39;: &#39;icotinib&#39;,
 &#39;NCT02014103&#39;: &#39;tacrolimus&#39;,
 &#39;NCT02018861&#39;: &#39;rituximab&#39;,
 &#39;NCT02030054&#39;: &#39;rosuvastatin&#39;,
 &#39;NCT02034890&#39;: &#39;hyaluronan&#39;,
 &#39;NCT02036086&#39;: &#39;vemurafenib&#39;,
 &#39;NCT02037126&#39;: &#39;diphenhydramine&#39;,
 &#39;NCT02047539&#39;: &#39;aspirin&#39;,
 &#39;NCT02049762&#39;: &#39;aspirin&#39;,
 &#39;NCT02056171&#39;: &#39;quetiapine&#39;,
 &#39;NCT02056405&#39;: &#39;mosapride&#39;,
 &#39;NCT02058940&#39;: &#39;exenatide&#39;,
 &#39;NCT02059499&#39;: &#39;imiquimod&#39;,
 &#39;NCT02066571&#39;: &#39;droxidopa&#39;,
 &#39;NCT02067013&#39;: &#39;ranibizumab&#39;,
 &#39;NCT02071940&#39;: &#39;pexidartinib&#39;,
 &#39;NCT02073747&#39;: &#39;salbutamol&#39;,
 &#39;NCT02073838&#39;: &#39;vismodegib&#39;,
 &#39;NCT02074904&#39;: &#39;topiramate&#39;,
 &#39;NCT02077998&#39;: &#39;oxaliplatin&#39;,
 &#39;NCT02080637&#39;: &#39;ambrisentan&#39;,
 &#39;NCT02082405&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02086500&#39;: &#39;tranexamic acid&#39;,
 &#39;NCT02086825&#39;: &#39;rifaximin&#39;,
 &#39;NCT02090348&#39;: &#39;dimethyl fumarate&#39;,
 &#39;NCT02091401&#39;: &#39;magnesium sulfate&#39;,
 &#39;NCT02095184&#39;: &#39;letrozole&#39;,
 &#39;NCT02098629&#39;: &#39;milrinone&#39;,
 &#39;NCT02099747&#39;: &#39;eltrombopag&#39;,
 &#39;NCT02101047&#39;: &#39;phenylephrine&#39;,
 &#39;NCT02106364&#39;: &#39;insulin glargine&#39;,
 &#39;NCT02106572&#39;: &#39;mitomycin&#39;,
 &#39;NCT02108860&#39;: &#39;abatacept&#39;,
 &#39;NCT02109627&#39;: &#39;cytarabine&#39;,
 &#39;NCT02109653&#39;: &#39;encorafenib&#39;,
 &#39;NCT02113891&#39;: &#39;eculizumab&#39;,
 &#39;NCT02116335&#39;: &#39;bosentan&#39;,
 &#39;NCT02117765&#39;: &#39;ustekinumab&#39;,
 &#39;NCT02117817&#39;: &#39;buparlisib&#39;,
 &#39;NCT02121405&#39;: &#39;oxaliplatin&#39;,
 &#39;NCT02122081&#39;: &#39;tacrolimus&#39;,
 &#39;NCT02124811&#39;: &#39;minocycline&#39;,
 &#39;NCT02128360&#39;: &#39;letrozole&#39;,
 &#39;NCT02129322&#39;: &#39;oxaliplatin&#39;,
 &#39;NCT02130323&#39;: &#39;imiquimod&#39;,
 &#39;NCT02132598&#39;: &#39;cabozantinib&#39;,
 &#39;NCT02137265&#39;: &#39;clomiphene&#39;,
 &#39;NCT02138058&#39;: &#39;topiramate&#39;,
 &#39;NCT02141178&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02147834&#39;: &#39;ranolazine&#39;,
 &#39;NCT02153177&#39;: &#39;ibuprofen&#39;,
 &#39;NCT02154061&#39;: &#39;vancomycin&#39;,
 &#39;NCT02155920&#39;: &#39;everolimus&#39;,
 &#39;NCT02158052&#39;: &#39;tacrolimus&#39;,
 &#39;NCT02158806&#39;: &#39;aspirin&#39;,
 &#39;NCT02159027&#39;: &#39;maraviroc&#39;,
 &#39;NCT02159495&#39;: &#39;fludarabine phosphate&#39;,
 &#39;NCT02162420&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02162433&#39;: &#39;dexmedetomidine&#39;,
 &#39;NCT02164500&#39;: &#39;ruxolitinib&#39;,
 &#39;NCT02164578&#39;: &#39;rivaroxaban&#39;,
 &#39;NCT02165644&#39;: &#39;nimodipine&#39;,
 &#39;NCT02166658&#39;: &#39;cabazitaxel&#39;,
 &#39;NCT02171416&#39;: &#39;rilonacept&#39;,
 &#39;NCT02174094&#39;: &#39;clobazam&#39;,
 &#39;NCT02176031&#39;: &#39;natalizumab&#39;,
 &#39;NCT02177838&#39;: &#39;cisplatin&#39;,
 &#39;NCT02179177&#39;: &#39;apixaban&#39;,
 &#39;NCT02180204&#39;: &#39;tenecteplase&#39;,
 &#39;NCT02186015&#39;: &#39;cholecalciferolvitamin d3&#39;,
 &#39;NCT02186158&#39;: &#39;vitamin c&#39;,
 &#39;NCT02186405&#39;: &#39;levothyroxine&#39;,
 &#39;NCT02186574&#39;: &#39;tenofovir&#39;,
 &#39;NCT02187211&#39;: &#39;minocycline&#39;,
 &#39;NCT02187809&#39;: &#39;clobazam&#39;,
 &#39;NCT02188121&#39;: &#39;simvastatin&#39;,
 &#39;NCT02193347&#39;: &#39;temozolomide&#39;,
 &#39;NCT02194842&#39;: &#39;enzalutamide&#39;,
 &#39;NCT02194933&#39;: &#39;brexpiprazole&#39;,
 &#39;NCT02197221&#39;: &#39;melphalan&#39;,
 &#39;NCT02197286&#39;: &#39;cholecalciferolvitamin d3&#39;,
 &#39;NCT02201563&#39;: &#39;minocycline&#39;,
 &#39;NCT02203643&#39;: &#39;lenalidomide&#39;,
 &#39;NCT02205047&#39;: &#39;trastuzumab&#39;,
 &#39;NCT02206984&#39;: &#39;tamoxifen&#39;,
 &#39;NCT02211014&#39;: &#39;acalabrutinib&#39;,
 &#39;NCT02213289&#39;: &#39;trastuzumab&#39;,
 &#39;NCT02214004&#39;: &#39;trastuzumab&#39;,
 &#39;NCT02215174&#39;: &#39;rosuvastatin&#39;,
 &#39;NCT02216149&#39;: &#39;oxaliplatin&#39;,
 &#39;NCT02216383&#39;: &#39;carbetocin&#39;,
 &#39;NCT02217501&#39;: &#39;clopidogrel&#39;,
 &#39;NCT02220972&#39;: &#39;perampanel&#39;,
 &#39;NCT02222623&#39;: &#39;nph insulin&#39;,
 &#39;NCT02224768&#39;: &#39;ipilimumab&#39;,
 &#39;NCT02228681&#39;: &#39;tamoxifen&#39;,
 &#39;NCT02229240&#39;: &#39;albiglutide&#39;,
 &#39;NCT02229266&#39;: &#39;cytarabine&#39;,
 &#39;NCT02230176&#39;: &#39;sunitinib&#39;,
 &#39;NCT02230306&#39;: &#39;vemurafenib&#39;,
 &#39;NCT02230332&#39;: &#39;alendronic acid&#39;,
 &#39;NCT02231008&#39;: &#39;tasimelteon&#39;,
 &#39;NCT02232386&#39;: &#39;rituximab&#39;,
 &#39;NCT02232516&#39;: &#39;romidepsin&#39;,
 &#39;NCT02234050&#39;: &#39;trabectedin&#39;,
 &#39;NCT02235298&#39;: &#39;dapagliflozin&#39;,
 &#39;NCT02235324&#39;: &#39;fluorouracil&#39;,
 &#39;NCT02236078&#39;: &#39;rifampicin&#39;,
 &#39;NCT02237157&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02238808&#39;: &#39;17β-estradiol&#39;,
 &#39;NCT02239458&#39;: &#39;saxagliptin&#39;,
 &#39;NCT02240537&#39;: &#39;sargramostim&#39;,
 &#39;NCT02240602&#39;: &#39;oxycodone&#39;,
 &#39;NCT02241096&#39;: &#39;lidocaine&#39;,
 &#39;NCT02242097&#39;: &#39;ibrutinib&#39;,
 &#39;NCT02248870&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02250807&#39;: &#39;sofosbuvir&#39;,
 &#39;NCT02252328&#39;: &#39;simvastatin&#39;,
 &#39;NCT02252406&#39;: &#39;ranolazine&#39;,
 &#39;NCT02252536&#39;: &#39;gabapentin enacarbil&#39;,
 &#39;NCT02254551&#39;: &#39;sonidegib&#39;,
 &#39;NCT02255175&#39;: &#39;progesterone&#39;,
 &#39;NCT02255682&#39;: &#39;simvastatin&#39;,
 &#39;NCT02256280&#39;: &#39;neostigmine&#39;,
 &#39;NCT02256345&#39;: &#39;potassium chloride&#39;,
 &#39;NCT02258009&#39;: &#39;ranibizumab&#39;,
 &#39;NCT02258074&#39;: &#39;niacinamide&#39;,
 &#39;NCT02260154&#39;: &#39;mebeverine&#39;,
 &#39;NCT02260440&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02260648&#39;: &#39;ezetimibe&#39;,
 &#39;NCT02262416&#39;: &#39;leuprolide&#39;,
 &#39;NCT02262936&#39;: &#39;fesoterodine&#39;,
 &#39;NCT02263547&#39;: &#39;teriflunomide&#39;,
 &#39;NCT02263898&#39;: &#39;binimetinib&#39;,
 &#39;NCT02264210&#39;: &#39;icotinib&#39;,
 &#39;NCT02265367&#39;: &#39;levomilnacipran&#39;,
 &#39;NCT02267707&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02268448&#39;: &#39;naltrexone&#39;,
 &#39;NCT02268864&#39;: &#39;simeprevir&#39;,
 &#39;NCT02269072&#39;: &#39;testosterone&#39;,
 &#39;NCT02269319&#39;: &#39;linezolid&#39;,
 &#39;NCT02269358&#39;: &#39;methotrexate&#39;,
 &#39;NCT02269644&#39;: &#39;linezolid&#39;,
 &#39;NCT02269969&#39;: &#39;tobramycin&#39;,
 &#39;NCT02270242&#39;: &#39;aspirin&#39;,
 &#39;NCT02272725&#39;: &#39;ibuprofen&#39;,
 &#39;NCT02272946&#39;: &#39;canakinumab&#39;,
 &#39;NCT02273700&#39;: &#39;rivaroxaban&#39;,
 &#39;NCT02274792&#39;: &#39;etanercept&#39;,
 &#39;NCT02275169&#39;: &#39;urofollitropin&#39;,
 &#39;NCT02277132&#39;: &#39;sildenafil&#39;,
 &#39;NCT02277184&#39;: &#39;cisplatin&#39;,
 &#39;NCT02277197&#39;: &#39;cetuximab&#39;,
 &#39;NCT02277457&#39;: &#39;erlotinib&#39;,
 &#39;NCT02278081&#39;: &#39;lansoprazole&#39;,
 &#39;NCT02278315&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02279407&#39;: &#39;dapagliflozin&#39;,
 &#39;NCT02279576&#39;: &#39;pazopanib&#39;,
 &#39;NCT02280239&#39;: &#39;acetaminophen&#39;,
 &#39;NCT02280486&#39;: &#39;saxagliptin&#39;,
 &#39;NCT02281058&#39;: &#39;abatacept&#39;,
 &#39;NCT02281266&#39;: &#39;thymalfasin&#39;,
 &#39;NCT02281799&#39;: &#39;azathioprine&#39;,
 &#39;NCT02282176&#39;: &#39;azithromycin&#39;,
 &#39;NCT02282891&#39;: &#39;propofol&#39;,
 &#39;NCT02283177&#39;: &#39;idarubicin&#39;,
 &#39;NCT02283281&#39;: &#39;tetrahydrocannabinol&#39;,
 &#39;NCT02283294&#39;: &#39;warfarin&#39;,
 &#39;NCT02285140&#39;: &#39;vancomycin&#39;,
 &#39;NCT02286206&#39;: &#39;clozapine&#39;,
 &#39;NCT02286830&#39;: &#39;zoledronic acid&#39;,
 &#39;NCT02286921&#39;: &#39;testosterone enanthate&#39;,
 &#39;NCT02287181&#39;: &#39;remifentanil&#39;,
 &#39;NCT02287311&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02288156&#39;: &#39;capsaicin&#39;,
 &#39;NCT02288897&#39;: &#39;dacarbazine&#39;,
 &#39;NCT02289144&#39;: &#39;ceritinib&#39;,
 &#39;NCT02289547&#39;: &#39;capecitabine&#39;,
 &#39;NCT02289807&#39;: &#39;cisplatin&#39;,
 &#39;NCT02289963&#39;: &#39;alirocumab&#39;,
 &#39;NCT02290327&#39;: &#39;pantoprazole&#39;,
 &#39;NCT02291055&#39;: &#39;durvalumab&#39;,
 &#39;NCT02291419&#39;: &#39;aspirin&#39;,
 &#39;NCT02292225&#39;: &#39;obinutuzumab&#39;,
 &#39;NCT02292667&#39;: &#39;acetaminophen&#39;,
 &#39;NCT02293109&#39;: &#39;methylprednisolone&#39;,
 &#39;NCT02295475&#39;: &#39;warfarin&#39;,
 &#39;NCT02295722&#39;: &#39;melphalan&#39;,
 &#39;NCT02295826&#39;: &#39;aspirin&#39;,
 &#39;NCT02296112&#39;: &#39;trametinib&#39;,
 &#39;NCT02296281&#39;: &#39;pirfenidone&#39;,
 &#39;NCT02296398&#39;: &#39;romidepsin&#39;,
 &#39;NCT02296671&#39;: &#39;pemetrexed&#39;,
 &#39;NCT02296801&#39;: &#39;palbociclib&#39;,
 &#39;NCT02296931&#39;: &#39;magnesium sulfate&#39;,
 &#39;NCT02297763&#39;: &#39;quetiapine&#39;,
 &#39;NCT02297945&#39;: &#39;metyrapone&#39;,
 &#39;NCT02298257&#39;: &#39;vinblastine&#39;,
 &#39;NCT02298283&#39;: &#39;procarbazine&#39;,
 &#39;NCT02298348&#39;: &#39;topotecan&#39;,
 &#39;NCT02299726&#39;: &#39;spironolactone&#39;,
 &#39;NCT02299817&#39;: &#39;denosumab&#39;,
 &#39;NCT02301000&#39;: &#39;metronidazole&#39;,
 &#39;NCT02301156&#39;: &#39;ibrutinib&#39;,
 &#39;NCT02301780&#39;: &#39;aspirin&#39;,
 &#39;NCT02301806&#39;: &#39;sitagliptin&#39;,
 &#39;NCT02301949&#39;: &#39;thalidomide&#39;,
 &#39;NCT02303730&#39;: &#39;insulin glargine&#39;,
 &#39;NCT02303795&#39;: &#39;warfarin&#39;,
 &#39;NCT02304081&#39;: &#39;saxagliptin&#39;,
 &#39;NCT02304094&#39;: &#39;methylprednisolone&#39;,
 &#39;NCT02304263&#39;: &#39;iohexol&#39;,
 &#39;NCT02304705&#39;: &#39;sildenafil&#39;,
 &#39;NCT02304757&#39;: &#39;alendronate sodium trihydratealendronic acid&#39;,
 &#39;NCT02305186&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02306473&#39;: &#39;mannitol&#39;,
 &#39;NCT02306850&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02307006&#39;: &#39;ceftaroline fosamil&#39;,
 &#39;NCT02307149&#39;: &#39;ipilimumab&#39;,
 &#39;NCT02308007&#39;: &#39;terconazole&#39;,
 &#39;NCT02308072&#39;: &#39;olaparib&#39;,
 &#39;NCT02309359&#39;: &#39;methotrexate&#39;,
 &#39;NCT02309580&#39;: &#39;ibrutinib&#39;,
 &#39;NCT02310243&#39;: &#39;palbociclib&#39;,
 &#39;NCT02310867&#39;: &#39;belatacept&#39;,
 &#39;NCT02311569&#39;: &#39;mirabegron&#39;,
 &#39;NCT02312063&#39;: &#39;sitagliptin&#39;,
 &#39;NCT02312375&#39;: &#39;fimasartan&#39;,
 &#39;NCT02312804&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02312908&#39;: &#39;clonazepam&#39;,
 &#39;NCT02313389&#39;: &#39;rituximab&#39;,
 &#39;NCT02313675&#39;: &#39;acetaminophen&#39;,
 &#39;NCT02313792&#39;: &#39;palifermin&#39;,
 &#39;NCT02314403&#39;: &#39;rituximab&#39;,
 &#39;NCT02315495&#39;: &#39;saxagliptin&#39;,
 &#39;NCT02315534&#39;: &#39;temozolomide&#39;,
 &#39;NCT02315768&#39;: &#39;ibrutinib&#39;,
 &#39;NCT02316249&#39;: &#39;17β-estradiol&#39;,
 &#39;NCT02317159&#39;: &#39;imatinib&#39;,
 &#39;NCT02317926&#39;: &#39;levothyroxine&#39;,
 &#39;NCT02318225&#39;: &#39;misoprostol&#39;,
 &#39;NCT02318446&#39;: &#39;folic acid&#39;,
 &#39;NCT02319031&#39;: &#39;sofosbuvir&#39;,
 &#39;NCT02319343&#39;: &#39;methylprednisolone&#39;,
 &#39;NCT02320734&#39;: &#39;rocuronium&#39;,
 &#39;NCT02321280&#39;: &#39;denosumab&#39;,
 &#39;NCT02321852&#39;: &#39;triflusal&#39;,
 &#39;NCT02322502&#39;: &#39;sevoflurane&#39;,
 &#39;NCT02322580&#39;: &#39;etanercept&#39;,
 &#39;NCT02322892&#39;: &#39;thiamine ion&#39;,
 &#39;NCT02323217&#39;: &#39;isocarboxazid&#39;,
 &#39;NCT02323230&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02323269&#39;: &#39;dimethyl fumarate&#39;,
 &#39;NCT02323399&#39;: &#39;phenylephrine&#39;,
 &#39;NCT02324010&#39;: &#39;sitagliptin&#39;,
 &#39;NCT02324166&#39;: &#39;lidocaine&#39;,
 &#39;NCT02324543&#39;: &#39;capecitabine&#39;,
 &#39;NCT02324738&#39;: &#39;mefloquinemefloquine&#39;,
 &#39;NCT02325401&#39;: &#39;cisplatin&#39;,
 &#39;NCT02325882&#39;: &#39;dexmedetomidine&#39;,
 &#39;NCT02325960&#39;: &#39;insulin glargine&#39;,
 &#39;NCT02325986&#39;: &#39;fluorouracil&#39;,
 &#39;NCT02326103&#39;: &#39;ciprofloxacin&#39;,
 &#39;NCT02326220&#39;: &#39;alirocumab&#39;,
 &#39;NCT02326285&#39;: &#39;gefitinib&#39;,
 &#39;NCT02326311&#39;: &#39;nilotinib&#39;,
 &#39;NCT02326727&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02327039&#39;: &#39;dapagliflozin&#39;,
 &#39;NCT02327143&#39;: &#39;abemaciclib&#39;,
 &#39;NCT02327676&#39;: &#39;emtricitabine&#39;,
 &#39;NCT02327702&#39;: &#39;emtricitabine&#39;,
 &#39;NCT02327715&#39;: &#39;emtricitabine&#39;,
 &#39;NCT02328118&#39;: &#39;ranibizumab&#39;,
 &#39;NCT02328495&#39;: &#39;misoprostol&#39;,
 &#39;NCT02328755&#39;: &#39;methotrexate&#39;,
 &#39;NCT02329379&#39;: &#39;levothyroxine&#39;,
 &#39;NCT02329964&#39;: &#39;neostigmine&#39;,
 &#39;NCT02330406&#39;: &#39;sitagliptin&#39;,
 &#39;NCT02330419&#39;: &#39;naltrexone&#39;,
 &#39;NCT02330705&#39;: &#39;chorionic gonadotropin&#39;,
 &#39;NCT02330757&#39;: &#39;estradiol valerate&#39;,
 &#39;NCT02330991&#39;: &#39;temozolomide&#39;,
 &#39;NCT02331095&#39;: &#39;warfarin&#39;,
 &#39;NCT02331368&#39;: &#39;melphalan&#39;,
 &#39;NCT02331498&#39;: &#39;pazopanib&#39;,
 &#39;NCT02331862&#39;: &#39;methylprednisolone&#39;,
 &#39;NCT02332031&#39;: &#39;levothyroxine&#39;,
 &#39;NCT02332291&#39;: &#39;escitalopram&#39;,
 &#39;NCT02332447&#39;: &#39;naloxone&#39;,
 &#39;NCT02332590&#39;: &#39;adalimumab&#39;,
 &#39;NCT02332603&#39;: &#39;methylprednisolone&#39;,
 &#39;NCT02332616&#39;: &#39;methylprednisolone&#39;,
 &#39;NCT02332629&#39;: &#39;methylprednisolone&#39;,
 &#39;NCT02332902&#39;: &#39;everolimus&#39;,
 &#39;NCT02333565&#39;: &#39;octreotideoctreotide&#39;,
 &#39;NCT02333643&#39;: &#39;furosemide&#39;,
 &#39;NCT02333799&#39;: &#39;linezolid&#39;,
 &#39;NCT02334046&#39;: &#39;sevoflurane&#39;,
 &#39;NCT02334124&#39;: &#39;flucloxacillin&#39;,
 &#39;NCT02335190&#39;: &#39;lidocaine&#39;,
 &#39;NCT02335281&#39;: &#39;mesalamine&#39;,
 &#39;NCT02335346&#39;: &#39;duloxetine&#39;,
 &#39;NCT02336165&#39;: &#39;durvalumab&#39;,
 &#39;NCT02336815&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02337491&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02337881&#39;: &#39;sildenafil&#39;,
 &#39;NCT02337985&#39;: &#39;prednisone&#39;,
 &#39;NCT02338037&#39;: &#39;eribulin&#39;,
 &#39;NCT02338323&#39;: &#39;febuxostat&#39;,
 &#39;NCT02338414&#39;: &#39;romiplostim&#39;,
 &#39;NCT02338518&#39;: &#39;oxaliplatin&#39;,
 &#39;NCT02338570&#39;: &#39;everolimus&#39;,
 &#39;NCT02338635&#39;: &#39;ursodiol&#39;,
 &#39;NCT02338960&#39;: &#39;bremelanotide&#39;,
 &#39;NCT02339662&#39;: &#39;gabapentin&#39;,
 &#39;NCT02339753&#39;: &#39;carboplatin&#39;,
 &#39;NCT02340117&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02340611&#39;: &#39;olaparib&#39;,
 &#39;NCT02340949&#39;: &#39;oxaliplatin&#39;,
 &#39;NCT02340962&#39;: &#39;ribavirin&#39;,
 &#39;NCT02341482&#39;: &#39;itraconazole&#39;,
 &#39;NCT02341794&#39;: &#39;rosuvastatin&#39;,
 &#39;NCT02341833&#39;: &#39;sevoflurane&#39;,
 &#39;NCT02341911&#39;: &#39;gemcitabinecisplatin&#39;,
 &#39;NCT02342002&#39;: &#39;misoprostol&#39;,
 &#39;NCT02342379&#39;: &#39;bevacizumab&#39;,
 &#39;NCT02342418&#39;: &#39;tedizolid phosphate&#39;,
 &#39;NCT02342639&#39;: &#39;rifaximin&#39;,
 &#39;NCT02342717&#39;: &#39;itraconazole&#39;,
 &#39;NCT02342782&#39;: &#39;melphalan&#39;,
 &#39;NCT02342886&#39;: &#39;pyrazinamide&#39;,
 &#39;NCT02343263&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02343276&#39;: &#39;nitroglycerin&#39;,
 &#39;NCT02343289&#39;: &#39;esketamine&#39;,
 &#39;NCT02343393&#39;: &#39;hydralazine&#39;,
 &#39;NCT02343575&#39;: &#39;haloperidol&#39;,
 &#39;NCT02343679&#39;: &#39;ceritinib&#39;,
 &#39;NCT02343952&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02344017&#39;: &#39;prednisone&#39;,
 &#39;NCT02344225&#39;: &#39;ibuprofen&#39;,
 &#39;NCT02344264&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02344290&#39;: &#39;pitavastatin&#39;,
 &#39;NCT02344316&#39;: &#39;melatonin&#39;,
 &#39;NCT02344472&#39;: &#39;trastuzumab&#39;,
 &#39;NCT02344589&#39;: &#39;lidocaine&#39;,
 &#39;NCT02344628&#39;: &#39;azithromycin&#39;,
 &#39;NCT02344641&#39;: &#39;exenatide&#39;,
 &#39;NCT02345239&#39;: &#39;pantoprazole&#39;,
 &#39;NCT02345304&#39;: &#39;warfarin&#39;,
 &#39;NCT02345460&#39;: &#39;oxaliplatin&#39;,
 &#39;NCT02345616&#39;: &#39;nitric oxide (radical)&#39;,
 &#39;NCT02345681&#39;: &#39;furosemide&#39;,
 &#39;NCT02346110&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02346253&#39;: &#39;goserelin&#39;,
 &#39;NCT02346539&#39;: &#39;(−)-nicotine&#39;,
 &#39;NCT02346682&#39;: &#39;venlafaxine&#39;,
 &#39;NCT02347111&#39;: &#39;sotalol&#39;,
 &#39;NCT02347878&#39;: &#39;aprepitant&#39;,
 &#39;NCT02347891&#39;: &#39;belimumab&#39;,
 &#39;NCT02348281&#39;: &#39;bicalutamide&#39;,
 &#39;NCT02348450&#39;: &#39;irinotecan&#39;,
 &#39;NCT02349243&#39;: &#39;entacapone&#39;,
 &#39;NCT02349828&#39;: &#39;aciclovir&#39;,
 &#39;NCT02349906&#39;: &#39;treosulfan&#39;,
 &#39;NCT02349919&#39;: &#39;procaterol&#39;,
 &#39;NCT02350543&#39;: &#39;aspirin&#39;,
 &#39;NCT02351102&#39;: &#39;valacyclovir&#39;,
 &#39;NCT02351128&#39;: &#39;lanreotide&#39;,
 &#39;NCT02351232&#39;: &#39;liraglutide&#39;,
 &#39;NCT02351310&#39;: &#39;betamethasone&#39;,
 &#39;NCT02351739&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02351869&#39;: &#39;nitrous oxide&#39;,
 &#39;NCT02351882&#39;: &#39;nabilonenabilone&#39;,
 &#39;NCT02352090&#39;: &#39;dienogest&#39;,
 &#39;NCT02352558&#39;: &#39;imatinib&#39;,
 &#39;NCT02352987&#39;: &#39;salicylic acid&#39;,
 &#39;NCT02353078&#39;: &#39;sucralfate&#39;,
 &#39;NCT02353169&#39;: &#39;dexmedetomidine&#39;,
 &#39;NCT02353182&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02353676&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02353780&#39;: &#39;tocilizumab&#39;,
 &#39;NCT02353936&#39;: &#39;afatinib&#39;,
 &#39;NCT02353988&#39;: &#39;bicalutamide&#39;,
 &#39;NCT02354170&#39;: &#39;mifepristone&#39;,
 &#39;NCT02354222&#39;: &#39;canagliflozin&#39;,
 &#39;NCT02354235&#39;: &#39;canagliflozin&#39;,
 &#39;NCT02354560&#39;: &#39;erythromycin&#39;,
 &#39;NCT02354586&#39;: &#39;niraparib&#39;,
 &#39;NCT02354807&#39;: &#39;mirabegron&#39;,
 &#39;NCT02355119&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02355678&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02355821&#39;: &#39;moxonidine&#39;,
 &#39;NCT02356705&#39;: &#39;lidocaine&#39;,
 &#39;NCT02357004&#39;: &#39;carvedilol&#39;,
 &#39;NCT02357303&#39;: &#39;l-cysteineacetylcysteine&#39;,
 &#39;NCT02357342&#39;: &#39;sirolimus&#39;,
 &#39;NCT02357563&#39;: &#39;ulipristal acetate&#39;,
 &#39;NCT02357654&#39;: &#39;gonadorelin&#39;,
 &#39;NCT02357693&#39;: &#39;aprepitant&#39;,
 &#39;NCT02357732&#39;: &#39;trametinib&#39;,
 &#39;NCT02358057&#39;: &#39;dexmedetomidine&#39;,
 &#39;NCT02358356&#39;: &#39;temozolomide&#39;,
 &#39;NCT02358369&#39;: &#39;bimatoprost&#39;,
 &#39;NCT02358473&#39;: &#39;docetaxel&#39;,
 &#39;NCT02358499&#39;: &#39;posaconazole&#39;,
 &#39;NCT02358824&#39;: &#39;telmisartan&#39;,
 &#39;NCT02359058&#39;: &#39;ramucirumab&#39;,
 &#39;NCT02359110&#39;: &#39;gabapentin&#39;,
 &#39;NCT02359162&#39;: &#39;vincristine&#39;,
 &#39;NCT02359448&#39;: &#39;melatonin&#39;,
 &#39;NCT02359474&#39;: &#39;trabectedin&#39;,
 &#39;NCT02359552&#39;: &#39;rasagiline&#39;,
 &#39;NCT02360384&#39;: &#39;linaclotide&#39;,
 &#39;NCT02360618&#39;: &#39;simvastatin&#39;,
 &#39;NCT02360631&#39;: &#39;varenicline&#39;,
 &#39;NCT02360774&#39;: &#39;canagliflozin&#39;,
 &#39;NCT02361060&#39;: &#39;neostigmine&#39;,
 &#39;NCT02361190&#39;: &#39;testosterone&#39;,
 &#39;NCT02361216&#39;: &#39;ingenol mebutate&#39;,
 &#39;NCT02361476&#39;: &#39;clonidine&#39;,
 &#39;NCT02361502&#39;: &#39;mirabegron&#39;,
 &#39;NCT02361619&#39;: &#39;esomeprazole&#39;,
 &#39;NCT02361879&#39;: &#39;ulipristal acetate&#39;,
 &#39;NCT02361892&#39;: &#39;ulipristal acetate&#39;,
 &#39;NCT02361905&#39;: &#39;ulipristal acetate&#39;,
 &#39;NCT02362035&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02362165&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02362529&#39;: &#39;minocycline&#39;,
 &#39;NCT02362997&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02363335&#39;: &#39;sitagliptin&#39;,
 &#39;NCT02363738&#39;: &#39;infliximab&#39;,
 &#39;NCT02363946&#39;: &#39;diphenhydramine&#39;,
 &#39;NCT02364882&#39;: &#39;sildenafil&#39;,
 &#39;NCT02364934&#39;: &#39;sevoflurane&#39;,
 &#39;NCT02365441&#39;: &#39;imatinib&#39;,
 &#39;NCT02365532&#39;: &#39;dofetilide&#39;,
 &#39;NCT02365558&#39;: &#39;omeprazole&#39;,
 &#39;NCT02365571&#39;: &#39;itraconazole&#39;,
 &#39;NCT02365727&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02365766&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02365961&#39;: &#39;epinephrine&#39;,
 &#39;NCT02366065&#39;: &#39;acetaminophen&#39;,
 &#39;NCT02366299&#39;: &#39;propofol&#39;,
 &#39;NCT02366663&#39;: &#39;melphalan&#39;,
 &#39;NCT02366728&#39;: &#39;temozolomide&#39;,
 &#39;NCT02367118&#39;: &#39;prednisone&#39;,
 &#39;NCT02367248&#39;: &#39;deferoxamine&#39;,
 &#39;NCT02367404&#39;: &#39;duloxetine&#39;,
 &#39;NCT02368054&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02368795&#39;: &#39;indomethacin&#39;,
 &#39;NCT02369159&#39;: &#39;peramivir&#39;,
 &#39;NCT02369172&#39;: &#39;bupropion&#39;,
 &#39;NCT02369406&#39;: &#39;zidovudine&#39;,
 &#39;NCT02369900&#39;: &#39;esmolol&#39;,
 &#39;NCT02370238&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02370550&#39;: &#39;prednisone&#39;,
 &#39;NCT02370615&#39;: &#39;itraconazole&#39;,
 &#39;NCT02370680&#39;: &#39;aspirin&#39;,
 &#39;NCT02371187&#39;: &#39;dapagliflozin&#39;,
 &#39;NCT02371304&#39;: &#39;capecitabine&#39;,
 &#39;NCT02371408&#39;: &#39;sofosbuvir&#39;,
 &#39;NCT02371681&#39;: &#39;rifampicin&#39;,
 &#39;NCT02371798&#39;: &#39;gadopentetate dimeglumine&#39;,
 &#39;NCT02371889&#39;: &#39;topiramate&#39;,
 &#39;NCT02372253&#39;: &#39;verapamil&#39;,
 &#39;NCT02372318&#39;: &#39;nalmefene&#39;,
 &#39;NCT02372955&#39;: &#39;dapagliflozin&#39;,
 &#39;NCT02373202&#39;: &#39;tacrolimus&#39;,
 &#39;NCT02373241&#39;: &#39;losartan&#39;,
 &#39;NCT02373514&#39;: &#39;acetaminophen&#39;,
 &#39;NCT02373865&#39;: &#39;sitagliptin&#39;,
 &#39;NCT02374008&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02374489&#39;: &#39;ceritinib&#39;,
 &#39;NCT02374853&#39;: &#39;vancomycin&#39;,
 &#39;NCT02374957&#39;: &#39;cilostazol&#39;,
 &#39;NCT02375100&#39;: &#39;(r,r) tramadol&#39;,
 &#39;NCT02375191&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02375204&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02375295&#39;: &#39;ciprofloxacin&#39;,
 &#39;NCT02375581&#39;: &#39;icotinib&#39;,
 &#39;NCT02375646&#39;: &#39;warfarin&#39;,
 &#39;NCT02375672&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02375880&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02376283&#39;: &#39;prasugrel&#39;,
 &#39;NCT02376296&#39;: &#39;docetaxel&#39;,
 &#39;NCT02376803&#39;: &#39;warfarin&#39;,
 &#39;NCT02377479&#39;: &#39;letrozole&#39;,
 &#39;NCT02378142&#39;: &#39;pazopanib&#39;,
 &#39;NCT02378480&#39;: &#39;omadacycline&#39;,
 &#39;NCT02378623&#39;: &#39;apixaban&#39;,
 &#39;NCT02378714&#39;: &#39;varenicline&#39;,
 &#39;NCT02379390&#39;: &#39;prednisone&#39;,
 &#39;NCT02379676&#39;: &#39;clopidogrel&#39;,
 &#39;NCT02379806&#39;: &#39;enoxaparin&#39;,
 &#39;NCT02380313&#39;: &#39;prednisone&#39;,
 &#39;NCT02380625&#39;: &#39;azithromycin&#39;,
 &#39;NCT02381249&#39;: &#39;octreotideoctreotide&#39;,
 &#39;NCT02381353&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02381717&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02382354&#39;: &#39;remifentanil&#39;,
 &#39;NCT02382406&#39;: &#39;carboplatin&#39;,
 &#39;NCT02382510&#39;: &#39;tiotropium&#39;,
 &#39;NCT02382575&#39;: &#39;tacrolimus&#39;,
 &#39;NCT02382666&#39;: &#39;rolapitant&#39;,
 &#39;NCT02382848&#39;: &#39;prazosin&#39;,
 &#39;NCT02382939&#39;: &#39;somatropin recombinant&#39;,
 &#39;NCT02383030&#39;: &#39;fulvestrant&#39;,
 &#39;NCT02383927&#39;: &#39;tipifarnib&#39;,
 &#39;NCT02384122&#39;: &#39;octreotideoctreotide&#39;,
 &#39;NCT02384200&#39;: &#39;vancomycin&#39;,
 &#39;NCT02384343&#39;: &#39;dexmedetomidine&#39;,
 &#39;NCT02384746&#39;: &#39;fulvestrant&#39;,
 &#39;NCT02384759&#39;: &#39;aflibercept&#39;,
 &#39;NCT02384850&#39;: &#39;oxaliplatin&#39;,
 &#39;NCT02384915&#39;: &#39;prilocaine&#39;,
 &#39;NCT02385032&#39;: &#39;ursodiol&#39;,
 &#39;NCT02385136&#39;: &#39;temozolomide&#39;,
 &#39;NCT02385422&#39;: &#39;carvedilol&#39;,
 &#39;NCT02385448&#39;: &#39;dienogest&#39;,
 &#39;NCT02385851&#39;: &#39;pegfilgrastim&#39;,
 &#39;NCT02386059&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02386449&#39;: &#39;sodium picosulfate&#39;,
 &#39;NCT02386735&#39;: &#39;prednisone&#39;,
 &#39;NCT02387086&#39;: &#39;thalidomide&#39;,
 &#39;NCT02387216&#39;: &#39;docetaxel&#39;,
 &#39;NCT02387242&#39;: &#39;rifampicin&#39;,
 &#39;NCT02387450&#39;: &#39;sildenafil&#39;,
 &#39;NCT02387619&#39;: &#39;rosuvastatin&#39;,
 &#39;NCT02387710&#39;: &#39;tiagabine&#39;,
 &#39;NCT02387762&#39;: &#39;methotrexate&#39;,
 &#39;NCT02387801&#39;: &#39;ixekizumab&#39;,
 &#39;NCT02387814&#39;: &#39;abemaciclib&#39;,
 &#39;NCT02387918&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02388035&#39;: &#39;cefotaxime&#39;,
 &#39;NCT02388191&#39;: &#39;naproxen&#39;,
 &#39;NCT02389543&#39;: &#39;lenalidomide&#39;,
 &#39;NCT02389712&#39;: &#39;lamotrigine&#39;,
 &#39;NCT02389738&#39;: &#39;temozolomide&#39;,
 &#39;NCT02389829&#39;: &#39;diphenhydramine&#39;,
 &#39;NCT02389868&#39;: &#39;lovastatin&#39;,
 &#39;NCT02389920&#39;: &#39;nilotinib&#39;,
 &#39;NCT02389985&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02390063&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02390362&#39;: &#39;rituximab&#39;,
 &#39;NCT02390427&#39;: &#39;trastuzumab&#39;,
 &#39;NCT02390544&#39;: &#39;melphalan&#39;,
 &#39;NCT02390739&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02390817&#39;: &#39;neostigmine&#39;,
 &#39;NCT02390843&#39;: &#39;topotecan&#39;,
 &#39;NCT02391571&#39;: &#39;oxycodone&#39;,
 &#39;NCT02391636&#39;: &#39;carbetocin&#39;,
 &#39;NCT02392208&#39;: &#39;telavancin&#39;,
 &#39;NCT02392377&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02392780&#39;: &#39;methylprednisolone&#39;,
 &#39;NCT02393157&#39;: &#39;obinutuzumab&#39;,
 &#39;NCT02393248&#39;: &#39;trastuzumab&#39;,
 &#39;NCT02393586&#39;: &#39;rifampicin&#39;,
 &#39;NCT02393664&#39;: &#39;sevoflurane&#39;,
 &#39;NCT02393742&#39;: &#39;sodium nitrite&#39;,
 &#39;NCT02394002&#39;: &#39;propofol&#39;,
 &#39;NCT02394106&#39;: &#39;ofatumumab&#39;,
 &#39;NCT02394119&#39;: &#39;rituximab&#39;,
 &#39;NCT02394652&#39;: &#39;cisplatin&#39;,
 &#39;NCT02394665&#39;: &#39;temozolomide&#39;,
 &#39;NCT02394951&#39;: &#39;pregabalin&#39;,
 &#39;NCT02395016&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02395627&#39;: &#39;tamoxifen&#39;,
 &#39;NCT02395640&#39;: &#39;oxaliplatin&#39;,
 &#39;NCT02395848&#39;: &#39;fidaxomicin&#39;,
 &#39;NCT02396303&#39;: &#39;carbetocin&#39;,
 &#39;NCT02396433&#39;: &#39;eribulin&#39;,
 &#39;NCT02397330&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02397421&#39;: &#39;dapagliflozin&#39;,
 &#39;NCT02397538&#39;: &#39;rosuvastatin&#39;,
 &#39;NCT02397590&#39;: &#39;fimasartan&#39;,
 &#39;NCT02398123&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02398201&#39;: &#39;bezafibrate&#39;,
 &#39;NCT02398240&#39;: &#39;vincristine&#39;,
 &#39;NCT02398539&#39;: &#39;triamcinolone&#39;,
 &#39;NCT02398552&#39;: &#39;sunitinib&#39;,
 &#39;NCT02398656&#39;: &#39;tenecteplase&#39;,
 &#39;NCT02399085&#39;: &#39;lenalidomide&#39;,
 &#39;NCT02399137&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02399475&#39;: &#39;liothyronine&#39;,
 &#39;NCT02399566&#39;: &#39;erlotinib&#39;,
 &#39;NCT02399709&#39;: &#39;simvastatin&#39;,
 &#39;NCT02399943&#39;: &#39;trametinib&#39;,
 &#39;NCT02400021&#39;: &#39;progesterone&#39;,
 &#39;NCT02400112&#39;: &#39;vancomycin&#39;,
 &#39;NCT02400281&#39;: &#39;mitoxantrone&#39;,
 &#39;NCT02400333&#39;: &#39;ticagrelor&#39;,
 &#39;NCT02400437&#39;: &#39;rituximab&#39;,
 &#39;NCT02400463&#39;: &#39;ruxolitinib&#39;,
 &#39;NCT02400645&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02400749&#39;: &#39;apremilast&#39;,
 &#39;NCT02400775&#39;: &#39;azilsartan medoxomil&#39;,
 &#39;NCT02400866&#39;: &#39;olanzapine&#39;,
 &#39;NCT02400879&#39;: &#39;remifentanil&#39;,
 &#39;NCT02401048&#39;: &#39;durvalumab&#39;,
 &#39;NCT02401269&#39;: &#39;aspirin&#39;,
 &#39;NCT02401295&#39;: &#39;itraconazole&#39;,
 &#39;NCT02401425&#39;: &#39;misoprostol&#39;,
 &#39;NCT02401542&#39;: &#39;docetaxel&#39;,
 &#39;NCT02401815&#39;: &#39;sunitinib&#39;,
 &#39;NCT02401828&#39;: &#39;dolutegravir&#39;,
 &#39;NCT02401880&#39;: &#39;linagliptin&#39;,
 &#39;NCT02401945&#39;: &#39;aflibercept&#39;,
 &#39;NCT02402465&#39;: &#39;fluticasone propionate&#39;,
 &#39;NCT02402595&#39;: &#39;itraconazole&#39;,
 &#39;NCT02402725&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02403063&#39;: &#39;neostigmine&#39;,
 &#39;NCT02403830&#39;: &#39;methylnaltrexone&#39;,
 &#39;NCT02404051&#39;: &#39;fulvestrant&#39;,
 &#39;NCT02404077&#39;: &#39;clonidine&#39;,
 &#39;NCT02404155&#39;: &#39;clozapine&#39;,
 &#39;NCT02404233&#39;: &#39;rilpivirine&#39;,
 &#39;NCT02404558&#39;: &#39;tocilizumab&#39;,
 &#39;NCT02404675&#39;: &#39;icotinib&#39;,
 &#39;NCT02404779&#39;: &#39;cisatracurium besylate&#39;,
 &#39;NCT02404896&#39;: &#39;metreleptin&#39;,
 &#39;NCT02405156&#39;: &#39;misoprostol&#39;,
 &#39;NCT02405585&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02405676&#39;: &#39;rituximab&#39;,
 &#39;NCT02405988&#39;: &#39;remifentanil&#39;,
 &#39;NCT02406170&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02406183&#39;: &#39;ipilimumab&#39;,
 &#39;NCT02406261&#39;: &#39;simvastatin&#39;,
 &#39;NCT02406300&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02406521&#39;: &#39;pazopanib&#39;,
 &#39;NCT02406560&#39;: &#39;tafamidis&#39;,
 &#39;NCT02406950&#39;: &#39;sitagliptin&#39;,
 &#39;NCT02407210&#39;: &#39;olmesartan&#39;,
 &#39;NCT02407314&#39;: &#39;aspirin&#39;,
 &#39;NCT02407626&#39;: &#39;sevoflurane&#39;,
 &#39;NCT02407808&#39;: &#39;tetrahydrocannabinol&#39;,
 &#39;NCT02407821&#39;: &#39;escitalopram&#39;,
 &#39;NCT02407899&#39;: &#39;cholecalciferolvitamin d3&#39;,
 &#39;NCT02407912&#39;: &#39;cisplatin&#39;,
 &#39;NCT02408042&#39;: &#39;rituximab&#39;,
 &#39;NCT02408068&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02408120&#39;: &#39;insulin glargine&#39;,
 &#39;NCT02408419&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02408705&#39;: &#39;liraglutide&#39;,
 &#39;NCT02408770&#39;: &#39;ulipristal acetate&#39;,
 &#39;NCT02408978&#39;: &#39;naproxen&#39;,
 &#39;NCT02409004&#39;: &#39;rifampicin&#39;,
 &#39;NCT02409199&#39;: &#39;docetaxel&#39;,
 &#39;NCT02409810&#39;: &#39;dexmedetomidine&#39;,
 &#39;NCT02410135&#39;: &#39;mirabegron&#39;,
 &#39;NCT02410590&#39;: &#39;succinylcholine&#39;,
 &#39;NCT02410707&#39;: &#39;propofol&#39;,
 &#39;NCT02410759&#39;: &#39;ergonovine&#39;,
 &#39;NCT02411773&#39;: &#39;sodium bicarbonate&#39;,
 &#39;NCT02412085&#39;: &#39;golimumab&#39;,
 &#39;NCT02412228&#39;: &#39;ixazomib&#39;,
 &#39;NCT02412670&#39;: &#39;vinblastine&#39;,
 &#39;NCT02412852&#39;: &#39;sodium nitrite&#39;,
 &#39;NCT02412917&#39;: &#39;valacyclovir&#39;,
 &#39;NCT02413008&#39;: &#39;estriol&#39;,
 &#39;NCT02413047&#39;: &#39;methotrexate&#39;,
 &#39;NCT02413203&#39;: &#39;celecoxib&#39;,
 &#39;NCT02413320&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02413593&#39;: &#39;ribavirin&#39;,
 &#39;NCT02413658&#39;: &#39;phenytoin&#39;,
 &#39;NCT02413736&#39;: &#39;imatinib&#39;,
 &#39;NCT02414204&#39;: &#39;sildenafil&#39;,
 &#39;NCT02414568&#39;: &#39;vinblastine&#39;,
 &#39;NCT02414685&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02414724&#39;: &#39;ribociclib&#39;,
 &#39;NCT02414945&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02415062&#39;: &#39;donepezil&#39;,
 &#39;NCT02415608&#39;: &#39;ibrutinib&#39;,
 &#39;NCT02415699&#39;: &#39;oxaliplatin&#39;,
 &#39;NCT02416388&#39;: &#39;vosaroxin&#39;,
 &#39;NCT02416570&#39;: &#39;clarithromycin&#39;,
 &#39;NCT02416583&#39;: &#39;dinoprostone&#39;,
 &#39;NCT02416778&#39;: &#39;ferric carboxymaltose&#39;,
 &#39;NCT02416999&#39;: &#39;temozolomide&#39;,
 &#39;NCT02417129&#39;: &#39;rituximab&#39;,
 &#39;NCT02417883&#39;: &#39;furosemide&#39;,
 &#39;NCT02417935&#39;: &#39;pregabalin&#39;,
 &#39;NCT02418182&#39;: &#39;acetaminophen&#39;,
 &#39;NCT02418624&#39;: &#39;carboplatin&#39;,
 &#39;NCT02418884&#39;: &#39;rosuvastatin&#39;,
 &#39;NCT02418949&#39;: &#39;cyproheptadine&#39;,
 &#39;NCT02419105&#39;: &#39;testosterone&#39;,
 &#39;NCT02419378&#39;: &#39;alemtuzumab&#39;,
 &#39;NCT02419651&#39;: &#39;(r,r) tramadol&#39;,
 &#39;NCT02419729&#39;: &#39;ethinylestradiol17β-estradiol&#39;,
 &#39;NCT02419937&#39;: &#39;tocilizumab&#39;,
 &#39;NCT02420210&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02420314&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02420392&#39;: &#39;dapagliflozin&#39;,
 &#39;NCT02420782&#39;: &#39;pilocarpine&#39;,
 &#39;NCT02420899&#39;: &#39;rosuvastatin&#39;,
 &#39;NCT02420938&#39;: &#39;rituximab&#39;,
 &#39;NCT02421419&#39;: &#39;lidocaine&#39;,
 &#39;NCT02421588&#39;: &#39;topotecan&#39;,
 &#39;NCT02421640&#39;: &#39;cisplatin&#39;,
 &#39;NCT02422108&#39;: &#39;denosumab&#39;,
 &#39;NCT02422199&#39;: &#39;lapatinib&#39;,
 &#39;NCT02422446&#39;: &#39;icosapent ethyl&#39;,
 &#39;NCT02422485&#39;: &#39;salsalate&#39;,
 &#39;NCT02422563&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02422654&#39;: &#39;eliglustat&#39;,
 &#39;NCT02422706&#39;: &#39;omeprazole&#39;,
 &#39;NCT02422719&#39;: &#39;radotinib&#39;,
 &#39;NCT02422823&#39;: &#39;epinephrine&#39;,
 &#39;NCT02422966&#39;: &#39;acetaminophen&#39;,
 &#39;NCT02423018&#39;: &#39;pregabalin&#39;,
 &#39;NCT02423083&#39;: &#39;guanabenz&#39;,
 &#39;NCT02423239&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02423265&#39;: &#39;ranolazine&#39;,
 &#39;NCT02423759&#39;: &#39;ciprofloxacin&#39;,
 &#39;NCT02423928&#39;: &#39;ipilimumab&#39;,
 &#39;NCT02423980&#39;: &#39;glucagon&#39;,
 &#39;NCT02424071&#39;: &#39;melatonin&#39;,
 &#39;NCT02424149&#39;: &#39;phenazopyridine&#39;,
 &#39;NCT02424201&#39;: &#39;vitamin c&#39;,
 &#39;NCT02424461&#39;: &#39;ceftriaxone&#39;,
 &#39;NCT02424617&#39;: &#39;erlotinib&#39;,
 &#39;NCT02424968&#39;: &#39;mycophenolate mofetil&#39;,
 &#39;NCT02425449&#39;: &#39;succinylcholine&#39;,
 &#39;NCT02425566&#39;: &#39;nitroglycerin&#39;,
 &#39;NCT02425709&#39;: &#39;(r,r) tramadol&#39;,
 &#39;NCT02425878&#39;: &#39;ulipristal acetate&#39;,
 &#39;NCT02426060&#39;: &#39;warfarin&#39;,
 &#39;NCT02426177&#39;: &#39;nifedipine&#39;,
 &#39;NCT02426294&#39;: &#39;pioglitazone&#39;,
 &#39;NCT02426450&#39;: &#39;oxaliplatin&#39;,
 &#39;NCT02426775&#39;: &#39;carglumic acid&#39;,
 &#39;NCT02426918&#39;: &#39;linezolid&#39;,
 &#39;NCT02427126&#39;: &#39;aspirin&#39;,
 &#39;NCT02427165&#39;: &#39;salbutamol&#39;,
 &#39;NCT02427334&#39;: &#39;fluoxetine&#39;,
 &#39;NCT02427594&#39;: &#39;sodium bicarbonate&#39;,
 &#39;NCT02427893&#39;: &#39;vemurafenib&#39;,
 &#39;NCT02428231&#39;: &#39;dimethyl fumarate&#39;,
 &#39;NCT02428257&#39;: &#39;ephedrine&#39;,
 &#39;NCT02428283&#39;: &#39;sevoflurane&#39;,
 &#39;NCT02428712&#39;: &#39;plx8394&#39;,
 &#39;NCT02428751&#39;: &#39;vincristine&#39;,
 &#39;NCT02428764&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02428777&#39;: &#39;(r,r) tramadol&#39;,
 &#39;NCT02429037&#39;: &#39;cisplatin&#39;,
 &#39;NCT02429089&#39;: &#39;ribociclib&#39;,
 &#39;NCT02429232&#39;: &#39;pioglitazone&#39;,
 &#39;NCT02429271&#39;: &#39;clopidogrel&#39;,
 &#39;NCT02429557&#39;: &#39;midodrine&#39;,
 &#39;NCT02429622&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02429687&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02429700&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02429726&#39;: &#39;cisplatin&#39;,
 &#39;NCT02429934&#39;: &#39;abatacept&#39;,
 &#39;NCT02429960&#39;: &#39;remifentanil&#39;,
 &#39;NCT02430532&#39;: &#39;dimethyl fumarate&#39;,
 &#39;NCT02430545&#39;: &#39;rifampicin&#39;,
 &#39;NCT02430896&#39;: &#39;atomoxetine&#39;,
 &#39;NCT02431013&#39;: &#39;simvastatin&#39;,
 &#39;NCT02431065&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02431143&#39;: &#39;miltefosine&#39;,
 &#39;NCT02431325&#39;: &#39;teduglutide&#39;,
 &#39;NCT02431559&#39;: &#39;durvalumab&#39;,
 &#39;NCT02431754&#39;: &#39;tadalafil&#39;,
 &#39;NCT02431936&#39;: &#39;prazosin&#39;,
 &#39;NCT02432365&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02432456&#39;: &#39;pantoprazole&#39;,
 &#39;NCT02432560&#39;: &#39;sirolimus&#39;,
 &#39;NCT02432716&#39;: &#39;insulin glulisine&#39;,
 &#39;NCT02432833&#39;: &#39;tacrolimus&#39;,
 &#39;NCT02432846&#39;: &#39;sunitinib&#39;,
 &#39;NCT02432872&#39;: &#39;cytarabine&#39;,
 &#39;NCT02432976&#39;: &#39;exenatide&#39;,
 &#39;NCT02433418&#39;: &#39;diclofenac&#39;,
 &#39;NCT02433626&#39;: &#39;cisplatin&#39;,
 &#39;NCT02433665&#39;: &#39;iopamidol&#39;,
 &#39;NCT02433678&#39;: &#39;dapagliflozin&#39;,
 &#39;NCT02433704&#39;: &#39;cefazolin&#39;,
 &#39;NCT02433730&#39;: &#39;testosterone&#39;,
 &#39;NCT02433847&#39;: &#39;mosapride&#39;,
 &#39;NCT02434354&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02434614&#39;: &#39;docetaxelcisplatinfluorouracil&#39;,
 &#39;NCT02434861&#39;: &#39;sulfasalazine&#39;,
 &#39;NCT02435186&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02436265&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02436408&#39;: &#39;vismodegib&#39;,
 &#39;NCT02436668&#39;: &#39;ibrutinib&#39;,
 &#39;NCT02436993&#39;: &#39;trastuzumab&#39;,
 &#39;NCT02437045&#39;: &#39;meropenem&#39;,
 &#39;NCT02437136&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02437253&#39;: &#39;adalimumab&#39;,
 &#39;NCT02437370&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02437825&#39;: &#39;octreotideoctreotide&#39;,
 &#39;NCT02438007&#39;: &#39;enzalutamide&#39;,
 &#39;NCT02438137&#39;: &#39;dimethyl fumarate&#39;,
 &#39;NCT02438371&#39;: &#39;nifedipine&#39;,
 &#39;NCT02439034&#39;: &#39;acetaminophen&#39;,
 &#39;NCT02439190&#39;: &#39;clopidogrel&#39;,
 &#39;NCT02439281&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02439411&#39;: &#39;trametinib&#39;,
 &#39;NCT02439814&#39;: &#39;pregnenolone&#39;,
 &#39;NCT02439905&#39;: &#39;dexmedetomidine&#39;,
 &#39;NCT02439957&#39;: &#39;valganciclovir&#39;,
 &#39;NCT02439970&#39;: &#39;valganciclovir&#39;,
 &#39;NCT02440009&#39;: &#39;itraconazole&#39;,
 &#39;NCT02440204&#39;: &#39;sevoflurane&#39;,
 &#39;NCT02440399&#39;: &#39;acetaminophen&#39;,
 &#39;NCT02440464&#39;: &#39;melphalan&#39;,
 &#39;NCT02440581&#39;: &#39;teriparatide&#39;,
 &#39;NCT02440789&#39;: &#39;sirolimus&#39;,
 &#39;NCT02440841&#39;: &#39;rifampicin&#39;,
 &#39;NCT02441270&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02441491&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02441686&#39;: &#39;lenalidomide&#39;,
 &#39;NCT02441894&#39;: &#39;prednisolone&#39;,
 &#39;NCT02441907&#39;: &#39;aflibercept&#39;,
 &#39;NCT02441946&#39;: &#39;loperamide&#39;,
 &#39;NCT02442063&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02442674&#39;: &#39;tolvaptan&#39;,
 &#39;NCT02442817&#39;: &#39;linagliptin&#39;,
 &#39;NCT02443142&#39;: &#39;ibuprofen&#39;,
 &#39;NCT02443194&#39;: &#39;duloxetine&#39;,
 &#39;NCT02443545&#39;: &#39;deferiprone&#39;,
 &#39;NCT02443844&#39;: &#39;tamsulosin&#39;,
 &#39;NCT02443922&#39;: &#39;sitagliptin&#39;,
 &#39;NCT02444013&#39;: &#39;folic acid&#39;,
 &#39;NCT02444091&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02444364&#39;: &#39;sitagliptin&#39;,
 &#39;NCT02444637&#39;: &#39;rivastigmine&#39;,
 &#39;NCT02444728&#39;: &#39;methylprednisolone&#39;,
 &#39;NCT02444819&#39;: &#39;olmutinib&#39;,
 &#39;NCT02445508&#39;: &#39;sevelamer&#39;,
 &#39;NCT02445716&#39;: &#39;testosterone&#39;,
 &#39;NCT02445872&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02445898&#39;: &#39;methylprednisolone&#39;,
 &#39;NCT02446093&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02446145&#39;: &#39;eltrombopag&#39;,
 &#39;NCT02446652&#39;: &#39;paclitaxel&#39;,
 &#39;NCT02446704&#39;: &#39;temozolomide&#39;,
 &#39;NCT02446782&#39;: &#39;cefazolin&#39;,
 &#39;NCT02446834&#39;: &#39;acarbose&#39;,
 &#39;NCT02446860&#39;: &#39;nivolumab&#39;,
 &#39;NCT02446964&#39;: &#39;tacrolimus&#39;,
 &#39;NCT02447055&#39;: &#39;tacrolimus&#39;,
 &#39;NCT02447094&#39;: &#39;alteplase&#39;,
 &#39;NCT02447185&#39;: &#39;ranibizumab&#39;,
 &#39;NCT02447315&#39;: &#39;pilocarpine&#39;,
 &#39;NCT02447796&#39;: &#39;propofol&#39;,
 &#39;NCT02447809&#39;: &#39;clopidogrel&#39;,
 &#39;NCT02447822&#39;: &#39;anti-thymocyte globulin (rabbit)&#39;,
 &#39;NCT02447874&#39;: &#39;l-arginine&#39;,
 &#39;NCT02448069&#39;: &#39;(21r)-argatroban&#39;,
 &#39;NCT02448095&#39;: &#39;ponatinib&#39;,
 &#39;NCT02448199&#39;: &#39;meloxicam&#39;,
 &#39;NCT02448303&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02448550&#39;: &#39;bivalirudin&#39;,
 &#39;NCT02448654&#39;: &#39;tolcapone&#39;,
 &#39;NCT02448771&#39;: &#39;palbociclib&#39;,
 &#39;NCT02448797&#39;: &#39;icotinib&#39;,
 &#39;NCT02449161&#39;: &#39;progesteronemedroxyprogesterone acetate&#39;,
 &#39;NCT02449252&#39;: &#39;vincristine&#39;,
 &#39;NCT02449265&#39;: &#39;vincristine&#39;,
 &#39;NCT02449278&#39;: &#39;vincristine&#39;,
 &#39;NCT02449720&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02449915&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02450084&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02450253&#39;: &#39;tadalafil&#39;,
 &#39;NCT02450552&#39;: &#39;ezogabine&#39;,
 &#39;NCT02450656&#39;: &#39;selumetinib&#39;,
 &#39;NCT02450773&#39;: &#39;furosemide&#39;,
 &#39;NCT02450786&#39;: &#39;donepezil&#39;,
 &#39;NCT02450968&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02450994&#39;: &#39;dexamethasone&#39;,
 &#39;NCT02451072&#39;: &#39;lysergic acid diethylamide&#39;,
 &#39;NCT02451150&#39;: &#39;azilsartan medoxomil&#39;,
 &#39;NCT02451202&#39;: &#39;rocuronium&#39;,
 &#39;NCT02451306&#39;: &#39;quetiapine&#39;,
 &#39;NCT02451462&#39;: &#39;zoledronic acid&#39;,
 &#39;NCT02451527&#39;: &#39;digoxin&#39;,
 &#39;NCT02451540&#39;: &#39;roflumilast&#39;,
 &#39;NCT02451826&#39;: &#39;ulipristal acetate&#39;,
 &#39;NCT02452255&#39;: &#39;fenofibrate&#39;,
 &#39;NCT02452281&#39;: &#39;ipilimumab&#39;,
 &#39;NCT02452294&#39;: &#39;buparlisib&#39;,
 &#39;NCT02452424&#39;: &#39;pexidartinib&#39;,
 &#39;NCT02452437&#39;: &#39;oxycodone&#39;,
 &#39;NCT02452528&#39;: &#39;tenofovir&#39;,
 &#39;NCT02452983&#39;: &#39;sertraline&#39;,
 &#39;NCT02453321&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02453464&#39;: &#39;irinotecan&#39;,
 &#39;NCT02453841&#39;: &#39;oxymetazoline&#39;,
 &#39;NCT02454179&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02454205&#39;: &#39;pyrazinamide&#39;,
 &#39;NCT02454322&#39;: &#39;magnesium sulfate&#39;,
 &#39;NCT02454491&#39;: &#39;verapamil&#39;,
 &#39;NCT02454504&#39;: &#39;neostigmine&#39;,
 &#39;NCT02454894&#39;: &#39;lidocaine&#39;,
 &#39;NCT02455154&#39;: &#39;letrozole&#39;,
 &#39;NCT02455245&#39;: &#39;vincristine&#39;,
 &#39;NCT02455609&#39;: &#39;dexmedetomidine&#39;,
 &#39;NCT02455726&#39;: &#39;pregabalin&#39;,
 &#39;NCT02456207&#39;: &#39;rituximab&#39;,
 &#39;NCT02456350&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02456532&#39;: &#39;eszopiclone&#39;,
 &#39;NCT02456701&#39;: &#39;vemurafenib&#39;,
 &#39;NCT02456844&#39;: &#39;montelukast&#39;,
 &#39;NCT02456896&#39;: &#39;oxcarbazepine&#39;,
 &#39;NCT02456948&#39;: &#39;minocycline&#39;,
 &#39;NCT02457130&#39;: &#39;clopidogrel&#39;,
 &#39;NCT02457156&#39;: &#39;octreotideoctreotide&#39;,
 &#39;NCT02457650&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02457910&#39;: &#39;taselisib&#39;,
 &#39;NCT02458196&#39;: &#39;prednisone&#39;,
 &#39;NCT02458235&#39;: &#39;azacitidine&#39;,
 &#39;NCT02458781&#39;: &#39;metronidazole&#39;,
 &#39;NCT02459392&#39;: &#39;hyaluronan&#39;,
 &#39;NCT02459509&#39;: &#39;dexmedetomidine&#39;,
 &#39;NCT02460133&#39;: &#39;ritonavir&#39;,
 &#39;NCT02460276&#39;: &#39;rituximab&#39;,
 &#39;NCT02460419&#39;: &#39;capecitabine&#39;,
 &#39;NCT02460640&#39;: &#39;ropivacaine&#39;,
 &#39;NCT02460887&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02461693&#39;: &#39;caffeine&#39;,
 &#39;NCT02461745&#39;: &#39;ombitasvir&#39;,
 &#39;NCT02461836&#39;: &#39;gemcitabine&#39;,
 &#39;NCT02461888&#39;: &#39;ixazomib&#39;,
 &#39;NCT02462148&#39;: &#39;epinephrine&#39;,
 &#39;NCT02462161&#39;: &#39;insulin aspart&#39;,
 &#39;NCT02462174&#39;: &#39;bupivacaine&#39;,
 &#39;NCT02462252&#39;: &#39;methylprednisolone&#39;,
 &#39;NCT02462304&#39;: &#39;ranibizumab&#39;,
 &#39;NCT02462369&#39;: &#39;saxagliptin&#39;,
 &#39;NCT02462473&#39;: &#39;risperidone&#39;,
 &#39;NCT02462538&#39;: &#39;imatinib&#39;,
 &#39;NCT02462837&#39;: &#39;mirabegron&#39;,
 &#39;NCT02462915&#39;: &#39;lidocaine&#39;,
 &#39;NCT02462941&#39;: &#39;adenosine&#39;,
 &#39;NCT02463110&#39;: &#39;sertraline&#39;,
 &#39;NCT02463409&#39;: &#39;theophylline&#39;,
 &#39;NCT02463552&#39;: &#39;naproxen&#39;,
 &#39;NCT02463747&#39;: &#39;vancomycin&#39;,
 &#39;NCT02464020&#39;: &#39;vancomycin&#39;,
 &#39;NCT02464033&#39;: &#39;etanercept&#39;,
 &#39;NCT02464059&#39;: &#39;cholecalciferolvitamin d3&#39;,
 &#39;NCT02464176&#39;: &#39;epinephrine&#39;,
 &#39;NCT02464228&#39;: &#39;tipifarnib&#39;,
 &#39;NCT02464722&#39;: &#39;rocuronium&#39;,
 &#39;NCT02465385&#39;: &#39;linaclotide&#39;,
 &#39;NCT02465593&#39;: &#39;capecitabine&#39;,
 &#39;NCT02465736&#39;: &#39;docetaxel&#39;,
 &#39;NCT02465853&#39;: &#39;hyaluronan&#39;,
 &#39;NCT02465983&#39;: &#39;cyclophosphamide&#39;,
 &#39;NCT02466022&#39;: &#39;dexmedetomidine&#39;,
 &#39;NCT02466191&#39;: &#39;memantine&#39;,
 &#39;NCT02466997&#39;: &#39;tacrolimus&#39;,
 &#39;NCT02467361&#39;: &#39;pembrolizumab&#39;,
 &#39;NCT02467504&#39;: &#39;methotrexate&#39;,
 &#39;NCT02467517&#39;: &#39;magnesium sulfate&#39;,
 &#39;NCT02467595&#39;: &#39;sevoflurane&#39;,
 &#39;NCT02467647&#39;: &#39;thalidomide&#39;,
 ...}</pre>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h1 id="Task-2:">Task 2:<a class="anchor-link" href="#Task-2:">&#182;</a></h1>
</div>
</div>
</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<p>This matches the drugs found in the trials to the descriptions from usan_stems</p>

</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[11]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">df_usan_all</span> <span class="o">=</span> <span class="n">pd</span><span class="o">.</span><span class="n">read_csv</span><span class="p">(</span><span class="sa">r</span><span class="s2">&quot;data/trialsdata/usan_stems.csv&quot;</span><span class="p">,</span> <span class="n">header</span><span class="o">=</span><span class="kc">None</span><span class="p">,</span> <span class="n">sep</span><span class="o">=</span><span class="s1">&#39;</span><span class="se">\n</span><span class="s1">&#39;</span><span class="p">)</span>
<span class="n">df_usan_all</span> <span class="o">=</span> <span class="n">df_usan_all</span><span class="p">[</span><span class="mi">0</span><span class="p">]</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">split</span><span class="p">(</span><span class="s1">&#39;,&#39;</span><span class="p">,</span> <span class="n">expand</span><span class="o">=</span><span class="kc">True</span><span class="p">)</span>
<span class="n">headers</span> <span class="o">=</span> <span class="nb">list</span><span class="p">(</span><span class="n">df_usan_all</span><span class="o">.</span><span class="n">iloc</span><span class="p">[</span><span class="mi">0</span><span class="p">]</span><span class="o">.</span><span class="n">fillna</span><span class="p">(</span><span class="s2">&quot;rename&quot;</span><span class="p">))</span> 
<span class="n">headers</span> <span class="o">=</span> <span class="p">[</span><span class="n">i</span><span class="o">.</span><span class="n">replace</span><span class="p">(</span><span class="s1">&#39;</span><span class="se">\&quot;</span><span class="s1">&#39;</span><span class="p">,</span> <span class="s2">&quot;&quot;</span><span class="p">)</span> <span class="k">for</span> <span class="n">i</span> <span class="ow">in</span> <span class="n">headers</span><span class="p">]</span>
<span class="nb">print</span><span class="p">(</span><span class="n">headers</span><span class="p">)</span>
<span class="c1">#temporary renaming empty the empty columns</span>
<span class="n">df_usan_all</span><span class="o">.</span><span class="n">columns</span> <span class="o">=</span> <span class="p">[</span><span class="s1">&#39;name&#39;</span><span class="p">,</span> <span class="s1">&#39;stem&#39;</span><span class="p">,</span> <span class="s1">&#39;definition&#39;</span><span class="p">,</span> <span class="s1">&#39;example&#39;</span><span class="p">,</span> <span class="s1">&#39;1&#39;</span><span class="p">,</span> <span class="s1">&#39;2&#39;</span><span class="p">,</span> <span class="s1">&#39;3&#39;</span><span class="p">,</span> <span class="s1">&#39;4&#39;</span><span class="p">,</span> <span class="s1">&#39;5&#39;</span><span class="p">,</span> <span class="s1">&#39;6&#39;</span><span class="p">]</span>
<span class="n">df_usan_all</span><span class="o">.</span><span class="n">drop</span><span class="p">(</span><span class="n">index</span><span class="o">=</span><span class="mi">0</span><span class="p">,</span> <span class="n">inplace</span><span class="o">=</span><span class="kc">True</span><span class="p">)</span>
<span class="n">df_usan_all</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>[&#39;name&#39;, &#39;stem&#39;, &#39;definition&#39;, &#39;example&#39;, &#39;&#39;, &#39;rename&#39;, &#39;rename&#39;, &#39;rename&#39;, &#39;rename&#39;, &#39;rename&#39;]
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt output_prompt">Out[11]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">
<div>
<style scoped>
    .dataframe tbody tr th:only-of-type {
        vertical-align: middle;
    }

    .dataframe tbody tr th {
        vertical-align: top;
    }

    .dataframe thead th {
        text-align: right;
    }
</style>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>name</th>
      <th>stem</th>
      <th>definition</th>
      <th>example</th>
      <th>1</th>
      <th>2</th>
      <th>3</th>
      <th>4</th>
      <th>5</th>
      <th>6</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>1</th>
      <td>abine</td>
      <td>"-abine"</td>
      <td>"nucleoside antiviral or antineoplastic agents</td>
      <td>cytarabine or azarabine derivatives"</td>
      <td></td>
      <td></td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
    </tr>
    <tr>
      <th>2</th>
      <td>ac</td>
      <td>"-ac"</td>
      <td>"anti-inflammatory agents (acetic acid derivat...</td>
      <td>"bromfenac"</td>
      <td></td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
    </tr>
    <tr>
      <th>3</th>
      <td>subgroup:</td>
      <td></td>
      <td></td>
      <td></td>
      <td></td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
    </tr>
    <tr>
      <th>4</th>
      <td></td>
      <td>"-zolac"</td>
      <td>"anti-inflammatory - pyrazole acetic acid deri...</td>
      <td>"  pyrazole acetic acid derivatives"</td>
      <td>"rovazolac"</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
    </tr>
    <tr>
      <th>5</th>
      <td>acetam</td>
      <td>"-acetam"</td>
      <td>"nootropic agents (learning</td>
      <td>cognitive enhancers)</td>
      <td>piracetam type"</td>
      <td></td>
      <td></td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
    </tr>
    <tr>
      <th>...</th>
      <td>...</td>
      <td>...</td>
      <td>...</td>
      <td>...</td>
      <td>...</td>
      <td>...</td>
      <td>...</td>
      <td>...</td>
      <td>...</td>
      <td>...</td>
    </tr>
    <tr>
      <th>758</th>
      <td>zolid</td>
      <td>"-zolid"</td>
      <td>"oxazolidinone antibacterials"</td>
      <td>"eperezolid"</td>
      <td></td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
    </tr>
    <tr>
      <th>759</th>
      <td>zomib</td>
      <td>"-zomib"</td>
      <td>"proteozome inhibitors"</td>
      <td>"bortezomib"</td>
      <td></td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
    </tr>
    <tr>
      <th>760</th>
      <td>zotan</td>
      <td>"-zotan"</td>
      <td>"5-HT1A receptor agonists/antagonists acting p...</td>
      <td>"robalzotan"</td>
      <td></td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
    </tr>
    <tr>
      <th>761</th>
      <td>zotide</td>
      <td>"-zotide"</td>
      <td>"peptides"</td>
      <td></td>
      <td></td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
    </tr>
    <tr>
      <th>762</th>
      <td>zumab</td>
      <td>"-zumab"</td>
      <td>"monoclonal antibodies"</td>
      <td></td>
      <td></td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
      <td>None</td>
    </tr>
  </tbody>
</table>
<p>762 rows × 10 columns</p>
</div>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[12]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">df_usan</span> <span class="o">=</span> <span class="n">df_usan_all</span><span class="o">.</span><span class="n">loc</span><span class="p">[</span><span class="o">~</span><span class="n">df_usan_all</span><span class="p">[</span><span class="s1">&#39;name&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">contains</span><span class="p">(</span><span class="s2">&quot;subgroup:&quot;</span><span class="p">,</span><span class="n">regex</span><span class="o">=</span><span class="kc">False</span><span class="p">)]</span>
<span class="n">df_usan</span> <span class="o">=</span> <span class="n">df_usan</span><span class="o">.</span><span class="n">loc</span><span class="p">[</span><span class="o">~</span><span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;name&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">contains</span><span class="p">(</span><span class="s2">&quot;subgroups:&quot;</span><span class="p">,</span><span class="n">regex</span><span class="o">=</span><span class="kc">False</span><span class="p">)]</span>
<span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;name&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;name&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">replace</span><span class="p">(</span><span class="s2">&quot;&quot;</span><span class="p">,</span> <span class="n">np</span><span class="o">.</span><span class="n">NaN</span> <span class="p">)</span>
<span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;name&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;name&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">fillna</span><span class="p">(</span><span class="n">method</span><span class="o">=</span><span class="s1">&#39;ffill&#39;</span><span class="p">)</span>
<span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;definition&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;definition&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">str</span><span class="o">.</span><span class="n">strip</span><span class="p">(</span><span class="s1">&#39; &quot; &quot; &#39;</span><span class="p">)</span>
<span class="n">df_usan</span> <span class="o">=</span> <span class="n">df_usan</span><span class="o">.</span><span class="n">fillna</span><span class="p">(</span><span class="s2">&quot;&quot;</span><span class="p">)</span>
<span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;example_all&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;definition&#39;</span><span class="p">]</span> <span class="o">+</span> <span class="s2">&quot;,&quot;</span> <span class="o">+</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;example&#39;</span><span class="p">]</span> <span class="o">+</span> <span class="s2">&quot;,&quot;</span>  <span class="o">+</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;1&#39;</span><span class="p">]</span> <span class="o">+</span> <span class="s2">&quot;,&quot;</span> <span class="o">+</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;2&#39;</span><span class="p">]</span> <span class="o">+</span> <span class="s2">&quot;,&quot;</span> <span class="o">+</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;3&#39;</span><span class="p">]</span> <span class="o">+</span> <span class="s2">&quot;,&quot;</span> <span class="o">+</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;4&#39;</span><span class="p">]</span> <span class="o">+</span> <span class="s2">&quot;,&quot;</span> <span class="o">+</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;5&#39;</span><span class="p">]</span> <span class="o">+</span> <span class="s2">&quot;,&quot;</span> <span class="o">+</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;6&#39;</span><span class="p">]</span> 
<span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;example_all&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">df_usan</span><span class="p">[</span><span class="s1">&#39;example_all&#39;</span><span class="p">]</span><span class="o">.</span><span class="n">replace</span><span class="p">(</span><span class="s1">&#39;</span><span class="se">\&quot;</span><span class="s1">&#39;</span><span class="p">,</span> <span class="s1">&#39;&#39;</span><span class="p">)</span>
<span class="n">df_usan</span><span class="o">.</span><span class="n">drop</span><span class="p">(</span><span class="n">columns</span> <span class="o">=</span> <span class="p">[</span><span class="s1">&#39;example&#39;</span><span class="p">,</span> <span class="s1">&#39;1&#39;</span><span class="p">,</span> <span class="s1">&#39;2&#39;</span><span class="p">,</span> <span class="s1">&#39;3&#39;</span><span class="p">,</span> <span class="s1">&#39;4&#39;</span><span class="p">,</span> <span class="s1">&#39;5&#39;</span><span class="p">,</span> <span class="s1">&#39;6&#39;</span><span class="p">],</span> <span class="n">inplace</span> <span class="o">=</span> <span class="kc">True</span><span class="p">)</span>
<span class="n">df_usan</span><span class="o">.</span><span class="n">sample</span><span class="p">(</span><span class="n">n</span><span class="o">=</span><span class="mi">10</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[12]:</div>



<div class="output_html rendered_html output_subarea output_execute_result">
<div>
<style scoped>
    .dataframe tbody tr th:only-of-type {
        vertical-align: middle;
    }

    .dataframe tbody tr th {
        vertical-align: top;
    }

    .dataframe thead th {
        text-align: right;
    }
</style>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>name</th>
      <th>stem</th>
      <th>definition</th>
      <th>example_all</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>375</th>
      <td>minib</td>
      <td>"-minib"</td>
      <td>kinase inhibitor</td>
      <td>kinase inhibitor, binds to myristoyl binding s...</td>
    </tr>
    <tr>
      <th>518</th>
      <td>punil</td>
      <td>"-punil"</td>
      <td>mitochondrial benzodiazepine receptor (MBR) se...</td>
      <td>mitochondrial benzodiazepine receptor (MBR) se...</td>
    </tr>
    <tr>
      <th>92</th>
      <td>butazone</td>
      <td>"-butazone"</td>
      <td>anti-inflammatory analgesics (phenylbutazone t...</td>
      <td>anti-inflammatory analgesics (phenylbutazone t...</td>
    </tr>
    <tr>
      <th>678</th>
      <td>tiostat</td>
      <td>"-tiostat"</td>
      <td>enzyme inhibitors</td>
      <td>enzyme inhibitors,,,,,,,</td>
    </tr>
    <tr>
      <th>624</th>
      <td>tant</td>
      <td>"-tant"</td>
      <td>tachykinin (neurokinin) receptor antagonists</td>
      <td>tachykinin (neurokinin) receptor antagonists,,...</td>
    </tr>
    <tr>
      <th>91</th>
      <td>butan</td>
      <td>"-butan"</td>
      <td>antiseptics (dapabutan type)</td>
      <td>antiseptics (dapabutan type),"lopobutan",,,,,,</td>
    </tr>
    <tr>
      <th>724</th>
      <td>vir</td>
      <td>"-atovir"</td>
      <td>respiratory syncytial virus (RSV) fusion inhib...</td>
      <td>respiratory syncytial virus (RSV) fusion inhib...</td>
    </tr>
    <tr>
      <th>601</th>
      <td>stat</td>
      <td>"-tristat"</td>
      <td>tryptophan hydroxylase inhibitors</td>
      <td>tryptophan hydroxylase inhibitors,"telotristat...</td>
    </tr>
    <tr>
      <th>279</th>
      <td>gramostim</td>
      <td>"-gramostim"</td>
      <td>colony-stimulating factors</td>
      <td>colony-stimulating factors,,,,,,,</td>
    </tr>
    <tr>
      <th>303</th>
      <td>irudin</td>
      <td>"-irudin"</td>
      <td>anticoagulants (hirudin type)</td>
      <td>anticoagulants (hirudin type),"desirudin",,,,,,</td>
    </tr>
  </tbody>
</table>
</div>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[87]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="c1">#dict(df_usan[[&#39;name&#39;, &#39;definition&#39;]])</span>
<span class="n">usan_dict</span> <span class="o">=</span> <span class="nb">dict</span><span class="p">(</span><span class="nb">zip</span><span class="p">(</span><span class="n">df_usan</span><span class="o">.</span><span class="n">name</span><span class="p">,</span> <span class="n">df_usan</span><span class="o">.</span><span class="n">definition</span><span class="p">))</span>
<span class="c1">#print(usan_dict)</span>
<span class="n">output_list_usan</span> <span class="o">=</span> <span class="p">[]</span>

<span class="k">for</span> <span class="n">drug</span> <span class="ow">in</span> <span class="nb">list</span><span class="p">(</span><span class="n">df3_drugs</span><span class="p">[</span><span class="s1">&#39;drugs&#39;</span><span class="p">]):</span>
    <span class="c1">#print(&quot;the drug: &quot;, drug)</span>
    <span class="n">drug_usan</span> <span class="o">=</span> <span class="p">{}</span>
    <span class="n">usan_codes</span> <span class="o">=</span> <span class="p">[]</span>
    <span class="n">drug_usan</span><span class="p">[</span><span class="s1">&#39;drug&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">drug</span>
    <span class="k">for</span> <span class="n">k</span><span class="p">,</span> <span class="n">v</span> <span class="ow">in</span> <span class="n">usan_dict</span><span class="o">.</span><span class="n">items</span><span class="p">():</span> 
        <span class="k">if</span> <span class="n">drug</span><span class="o">.</span><span class="n">endswith</span><span class="p">(</span><span class="n">k</span><span class="p">):</span> 
            <span class="n">usandict</span> <span class="o">=</span> <span class="p">{}</span>
            <span class="c1">#print(&quot;k &quot;, k)</span>
            <span class="n">usandict</span><span class="p">[</span><span class="s1">&#39;description&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">v</span>
            <span class="n">usan_codes</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">usandict</span><span class="p">)</span>
            <span class="k">continue</span>
            <span class="c1">#print(usan_codes)</span>
    <span class="k">if</span> <span class="nb">len</span><span class="p">(</span><span class="n">usan_codes</span><span class="p">)</span> <span class="o">&gt;</span> <span class="mi">0</span><span class="p">:</span>
        <span class="n">drug_usan</span><span class="p">[</span><span class="s1">&#39;usan_codes&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">usan_codes</span>
        <span class="n">output_list_usan</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">drug_usan</span><span class="p">)</span>
            
<span class="c1">#drugs_usan    </span>
<span class="c1">#print(list(df3_drugs[&#39;drugs&#39;]))</span>
<span class="n">output_list_usan</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[87]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>[{&#39;drug&#39;: &#39;labetalololmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;magnesium sulfateolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;sildenafil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;}]},
 {&#39;drug&#39;: &#39;fluorouracil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;uracil type antineoplastics&#39;},
   {&#39;description&#39;: &#39;uracil derivatives used as thyroid antagonists and as antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;mitomycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;sorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;donepezilolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;preotactolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;preotactolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;nifedipine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(nifedipine type)&#39;}]},
 {&#39;drug&#39;: &#39;omeprazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proton pump inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;aminolevulinic acidolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;zolpidem&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypnotics/sedatives (zolpidem type)&#39;}]},
 {&#39;drug&#39;: &#39;lamivudine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;ipilimumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;moxifloxacin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;buparlisib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;cytarabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;antineoplastics (arabinofuranosyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;methotrexate&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;temsirolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;imiquimod&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;toll-like receptor&#39;}]},
 {&#39;drug&#39;: &#39;orlistat&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;},
   {&#39;description&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;progesterone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;carmustine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;cytarabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;antineoplastics (arabinofuranosyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;sitagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;lidocaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;lopinavirritonavir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;raltegravir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;esmolol&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;beta-blockers (propranolol type)&#39;}]},
 {&#39;drug&#39;: &#39;remifentanil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;acarbosemetforminolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;aliskiren&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;renin inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;hydrochlorothiazide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;diuretics (thiazide derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ramipril&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antihypertensives (ACE inhibitors)&#39;}]},
 {&#39;drug&#39;: &#39;pazopanib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiogenesis inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;topotecan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;fluorouracil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;uracil type antineoplastics&#39;},
   {&#39;description&#39;: &#39;uracil derivatives used as thyroid antagonists and as antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;mitomycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;conivaptan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;vasopressin receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;fosphenytoin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiepileptics (hydantoin derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;(s)-etiracetam&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nootropic agents (learning&#39;},
   {&#39;description&#39;: &#39;nootropic agents (learning&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;udenafil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;}]},
 {&#39;drug&#39;: &#39;exenatide&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;buparlisib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;cabozantinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;denosumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;empagliflozin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phlorozin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;sitagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;icotinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;tacrolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;carboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ifosfamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;}]},
 {&#39;drug&#39;: &#39;rituximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;rosuvastatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;cobimetinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;vemurafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanolmesartanvareniclineolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;quetiapine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;exenatide&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;fluorouracil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;uracil type antineoplastics&#39;},
   {&#39;description&#39;: &#39;uracil derivatives used as thyroid antagonists and as antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;imiquimod&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;toll-like receptor&#39;}]},
 {&#39;drug&#39;: &#39;droxidopa&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dopamine receptor agonists&#39;}]},
 {&#39;drug&#39;: &#39;ranibizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;pexidartinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;decitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;vismodegib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hedgehog signaling inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ambrisentan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;endothelin receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bortezomib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proteozome inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;anastrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;letrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;esmolol&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;beta-blockers (propranolol type)&#39;}]},
 {&#39;drug&#39;: &#39;milrinone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cardiotonics (amrinone type)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;eltrombopag&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thrombopoetin agonists&#39;}]},
 {&#39;drug&#39;: &#39;mitomycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;abatacept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiviral receptors&#39;},
   {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;}]},
 {&#39;drug&#39;: &#39;cytarabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;antineoplastics (arabinofuranosyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;encorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;everolimusolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;eculizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;bosentan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;endothelin receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ustekinumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;buparlisib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;capecitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;methotrexate&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;tacrolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;minocycline&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;letrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;sorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;imiquimod&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;toll-like receptor&#39;}]},
 {&#39;drug&#39;: &#39;cabozantinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;ivacaftor&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cystic fibrosis transmembrane regulator (CFTR) protein modulators&#39;}]},
 {&#39;drug&#39;: &#39;clomiphene&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiestrogens of the clomifene and tamoxifen groups&#39;}]},
 {&#39;drug&#39;: &#39;lopinavirritonavirolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;nevirapineolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;raltegravirolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;ranolazine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;}]},
 {&#39;drug&#39;: &#39;ibuprofenhydrocodoneacetaminophenomeprazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proton pump inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;metronidazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;}]},
 {&#39;drug&#39;: &#39;vancomycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;everolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;tacrolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;maraviroc&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunomodulators&#39;}]},
 {&#39;drug&#39;: &#39;alemtuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;ruxolitinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;rivaroxaban&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antithrombotics&#39;}]},
 {&#39;drug&#39;: &#39;acetazolamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;carbonic anhydrase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;nimodipine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(nifedipine type)&#39;}]},
 {&#39;drug&#39;: &#39;cabazitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;rilonacept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiviral receptors&#39;},
   {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;}]},
 {&#39;drug&#39;: &#39;methylprednisolone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;natalizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;apixaban&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antithrombotics&#39;}]},
 {&#39;drug&#39;: &#39;alteplase&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;},
   {&#39;description&#39;: &#39;enzymes&#39;}]},
 {&#39;drug&#39;: &#39;tenecteplase&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;},
   {&#39;description&#39;: &#39;enzymes&#39;}]},
 {&#39;drug&#39;: &#39;tenofovir&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;minocycline&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;losartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;simvastatin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;enzalutamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;brexpiprazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proton pump inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;dasabuvirolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ritonavirombitasvirolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ribavirinolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;minocycline&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;carfilzomib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proteozome inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;lenalidomide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thalidomide derivatives&#39;}]},
 {&#39;drug&#39;: &#39;fluorouracilcapecitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;pertuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;trastuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;anastrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;fulvestrant&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;estrogen antagonists&#39;}]},
 {&#39;drug&#39;: &#39;metronidazoleolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;acalabrutinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;},
   {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;nivolumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;ramucirumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;trastuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;letrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;trastuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;enalaprilhydrochlorothiazide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;diuretics (thiazide derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;rosuvastatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;capecitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;carbetocin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;oxytocin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;aspirinolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;clopidogrel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-grel&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;tauroursodeoxycholic acidolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;perampanel&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;ionotropic non-NMDA (N-methyl D-aspartate) glutamate receptors [AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor) and/or KA (kainite antagonist) receptors]&#39;}]},
 {&#39;drug&#39;: &#39;ipilimumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;everolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;letrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;albiglutide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;peptides&#39;},
   {&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;cytarabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;antineoplastics (arabinofuranosyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;aspirinolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;naproxenolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;sunitinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;cobimetinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;vemurafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;tasimelteon&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;selective melatonin receptor agonist&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;},
   {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;rituximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;lenalidomide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thalidomide derivatives&#39;}]},
 {&#39;drug&#39;: &#39;romidepsin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;depsipeptide derivatives&#39;}]},
 {&#39;drug&#39;: &#39;trabectedin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;ecteinascidin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;dapagliflozin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phlorozin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;fluorouracil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;uracil type antineoplastics&#39;},
   {&#39;description&#39;: &#39;uracil derivatives used as thyroid antagonists and as antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;capreomycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;moxifloxacin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;lurasidoneolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;saxagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;sargramostim&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;colony-stimulating factors&#39;},
   {&#39;description&#39;: &#39;colony-stimulating factors&#39;},
   {&#39;description&#39;: &#39;interleukin 3 deriviatives&#39;}]},
 {&#39;drug&#39;: &#39;lidocaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;},
   {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;simeprevir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;sofosbuvir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;simvastatin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;ranolazine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;}]},
 {&#39;drug&#39;: &#39;bortezomib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proteozome inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;sonidegib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hedgehog signaling inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;progesterone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;simvastatin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;neostigmine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;}]},
 {&#39;drug&#39;: &#39;aflibercept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;},
   {&#39;description&#39;: &#39;antiviral receptors&#39;}]},
 {&#39;drug&#39;: &#39;ranibizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;mebeverine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;spasmolytic agents (papaverine type)&#39;}]},
 {&#39;drug&#39;: &#39;azacitidine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;ezetimibe&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antihyperlipidaemics&#39;}]},
 {&#39;drug&#39;: &#39;desmopressin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;binimetinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;icotinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;daclatasvir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;simeprevir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;anastrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;nesiritide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;peptides&#39;},
   {&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;testosterone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;linezolid&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;}]},
 {&#39;drug&#39;: &#39;methotrexate&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;azithromycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;linezolid&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;}]},
 {&#39;drug&#39;: &#39;tobramycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;ibuprofen&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;}]},
 {&#39;drug&#39;: &#39;rifaximinomeprazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proton pump inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;canakinumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartancinacalcetolmesartancalcium acetateolmesartanolmesartanolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;rivaroxaban&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antithrombotics&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;etanercept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiviral receptors&#39;},
   {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;pemetrexedcisplatingemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;sildenafil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;cetuximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;crizotinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;erlotinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;lansoprazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proton pump inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;regorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;dapagliflozin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phlorozin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;pazopanib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiogenesis inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;saxagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;abatacept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiviral receptors&#39;},
   {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;azithromycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;crenolanib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiogenesis inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;cytarabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;antineoplastics (arabinofuranosyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;daunorubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;idarubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;apixaban&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antithrombotics&#39;}]},
 {&#39;drug&#39;: &#39;warfarin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;warfarin analogs&#39;}]},
 {&#39;drug&#39;: &#39;voriconazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;}]},
 {&#39;drug&#39;: &#39;atazanavirlamivudine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;atazanavirl-argininetenofoviremtricitabinel-argininetenofoviremtricitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;l-arginineabacavirlamivudinelopinavirl-arginineabacavirlamivudinelopinavirl-argininetenofoviremtricitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;abacavirtenofovirtenofovirtenofoviremtricitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;lamivudinetenofoviremtricitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;tenofoviremtricitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;lamivudine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;raltegravirlamivudine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;vancomycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;enzalutamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanintravenous immunoglobulinolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;remifentanil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;regorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ceritinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;capecitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;alirocumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;pantoprazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proton pump inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;formoterol&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;bronchodilators (phenethylamine derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;durvalumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;obinutuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;carfilzomib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proteozome inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;cytarabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;antineoplastics (arabinofuranosyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;doxorubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;methotrexate&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;methylprednisolone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;apixaban&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antithrombotics&#39;}]},
 {&#39;drug&#39;: &#39;warfarin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;warfarin analogs&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;trametinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;romidepsin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;depsipeptide derivatives&#39;}]},
 {&#39;drug&#39;: &#39;fluorouracil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;uracil type antineoplastics&#39;},
   {&#39;description&#39;: &#39;uracil derivatives used as thyroid antagonists and as antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;pemetrexed&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;letrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;palbociclib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;}]},
 {&#39;drug&#39;: &#39;quetiapine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;brentuximab vedotin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;}]},
 {&#39;drug&#39;: &#39;doxorubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;vinblastine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;}]},
 {&#39;drug&#39;: &#39;doxorubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;brentuximab vedotin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;}]},
 {&#39;drug&#39;: &#39;pegfilgrastimfilgrastim&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;colony-stimulating factors&#39;},
   {&#39;description&#39;: &#39;interleukin 3 deriviatives&#39;}]},
 {&#39;drug&#39;: &#39;sorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;topotecan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;denosumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;metronidazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;},
   {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;sitagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;thalidomide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thalidomide derivatives&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;exenatide&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;rivaroxaban&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antithrombotics&#39;}]},
 {&#39;drug&#39;: &#39;warfarin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;warfarin analogs&#39;}]},
 {&#39;drug&#39;: &#39;saxagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;methylprednisolone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;sildenafil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;}]},
 {&#39;drug&#39;: &#39;l-histidine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;ipilimumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;metronidazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;}]},
 {&#39;drug&#39;: &#39;terconazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;}]},
 {&#39;drug&#39;: &#39;terconazolemetronidazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olaparib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;methotrexate&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;},
   {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;palbociclib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;}]},
 {&#39;drug&#39;: &#39;belatacept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiviral receptors&#39;},
   {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;}]},
 {&#39;drug&#39;: &#39;mirabegron&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;}]},
 {&#39;drug&#39;: &#39;sitagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;fimasartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;infigratinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;carboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;clonazepam&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antianxiety agents (diazepam type)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;palifermin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;transforming growth factors&#39;},
   {&#39;description&#39;: &#39;growth factors&#39;}]},
 {&#39;drug&#39;: &#39;belatacept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiviral receptors&#39;},
   {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;}]},
 {&#39;drug&#39;: &#39;rituximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;praziquantelolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;saxagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;obinutuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;},
   {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;regorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;vorinostat&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;},
   {&#39;description&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;imatinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;daclatasvir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;sofosbuvir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;methylprednisolone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;insulin glargineolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;insulin glargineolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;rocuronium&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-curonium&#39;},
   {&#39;description&#39;: &#39;quaternary ammonium derivatives&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;denosumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;triflusal&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-sal-&#39;}]},
 {&#39;drug&#39;: &#39;pemetrexedgemcitabinepaclitaxeldocetaxel&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;desflurane&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;sevoflurane&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;etanercept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiviral receptors&#39;},
   {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;}]},
 {&#39;drug&#39;: &#39;sitagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;lidocaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;irinotecan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;capecitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanpembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumabolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;exenatide&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;fluorouracil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;uracil type antineoplastics&#39;},
   {&#39;description&#39;: &#39;uracil derivatives used as thyroid antagonists and as antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;ciprofloxacin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;alirocumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;docetaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;gefitinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;dasatinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;imatinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;nilotinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;anakinraolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;isoflurane&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ropivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;dapagliflozin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phlorozin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;abemaciclib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;}]},
 {&#39;drug&#39;: &#39;emtricitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;emtricitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;emtricitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;ranibizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;methotrexate&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;neostigmine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;}]},
 {&#39;drug&#39;: &#39;sitagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;warfarin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;warfarin analogs&#39;}]},
 {&#39;drug&#39;: &#39;lenalidomide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thalidomide derivatives&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;pazopanib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiogenesis inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;methylprednisolone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;sorafenibolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;adalimumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;methylprednisolone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;methylprednisolone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;methylprednisolone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;everolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;vortioxetine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thioether derivatives&#39;},
   {&#39;description&#39;: &#39;antidepressants (fluoxetine type)&#39;}]},
 {&#39;drug&#39;: &#39;everolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;octreotideoctreotide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;peptides&#39;},
   {&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;digoxin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;}]},
 {&#39;drug&#39;: &#39;furosemide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;diuretics (furosemide type)&#39;}]},
 {&#39;drug&#39;: &#39;bedaquiline&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics&#39;}]},
 {&#39;drug&#39;: &#39;linezolid&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;}]},
 {&#39;drug&#39;: &#39;remifentanil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;sevoflurane&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;flucloxacillin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;penicillins&#39;}]},
 {&#39;drug&#39;: &#39;lidocaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;duloxetine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thioether derivatives&#39;}]},
 {&#39;drug&#39;: &#39;durvalumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;bevacizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;sildenafil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;}]},
 {&#39;drug&#39;: &#39;doxorubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;eribulin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (mitotic inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;febuxostat&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;},
   {&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;romiplostim&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;interleukin 3 deriviatives&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;everolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;bremelanotide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumabolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;amitriptyline&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antidepressants (dibenzol[a&#39;}]},
 {&#39;drug&#39;: &#39;carboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;cediranib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiogenesis inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olaparib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;aflibercept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;},
   {&#39;description&#39;: &#39;antiviral receptors&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;itraconazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;}]},
 {&#39;drug&#39;: &#39;rosuvastatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;sevoflurane&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabinecarboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabinecisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;mifepristone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;progesterone receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bevacizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;itraconazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;}]},
 {&#39;drug&#39;: &#39;carmustine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;cytarabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;antineoplastics (arabinofuranosyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;moxifloxacin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;cilnidipinevalsartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;cilnidipinevalsartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;clarithromycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;hydralazine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antihypertensives (hydrazine-phthalazines)&#39;},
   {&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;}]},
 {&#39;drug&#39;: &#39;haloperidol&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(see -perone)&#39;}]},
 {&#39;drug&#39;: &#39;ceritinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;ibuprofen&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;}]},
 {&#39;drug&#39;: &#39;ketorolac&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;}]},
 {&#39;drug&#39;: &#39;ropivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;pitavastatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;anastrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;capecitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;docetaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;exemestane&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;}]},
 {&#39;drug&#39;: &#39;fulvestrant&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;estrogen antagonists&#39;}]},
 {&#39;drug&#39;: &#39;letrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;pertuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;trastuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;lidocaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;azithromycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;exenatide&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;formoterol&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;bronchodilators (phenethylamine derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;pantoprazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proton pump inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;digoxin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;}]},
 {&#39;drug&#39;: &#39;omeprazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proton pump inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;warfarin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;warfarin analogs&#39;}]},
 {&#39;drug&#39;: &#39;fluorouracil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;uracil type antineoplastics&#39;},
   {&#39;description&#39;: &#39;uracil derivatives used as thyroid antagonists and as antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;furosemide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;diuretics (furosemide type)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bicalutamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;degarelix&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hormone-release inhibiting peptides&#39;}]},
 {&#39;drug&#39;: &#39;goserelin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thyrotropin releasing hormone analogues&#39;}]},
 {&#39;drug&#39;: &#39;lopinavirzidovudinelamivudineabacavirlamivudine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;venlafaxine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antianxiety&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;levodopa&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dopamine receptor agonists&#39;}]},
 {&#39;drug&#39;: &#39;sotalol&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;combined alpha and beta blockers&#39;}]},
 {&#39;drug&#39;: &#39;aprepitant&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;},
   {&#39;description&#39;: &#39;NK1 receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;belimumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;bicalutamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;irinotecan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;entacapone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;catechol-O-methyltransferase (COMT) inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;aciclovir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;treosulfan&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;procaterol&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;bronchodilators (phenethylamine derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;valacyclovir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;lanreotide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;peptides&#39;},
   {&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;liraglutide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;peptides&#39;},
   {&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bortezomib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proteozome inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;dienogest&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;progestins&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bortezomib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proteozome inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;},
   {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;imatinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;remifentanil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ropivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;abatacept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiviral receptors&#39;},
   {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;tocilizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;afatinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;flutemetamol f-18olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bicalutamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;mifepristone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;progesterone receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;canagliflozin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phlorozin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;canagliflozin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phlorozin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;erythromycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;niraparib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;mirabegron&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;}]},
 {&#39;drug&#39;: &#39;sorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bisoprolol&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;beta-blockers (propranolol type)&#39;}]},
 {&#39;drug&#39;: &#39;lidocaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;sirolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;oritavancin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;vancomycin-related compounds&#39;}]},
 {&#39;drug&#39;: &#39;gonadorelin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thyrotropin releasing hormone analogues&#39;}]},
 {&#39;drug&#39;: &#39;aprepitant&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;},
   {&#39;description&#39;: &#39;NK1 receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;dabrafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;nivolumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;trametinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;alfentanil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;capecitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;bimatoprost&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-prost&#39;}]},
 {&#39;drug&#39;: &#39;sorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;docetaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;posaconazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;}]},
 {&#39;drug&#39;: &#39;ketorolac&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;}]},
 {&#39;drug&#39;: &#39;ketorolacolmesartanolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;levamlodipine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(nifedipine type)&#39;}]},
 {&#39;drug&#39;: &#39;telmisartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;capecitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ramucirumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;doxorubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;pegaspargase&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;}]},
 {&#39;drug&#39;: &#39;trabectedin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;ecteinascidin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;rasagiline&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Monoamine oxidase (MAO) inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;infliximabolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;infliximabolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;linaclotide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;simvastatin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;varenicline&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;}]},
 {&#39;drug&#39;: &#39;canagliflozin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phlorozin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;neostigmine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;}]},
 {&#39;drug&#39;: &#39;testosterone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;mirabegron&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;clarithromycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;diclofenac&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;}]},
 {&#39;drug&#39;: &#39;esomeprazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proton pump inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;acalabrutinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;},
   {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;acalabrutinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;},
   {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;bortezomib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proteozome inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;doxorubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;celecoxib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cyclooxygenase-2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;minocycline&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;roflumilast&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;leukotriene biosynthesis inhibitors&#39;},
   {&#39;description&#39;: &#39;antiasthmatics/antiallergics (not acting primarily as antihistamines)&#39;}]},
 {&#39;drug&#39;: &#39;roflumilastsitagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;sitagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;infliximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;sildenafil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;}]},
 {&#39;drug&#39;: &#39;sevoflurane&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;imatinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;regorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;dofetilide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;class III antiarrhythmic agents&#39;}]},
 {&#39;drug&#39;: &#39;omeprazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proton pump inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;itraconazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;}]},
 {&#39;drug&#39;: &#39;lanreotideolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ropivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;carmustine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;cytarabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;antineoplastics (arabinofuranosyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;basiliximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;rivaroxabanolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;duloxetine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thioether derivatives&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxelolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;oseltamivir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;peramivir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;acetaminophenolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;lopinavir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;lamivudine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;zidovudine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;esmolol&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;beta-blockers (propranolol type)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;digoxin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;}]},
 {&#39;drug&#39;: &#39;itraconazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;}]},
 {&#39;drug&#39;: &#39;dapagliflozin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phlorozin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;capecitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;sofosbuvir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;moxifloxacin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;verapamil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;coronary vasodilators (verapamil type)&#39;}]},
 {&#39;drug&#39;: &#39;dapagliflozin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phlorozin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;mizoribine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;ribofuranil derivatives (pyrazofurin type)&#39;}]},
 {&#39;drug&#39;: &#39;sulfasalazine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;}]},
 {&#39;drug&#39;: &#39;tacrolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;losartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;dexketoprofen&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;}]},
 {&#39;drug&#39;: &#39;sitagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;ropivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;ceritinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;vancomycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;(r,r) tramadol&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-adol-&#39;}]},
 {&#39;drug&#39;: &#39;ropivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;carboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;pegfilgrastimfilgrastim&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;colony-stimulating factors&#39;},
   {&#39;description&#39;: &#39;interleukin 3 deriviatives&#39;}]},
 {&#39;drug&#39;: &#39;ifosfamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;ciprofloxacin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;icotinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;warfarin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;warfarin analogs&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;clopidogrel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-grel&#39;}]},
 {&#39;drug&#39;: &#39;prasugrel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-grel&#39;}]},
 {&#39;drug&#39;: &#39;docetaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;warfarin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;warfarin analogs&#39;}]},
 {&#39;drug&#39;: &#39;clomiphene&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiestrogens of the clomifene and tamoxifen groups&#39;}]},
 {&#39;drug&#39;: &#39;letrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;pazopanib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiogenesis inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;linezolid&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;}]},
 {&#39;drug&#39;: &#39;omadacycline&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;apixaban&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antithrombotics&#39;}]},
 {&#39;drug&#39;: &#39;varenicline&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;}]},
 {&#39;drug&#39;: &#39;clopidogrel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-grel&#39;}]},
 {&#39;drug&#39;: &#39;enoxaparin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;heparin derivatives and low molecular weight (or depolymerized) heparins&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;abiraterone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;enzalutamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;azithromycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;ketorolac&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;}]},
 {&#39;drug&#39;: &#39;octreotideoctreotide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;peptides&#39;},
   {&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;remifentanil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;carboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumabolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumabolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;tiotropium&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-curonium&#39;}]},
 {&#39;drug&#39;: &#39;rituximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;tacrolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;rolapitant&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;},
   {&#39;description&#39;: &#39;NK1 receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;prazosin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antihypertensives (prazosin type)&#39;}]},
 {&#39;drug&#39;: &#39;fulvestrant&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;estrogen antagonists&#39;}]},
 {&#39;drug&#39;: &#39;tipifarnib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;farnesyl transferase inhibitor&#39;}]},
 {&#39;drug&#39;: &#39;octreotideoctreotide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;peptides&#39;},
   {&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ampicillin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;penicillins&#39;}]},
 {&#39;drug&#39;: &#39;vancomycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;lamivudine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;fulvestrant&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;estrogen antagonists&#39;}]},
 {&#39;drug&#39;: &#39;aflibercept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;},
   {&#39;description&#39;: &#39;antiviral receptors&#39;}]},
 {&#39;drug&#39;: &#39;fluorouracil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;uracil type antineoplastics&#39;},
   {&#39;description&#39;: &#39;uracil derivatives used as thyroid antagonists and as antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;prilocaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ingenol mebutateolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ingenol mebutateolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;dienogest&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;progestins&#39;}]},
 {&#39;drug&#39;: &#39;pegfilgrastim&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;colony-stimulating factors&#39;},
   {&#39;description&#39;: &#39;interleukin 3 deriviatives&#39;}]},
 {&#39;drug&#39;: &#39;sodium picosulfatemagnesium oxideolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;gefitinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;thalidomide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thalidomide derivatives&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;docetaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;sildenafil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;}]},
 {&#39;drug&#39;: &#39;rosuvastatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;telmisartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;tiagabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;acalabrutinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;},
   {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;methotrexate&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ixekizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;abemaciclib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;lorcaserin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;serotonin receptor agonists&#39;}]},
 {&#39;drug&#39;: &#39;lenalidomide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thalidomide derivatives&#39;}]},
 {&#39;drug&#39;: &#39;fluoxetine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thioether derivatives&#39;}]},
 {&#39;drug&#39;: &#39;lamotrigine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;sodium channel blockers&#39;}]},
 {&#39;drug&#39;: &#39;regadenoson&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;adenosine A receptor agonists&#39;}]},
 {&#39;drug&#39;: &#39;lovastatin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;nilotinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ivacaftor&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cystic fibrosis transmembrane regulator (CFTR) protein modulators&#39;}]},
 {&#39;drug&#39;: &#39;lumacaftor&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cystic fibrosis transmembrane regulator (CFTR) protein modulators&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;rituximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;pertuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;taselisib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;ado-trastuzumab emtansine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;maytansinoid derivatives&#39;}]},
 {&#39;drug&#39;: &#39;trastuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinibolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinibolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinibolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinibolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinibolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;aldesleukin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;interleukin-4 analogues and derivatives&#39;},
   {&#39;description&#39;: &#39;interleukins&#39;}]},
 {&#39;drug&#39;: &#39;neostigmine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;}]},
 {&#39;drug&#39;: &#39;simvastatin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;topotecan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;carbetocin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;oxytocin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;telavancin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;vancomycin-related compounds&#39;}]},
 {&#39;drug&#39;: &#39;ivacaftor&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cystic fibrosis transmembrane regulator (CFTR) protein modulators&#39;}]},
 {&#39;drug&#39;: &#39;tezacaftorivacaftor&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cystic fibrosis transmembrane regulator (CFTR) protein modulators&#39;}]},
 {&#39;drug&#39;: &#39;carboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;fluorouracil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;uracil type antineoplastics&#39;},
   {&#39;description&#39;: &#39;uracil derivatives used as thyroid antagonists and as antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;cetrorelixolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;methylprednisolone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;carboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ifosfamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;}]},
 {&#39;drug&#39;: &#39;obinutuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;docetaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;trastuzumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;amoxicillin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;penicillins&#39;}]},
 {&#39;drug&#39;: &#39;lorcaserin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;serotonin receptor agonists&#39;}]},
 {&#39;drug&#39;: &#39;propofolbupivacaine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;sevofluranerocuronium&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-curonium&#39;},
   {&#39;description&#39;: &#39;quaternary ammonium derivatives&#39;}]},
 {&#39;drug&#39;: &#39;aspirinolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ofatumumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;ofatumumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;rituximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;vorapaxar&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Protease-activated receptor 1 (PAR1) antagonists&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;adalimumabolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;adalimumabolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;vortioxetine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thioether derivatives&#39;},
   {&#39;description&#39;: &#39;antidepressants (fluoxetine type)&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;vorinostat&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;},
   {&#39;description&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;capecitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;epirubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;fidaxomicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Micromonospora strains)&#39;}]},
 {&#39;drug&#39;: &#39;l-histidine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;}]},
 {&#39;drug&#39;: &#39;l-histidine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;voriconazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;}]},
 {&#39;drug&#39;: &#39;carbetocin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;oxytocin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;carboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;eribulin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (mitotic inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;dapagliflozin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phlorozin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;fimasartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;rosuvastatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;fimasartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;bezafibrate&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-fibrate&#39;}]},
 {&#39;drug&#39;: &#39;brentuximab vedotin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;}]},
 {&#39;drug&#39;: &#39;doxorubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;rituximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;regorafenibolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;triamcinolone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;sunitinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;tenecteplase&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;},
   {&#39;description&#39;: &#39;enzymes&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartanmethylprednisolone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;lenalidomide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;thalidomide derivatives&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;ombitasvirritonavirdasabuvir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;ribavirinolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;sofosbuvirolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;erlotinibpemetrexed&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;simvastatin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;panitumumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;trametinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;progesterone&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;non-steroid antiandrogens&#39;}]},
 {&#39;drug&#39;: &#39;vancomycin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;}]},
 {&#39;drug&#39;: &#39;azacitidine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;}]},
 {&#39;drug&#39;: &#39;cytarabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;antineoplastics (arabinofuranosyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;pegfilgrastimfilgrastim&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;colony-stimulating factors&#39;},
   {&#39;description&#39;: &#39;interleukin 3 deriviatives&#39;}]},
 {&#39;drug&#39;: &#39;idarubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;mitoxantrone&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ixazomib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proteozome inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;rituximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;ruxolitinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;ketorolac&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;}]},
 {&#39;drug&#39;: &#39;apremilast&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;leukotriene biosynthesis inhibitors&#39;},
   {&#39;description&#39;: &#39;antiasthmatics/antiallergics (not acting primarily as antihistamines)&#39;}]},
 {&#39;drug&#39;: &#39;remifentanil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ibrutinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;},
   {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;durvalumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;insulin glargineolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;celecoxib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cyclooxygenase-2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;itraconazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;}]},
 {&#39;drug&#39;: &#39;letrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;docetaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;pexidartinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;sunitinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;dolutegravir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;empagliflozin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;phlorozin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;linagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;aflibercept&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;},
   {&#39;description&#39;: &#39;antiviral receptors&#39;}]},
 {&#39;drug&#39;: &#39;itraconazole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;oxaliplatinfluorouracil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;uracil type antineoplastics&#39;},
   {&#39;description&#39;: &#39;uracil derivatives used as thyroid antagonists and as antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;neostigmine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;}]},
 {&#39;drug&#39;: &#39;everolimus&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;immunosuppressant&#39;},
   {&#39;description&#39;: &#39;immunosuppressives&#39;}]},
 {&#39;drug&#39;: &#39;exemestane&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;}]},
 {&#39;drug&#39;: &#39;fulvestrant&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;estrogen antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;lamotrigineolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;lamotrigineolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;darunavircobicistat&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;tocilizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;icotinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;metreleptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;leptin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;letrozole&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;rituximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;remifentanil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;regorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;ipilimumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;donepezil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#34;acetylcholinesterase inhibitors used in the treatment of Alzheimer&#39;s disease&#34;}]},
 {&#39;drug&#39;: &#39;simvastatin&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;enzyme inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;bupivacainelevobupivacaine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;ropivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;sevofluranedesflurane&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;pazopanib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiogenesis inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;sorafenib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;tafamidis&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antimyloidotics&#39;}]},
 {&#39;drug&#39;: &#39;sitagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;fosaprepitantolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;sevoflurane&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;saxagliptin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;brentuximab vedotin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;}]},
 {&#39;drug&#39;: &#39;carboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ifosfamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;}]},
 {&#39;drug&#39;: &#39;pembrolizumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;rituximab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;bupivacaine&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;local anesthetics&#39;}]},
 {&#39;drug&#39;: &#39;liraglutide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;peptides&#39;},
   {&#39;description&#39;: &#39;zonulin antagonists&#39;}]},
 {&#39;drug&#39;: &#39;ataluren&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;inducers of ribosomal readthrough on nonsense mutation mRNA stop codons&#39;}]},
 {&#39;drug&#39;: &#39;docetaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;mirabegron&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;}]},
 {&#39;drug&#39;: &#39;neostigmine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;}]},
 {&#39;drug&#39;: &#39;rocuronium&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;-curonium&#39;},
   {&#39;description&#39;: &#39;quaternary ammonium derivatives&#39;}]},
 {&#39;drug&#39;: &#39;carbetocin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;oxytocin derivatives&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;brexpiprazoleolmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;metformin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;hypoglycemics (phenformin type)&#39;}]},
 {&#39;drug&#39;: &#39;golimumab&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;monoclonal antibodies&#39;},
   {&#39;description&#39;: &#39;monoclonal antibodies&#39;}]},
 {&#39;drug&#39;: &#39;ixazomib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;proteozome inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;carboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;doxorubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;gemcitabine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;},
   {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;}]},
 {&#39;drug&#39;: &#39;methotrexate&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;vinblastine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;}]},
 {&#39;drug&#39;: &#39;valacyclovir&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antivirals&#39;},
   {&#39;description&#39;: &#39;antivirals&#39;}]},
 {&#39;drug&#39;: &#39;methotrexate&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;celecoxib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;cyclooxygenase-2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;carboplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;docetaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;doxorubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;paclitaxel&#39;, &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics&#39;}]},
 {&#39;drug&#39;: &#39;phenytoin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antiepileptics (hydantoin derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;imatinib&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;}]},
 {&#39;drug&#39;: &#39;sildenafil&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;bendamustine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;doxorubicin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;}]},
 {&#39;drug&#39;: &#39;vinblastine&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;}]},
 {&#39;drug&#39;: &#39;olmesartan&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;}]},
 {&#39;drug&#39;: &#39;cisplatin&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;}]},
 {&#39;drug&#39;: &#39;ifosfamide&#39;,
  &#39;usan_codes&#39;: [{&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;}]},
 ...]</pre>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h1 id="Task-3:">Task 3:<a class="anchor-link" href="#Task-3:">&#182;</a></h1>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[88]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">task_3</span><span class="p">(</span><span class="n">output_list_usan</span><span class="p">,</span> <span class="n">output_dict_nct</span><span class="p">):</span>
    <span class="n">output_list_3</span> <span class="o">=</span> <span class="p">[]</span>
    <span class="k">for</span> <span class="n">drug</span> <span class="ow">in</span> <span class="n">output_list_usan</span><span class="p">:</span>
        <span class="n">drug_description</span> <span class="o">=</span> <span class="p">{}</span>
        <span class="n">trials</span> <span class="o">=</span> <span class="p">[]</span>
        <span class="c1">#print(drug[&#39;drug&#39;])</span>
        <span class="c1">#print(drug[&quot;usan_codes&quot;][0][&quot;description&quot;])</span>
        <span class="k">for</span> <span class="n">k</span><span class="p">,</span><span class="n">v</span> <span class="ow">in</span> <span class="n">output_dict_nct</span><span class="o">.</span><span class="n">items</span><span class="p">():</span>
            <span class="c1">#print(k, v)</span>
            <span class="k">if</span> <span class="n">v</span> <span class="o">==</span> <span class="n">drug</span><span class="p">[</span><span class="s1">&#39;drug&#39;</span><span class="p">]:</span>
                <span class="c1">#print(&quot;YES&quot;)                </span>
                <span class="n">trials</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">k</span><span class="p">)</span>        
        <span class="k">if</span> <span class="nb">len</span><span class="p">(</span><span class="n">trials</span><span class="p">)</span> <span class="o">&gt;</span> <span class="mi">0</span><span class="p">:</span>
            <span class="n">drug_description</span><span class="p">[</span><span class="s1">&#39;description&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">drug</span><span class="p">[</span><span class="s2">&quot;usan_codes&quot;</span><span class="p">][</span><span class="mi">0</span><span class="p">][</span><span class="s2">&quot;description&quot;</span><span class="p">]</span>
            <span class="n">drug_description</span><span class="p">[</span><span class="s1">&#39;trials&#39;</span><span class="p">]</span> <span class="o">=</span> <span class="n">trials</span>
            <span class="n">output_list_3</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">drug_description</span><span class="p">)</span>
    <span class="k">return</span> <span class="n">output_list_3</span>
                
</pre></div>

    </div>
</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[89]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">task_3</span><span class="p">(</span><span class="n">output_list_usan</span><span class="p">,</span> <span class="n">output_dict_nct</span><span class="p">)</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[89]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>[{&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT01171482&#39;, &#39;NCT01953406&#39;, &#39;NCT02106572&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01255046&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;(nifedipine type)&#39;,
  &#39;trials&#39;: [&#39;NCT01360034&#39;,
   &#39;NCT02426177&#39;,
   &#39;NCT02438371&#39;,
   &#39;NCT02513927&#39;,
   &#39;NCT02563405&#39;,
   &#39;NCT02591004&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01408849&#39;,
   &#39;NCT02365558&#39;,
   &#39;NCT02422706&#39;,
   &#39;NCT02552537&#39;,
   &#39;NCT02609386&#39;,
   &#39;NCT02621359&#39;,
   &#39;NCT02893709&#39;]},
 {&#39;description&#39;: &#39;hypnotics/sedatives (zolpidem type)&#39;,
  &#39;trials&#39;: [&#39;NCT01485393&#39;, &#39;NCT02578472&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT01528865&#39;,
   &#39;NCT02482272&#39;,
   &#39;NCT02566707&#39;,
   &#39;NCT02581202&#39;,
   &#39;NCT02650271&#39;,
   &#39;NCT02652793&#39;,
   &#39;NCT02770508&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01530984&#39;,
   &#39;NCT02224768&#39;,
   &#39;NCT02307149&#39;,
   &#39;NCT02406183&#39;,
   &#39;NCT02423928&#39;,
   &#39;NCT02452281&#39;,
   &#39;NCT02498756&#39;,
   &#39;NCT02608437&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02479308&#39;, &#39;NCT02515864&#39;, &#39;NCT02537288&#39;, &#39;NCT02559310&#39;]},
 {&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01613677&#39;, &#39;NCT02117817&#39;, &#39;NCT02452294&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;, &#39;trials&#39;: [&#39;NCT01614197&#39;]},
 {&#39;description&#39;: &#39;toll-like receptor&#39;,
  &#39;trials&#39;: [&#39;NCT01663558&#39;, &#39;NCT02059499&#39;, &#39;NCT02130323&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT01718444&#39;,
   &#39;NCT02255175&#39;,
   &#39;NCT02400021&#39;,
   &#39;NCT02470676&#39;,
   &#39;NCT02579421&#39;,
   &#39;NCT02601898&#39;,
   &#39;NCT02655146&#39;,
   &#39;NCT02697331&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT01854762&#39;]},
 {&#39;description&#39;: &#39;beta-blockers (propranolol type)&#39;,
  &#39;trials&#39;: [&#39;NCT02369900&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antihypertensives (ACE inhibitors)&#39;,
  &#39;trials&#39;: [&#39;NCT01922141&#39;, &#39;NCT02499822&#39;, &#39;NCT02842424&#39;]},
 {&#39;description&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02279576&#39;, &#39;NCT02331498&#39;, &#39;NCT02378142&#39;, &#39;NCT02406521&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01931098&#39;,
   &#39;NCT02298348&#39;,
   &#39;NCT02390843&#39;,
   &#39;NCT02421588&#39;,
   &#39;NCT02866370&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT01171482&#39;, &#39;NCT01953406&#39;, &#39;NCT02106572&#39;]},
 {&#39;description&#39;: &#39;nootropic agents (learning&#39;, &#39;trials&#39;: [&#39;NCT01960075&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01967251&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01613677&#39;, &#39;NCT02117817&#39;, &#39;NCT02452294&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01979393&#39;, &#39;NCT02132598&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01983475&#39;,
   &#39;NCT02299817&#39;,
   &#39;NCT02321280&#39;,
   &#39;NCT02422108&#39;,
   &#39;NCT02613416&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02577315&#39;, &#39;NCT02637973&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02009605&#39;,
   &#39;NCT02264210&#39;,
   &#39;NCT02375581&#39;,
   &#39;NCT02404675&#39;,
   &#39;NCT02448797&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02014103&#39;,
   &#39;NCT02122081&#39;,
   &#39;NCT02158052&#39;,
   &#39;NCT02373202&#39;,
   &#39;NCT02382575&#39;,
   &#39;NCT02432833&#39;,
   &#39;NCT02446964&#39;,
   &#39;NCT02447055&#39;,
   &#39;NCT02466997&#39;,
   &#39;NCT02495077&#39;,
   &#39;NCT02498977&#39;,
   &#39;NCT02528877&#39;,
   &#39;NCT02608606&#39;,
   &#39;NCT02743247&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02036086&#39;,
   &#39;NCT02230306&#39;,
   &#39;NCT02427893&#39;,
   &#39;NCT02456701&#39;,
   &#39;NCT02638428&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02056171&#39;, &#39;NCT02297763&#39;, &#39;NCT02451306&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;toll-like receptor&#39;,
  &#39;trials&#39;: [&#39;NCT01663558&#39;, &#39;NCT02059499&#39;, &#39;NCT02130323&#39;]},
 {&#39;description&#39;: &#39;dopamine receptor agonists&#39;, &#39;trials&#39;: [&#39;NCT02066571&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02067013&#39;,
   &#39;NCT02258009&#39;,
   &#39;NCT02328118&#39;,
   &#39;NCT02447185&#39;,
   &#39;NCT02462304&#39;,
   &#39;NCT02511613&#39;,
   &#39;NCT02522897&#39;,
   &#39;NCT02527733&#39;,
   &#39;NCT02646670&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02071940&#39;, &#39;NCT02452424&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02487563&#39;]},
 {&#39;description&#39;: &#39;hedgehog signaling inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02073838&#39;, &#39;NCT02436408&#39;, &#39;NCT02523014&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;endothelin receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02080637&#39;, &#39;NCT02712346&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;beta-blockers (propranolol type)&#39;,
  &#39;trials&#39;: [&#39;NCT02369900&#39;]},
 {&#39;description&#39;: &#39;cardiotonics (amrinone type)&#39;,
  &#39;trials&#39;: [&#39;NCT02098629&#39;, &#39;NCT02640846&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;thrombopoetin agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02099747&#39;, &#39;NCT02446145&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT01171482&#39;, &#39;NCT01953406&#39;, &#39;NCT02106572&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02108860&#39;,
   &#39;NCT02281058&#39;,
   &#39;NCT02429934&#39;,
   &#39;NCT02594735&#39;,
   &#39;NCT02598466&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02109653&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02113891&#39;, &#39;NCT02493725&#39;, &#39;NCT02574403&#39;]},
 {&#39;description&#39;: &#39;endothelin receptor antagonists&#39;, &#39;trials&#39;: [&#39;NCT02116335&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02117765&#39;, &#39;NCT02561806&#39;]},
 {&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01613677&#39;, &#39;NCT02117817&#39;, &#39;NCT02452294&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02014103&#39;,
   &#39;NCT02122081&#39;,
   &#39;NCT02158052&#39;,
   &#39;NCT02373202&#39;,
   &#39;NCT02382575&#39;,
   &#39;NCT02432833&#39;,
   &#39;NCT02446964&#39;,
   &#39;NCT02447055&#39;,
   &#39;NCT02466997&#39;,
   &#39;NCT02495077&#39;,
   &#39;NCT02498977&#39;,
   &#39;NCT02528877&#39;,
   &#39;NCT02608606&#39;,
   &#39;NCT02743247&#39;]},
 {&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02124811&#39;,
   &#39;NCT02187211&#39;,
   &#39;NCT02201563&#39;,
   &#39;NCT02362529&#39;,
   &#39;NCT02456948&#39;,
   &#39;NCT02515955&#39;,
   &#39;NCT02533232&#39;,
   &#39;NCT02564978&#39;,
   &#39;NCT02569307&#39;,
   &#39;NCT02907437&#39;,
   &#39;NCT02928692&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;toll-like receptor&#39;,
  &#39;trials&#39;: [&#39;NCT01663558&#39;, &#39;NCT02059499&#39;, &#39;NCT02130323&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01979393&#39;, &#39;NCT02132598&#39;]},
 {&#39;description&#39;: &#39;antiestrogens of the clomifene and tamoxifen groups&#39;,
  &#39;trials&#39;: [&#39;NCT02137265&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trials&#39;: [&#39;NCT02147834&#39;, &#39;NCT02252406&#39;, &#39;NCT02423265&#39;]},
 {&#39;description&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02301000&#39;,
   &#39;NCT02458781&#39;,
   &#39;NCT02527941&#39;,
   &#39;NCT02642250&#39;,
   &#39;NCT02969928&#39;,
   &#39;NCT03692299&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02154061&#39;,
   &#39;NCT02285140&#39;,
   &#39;NCT02374853&#39;,
   &#39;NCT02384200&#39;,
   &#39;NCT02400112&#39;,
   &#39;NCT02463747&#39;,
   &#39;NCT02464020&#39;,
   &#39;NCT02605213&#39;,
   &#39;NCT02607618&#39;,
   &#39;NCT02631408&#39;,
   &#39;NCT02660346&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02014103&#39;,
   &#39;NCT02122081&#39;,
   &#39;NCT02158052&#39;,
   &#39;NCT02373202&#39;,
   &#39;NCT02382575&#39;,
   &#39;NCT02432833&#39;,
   &#39;NCT02446964&#39;,
   &#39;NCT02447055&#39;,
   &#39;NCT02466997&#39;,
   &#39;NCT02495077&#39;,
   &#39;NCT02498977&#39;,
   &#39;NCT02528877&#39;,
   &#39;NCT02608606&#39;,
   &#39;NCT02743247&#39;]},
 {&#39;description&#39;: &#39;immunomodulators&#39;, &#39;trials&#39;: [&#39;NCT02159027&#39;, &#39;NCT02961829&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02419378&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02164500&#39;, &#39;NCT02400463&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;,
  &#39;trials&#39;: [&#39;NCT02164578&#39;,
   &#39;NCT02273700&#39;,
   &#39;NCT02549963&#39;,
   &#39;NCT02610933&#39;,
   &#39;NCT02627053&#39;,
   &#39;NCT02642419&#39;]},
 {&#39;description&#39;: &#39;(nifedipine type)&#39;, &#39;trials&#39;: [&#39;NCT02165644&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;, &#39;trials&#39;: [&#39;NCT02166658&#39;, &#39;NCT02478502&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;, &#39;trials&#39;: [&#39;NCT02171416&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02176031&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;, &#39;trials&#39;: [&#39;NCT02179177&#39;, &#39;NCT02378623&#39;]},
 {&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;trials&#39;: [&#39;NCT02447094&#39;]},
 {&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;trials&#39;: [&#39;NCT02180204&#39;, &#39;NCT02398656&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02186574&#39;,
   &#39;NCT02452528&#39;,
   &#39;NCT02475915&#39;,
   &#39;NCT02505009&#39;,
   &#39;NCT02560649&#39;,
   &#39;NCT02577029&#39;,
   &#39;NCT02585947&#39;,
   &#39;NCT02632474&#39;]},
 {&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02124811&#39;,
   &#39;NCT02187211&#39;,
   &#39;NCT02201563&#39;,
   &#39;NCT02362529&#39;,
   &#39;NCT02456948&#39;,
   &#39;NCT02515955&#39;,
   &#39;NCT02533232&#39;,
   &#39;NCT02564978&#39;,
   &#39;NCT02569307&#39;,
   &#39;NCT02907437&#39;,
   &#39;NCT02928692&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02373241&#39;, &#39;NCT02663141&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02194842&#39;,
   &#39;NCT02438007&#39;,
   &#39;NCT02507570&#39;,
   &#39;NCT02814968&#39;,
   &#39;NCT02815033&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;, &#39;trials&#39;: [&#39;NCT02194933&#39;]},
 {&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02124811&#39;,
   &#39;NCT02187211&#39;,
   &#39;NCT02201563&#39;,
   &#39;NCT02362529&#39;,
   &#39;NCT02456948&#39;,
   &#39;NCT02515955&#39;,
   &#39;NCT02533232&#39;,
   &#39;NCT02564978&#39;,
   &#39;NCT02569307&#39;,
   &#39;NCT02907437&#39;,
   &#39;NCT02928692&#39;]},
 {&#39;description&#39;: &#39;proteozome inhibitors&#39;, &#39;trials&#39;: [&#39;NCT02474927&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;estrogen antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02383030&#39;, &#39;NCT02384746&#39;, &#39;NCT02404051&#39;, &#39;NCT02530411&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02211014&#39;, &#39;NCT02537444&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02446860&#39;,
   &#39;NCT02497508&#39;,
   &#39;NCT02499367&#39;,
   &#39;NCT02550249&#39;,
   &#39;NCT02569242&#39;,
   &#39;NCT02637531&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02359058&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;oxytocin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02216383&#39;, &#39;NCT02391636&#39;, &#39;NCT02396303&#39;, &#39;NCT02528136&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02217501&#39;,
   &#39;NCT02379676&#39;,
   &#39;NCT02429271&#39;,
   &#39;NCT02439190&#39;,
   &#39;NCT02447809&#39;,
   &#39;NCT02457130&#39;,
   &#39;NCT02469740&#39;,
   &#39;NCT02486367&#39;,
   &#39;NCT02499666&#39;,
   &#39;NCT02505399&#39;,
   &#39;NCT02513004&#39;,
   &#39;NCT02514642&#39;,
   &#39;NCT02519608&#39;,
   &#39;NCT02560688&#39;,
   &#39;NCT02578537&#39;,
   &#39;NCT02578706&#39;,
   &#39;NCT02580149&#39;,
   &#39;NCT02612480&#39;,
   &#39;NCT02626169&#39;,
   &#39;NCT02639143&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;ionotropic non-NMDA (N-methyl D-aspartate) glutamate receptors [AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor) and/or KA (kainite antagonist) receptors]&#39;,
  &#39;trials&#39;: [&#39;NCT02220972&#39;, &#39;NCT02668146&#39;, &#39;NCT02727101&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01530984&#39;,
   &#39;NCT02224768&#39;,
   &#39;NCT02307149&#39;,
   &#39;NCT02406183&#39;,
   &#39;NCT02423928&#39;,
   &#39;NCT02452281&#39;,
   &#39;NCT02498756&#39;,
   &#39;NCT02608437&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;, &#39;trials&#39;: [&#39;NCT02229240&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02230176&#39;,
   &#39;NCT02398552&#39;,
   &#39;NCT02401815&#39;,
   &#39;NCT02432846&#39;,
   &#39;NCT02483247&#39;]},
 {&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02036086&#39;,
   &#39;NCT02230306&#39;,
   &#39;NCT02427893&#39;,
   &#39;NCT02456701&#39;,
   &#39;NCT02638428&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;selective melatonin receptor agonist&#39;,
  &#39;trials&#39;: [&#39;NCT02231008&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;depsipeptide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02232516&#39;, &#39;NCT02296398&#39;, &#39;NCT02512172&#39;]},
 {&#39;description&#39;: &#39;ecteinascidin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02234050&#39;, &#39;NCT02359474&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02479308&#39;, &#39;NCT02515864&#39;, &#39;NCT02537288&#39;, &#39;NCT02559310&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02239458&#39;,
   &#39;NCT02280486&#39;,
   &#39;NCT02304081&#39;,
   &#39;NCT02315495&#39;,
   &#39;NCT02462369&#39;,
   &#39;NCT02481479&#39;,
   &#39;NCT02597101&#39;,
   &#39;NCT02605772&#39;,
   &#39;NCT02742233&#39;]},
 {&#39;description&#39;: &#39;colony-stimulating factors&#39;, &#39;trials&#39;: [&#39;NCT02240537&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02268864&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02250807&#39;,
   &#39;NCT02319031&#39;,
   &#39;NCT02371408&#39;,
   &#39;NCT02473211&#39;,
   &#39;NCT02485080&#39;,
   &#39;NCT02551861&#39;,
   &#39;NCT02556086&#39;,
   &#39;NCT02596880&#39;,
   &#39;NCT02640157&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trials&#39;: [&#39;NCT02147834&#39;, &#39;NCT02252406&#39;, &#39;NCT02423265&#39;]},
 {&#39;description&#39;: &#39;hedgehog signaling inhibitors&#39;, &#39;trials&#39;: [&#39;NCT02254551&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT01718444&#39;,
   &#39;NCT02255175&#39;,
   &#39;NCT02400021&#39;,
   &#39;NCT02470676&#39;,
   &#39;NCT02579421&#39;,
   &#39;NCT02601898&#39;,
   &#39;NCT02655146&#39;,
   &#39;NCT02697331&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trials&#39;: [&#39;NCT02384759&#39;,
   &#39;NCT02401945&#39;,
   &#39;NCT02441907&#39;,
   &#39;NCT02537054&#39;,
   &#39;NCT02550002&#39;,
   &#39;NCT02559180&#39;,
   &#39;NCT02586727&#39;,
   &#39;NCT02597855&#39;,
   &#39;NCT02669953&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02067013&#39;,
   &#39;NCT02258009&#39;,
   &#39;NCT02328118&#39;,
   &#39;NCT02447185&#39;,
   &#39;NCT02462304&#39;,
   &#39;NCT02511613&#39;,
   &#39;NCT02522897&#39;,
   &#39;NCT02527733&#39;,
   &#39;NCT02646670&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;spasmolytic agents (papaverine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02260154&#39;]},
 {&#39;description&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02458235&#39;, &#39;NCT02489929&#39;, &#39;NCT02543879&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;antihyperlipidaemics&#39;, &#39;trials&#39;: [&#39;NCT02260648&#39;]},
 {&#39;description&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02506023&#39;, &#39;NCT02937896&#39;, &#39;NCT03343418&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02263898&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02009605&#39;,
   &#39;NCT02264210&#39;,
   &#39;NCT02375581&#39;,
   &#39;NCT02404675&#39;,
   &#39;NCT02448797&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02496078&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02268864&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;, &#39;trials&#39;: [&#39;NCT02608996&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02269072&#39;,
   &#39;NCT02361190&#39;,
   &#39;NCT02419105&#39;,
   &#39;NCT02433730&#39;,
   &#39;NCT02445716&#39;]},
 {&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trials&#39;: [&#39;NCT02269319&#39;,
   &#39;NCT02269644&#39;,
   &#39;NCT02333799&#39;,
   &#39;NCT02426918&#39;,
   &#39;NCT02570490&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02282176&#39;,
   &#39;NCT02344628&#39;,
   &#39;NCT02380625&#39;,
   &#39;NCT02527005&#39;,
   &#39;NCT02531984&#39;,
   &#39;NCT02544984&#39;,
   &#39;NCT02630394&#39;,
   &#39;NCT02839408&#39;]},
 {&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trials&#39;: [&#39;NCT02269319&#39;,
   &#39;NCT02269644&#39;,
   &#39;NCT02333799&#39;,
   &#39;NCT02426918&#39;,
   &#39;NCT02570490&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02269969&#39;, &#39;NCT02489955&#39;, &#39;NCT02526004&#39;, &#39;NCT03705962&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02153177&#39;,
   &#39;NCT02272725&#39;,
   &#39;NCT02344225&#39;,
   &#39;NCT02443142&#39;,
   &#39;NCT02476422&#39;,
   &#39;NCT02480114&#39;,
   &#39;NCT02482155&#39;,
   &#39;NCT02507219&#39;,
   &#39;NCT02521207&#39;,
   &#39;NCT02531451&#39;,
   &#39;NCT02588027&#39;,
   &#39;NCT02593721&#39;,
   &#39;NCT02602483&#39;,
   &#39;NCT02629354&#39;,
   &#39;NCT02666846&#39;,
   &#39;NCT02902913&#39;,
   &#39;NCT03055247&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02272946&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;,
  &#39;trials&#39;: [&#39;NCT02164578&#39;,
   &#39;NCT02273700&#39;,
   &#39;NCT02549963&#39;,
   &#39;NCT02610933&#39;,
   &#39;NCT02627053&#39;,
   &#39;NCT02642419&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02274792&#39;, &#39;NCT02322580&#39;, &#39;NCT02464033&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02277197&#39;, &#39;NCT02484833&#39;, &#39;NCT02490436&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02487316&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02277457&#39;, &#39;NCT02399566&#39;, &#39;NCT02424617&#39;, &#39;NCT02556593&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02278081&#39;, &#39;NCT02633930&#39;, &#39;NCT02759393&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02279576&#39;, &#39;NCT02331498&#39;, &#39;NCT02378142&#39;, &#39;NCT02406521&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02239458&#39;,
   &#39;NCT02280486&#39;,
   &#39;NCT02304081&#39;,
   &#39;NCT02315495&#39;,
   &#39;NCT02462369&#39;,
   &#39;NCT02481479&#39;,
   &#39;NCT02597101&#39;,
   &#39;NCT02605772&#39;,
   &#39;NCT02742233&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02108860&#39;,
   &#39;NCT02281058&#39;,
   &#39;NCT02429934&#39;,
   &#39;NCT02594735&#39;,
   &#39;NCT02598466&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02282176&#39;,
   &#39;NCT02344628&#39;,
   &#39;NCT02380625&#39;,
   &#39;NCT02527005&#39;,
   &#39;NCT02531984&#39;,
   &#39;NCT02544984&#39;,
   &#39;NCT02630394&#39;,
   &#39;NCT02839408&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02283177&#39;, &#39;NCT02560025&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;, &#39;trials&#39;: [&#39;NCT02179177&#39;, &#39;NCT02378623&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT01528865&#39;,
   &#39;NCT02482272&#39;,
   &#39;NCT02566707&#39;,
   &#39;NCT02581202&#39;,
   &#39;NCT02650271&#39;,
   &#39;NCT02652793&#39;,
   &#39;NCT02770508&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02154061&#39;,
   &#39;NCT02285140&#39;,
   &#39;NCT02374853&#39;,
   &#39;NCT02384200&#39;,
   &#39;NCT02400112&#39;,
   &#39;NCT02463747&#39;,
   &#39;NCT02464020&#39;,
   &#39;NCT02605213&#39;,
   &#39;NCT02607618&#39;,
   &#39;NCT02631408&#39;,
   &#39;NCT02660346&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02194842&#39;,
   &#39;NCT02438007&#39;,
   &#39;NCT02507570&#39;,
   &#39;NCT02814968&#39;,
   &#39;NCT02815033&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02289144&#39;, &#39;NCT02343679&#39;, &#39;NCT02374489&#39;, &#39;NCT02638909&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02289963&#39;, &#39;NCT02326220&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02290327&#39;, &#39;NCT02345239&#39;, &#39;NCT02432456&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02291055&#39;,
   &#39;NCT02336165&#39;,
   &#39;NCT02401048&#39;,
   &#39;NCT02431559&#39;,
   &#39;NCT02489448&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02292225&#39;,
   &#39;NCT02393157&#39;,
   &#39;NCT02475681&#39;,
   &#39;NCT02495454&#39;,
   &#39;NCT02537613&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;proteozome inhibitors&#39;, &#39;trials&#39;: [&#39;NCT02474927&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;, &#39;trials&#39;: [&#39;NCT02179177&#39;, &#39;NCT02378623&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02296112&#39;,
   &#39;NCT02357732&#39;,
   &#39;NCT02399943&#39;,
   &#39;NCT02439411&#39;,
   &#39;NCT02538627&#39;]},
 {&#39;description&#39;: &#39;depsipeptide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02232516&#39;, &#39;NCT02296398&#39;, &#39;NCT02512172&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02296671&#39;,
   &#39;NCT02488694&#39;,
   &#39;NCT02489903&#39;,
   &#39;NCT02518802&#39;,
   &#39;NCT02588781&#39;,
   &#39;NCT02603003&#39;,
   &#39;NCT02868892&#39;,
   &#39;NCT02980991&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02296801&#39;,
   &#39;NCT02310243&#39;,
   &#39;NCT02448771&#39;,
   &#39;NCT02513394&#39;,
   &#39;NCT02530320&#39;,
   &#39;NCT02592083&#39;,
   &#39;NCT02806648&#39;]},
 {&#39;description&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02056171&#39;, &#39;NCT02297763&#39;, &#39;NCT02451306&#39;]},
 {&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trials&#39;: [&#39;NCT02497131&#39;, &#39;NCT02499627&#39;, &#39;NCT02533570&#39;, &#39;NCT02780011&#39;]},
 {&#39;description&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;,
  &#39;trials&#39;: [&#39;NCT02298257&#39;, &#39;NCT02412670&#39;, &#39;NCT02414568&#39;]},
 {&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trials&#39;: [&#39;NCT02497131&#39;, &#39;NCT02499627&#39;, &#39;NCT02533570&#39;, &#39;NCT02780011&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01931098&#39;,
   &#39;NCT02298348&#39;,
   &#39;NCT02390843&#39;,
   &#39;NCT02421588&#39;,
   &#39;NCT02866370&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01983475&#39;,
   &#39;NCT02299817&#39;,
   &#39;NCT02321280&#39;,
   &#39;NCT02422108&#39;,
   &#39;NCT02613416&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02301000&#39;,
   &#39;NCT02458781&#39;,
   &#39;NCT02527941&#39;,
   &#39;NCT02642250&#39;,
   &#39;NCT02969928&#39;,
   &#39;NCT03692299&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02301949&#39;,
   &#39;NCT02387086&#39;,
   &#39;NCT02467647&#39;,
   &#39;NCT02545907&#39;,
   &#39;NCT02586038&#39;,
   &#39;NCT02649101&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;,
  &#39;trials&#39;: [&#39;NCT02164578&#39;,
   &#39;NCT02273700&#39;,
   &#39;NCT02549963&#39;,
   &#39;NCT02610933&#39;,
   &#39;NCT02627053&#39;,
   &#39;NCT02642419&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02239458&#39;,
   &#39;NCT02280486&#39;,
   &#39;NCT02304081&#39;,
   &#39;NCT02315495&#39;,
   &#39;NCT02462369&#39;,
   &#39;NCT02481479&#39;,
   &#39;NCT02597101&#39;,
   &#39;NCT02605772&#39;,
   &#39;NCT02742233&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01530984&#39;,
   &#39;NCT02224768&#39;,
   &#39;NCT02307149&#39;,
   &#39;NCT02406183&#39;,
   &#39;NCT02423928&#39;,
   &#39;NCT02452281&#39;,
   &#39;NCT02498756&#39;,
   &#39;NCT02608437&#39;]},
 {&#39;description&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02301000&#39;,
   &#39;NCT02458781&#39;,
   &#39;NCT02527941&#39;,
   &#39;NCT02642250&#39;,
   &#39;NCT02969928&#39;,
   &#39;NCT03692299&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02308007&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02308072&#39;, &#39;NCT02340611&#39;, &#39;NCT02477644&#39;, &#39;NCT02533765&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02296801&#39;,
   &#39;NCT02310243&#39;,
   &#39;NCT02448771&#39;,
   &#39;NCT02513394&#39;,
   &#39;NCT02530320&#39;,
   &#39;NCT02592083&#39;,
   &#39;NCT02806648&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02310867&#39;, &#39;NCT02560558&#39;]},
 {&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02311569&#39;,
   &#39;NCT02354807&#39;,
   &#39;NCT02361502&#39;,
   &#39;NCT02410135&#39;,
   &#39;NCT02462837&#39;,
   &#39;NCT02495389&#39;,
   &#39;NCT02536976&#39;,
   &#39;NCT02540707&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02312375&#39;, &#39;NCT02397590&#39;, &#39;NCT02566187&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antianxiety agents (diazepam type)&#39;,
  &#39;trials&#39;: [&#39;NCT02312908&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;transforming growth factors&#39;, &#39;trials&#39;: [&#39;NCT02313792&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02310867&#39;, &#39;NCT02560558&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02239458&#39;,
   &#39;NCT02280486&#39;,
   &#39;NCT02304081&#39;,
   &#39;NCT02315495&#39;,
   &#39;NCT02462369&#39;,
   &#39;NCT02481479&#39;,
   &#39;NCT02597101&#39;,
   &#39;NCT02605772&#39;,
   &#39;NCT02742233&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02292225&#39;,
   &#39;NCT02393157&#39;,
   &#39;NCT02475681&#39;,
   &#39;NCT02495454&#39;,
   &#39;NCT02537613&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02317159&#39;,
   &#39;NCT02352558&#39;,
   &#39;NCT02365441&#39;,
   &#39;NCT02413736&#39;,
   &#39;NCT02462538&#39;,
   &#39;NCT02576080&#39;,
   &#39;NCT02614404&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02496078&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02250807&#39;,
   &#39;NCT02319031&#39;,
   &#39;NCT02371408&#39;,
   &#39;NCT02473211&#39;,
   &#39;NCT02485080&#39;,
   &#39;NCT02551861&#39;,
   &#39;NCT02556086&#39;,
   &#39;NCT02596880&#39;,
   &#39;NCT02640157&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;-curonium&#39;,
  &#39;trials&#39;: [&#39;NCT02320734&#39;,
   &#39;NCT02451202&#39;,
   &#39;NCT02464722&#39;,
   &#39;NCT02471521&#39;,
   &#39;NCT02546843&#39;,
   &#39;NCT02553629&#39;,
   &#39;NCT02601508&#39;,
   &#39;NCT02711917&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01983475&#39;,
   &#39;NCT02299817&#39;,
   &#39;NCT02321280&#39;,
   &#39;NCT02422108&#39;,
   &#39;NCT02613416&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;-sal-&#39;, &#39;trials&#39;: [&#39;NCT02321852&#39;, &#39;NCT02616497&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02274792&#39;, &#39;NCT02322580&#39;, &#39;NCT02464033&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02348450&#39;,
   &#39;NCT02453464&#39;,
   &#39;NCT02596503&#39;,
   &#39;NCT02641873&#39;,
   &#39;NCT02662959&#39;,
   &#39;NCT02934529&#39;,
   &#39;NCT03400592&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02326103&#39;,
   &#39;NCT02375295&#39;,
   &#39;NCT02423759&#39;,
   &#39;NCT02598362&#39;,
   &#39;NCT02734732&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02289963&#39;, &#39;NCT02326220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02326285&#39;, &#39;NCT02484755&#39;, &#39;NCT02804776&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02317159&#39;,
   &#39;NCT02352558&#39;,
   &#39;NCT02365441&#39;,
   &#39;NCT02413736&#39;,
   &#39;NCT02462538&#39;,
   &#39;NCT02576080&#39;,
   &#39;NCT02614404&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02326311&#39;, &#39;NCT02389920&#39;, &#39;NCT02733445&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02512809&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02327143&#39;, &#39;NCT02387814&#39;, &#39;NCT02482935&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02327676&#39;, &#39;NCT02327702&#39;, &#39;NCT02327715&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02327676&#39;, &#39;NCT02327702&#39;, &#39;NCT02327715&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02327676&#39;, &#39;NCT02327702&#39;, &#39;NCT02327715&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02067013&#39;,
   &#39;NCT02258009&#39;,
   &#39;NCT02328118&#39;,
   &#39;NCT02447185&#39;,
   &#39;NCT02462304&#39;,
   &#39;NCT02511613&#39;,
   &#39;NCT02522897&#39;,
   &#39;NCT02527733&#39;,
   &#39;NCT02646670&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02279576&#39;, &#39;NCT02331498&#39;, &#39;NCT02378142&#39;, &#39;NCT02406521&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02332590&#39;,
   &#39;NCT02437253&#39;,
   &#39;NCT02489227&#39;,
   &#39;NCT02492217&#39;,
   &#39;NCT02533375&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02333565&#39;,
   &#39;NCT02381249&#39;,
   &#39;NCT02384122&#39;,
   &#39;NCT02437825&#39;,
   &#39;NCT02457156&#39;]},
 {&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trials&#39;: [&#39;NCT02451527&#39;]},
 {&#39;description&#39;: &#39;diuretics (furosemide type)&#39;,
  &#39;trials&#39;: [&#39;NCT02333643&#39;,
   &#39;NCT02345681&#39;,
   &#39;NCT02417883&#39;,
   &#39;NCT02450773&#39;,
   &#39;NCT02689180&#39;,
   &#39;NCT02881866&#39;]},
 {&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trials&#39;: [&#39;NCT02269319&#39;,
   &#39;NCT02269644&#39;,
   &#39;NCT02333799&#39;,
   &#39;NCT02426918&#39;,
   &#39;NCT02570490&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;penicillins&#39;, &#39;trials&#39;: [&#39;NCT02334124&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02335346&#39;, &#39;NCT02367404&#39;, &#39;NCT02443194&#39;, &#39;NCT02600247&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02291055&#39;,
   &#39;NCT02336165&#39;,
   &#39;NCT02401048&#39;,
   &#39;NCT02431559&#39;,
   &#39;NCT02489448&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02342379&#39;,
   &#39;NCT02511405&#39;,
   &#39;NCT02521051&#39;,
   &#39;NCT02594423&#39;,
   &#39;NCT02648711&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (mitotic inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02338037&#39;, &#39;NCT02396433&#39;]},
 {&#39;description&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02338323&#39;]},
 {&#39;description&#39;: &#39;interleukin 3 deriviatives&#39;,
  &#39;trials&#39;: [&#39;NCT02338414&#39;, &#39;NCT02868060&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;, &#39;trials&#39;: [&#39;NCT02338960&#39;]},
 {&#39;description&#39;: &#39;antidepressants (dibenzol[a&#39;, &#39;trials&#39;: [&#39;NCT02519400&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02308072&#39;, &#39;NCT02340611&#39;, &#39;NCT02477644&#39;, &#39;NCT02533765&#39;]},
 {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trials&#39;: [&#39;NCT02384759&#39;,
   &#39;NCT02401945&#39;,
   &#39;NCT02441907&#39;,
   &#39;NCT02537054&#39;,
   &#39;NCT02550002&#39;,
   &#39;NCT02559180&#39;,
   &#39;NCT02586727&#39;,
   &#39;NCT02597855&#39;,
   &#39;NCT02669953&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02341911&#39;]},
 {&#39;description&#39;: &#39;progesterone receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02354170&#39;, &#39;NCT02642939&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02342379&#39;,
   &#39;NCT02511405&#39;,
   &#39;NCT02521051&#39;,
   &#39;NCT02594423&#39;,
   &#39;NCT02648711&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02479308&#39;, &#39;NCT02515864&#39;, &#39;NCT02537288&#39;, &#39;NCT02559310&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02416570&#39;, &#39;NCT02573935&#39;]},
 {&#39;description&#39;: &#39;antihypertensives (hydrazine-phthalazines)&#39;,
  &#39;trials&#39;: [&#39;NCT02343393&#39;]},
 {&#39;description&#39;: &#39;(see -perone)&#39;, &#39;trials&#39;: [&#39;NCT02343575&#39;, &#39;NCT02747511&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02289144&#39;, &#39;NCT02343679&#39;, &#39;NCT02374489&#39;, &#39;NCT02638909&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02153177&#39;,
   &#39;NCT02272725&#39;,
   &#39;NCT02344225&#39;,
   &#39;NCT02443142&#39;,
   &#39;NCT02476422&#39;,
   &#39;NCT02480114&#39;,
   &#39;NCT02482155&#39;,
   &#39;NCT02507219&#39;,
   &#39;NCT02521207&#39;,
   &#39;NCT02531451&#39;,
   &#39;NCT02588027&#39;,
   &#39;NCT02593721&#39;,
   &#39;NCT02602483&#39;,
   &#39;NCT02629354&#39;,
   &#39;NCT02666846&#39;,
   &#39;NCT02902913&#39;,
   &#39;NCT03055247&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02344290&#39;, &#39;NCT02595268&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;,
  &#39;trials&#39;: [&#39;NCT02623751&#39;]},
 {&#39;description&#39;: &#39;estrogen antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02383030&#39;, &#39;NCT02384746&#39;, &#39;NCT02404051&#39;, &#39;NCT02530411&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02282176&#39;,
   &#39;NCT02344628&#39;,
   &#39;NCT02380625&#39;,
   &#39;NCT02527005&#39;,
   &#39;NCT02531984&#39;,
   &#39;NCT02544984&#39;,
   &#39;NCT02630394&#39;,
   &#39;NCT02839408&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02290327&#39;, &#39;NCT02345239&#39;, &#39;NCT02432456&#39;]},
 {&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trials&#39;: [&#39;NCT02451527&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01408849&#39;,
   &#39;NCT02365558&#39;,
   &#39;NCT02422706&#39;,
   &#39;NCT02552537&#39;,
   &#39;NCT02609386&#39;,
   &#39;NCT02621359&#39;,
   &#39;NCT02893709&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;diuretics (furosemide type)&#39;,
  &#39;trials&#39;: [&#39;NCT02333643&#39;,
   &#39;NCT02345681&#39;,
   &#39;NCT02417883&#39;,
   &#39;NCT02450773&#39;,
   &#39;NCT02689180&#39;,
   &#39;NCT02881866&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02348281&#39;, &#39;NCT02353988&#39;, &#39;NCT02605226&#39;, &#39;NCT02615223&#39;]},
 {&#39;description&#39;: &#39;hormone-release inhibiting peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02526784&#39;]},
 {&#39;description&#39;: &#39;thyrotropin releasing hormone analogues&#39;,
  &#39;trials&#39;: [&#39;NCT02346253&#39;, &#39;NCT02483767&#39;]},
 {&#39;description&#39;: &#39;antianxiety&#39;, &#39;trials&#39;: [&#39;NCT02346682&#39;, &#39;NCT02655354&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;dopamine receptor agonists&#39;, &#39;trials&#39;: [&#39;NCT02554734&#39;]},
 {&#39;description&#39;: &#39;combined alpha and beta blockers&#39;,
  &#39;trials&#39;: [&#39;NCT02347111&#39;]},
 {&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02347878&#39;, &#39;NCT02357693&#39;, &#39;NCT02646020&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02347891&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02348281&#39;, &#39;NCT02353988&#39;, &#39;NCT02605226&#39;, &#39;NCT02615223&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02348450&#39;,
   &#39;NCT02453464&#39;,
   &#39;NCT02596503&#39;,
   &#39;NCT02641873&#39;,
   &#39;NCT02662959&#39;,
   &#39;NCT02934529&#39;,
   &#39;NCT03400592&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;catechol-O-methyltransferase (COMT) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02349243&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02349828&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;, &#39;trials&#39;: [&#39;NCT02349906&#39;]},
 {&#39;description&#39;: &#39;bronchodilators (phenethylamine derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02349919&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02351102&#39;, &#39;NCT02412917&#39;, &#39;NCT02571166&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;, &#39;trials&#39;: [&#39;NCT02351128&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02351232&#39;,
   &#39;NCT02408705&#39;,
   &#39;NCT02472717&#39;,
   &#39;NCT02473809&#39;,
   &#39;NCT02490176&#39;,
   &#39;NCT02507128&#39;,
   &#39;NCT02518945&#39;,
   &#39;NCT02545738&#39;,
   &#39;NCT02584582&#39;,
   &#39;NCT02617654&#39;,
   &#39;NCT02638805&#39;,
   &#39;NCT02660047&#39;,
   &#39;NCT02909933&#39;,
   &#39;NCT03010683&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;progestins&#39;,
  &#39;trials&#39;: [&#39;NCT02352090&#39;, &#39;NCT02385448&#39;, &#39;NCT02599077&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02317159&#39;,
   &#39;NCT02352558&#39;,
   &#39;NCT02365441&#39;,
   &#39;NCT02413736&#39;,
   &#39;NCT02462538&#39;,
   &#39;NCT02576080&#39;,
   &#39;NCT02614404&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02108860&#39;,
   &#39;NCT02281058&#39;,
   &#39;NCT02429934&#39;,
   &#39;NCT02594735&#39;,
   &#39;NCT02598466&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02353780&#39;,
   &#39;NCT02404558&#39;,
   &#39;NCT02419937&#39;,
   &#39;NCT02469896&#39;,
   &#39;NCT02778789&#39;,
   &#39;NCT02797769&#39;,
   &#39;NCT02888496&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02353936&#39;, &#39;NCT02491099&#39;, &#39;NCT02506517&#39;, &#39;NCT02511847&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02348281&#39;, &#39;NCT02353988&#39;, &#39;NCT02605226&#39;, &#39;NCT02615223&#39;]},
 {&#39;description&#39;: &#39;progesterone receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02354170&#39;, &#39;NCT02642939&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02354222&#39;, &#39;NCT02354235&#39;, &#39;NCT02360774&#39;, &#39;NCT02597309&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02354222&#39;, &#39;NCT02354235&#39;, &#39;NCT02360774&#39;, &#39;NCT02597309&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02354560&#39;]},
 {&#39;description&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02354586&#39;]},
 {&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02311569&#39;,
   &#39;NCT02354807&#39;,
   &#39;NCT02361502&#39;,
   &#39;NCT02410135&#39;,
   &#39;NCT02462837&#39;,
   &#39;NCT02495389&#39;,
   &#39;NCT02536976&#39;,
   &#39;NCT02540707&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02357342&#39;,
   &#39;NCT02432560&#39;,
   &#39;NCT02440789&#39;,
   &#39;NCT02505893&#39;,
   &#39;NCT02513303&#39;,
   &#39;NCT02574728&#39;,
   &#39;NCT02638389&#39;,
   &#39;NCT02675153&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;thyrotropin releasing hormone analogues&#39;,
  &#39;trials&#39;: [&#39;NCT02357654&#39;]},
 {&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02347878&#39;, &#39;NCT02357693&#39;, &#39;NCT02646020&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02446860&#39;,
   &#39;NCT02497508&#39;,
   &#39;NCT02499367&#39;,
   &#39;NCT02550249&#39;,
   &#39;NCT02569242&#39;,
   &#39;NCT02637531&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02296112&#39;,
   &#39;NCT02357732&#39;,
   &#39;NCT02399943&#39;,
   &#39;NCT02439411&#39;,
   &#39;NCT02538627&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;-prost&#39;, &#39;trials&#39;: [&#39;NCT02358369&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02358499&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02358824&#39;, &#39;NCT02593110&#39;, &#39;NCT02933658&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02359058&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;trials&#39;: [&#39;NCT02631109&#39;, &#39;NCT02631239&#39;]},
 {&#39;description&#39;: &#39;ecteinascidin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02234050&#39;, &#39;NCT02359474&#39;]},
 {&#39;description&#39;: &#39;Monoamine oxidase (MAO) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02359552&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02360384&#39;, &#39;NCT02465385&#39;, &#39;NCT02559206&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02360631&#39;,
   &#39;NCT02378714&#39;,
   &#39;NCT02488889&#39;,
   &#39;NCT02562521&#39;,
   &#39;NCT02683161&#39;,
   &#39;NCT02933372&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02354222&#39;, &#39;NCT02354235&#39;, &#39;NCT02360774&#39;, &#39;NCT02597309&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02269072&#39;,
   &#39;NCT02361190&#39;,
   &#39;NCT02419105&#39;,
   &#39;NCT02433730&#39;,
   &#39;NCT02445716&#39;]},
 {&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02311569&#39;,
   &#39;NCT02354807&#39;,
   &#39;NCT02361502&#39;,
   &#39;NCT02410135&#39;,
   &#39;NCT02462837&#39;,
   &#39;NCT02495389&#39;,
   &#39;NCT02536976&#39;,
   &#39;NCT02540707&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02416570&#39;, &#39;NCT02573935&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02361619&#39;, &#39;NCT02473640&#39;, &#39;NCT02552641&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02211014&#39;, &#39;NCT02537444&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02211014&#39;, &#39;NCT02537444&#39;]},
 {&#39;description&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02413203&#39;, &#39;NCT02502500&#39;, &#39;NCT02961998&#39;]},
 {&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02124811&#39;,
   &#39;NCT02187211&#39;,
   &#39;NCT02201563&#39;,
   &#39;NCT02362529&#39;,
   &#39;NCT02456948&#39;,
   &#39;NCT02515955&#39;,
   &#39;NCT02533232&#39;,
   &#39;NCT02564978&#39;,
   &#39;NCT02569307&#39;,
   &#39;NCT02907437&#39;,
   &#39;NCT02928692&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;leukotriene biosynthesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02451540&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02363738&#39;, &#39;NCT02522169&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02317159&#39;,
   &#39;NCT02352558&#39;,
   &#39;NCT02365441&#39;,
   &#39;NCT02413736&#39;,
   &#39;NCT02462538&#39;,
   &#39;NCT02576080&#39;,
   &#39;NCT02614404&#39;]},
 {&#39;description&#39;: &#39;class III antiarrhythmic agents&#39;, &#39;trials&#39;: [&#39;NCT02365532&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01408849&#39;,
   &#39;NCT02365558&#39;,
   &#39;NCT02422706&#39;,
   &#39;NCT02552537&#39;,
   &#39;NCT02609386&#39;,
   &#39;NCT02621359&#39;,
   &#39;NCT02893709&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02335346&#39;, &#39;NCT02367404&#39;, &#39;NCT02443194&#39;, &#39;NCT02600247&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02561169&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02369159&#39;, &#39;NCT02635724&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT01528865&#39;,
   &#39;NCT02482272&#39;,
   &#39;NCT02566707&#39;,
   &#39;NCT02581202&#39;,
   &#39;NCT02650271&#39;,
   &#39;NCT02652793&#39;,
   &#39;NCT02770508&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;, &#39;trials&#39;: [&#39;NCT02369406&#39;]},
 {&#39;description&#39;: &#39;beta-blockers (propranolol type)&#39;,
  &#39;trials&#39;: [&#39;NCT02369900&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trials&#39;: [&#39;NCT02451527&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02250807&#39;,
   &#39;NCT02319031&#39;,
   &#39;NCT02371408&#39;,
   &#39;NCT02473211&#39;,
   &#39;NCT02485080&#39;,
   &#39;NCT02551861&#39;,
   &#39;NCT02556086&#39;,
   &#39;NCT02596880&#39;,
   &#39;NCT02640157&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02479308&#39;, &#39;NCT02515864&#39;, &#39;NCT02537288&#39;, &#39;NCT02559310&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;coronary vasodilators (verapamil type)&#39;,
  &#39;trials&#39;: [&#39;NCT02372253&#39;, &#39;NCT02454491&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trials&#39;: [&#39;NCT02434861&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02014103&#39;,
   &#39;NCT02122081&#39;,
   &#39;NCT02158052&#39;,
   &#39;NCT02373202&#39;,
   &#39;NCT02382575&#39;,
   &#39;NCT02432833&#39;,
   &#39;NCT02446964&#39;,
   &#39;NCT02447055&#39;,
   &#39;NCT02466997&#39;,
   &#39;NCT02495077&#39;,
   &#39;NCT02498977&#39;,
   &#39;NCT02528877&#39;,
   &#39;NCT02608606&#39;,
   &#39;NCT02743247&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02373241&#39;, &#39;NCT02663141&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02289144&#39;, &#39;NCT02343679&#39;, &#39;NCT02374489&#39;, &#39;NCT02638909&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02154061&#39;,
   &#39;NCT02285140&#39;,
   &#39;NCT02374853&#39;,
   &#39;NCT02384200&#39;,
   &#39;NCT02400112&#39;,
   &#39;NCT02463747&#39;,
   &#39;NCT02464020&#39;,
   &#39;NCT02605213&#39;,
   &#39;NCT02607618&#39;,
   &#39;NCT02631408&#39;,
   &#39;NCT02660346&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;-adol-&#39;,
  &#39;trials&#39;: [&#39;NCT02375100&#39;,
   &#39;NCT02419651&#39;,
   &#39;NCT02425709&#39;,
   &#39;NCT02428777&#39;,
   &#39;NCT02484859&#39;,
   &#39;NCT02497326&#39;,
   &#39;NCT02851394&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02326103&#39;,
   &#39;NCT02375295&#39;,
   &#39;NCT02423759&#39;,
   &#39;NCT02598362&#39;,
   &#39;NCT02734732&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02009605&#39;,
   &#39;NCT02264210&#39;,
   &#39;NCT02375581&#39;,
   &#39;NCT02404675&#39;,
   &#39;NCT02448797&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02217501&#39;,
   &#39;NCT02379676&#39;,
   &#39;NCT02429271&#39;,
   &#39;NCT02439190&#39;,
   &#39;NCT02447809&#39;,
   &#39;NCT02457130&#39;,
   &#39;NCT02469740&#39;,
   &#39;NCT02486367&#39;,
   &#39;NCT02499666&#39;,
   &#39;NCT02505399&#39;,
   &#39;NCT02513004&#39;,
   &#39;NCT02514642&#39;,
   &#39;NCT02519608&#39;,
   &#39;NCT02560688&#39;,
   &#39;NCT02578537&#39;,
   &#39;NCT02578706&#39;,
   &#39;NCT02580149&#39;,
   &#39;NCT02612480&#39;,
   &#39;NCT02626169&#39;,
   &#39;NCT02639143&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02376283&#39;, &#39;NCT02487732&#39;, &#39;NCT02548611&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;antiestrogens of the clomifene and tamoxifen groups&#39;,
  &#39;trials&#39;: [&#39;NCT02137265&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02279576&#39;, &#39;NCT02331498&#39;, &#39;NCT02378142&#39;, &#39;NCT02406521&#39;]},
 {&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trials&#39;: [&#39;NCT02269319&#39;,
   &#39;NCT02269644&#39;,
   &#39;NCT02333799&#39;,
   &#39;NCT02426918&#39;,
   &#39;NCT02570490&#39;]},
 {&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02378480&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;, &#39;trials&#39;: [&#39;NCT02179177&#39;, &#39;NCT02378623&#39;]},
 {&#39;description&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02360631&#39;,
   &#39;NCT02378714&#39;,
   &#39;NCT02488889&#39;,
   &#39;NCT02562521&#39;,
   &#39;NCT02683161&#39;,
   &#39;NCT02933372&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02217501&#39;,
   &#39;NCT02379676&#39;,
   &#39;NCT02429271&#39;,
   &#39;NCT02439190&#39;,
   &#39;NCT02447809&#39;,
   &#39;NCT02457130&#39;,
   &#39;NCT02469740&#39;,
   &#39;NCT02486367&#39;,
   &#39;NCT02499666&#39;,
   &#39;NCT02505399&#39;,
   &#39;NCT02513004&#39;,
   &#39;NCT02514642&#39;,
   &#39;NCT02519608&#39;,
   &#39;NCT02560688&#39;,
   &#39;NCT02578537&#39;,
   &#39;NCT02578706&#39;,
   &#39;NCT02580149&#39;,
   &#39;NCT02612480&#39;,
   &#39;NCT02626169&#39;,
   &#39;NCT02639143&#39;]},
 {&#39;description&#39;: &#39;heparin derivatives and low molecular weight (or depolymerized) heparins&#39;,
  &#39;trials&#39;: [&#39;NCT02379806&#39;, &#39;NCT02696330&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02194842&#39;,
   &#39;NCT02438007&#39;,
   &#39;NCT02507570&#39;,
   &#39;NCT02814968&#39;,
   &#39;NCT02815033&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02282176&#39;,
   &#39;NCT02344628&#39;,
   &#39;NCT02380625&#39;,
   &#39;NCT02527005&#39;,
   &#39;NCT02531984&#39;,
   &#39;NCT02544984&#39;,
   &#39;NCT02630394&#39;,
   &#39;NCT02839408&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02333565&#39;,
   &#39;NCT02381249&#39;,
   &#39;NCT02384122&#39;,
   &#39;NCT02437825&#39;,
   &#39;NCT02457156&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;-curonium&#39;,
  &#39;trials&#39;: [&#39;NCT02382510&#39;, &#39;NCT02622243&#39;, &#39;NCT02627625&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02014103&#39;,
   &#39;NCT02122081&#39;,
   &#39;NCT02158052&#39;,
   &#39;NCT02373202&#39;,
   &#39;NCT02382575&#39;,
   &#39;NCT02432833&#39;,
   &#39;NCT02446964&#39;,
   &#39;NCT02447055&#39;,
   &#39;NCT02466997&#39;,
   &#39;NCT02495077&#39;,
   &#39;NCT02498977&#39;,
   &#39;NCT02528877&#39;,
   &#39;NCT02608606&#39;,
   &#39;NCT02743247&#39;]},
 {&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02382666&#39;]},
 {&#39;description&#39;: &#39;antihypertensives (prazosin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02382848&#39;, &#39;NCT02431936&#39;]},
 {&#39;description&#39;: &#39;estrogen antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02383030&#39;, &#39;NCT02384746&#39;, &#39;NCT02404051&#39;, &#39;NCT02530411&#39;]},
 {&#39;description&#39;: &#39;farnesyl transferase inhibitor&#39;,
  &#39;trials&#39;: [&#39;NCT02383927&#39;, &#39;NCT02464228&#39;, &#39;NCT02535650&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02333565&#39;,
   &#39;NCT02381249&#39;,
   &#39;NCT02384122&#39;,
   &#39;NCT02437825&#39;,
   &#39;NCT02457156&#39;]},
 {&#39;description&#39;: &#39;penicillins&#39;, &#39;trials&#39;: [&#39;NCT02477423&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02154061&#39;,
   &#39;NCT02285140&#39;,
   &#39;NCT02374853&#39;,
   &#39;NCT02384200&#39;,
   &#39;NCT02400112&#39;,
   &#39;NCT02463747&#39;,
   &#39;NCT02464020&#39;,
   &#39;NCT02605213&#39;,
   &#39;NCT02607618&#39;,
   &#39;NCT02631408&#39;,
   &#39;NCT02660346&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT01528865&#39;,
   &#39;NCT02482272&#39;,
   &#39;NCT02566707&#39;,
   &#39;NCT02581202&#39;,
   &#39;NCT02650271&#39;,
   &#39;NCT02652793&#39;,
   &#39;NCT02770508&#39;]},
 {&#39;description&#39;: &#39;estrogen antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02383030&#39;, &#39;NCT02384746&#39;, &#39;NCT02404051&#39;, &#39;NCT02530411&#39;]},
 {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trials&#39;: [&#39;NCT02384759&#39;,
   &#39;NCT02401945&#39;,
   &#39;NCT02441907&#39;,
   &#39;NCT02537054&#39;,
   &#39;NCT02550002&#39;,
   &#39;NCT02559180&#39;,
   &#39;NCT02586727&#39;,
   &#39;NCT02597855&#39;,
   &#39;NCT02669953&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02384915&#39;, &#39;NCT02813382&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;progestins&#39;,
  &#39;trials&#39;: [&#39;NCT02352090&#39;, &#39;NCT02385448&#39;, &#39;NCT02599077&#39;]},
 {&#39;description&#39;: &#39;colony-stimulating factors&#39;,
  &#39;trials&#39;: [&#39;NCT02385851&#39;, &#39;NCT03404752&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02326285&#39;, &#39;NCT02484755&#39;, &#39;NCT02804776&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02301949&#39;,
   &#39;NCT02387086&#39;,
   &#39;NCT02467647&#39;,
   &#39;NCT02545907&#39;,
   &#39;NCT02586038&#39;,
   &#39;NCT02649101&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02358824&#39;, &#39;NCT02593110&#39;, &#39;NCT02933658&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02387710&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02211014&#39;, &#39;NCT02537444&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02387801&#39;, &#39;NCT02513550&#39;, &#39;NCT02543918&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02327143&#39;, &#39;NCT02387814&#39;, &#39;NCT02482935&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02427334&#39;,
   &#39;NCT02473250&#39;,
   &#39;NCT02488538&#39;,
   &#39;NCT02562053&#39;,
   &#39;NCT02601677&#39;]},
 {&#39;description&#39;: &#39;sodium channel blockers&#39;,
  &#39;trials&#39;: [&#39;NCT02389712&#39;, &#39;NCT02556060&#39;, &#39;NCT02708849&#39;]},
 {&#39;description&#39;: &#39;adenosine A receptor agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02589977&#39;, &#39;NCT02597543&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02389868&#39;, &#39;NCT02563860&#39;, &#39;NCT02603770&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02326311&#39;, &#39;NCT02389920&#39;, &#39;NCT02733445&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02457910&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01931098&#39;,
   &#39;NCT02298348&#39;,
   &#39;NCT02390843&#39;,
   &#39;NCT02421588&#39;,
   &#39;NCT02866370&#39;]},
 {&#39;description&#39;: &#39;oxytocin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02216383&#39;, &#39;NCT02391636&#39;, &#39;NCT02396303&#39;, &#39;NCT02528136&#39;]},
 {&#39;description&#39;: &#39;vancomycin-related compounds&#39;, &#39;trials&#39;: [&#39;NCT02392208&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02292225&#39;,
   &#39;NCT02393157&#39;,
   &#39;NCT02475681&#39;,
   &#39;NCT02495454&#39;,
   &#39;NCT02537613&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;penicillins&#39;, &#39;trials&#39;: [&#39;NCT02830347&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02394106&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02394106&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02549677&#39;, &#39;NCT02627248&#39;, &#39;NCT02631499&#39;, &#39;NCT02638857&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Micromonospora strains)&#39;,
  &#39;trials&#39;: [&#39;NCT02395848&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;oxytocin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02216383&#39;, &#39;NCT02391636&#39;, &#39;NCT02396303&#39;, &#39;NCT02528136&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (mitotic inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02338037&#39;, &#39;NCT02396433&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02312375&#39;, &#39;NCT02397590&#39;, &#39;NCT02566187&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02312375&#39;, &#39;NCT02397590&#39;, &#39;NCT02566187&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;-fibrate&#39;, &#39;trials&#39;: [&#39;NCT02398201&#39;, &#39;NCT02481245&#39;]},
 {&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trials&#39;: [&#39;NCT02497131&#39;, &#39;NCT02499627&#39;, &#39;NCT02533570&#39;, &#39;NCT02780011&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02398539&#39;, &#39;NCT02655523&#39;, &#39;NCT02704507&#39;, &#39;NCT02967302&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02230176&#39;,
   &#39;NCT02398552&#39;,
   &#39;NCT02401815&#39;,
   &#39;NCT02432846&#39;,
   &#39;NCT02483247&#39;]},
 {&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;trials&#39;: [&#39;NCT02180204&#39;, &#39;NCT02398656&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02476045&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02296112&#39;,
   &#39;NCT02357732&#39;,
   &#39;NCT02399943&#39;,
   &#39;NCT02439411&#39;,
   &#39;NCT02538627&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT01718444&#39;,
   &#39;NCT02255175&#39;,
   &#39;NCT02400021&#39;,
   &#39;NCT02470676&#39;,
   &#39;NCT02579421&#39;,
   &#39;NCT02601898&#39;,
   &#39;NCT02655146&#39;,
   &#39;NCT02697331&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02154061&#39;,
   &#39;NCT02285140&#39;,
   &#39;NCT02374853&#39;,
   &#39;NCT02384200&#39;,
   &#39;NCT02400112&#39;,
   &#39;NCT02463747&#39;,
   &#39;NCT02464020&#39;,
   &#39;NCT02605213&#39;,
   &#39;NCT02607618&#39;,
   &#39;NCT02631408&#39;,
   &#39;NCT02660346&#39;]},
 {&#39;description&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02458235&#39;, &#39;NCT02489929&#39;, &#39;NCT02543879&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02283177&#39;, &#39;NCT02560025&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;, &#39;trials&#39;: [&#39;NCT02400281&#39;, &#39;NCT02632708&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02412228&#39;, &#39;NCT02461888&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02164500&#39;, &#39;NCT02400463&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;leukotriene biosynthesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02400749&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02291055&#39;,
   &#39;NCT02336165&#39;,
   &#39;NCT02401048&#39;,
   &#39;NCT02431559&#39;,
   &#39;NCT02489448&#39;]},
 {&#39;description&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02413203&#39;, &#39;NCT02502500&#39;, &#39;NCT02961998&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02071940&#39;, &#39;NCT02452424&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02230176&#39;,
   &#39;NCT02398552&#39;,
   &#39;NCT02401815&#39;,
   &#39;NCT02432846&#39;,
   &#39;NCT02483247&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02401828&#39;, &#39;NCT02487706&#39;, &#39;NCT02513147&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02577315&#39;, &#39;NCT02637973&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02401880&#39;, &#39;NCT02442817&#39;, &#39;NCT02608177&#39;, &#39;NCT02851745&#39;]},
 {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trials&#39;: [&#39;NCT02384759&#39;,
   &#39;NCT02401945&#39;,
   &#39;NCT02441907&#39;,
   &#39;NCT02537054&#39;,
   &#39;NCT02550002&#39;,
   &#39;NCT02559180&#39;,
   &#39;NCT02586727&#39;,
   &#39;NCT02597855&#39;,
   &#39;NCT02669953&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;,
  &#39;trials&#39;: [&#39;NCT02623751&#39;]},
 {&#39;description&#39;: &#39;estrogen antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02383030&#39;, &#39;NCT02384746&#39;, &#39;NCT02404051&#39;, &#39;NCT02530411&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02353780&#39;,
   &#39;NCT02404558&#39;,
   &#39;NCT02419937&#39;,
   &#39;NCT02469896&#39;,
   &#39;NCT02778789&#39;,
   &#39;NCT02797769&#39;,
   &#39;NCT02888496&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02009605&#39;,
   &#39;NCT02264210&#39;,
   &#39;NCT02375581&#39;,
   &#39;NCT02404675&#39;,
   &#39;NCT02448797&#39;]},
 {&#39;description&#39;: &#39;leptin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02404896&#39;, &#39;NCT02654977&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01530984&#39;,
   &#39;NCT02224768&#39;,
   &#39;NCT02307149&#39;,
   &#39;NCT02406183&#39;,
   &#39;NCT02423928&#39;,
   &#39;NCT02452281&#39;,
   &#39;NCT02498756&#39;,
   &#39;NCT02608437&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#34;acetylcholinesterase inhibitors used in the treatment of Alzheimer&#39;s disease&#34;,
  &#39;trials&#39;: [&#39;NCT02415062&#39;, &#39;NCT02450786&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02279576&#39;, &#39;NCT02331498&#39;, &#39;NCT02378142&#39;, &#39;NCT02406521&#39;]},
 {&#39;description&#39;: &#39;antimyloidotics&#39;, &#39;trials&#39;: [&#39;NCT02406560&#39;, &#39;NCT02534740&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02239458&#39;,
   &#39;NCT02280486&#39;,
   &#39;NCT02304081&#39;,
   &#39;NCT02315495&#39;,
   &#39;NCT02462369&#39;,
   &#39;NCT02481479&#39;,
   &#39;NCT02597101&#39;,
   &#39;NCT02605772&#39;,
   &#39;NCT02742233&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trials&#39;: [&#39;NCT02497131&#39;, &#39;NCT02499627&#39;, &#39;NCT02533570&#39;, &#39;NCT02780011&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02351232&#39;,
   &#39;NCT02408705&#39;,
   &#39;NCT02472717&#39;,
   &#39;NCT02473809&#39;,
   &#39;NCT02490176&#39;,
   &#39;NCT02507128&#39;,
   &#39;NCT02518945&#39;,
   &#39;NCT02545738&#39;,
   &#39;NCT02584582&#39;,
   &#39;NCT02617654&#39;,
   &#39;NCT02638805&#39;,
   &#39;NCT02660047&#39;,
   &#39;NCT02909933&#39;,
   &#39;NCT03010683&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02311569&#39;,
   &#39;NCT02354807&#39;,
   &#39;NCT02361502&#39;,
   &#39;NCT02410135&#39;,
   &#39;NCT02462837&#39;,
   &#39;NCT02495389&#39;,
   &#39;NCT02536976&#39;,
   &#39;NCT02540707&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;-curonium&#39;,
  &#39;trials&#39;: [&#39;NCT02320734&#39;,
   &#39;NCT02451202&#39;,
   &#39;NCT02464722&#39;,
   &#39;NCT02471521&#39;,
   &#39;NCT02546843&#39;,
   &#39;NCT02553629&#39;,
   &#39;NCT02601508&#39;,
   &#39;NCT02711917&#39;]},
 {&#39;description&#39;: &#39;oxytocin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02216383&#39;, &#39;NCT02391636&#39;, &#39;NCT02396303&#39;, &#39;NCT02528136&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02412085&#39;]},
 {&#39;description&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02412228&#39;, &#39;NCT02461888&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;,
  &#39;trials&#39;: [&#39;NCT02298257&#39;, &#39;NCT02412670&#39;, &#39;NCT02414568&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02351102&#39;, &#39;NCT02412917&#39;, &#39;NCT02571166&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02413203&#39;, &#39;NCT02502500&#39;, &#39;NCT02961998&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antiepileptics (hydantoin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02413658&#39;, &#39;NCT02595723&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02317159&#39;,
   &#39;NCT02352558&#39;,
   &#39;NCT02365441&#39;,
   &#39;NCT02413736&#39;,
   &#39;NCT02462538&#39;,
   &#39;NCT02576080&#39;,
   &#39;NCT02614404&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02753062&#39;]},
 {&#39;description&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;,
  &#39;trials&#39;: [&#39;NCT02298257&#39;, &#39;NCT02412670&#39;, &#39;NCT02414568&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02414724&#39;, &#39;NCT02429089&#39;, &#39;NCT02494921&#39;, &#39;NCT02608216&#39;]},
 {&#39;description&#39;: &#34;acetylcholinesterase inhibitors used in the treatment of Alzheimer&#39;s disease&#34;,
  &#39;trials&#39;: [&#39;NCT02415062&#39;, &#39;NCT02450786&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02283177&#39;, &#39;NCT02560025&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trials&#39;: [&#39;NCT02416388&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02416570&#39;, &#39;NCT02573935&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;diuretics (furosemide type)&#39;,
  &#39;trials&#39;: [&#39;NCT02333643&#39;,
   &#39;NCT02345681&#39;,
   &#39;NCT02417883&#39;,
   &#39;NCT02450773&#39;,
   &#39;NCT02689180&#39;,
   &#39;NCT02881866&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02335346&#39;, &#39;NCT02367404&#39;, &#39;NCT02443194&#39;, &#39;NCT02600247&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02269072&#39;,
   &#39;NCT02361190&#39;,
   &#39;NCT02419105&#39;,
   &#39;NCT02433730&#39;,
   &#39;NCT02445716&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02419378&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;-adol-&#39;,
  &#39;trials&#39;: [&#39;NCT02375100&#39;,
   &#39;NCT02419651&#39;,
   &#39;NCT02425709&#39;,
   &#39;NCT02428777&#39;,
   &#39;NCT02484859&#39;,
   &#39;NCT02497326&#39;,
   &#39;NCT02851394&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02353780&#39;,
   &#39;NCT02404558&#39;,
   &#39;NCT02419937&#39;,
   &#39;NCT02469896&#39;,
   &#39;NCT02778789&#39;,
   &#39;NCT02797769&#39;,
   &#39;NCT02888496&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01931098&#39;,
   &#39;NCT02298348&#39;,
   &#39;NCT02390843&#39;,
   &#39;NCT02421588&#39;,
   &#39;NCT02866370&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01983475&#39;,
   &#39;NCT02299817&#39;,
   &#39;NCT02321280&#39;,
   &#39;NCT02422108&#39;,
   &#39;NCT02613416&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02422199&#39;, &#39;NCT02559778&#39;, &#39;NCT02581124&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02422654&#39;, &#39;NCT02536911&#39;, &#39;NCT02536937&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02416570&#39;, &#39;NCT02573935&#39;]},
 {&#39;description&#39;: &#39;antiparasitics (salicylanilide derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02612922&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01408849&#39;,
   &#39;NCT02365558&#39;,
   &#39;NCT02422706&#39;,
   &#39;NCT02552537&#39;,
   &#39;NCT02609386&#39;,
   &#39;NCT02621359&#39;,
   &#39;NCT02893709&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02422719&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02153177&#39;,
   &#39;NCT02272725&#39;,
   &#39;NCT02344225&#39;,
   &#39;NCT02443142&#39;,
   &#39;NCT02476422&#39;,
   &#39;NCT02480114&#39;,
   &#39;NCT02482155&#39;,
   &#39;NCT02507219&#39;,
   &#39;NCT02521207&#39;,
   &#39;NCT02531451&#39;,
   &#39;NCT02588027&#39;,
   &#39;NCT02593721&#39;,
   &#39;NCT02602483&#39;,
   &#39;NCT02629354&#39;,
   &#39;NCT02666846&#39;,
   &#39;NCT02902913&#39;,
   &#39;NCT03055247&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trials&#39;: [&#39;NCT02147834&#39;, &#39;NCT02252406&#39;, &#39;NCT02423265&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02326103&#39;,
   &#39;NCT02375295&#39;,
   &#39;NCT02423759&#39;,
   &#39;NCT02598362&#39;,
   &#39;NCT02734732&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01530984&#39;,
   &#39;NCT02224768&#39;,
   &#39;NCT02307149&#39;,
   &#39;NCT02406183&#39;,
   &#39;NCT02423928&#39;,
   &#39;NCT02452281&#39;,
   &#39;NCT02498756&#39;,
   &#39;NCT02608437&#39;]},
 {&#39;description&#39;: &#39;synthetic glucagon analogs&#39;, &#39;trials&#39;: [&#39;NCT02423980&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02277457&#39;, &#39;NCT02399566&#39;, &#39;NCT02424617&#39;, &#39;NCT02556593&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;-adol-&#39;,
  &#39;trials&#39;: [&#39;NCT02375100&#39;,
   &#39;NCT02419651&#39;,
   &#39;NCT02425709&#39;,
   &#39;NCT02428777&#39;,
   &#39;NCT02484859&#39;,
   &#39;NCT02497326&#39;,
   &#39;NCT02851394&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;(nifedipine type)&#39;,
  &#39;trials&#39;: [&#39;NCT01360034&#39;,
   &#39;NCT02426177&#39;,
   &#39;NCT02438371&#39;,
   &#39;NCT02513927&#39;,
   &#39;NCT02563405&#39;,
   &#39;NCT02591004&#39;]},
 {&#39;description&#39;: &#39;peroxisome proliferator activiating receptor (PPAR) agonists (thiazolidene derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02426294&#39;, &#39;NCT02429232&#39;, &#39;NCT02535832&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trials&#39;: [&#39;NCT02269319&#39;,
   &#39;NCT02269644&#39;,
   &#39;NCT02333799&#39;,
   &#39;NCT02426918&#39;,
   &#39;NCT02570490&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;, &#39;trials&#39;: [&#39;NCT02179177&#39;, &#39;NCT02378623&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;progestins&#39;,
  &#39;trials&#39;: [&#39;NCT02352090&#39;, &#39;NCT02385448&#39;, &#39;NCT02599077&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02427334&#39;,
   &#39;NCT02473250&#39;,
   &#39;NCT02488538&#39;,
   &#39;NCT02562053&#39;,
   &#39;NCT02601677&#39;]},
 {&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02036086&#39;,
   &#39;NCT02230306&#39;,
   &#39;NCT02427893&#39;,
   &#39;NCT02456701&#39;,
   &#39;NCT02638428&#39;]},
 {&#39;description&#39;: &#39;sympathomimetics&#39;, &#39;trials&#39;: [&#39;NCT02428257&#39;, &#39;NCT02522858&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;-adol-&#39;,
  &#39;trials&#39;: [&#39;NCT02375100&#39;,
   &#39;NCT02419651&#39;,
   &#39;NCT02425709&#39;,
   &#39;NCT02428777&#39;,
   &#39;NCT02484859&#39;,
   &#39;NCT02497326&#39;,
   &#39;NCT02851394&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02414724&#39;, &#39;NCT02429089&#39;, &#39;NCT02494921&#39;, &#39;NCT02608216&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02401880&#39;, &#39;NCT02442817&#39;, &#39;NCT02608177&#39;, &#39;NCT02851745&#39;]},
 {&#39;description&#39;: &#39;peroxisome proliferator activiating receptor (PPAR) agonists (thiazolidene derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02426294&#39;, &#39;NCT02429232&#39;, &#39;NCT02535832&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02217501&#39;,
   &#39;NCT02379676&#39;,
   &#39;NCT02429271&#39;,
   &#39;NCT02439190&#39;,
   &#39;NCT02447809&#39;,
   &#39;NCT02457130&#39;,
   &#39;NCT02469740&#39;,
   &#39;NCT02486367&#39;,
   &#39;NCT02499666&#39;,
   &#39;NCT02505399&#39;,
   &#39;NCT02513004&#39;,
   &#39;NCT02514642&#39;,
   &#39;NCT02519608&#39;,
   &#39;NCT02560688&#39;,
   &#39;NCT02578537&#39;,
   &#39;NCT02578706&#39;,
   &#39;NCT02580149&#39;,
   &#39;NCT02612480&#39;,
   &#39;NCT02626169&#39;,
   &#39;NCT02639143&#39;]},
 {&#39;description&#39;: &#39;sympathomimetics&#39;, &#39;trials&#39;: [&#39;NCT02429557&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02108860&#39;,
   &#39;NCT02281058&#39;,
   &#39;NCT02429934&#39;,
   &#39;NCT02594735&#39;,
   &#39;NCT02598466&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02430896&#39;, &#39;NCT02500732&#39;, &#39;NCT02874937&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02484261&#39;, &#39;NCT02547402&#39;, &#39;NCT02621957&#39;, &#39;NCT02992548&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;, &#39;trials&#39;: [&#39;NCT02431325&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02291055&#39;,
   &#39;NCT02336165&#39;,
   &#39;NCT02401048&#39;,
   &#39;NCT02431559&#39;,
   &#39;NCT02489448&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT02431754&#39;,
   &#39;NCT02450253&#39;,
   &#39;NCT02554045&#39;,
   &#39;NCT02595684&#39;,
   &#39;NCT02601989&#39;]},
 {&#39;description&#39;: &#39;antihypertensives (prazosin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02382848&#39;, &#39;NCT02431936&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02153177&#39;,
   &#39;NCT02272725&#39;,
   &#39;NCT02344225&#39;,
   &#39;NCT02443142&#39;,
   &#39;NCT02476422&#39;,
   &#39;NCT02480114&#39;,
   &#39;NCT02482155&#39;,
   &#39;NCT02507219&#39;,
   &#39;NCT02521207&#39;,
   &#39;NCT02531451&#39;,
   &#39;NCT02588027&#39;,
   &#39;NCT02593721&#39;,
   &#39;NCT02602483&#39;,
   &#39;NCT02629354&#39;,
   &#39;NCT02666846&#39;,
   &#39;NCT02902913&#39;,
   &#39;NCT03055247&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02290327&#39;, &#39;NCT02345239&#39;, &#39;NCT02432456&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02357342&#39;,
   &#39;NCT02432560&#39;,
   &#39;NCT02440789&#39;,
   &#39;NCT02505893&#39;,
   &#39;NCT02513303&#39;,
   &#39;NCT02574728&#39;,
   &#39;NCT02638389&#39;,
   &#39;NCT02675153&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02230176&#39;,
   &#39;NCT02398552&#39;,
   &#39;NCT02401815&#39;,
   &#39;NCT02432846&#39;,
   &#39;NCT02483247&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02269072&#39;,
   &#39;NCT02361190&#39;,
   &#39;NCT02419105&#39;,
   &#39;NCT02433730&#39;,
   &#39;NCT02445716&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;, &#39;trials&#39;: [&#39;NCT02434614&#39;]},
 {&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trials&#39;: [&#39;NCT02451527&#39;]},
 {&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02382666&#39;]},
 {&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trials&#39;: [&#39;NCT02434861&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;hedgehog signaling inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02073838&#39;, &#39;NCT02436408&#39;, &#39;NCT02523014&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02342379&#39;,
   &#39;NCT02511405&#39;,
   &#39;NCT02521051&#39;,
   &#39;NCT02594423&#39;,
   &#39;NCT02648711&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;antibacterial  antibiotics&#39;, &#39;trials&#39;: [&#39;NCT02437045&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02332590&#39;,
   &#39;NCT02437253&#39;,
   &#39;NCT02489227&#39;,
   &#39;NCT02492217&#39;,
   &#39;NCT02533375&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02333565&#39;,
   &#39;NCT02381249&#39;,
   &#39;NCT02384122&#39;,
   &#39;NCT02437825&#39;,
   &#39;NCT02457156&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02194842&#39;,
   &#39;NCT02438007&#39;,
   &#39;NCT02507570&#39;,
   &#39;NCT02814968&#39;,
   &#39;NCT02815033&#39;]},
 {&#39;description&#39;: &#39;(nifedipine type)&#39;,
  &#39;trials&#39;: [&#39;NCT01360034&#39;,
   &#39;NCT02426177&#39;,
   &#39;NCT02438371&#39;,
   &#39;NCT02513927&#39;,
   &#39;NCT02563405&#39;,
   &#39;NCT02591004&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02491736&#39;, &#39;NCT02491879&#39;]},
 {&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02468557&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02217501&#39;,
   &#39;NCT02379676&#39;,
   &#39;NCT02429271&#39;,
   &#39;NCT02439190&#39;,
   &#39;NCT02447809&#39;,
   &#39;NCT02457130&#39;,
   &#39;NCT02469740&#39;,
   &#39;NCT02486367&#39;,
   &#39;NCT02499666&#39;,
   &#39;NCT02505399&#39;,
   &#39;NCT02513004&#39;,
   &#39;NCT02514642&#39;,
   &#39;NCT02519608&#39;,
   &#39;NCT02560688&#39;,
   &#39;NCT02578537&#39;,
   &#39;NCT02578706&#39;,
   &#39;NCT02580149&#39;,
   &#39;NCT02612480&#39;,
   &#39;NCT02626169&#39;,
   &#39;NCT02639143&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02342379&#39;,
   &#39;NCT02511405&#39;,
   &#39;NCT02521051&#39;,
   &#39;NCT02594423&#39;,
   &#39;NCT02648711&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02296112&#39;,
   &#39;NCT02357732&#39;,
   &#39;NCT02399943&#39;,
   &#39;NCT02439411&#39;,
   &#39;NCT02538627&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02439814&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02439957&#39;, &#39;NCT02439970&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02439957&#39;, &#39;NCT02439970&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02412228&#39;, &#39;NCT02461888&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;, &#39;trials&#39;: [&#39;NCT02440581&#39;, &#39;NCT02656810&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02357342&#39;,
   &#39;NCT02432560&#39;,
   &#39;NCT02440789&#39;,
   &#39;NCT02505893&#39;,
   &#39;NCT02513303&#39;,
   &#39;NCT02574728&#39;,
   &#39;NCT02638389&#39;,
   &#39;NCT02675153&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02441894&#39;,
   &#39;NCT02631603&#39;,
   &#39;NCT02695797&#39;,
   &#39;NCT02912182&#39;,
   &#39;NCT02949349&#39;]},
 {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trials&#39;: [&#39;NCT02384759&#39;,
   &#39;NCT02401945&#39;,
   &#39;NCT02441907&#39;,
   &#39;NCT02537054&#39;,
   &#39;NCT02550002&#39;,
   &#39;NCT02559180&#39;,
   &#39;NCT02586727&#39;,
   &#39;NCT02597855&#39;,
   &#39;NCT02669953&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02327143&#39;, &#39;NCT02387814&#39;, &#39;NCT02482935&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;vasopressin receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02442674&#39;, &#39;NCT02476409&#39;, &#39;NCT02545114&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02401880&#39;, &#39;NCT02442817&#39;, &#39;NCT02608177&#39;, &#39;NCT02851745&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02153177&#39;,
   &#39;NCT02272725&#39;,
   &#39;NCT02344225&#39;,
   &#39;NCT02443142&#39;,
   &#39;NCT02476422&#39;,
   &#39;NCT02480114&#39;,
   &#39;NCT02482155&#39;,
   &#39;NCT02507219&#39;,
   &#39;NCT02521207&#39;,
   &#39;NCT02531451&#39;,
   &#39;NCT02588027&#39;,
   &#39;NCT02593721&#39;,
   &#39;NCT02602483&#39;,
   &#39;NCT02629354&#39;,
   &#39;NCT02666846&#39;,
   &#39;NCT02902913&#39;,
   &#39;NCT03055247&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02335346&#39;, &#39;NCT02367404&#39;, &#39;NCT02443194&#39;, &#39;NCT02600247&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02444637&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02444819&#39;, &#39;NCT02485652&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;dendrimers&#39;, &#39;trials&#39;: [&#39;NCT02445508&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02269072&#39;,
   &#39;NCT02361190&#39;,
   &#39;NCT02419105&#39;,
   &#39;NCT02433730&#39;,
   &#39;NCT02445716&#39;]},
 {&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02347878&#39;, &#39;NCT02357693&#39;, &#39;NCT02646020&#39;]},
 ...]</pre>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing text_cell rendered"><div class="prompt input_prompt">
</div><div class="inner_cell">
<div class="text_cell_render border-box-sizing rendered_html">
<h1 id="Task-4:">Task 4:<a class="anchor-link" href="#Task-4:">&#182;</a></h1>
</div>
</div>
</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[91]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="n">task3_list</span> <span class="o">=</span> <span class="n">task_3</span><span class="p">(</span><span class="n">output_list_usan</span><span class="p">,</span> <span class="n">output_dict_nct</span><span class="p">)</span>
<span class="n">task3_list</span>
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt output_prompt">Out[91]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>[{&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT01171482&#39;, &#39;NCT01953406&#39;, &#39;NCT02106572&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01255046&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;(nifedipine type)&#39;,
  &#39;trials&#39;: [&#39;NCT01360034&#39;,
   &#39;NCT02426177&#39;,
   &#39;NCT02438371&#39;,
   &#39;NCT02513927&#39;,
   &#39;NCT02563405&#39;,
   &#39;NCT02591004&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01408849&#39;,
   &#39;NCT02365558&#39;,
   &#39;NCT02422706&#39;,
   &#39;NCT02552537&#39;,
   &#39;NCT02609386&#39;,
   &#39;NCT02621359&#39;,
   &#39;NCT02893709&#39;]},
 {&#39;description&#39;: &#39;hypnotics/sedatives (zolpidem type)&#39;,
  &#39;trials&#39;: [&#39;NCT01485393&#39;, &#39;NCT02578472&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT01528865&#39;,
   &#39;NCT02482272&#39;,
   &#39;NCT02566707&#39;,
   &#39;NCT02581202&#39;,
   &#39;NCT02650271&#39;,
   &#39;NCT02652793&#39;,
   &#39;NCT02770508&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01530984&#39;,
   &#39;NCT02224768&#39;,
   &#39;NCT02307149&#39;,
   &#39;NCT02406183&#39;,
   &#39;NCT02423928&#39;,
   &#39;NCT02452281&#39;,
   &#39;NCT02498756&#39;,
   &#39;NCT02608437&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02479308&#39;, &#39;NCT02515864&#39;, &#39;NCT02537288&#39;, &#39;NCT02559310&#39;]},
 {&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01613677&#39;, &#39;NCT02117817&#39;, &#39;NCT02452294&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;, &#39;trials&#39;: [&#39;NCT01614197&#39;]},
 {&#39;description&#39;: &#39;toll-like receptor&#39;,
  &#39;trials&#39;: [&#39;NCT01663558&#39;, &#39;NCT02059499&#39;, &#39;NCT02130323&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT01718444&#39;,
   &#39;NCT02255175&#39;,
   &#39;NCT02400021&#39;,
   &#39;NCT02470676&#39;,
   &#39;NCT02579421&#39;,
   &#39;NCT02601898&#39;,
   &#39;NCT02655146&#39;,
   &#39;NCT02697331&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT01854762&#39;]},
 {&#39;description&#39;: &#39;beta-blockers (propranolol type)&#39;,
  &#39;trials&#39;: [&#39;NCT02369900&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antihypertensives (ACE inhibitors)&#39;,
  &#39;trials&#39;: [&#39;NCT01922141&#39;, &#39;NCT02499822&#39;, &#39;NCT02842424&#39;]},
 {&#39;description&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02279576&#39;, &#39;NCT02331498&#39;, &#39;NCT02378142&#39;, &#39;NCT02406521&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01931098&#39;,
   &#39;NCT02298348&#39;,
   &#39;NCT02390843&#39;,
   &#39;NCT02421588&#39;,
   &#39;NCT02866370&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT01171482&#39;, &#39;NCT01953406&#39;, &#39;NCT02106572&#39;]},
 {&#39;description&#39;: &#39;nootropic agents (learning&#39;, &#39;trials&#39;: [&#39;NCT01960075&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01967251&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01613677&#39;, &#39;NCT02117817&#39;, &#39;NCT02452294&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01979393&#39;, &#39;NCT02132598&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01983475&#39;,
   &#39;NCT02299817&#39;,
   &#39;NCT02321280&#39;,
   &#39;NCT02422108&#39;,
   &#39;NCT02613416&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02577315&#39;, &#39;NCT02637973&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02009605&#39;,
   &#39;NCT02264210&#39;,
   &#39;NCT02375581&#39;,
   &#39;NCT02404675&#39;,
   &#39;NCT02448797&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02014103&#39;,
   &#39;NCT02122081&#39;,
   &#39;NCT02158052&#39;,
   &#39;NCT02373202&#39;,
   &#39;NCT02382575&#39;,
   &#39;NCT02432833&#39;,
   &#39;NCT02446964&#39;,
   &#39;NCT02447055&#39;,
   &#39;NCT02466997&#39;,
   &#39;NCT02495077&#39;,
   &#39;NCT02498977&#39;,
   &#39;NCT02528877&#39;,
   &#39;NCT02608606&#39;,
   &#39;NCT02743247&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02036086&#39;,
   &#39;NCT02230306&#39;,
   &#39;NCT02427893&#39;,
   &#39;NCT02456701&#39;,
   &#39;NCT02638428&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02056171&#39;, &#39;NCT02297763&#39;, &#39;NCT02451306&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;toll-like receptor&#39;,
  &#39;trials&#39;: [&#39;NCT01663558&#39;, &#39;NCT02059499&#39;, &#39;NCT02130323&#39;]},
 {&#39;description&#39;: &#39;dopamine receptor agonists&#39;, &#39;trials&#39;: [&#39;NCT02066571&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02067013&#39;,
   &#39;NCT02258009&#39;,
   &#39;NCT02328118&#39;,
   &#39;NCT02447185&#39;,
   &#39;NCT02462304&#39;,
   &#39;NCT02511613&#39;,
   &#39;NCT02522897&#39;,
   &#39;NCT02527733&#39;,
   &#39;NCT02646670&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02071940&#39;, &#39;NCT02452424&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02487563&#39;]},
 {&#39;description&#39;: &#39;hedgehog signaling inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02073838&#39;, &#39;NCT02436408&#39;, &#39;NCT02523014&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;endothelin receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02080637&#39;, &#39;NCT02712346&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;beta-blockers (propranolol type)&#39;,
  &#39;trials&#39;: [&#39;NCT02369900&#39;]},
 {&#39;description&#39;: &#39;cardiotonics (amrinone type)&#39;,
  &#39;trials&#39;: [&#39;NCT02098629&#39;, &#39;NCT02640846&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;thrombopoetin agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02099747&#39;, &#39;NCT02446145&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT01171482&#39;, &#39;NCT01953406&#39;, &#39;NCT02106572&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02108860&#39;,
   &#39;NCT02281058&#39;,
   &#39;NCT02429934&#39;,
   &#39;NCT02594735&#39;,
   &#39;NCT02598466&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02109653&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02113891&#39;, &#39;NCT02493725&#39;, &#39;NCT02574403&#39;]},
 {&#39;description&#39;: &#39;endothelin receptor antagonists&#39;, &#39;trials&#39;: [&#39;NCT02116335&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02117765&#39;, &#39;NCT02561806&#39;]},
 {&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01613677&#39;, &#39;NCT02117817&#39;, &#39;NCT02452294&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02014103&#39;,
   &#39;NCT02122081&#39;,
   &#39;NCT02158052&#39;,
   &#39;NCT02373202&#39;,
   &#39;NCT02382575&#39;,
   &#39;NCT02432833&#39;,
   &#39;NCT02446964&#39;,
   &#39;NCT02447055&#39;,
   &#39;NCT02466997&#39;,
   &#39;NCT02495077&#39;,
   &#39;NCT02498977&#39;,
   &#39;NCT02528877&#39;,
   &#39;NCT02608606&#39;,
   &#39;NCT02743247&#39;]},
 {&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02124811&#39;,
   &#39;NCT02187211&#39;,
   &#39;NCT02201563&#39;,
   &#39;NCT02362529&#39;,
   &#39;NCT02456948&#39;,
   &#39;NCT02515955&#39;,
   &#39;NCT02533232&#39;,
   &#39;NCT02564978&#39;,
   &#39;NCT02569307&#39;,
   &#39;NCT02907437&#39;,
   &#39;NCT02928692&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;toll-like receptor&#39;,
  &#39;trials&#39;: [&#39;NCT01663558&#39;, &#39;NCT02059499&#39;, &#39;NCT02130323&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01979393&#39;, &#39;NCT02132598&#39;]},
 {&#39;description&#39;: &#39;antiestrogens of the clomifene and tamoxifen groups&#39;,
  &#39;trials&#39;: [&#39;NCT02137265&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trials&#39;: [&#39;NCT02147834&#39;, &#39;NCT02252406&#39;, &#39;NCT02423265&#39;]},
 {&#39;description&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02301000&#39;,
   &#39;NCT02458781&#39;,
   &#39;NCT02527941&#39;,
   &#39;NCT02642250&#39;,
   &#39;NCT02969928&#39;,
   &#39;NCT03692299&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02154061&#39;,
   &#39;NCT02285140&#39;,
   &#39;NCT02374853&#39;,
   &#39;NCT02384200&#39;,
   &#39;NCT02400112&#39;,
   &#39;NCT02463747&#39;,
   &#39;NCT02464020&#39;,
   &#39;NCT02605213&#39;,
   &#39;NCT02607618&#39;,
   &#39;NCT02631408&#39;,
   &#39;NCT02660346&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02014103&#39;,
   &#39;NCT02122081&#39;,
   &#39;NCT02158052&#39;,
   &#39;NCT02373202&#39;,
   &#39;NCT02382575&#39;,
   &#39;NCT02432833&#39;,
   &#39;NCT02446964&#39;,
   &#39;NCT02447055&#39;,
   &#39;NCT02466997&#39;,
   &#39;NCT02495077&#39;,
   &#39;NCT02498977&#39;,
   &#39;NCT02528877&#39;,
   &#39;NCT02608606&#39;,
   &#39;NCT02743247&#39;]},
 {&#39;description&#39;: &#39;immunomodulators&#39;, &#39;trials&#39;: [&#39;NCT02159027&#39;, &#39;NCT02961829&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02419378&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02164500&#39;, &#39;NCT02400463&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;,
  &#39;trials&#39;: [&#39;NCT02164578&#39;,
   &#39;NCT02273700&#39;,
   &#39;NCT02549963&#39;,
   &#39;NCT02610933&#39;,
   &#39;NCT02627053&#39;,
   &#39;NCT02642419&#39;]},
 {&#39;description&#39;: &#39;(nifedipine type)&#39;, &#39;trials&#39;: [&#39;NCT02165644&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;, &#39;trials&#39;: [&#39;NCT02166658&#39;, &#39;NCT02478502&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;, &#39;trials&#39;: [&#39;NCT02171416&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02176031&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;, &#39;trials&#39;: [&#39;NCT02179177&#39;, &#39;NCT02378623&#39;]},
 {&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;trials&#39;: [&#39;NCT02447094&#39;]},
 {&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;trials&#39;: [&#39;NCT02180204&#39;, &#39;NCT02398656&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02186574&#39;,
   &#39;NCT02452528&#39;,
   &#39;NCT02475915&#39;,
   &#39;NCT02505009&#39;,
   &#39;NCT02560649&#39;,
   &#39;NCT02577029&#39;,
   &#39;NCT02585947&#39;,
   &#39;NCT02632474&#39;]},
 {&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02124811&#39;,
   &#39;NCT02187211&#39;,
   &#39;NCT02201563&#39;,
   &#39;NCT02362529&#39;,
   &#39;NCT02456948&#39;,
   &#39;NCT02515955&#39;,
   &#39;NCT02533232&#39;,
   &#39;NCT02564978&#39;,
   &#39;NCT02569307&#39;,
   &#39;NCT02907437&#39;,
   &#39;NCT02928692&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02373241&#39;, &#39;NCT02663141&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02194842&#39;,
   &#39;NCT02438007&#39;,
   &#39;NCT02507570&#39;,
   &#39;NCT02814968&#39;,
   &#39;NCT02815033&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;, &#39;trials&#39;: [&#39;NCT02194933&#39;]},
 {&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02124811&#39;,
   &#39;NCT02187211&#39;,
   &#39;NCT02201563&#39;,
   &#39;NCT02362529&#39;,
   &#39;NCT02456948&#39;,
   &#39;NCT02515955&#39;,
   &#39;NCT02533232&#39;,
   &#39;NCT02564978&#39;,
   &#39;NCT02569307&#39;,
   &#39;NCT02907437&#39;,
   &#39;NCT02928692&#39;]},
 {&#39;description&#39;: &#39;proteozome inhibitors&#39;, &#39;trials&#39;: [&#39;NCT02474927&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;estrogen antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02383030&#39;, &#39;NCT02384746&#39;, &#39;NCT02404051&#39;, &#39;NCT02530411&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02211014&#39;, &#39;NCT02537444&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02446860&#39;,
   &#39;NCT02497508&#39;,
   &#39;NCT02499367&#39;,
   &#39;NCT02550249&#39;,
   &#39;NCT02569242&#39;,
   &#39;NCT02637531&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02359058&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;oxytocin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02216383&#39;, &#39;NCT02391636&#39;, &#39;NCT02396303&#39;, &#39;NCT02528136&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02217501&#39;,
   &#39;NCT02379676&#39;,
   &#39;NCT02429271&#39;,
   &#39;NCT02439190&#39;,
   &#39;NCT02447809&#39;,
   &#39;NCT02457130&#39;,
   &#39;NCT02469740&#39;,
   &#39;NCT02486367&#39;,
   &#39;NCT02499666&#39;,
   &#39;NCT02505399&#39;,
   &#39;NCT02513004&#39;,
   &#39;NCT02514642&#39;,
   &#39;NCT02519608&#39;,
   &#39;NCT02560688&#39;,
   &#39;NCT02578537&#39;,
   &#39;NCT02578706&#39;,
   &#39;NCT02580149&#39;,
   &#39;NCT02612480&#39;,
   &#39;NCT02626169&#39;,
   &#39;NCT02639143&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;ionotropic non-NMDA (N-methyl D-aspartate) glutamate receptors [AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor) and/or KA (kainite antagonist) receptors]&#39;,
  &#39;trials&#39;: [&#39;NCT02220972&#39;, &#39;NCT02668146&#39;, &#39;NCT02727101&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01530984&#39;,
   &#39;NCT02224768&#39;,
   &#39;NCT02307149&#39;,
   &#39;NCT02406183&#39;,
   &#39;NCT02423928&#39;,
   &#39;NCT02452281&#39;,
   &#39;NCT02498756&#39;,
   &#39;NCT02608437&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;, &#39;trials&#39;: [&#39;NCT02229240&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02230176&#39;,
   &#39;NCT02398552&#39;,
   &#39;NCT02401815&#39;,
   &#39;NCT02432846&#39;,
   &#39;NCT02483247&#39;]},
 {&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02036086&#39;,
   &#39;NCT02230306&#39;,
   &#39;NCT02427893&#39;,
   &#39;NCT02456701&#39;,
   &#39;NCT02638428&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;selective melatonin receptor agonist&#39;,
  &#39;trials&#39;: [&#39;NCT02231008&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;depsipeptide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02232516&#39;, &#39;NCT02296398&#39;, &#39;NCT02512172&#39;]},
 {&#39;description&#39;: &#39;ecteinascidin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02234050&#39;, &#39;NCT02359474&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02479308&#39;, &#39;NCT02515864&#39;, &#39;NCT02537288&#39;, &#39;NCT02559310&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02239458&#39;,
   &#39;NCT02280486&#39;,
   &#39;NCT02304081&#39;,
   &#39;NCT02315495&#39;,
   &#39;NCT02462369&#39;,
   &#39;NCT02481479&#39;,
   &#39;NCT02597101&#39;,
   &#39;NCT02605772&#39;,
   &#39;NCT02742233&#39;]},
 {&#39;description&#39;: &#39;colony-stimulating factors&#39;, &#39;trials&#39;: [&#39;NCT02240537&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02268864&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02250807&#39;,
   &#39;NCT02319031&#39;,
   &#39;NCT02371408&#39;,
   &#39;NCT02473211&#39;,
   &#39;NCT02485080&#39;,
   &#39;NCT02551861&#39;,
   &#39;NCT02556086&#39;,
   &#39;NCT02596880&#39;,
   &#39;NCT02640157&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trials&#39;: [&#39;NCT02147834&#39;, &#39;NCT02252406&#39;, &#39;NCT02423265&#39;]},
 {&#39;description&#39;: &#39;hedgehog signaling inhibitors&#39;, &#39;trials&#39;: [&#39;NCT02254551&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT01718444&#39;,
   &#39;NCT02255175&#39;,
   &#39;NCT02400021&#39;,
   &#39;NCT02470676&#39;,
   &#39;NCT02579421&#39;,
   &#39;NCT02601898&#39;,
   &#39;NCT02655146&#39;,
   &#39;NCT02697331&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trials&#39;: [&#39;NCT02384759&#39;,
   &#39;NCT02401945&#39;,
   &#39;NCT02441907&#39;,
   &#39;NCT02537054&#39;,
   &#39;NCT02550002&#39;,
   &#39;NCT02559180&#39;,
   &#39;NCT02586727&#39;,
   &#39;NCT02597855&#39;,
   &#39;NCT02669953&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02067013&#39;,
   &#39;NCT02258009&#39;,
   &#39;NCT02328118&#39;,
   &#39;NCT02447185&#39;,
   &#39;NCT02462304&#39;,
   &#39;NCT02511613&#39;,
   &#39;NCT02522897&#39;,
   &#39;NCT02527733&#39;,
   &#39;NCT02646670&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;spasmolytic agents (papaverine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02260154&#39;]},
 {&#39;description&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02458235&#39;, &#39;NCT02489929&#39;, &#39;NCT02543879&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;antihyperlipidaemics&#39;, &#39;trials&#39;: [&#39;NCT02260648&#39;]},
 {&#39;description&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02506023&#39;, &#39;NCT02937896&#39;, &#39;NCT03343418&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02263898&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02009605&#39;,
   &#39;NCT02264210&#39;,
   &#39;NCT02375581&#39;,
   &#39;NCT02404675&#39;,
   &#39;NCT02448797&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02496078&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02268864&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;, &#39;trials&#39;: [&#39;NCT02608996&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02269072&#39;,
   &#39;NCT02361190&#39;,
   &#39;NCT02419105&#39;,
   &#39;NCT02433730&#39;,
   &#39;NCT02445716&#39;]},
 {&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trials&#39;: [&#39;NCT02269319&#39;,
   &#39;NCT02269644&#39;,
   &#39;NCT02333799&#39;,
   &#39;NCT02426918&#39;,
   &#39;NCT02570490&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02282176&#39;,
   &#39;NCT02344628&#39;,
   &#39;NCT02380625&#39;,
   &#39;NCT02527005&#39;,
   &#39;NCT02531984&#39;,
   &#39;NCT02544984&#39;,
   &#39;NCT02630394&#39;,
   &#39;NCT02839408&#39;]},
 {&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trials&#39;: [&#39;NCT02269319&#39;,
   &#39;NCT02269644&#39;,
   &#39;NCT02333799&#39;,
   &#39;NCT02426918&#39;,
   &#39;NCT02570490&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02269969&#39;, &#39;NCT02489955&#39;, &#39;NCT02526004&#39;, &#39;NCT03705962&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02153177&#39;,
   &#39;NCT02272725&#39;,
   &#39;NCT02344225&#39;,
   &#39;NCT02443142&#39;,
   &#39;NCT02476422&#39;,
   &#39;NCT02480114&#39;,
   &#39;NCT02482155&#39;,
   &#39;NCT02507219&#39;,
   &#39;NCT02521207&#39;,
   &#39;NCT02531451&#39;,
   &#39;NCT02588027&#39;,
   &#39;NCT02593721&#39;,
   &#39;NCT02602483&#39;,
   &#39;NCT02629354&#39;,
   &#39;NCT02666846&#39;,
   &#39;NCT02902913&#39;,
   &#39;NCT03055247&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02272946&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;,
  &#39;trials&#39;: [&#39;NCT02164578&#39;,
   &#39;NCT02273700&#39;,
   &#39;NCT02549963&#39;,
   &#39;NCT02610933&#39;,
   &#39;NCT02627053&#39;,
   &#39;NCT02642419&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02274792&#39;, &#39;NCT02322580&#39;, &#39;NCT02464033&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02277197&#39;, &#39;NCT02484833&#39;, &#39;NCT02490436&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02487316&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02277457&#39;, &#39;NCT02399566&#39;, &#39;NCT02424617&#39;, &#39;NCT02556593&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02278081&#39;, &#39;NCT02633930&#39;, &#39;NCT02759393&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02279576&#39;, &#39;NCT02331498&#39;, &#39;NCT02378142&#39;, &#39;NCT02406521&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02239458&#39;,
   &#39;NCT02280486&#39;,
   &#39;NCT02304081&#39;,
   &#39;NCT02315495&#39;,
   &#39;NCT02462369&#39;,
   &#39;NCT02481479&#39;,
   &#39;NCT02597101&#39;,
   &#39;NCT02605772&#39;,
   &#39;NCT02742233&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02108860&#39;,
   &#39;NCT02281058&#39;,
   &#39;NCT02429934&#39;,
   &#39;NCT02594735&#39;,
   &#39;NCT02598466&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02282176&#39;,
   &#39;NCT02344628&#39;,
   &#39;NCT02380625&#39;,
   &#39;NCT02527005&#39;,
   &#39;NCT02531984&#39;,
   &#39;NCT02544984&#39;,
   &#39;NCT02630394&#39;,
   &#39;NCT02839408&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02283177&#39;, &#39;NCT02560025&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;, &#39;trials&#39;: [&#39;NCT02179177&#39;, &#39;NCT02378623&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT01528865&#39;,
   &#39;NCT02482272&#39;,
   &#39;NCT02566707&#39;,
   &#39;NCT02581202&#39;,
   &#39;NCT02650271&#39;,
   &#39;NCT02652793&#39;,
   &#39;NCT02770508&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02154061&#39;,
   &#39;NCT02285140&#39;,
   &#39;NCT02374853&#39;,
   &#39;NCT02384200&#39;,
   &#39;NCT02400112&#39;,
   &#39;NCT02463747&#39;,
   &#39;NCT02464020&#39;,
   &#39;NCT02605213&#39;,
   &#39;NCT02607618&#39;,
   &#39;NCT02631408&#39;,
   &#39;NCT02660346&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02194842&#39;,
   &#39;NCT02438007&#39;,
   &#39;NCT02507570&#39;,
   &#39;NCT02814968&#39;,
   &#39;NCT02815033&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02289144&#39;, &#39;NCT02343679&#39;, &#39;NCT02374489&#39;, &#39;NCT02638909&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02289963&#39;, &#39;NCT02326220&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02290327&#39;, &#39;NCT02345239&#39;, &#39;NCT02432456&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02291055&#39;,
   &#39;NCT02336165&#39;,
   &#39;NCT02401048&#39;,
   &#39;NCT02431559&#39;,
   &#39;NCT02489448&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02292225&#39;,
   &#39;NCT02393157&#39;,
   &#39;NCT02475681&#39;,
   &#39;NCT02495454&#39;,
   &#39;NCT02537613&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;proteozome inhibitors&#39;, &#39;trials&#39;: [&#39;NCT02474927&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;, &#39;trials&#39;: [&#39;NCT02179177&#39;, &#39;NCT02378623&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02296112&#39;,
   &#39;NCT02357732&#39;,
   &#39;NCT02399943&#39;,
   &#39;NCT02439411&#39;,
   &#39;NCT02538627&#39;]},
 {&#39;description&#39;: &#39;depsipeptide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02232516&#39;, &#39;NCT02296398&#39;, &#39;NCT02512172&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02296671&#39;,
   &#39;NCT02488694&#39;,
   &#39;NCT02489903&#39;,
   &#39;NCT02518802&#39;,
   &#39;NCT02588781&#39;,
   &#39;NCT02603003&#39;,
   &#39;NCT02868892&#39;,
   &#39;NCT02980991&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02296801&#39;,
   &#39;NCT02310243&#39;,
   &#39;NCT02448771&#39;,
   &#39;NCT02513394&#39;,
   &#39;NCT02530320&#39;,
   &#39;NCT02592083&#39;,
   &#39;NCT02806648&#39;]},
 {&#39;description&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02056171&#39;, &#39;NCT02297763&#39;, &#39;NCT02451306&#39;]},
 {&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trials&#39;: [&#39;NCT02497131&#39;, &#39;NCT02499627&#39;, &#39;NCT02533570&#39;, &#39;NCT02780011&#39;]},
 {&#39;description&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;,
  &#39;trials&#39;: [&#39;NCT02298257&#39;, &#39;NCT02412670&#39;, &#39;NCT02414568&#39;]},
 {&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trials&#39;: [&#39;NCT02497131&#39;, &#39;NCT02499627&#39;, &#39;NCT02533570&#39;, &#39;NCT02780011&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01931098&#39;,
   &#39;NCT02298348&#39;,
   &#39;NCT02390843&#39;,
   &#39;NCT02421588&#39;,
   &#39;NCT02866370&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01983475&#39;,
   &#39;NCT02299817&#39;,
   &#39;NCT02321280&#39;,
   &#39;NCT02422108&#39;,
   &#39;NCT02613416&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02301000&#39;,
   &#39;NCT02458781&#39;,
   &#39;NCT02527941&#39;,
   &#39;NCT02642250&#39;,
   &#39;NCT02969928&#39;,
   &#39;NCT03692299&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02301949&#39;,
   &#39;NCT02387086&#39;,
   &#39;NCT02467647&#39;,
   &#39;NCT02545907&#39;,
   &#39;NCT02586038&#39;,
   &#39;NCT02649101&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;,
  &#39;trials&#39;: [&#39;NCT02164578&#39;,
   &#39;NCT02273700&#39;,
   &#39;NCT02549963&#39;,
   &#39;NCT02610933&#39;,
   &#39;NCT02627053&#39;,
   &#39;NCT02642419&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02239458&#39;,
   &#39;NCT02280486&#39;,
   &#39;NCT02304081&#39;,
   &#39;NCT02315495&#39;,
   &#39;NCT02462369&#39;,
   &#39;NCT02481479&#39;,
   &#39;NCT02597101&#39;,
   &#39;NCT02605772&#39;,
   &#39;NCT02742233&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01530984&#39;,
   &#39;NCT02224768&#39;,
   &#39;NCT02307149&#39;,
   &#39;NCT02406183&#39;,
   &#39;NCT02423928&#39;,
   &#39;NCT02452281&#39;,
   &#39;NCT02498756&#39;,
   &#39;NCT02608437&#39;]},
 {&#39;description&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02301000&#39;,
   &#39;NCT02458781&#39;,
   &#39;NCT02527941&#39;,
   &#39;NCT02642250&#39;,
   &#39;NCT02969928&#39;,
   &#39;NCT03692299&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02308007&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02308072&#39;, &#39;NCT02340611&#39;, &#39;NCT02477644&#39;, &#39;NCT02533765&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02296801&#39;,
   &#39;NCT02310243&#39;,
   &#39;NCT02448771&#39;,
   &#39;NCT02513394&#39;,
   &#39;NCT02530320&#39;,
   &#39;NCT02592083&#39;,
   &#39;NCT02806648&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02310867&#39;, &#39;NCT02560558&#39;]},
 {&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02311569&#39;,
   &#39;NCT02354807&#39;,
   &#39;NCT02361502&#39;,
   &#39;NCT02410135&#39;,
   &#39;NCT02462837&#39;,
   &#39;NCT02495389&#39;,
   &#39;NCT02536976&#39;,
   &#39;NCT02540707&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02312375&#39;, &#39;NCT02397590&#39;, &#39;NCT02566187&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antianxiety agents (diazepam type)&#39;,
  &#39;trials&#39;: [&#39;NCT02312908&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;transforming growth factors&#39;, &#39;trials&#39;: [&#39;NCT02313792&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02310867&#39;, &#39;NCT02560558&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02239458&#39;,
   &#39;NCT02280486&#39;,
   &#39;NCT02304081&#39;,
   &#39;NCT02315495&#39;,
   &#39;NCT02462369&#39;,
   &#39;NCT02481479&#39;,
   &#39;NCT02597101&#39;,
   &#39;NCT02605772&#39;,
   &#39;NCT02742233&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02292225&#39;,
   &#39;NCT02393157&#39;,
   &#39;NCT02475681&#39;,
   &#39;NCT02495454&#39;,
   &#39;NCT02537613&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02317159&#39;,
   &#39;NCT02352558&#39;,
   &#39;NCT02365441&#39;,
   &#39;NCT02413736&#39;,
   &#39;NCT02462538&#39;,
   &#39;NCT02576080&#39;,
   &#39;NCT02614404&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02496078&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02250807&#39;,
   &#39;NCT02319031&#39;,
   &#39;NCT02371408&#39;,
   &#39;NCT02473211&#39;,
   &#39;NCT02485080&#39;,
   &#39;NCT02551861&#39;,
   &#39;NCT02556086&#39;,
   &#39;NCT02596880&#39;,
   &#39;NCT02640157&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;-curonium&#39;,
  &#39;trials&#39;: [&#39;NCT02320734&#39;,
   &#39;NCT02451202&#39;,
   &#39;NCT02464722&#39;,
   &#39;NCT02471521&#39;,
   &#39;NCT02546843&#39;,
   &#39;NCT02553629&#39;,
   &#39;NCT02601508&#39;,
   &#39;NCT02711917&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01983475&#39;,
   &#39;NCT02299817&#39;,
   &#39;NCT02321280&#39;,
   &#39;NCT02422108&#39;,
   &#39;NCT02613416&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;-sal-&#39;, &#39;trials&#39;: [&#39;NCT02321852&#39;, &#39;NCT02616497&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02274792&#39;, &#39;NCT02322580&#39;, &#39;NCT02464033&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02348450&#39;,
   &#39;NCT02453464&#39;,
   &#39;NCT02596503&#39;,
   &#39;NCT02641873&#39;,
   &#39;NCT02662959&#39;,
   &#39;NCT02934529&#39;,
   &#39;NCT03400592&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02326103&#39;,
   &#39;NCT02375295&#39;,
   &#39;NCT02423759&#39;,
   &#39;NCT02598362&#39;,
   &#39;NCT02734732&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02289963&#39;, &#39;NCT02326220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02326285&#39;, &#39;NCT02484755&#39;, &#39;NCT02804776&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02317159&#39;,
   &#39;NCT02352558&#39;,
   &#39;NCT02365441&#39;,
   &#39;NCT02413736&#39;,
   &#39;NCT02462538&#39;,
   &#39;NCT02576080&#39;,
   &#39;NCT02614404&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02326311&#39;, &#39;NCT02389920&#39;, &#39;NCT02733445&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02512809&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02327143&#39;, &#39;NCT02387814&#39;, &#39;NCT02482935&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02327676&#39;, &#39;NCT02327702&#39;, &#39;NCT02327715&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02327676&#39;, &#39;NCT02327702&#39;, &#39;NCT02327715&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02327676&#39;, &#39;NCT02327702&#39;, &#39;NCT02327715&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02067013&#39;,
   &#39;NCT02258009&#39;,
   &#39;NCT02328118&#39;,
   &#39;NCT02447185&#39;,
   &#39;NCT02462304&#39;,
   &#39;NCT02511613&#39;,
   &#39;NCT02522897&#39;,
   &#39;NCT02527733&#39;,
   &#39;NCT02646670&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02279576&#39;, &#39;NCT02331498&#39;, &#39;NCT02378142&#39;, &#39;NCT02406521&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02332590&#39;,
   &#39;NCT02437253&#39;,
   &#39;NCT02489227&#39;,
   &#39;NCT02492217&#39;,
   &#39;NCT02533375&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02333565&#39;,
   &#39;NCT02381249&#39;,
   &#39;NCT02384122&#39;,
   &#39;NCT02437825&#39;,
   &#39;NCT02457156&#39;]},
 {&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trials&#39;: [&#39;NCT02451527&#39;]},
 {&#39;description&#39;: &#39;diuretics (furosemide type)&#39;,
  &#39;trials&#39;: [&#39;NCT02333643&#39;,
   &#39;NCT02345681&#39;,
   &#39;NCT02417883&#39;,
   &#39;NCT02450773&#39;,
   &#39;NCT02689180&#39;,
   &#39;NCT02881866&#39;]},
 {&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trials&#39;: [&#39;NCT02269319&#39;,
   &#39;NCT02269644&#39;,
   &#39;NCT02333799&#39;,
   &#39;NCT02426918&#39;,
   &#39;NCT02570490&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;penicillins&#39;, &#39;trials&#39;: [&#39;NCT02334124&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02335346&#39;, &#39;NCT02367404&#39;, &#39;NCT02443194&#39;, &#39;NCT02600247&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02291055&#39;,
   &#39;NCT02336165&#39;,
   &#39;NCT02401048&#39;,
   &#39;NCT02431559&#39;,
   &#39;NCT02489448&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02342379&#39;,
   &#39;NCT02511405&#39;,
   &#39;NCT02521051&#39;,
   &#39;NCT02594423&#39;,
   &#39;NCT02648711&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (mitotic inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02338037&#39;, &#39;NCT02396433&#39;]},
 {&#39;description&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02338323&#39;]},
 {&#39;description&#39;: &#39;interleukin 3 deriviatives&#39;,
  &#39;trials&#39;: [&#39;NCT02338414&#39;, &#39;NCT02868060&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;, &#39;trials&#39;: [&#39;NCT02338960&#39;]},
 {&#39;description&#39;: &#39;antidepressants (dibenzol[a&#39;, &#39;trials&#39;: [&#39;NCT02519400&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02308072&#39;, &#39;NCT02340611&#39;, &#39;NCT02477644&#39;, &#39;NCT02533765&#39;]},
 {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trials&#39;: [&#39;NCT02384759&#39;,
   &#39;NCT02401945&#39;,
   &#39;NCT02441907&#39;,
   &#39;NCT02537054&#39;,
   &#39;NCT02550002&#39;,
   &#39;NCT02559180&#39;,
   &#39;NCT02586727&#39;,
   &#39;NCT02597855&#39;,
   &#39;NCT02669953&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02341911&#39;]},
 {&#39;description&#39;: &#39;progesterone receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02354170&#39;, &#39;NCT02642939&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02342379&#39;,
   &#39;NCT02511405&#39;,
   &#39;NCT02521051&#39;,
   &#39;NCT02594423&#39;,
   &#39;NCT02648711&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02479308&#39;, &#39;NCT02515864&#39;, &#39;NCT02537288&#39;, &#39;NCT02559310&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02416570&#39;, &#39;NCT02573935&#39;]},
 {&#39;description&#39;: &#39;antihypertensives (hydrazine-phthalazines)&#39;,
  &#39;trials&#39;: [&#39;NCT02343393&#39;]},
 {&#39;description&#39;: &#39;(see -perone)&#39;, &#39;trials&#39;: [&#39;NCT02343575&#39;, &#39;NCT02747511&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02289144&#39;, &#39;NCT02343679&#39;, &#39;NCT02374489&#39;, &#39;NCT02638909&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02153177&#39;,
   &#39;NCT02272725&#39;,
   &#39;NCT02344225&#39;,
   &#39;NCT02443142&#39;,
   &#39;NCT02476422&#39;,
   &#39;NCT02480114&#39;,
   &#39;NCT02482155&#39;,
   &#39;NCT02507219&#39;,
   &#39;NCT02521207&#39;,
   &#39;NCT02531451&#39;,
   &#39;NCT02588027&#39;,
   &#39;NCT02593721&#39;,
   &#39;NCT02602483&#39;,
   &#39;NCT02629354&#39;,
   &#39;NCT02666846&#39;,
   &#39;NCT02902913&#39;,
   &#39;NCT03055247&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02344290&#39;, &#39;NCT02595268&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;,
  &#39;trials&#39;: [&#39;NCT02623751&#39;]},
 {&#39;description&#39;: &#39;estrogen antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02383030&#39;, &#39;NCT02384746&#39;, &#39;NCT02404051&#39;, &#39;NCT02530411&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02282176&#39;,
   &#39;NCT02344628&#39;,
   &#39;NCT02380625&#39;,
   &#39;NCT02527005&#39;,
   &#39;NCT02531984&#39;,
   &#39;NCT02544984&#39;,
   &#39;NCT02630394&#39;,
   &#39;NCT02839408&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02290327&#39;, &#39;NCT02345239&#39;, &#39;NCT02432456&#39;]},
 {&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trials&#39;: [&#39;NCT02451527&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01408849&#39;,
   &#39;NCT02365558&#39;,
   &#39;NCT02422706&#39;,
   &#39;NCT02552537&#39;,
   &#39;NCT02609386&#39;,
   &#39;NCT02621359&#39;,
   &#39;NCT02893709&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;diuretics (furosemide type)&#39;,
  &#39;trials&#39;: [&#39;NCT02333643&#39;,
   &#39;NCT02345681&#39;,
   &#39;NCT02417883&#39;,
   &#39;NCT02450773&#39;,
   &#39;NCT02689180&#39;,
   &#39;NCT02881866&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02348281&#39;, &#39;NCT02353988&#39;, &#39;NCT02605226&#39;, &#39;NCT02615223&#39;]},
 {&#39;description&#39;: &#39;hormone-release inhibiting peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02526784&#39;]},
 {&#39;description&#39;: &#39;thyrotropin releasing hormone analogues&#39;,
  &#39;trials&#39;: [&#39;NCT02346253&#39;, &#39;NCT02483767&#39;]},
 {&#39;description&#39;: &#39;antianxiety&#39;, &#39;trials&#39;: [&#39;NCT02346682&#39;, &#39;NCT02655354&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;dopamine receptor agonists&#39;, &#39;trials&#39;: [&#39;NCT02554734&#39;]},
 {&#39;description&#39;: &#39;combined alpha and beta blockers&#39;,
  &#39;trials&#39;: [&#39;NCT02347111&#39;]},
 {&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02347878&#39;, &#39;NCT02357693&#39;, &#39;NCT02646020&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02347891&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02348281&#39;, &#39;NCT02353988&#39;, &#39;NCT02605226&#39;, &#39;NCT02615223&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02348450&#39;,
   &#39;NCT02453464&#39;,
   &#39;NCT02596503&#39;,
   &#39;NCT02641873&#39;,
   &#39;NCT02662959&#39;,
   &#39;NCT02934529&#39;,
   &#39;NCT03400592&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;catechol-O-methyltransferase (COMT) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02349243&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02349828&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;, &#39;trials&#39;: [&#39;NCT02349906&#39;]},
 {&#39;description&#39;: &#39;bronchodilators (phenethylamine derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02349919&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02351102&#39;, &#39;NCT02412917&#39;, &#39;NCT02571166&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;, &#39;trials&#39;: [&#39;NCT02351128&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02351232&#39;,
   &#39;NCT02408705&#39;,
   &#39;NCT02472717&#39;,
   &#39;NCT02473809&#39;,
   &#39;NCT02490176&#39;,
   &#39;NCT02507128&#39;,
   &#39;NCT02518945&#39;,
   &#39;NCT02545738&#39;,
   &#39;NCT02584582&#39;,
   &#39;NCT02617654&#39;,
   &#39;NCT02638805&#39;,
   &#39;NCT02660047&#39;,
   &#39;NCT02909933&#39;,
   &#39;NCT03010683&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;progestins&#39;,
  &#39;trials&#39;: [&#39;NCT02352090&#39;, &#39;NCT02385448&#39;, &#39;NCT02599077&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02317159&#39;,
   &#39;NCT02352558&#39;,
   &#39;NCT02365441&#39;,
   &#39;NCT02413736&#39;,
   &#39;NCT02462538&#39;,
   &#39;NCT02576080&#39;,
   &#39;NCT02614404&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02108860&#39;,
   &#39;NCT02281058&#39;,
   &#39;NCT02429934&#39;,
   &#39;NCT02594735&#39;,
   &#39;NCT02598466&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02353780&#39;,
   &#39;NCT02404558&#39;,
   &#39;NCT02419937&#39;,
   &#39;NCT02469896&#39;,
   &#39;NCT02778789&#39;,
   &#39;NCT02797769&#39;,
   &#39;NCT02888496&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02353936&#39;, &#39;NCT02491099&#39;, &#39;NCT02506517&#39;, &#39;NCT02511847&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02348281&#39;, &#39;NCT02353988&#39;, &#39;NCT02605226&#39;, &#39;NCT02615223&#39;]},
 {&#39;description&#39;: &#39;progesterone receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02354170&#39;, &#39;NCT02642939&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02354222&#39;, &#39;NCT02354235&#39;, &#39;NCT02360774&#39;, &#39;NCT02597309&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02354222&#39;, &#39;NCT02354235&#39;, &#39;NCT02360774&#39;, &#39;NCT02597309&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02354560&#39;]},
 {&#39;description&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02354586&#39;]},
 {&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02311569&#39;,
   &#39;NCT02354807&#39;,
   &#39;NCT02361502&#39;,
   &#39;NCT02410135&#39;,
   &#39;NCT02462837&#39;,
   &#39;NCT02495389&#39;,
   &#39;NCT02536976&#39;,
   &#39;NCT02540707&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02357342&#39;,
   &#39;NCT02432560&#39;,
   &#39;NCT02440789&#39;,
   &#39;NCT02505893&#39;,
   &#39;NCT02513303&#39;,
   &#39;NCT02574728&#39;,
   &#39;NCT02638389&#39;,
   &#39;NCT02675153&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;thyrotropin releasing hormone analogues&#39;,
  &#39;trials&#39;: [&#39;NCT02357654&#39;]},
 {&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02347878&#39;, &#39;NCT02357693&#39;, &#39;NCT02646020&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02446860&#39;,
   &#39;NCT02497508&#39;,
   &#39;NCT02499367&#39;,
   &#39;NCT02550249&#39;,
   &#39;NCT02569242&#39;,
   &#39;NCT02637531&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02296112&#39;,
   &#39;NCT02357732&#39;,
   &#39;NCT02399943&#39;,
   &#39;NCT02439411&#39;,
   &#39;NCT02538627&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;-prost&#39;, &#39;trials&#39;: [&#39;NCT02358369&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02358499&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02358824&#39;, &#39;NCT02593110&#39;, &#39;NCT02933658&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02359058&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;trials&#39;: [&#39;NCT02631109&#39;, &#39;NCT02631239&#39;]},
 {&#39;description&#39;: &#39;ecteinascidin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02234050&#39;, &#39;NCT02359474&#39;]},
 {&#39;description&#39;: &#39;Monoamine oxidase (MAO) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02359552&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02360384&#39;, &#39;NCT02465385&#39;, &#39;NCT02559206&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02360631&#39;,
   &#39;NCT02378714&#39;,
   &#39;NCT02488889&#39;,
   &#39;NCT02562521&#39;,
   &#39;NCT02683161&#39;,
   &#39;NCT02933372&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02354222&#39;, &#39;NCT02354235&#39;, &#39;NCT02360774&#39;, &#39;NCT02597309&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02269072&#39;,
   &#39;NCT02361190&#39;,
   &#39;NCT02419105&#39;,
   &#39;NCT02433730&#39;,
   &#39;NCT02445716&#39;]},
 {&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02311569&#39;,
   &#39;NCT02354807&#39;,
   &#39;NCT02361502&#39;,
   &#39;NCT02410135&#39;,
   &#39;NCT02462837&#39;,
   &#39;NCT02495389&#39;,
   &#39;NCT02536976&#39;,
   &#39;NCT02540707&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02416570&#39;, &#39;NCT02573935&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02361619&#39;, &#39;NCT02473640&#39;, &#39;NCT02552641&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02211014&#39;, &#39;NCT02537444&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02211014&#39;, &#39;NCT02537444&#39;]},
 {&#39;description&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02413203&#39;, &#39;NCT02502500&#39;, &#39;NCT02961998&#39;]},
 {&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02124811&#39;,
   &#39;NCT02187211&#39;,
   &#39;NCT02201563&#39;,
   &#39;NCT02362529&#39;,
   &#39;NCT02456948&#39;,
   &#39;NCT02515955&#39;,
   &#39;NCT02533232&#39;,
   &#39;NCT02564978&#39;,
   &#39;NCT02569307&#39;,
   &#39;NCT02907437&#39;,
   &#39;NCT02928692&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;leukotriene biosynthesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02451540&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02363738&#39;, &#39;NCT02522169&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02317159&#39;,
   &#39;NCT02352558&#39;,
   &#39;NCT02365441&#39;,
   &#39;NCT02413736&#39;,
   &#39;NCT02462538&#39;,
   &#39;NCT02576080&#39;,
   &#39;NCT02614404&#39;]},
 {&#39;description&#39;: &#39;class III antiarrhythmic agents&#39;, &#39;trials&#39;: [&#39;NCT02365532&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01408849&#39;,
   &#39;NCT02365558&#39;,
   &#39;NCT02422706&#39;,
   &#39;NCT02552537&#39;,
   &#39;NCT02609386&#39;,
   &#39;NCT02621359&#39;,
   &#39;NCT02893709&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02335346&#39;, &#39;NCT02367404&#39;, &#39;NCT02443194&#39;, &#39;NCT02600247&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02561169&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02369159&#39;, &#39;NCT02635724&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT01528865&#39;,
   &#39;NCT02482272&#39;,
   &#39;NCT02566707&#39;,
   &#39;NCT02581202&#39;,
   &#39;NCT02650271&#39;,
   &#39;NCT02652793&#39;,
   &#39;NCT02770508&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;, &#39;trials&#39;: [&#39;NCT02369406&#39;]},
 {&#39;description&#39;: &#39;beta-blockers (propranolol type)&#39;,
  &#39;trials&#39;: [&#39;NCT02369900&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trials&#39;: [&#39;NCT02451527&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02250807&#39;,
   &#39;NCT02319031&#39;,
   &#39;NCT02371408&#39;,
   &#39;NCT02473211&#39;,
   &#39;NCT02485080&#39;,
   &#39;NCT02551861&#39;,
   &#39;NCT02556086&#39;,
   &#39;NCT02596880&#39;,
   &#39;NCT02640157&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02479308&#39;, &#39;NCT02515864&#39;, &#39;NCT02537288&#39;, &#39;NCT02559310&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;coronary vasodilators (verapamil type)&#39;,
  &#39;trials&#39;: [&#39;NCT02372253&#39;, &#39;NCT02454491&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trials&#39;: [&#39;NCT02434861&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02014103&#39;,
   &#39;NCT02122081&#39;,
   &#39;NCT02158052&#39;,
   &#39;NCT02373202&#39;,
   &#39;NCT02382575&#39;,
   &#39;NCT02432833&#39;,
   &#39;NCT02446964&#39;,
   &#39;NCT02447055&#39;,
   &#39;NCT02466997&#39;,
   &#39;NCT02495077&#39;,
   &#39;NCT02498977&#39;,
   &#39;NCT02528877&#39;,
   &#39;NCT02608606&#39;,
   &#39;NCT02743247&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02373241&#39;, &#39;NCT02663141&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02289144&#39;, &#39;NCT02343679&#39;, &#39;NCT02374489&#39;, &#39;NCT02638909&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02154061&#39;,
   &#39;NCT02285140&#39;,
   &#39;NCT02374853&#39;,
   &#39;NCT02384200&#39;,
   &#39;NCT02400112&#39;,
   &#39;NCT02463747&#39;,
   &#39;NCT02464020&#39;,
   &#39;NCT02605213&#39;,
   &#39;NCT02607618&#39;,
   &#39;NCT02631408&#39;,
   &#39;NCT02660346&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;-adol-&#39;,
  &#39;trials&#39;: [&#39;NCT02375100&#39;,
   &#39;NCT02419651&#39;,
   &#39;NCT02425709&#39;,
   &#39;NCT02428777&#39;,
   &#39;NCT02484859&#39;,
   &#39;NCT02497326&#39;,
   &#39;NCT02851394&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02326103&#39;,
   &#39;NCT02375295&#39;,
   &#39;NCT02423759&#39;,
   &#39;NCT02598362&#39;,
   &#39;NCT02734732&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02009605&#39;,
   &#39;NCT02264210&#39;,
   &#39;NCT02375581&#39;,
   &#39;NCT02404675&#39;,
   &#39;NCT02448797&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02217501&#39;,
   &#39;NCT02379676&#39;,
   &#39;NCT02429271&#39;,
   &#39;NCT02439190&#39;,
   &#39;NCT02447809&#39;,
   &#39;NCT02457130&#39;,
   &#39;NCT02469740&#39;,
   &#39;NCT02486367&#39;,
   &#39;NCT02499666&#39;,
   &#39;NCT02505399&#39;,
   &#39;NCT02513004&#39;,
   &#39;NCT02514642&#39;,
   &#39;NCT02519608&#39;,
   &#39;NCT02560688&#39;,
   &#39;NCT02578537&#39;,
   &#39;NCT02578706&#39;,
   &#39;NCT02580149&#39;,
   &#39;NCT02612480&#39;,
   &#39;NCT02626169&#39;,
   &#39;NCT02639143&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02376283&#39;, &#39;NCT02487732&#39;, &#39;NCT02548611&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;antiestrogens of the clomifene and tamoxifen groups&#39;,
  &#39;trials&#39;: [&#39;NCT02137265&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02279576&#39;, &#39;NCT02331498&#39;, &#39;NCT02378142&#39;, &#39;NCT02406521&#39;]},
 {&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trials&#39;: [&#39;NCT02269319&#39;,
   &#39;NCT02269644&#39;,
   &#39;NCT02333799&#39;,
   &#39;NCT02426918&#39;,
   &#39;NCT02570490&#39;]},
 {&#39;description&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02378480&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;, &#39;trials&#39;: [&#39;NCT02179177&#39;, &#39;NCT02378623&#39;]},
 {&#39;description&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02360631&#39;,
   &#39;NCT02378714&#39;,
   &#39;NCT02488889&#39;,
   &#39;NCT02562521&#39;,
   &#39;NCT02683161&#39;,
   &#39;NCT02933372&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02217501&#39;,
   &#39;NCT02379676&#39;,
   &#39;NCT02429271&#39;,
   &#39;NCT02439190&#39;,
   &#39;NCT02447809&#39;,
   &#39;NCT02457130&#39;,
   &#39;NCT02469740&#39;,
   &#39;NCT02486367&#39;,
   &#39;NCT02499666&#39;,
   &#39;NCT02505399&#39;,
   &#39;NCT02513004&#39;,
   &#39;NCT02514642&#39;,
   &#39;NCT02519608&#39;,
   &#39;NCT02560688&#39;,
   &#39;NCT02578537&#39;,
   &#39;NCT02578706&#39;,
   &#39;NCT02580149&#39;,
   &#39;NCT02612480&#39;,
   &#39;NCT02626169&#39;,
   &#39;NCT02639143&#39;]},
 {&#39;description&#39;: &#39;heparin derivatives and low molecular weight (or depolymerized) heparins&#39;,
  &#39;trials&#39;: [&#39;NCT02379806&#39;, &#39;NCT02696330&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02194842&#39;,
   &#39;NCT02438007&#39;,
   &#39;NCT02507570&#39;,
   &#39;NCT02814968&#39;,
   &#39;NCT02815033&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02282176&#39;,
   &#39;NCT02344628&#39;,
   &#39;NCT02380625&#39;,
   &#39;NCT02527005&#39;,
   &#39;NCT02531984&#39;,
   &#39;NCT02544984&#39;,
   &#39;NCT02630394&#39;,
   &#39;NCT02839408&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02333565&#39;,
   &#39;NCT02381249&#39;,
   &#39;NCT02384122&#39;,
   &#39;NCT02437825&#39;,
   &#39;NCT02457156&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;-curonium&#39;,
  &#39;trials&#39;: [&#39;NCT02382510&#39;, &#39;NCT02622243&#39;, &#39;NCT02627625&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02014103&#39;,
   &#39;NCT02122081&#39;,
   &#39;NCT02158052&#39;,
   &#39;NCT02373202&#39;,
   &#39;NCT02382575&#39;,
   &#39;NCT02432833&#39;,
   &#39;NCT02446964&#39;,
   &#39;NCT02447055&#39;,
   &#39;NCT02466997&#39;,
   &#39;NCT02495077&#39;,
   &#39;NCT02498977&#39;,
   &#39;NCT02528877&#39;,
   &#39;NCT02608606&#39;,
   &#39;NCT02743247&#39;]},
 {&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02382666&#39;]},
 {&#39;description&#39;: &#39;antihypertensives (prazosin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02382848&#39;, &#39;NCT02431936&#39;]},
 {&#39;description&#39;: &#39;estrogen antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02383030&#39;, &#39;NCT02384746&#39;, &#39;NCT02404051&#39;, &#39;NCT02530411&#39;]},
 {&#39;description&#39;: &#39;farnesyl transferase inhibitor&#39;,
  &#39;trials&#39;: [&#39;NCT02383927&#39;, &#39;NCT02464228&#39;, &#39;NCT02535650&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02333565&#39;,
   &#39;NCT02381249&#39;,
   &#39;NCT02384122&#39;,
   &#39;NCT02437825&#39;,
   &#39;NCT02457156&#39;]},
 {&#39;description&#39;: &#39;penicillins&#39;, &#39;trials&#39;: [&#39;NCT02477423&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02154061&#39;,
   &#39;NCT02285140&#39;,
   &#39;NCT02374853&#39;,
   &#39;NCT02384200&#39;,
   &#39;NCT02400112&#39;,
   &#39;NCT02463747&#39;,
   &#39;NCT02464020&#39;,
   &#39;NCT02605213&#39;,
   &#39;NCT02607618&#39;,
   &#39;NCT02631408&#39;,
   &#39;NCT02660346&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT01528865&#39;,
   &#39;NCT02482272&#39;,
   &#39;NCT02566707&#39;,
   &#39;NCT02581202&#39;,
   &#39;NCT02650271&#39;,
   &#39;NCT02652793&#39;,
   &#39;NCT02770508&#39;]},
 {&#39;description&#39;: &#39;estrogen antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02383030&#39;, &#39;NCT02384746&#39;, &#39;NCT02404051&#39;, &#39;NCT02530411&#39;]},
 {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trials&#39;: [&#39;NCT02384759&#39;,
   &#39;NCT02401945&#39;,
   &#39;NCT02441907&#39;,
   &#39;NCT02537054&#39;,
   &#39;NCT02550002&#39;,
   &#39;NCT02559180&#39;,
   &#39;NCT02586727&#39;,
   &#39;NCT02597855&#39;,
   &#39;NCT02669953&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02384915&#39;, &#39;NCT02813382&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;progestins&#39;,
  &#39;trials&#39;: [&#39;NCT02352090&#39;, &#39;NCT02385448&#39;, &#39;NCT02599077&#39;]},
 {&#39;description&#39;: &#39;colony-stimulating factors&#39;,
  &#39;trials&#39;: [&#39;NCT02385851&#39;, &#39;NCT03404752&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02326285&#39;, &#39;NCT02484755&#39;, &#39;NCT02804776&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02301949&#39;,
   &#39;NCT02387086&#39;,
   &#39;NCT02467647&#39;,
   &#39;NCT02545907&#39;,
   &#39;NCT02586038&#39;,
   &#39;NCT02649101&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02358824&#39;, &#39;NCT02593110&#39;, &#39;NCT02933658&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02387710&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02211014&#39;, &#39;NCT02537444&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02387801&#39;, &#39;NCT02513550&#39;, &#39;NCT02543918&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02327143&#39;, &#39;NCT02387814&#39;, &#39;NCT02482935&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02427334&#39;,
   &#39;NCT02473250&#39;,
   &#39;NCT02488538&#39;,
   &#39;NCT02562053&#39;,
   &#39;NCT02601677&#39;]},
 {&#39;description&#39;: &#39;sodium channel blockers&#39;,
  &#39;trials&#39;: [&#39;NCT02389712&#39;, &#39;NCT02556060&#39;, &#39;NCT02708849&#39;]},
 {&#39;description&#39;: &#39;adenosine A receptor agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02589977&#39;, &#39;NCT02597543&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02389868&#39;, &#39;NCT02563860&#39;, &#39;NCT02603770&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02326311&#39;, &#39;NCT02389920&#39;, &#39;NCT02733445&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02457910&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01931098&#39;,
   &#39;NCT02298348&#39;,
   &#39;NCT02390843&#39;,
   &#39;NCT02421588&#39;,
   &#39;NCT02866370&#39;]},
 {&#39;description&#39;: &#39;oxytocin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02216383&#39;, &#39;NCT02391636&#39;, &#39;NCT02396303&#39;, &#39;NCT02528136&#39;]},
 {&#39;description&#39;: &#39;vancomycin-related compounds&#39;, &#39;trials&#39;: [&#39;NCT02392208&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02292225&#39;,
   &#39;NCT02393157&#39;,
   &#39;NCT02475681&#39;,
   &#39;NCT02495454&#39;,
   &#39;NCT02537613&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;penicillins&#39;, &#39;trials&#39;: [&#39;NCT02830347&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02394106&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02394106&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02549677&#39;, &#39;NCT02627248&#39;, &#39;NCT02631499&#39;, &#39;NCT02638857&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Micromonospora strains)&#39;,
  &#39;trials&#39;: [&#39;NCT02395848&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;oxytocin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02216383&#39;, &#39;NCT02391636&#39;, &#39;NCT02396303&#39;, &#39;NCT02528136&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (mitotic inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02338037&#39;, &#39;NCT02396433&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02312375&#39;, &#39;NCT02397590&#39;, &#39;NCT02566187&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02312375&#39;, &#39;NCT02397590&#39;, &#39;NCT02566187&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;-fibrate&#39;, &#39;trials&#39;: [&#39;NCT02398201&#39;, &#39;NCT02481245&#39;]},
 {&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trials&#39;: [&#39;NCT02497131&#39;, &#39;NCT02499627&#39;, &#39;NCT02533570&#39;, &#39;NCT02780011&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02398539&#39;, &#39;NCT02655523&#39;, &#39;NCT02704507&#39;, &#39;NCT02967302&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02230176&#39;,
   &#39;NCT02398552&#39;,
   &#39;NCT02401815&#39;,
   &#39;NCT02432846&#39;,
   &#39;NCT02483247&#39;]},
 {&#39;description&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;trials&#39;: [&#39;NCT02180204&#39;, &#39;NCT02398656&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02476045&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02296112&#39;,
   &#39;NCT02357732&#39;,
   &#39;NCT02399943&#39;,
   &#39;NCT02439411&#39;,
   &#39;NCT02538627&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT01718444&#39;,
   &#39;NCT02255175&#39;,
   &#39;NCT02400021&#39;,
   &#39;NCT02470676&#39;,
   &#39;NCT02579421&#39;,
   &#39;NCT02601898&#39;,
   &#39;NCT02655146&#39;,
   &#39;NCT02697331&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02154061&#39;,
   &#39;NCT02285140&#39;,
   &#39;NCT02374853&#39;,
   &#39;NCT02384200&#39;,
   &#39;NCT02400112&#39;,
   &#39;NCT02463747&#39;,
   &#39;NCT02464020&#39;,
   &#39;NCT02605213&#39;,
   &#39;NCT02607618&#39;,
   &#39;NCT02631408&#39;,
   &#39;NCT02660346&#39;]},
 {&#39;description&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02458235&#39;, &#39;NCT02489929&#39;, &#39;NCT02543879&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02283177&#39;, &#39;NCT02560025&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;, &#39;trials&#39;: [&#39;NCT02400281&#39;, &#39;NCT02632708&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02412228&#39;, &#39;NCT02461888&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02164500&#39;, &#39;NCT02400463&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;leukotriene biosynthesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02400749&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02291055&#39;,
   &#39;NCT02336165&#39;,
   &#39;NCT02401048&#39;,
   &#39;NCT02431559&#39;,
   &#39;NCT02489448&#39;]},
 {&#39;description&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02413203&#39;, &#39;NCT02502500&#39;, &#39;NCT02961998&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02071940&#39;, &#39;NCT02452424&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02230176&#39;,
   &#39;NCT02398552&#39;,
   &#39;NCT02401815&#39;,
   &#39;NCT02432846&#39;,
   &#39;NCT02483247&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02401828&#39;, &#39;NCT02487706&#39;, &#39;NCT02513147&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02577315&#39;, &#39;NCT02637973&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02401880&#39;, &#39;NCT02442817&#39;, &#39;NCT02608177&#39;, &#39;NCT02851745&#39;]},
 {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trials&#39;: [&#39;NCT02384759&#39;,
   &#39;NCT02401945&#39;,
   &#39;NCT02441907&#39;,
   &#39;NCT02537054&#39;,
   &#39;NCT02550002&#39;,
   &#39;NCT02559180&#39;,
   &#39;NCT02586727&#39;,
   &#39;NCT02597855&#39;,
   &#39;NCT02669953&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;,
  &#39;trials&#39;: [&#39;NCT02623751&#39;]},
 {&#39;description&#39;: &#39;estrogen antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02383030&#39;, &#39;NCT02384746&#39;, &#39;NCT02404051&#39;, &#39;NCT02530411&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02353780&#39;,
   &#39;NCT02404558&#39;,
   &#39;NCT02419937&#39;,
   &#39;NCT02469896&#39;,
   &#39;NCT02778789&#39;,
   &#39;NCT02797769&#39;,
   &#39;NCT02888496&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02009605&#39;,
   &#39;NCT02264210&#39;,
   &#39;NCT02375581&#39;,
   &#39;NCT02404675&#39;,
   &#39;NCT02448797&#39;]},
 {&#39;description&#39;: &#39;leptin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02404896&#39;, &#39;NCT02654977&#39;]},
 {&#39;description&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02095184&#39;,
   &#39;NCT02128360&#39;,
   &#39;NCT02377479&#39;,
   &#39;NCT02455154&#39;,
   &#39;NCT02470741&#39;,
   &#39;NCT02491320&#39;,
   &#39;NCT02551367&#39;,
   &#39;NCT02630485&#39;,
   &#39;NCT02647424&#39;,
   &#39;NCT02765373&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01530984&#39;,
   &#39;NCT02224768&#39;,
   &#39;NCT02307149&#39;,
   &#39;NCT02406183&#39;,
   &#39;NCT02423928&#39;,
   &#39;NCT02452281&#39;,
   &#39;NCT02498756&#39;,
   &#39;NCT02608437&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#34;acetylcholinesterase inhibitors used in the treatment of Alzheimer&#39;s disease&#34;,
  &#39;trials&#39;: [&#39;NCT02415062&#39;, &#39;NCT02450786&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02279576&#39;, &#39;NCT02331498&#39;, &#39;NCT02378142&#39;, &#39;NCT02406521&#39;]},
 {&#39;description&#39;: &#39;antimyloidotics&#39;, &#39;trials&#39;: [&#39;NCT02406560&#39;, &#39;NCT02534740&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02239458&#39;,
   &#39;NCT02280486&#39;,
   &#39;NCT02304081&#39;,
   &#39;NCT02315495&#39;,
   &#39;NCT02462369&#39;,
   &#39;NCT02481479&#39;,
   &#39;NCT02597101&#39;,
   &#39;NCT02605772&#39;,
   &#39;NCT02742233&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trials&#39;: [&#39;NCT02497131&#39;, &#39;NCT02499627&#39;, &#39;NCT02533570&#39;, &#39;NCT02780011&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01977339&#39;,
   &#39;NCT02141178&#39;,
   &#39;NCT02343263&#39;,
   &#39;NCT02353676&#39;,
   &#39;NCT02368054&#39;,
   &#39;NCT02381353&#39;,
   &#39;NCT02381717&#39;,
   &#39;NCT02397330&#39;,
   &#39;NCT02398123&#39;,
   &#39;NCT02400645&#39;,
   &#39;NCT02408419&#39;,
   &#39;NCT02449915&#39;,
   &#39;NCT02453321&#39;,
   &#39;NCT02462174&#39;,
   &#39;NCT02506660&#39;,
   &#39;NCT02514980&#39;,
   &#39;NCT02537860&#39;,
   &#39;NCT02540837&#39;,
   &#39;NCT02550262&#39;,
   &#39;NCT02563795&#39;,
   &#39;NCT02571283&#39;,
   &#39;NCT02581566&#39;,
   &#39;NCT02618876&#39;,
   &#39;NCT02696915&#39;,
   &#39;NCT02752971&#39;,
   &#39;NCT03004222&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02351232&#39;,
   &#39;NCT02408705&#39;,
   &#39;NCT02472717&#39;,
   &#39;NCT02473809&#39;,
   &#39;NCT02490176&#39;,
   &#39;NCT02507128&#39;,
   &#39;NCT02518945&#39;,
   &#39;NCT02545738&#39;,
   &#39;NCT02584582&#39;,
   &#39;NCT02617654&#39;,
   &#39;NCT02638805&#39;,
   &#39;NCT02660047&#39;,
   &#39;NCT02909933&#39;,
   &#39;NCT03010683&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trials&#39;: [&#39;NCT02311569&#39;,
   &#39;NCT02354807&#39;,
   &#39;NCT02361502&#39;,
   &#39;NCT02410135&#39;,
   &#39;NCT02462837&#39;,
   &#39;NCT02495389&#39;,
   &#39;NCT02536976&#39;,
   &#39;NCT02540707&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02256280&#39;,
   &#39;NCT02329964&#39;,
   &#39;NCT02361060&#39;,
   &#39;NCT02390817&#39;,
   &#39;NCT02403063&#39;,
   &#39;NCT02454504&#39;,
   &#39;NCT02543658&#39;,
   &#39;NCT02574611&#39;,
   &#39;NCT02666014&#39;]},
 {&#39;description&#39;: &#39;-curonium&#39;,
  &#39;trials&#39;: [&#39;NCT02320734&#39;,
   &#39;NCT02451202&#39;,
   &#39;NCT02464722&#39;,
   &#39;NCT02471521&#39;,
   &#39;NCT02546843&#39;,
   &#39;NCT02553629&#39;,
   &#39;NCT02601508&#39;,
   &#39;NCT02711917&#39;]},
 {&#39;description&#39;: &#39;oxytocin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02216383&#39;, &#39;NCT02391636&#39;, &#39;NCT02396303&#39;, &#39;NCT02528136&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02412085&#39;]},
 {&#39;description&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02412228&#39;, &#39;NCT02461888&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;,
  &#39;trials&#39;: [&#39;NCT02298257&#39;, &#39;NCT02412670&#39;, &#39;NCT02414568&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;,
  &#39;trials&#39;: [&#39;NCT02351102&#39;, &#39;NCT02412917&#39;, &#39;NCT02571166&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02413203&#39;, &#39;NCT02502500&#39;, &#39;NCT02961998&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antiepileptics (hydantoin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02413658&#39;, &#39;NCT02595723&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02317159&#39;,
   &#39;NCT02352558&#39;,
   &#39;NCT02365441&#39;,
   &#39;NCT02413736&#39;,
   &#39;NCT02462538&#39;,
   &#39;NCT02576080&#39;,
   &#39;NCT02614404&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT01132482&#39;,
   &#39;NCT02277132&#39;,
   &#39;NCT02304705&#39;,
   &#39;NCT02337881&#39;,
   &#39;NCT02364882&#39;,
   &#39;NCT02387450&#39;,
   &#39;NCT02414204&#39;,
   &#39;NCT02524184&#39;,
   &#39;NCT02595541&#39;,
   &#39;NCT02626182&#39;,
   &#39;NCT02795351&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02753062&#39;]},
 {&#39;description&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;,
  &#39;trials&#39;: [&#39;NCT02298257&#39;, &#39;NCT02412670&#39;, &#39;NCT02414568&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02414724&#39;, &#39;NCT02429089&#39;, &#39;NCT02494921&#39;, &#39;NCT02608216&#39;]},
 {&#39;description&#39;: &#34;acetylcholinesterase inhibitors used in the treatment of Alzheimer&#39;s disease&#34;,
  &#39;trials&#39;: [&#39;NCT02415062&#39;, &#39;NCT02450786&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02283177&#39;, &#39;NCT02560025&#39;]},
 {&#39;description&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02269358&#39;,
   &#39;NCT02309359&#39;,
   &#39;NCT02328755&#39;,
   &#39;NCT02387762&#39;,
   &#39;NCT02413047&#39;,
   &#39;NCT02467504&#39;,
   &#39;NCT02478424&#39;,
   &#39;NCT02480946&#39;,
   &#39;NCT02590510&#39;,
   &#39;NCT02715947&#39;,
   &#39;NCT02748785&#39;,
   &#39;NCT02764515&#39;,
   &#39;NCT02777736&#39;]},
 {&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trials&#39;: [&#39;NCT02416388&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02416570&#39;, &#39;NCT02573935&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;diuretics (furosemide type)&#39;,
  &#39;trials&#39;: [&#39;NCT02333643&#39;,
   &#39;NCT02345681&#39;,
   &#39;NCT02417883&#39;,
   &#39;NCT02450773&#39;,
   &#39;NCT02689180&#39;,
   &#39;NCT02881866&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02335346&#39;, &#39;NCT02367404&#39;, &#39;NCT02443194&#39;, &#39;NCT02600247&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02269072&#39;,
   &#39;NCT02361190&#39;,
   &#39;NCT02419105&#39;,
   &#39;NCT02433730&#39;,
   &#39;NCT02445716&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;, &#39;trials&#39;: [&#39;NCT02419378&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;-adol-&#39;,
  &#39;trials&#39;: [&#39;NCT02375100&#39;,
   &#39;NCT02419651&#39;,
   &#39;NCT02425709&#39;,
   &#39;NCT02428777&#39;,
   &#39;NCT02484859&#39;,
   &#39;NCT02497326&#39;,
   &#39;NCT02851394&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02353780&#39;,
   &#39;NCT02404558&#39;,
   &#39;NCT02419937&#39;,
   &#39;NCT02469896&#39;,
   &#39;NCT02778789&#39;,
   &#39;NCT02797769&#39;,
   &#39;NCT02888496&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02030054&#39;,
   &#39;NCT02215174&#39;,
   &#39;NCT02341794&#39;,
   &#39;NCT02387619&#39;,
   &#39;NCT02397538&#39;,
   &#39;NCT02418884&#39;,
   &#39;NCT02420899&#39;,
   &#39;NCT02482207&#39;,
   &#39;NCT02484027&#39;,
   &#39;NCT02502110&#39;,
   &#39;NCT02516826&#39;,
   &#39;NCT02561845&#39;,
   &#39;NCT02569645&#39;,
   &#39;NCT02569814&#39;,
   &#39;NCT02574845&#39;,
   &#39;NCT02586155&#39;,
   &#39;NCT02594800&#39;,
   &#39;NCT02643784&#39;,
   &#39;NCT02707224&#39;,
   &#39;NCT02800902&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT01836614&#39;,
   &#39;NCT02241096&#39;,
   &#39;NCT02324166&#39;,
   &#39;NCT02335190&#39;,
   &#39;NCT02344589&#39;,
   &#39;NCT02356705&#39;,
   &#39;NCT02421419&#39;,
   &#39;NCT02454894&#39;,
   &#39;NCT02462915&#39;,
   &#39;NCT02479789&#39;,
   &#39;NCT02510287&#39;,
   &#39;NCT02535273&#39;,
   &#39;NCT02590705&#39;,
   &#39;NCT02591199&#39;,
   &#39;NCT02595463&#39;,
   &#39;NCT02601651&#39;,
   &#39;NCT02620501&#39;,
   &#39;NCT02620683&#39;,
   &#39;NCT02644421&#39;,
   &#39;NCT02682134&#39;,
   &#39;NCT02733393&#39;,
   &#39;NCT02920905&#39;,
   &#39;NCT02990364&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01931098&#39;,
   &#39;NCT02298348&#39;,
   &#39;NCT02390843&#39;,
   &#39;NCT02421588&#39;,
   &#39;NCT02866370&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01983475&#39;,
   &#39;NCT02299817&#39;,
   &#39;NCT02321280&#39;,
   &#39;NCT02422108&#39;,
   &#39;NCT02613416&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02289547&#39;,
   &#39;NCT02324543&#39;,
   &#39;NCT02371304&#39;,
   &#39;NCT02460419&#39;,
   &#39;NCT02465593&#39;,
   &#39;NCT02473094&#39;,
   &#39;NCT02505750&#39;,
   &#39;NCT02548195&#39;,
   &#39;NCT02595320&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02422199&#39;, &#39;NCT02559778&#39;, &#39;NCT02581124&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02812654&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02422654&#39;, &#39;NCT02536911&#39;, &#39;NCT02536937&#39;]},
 {&#39;description&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trials&#39;: [&#39;NCT02416570&#39;, &#39;NCT02573935&#39;]},
 {&#39;description&#39;: &#39;antiparasitics (salicylanilide derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02612922&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01408849&#39;,
   &#39;NCT02365558&#39;,
   &#39;NCT02422706&#39;,
   &#39;NCT02552537&#39;,
   &#39;NCT02609386&#39;,
   &#39;NCT02621359&#39;,
   &#39;NCT02893709&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02422719&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02153177&#39;,
   &#39;NCT02272725&#39;,
   &#39;NCT02344225&#39;,
   &#39;NCT02443142&#39;,
   &#39;NCT02476422&#39;,
   &#39;NCT02480114&#39;,
   &#39;NCT02482155&#39;,
   &#39;NCT02507219&#39;,
   &#39;NCT02521207&#39;,
   &#39;NCT02531451&#39;,
   &#39;NCT02588027&#39;,
   &#39;NCT02593721&#39;,
   &#39;NCT02602483&#39;,
   &#39;NCT02629354&#39;,
   &#39;NCT02666846&#39;,
   &#39;NCT02902913&#39;,
   &#39;NCT03055247&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trials&#39;: [&#39;NCT02147834&#39;, &#39;NCT02252406&#39;, &#39;NCT02423265&#39;]},
 {&#39;description&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02326103&#39;,
   &#39;NCT02375295&#39;,
   &#39;NCT02423759&#39;,
   &#39;NCT02598362&#39;,
   &#39;NCT02734732&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT01530984&#39;,
   &#39;NCT02224768&#39;,
   &#39;NCT02307149&#39;,
   &#39;NCT02406183&#39;,
   &#39;NCT02423928&#39;,
   &#39;NCT02452281&#39;,
   &#39;NCT02498756&#39;,
   &#39;NCT02608437&#39;]},
 {&#39;description&#39;: &#39;synthetic glucagon analogs&#39;, &#39;trials&#39;: [&#39;NCT02423980&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02277457&#39;, &#39;NCT02399566&#39;, &#39;NCT02424617&#39;, &#39;NCT02556593&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;-adol-&#39;,
  &#39;trials&#39;: [&#39;NCT02375100&#39;,
   &#39;NCT02419651&#39;,
   &#39;NCT02425709&#39;,
   &#39;NCT02428777&#39;,
   &#39;NCT02484859&#39;,
   &#39;NCT02497326&#39;,
   &#39;NCT02851394&#39;]},
 {&#39;description&#39;: &#39;warfarin analogs&#39;,
  &#39;trials&#39;: [&#39;NCT02283294&#39;,
   &#39;NCT02295475&#39;,
   &#39;NCT02303795&#39;,
   &#39;NCT02331095&#39;,
   &#39;NCT02345304&#39;,
   &#39;NCT02375646&#39;,
   &#39;NCT02376803&#39;,
   &#39;NCT02426060&#39;,
   &#39;NCT02492230&#39;,
   &#39;NCT02506985&#39;,
   &#39;NCT02531568&#39;,
   &#39;NCT02540668&#39;,
   &#39;NCT02544932&#39;,
   &#39;NCT02617810&#39;,
   &#39;NCT02641899&#39;,
   &#39;NCT02647086&#39;,
   &#39;NCT02783040&#39;,
   &#39;NCT02853526&#39;,
   &#39;NCT02935855&#39;]},
 {&#39;description&#39;: &#39;(nifedipine type)&#39;,
  &#39;trials&#39;: [&#39;NCT01360034&#39;,
   &#39;NCT02426177&#39;,
   &#39;NCT02438371&#39;,
   &#39;NCT02513927&#39;,
   &#39;NCT02563405&#39;,
   &#39;NCT02591004&#39;]},
 {&#39;description&#39;: &#39;peroxisome proliferator activiating receptor (PPAR) agonists (thiazolidene derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02426294&#39;, &#39;NCT02429232&#39;, &#39;NCT02535832&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02235324&#39;, &#39;NCT02325986&#39;, &#39;NCT02500940&#39;, &#39;NCT02573220&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02077998&#39;,
   &#39;NCT02121405&#39;,
   &#39;NCT02129322&#39;,
   &#39;NCT02216149&#39;,
   &#39;NCT02338518&#39;,
   &#39;NCT02340949&#39;,
   &#39;NCT02345460&#39;,
   &#39;NCT02384850&#39;,
   &#39;NCT02395640&#39;,
   &#39;NCT02415699&#39;,
   &#39;NCT02426450&#39;,
   &#39;NCT02506842&#39;,
   &#39;NCT02515734&#39;,
   &#39;NCT02527785&#39;,
   &#39;NCT02527824&#39;,
   &#39;NCT02539537&#39;,
   &#39;NCT02551991&#39;,
   &#39;NCT02562716&#39;,
   &#39;NCT02569723&#39;,
   &#39;NCT02585479&#39;,
   &#39;NCT02605265&#39;,
   &#39;NCT02620865&#39;,
   &#39;NCT02635971&#39;,
   &#39;NCT02767375&#39;]},
 {&#39;description&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trials&#39;: [&#39;NCT02269319&#39;,
   &#39;NCT02269644&#39;,
   &#39;NCT02333799&#39;,
   &#39;NCT02426918&#39;,
   &#39;NCT02570490&#39;]},
 {&#39;description&#39;: &#39;antithrombotics&#39;, &#39;trials&#39;: [&#39;NCT02179177&#39;, &#39;NCT02378623&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;progestins&#39;,
  &#39;trials&#39;: [&#39;NCT02352090&#39;, &#39;NCT02385448&#39;, &#39;NCT02599077&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02427334&#39;,
   &#39;NCT02473250&#39;,
   &#39;NCT02488538&#39;,
   &#39;NCT02562053&#39;,
   &#39;NCT02601677&#39;]},
 {&#39;description&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02036086&#39;,
   &#39;NCT02230306&#39;,
   &#39;NCT02427893&#39;,
   &#39;NCT02456701&#39;,
   &#39;NCT02638428&#39;]},
 {&#39;description&#39;: &#39;sympathomimetics&#39;, &#39;trials&#39;: [&#39;NCT02428257&#39;, &#39;NCT02522858&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02018861&#39;,
   &#39;NCT02232386&#39;,
   &#39;NCT02313389&#39;,
   &#39;NCT02314403&#39;,
   &#39;NCT02390362&#39;,
   &#39;NCT02394119&#39;,
   &#39;NCT02400437&#39;,
   &#39;NCT02405676&#39;,
   &#39;NCT02408042&#39;,
   &#39;NCT02417129&#39;,
   &#39;NCT02420938&#39;,
   &#39;NCT02456207&#39;,
   &#39;NCT02460276&#39;,
   &#39;NCT02471911&#39;,
   &#39;NCT02484053&#39;,
   &#39;NCT02500251&#39;,
   &#39;NCT02525172&#39;,
   &#39;NCT02532192&#39;,
   &#39;NCT02576275&#39;,
   &#39;NCT02594163&#39;,
   &#39;NCT02594384&#39;,
   &#39;NCT02605694&#39;,
   &#39;NCT02626845&#39;,
   &#39;NCT02752204&#39;,
   &#39;NCT02787239&#39;,
   &#39;NCT02834286&#39;,
   &#39;NCT03002038&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;-adol-&#39;,
  &#39;trials&#39;: [&#39;NCT02375100&#39;,
   &#39;NCT02419651&#39;,
   &#39;NCT02425709&#39;,
   &#39;NCT02428777&#39;,
   &#39;NCT02484859&#39;,
   &#39;NCT02497326&#39;,
   &#39;NCT02851394&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02414724&#39;, &#39;NCT02429089&#39;, &#39;NCT02494921&#39;, &#39;NCT02608216&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02401880&#39;, &#39;NCT02442817&#39;, &#39;NCT02608177&#39;, &#39;NCT02851745&#39;]},
 {&#39;description&#39;: &#39;peroxisome proliferator activiating receptor (PPAR) agonists (thiazolidene derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02426294&#39;, &#39;NCT02429232&#39;, &#39;NCT02535832&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02217501&#39;,
   &#39;NCT02379676&#39;,
   &#39;NCT02429271&#39;,
   &#39;NCT02439190&#39;,
   &#39;NCT02447809&#39;,
   &#39;NCT02457130&#39;,
   &#39;NCT02469740&#39;,
   &#39;NCT02486367&#39;,
   &#39;NCT02499666&#39;,
   &#39;NCT02505399&#39;,
   &#39;NCT02513004&#39;,
   &#39;NCT02514642&#39;,
   &#39;NCT02519608&#39;,
   &#39;NCT02560688&#39;,
   &#39;NCT02578537&#39;,
   &#39;NCT02578706&#39;,
   &#39;NCT02580149&#39;,
   &#39;NCT02612480&#39;,
   &#39;NCT02626169&#39;,
   &#39;NCT02639143&#39;]},
 {&#39;description&#39;: &#39;sympathomimetics&#39;, &#39;trials&#39;: [&#39;NCT02429557&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antiviral receptors&#39;,
  &#39;trials&#39;: [&#39;NCT02108860&#39;,
   &#39;NCT02281058&#39;,
   &#39;NCT02429934&#39;,
   &#39;NCT02594735&#39;,
   &#39;NCT02598466&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02430896&#39;, &#39;NCT02500732&#39;, &#39;NCT02874937&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02484261&#39;, &#39;NCT02547402&#39;, &#39;NCT02621957&#39;, &#39;NCT02992548&#39;]},
 {&#39;description&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02188121&#39;,
   &#39;NCT02252328&#39;,
   &#39;NCT02255682&#39;,
   &#39;NCT02360618&#39;,
   &#39;NCT02399709&#39;,
   &#39;NCT02406261&#39;,
   &#39;NCT02431013&#39;,
   &#39;NCT02542969&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;, &#39;trials&#39;: [&#39;NCT02431325&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02291055&#39;,
   &#39;NCT02336165&#39;,
   &#39;NCT02401048&#39;,
   &#39;NCT02431559&#39;,
   &#39;NCT02489448&#39;]},
 {&#39;description&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trials&#39;: [&#39;NCT02431754&#39;,
   &#39;NCT02450253&#39;,
   &#39;NCT02554045&#39;,
   &#39;NCT02595684&#39;,
   &#39;NCT02601989&#39;]},
 {&#39;description&#39;: &#39;antihypertensives (prazosin type)&#39;,
  &#39;trials&#39;: [&#39;NCT02382848&#39;, &#39;NCT02431936&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02153177&#39;,
   &#39;NCT02272725&#39;,
   &#39;NCT02344225&#39;,
   &#39;NCT02443142&#39;,
   &#39;NCT02476422&#39;,
   &#39;NCT02480114&#39;,
   &#39;NCT02482155&#39;,
   &#39;NCT02507219&#39;,
   &#39;NCT02521207&#39;,
   &#39;NCT02531451&#39;,
   &#39;NCT02588027&#39;,
   &#39;NCT02593721&#39;,
   &#39;NCT02602483&#39;,
   &#39;NCT02629354&#39;,
   &#39;NCT02666846&#39;,
   &#39;NCT02902913&#39;,
   &#39;NCT03055247&#39;]},
 {&#39;description&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02290327&#39;, &#39;NCT02345239&#39;, &#39;NCT02432456&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02155920&#39;,
   &#39;NCT02332902&#39;,
   &#39;NCT02338570&#39;,
   &#39;NCT02493465&#39;,
   &#39;NCT02531932&#39;,
   &#39;NCT02577458&#39;,
   &#39;NCT02616848&#39;,
   &#39;NCT02687958&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02357342&#39;,
   &#39;NCT02432560&#39;,
   &#39;NCT02440789&#39;,
   &#39;NCT02505893&#39;,
   &#39;NCT02513303&#39;,
   &#39;NCT02574728&#39;,
   &#39;NCT02638389&#39;,
   &#39;NCT02675153&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02230176&#39;,
   &#39;NCT02398552&#39;,
   &#39;NCT02401815&#39;,
   &#39;NCT02432846&#39;,
   &#39;NCT02483247&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02109627&#39;, &#39;NCT02229266&#39;, &#39;NCT02432872&#39;, &#39;NCT02502968&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;zonulin antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT01969149&#39;,
   &#39;NCT02058940&#39;,
   &#39;NCT02344641&#39;,
   &#39;NCT02432976&#39;,
   &#39;NCT02690987&#39;,
   &#39;NCT02794402&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02235298&#39;,
   &#39;NCT02279407&#39;,
   &#39;NCT02327039&#39;,
   &#39;NCT02371187&#39;,
   &#39;NCT02372955&#39;,
   &#39;NCT02397421&#39;,
   &#39;NCT02420392&#39;,
   &#39;NCT02433678&#39;,
   &#39;NCT02520518&#39;,
   &#39;NCT02577159&#39;,
   &#39;NCT02585804&#39;,
   &#39;NCT02592421&#39;,
   &#39;NCT02608905&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02269072&#39;,
   &#39;NCT02361190&#39;,
   &#39;NCT02419105&#39;,
   &#39;NCT02433730&#39;,
   &#39;NCT02445716&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;uracil type antineoplastics&#39;, &#39;trials&#39;: [&#39;NCT02434614&#39;]},
 {&#39;description&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trials&#39;: [&#39;NCT02451527&#39;]},
 {&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02382666&#39;]},
 {&#39;description&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trials&#39;: [&#39;NCT02434861&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01971489&#39;,
   &#39;NCT02177838&#39;,
   &#39;NCT02277184&#39;,
   &#39;NCT02289807&#39;,
   &#39;NCT02325401&#39;,
   &#39;NCT02394652&#39;,
   &#39;NCT02407912&#39;,
   &#39;NCT02421640&#39;,
   &#39;NCT02429037&#39;,
   &#39;NCT02429726&#39;,
   &#39;NCT02433626&#39;,
   &#39;NCT02474368&#39;,
   &#39;NCT02498860&#39;,
   &#39;NCT02537223&#39;,
   &#39;NCT02567383&#39;,
   &#39;NCT02586207&#39;,
   &#39;NCT02610010&#39;,
   &#39;NCT02624128&#39;,
   &#39;NCT02633202&#39;,
   &#39;NCT02705612&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;hedgehog signaling inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02073838&#39;, &#39;NCT02436408&#39;, &#39;NCT02523014&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02242097&#39;,
   &#39;NCT02301156&#39;,
   &#39;NCT02309580&#39;,
   &#39;NCT02315768&#39;,
   &#39;NCT02415608&#39;,
   &#39;NCT02436668&#39;,
   &#39;NCT02471391&#39;,
   &#39;NCT02477696&#39;,
   &#39;NCT02514083&#39;,
   &#39;NCT02542514&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02342379&#39;,
   &#39;NCT02511405&#39;,
   &#39;NCT02521051&#39;,
   &#39;NCT02594423&#39;,
   &#39;NCT02648711&#39;]},
 {&#39;description&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02339753&#39;, &#39;NCT02382406&#39;, &#39;NCT02418624&#39;, &#39;NCT02590003&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02205047&#39;,
   &#39;NCT02213289&#39;,
   &#39;NCT02214004&#39;,
   &#39;NCT02344472&#39;,
   &#39;NCT02390427&#39;,
   &#39;NCT02393248&#39;,
   &#39;NCT02436993&#39;,
   &#39;NCT02510781&#39;,
   &#39;NCT02530424&#39;,
   &#39;NCT02569489&#39;,
   &#39;NCT02625441&#39;,
   &#39;NCT02656589&#39;,
   &#39;NCT02665637&#39;,
   &#39;NCT02678182&#39;,
   &#39;NCT02725424&#39;]},
 {&#39;description&#39;: &#39;antibacterial  antibiotics&#39;, &#39;trials&#39;: [&#39;NCT02437045&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02332590&#39;,
   &#39;NCT02437253&#39;,
   &#39;NCT02489227&#39;,
   &#39;NCT02492217&#39;,
   &#39;NCT02533375&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02358473&#39;,
   &#39;NCT02376296&#39;,
   &#39;NCT02387216&#39;,
   &#39;NCT02401542&#39;,
   &#39;NCT02409199&#39;,
   &#39;NCT02465736&#39;,
   &#39;NCT02484677&#39;,
   &#39;NCT02495896&#39;,
   &#39;NCT02513342&#39;,
   &#39;NCT02536495&#39;,
   &#39;NCT02633176&#39;,
   &#39;NCT02643407&#39;,
   &#39;NCT02760667&#39;,
   &#39;NCT03017404&#39;,
   &#39;NCT03071042&#39;]},
 {&#39;description&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trials&#39;: [&#39;NCT02237157&#39;,
   &#39;NCT02267707&#39;,
   &#39;NCT02340117&#39;,
   &#39;NCT02355119&#39;,
   &#39;NCT02375880&#39;,
   &#39;NCT02395016&#39;,
   &#39;NCT02399137&#39;,
   &#39;NCT02405585&#39;,
   &#39;NCT02423239&#39;,
   &#39;NCT02428764&#39;,
   &#39;NCT02446093&#39;,
   &#39;NCT02460887&#39;,
   &#39;NCT02461836&#39;,
   &#39;NCT02489409&#39;,
   &#39;NCT02492711&#39;,
   &#39;NCT02504333&#39;,
   &#39;NCT02512692&#39;,
   &#39;NCT02514421&#39;,
   &#39;NCT02529579&#39;,
   &#39;NCT02542111&#39;,
   &#39;NCT02544243&#39;,
   &#39;NCT02607202&#39;,
   &#39;NCT02632019&#39;,
   &#39;NCT02641847&#39;,
   &#39;NCT02707328&#39;,
   &#39;NCT02854072&#39;,
   &#39;NCT02957266&#39;,
   &#39;NCT03610100&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02260440&#39;,
   &#39;NCT02305186&#39;,
   &#39;NCT02306850&#39;,
   &#39;NCT02337491&#39;,
   &#39;NCT02343952&#39;,
   &#39;NCT02351739&#39;,
   &#39;NCT02362035&#39;,
   &#39;NCT02362997&#39;,
   &#39;NCT02365766&#39;,
   &#39;NCT02375672&#39;,
   &#39;NCT02434354&#39;,
   &#39;NCT02437136&#39;,
   &#39;NCT02437370&#39;,
   &#39;NCT02448303&#39;,
   &#39;NCT02454179&#39;,
   &#39;NCT02467361&#39;,
   &#39;NCT02492568&#39;,
   &#39;NCT02493361&#39;,
   &#39;NCT02500121&#39;,
   &#39;NCT02515227&#39;,
   &#39;NCT02528357&#39;,
   &#39;NCT02551432&#39;,
   &#39;NCT02557321&#39;,
   &#39;NCT02565992&#39;,
   &#39;NCT02607631&#39;,
   &#39;NCT02608385&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;,
  &#39;trials&#39;: [&#39;NCT02333565&#39;,
   &#39;NCT02381249&#39;,
   &#39;NCT02384122&#39;,
   &#39;NCT02437825&#39;,
   &#39;NCT02457156&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02194842&#39;,
   &#39;NCT02438007&#39;,
   &#39;NCT02507570&#39;,
   &#39;NCT02814968&#39;,
   &#39;NCT02815033&#39;]},
 {&#39;description&#39;: &#39;(nifedipine type)&#39;,
  &#39;trials&#39;: [&#39;NCT01360034&#39;,
   &#39;NCT02426177&#39;,
   &#39;NCT02438371&#39;,
   &#39;NCT02513927&#39;,
   &#39;NCT02563405&#39;,
   &#39;NCT02591004&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02491736&#39;, &#39;NCT02491879&#39;]},
 {&#39;description&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02468557&#39;]},
 {&#39;description&#39;: &#39;-grel&#39;,
  &#39;trials&#39;: [&#39;NCT02217501&#39;,
   &#39;NCT02379676&#39;,
   &#39;NCT02429271&#39;,
   &#39;NCT02439190&#39;,
   &#39;NCT02447809&#39;,
   &#39;NCT02457130&#39;,
   &#39;NCT02469740&#39;,
   &#39;NCT02486367&#39;,
   &#39;NCT02499666&#39;,
   &#39;NCT02505399&#39;,
   &#39;NCT02513004&#39;,
   &#39;NCT02514642&#39;,
   &#39;NCT02519608&#39;,
   &#39;NCT02560688&#39;,
   &#39;NCT02578537&#39;,
   &#39;NCT02578706&#39;,
   &#39;NCT02580149&#39;,
   &#39;NCT02612480&#39;,
   &#39;NCT02626169&#39;,
   &#39;NCT02639143&#39;]},
 {&#39;description&#39;: &#39;local anesthetics&#39;,
  &#39;trials&#39;: [&#39;NCT02326727&#39;,
   &#39;NCT02344264&#39;,
   &#39;NCT02353182&#39;,
   &#39;NCT02365727&#39;,
   &#39;NCT02374008&#39;,
   &#39;NCT02375191&#39;,
   &#39;NCT02406300&#39;,
   &#39;NCT02431065&#39;,
   &#39;NCT02436265&#39;,
   &#39;NCT02439281&#39;,
   &#39;NCT02449720&#39;,
   &#39;NCT02450084&#39;,
   &#39;NCT02460640&#39;,
   &#39;NCT02488473&#39;,
   &#39;NCT02494336&#39;,
   &#39;NCT02506855&#39;,
   &#39;NCT02512471&#39;,
   &#39;NCT02570503&#39;,
   &#39;NCT02576249&#39;,
   &#39;NCT02581683&#39;,
   &#39;NCT02586454&#39;,
   &#39;NCT02603900&#39;,
   &#39;NCT02607579&#39;,
   &#39;NCT02630290&#39;,
   &#39;NCT02698995&#39;,
   &#39;NCT02749162&#39;,
   &#39;NCT02793947&#39;,
   &#39;NCT02954484&#39;,
   &#39;NCT03005808&#39;,
   &#39;NCT03054610&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trials&#39;: [&#39;NCT02342379&#39;,
   &#39;NCT02511405&#39;,
   &#39;NCT02521051&#39;,
   &#39;NCT02594423&#39;,
   &#39;NCT02648711&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02296112&#39;,
   &#39;NCT02357732&#39;,
   &#39;NCT02399943&#39;,
   &#39;NCT02439411&#39;,
   &#39;NCT02538627&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02439814&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02439957&#39;, &#39;NCT02439970&#39;]},
 {&#39;description&#39;: &#39;antivirals&#39;, &#39;trials&#39;: [&#39;NCT02439957&#39;, &#39;NCT02439970&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT01885364&#39;,
   &#39;NCT02287181&#39;,
   &#39;NCT02382354&#39;,
   &#39;NCT02400879&#39;,
   &#39;NCT02405988&#39;,
   &#39;NCT02429960&#39;,
   &#39;NCT02486328&#39;,
   &#39;NCT02488486&#39;,
   &#39;NCT02536690&#39;,
   &#39;NCT02583217&#39;,
   &#39;NCT02593942&#39;,
   &#39;NCT02635802&#39;,
   &#39;NCT02818387&#39;,
   &#39;NCT03037892&#39;]},
 {&#39;description&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02322502&#39;,
   &#39;NCT02334046&#39;,
   &#39;NCT02341833&#39;,
   &#39;NCT02364934&#39;,
   &#39;NCT02393664&#39;,
   &#39;NCT02407626&#39;,
   &#39;NCT02428283&#39;,
   &#39;NCT02440204&#39;,
   &#39;NCT02467595&#39;,
   &#39;NCT02470442&#39;,
   &#39;NCT02489734&#39;,
   &#39;NCT02507700&#39;,
   &#39;NCT02510586&#39;,
   &#39;NCT02527083&#39;,
   &#39;NCT02530632&#39;,
   &#39;NCT02534623&#39;,
   &#39;NCT02550470&#39;,
   &#39;NCT02571426&#39;,
   &#39;NCT02604459&#39;,
   &#39;NCT02609087&#39;,
   &#39;NCT02609802&#39;,
   &#39;NCT02621255&#39;,
   &#39;NCT02709863&#39;,
   &#39;NCT02711280&#39;,
   &#39;NCT02771418&#39;,
   &#39;NCT02946437&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02433418&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02412228&#39;, &#39;NCT02461888&#39;]},
 {&#39;description&#39;: &#39;peptides&#39;, &#39;trials&#39;: [&#39;NCT02440581&#39;, &#39;NCT02656810&#39;]},
 {&#39;description&#39;: &#39;immunosuppressant&#39;,
  &#39;trials&#39;: [&#39;NCT02357342&#39;,
   &#39;NCT02432560&#39;,
   &#39;NCT02440789&#39;,
   &#39;NCT02505893&#39;,
   &#39;NCT02513303&#39;,
   &#39;NCT02574728&#39;,
   &#39;NCT02638389&#39;,
   &#39;NCT02675153&#39;]},
 {&#39;description&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trials&#39;: [&#39;NCT02341482&#39;,
   &#39;NCT02342717&#39;,
   &#39;NCT02365571&#39;,
   &#39;NCT02370615&#39;,
   &#39;NCT02401295&#39;,
   &#39;NCT02402595&#39;,
   &#39;NCT02440009&#39;,
   &#39;NCT02470832&#39;,
   &#39;NCT02475746&#39;,
   &#39;NCT02513446&#39;,
   &#39;NCT02567773&#39;]},
 {&#39;description&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02203643&#39;,
   &#39;NCT02389543&#39;,
   &#39;NCT02399085&#39;,
   &#39;NCT02441686&#39;,
   &#39;NCT02495922&#39;,
   &#39;NCT02521714&#39;,
   &#39;NCT02523040&#39;,
   &#39;NCT02633137&#39;,
   &#39;NCT02928419&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02441894&#39;,
   &#39;NCT02631603&#39;,
   &#39;NCT02695797&#39;,
   &#39;NCT02912182&#39;,
   &#39;NCT02949349&#39;]},
 {&#39;description&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trials&#39;: [&#39;NCT02384759&#39;,
   &#39;NCT02401945&#39;,
   &#39;NCT02441907&#39;,
   &#39;NCT02537054&#39;,
   &#39;NCT02550002&#39;,
   &#39;NCT02559180&#39;,
   &#39;NCT02586727&#39;,
   &#39;NCT02597855&#39;,
   &#39;NCT02669953&#39;]},
 {&#39;description&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trials&#39;: [&#39;NCT02327143&#39;, &#39;NCT02387814&#39;, &#39;NCT02482935&#39;]},
 {&#39;description&#39;: &#39;antineoplastics&#39;,
  &#39;trials&#39;: [&#39;NCT02312804&#39;,
   &#39;NCT02370238&#39;,
   &#39;NCT02375204&#39;,
   &#39;NCT02389985&#39;,
   &#39;NCT02392377&#39;,
   &#39;NCT02406170&#39;,
   &#39;NCT02413320&#39;,
   &#39;NCT02414685&#39;,
   &#39;NCT02420314&#39;,
   &#39;NCT02422563&#39;,
   &#39;NCT02429622&#39;,
   &#39;NCT02429687&#39;,
   &#39;NCT02429700&#39;,
   &#39;NCT02432365&#39;,
   &#39;NCT02435186&#39;,
   &#39;NCT02442063&#39;,
   &#39;NCT02446652&#39;,
   &#39;NCT02488967&#39;,
   &#39;NCT02492867&#39;,
   &#39;NCT02501954&#39;,
   &#39;NCT02513355&#39;,
   &#39;NCT02545010&#39;,
   &#39;NCT02560038&#39;,
   &#39;NCT02562898&#39;,
   &#39;NCT02567799&#39;,
   &#39;NCT02584478&#39;,
   &#39;NCT02595554&#39;,
   &#39;NCT02598687&#39;,
   &#39;NCT02599324&#39;,
   &#39;NCT02603679&#39;,
   &#39;NCT02607332&#39;,
   &#39;NCT02611700&#39;,
   &#39;NCT02614833&#39;,
   &#39;NCT02644863&#39;,
   &#39;NCT02948075&#39;]},
 {&#39;description&#39;: &#39;vasopressin receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02442674&#39;, &#39;NCT02476409&#39;, &#39;NCT02545114&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02401880&#39;, &#39;NCT02442817&#39;, &#39;NCT02608177&#39;, &#39;NCT02851745&#39;]},
 {&#39;description&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trials&#39;: [&#39;NCT02153177&#39;,
   &#39;NCT02272725&#39;,
   &#39;NCT02344225&#39;,
   &#39;NCT02443142&#39;,
   &#39;NCT02476422&#39;,
   &#39;NCT02480114&#39;,
   &#39;NCT02482155&#39;,
   &#39;NCT02507219&#39;,
   &#39;NCT02521207&#39;,
   &#39;NCT02531451&#39;,
   &#39;NCT02588027&#39;,
   &#39;NCT02593721&#39;,
   &#39;NCT02602483&#39;,
   &#39;NCT02629354&#39;,
   &#39;NCT02666846&#39;,
   &#39;NCT02902913&#39;,
   &#39;NCT03055247&#39;]},
 {&#39;description&#39;: &#39;thioether derivatives&#39;,
  &#39;trials&#39;: [&#39;NCT02335346&#39;, &#39;NCT02367404&#39;, &#39;NCT02443194&#39;, &#39;NCT02600247&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT01824264&#39;,
   &#39;NCT01984606&#39;,
   &#39;NCT02301806&#39;,
   &#39;NCT02312063&#39;,
   &#39;NCT02324010&#39;,
   &#39;NCT02330406&#39;,
   &#39;NCT02363335&#39;,
   &#39;NCT02373865&#39;,
   &#39;NCT02406950&#39;,
   &#39;NCT02443922&#39;,
   &#39;NCT02444364&#39;,
   &#39;NCT02512523&#39;,
   &#39;NCT02513771&#39;,
   &#39;NCT02577003&#39;,
   &#39;NCT02628392&#39;,
   &#39;NCT02639637&#39;,
   &#39;NCT02655757&#39;]},
 {&#39;description&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trials&#39;: [&#39;NCT02444637&#39;]},
 {&#39;description&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trials&#39;: [&#39;NCT02293109&#39;,
   &#39;NCT02304094&#39;,
   &#39;NCT02319343&#39;,
   &#39;NCT02331862&#39;,
   &#39;NCT02332603&#39;,
   &#39;NCT02332616&#39;,
   &#39;NCT02332629&#39;,
   &#39;NCT02392780&#39;,
   &#39;NCT02444728&#39;,
   &#39;NCT02445898&#39;,
   &#39;NCT02462252&#39;,
   &#39;NCT02535039&#39;,
   &#39;NCT02542592&#39;,
   &#39;NCT02552342&#39;,
   &#39;NCT02591953&#39;,
   &#39;NCT02645565&#39;,
   &#39;NCT02651350&#39;,
   &#39;NCT02819453&#39;]},
 {&#39;description&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trials&#39;: [&#39;NCT02444819&#39;, &#39;NCT02485652&#39;]},
 {&#39;description&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02407210&#39;,
   &#39;NCT02525822&#39;,
   &#39;NCT02547038&#39;,
   &#39;NCT02619799&#39;,
   &#39;NCT02646332&#39;,
   &#39;NCT02996916&#39;]},
 {&#39;description&#39;: &#39;dendrimers&#39;, &#39;trials&#39;: [&#39;NCT02445508&#39;]},
 {&#39;description&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trials&#39;: [&#39;NCT02269072&#39;,
   &#39;NCT02361190&#39;,
   &#39;NCT02419105&#39;,
   &#39;NCT02433730&#39;,
   &#39;NCT02445716&#39;]},
 {&#39;description&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trials&#39;: [&#39;NCT02347878&#39;, &#39;NCT02357693&#39;, &#39;NCT02646020&#39;]},
 ...]</pre>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[98]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span><span class="k">def</span> <span class="nf">make_task4_list</span><span class="p">():</span>
    <span class="n">trial_counts_list</span><span class="o">=</span> <span class="p">[]</span>

    <span class="k">for</span> <span class="n">i</span> <span class="ow">in</span> <span class="nb">range</span><span class="p">(</span><span class="mi">0</span><span class="p">,</span><span class="nb">len</span><span class="p">(</span><span class="n">task3_list</span><span class="p">)</span><span class="o">-</span><span class="mi">1</span><span class="p">,</span><span class="mi">2</span><span class="p">):</span>
        <span class="n">trial_counts_dict</span> <span class="o">=</span> <span class="p">{}</span>
        <span class="n">trial_counts_dict</span><span class="p">[</span><span class="s2">&quot;description1&quot;</span><span class="p">]</span> <span class="o">=</span> <span class="n">task3_list</span><span class="p">[</span><span class="n">i</span><span class="p">][</span><span class="s2">&quot;description&quot;</span><span class="p">]</span>
        <span class="n">trial_counts_dict</span><span class="p">[</span><span class="s2">&quot;description2&quot;</span><span class="p">]</span> <span class="o">=</span> <span class="n">task3_list</span><span class="p">[</span><span class="n">i</span><span class="o">+</span><span class="mi">1</span><span class="p">][</span><span class="s2">&quot;description&quot;</span><span class="p">]</span>
        <span class="n">trial_counts_dict</span><span class="p">[</span><span class="s2">&quot;trial_count&quot;</span><span class="p">]</span> <span class="o">=</span> <span class="nb">len</span><span class="p">(</span><span class="n">task3_list</span><span class="p">[</span><span class="n">i</span><span class="p">][</span><span class="s2">&quot;trials&quot;</span><span class="p">])</span> <span class="o">+</span> <span class="nb">len</span><span class="p">(</span><span class="n">task3_list</span><span class="p">[</span><span class="n">i</span><span class="o">+</span><span class="mi">1</span><span class="p">][</span><span class="s2">&quot;trials&quot;</span><span class="p">])</span>
        <span class="nb">print</span><span class="p">(</span><span class="n">trial_counts_dict</span><span class="p">)</span>
        <span class="n">trial_counts_list</span><span class="o">.</span><span class="n">append</span><span class="p">(</span><span class="n">trial_counts_dict</span><span class="p">)</span>
        <span class="k">return</span> <span class="n">trial_counts_list</span>
    
<span class="n">trial_counts_list</span>
    
</pre></div>

    </div>
</div>
</div>

<div class="output_wrapper">
<div class="output">


<div class="output_area">

    <div class="prompt"></div>


<div class="output_subarea output_stream output_stdout output_text">
<pre>{&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;(nifedipine type)&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;hypnotics/sedatives (zolpidem type)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;toll-like receptor&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;beta-blockers (propranolol type)&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;antihypertensives (ACE inhibitors)&#39;, &#39;description2&#39;: &#39;angiogenesis inhibitors&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;nootropic agents (learning&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;description2&#39;: &#39;zonulin antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 54}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;phlorozin derivatives&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;isophosphoramide mustard derivatives&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 56}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;, &#39;description2&#39;: &#39;zonulin antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;uracil type antineoplastics&#39;, &#39;description2&#39;: &#39;toll-like receptor&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;dopamine receptor agonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;hedgehog signaling inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;endothelin receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;beta-blockers (propranolol type)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;cardiotonics (amrinone type)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;thrombopoetin agonists&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;antiviral receptors&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;endothelin receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 37}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;toll-like receptor&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;antiestrogens of the clomifene and tamoxifen groups&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;immunomodulators&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;antithrombotics&#39;, &#39;description2&#39;: &#39;(nifedipine type)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antiviral receptors&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antithrombotics&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;, &#39;description2&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;description2&#39;: &#39;proteozome inhibitors&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;thalidomide derivatives&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;estrogen antagonists&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;oxytocin derivatives&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;ionotropic non-NMDA (N-methyl D-aspartate) glutamate receptors [AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor) and/or KA (kainite antagonist) receptors]&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;selective melatonin receptor agonist&#39;, &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;thalidomide derivatives&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;depsipeptide derivatives&#39;, &#39;description2&#39;: &#39;ecteinascidin derivatives&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;phlorozin derivatives&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;colony-stimulating factors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;, &#39;description2&#39;: &#39;hedgehog signaling inhibitors&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;description2&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;spasmolytic agents (papaverine type)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;antihyperlipidaemics&#39;, &#39;description2&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;oxazolidinone antibacterials&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;antithrombotics&#39;, &#39;description2&#39;: &#39;antiviral receptors&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;phlorozin derivatives&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;angiogenesis inhibitors&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;antiviral receptors&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;antithrombotics&#39;, &#39;description2&#39;: &#39;warfarin analogs&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;proteozome inhibitors&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;antithrombotics&#39;, &#39;description2&#39;: &#39;warfarin analogs&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;depsipeptide derivatives&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;, &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;, &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;, &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;thalidomide derivatives&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;zonulin antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antithrombotics&#39;, &#39;description2&#39;: &#39;warfarin analogs&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 37}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;, &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;description2&#39;: &#39;antiviral receptors&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;β3 adrenoreceptor agonists&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antianxiety agents (diazepam type)&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;transforming growth factors&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antiviral receptors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;-curonium&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;-sal-&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;antiviral receptors&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;zonulin antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;phlorozin derivatives&#39;, &#39;trial_count&#39;: 43}
{&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;warfarin analogs&#39;, &#39;description2&#39;: &#39;thalidomide derivatives&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiogenesis inhibitors&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;description2&#39;: &#39;diuretics (furosemide type)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;penicillins&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;thioether derivatives&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;trial_count&#39;: 37}
{&#39;description1&#39;: &#39;antineoplastics (mitotic inhibitors&#39;, &#39;description2&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;interleukin 3 deriviatives&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;zonulin antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;antidepressants (dibenzol[a&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;progesterone receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;antihypertensives (hydrazine-phthalazines)&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;(see -perone)&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;trial_count&#39;: 43}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;, &#39;description2&#39;: &#39;estrogen antagonists&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 45}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 38}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;zonulin antagonists&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;warfarin analogs&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;diuretics (furosemide type)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;hormone-release inhibiting peptides&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;thyrotropin releasing hormone analogues&#39;, &#39;description2&#39;: &#39;antianxiety&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;dopamine receptor agonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;combined alpha and beta blockers&#39;, &#39;description2&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;catechol-O-methyltransferase (COMT) inhibitors&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;bronchodilators (phenethylamine derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;progestins&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 56}
{&#39;description1&#39;: &#39;antiviral receptors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;progesterone receptor antagonists&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;phlorozin derivatives&#39;, &#39;description2&#39;: &#39;phlorozin derivatives&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;β3 adrenoreceptor agonists&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;thyrotropin releasing hormone analogues&#39;, &#39;description2&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;-prost&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 52}
{&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;, &#39;description2&#39;: &#39;ecteinascidin derivatives&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;Monoamine oxidase (MAO) inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;zonulin antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;phlorozin derivatives&#39;, &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;β3 adrenoreceptor agonists&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;cyclooxygenase-2 inhibitors&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 37}
{&#39;description1&#39;: &#39;leukotriene biosynthesis inhibitors&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;class III antiarrhythmic agents&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 50}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 54}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;thioether derivatives&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;beta-blockers (propranolol type)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;description2&#39;: &#39;phlorozin derivatives&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;coronary vasodilators (verapamil type)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;phlorozin derivatives&#39;, &#39;description2&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 47}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;-adol-&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;isophosphoramide mustard derivatives&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;warfarin analogs&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 46}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 48}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;warfarin analogs&#39;, &#39;description2&#39;: &#39;antiestrogens of the clomifene and tamoxifen groups&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;angiogenesis inhibitors&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;, &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;antithrombotics&#39;, &#39;description2&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;heparin derivatives and low molecular weight (or depolymerized) heparins&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;-curonium&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 41}
{&#39;description1&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;, &#39;description2&#39;: &#39;antihypertensives (prazosin type)&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;estrogen antagonists&#39;, &#39;description2&#39;: &#39;farnesyl transferase inhibitor&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;penicillins&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;estrogen antagonists&#39;, &#39;description2&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;uracil type antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;progestins&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;colony-stimulating factors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;thalidomide derivatives&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;thalidomide derivatives&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;thioether derivatives&#39;, &#39;description2&#39;: &#39;sodium channel blockers&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;adenosine A receptor agonists&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 38}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;oxytocin derivatives&#39;, &#39;description2&#39;: &#39;vancomycin-related compounds&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 59}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;isophosphoramide mustard derivatives&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 41}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;penicillins&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 48}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;antibiotics (Micromonospora strains)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;oxytocin derivatives&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;antineoplastics (mitotic inhibitors&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;phlorozin derivatives&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;-fibrate&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;synthetic analogs of the dolastatin series&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;thalidomide derivatives&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 37}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;proteozome inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;leukotriene biosynthesis inhibitors&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;cyclooxygenase-2 inhibitors&#39;, &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;phlorozin derivatives&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;estrogen antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;leptin derivatives&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 38}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 41}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 43}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#34;acetylcholinesterase inhibitors used in the treatment of Alzheimer&#39;s disease&#34;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 38}
{&#39;description1&#39;: &#39;angiogenesis inhibitors&#39;, &#39;description2&#39;: &#39;antimyloidotics&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;synthetic analogs of the dolastatin series&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;isophosphoramide mustard derivatives&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 53}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;β3 adrenoreceptor agonists&#39;, &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;-curonium&#39;, &#39;description2&#39;: &#39;oxytocin derivatives&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;proteozome inhibitors&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 41}
{&#39;description1&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;description2&#39;: &#39;cyclooxygenase-2 inhibitors&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antiepileptics (hydantoin derivatives)&#39;, &#39;trial_count&#39;: 37}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;isophosphoramide mustard derivatives&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 63}
{&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;description2&#39;: &#34;acetylcholinesterase inhibitors used in the treatment of Alzheimer&#39;s disease&#34;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;uracil type antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;diuretics (furosemide type)&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;thioether derivatives&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;-adol-&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;phlorozin derivatives&#39;, &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 47}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;isophosphoramide mustard derivatives&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 41}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;antiparasitics (salicylanilide derivatives)&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;synthetic glucagon analogs&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;-adol-&#39;, &#39;description2&#39;: &#39;warfarin analogs&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;(nifedipine type)&#39;, &#39;description2&#39;: &#39;peroxisome proliferator activiating receptor (PPAR) agonists (thiazolidene derivatives)&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;uracil type antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;, &#39;description2&#39;: &#39;antithrombotics&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;progestins&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;thioether derivatives&#39;, &#39;description2&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;sympathomimetics&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 56}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;-adol-&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;peroxisome proliferator activiating receptor (PPAR) agonists (thiazolidene derivatives)&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;sympathomimetics&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 55}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antiviral receptors&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;thioether derivatives&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 38}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;description2&#39;: &#39;antihypertensives (prazosin type)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;trial_count&#39;: 52}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;zonulin antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;phlorozin derivatives&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;description2&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 65}
{&#39;description1&#39;: &#39;hedgehog signaling inhibitors&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antibacterial  antibiotics&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 43}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;(nifedipine type)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;proteozome inhibitors&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;thalidomide derivatives&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;vasopressin receptor antagonists&#39;, &#39;trial_count&#39;: 38}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;thioether derivatives&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;dendrimers&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 46}
{&#39;description1&#39;: &#39;thrombopoetin agonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antihypertensives (hydrazine-phthalazines)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;colony-stimulating factors&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;antithrombotics (thromboxane A2 receptor antagonists)&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;anti-inflammatory agents  (isoxicam type)&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;anticoagulants (hirudin type)&#39;, &#39;description2&#39;: &#39;catechol-O-methyltransferase (COMT) inhibitors&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 56}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;diuretics (furosemide type)&#39;, &#39;description2&#39;: &#34;acetylcholinesterase inhibitors used in the treatment of Alzheimer&#39;s disease&#34;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;-curonium&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;, &#39;description2&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;leukotriene biosynthesis inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;-fibrate&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;selective serotonin reuptake inhibitors (SSRI)&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;description2&#39;: &#39;antihistamines/local vasoconstrictors (antazoline type)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;coronary vasodilators (verapamil type)&#39;, &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;hypnotics/tranquilizers (zopiclone type)&#39;, &#39;description2&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;description2&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;thalidomide derivatives&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 50}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;proteozome inhibitors&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;(see -perone)&#39;, &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;β3 adrenoreceptor agonists&#39;, &#39;description2&#39;: &#39;selective serotonin reuptake inhibitors (SSRI)&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antibacterial  antibiotics&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;antiviral receptors&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;farnesyl transferase inhibitor&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;-curonium&#39;, &#39;description2&#39;: &#39;zonulin antagonists&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;uracil type antineoplastics&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;thalidomide derivatives&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;description2&#39;: &#39;(see -perone)&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;colony-stimulating factors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;-curonium&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;isophosphoramide mustard derivatives&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;thioether derivatives&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;proteozome inhibitors&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;immunomodulators&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;vasopressin receptor antagonists&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;penicillins&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;, &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;-fibrate&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 37}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 41}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;anxiolytics (buspirone type)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;thyrotropin releasing hormone analogues&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;-adol-&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antimigraine agents (5-HT1 receptor agonists)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;uracil type antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;-mantadine&#39;, &#39;description2&#39;: &#39;antimigraine agents (5-HT1 receptor agonists)&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;theophylline derivatives&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 44}
{&#39;description1&#39;: &#39;thioether derivatives&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;colony-stimulating factors&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;trial_count&#39;: 43}
{&#39;description1&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;, &#39;description2&#39;: &#39;antibiotics obtained from Streptomyces kanamyceticus (related to kanamycin)&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;warfarin analogs&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;antineoplastics (mitotic inhibitors&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;(see -perone)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;zonulin antagonists&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;hormone-release inhibiting peptides&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;colony-stimulating factors&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;β3 adrenoreceptor agonists&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 43}
{&#39;description1&#39;: &#39;thalidomide derivatives&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiogenesis inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;synthetic analogs of the dolastatin series&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;-adol-&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;, &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;antihypertensives (ACE inhibitors)&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;thioether derivatives&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 55}
{&#39;description1&#39;: &#39;cyclooxygenase-2 inhibitors&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;cyclooxygenase-2 inhibitors&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;beta-blockers (propranolol type)&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;description2&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;, &#39;description2&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;uracil type antineoplastics&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 52}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;antithrombotics&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;warfarin analogs&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;antineoplastics (thiotepa derivatives)&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 52}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;depsipeptide derivatives&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 47}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 48}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;proteozome inhibitors&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;trial_count&#39;: 42}
{&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;description2&#39;: &#39;dopamine receptor agonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;(nifedipine type)&#39;, &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 54}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 46}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;uracil type antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;proteozome inhibitors&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;thalidomide derivatives&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;description2&#39;: &#39;phlorozin derivatives&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;antidepressants (dibenzol[a&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 46}
{&#39;description1&#39;: &#39;phlorozin derivatives&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;thalidomide derivatives&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;sympathomimetics&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;hedgehog signaling inhibitors&#39;, &#39;description2&#39;: &#39;thalidomide derivatives&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;hormone-release inhibiting peptides&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;oxytocin derivatives&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;description2&#39;: &#39;estrogen antagonists&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;estrogen antagonists&#39;, &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 41}
{&#39;description1&#39;: &#39;theophylline derivatives&#39;, &#39;description2&#39;: &#39;-prost&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;colony-stimulating factors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;warfarin analogs&#39;, &#39;description2&#39;: &#39;positive inotropic agents (pimobendan type)&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;, &#39;description2&#39;: &#39;leukotriene biosynthesis inhibitors&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 52}
{&#39;description1&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;, &#39;description2&#39;: &#39;antimyloidotics&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 49}
{&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;description2&#39;: &#39;farnesyl transferase inhibitor&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;peroxisome proliferator activiating receptor (PPAR) agonists (thiazolidene derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;β3 adrenoreceptor agonists&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;description2&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;warfarin analogs&#39;, &#39;description2&#39;: &#39;β3 adrenoreceptor agonists&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 46}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;trial_count&#39;: 38}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;thalidomide derivatives&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;warfarin analogs&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;vasopressin receptor antagonists&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;proteozome inhibitors&#39;, &#39;description2&#39;: &#39;thalidomide derivatives&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;-curonium&#39;, &#39;description2&#39;: &#39;-curonium&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;bronchodilators (phenethylamine derivatives)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;interleukin-4 (IL-4) receptor antagonists&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antihyperlipidaemics&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;anti-inflammatory agents  (isoxicam type)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;, &#39;description2&#39;: &#39;antithrombotics&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;description2&#39;: &#39;antimycobacterials (diaminodiphenylsulfone derivatives)&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 52}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;penicillins&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;description2&#39;: &#39;-curonium&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;dopamine receptor agonists&#39;, &#39;description2&#39;: &#39;sodium channel blockers&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;description2&#39;: &#39;zonulin antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;leukotriene biosynthesis inhibitors&#39;, &#39;description2&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 48}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;hormone-release inhibiting peptides&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antiviral receptors&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;thalidomide derivatives&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;thioether derivatives&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;, &#39;description2&#39;: &#39;(see -perone)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;uracil type antineoplastics&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 52}
{&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 45}
{&#39;description1&#39;: &#39;(nifedipine type)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;angiogenesis inhibitors&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 46}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 44}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;oxazolidinone antibacterials&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;proteozome inhibitors&#39;, &#39;description2&#39;: &#39;angiogenesis inhibitors&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;t-RNA synthetase inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;uracil type antineoplastics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;antibiotics obtained from Streptomyces kanamyceticus (related to kanamycin)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;description2&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;cyclooxygenase-2 inhibitors&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;diuretics (furosemide type)&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 48}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;, &#39;description2&#39;: &#39;serine/threonine kinase inhibitors&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;phlorozin derivatives&#39;, &#39;description2&#39;: &#39;phlorozin derivatives&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;proteozome inhibitors&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;thalidomide derivatives&#39;, &#39;description2&#39;: &#39;hypnotics/sedatives (zolpidem type)&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;zonulin antagonists&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;phlorozin derivatives&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;thalidomide derivatives&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;adenosine A receptor agonists&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;(nifedipine type)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;phlorozin derivatives&#39;, &#39;description2&#39;: &#39;theophylline derivatives&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;, &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 54}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antiviral receptors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;cardiotonics (amrinone type)&#39;, &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 55}
{&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;description2&#39;: &#39;antiepileptics (hydantoin derivatives)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antithrombotics&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics (mitotic inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;phlorozin derivatives&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;adenosine A receptor agonists&#39;, &#39;description2&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;antiviral receptors&#39;, &#39;description2&#39;: &#39;bronchodilators (phenethylamine derivatives)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;progestins&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;thioether derivatives&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;-curonium&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;thioether derivatives&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;cyclooxygenase-2 inhibitors&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 38}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 56}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;-adol-&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 51}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 65}
{&#39;description1&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;phlorozin derivatives&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;antimigraine agents (5-HT1 receptor agonists)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;antithrombotics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 55}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;antiparasitics (salicylanilide derivatives)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;-sal-&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;antineoplastics (mitotic inhibitors&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;serotonin 5-HT3 receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;warfarin analogs&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 52}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;trial_count&#39;: 52}
{&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;description2&#39;: &#39;antiparasitics (salicylanilide derivatives)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;-curonium&#39;, &#39;description2&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;guanaline cyclase activators&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antithrombotics&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;-curonium&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;proteozome inhibitors&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;catechol-O-methyltransferase (COMT) inhibitors&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;thalidomide derivatives&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;antithrombotics&#39;, &#39;description2&#39;: &#39;antiarrhythmics (propafenone derivatives)&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;penicillins&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 37}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 52}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;phlorozin derivatives&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;isophosphoramide mustard derivatives&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiogenesis inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;zonulin antagonists&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;positive inotropic agents (pimobendan type)&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;cardiotonics (amrinone type)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 22}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 43}
{&#39;description1&#39;: &#39;uracil type antineoplastics&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;description2&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;antihypertensives (ACE inhibitors)&#39;, &#39;description2&#39;: &#39;warfarin analogs&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;, &#39;description2&#39;: &#39;antithrombotics&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;progesterone receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 35}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 43}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 41}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;penicillins&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;warfarin analogs&#39;, &#39;description2&#39;: &#39;antiestrogens of the clomifene and tamoxifen groups&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;thalidomide derivatives&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;endothelin receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;catechol-O-methyltransferase (COMT) inhibitors&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;antineoplastics (thiotepa derivatives)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;leptin derivatives&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;thioether derivatives&#39;, &#39;description2&#39;: &#39;thioether derivatives&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;thioether derivatives&#39;, &#39;description2&#39;: &#39;antihypertensives (prazosin type)&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;antianxiety&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;antineoplastics (thiotepa derivatives)&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;cyclooxygenase-2 inhibitors&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;ionotropic non-NMDA (N-methyl D-aspartate) glutamate receptors [AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor) and/or KA (kainite antagonist) receptors]&#39;, &#39;description2&#39;: &#39;pentamidine derivatives/analogues&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;immunosuppressant&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 38}
{&#39;description1&#39;: &#39;antifungal antibiotics (undefined group)&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;colony-stimulating factors&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;description2&#39;: &#39;diuretics (furosemide type)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;benzodiazepine receptor agonists/antagonists&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;zonulin antagonists&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;heparin derivatives and low molecular weight (or depolymerized) heparins&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 53}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 46}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;sodium channel blockers&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;beta-blockers (propranolol type)&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;-curonium&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;endothelin receptor antagonists&#39;, &#39;description2&#39;: &#39;sympathomimetics&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 39}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;ionotropic non-NMDA (N-methyl D-aspartate) glutamate receptors [AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor) and/or KA (kainite antagonist) receptors]&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;description2&#39;: &#39;immunosuppressant&#39;, &#39;trial_count&#39;: 23}
{&#39;description1&#39;: &#39;(see -perone)&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 15}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 53}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;, &#39;description2&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 13}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;description2&#39;: &#39;isophosphoramide mustard derivatives&#39;, &#39;trial_count&#39;: 21}
{&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;cyclooxygenase-2 inhibitors&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;fluoroquinolone derivatives&#39;, &#39;trial_count&#39;: 2}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;warfarin analogs&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;-prost&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;zonulin antagonists&#39;, &#39;trial_count&#39;: 36}
{&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 17}
{&#39;description1&#39;: &#39;theophylline derivatives&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;-prost&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;anxiolytics (buspirone type)&#39;, &#39;description2&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;selective serotonin reuptake inhibitors (SSRI)&#39;, &#39;description2&#39;: &#39;isophosphoramide mustard derivatives&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;, &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 24}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;penicillins&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;antihypertensives (ACE inhibitors)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;thrombopoetin agonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 29}
{&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;description2&#39;: &#39;antihypertensives (ACE inhibitors)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;-adol-&#39;, &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;warfarin analogs&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 34}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;angiogenesis inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 38}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;interleukin 3 deriviatives&#39;, &#39;description2&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;thioether derivatives&#39;, &#39;description2&#39;: &#39;diuretics (furosemide type)&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;trial_count&#39;: 28}
{&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 19}
{&#39;description1&#39;: &#39;selective serotonin reuptake inhibitors (SSRI)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 27}
{&#39;description1&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;, &#39;description2&#39;: &#39;thrombopoetin agonists&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;thalidomide derivatives&#39;, &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;, &#39;description2&#39;: &#39;enzyme inhibitors&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;uracil type antineoplastics&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 14}
{&#39;description1&#39;: &#39;monoclonal antibodies&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antithrombotics&#39;, &#39;description2&#39;: &#39;antithrombotics&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;antithrombotics&#39;, &#39;description2&#39;: &#39;warfarin analogs&#39;, &#39;trial_count&#39;: 25}
{&#39;description1&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;, &#39;description2&#39;: &#39;toll-like receptor&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;antithrombotics&#39;, &#39;description2&#39;: &#39;antithrombotics&#39;, &#39;trial_count&#39;: 4}
{&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 32}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 40}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 50}
{&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;immunomodulators&#39;, &#39;trial_count&#39;: 5}
{&#39;description1&#39;: &#39;cyclooxygenase-2 inhibitors&#39;, &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;penicillins&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 3}
{&#39;description1&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;, &#39;description2&#39;: &#39;proton pump inhibitors&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 26}
{&#39;description1&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 31}
{&#39;description1&#39;: &#39;enzyme inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;monoclonal antibodies&#39;, &#39;trial_count&#39;: 33}
{&#39;description1&#39;: &#39;local anesthetics&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 56}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;theophylline derivatives&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 12}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 20}
{&#39;description1&#39;: &#39;serotonin 5-HT3 receptor antagonists&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 18}
{&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 16}
{&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 44}
{&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;, &#39;description2&#39;: &#39;local anesthetics&#39;, &#39;trial_count&#39;: 43}
{&#39;description1&#39;: &#39;antineoplastics&#39;, &#39;description2&#39;: &#39;antineoplastics&#39;, &#39;trial_count&#39;: 50}
{&#39;description1&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;, &#39;trial_count&#39;: 11}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 8}
{&#39;description1&#39;: &#39;proton pump inhibitors&#39;, &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;trial_count&#39;: 9}
{&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;, &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;, &#39;trial_count&#39;: 6}
{&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;, &#39;description2&#39;: &#39;antihypertensives (ACE inhibitors)&#39;, &#39;trial_count&#39;: 7}
{&#39;description1&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;, &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;, &#39;trial_count&#39;: 10}
{&#39;description1&#39;: &#39;antiarrhythmics (propafenone derivatives)&#39;, &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;, &#39;trial_count&#39;: 30}
{&#39;description1&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;, &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;, &#39;trial_count&#39;: 10}
</pre>
</div>
</div>

<div class="output_area">

    <div class="prompt output_prompt">Out[98]:</div>




<div class="output_text output_subarea output_execute_result">
<pre>[{&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;description2&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;(nifedipine type)&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;hypnotics/sedatives (zolpidem type)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;description2&#39;: &#39;immunosuppressant&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;toll-like receptor&#39;,
  &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;beta-blockers (propranolol type)&#39;,
  &#39;trial_count&#39;: 2},
 {&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 20},
 {&#39;description1&#39;: &#39;antihypertensives (ACE inhibitors)&#39;,
  &#39;description2&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;description2&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;nootropic agents (learning&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;description2&#39;: &#39;zonulin antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 54},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 56},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 34},
 {&#39;description1&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;,
  &#39;description2&#39;: &#39;zonulin antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;description2&#39;: &#39;toll-like receptor&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;dopamine receptor agonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;hedgehog signaling inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;endothelin receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;beta-blockers (propranolol type)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;cardiotonics (amrinone type)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;thrombopoetin agonists&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;antiviral receptors&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;endothelin receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 37},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 34},
 {&#39;description1&#39;: &#39;toll-like receptor&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;antiestrogens of the clomifene and tamoxifen groups&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;immunosuppressant&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;immunomodulators&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;antithrombotics&#39;,
  &#39;description2&#39;: &#39;(nifedipine type)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antiviral receptors&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antithrombotics&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;description2&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;description2&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;thalidomide derivatives&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;estrogen antagonists&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;oxytocin derivatives&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;-grel&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;ionotropic non-NMDA (N-methyl D-aspartate) glutamate receptors [AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor) and/or KA (kainite antagonist) receptors]&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;immunosuppressant&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;description2&#39;: &#39;peptides&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;selective melatonin receptor agonist&#39;,
  &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;depsipeptide derivatives&#39;,
  &#39;description2&#39;: &#39;ecteinascidin derivatives&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;phlorozin derivatives&#39;,
  &#39;description2&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;colony-stimulating factors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;description2&#39;: &#39;hedgehog signaling inhibitors&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;description2&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;spasmolytic agents (papaverine type)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;antihyperlipidaemics&#39;,
  &#39;description2&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 2},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;antithrombotics&#39;,
  &#39;description2&#39;: &#39;antiviral receptors&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;proton pump inhibitors&#39;,
  &#39;description2&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;antiviral receptors&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;antithrombotics&#39;,
  &#39;description2&#39;: &#39;warfarin analogs&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;antithrombotics&#39;,
  &#39;description2&#39;: &#39;warfarin analogs&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;depsipeptide derivatives&#39;,
  &#39;description2&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;,
  &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;,
  &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;,
  &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;zonulin antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antithrombotics&#39;,
  &#39;description2&#39;: &#39;warfarin analogs&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 37},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 34},
 {&#39;description1&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;,
  &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;description2&#39;: &#39;antiviral receptors&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antianxiety agents (diazepam type)&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;transforming growth factors&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antiviral receptors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;-curonium&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;-sal-&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;description2&#39;: &#39;antiviral receptors&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trial_count&#39;: 35},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;zonulin antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 35},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trial_count&#39;: 43},
 {&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;warfarin analogs&#39;,
  &#39;description2&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;immunosuppressant&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;peptides&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;fluoroquinolone derivatives&#39;,
  &#39;description2&#39;: &#39;diuretics (furosemide type)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;description2&#39;: &#39;penicillins&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;thioether derivatives&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trial_count&#39;: 37},
 {&#39;description1&#39;: &#39;antineoplastics (mitotic inhibitors&#39;,
  &#39;description2&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;interleukin 3 deriviatives&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;zonulin antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;antidepressants (dibenzol[a&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;progesterone receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;antihypertensives (hydrazine-phthalazines)&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;(see -perone)&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trial_count&#39;: 43},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;,
  &#39;description2&#39;: &#39;estrogen antagonists&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 45},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 38},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;zonulin antagonists&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;fluoroquinolone derivatives&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;warfarin analogs&#39;,
  &#39;description2&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;diuretics (furosemide type)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;hormone-release inhibiting peptides&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;thyrotropin releasing hormone analogues&#39;,
  &#39;description2&#39;: &#39;antianxiety&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;dopamine receptor agonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;combined alpha and beta blockers&#39;,
  &#39;description2&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;catechol-O-methyltransferase (COMT) inhibitors&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 2},
 {&#39;description1&#39;: &#39;bronchodilators (phenethylamine derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;progestins&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 56},
 {&#39;description1&#39;: &#39;antiviral receptors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;progesterone receptor antagonists&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;phlorozin derivatives&#39;,
  &#39;description2&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;trial_count&#39;: 2},
 {&#39;description1&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;thyrotropin releasing hormone analogues&#39;,
  &#39;description2&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;-prost&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 52},
 {&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;description2&#39;: &#39;ecteinascidin derivatives&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;Monoamine oxidase (MAO) inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;zonulin antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;phlorozin derivatives&#39;,
  &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 37},
 {&#39;description1&#39;: &#39;leukotriene biosynthesis inhibitors&#39;,
  &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;class III antiarrhythmic agents&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;proton pump inhibitors&#39;,
  &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 50},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 54},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;thioether derivatives&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;beta-blockers (propranolol type)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;fluoroquinolone derivatives&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;description2&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;coronary vasodilators (verapamil type)&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;phlorozin derivatives&#39;,
  &#39;description2&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 47},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;-adol-&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 34},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;warfarin analogs&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 46},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;-grel&#39;,
  &#39;trial_count&#39;: 48},
 {&#39;description1&#39;: &#39;-grel&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;warfarin analogs&#39;,
  &#39;description2&#39;: &#39;antiestrogens of the clomifene and tamoxifen groups&#39;,
  &#39;trial_count&#39;: 20},
 {&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;description2&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;antithrombotics&#39;,
  &#39;description2&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;-grel&#39;,
  &#39;description2&#39;: &#39;heparin derivatives and low molecular weight (or depolymerized) heparins&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;peptides&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;-curonium&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;immunosuppressant&#39;,
  &#39;trial_count&#39;: 41},
 {&#39;description1&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antihypertensives (prazosin type)&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;estrogen antagonists&#39;,
  &#39;description2&#39;: &#39;farnesyl transferase inhibitor&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;peptides&#39;, &#39;description2&#39;: &#39;penicillins&#39;, &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;estrogen antagonists&#39;,
  &#39;description2&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;progestins&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;colony-stimulating factors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;thioether derivatives&#39;,
  &#39;description2&#39;: &#39;sodium channel blockers&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;adenosine A receptor agonists&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 38},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;oxytocin derivatives&#39;,
  &#39;description2&#39;: &#39;vancomycin-related compounds&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 59},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 41},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;penicillins&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 2},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 48},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 35},
 {&#39;description1&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;antibiotics (Micromonospora strains)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;oxytocin derivatives&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;antineoplastics (mitotic inhibitors&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;phlorozin derivatives&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;-fibrate&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;thalidomide derivatives&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 37},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;proteozome inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;leukotriene biosynthesis inhibitors&#39;,
  &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 35},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;antineoplastics (aromatase inhibitors)&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;estrogen antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;leptin derivatives&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 38},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trial_count&#39;: 41},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 43},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#34;acetylcholinesterase inhibitors used in the treatment of Alzheimer&#39;s disease&#34;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 38},
 {&#39;description1&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;description2&#39;: &#39;antimyloidotics&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 53},
 {&#39;description1&#39;: &#39;peptides&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;-curonium&#39;,
  &#39;description2&#39;: &#39;oxytocin derivatives&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 41},
 {&#39;description1&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;description2&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antiepileptics (hydantoin derivatives)&#39;,
  &#39;trial_count&#39;: 37},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 63},
 {&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;description2&#39;: &#34;acetylcholinesterase inhibitors used in the treatment of Alzheimer&#39;s disease&#34;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;fluoroquinolone derivatives&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;diuretics (furosemide type)&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;thioether derivatives&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;-adol-&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;phlorozin derivatives&#39;,
  &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 47},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 41},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;antiparasitics (salicylanilide derivatives)&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 34},
 {&#39;description1&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;synthetic glucagon analogs&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;-adol-&#39;,
  &#39;description2&#39;: &#39;warfarin analogs&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;(nifedipine type)&#39;,
  &#39;description2&#39;: &#39;peroxisome proliferator activiating receptor (PPAR) agonists (thiazolidene derivatives)&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;description2&#39;: &#39;antithrombotics&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;progestins&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;thioether derivatives&#39;,
  &#39;description2&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;sympathomimetics&#39;,
  &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 56},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;-adol-&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;peroxisome proliferator activiating receptor (PPAR) agonists (thiazolidene derivatives)&#39;,
  &#39;description2&#39;: &#39;-grel&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;sympathomimetics&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 55},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antiviral receptors&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;description2&#39;: &#39;thioether derivatives&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 38},
 {&#39;description1&#39;: &#39;peptides&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;description2&#39;: &#39;antihypertensives (prazosin type)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trial_count&#39;: 52},
 {&#39;description1&#39;: &#39;proton pump inhibitors&#39;,
  &#39;description2&#39;: &#39;immunosuppressant&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;zonulin antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;phlorozin derivatives&#39;,
  &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;fluoroquinolone derivatives&#39;,
  &#39;description2&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trial_count&#39;: 2},
 {&#39;description1&#39;: &#39;antiarrhythmic/antianginal/antihypertensive agents&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 65},
 {&#39;description1&#39;: &#39;hedgehog signaling inhibitors&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antibacterial  antibiotics&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 43},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;peptides&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;(nifedipine type)&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;description2&#39;: &#39;-grel&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;proteozome inhibitors&#39;,
  &#39;description2&#39;: &#39;peptides&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;thalidomide derivatives&#39;,
  &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;vasopressin receptor antagonists&#39;,
  &#39;trial_count&#39;: 38},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;thioether derivatives&#39;,
  &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 20},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;dendrimers&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 46},
 {&#39;description1&#39;: &#39;thrombopoetin agonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;antihypertensives (hydrazine-phthalazines)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 20},
 {&#39;description1&#39;: &#39;colony-stimulating factors&#39;,
  &#39;description2&#39;: &#39;immunosuppressant&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;-grel&#39;,
  &#39;description2&#39;: &#39;antithrombotics (thromboxane A2 receptor antagonists)&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory agents  (isoxicam type)&#39;,
  &#39;trial_count&#39;: 2},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;anticoagulants (hirudin type)&#39;,
  &#39;description2&#39;: &#39;catechol-O-methyltransferase (COMT) inhibitors&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 56},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trial_count&#39;: 35},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;diuretics (furosemide type)&#39;,
  &#39;description2&#39;: &#34;acetylcholinesterase inhibitors used in the treatment of Alzheimer&#39;s disease&#34;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;-curonium&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;,
  &#39;description2&#39;: &#39;fluoroquinolone derivatives&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;leukotriene biosynthesis inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;-fibrate&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;selective serotonin reuptake inhibitors (SSRI)&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;description2&#39;: &#39;antihistamines/local vasoconstrictors (antazoline type)&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;coronary vasodilators (verapamil type)&#39;,
  &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;hypnotics/tranquilizers (zopiclone type)&#39;,
  &#39;description2&#39;: &#39;rapidly accelerated fibrosarcoma (RAF) kinase inhibitors&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;peptides&#39;, &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;description2&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 50},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 34},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;proton pump inhibitors&#39;,
  &#39;description2&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;(see -perone)&#39;,
  &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;description2&#39;: &#39;selective serotonin reuptake inhibitors (SSRI)&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antibacterial  antibiotics&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;antiviral receptors&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;farnesyl transferase inhibitor&#39;,
  &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;-curonium&#39;,
  &#39;description2&#39;: &#39;zonulin antagonists&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 35},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;immunosuppressant&#39;,
  &#39;trial_count&#39;: 20},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;description2&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;description2&#39;: &#39;(see -perone)&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;-grel&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;colony-stimulating factors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;-curonium&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;isophosphoramide mustard derivatives&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;description2&#39;: &#39;peptides&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;thioether derivatives&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;proton pump inhibitors&#39;,
  &#39;description2&#39;: &#39;peptides&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;proteozome inhibitors&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;immunomodulators&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;vasopressin receptor antagonists&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;penicillins&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;peptides&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;-fibrate&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 37},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 41},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;anxiolytics (buspirone type)&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;thyrotropin releasing hormone analogues&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;description2&#39;: &#39;-adol-&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antimigraine agents (5-HT1 receptor agonists)&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;-mantadine&#39;,
  &#39;description2&#39;: &#39;antimigraine agents (5-HT1 receptor agonists)&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;description2&#39;: &#39;-grel&#39;,
  &#39;trial_count&#39;: 34},
 {&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;theophylline derivatives&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trial_count&#39;: 44},
 {&#39;description1&#39;: &#39;thioether derivatives&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;colony-stimulating factors&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;description2&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trial_count&#39;: 35},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;,
  &#39;trial_count&#39;: 43},
 {&#39;description1&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;,
  &#39;description2&#39;: &#39;antibiotics obtained from Streptomyces kanamyceticus (related to kanamycin)&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;peptides&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;warfarin analogs&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 35},
 {&#39;description1&#39;: &#39;antineoplastics (mitotic inhibitors&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;(see -perone)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;zonulin antagonists&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;hormone-release inhibiting peptides&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;colony-stimulating factors&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 43},
 {&#39;description1&#39;: &#39;thalidomide derivatives&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;-adol-&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;,
  &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;-grel&#39;,
  &#39;description2&#39;: &#39;antihypertensives (ACE inhibitors)&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;thioether derivatives&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;proton pump inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 55},
 {&#39;description1&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;-grel&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;beta-blockers (propranolol type)&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;description2&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory - pyrazole acetic acid derivatives&#39;,
  &#39;trial_count&#39;: 2},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;description2&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 52},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;antithrombotics&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;warfarin analogs&#39;,
  &#39;description2&#39;: &#39;peptides&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;antineoplastics (thiotepa derivatives)&#39;,
  &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 52},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;depsipeptide derivatives&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trial_count&#39;: 47},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 48},
 {&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;description2&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trial_count&#39;: 2},
 {&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 35},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trial_count&#39;: 42},
 {&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;description2&#39;: &#39;dopamine receptor agonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trial_count&#39;: 20},
 {&#39;description1&#39;: &#39;(nifedipine type)&#39;,
  &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 54},
 {&#39;description1&#39;: &#39;-grel&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 46},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;thalidomide derivatives&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;,
  &#39;description2&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;peptides&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 20},
 {&#39;description1&#39;: &#39;antidepressants (dibenzol[a&#39;,
  &#39;description2&#39;: &#39;-grel&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 46},
 {&#39;description1&#39;: &#39;phlorozin derivatives&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;description2&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;sympathomimetics&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;hedgehog signaling inhibitors&#39;,
  &#39;description2&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;hormone-release inhibiting peptides&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antiprotozoal substances (metronidazole type)&#39;,
  &#39;trial_count&#39;: 34},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;oxytocin derivatives&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;immunosuppressant&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;description2&#39;: &#39;estrogen antagonists&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;estrogen antagonists&#39;,
  &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 41},
 {&#39;description1&#39;: &#39;theophylline derivatives&#39;,
  &#39;description2&#39;: &#39;-prost&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;colony-stimulating factors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;warfarin analogs&#39;,
  &#39;description2&#39;: &#39;positive inotropic agents (pimobendan type)&#39;,
  &#39;trial_count&#39;: 20},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;immunosuppressant&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;description2&#39;: &#39;leukotriene biosynthesis inhibitors&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 52},
 {&#39;description1&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;,
  &#39;description2&#39;: &#39;antimyloidotics&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trial_count&#39;: 19},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 49},
 {&#39;description1&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;description2&#39;: &#39;farnesyl transferase inhibitor&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;enzymes - urokinase-type plasminogen activators&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;peroxisome proliferator activiating receptor (PPAR) agonists (thiazolidene derivatives)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;description2&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trial_count&#39;: 35},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;warfarin analogs&#39;,
  &#39;description2&#39;: &#39;β3 adrenoreceptor agonists&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 46},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trial_count&#39;: 38},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 20},
 {&#39;description1&#39;: &#39;thalidomide derivatives&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;H2-receptor antagonists (cimetidine type)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 34},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;warfarin analogs&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;vasopressin receptor antagonists&#39;,
  &#39;description2&#39;: &#39;peptides&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;proteozome inhibitors&#39;,
  &#39;description2&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;-curonium&#39;, &#39;description2&#39;: &#39;-curonium&#39;, &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;proton pump inhibitors&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;bronchodilators (phenethylamine derivatives)&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;interleukin-4 (IL-4) receptor antagonists&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antihyperlipidaemics&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;anti-inflammatory agents  (isoxicam type)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 16},
 {&#39;description1&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;description2&#39;: &#39;antithrombotics&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;description2&#39;: &#39;antimycobacterials (diaminodiphenylsulfone derivatives)&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 52},
 {&#39;description1&#39;: &#39;aromatase inhibitors (imidazole/triazole derivatives)&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;penicillins&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;description2&#39;: &#39;-curonium&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;dopamine receptor agonists&#39;,
  &#39;description2&#39;: &#39;sodium channel blockers&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;description2&#39;: &#39;zonulin antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;leukotriene biosynthesis inhibitors&#39;,
  &#39;description2&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastic antibiotics (daunorubicin type)&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 48},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;hormone-release inhibiting peptides&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antiviral receptors&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;antivirals&#39;, &#39;description2&#39;: &#39;-grel&#39;, &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;thalidomide derivatives&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;thioether derivatives&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;antipsychotics (dibenzothiazepine derivatives)&#39;,
  &#39;description2&#39;: &#39;(see -perone)&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;nicotinic acetylcholine receptor partial agonists/agonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;trial_count&#39;: 52},
 {&#39;description1&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 45},
 {&#39;description1&#39;: &#39;(nifedipine type)&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;systemic antifungals (miconazole type)&#39;,
  &#39;trial_count&#39;: 17},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;antibiotics (tetracycline derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 46},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;proton pump inhibitors&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 44},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;oxazolidinone antibacterials&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;proteozome inhibitors&#39;,
  &#39;description2&#39;: &#39;angiogenesis inhibitors&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;t-RNA synthetase inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;uracil type antineoplastics&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;description2&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;antibiotics obtained from Streptomyces kanamyceticus (related to kanamycin)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;cholinesterase inhibitors (physostigmine type)&#39;,
  &#39;description2&#39;: &#39;phosphatidylinositol 3-kinase (PI3K) inhibitors&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;description2&#39;: &#39;immunosuppressant&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;diuretics (furosemide type)&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antihistaminics (histamine-H1 receptor antagonists)&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;trial_count&#39;: 48},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;,
  &#39;trial_count&#39;: 31},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;tachykinin (neurokinin) receptor antagonists&#39;,
  &#39;trial_count&#39;: 30},
 {&#39;description1&#39;: &#39;poly-ADP-ribose polymerase inhibitors&#39;,
  &#39;description2&#39;: &#39;serine/threonine kinase inhibitors&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;phlorozin derivatives&#39;,
  &#39;description2&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;proteozome inhibitors&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;thalidomide derivatives&#39;,
  &#39;description2&#39;: &#39;hypnotics/sedatives (zolpidem type)&#39;,
  &#39;trial_count&#39;: 4},
 {&#39;description1&#39;: &#39;-grel&#39;, &#39;description2&#39;: &#39;antivirals&#39;, &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;-grel&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;-grel&#39;,
  &#39;description2&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 33},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;Tyrosine kinase inhibitors ERK1 and ERK2 inhibitors&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 3},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 24},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;zonulin antagonists&#39;,
  &#39;description2&#39;: &#39;peptides&#39;,
  &#39;trial_count&#39;: 20},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 26},
 {&#39;description1&#39;: &#39;phlorozin derivatives&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 21},
 {&#39;description1&#39;: &#39;thalidomide derivatives&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 40},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;vasoconstrictors (vasopressin derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;adenosine A receptor agonists&#39;,
  &#39;description2&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;trial_count&#39;: 6},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 34},
 {&#39;description1&#39;: &#39;antimetabolites (folic acid derivatives)&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 36},
 {&#39;description1&#39;: &#39;(nifedipine type)&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 29},
 {&#39;description1&#39;: &#39;steroids (not prednisolone derivatives)&#39;,
  &#39;description2&#39;: &#39;cyclin dependent kinase inhibitors (formerly -cidib)&#39;,
  &#39;trial_count&#39;: 25},
 {&#39;description1&#39;: &#39;phlorozin derivatives&#39;,
  &#39;description2&#39;: &#39;theophylline derivatives&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;trial_count&#39;: 23},
 {&#39;description1&#39;: &#39;narcotic analgesics (fentanyl derivatives)&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;antineoplastics (chloroethylamine derivatives)&#39;,
  &#39;description2&#39;: &#39;synthetic analogs of the dolastatin series&#39;,
  &#39;trial_count&#39;: 5},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 54},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antiviral receptors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;enzyme inhibitors&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 22},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 32},
 {&#39;description1&#39;: &#39;cardiotonics (amrinone type)&#39;,
  &#39;description2&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;trial_count&#39;: 13},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 55},
 {&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;description2&#39;: &#39;antiepileptics (hydantoin derivatives)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antithrombotics&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics (mitotic inhibitors&#39;,
  &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trial_count&#39;: 9},
 {&#39;description1&#39;: &#39;antivirals&#39;,
  &#39;description2&#39;: &#39;antivirals&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;peptides&#39;,
  &#39;description2&#39;: &#39;dipeptidyl aminopeptidase-IV inhibitors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;phlorozin derivatives&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;adenosine A receptor agonists&#39;,
  &#39;description2&#39;: &#39;receptor molecules or membrane ligands&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;antibacterials (quinolone derivatives)&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;antiviral receptors&#39;,
  &#39;description2&#39;: &#39;bronchodilators (phenethylamine derivatives)&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;progestins&#39;,
  &#39;description2&#39;: &#39;monoclonal antibodies&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;monoclonal antibodies&#39;,
  &#39;description2&#39;: &#39;antineoplastics&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;immunosuppressant&#39;,
  &#39;description2&#39;: &#39;tyrosine kinase inhibitors&#39;,
  &#39;trial_count&#39;: 18},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;thioether derivatives&#39;,
  &#39;trial_count&#39;: 39},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 12},
 {&#39;description1&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;description2&#39;: &#39;-curonium&#39;,
  &#39;trial_count&#39;: 14},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;thioether derivatives&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;description2&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;,
  &#39;trial_count&#39;: 10},
 {&#39;description1&#39;: &#39;xanthine oxidase/dehydrogenase inhibitors&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 8},
 {&#39;description1&#39;: &#39;(PDE5) inhibitors containing a sulfonamide moiety&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 11},
 {&#39;description1&#39;: &#39;anti-inflammatory/analgesic agents (ibuprofen type)&#39;,
  &#39;description2&#39;: &#39;cyclooxygenase-2 inhibitors&#39;,
  &#39;trial_count&#39;: 20},
 {&#39;description1&#39;: &#39;antineoplastics (platinum derivatives)&#39;,
  &#39;description2&#39;: &#39;antineoplastic thymidylate synthetase inhibitors&#39;,
  &#39;trial_count&#39;: 28},
 {&#39;description1&#39;: &#39;antineoplastics&#39;,
  &#39;description2&#39;: &#39;enzyme inhibitors&#39;,
  &#39;trial_count&#39;: 38},
 {&#39;description1&#39;: &#39;local anesthetics&#39;,
  &#39;description2&#39;: &#39;local anesthetics&#39;,
  &#39;trial_count&#39;: 56},
 {&#39;description1&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;description2&#39;: &#39;angiotensin II receptor antagonists&#39;,
  &#39;trial_count&#39;: 7},
 {&#39;description1&#39;: &#39;-adol-&#39;,
  &#39;description2&#39;: &#39;general inhalation anesthetics (halogenated alkane derivatives)&#39;,
  &#39;trial_count&#39;: 27},
 {&#39;description1&#39;: &#39;antibiotics (Streptomyces strain)&#39;,
  &#39;description2&#39;: &#39;non-steroid antiandrogens&#39;,
  &#39;trial_count&#39;: 15},
 {&#39;description1&#39;: &#39;nucleoside antiviral or antineoplastic agents&#39;,
  &#39;description2&#39;: &#39;antineoplastics (camptothecin derivatives)&#39;,
  &#39;trial_count&#39;: 16},
 ...]</pre>
</div>

</div>

</div>
</div>

</div>
<div class="cell border-box-sizing code_cell rendered">
<div class="input">
<div class="prompt input_prompt">In&nbsp;[&nbsp;]:</div>
<div class="inner_cell">
    <div class="input_area">
<div class=" highlight hl-ipython3"><pre><span></span> 
</pre></div>

    </div>
</div>
</div>

</div>
    </div>
  </div>
</body>

 


</html>
